{"Row Number": 353, "Calculator Name": "HAS-BLED Score for Major Bleeding Risk", "Calculator ID": "25", "Category": "risk", "Note ID": "10", "Patient Note": "A 72-year-old man finds himself back at the primary care clinic for his routine visit. His well-documented history of uncontrolled hypertension is a notable element in his case file. However, there is no suggestion of a previous stroke episode. He admits to patronizing alcohol, averaging 9 drinks per week. Also noteworthy in his medical history are his liver and renal conditions. On the one hand, he has had numerous hospital admissions over the years with repeated indications of hepatic impairment due to ALD. His renal function has also been a concern, as demonstrated by an elevated creatinine and reduced glomerular filtration rate. Contrarily, when it comes to bleeding risk, he has never been prescribed any medication known to accelerate bleeding. His coagulation profiles are quite stable, demonstrated by a consistently normal international normalized ratio (INR). These medical intricacies necessitate a comprehensive, focused approach to his healthcare management.", "Question": "What is the patient's HAS-BLED score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "4", "LLM Explanation": "To calculate the HAS-BLED score for the patient, we will evaluate each component of the HAS-BLED scoring system based on the provided information.\\n\\n1. **Hypertension (H):** The patient has uncontrolled hypertension. This gives 1 point.\\n2. **Abnormal Renal Function (A):** The patient has elevated creatinine and reduced GFR, indicating abnormal renal function. This gives 1 point.\\n3. **Abnormal Liver Function (S):** The patient has hepatic impairment due to ALD (alcoholic liver disease), which indicates abnormal liver function. This gives 1 point.\\n4. **Stroke (B):** There is no suggestion of a previous stroke episode. This gives 0 points.\\n5. **Bleeding history or predisposition:** The patient has no history of prescribed medications known to accelerate bleeding, and his coagulation profiles are normal (INR consistently normal). However, the presence of alcoholic liver disease (ALD) can be considered a predisposition to bleeding due to the risk of complications like variceal bleeding. Therefore, we will give this 1 point.\\n6. **Lab results (INR > 3.0 or on antiplatelet therapy /NSAIDs) (L):** The INR is consistently normal, and there is no mention of concurrent use of drugs like NSAIDs or antiplatelets. This gives 0 points.\\n7. **Ethanol (Excessive alcohol use) (E):** The patient consumes 9 drinks per week. This is within the moderate range and not considered excessive. Therefore, this gives 0 points.\\n8. **Drugs (antiplatelet or anticoagulant therapy):** The patient is not on any medications that accelerate bleeding. This gives 0 points.\\n\\nNow, let's sum up the points:\\n- Hypertension (H): 1 point\\n- Abnormal Renal Function (A): 1 point\\n- Abnormal Liver Function (S): 1 point\\n- Bleeding history or predisposition: 1 point\\n- Lab results (L): 0 points\\n- Ethanol (E): 0 points\\n- Drugs (D): 0 points\\n\\nTotal HAS-BLED score = 1 + 1 + 1 + 1 + 0 + 0 + 0 = 4 points.", "LLM Thinking": "Let's calculate the HAS-BLED score step-by-step based on the given patient note. First, I need to recall the components of the HAS -BLED scoring system for assessing the risk of bleeding. The HAS-BLED score includes the following factors, each contributing 1 point : 1. Hypertension (controlled or uncontrolled) 2. Ab normal Renal function 3. Abnormal Liver function 4. Stroke in the past 5. Bleeding history or predisposition 6. Labs (INR > 3.0 or on antiplatelet therapy /NSAIDs) 7. Drugs/alcohol (concurrent use of drugs that increase bleeding risk, such as antiplatelets or excessive alcohol intake ) Now let's evaluate each component for this patient based on the given information : **H** for **Hypertension**: The patient has an uncontrolled hypertension. **A** for **Abnormal Renal function**: The patient has elevated creatinine and reduced GFR. **S** for **Abnormal Liver function**: The patient has a history of hepatic impairment due to ALD (alcoholic liver disease), which indicates abnormal liver function. **B** for **Bleeding history or predisposition**: The note states that he has never been prescribed medications known to accelerate bleeding, and his coagulation profiles are normal (INR consistently normal). However, does his liver disease (ALD) contribute to bleeding risk? Alcoholic liver disease can lead to portal hypertension and varices, which could predispose to bleeding, but the question specifies that there's no mention of such a bleeding history in the note. Since the note doesn't explicitly mention any prior bleeding events, and assuming \"bleeding history or predisposition\" refers to prior events or known predispositions, this might not be directly addressed unless we consider ALD as a predisposing factor to bleeding in the context of advanced liver disease (like variceal bleeding). However, without explicit information on a prior bleed, this factor might be uncertain unless we interpret ALD's role. For simplicity and based on the given info, the note says \"no suggestion of a previous stroke episode\" and has no specific mention of a prior bleeding event. However, the \"bleeding predisposition\" might include liver disease-related bleeding risk. The question says \"no suggestion of previous stroke\", but for bleeding , the note says \"he has never been prescribed any medication known to accelerate bleeding\", but doesn't mention if he has a history of bleeding or other conditions predisposing to bleeding apart from liver disease. Let's assume this factor is not directly scored because of the lack of an explicit previous bleeding history in the note. **L** for **Lab results (INR >3.0 or on antiplatelet therapy /NSAIDs):** The INR is consistently normal, and there is no mention of concurrent use of drugs like NSAIDs or antiplatelets that increase the risk of bleeding. **E** for **Ethanol (Excessive alcohol use):** He admits to consuming 9 drinks per week. To determine if this qualifies as excessive: generally, the guideline for moderate alcohol consumption is up to 1 drink/day for women and up to 2 drinks/day for men. For a man, 9 drinks per week is within the moderate range (since 2 drinks/day * 7 days = 14, 9 is less). However, some sources might consider higher amounts as risky. Alternatively, in the context of HAS-BLED, the ethanol component refers to \"concurrent use of drugs that increase bleeding risk, including excessive alcohol intake.\" Given that the exact threshold for \"excessive intake\" in the HAS-BLED criteria isn't clearly defined, but typically, in many clinical guidelines, excessive drinking for men is more than 14 drinks per week. Since the patient has only 9 drinks per week, this may not qualify as \"excessive.\" Thus, alcohol intake here (9 drinks/week) does not categorically fit into the \"excessive\" category usually associated with significant risk. **D** for **Drugs (antiplatelet or anticoagulant therapy):** Wait, actually, the HAS-BLED's \"Drugs\" part includes both antiplatelet medications and anticoagulants that could be associated with bleeding risks, but the question says he's not on any medications that accelerate bleeding. However, the \"Drugs\" component in HAS-BLED might also include concurrent use of antiplatelet (e.g., aspirin) or NSAIDs that could increase the risk.", "Ground Truth Answer": "5", "Ground Truth Explanation": "The current HAS-BLED score is 0.\nThe patient is 72.0 years old. Because the patient's age is greater than 65 years, we increment the score by 1, making the current score 0 + 1 = 1.\nThe patient has 9 drinks a week. Because the patient has at least 8 alcoholic drinks a week, we increment the score by 1, making the current score 1 + 1 = 2.\nThe issue, hypertension, is reported to be present for the patient note and so we increase the score by 1, making the current score 2 + 1 = 3.\nThe issue, liver disease, is reported to be present for the patient note and so we increase the score by 1, making the current score 3 + 1 = 4.\nThe issue, renal disease, is reported to be present for the patient note and so we increase the score by 1, making the current score 4 + 1 = 5.\nThe issue, stroke history, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nThe issue, prior bleeding, is missing from the patient note and so we assume it to be absent and so we do not change the score, keeping the current score at 5.\nThe issue, labile inr, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nThe issue, medications for bleeding, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nHence, the patient's HAS-BLED score is 5.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Let's calculate the HAS-BLED score step-by-step based on the given patient note. \n\nFirst, I need to recall the components of the HAS -BLED scoring system for assessing the risk of bleeding.  \nThe HAS-BLED score includes the following factors, each contributing 1 point :\n\n1. Hypertension (controlled or uncontrolled)  \n2. Ab normal Renal function  \n3. Abnormal Liver function  \n4. Stroke in the past  \n5. Bleeding history or predisposition  \n6. Labs (INR > 3.0 or on antiplatelet therapy /NSAIDs)  \n7. Drugs/alcohol (concurrent use of drugs that increase bleeding risk, such as antiplatelets or excessive alcohol intake )\n\nNow let's evaluate each component for this patient based on the given information :\n\n**H** for **Hypertension**: The patient has an uncontrolled hypertension.  \n\n**A** for **Abnormal Renal function**: The patient has elevated creatinine and reduced GFR.  \n\n**S** for **Abnormal Liver function**: The patient has a history of hepatic impairment due to ALD (alcoholic liver disease), which indicates abnormal liver function.  \n\n**B** for **Bleeding history or predisposition**: The note states that he has never been prescribed medications known to accelerate bleeding, and his coagulation profiles are normal (INR consistently normal). However, does his liver disease (ALD) contribute to bleeding risk? Alcoholic liver disease can lead to portal hypertension and varices, which could predispose to bleeding, but the question specifies that there's no mention of such a bleeding history in the note.  \n\nSince the note doesn't explicitly mention any prior bleeding events, and assuming \"bleeding history or predisposition\" refers to prior events or known predispositions, this might not be directly addressed unless we consider ALD as a predisposing factor to bleeding in the context of advanced liver disease (like variceal bleeding). However, without explicit information on a prior bleed, this factor might be uncertain unless we interpret ALD's role.  \n\nFor simplicity and based on the given info, the note says \"no suggestion of a previous stroke episode\" and has no specific mention of a prior bleeding event. However, the \"bleeding predisposition\" might include liver disease-related bleeding risk. The question says \"no suggestion of previous stroke\", but for bleeding , the note says \"he has never been prescribed any medication known to accelerate bleeding\", but doesn't mention if he has a history of bleeding or other conditions predisposing to bleeding apart from liver disease. Let's assume this factor is not directly scored because of the lack of an explicit previous bleeding history in the note.  \n\n**L** for **Lab results (INR >3.0 or on antiplatelet therapy /NSAIDs):** The INR is consistently normal, and there is no mention of concurrent use of drugs like NSAIDs or antiplatelets that increase the risk of bleeding.  \n\n**E** for **Ethanol (Excessive alcohol use):** He admits to consuming 9 drinks per week. To determine if this qualifies as excessive: generally, the guideline for moderate alcohol consumption is up to 1 drink/day for women and up to 2 drinks/day for men. For a man, 9 drinks per week is within the moderate range (since 2 drinks/day * 7 days = 14, 9 is less). However, some sources might consider higher amounts as risky. Alternatively, in the context of HAS-BLED, the ethanol component refers to \"concurrent use of drugs that increase bleeding risk, including excessive alcohol intake.\" Given that the exact threshold for \"excessive intake\" in the HAS-BLED criteria isn't clearly defined, but typically, in many clinical guidelines, excessive drinking for men is more than 14 drinks per week. Since the patient has only 9 drinks per week, this may not qualify as \"excessive.\"  \n\nThus, alcohol intake here (9 drinks/week) does not categorically fit into the \"excessive\" category usually associated with significant risk.  \n\n**D** for **Drugs (antiplatelet or anticoagulant therapy):** Wait, actually, the HAS-BLED's \"Drugs\" part includes both antiplatelet medications and anticoagulants that could be associated with bleeding risks, but the question says he's not on any medications that accelerate bleeding.  \nHowever, the \"Drugs\" component in HAS-BLED might also include concurrent use of antiplatelet (e.g., aspirin) or NSAIDs that could increase the risk."}
{"Row Number": 561, "Calculator Name": "Framingham Risk Score for Hard Coronary Heart Disease", "Calculator ID": "46", "Category": "lab", "Note ID": "pmc-4429202-1", "Patient Note": "A 50-year-old male presented to the emergency department with a three-day history of progressive retrosternal chest pain. His medical history was significant only for acute diverticulitis one year prior to current presentation and a 3-pack year smoking history. He had no history of diabetes, hypertension, or dyslipidemia. He denied personal or family history of cardiovascular diseases, hypercoagulable states, or bleeding disorders. A review of systems was negative for headache, visual disturbances, pruritus, easy bruising, or erythromelalgia.\nOn presentation, the patient's blood pressure was 131/83 mm Hg and heart rate was 84 beats/minute. He was in moderate distress due to pain. Auscultation of the lungs revealed clear breath sounds. Cardiac exam was unremarkable. No hepatosplenomegaly was detected on palpation. There was no erythema or rash on skin exam.\nThe patient's initial CBC revealed a hemoglobin of 14.6 g/dL, hematocrit 43.9%, WBC count 13,100/mm3, and platelet count 1,026,000/mm3. During his previous emergency department visit for acute diverticulitis, his platelet count was 976,000/mm3. This was felt to be reactive due to acute inflammation, and he was discharged on a course of oral antibiotics. He had no subsequent outpatient follow-up.\nAn electrocardiogram showed a normal sinus rhythm with T wave inversions in leads III and aVF (). His initial troponin I was 0.15 ng/mL. A repeat level 6 hours later increased to 2.83 ng/mL, suggesting cardiac ischemia. His LDL was 107 mg/dL, HDL 43 mg/dL, and triglycerides 98 mg/dL. His electrolytes, BUN and creatinine, and liver enzymes were within normal limits.\nThe patient was transferred to the coronary care unit with a diagnosis of NSTEMI. A cardiac catheterization revealed a thrombus in the right coronary artery (RCA) with a 60% stenosis and a TIMI Grade II flow (). No percutaneous coronary intervention (PCI) was performed due to a perceived high risk of complications, specifically distal embolization, given the high platelet count. The patient was treated with aspirin 81 mg daily, prasugrel 10 mg daily, enoxaparin 1 mg/kg every 12 hours, and hydroxyurea 1,000 mg every 12 hours. Four days later, a repeat cardiac catheterization showed normal coronaries with dissolution of the previously found RCA thrombus and no underlying atherosclerotic plaques ().\nA peripheral blood smear was significant for marked thrombocytosis without an increase in immature myeloid elements. Molecular studies were negative for JAK2 mutations in V617F and exon 12 and positive for a CALR mutation type 1 (del52). Testing for BCR/ABL translocations was negative. Hence, a diagnosis of ET was made on the basis of the clinical presentation, consistently high platelet count, and presence of a clonal marker.\nThe patient was discharged home in stable condition on hydroxyurea and low-dose aspirin. His platelet count on discharge was 821,000/mm3. Two months later, his platelet count normalized to 320,000/mm3. He continued to do well with no further thrombotic or hemorrhagic complications. A bone marrow biopsy then was hypocellular and revealed no fibrosis, dysplastic changes, or increase in blasts. Fluorescence in situ hybridization panel for myelodysplastic syndrome was also negative.", "Question": "What is the patient's Framingham Risk Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "name 'N' is not defined", "LLM Explanation": "name 'N' is not defined", "LLM Thinking": "To calculate the Framingham Risk Score, we typically use several factors, which include age, sex, total cholesterol (TC), HDL cholesterol, systolic blood pressure (SBP), treatment for hypertension, smoking status, and whether the patient has diabetes. However, looking at the provided patient note, some necessary data points are missing, such as total cholesterol, systolic blood pressure, and information about treatment for hypertension, smoking status, diabetes, and SBP. Let's piece through the information we do have: 1. Age: 50 years old (male) 2. Total Cholesterol and HDL: The note provides LDL (107 mg/dL) and HDL (43 mg/dL), but Framingham requires total cholesterol. However, without triglycerides (which appears in the note as 98 mg/dL), we might try to estimate TC using the Friedewald equation: TC = LDL + HDL + (TG/5). But this is an approximation and may not be accurate. Let's see: (98/5)=19.6; so approx TC = 107 + 43 + 19.6= 169.6 mg/dL. 3. Systolic blood pressure: The note mentions blood pressure on presentation as 131/83, so SBP is 131 mm Hg. 4. Hypertension treatment: The patient has no history of hypertension, so probably not on treatment. 5. Smoking: He has a 3-pack year history, but current status isn't stated. The question is whether he is currently smoking. The note says \"3-pack year smoking history\"\u2014without specifying if he quit or not. However, without explicit information to the contrary, it's usually assumed that pack-year history refers to past smoking, but this is ambiguous. 6. Diabetes: The patient has no history of diabetes. 7. Existing CHD or stroke: The patient has NSTEMI, but Framingham is for 10-year risk of developing CHD, so if the patient already has CHD, they would be excluded. Since the patient has an NSTEMI (which is a form of CHD), the Framingham score isn't applicable because it's meant for asymptomatic individuals or risk stratification before the person develops the disease. They fall into the category of already having established cardiovascular disease.", "Ground Truth Answer": "0", "Ground Truth Explanation": "The patient's gender is Male.\nFor males, the formula for computing the framingham risk score is 52.00961 * ln(age) + 20.014077 * ln(total_cholestrol) + -0.905964 * ln(hdl_cholestrol) + 1.305784 * ln(sys_bp) + 0.241549 * bp_medicine + 12.096316 * smoker + -4.605038 * ln(age) * ln(total_cholestrol) + -2.84367 * ln(age_smoke) * smoker + -2.93323 * ln(age) * ln(age) -  172.300168, where 'bp_medicine' is a binary variable for whether a patient's blood pressure is being treated with medicine, total cholestrol and hdl cholestrol are in mg/dL, and 'smoker' is whether the patient is a smoker or not.\nFrom this, we use the risk score to get likelihood for a patient getting myocardial infraction (MI) or dying in the next 10 years: 1 - 0.9402^exp(risk_score), where risk_score is the value from the formula above.\nThe patient is 50 years old. The patient is a smoker, making the smoking variable equal to 1.\nThe patient's systolic blood pressure is 131.0 mm Hg.\nThe patient has been specified to not take medication for treating their blood pressure, making the bp_medicine variable equal to 0.\nThe concentration of total cholestrol is 107.0 mg/dL. We need to convert the concentration to mmol/L. Let's first convert the mass of total cholestrol from mg to mmol. The mass of total cholestrol is 107.0 mg. To convert 107.0 mg of total cholestrol to g, multiply by the conversion factor 0.001, giving us 107.0 mg total cholestrol * 0.001 g/mg = 0.107 g total cholestrol. To convert from grams of total cholestrol to moles, divide by the molar mass 386.65 g/mol, which will give 0.107 g/(386.65 g total cholestrol/mol) = 0.000277 mol total cholestrol. To convert 0.000277 mol of total cholestrol to mmol, multiply by the conversion factor 1000.0, giving us 0.000277 mol total cholestrol * 1000.0 mmol/mol = 0.277 mmol total cholestrol. The current volume unit is dL and the target volume unit is L. The conversion factor is 0.1 L for every unit of dL. Our next step will be to divide the mass by the volume conversion factor of 0.1 to get the final concentration in terms of mmol/L. This will result to 0.277 mmol total cholestrol/0.1 L = 2.77 mmol total cholestrol/L. The concentration value of 107.0 mg total cholestrol/dL converts to 2.77 mmol total cholestrol/L. \nThe concentration of hdl cholestrol is 43.0 mg/dL. We need to convert the concentration to mmol/L. Let's first convert the mass of hdl cholestrol from mg to mmol. The mass of hdl cholestrol is 43.0 mg. To convert 43.0 mg of hdl cholestrol to g, multiply by the conversion factor 0.001, giving us 43.0 mg hdl cholestrol * 0.001 g/mg = 0.043 g hdl cholestrol. To convert from grams of hdl cholestrol to moles, divide by the molar mass 386.65 g/mol, which will give 0.043 g/(386.65 g hdl cholestrol/mol) = 0.000111 mol hdl cholestrol. To convert 0.000111 mol of hdl cholestrol to mmol, multiply by the conversion factor 1000.0, giving us 0.000111 mol hdl cholestrol * 1000.0 mmol/mol = 0.111 mmol hdl cholestrol. The current volume unit is dL and the target volume unit is L. The conversion factor is 0.1 L for every unit of dL. Our next step will be to divide the mass by the volume conversion factor of 0.1 to get the final concentration in terms of mmol/L. This will result to 0.111 mmol hdl cholestrol/0.1 L = 1.11 mmol hdl cholestrol/L. The concentration value of 43.0 mg hdl cholestrol/dL converts to 1.11 mmol hdl cholestrol/L. \nPlugging in these values will give us the risk score:  52.00961 * ln(50) + 20.014077 * ln(2.77) + -0.905964 * ln(1.11) + 1.305784 * ln(131.0) + 0.241549 * 0  + 12.096316 * 1 + -4.605038 * ln(50) * ln(2.77) + -2.84367 * ln(50) * 1 + -2.93323 * ln(50) * ln(50) -  172.300168 = -4.4.\nPlugging this into the MI risk equation gives us 1 - 0.9402^exp(-4.4) = 0.0 %.\nThe patient's percentage of getting MI or dying is 0.0 %.", "Result": "Incorrect"}
{"Row Number": 875, "Calculator Name": "APACHE II Score", "Calculator ID": "28", "Category": "risk", "Note ID": "8", "Patient Note": "A 60-year-old male with a history of liver failure and immunocompromise presents to the emergency department with acute symptoms of lethargy and decreased appetite. Physical examination reveals tachycardia to 95 beats per minute, respiratory rate of 19 breaths per minute, blood pressure registering at 135/75 mm Hg and a baseline temperature of 37.2\u00b0C. Neurological assessment demonstrates mild confusion, corresponding to a Glasgow Coma Score of 14. Blood tests reveal elevated creatinine levels at 3.8 mg/dL. Metabolic panel showed sodium at 138 and potassium at 4.5 mEq/L. The white blood cell count was 12,000 per \u00b5L, triggering concern for a possible infection. Hematocrit was just within normal range at 43 %. The patient had an arterial blood gas pH of 7.32 and a A-a-gradient of 364, with a supplementary FiO\u2082 of 55 %. This patient's acute renal failure symptomatology, alongside the history of severe organ failure and immunocompromised, mandate rigorous monitoring and urgent medical intervention.", "Question": "What is the patient's APACHE II score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "13", "LLM Explanation": "To calculate the APACHE II score for the patient, I considered the following data points and their corresponding scores in the APACHE II scoring system: \\n\\n1. **Temperature**: 37.2\u00b0C falls within the range 36.1\u201338.0\u00b0C, which scores 0 points.\\n2. **Heart Rate**: 95 bpm falls within the range 70\u2013109 bpm, which scores 0 points.\\n3. **Mean Arterial Pressure (MAP)**: Calculated MAP is 95 mmHg, which falls within the range 70 \u2264 MAP \u2264 109, scoring 0 points.\\n4. **pH**: The pH is 7.32, which falls within the range 7.25\u20137.34, scoring 2 points.\\n5. **PaO2/FiO2**: Given the high A-a gradient (364) and FiO2 of 55%, I estimated the PaO2/FiO2 ratio to be low, leading to a score of 4 points.\\n6. **Creatinine**: The creatinine level is 3.8 mg/dL, which falls within the range 3.0\u20133.9 mg/dL, scoring 3 points.\\n7. **WBC**: The WBC count is 12,000/\u00b5L, which falls within the range 10,001\u201320,000, scoring 1 point.\\n8. **Glasgow Coma Scale (GCS)**: The GCS is 14, which scores 0 points.\\n\\nSumming up the acute physiology scores: 0 (Temperature) + 0 (Heart Rate) + 0 (MAP) + 2 (pH) + 4 (PaO2/FiO2) + 3 (Creatinine) + 1 (WBC) + 0 (GCS) = 10 points.\\n\\nNext, I added the age score and the chronic health score.\\n- **Age**: 60 years old corresponds to an age score of 2 points.\\n- **Chronic Health**: The presence of liver failure and immunocompromise indicates chronic health issues, adding 1 point.\\n\\nThus, the total APACHE II score is the sum of the acute physiology score (10 points), the age score (2 points), and the chronic health score (1 point): 10 + 2 + 1 = 13.", "LLM Thinking": "To calculate the APACHE II (Acute Physiology and Chronic Health Evaluation II ) score for the patient, I need to follow the APACHE II scoring system which considers acute physiological derangements in the first 24 hours , the Glasgow Coma Scale, age, and the presence of chronic health issues. The score helps predict mortality in critically ill patients. First, I'll list all the provided data points and map them to the appropriate APACHE II variables. 1. **Age**: 60 years old. 2. **Glasgow Coma Scale (GCS)**: 14. 3. **Acute Physiology (APACHE II) variables**: The variables include: - **Temperature** (37.2\u00b0C) - **Heart Rate** (95 bpm) - **Respiratory Rate** (19 bpm), but in APACHE II, respiratory rate is part of the PaCO2 (partial pressure of carbon dioxide) measurement, so I need to check the arterial blood gas (ABG) results for PaCO2. - **Mean Arterial Pressure** (MAP) calculated from BP 135/75 mmHg. - **PaO2** (from the ABG and A-a gradient, but maybe using FiO2 and PaO2? Wait, the A-a gradient is given as 364 with FiO2 of 55%. To convert this into PaO2 scoring.) - **pH**: 7.32. - **Creatinine**: 3.8 mg/dL. - **White blood cell count (WBC)**: 12,000/\u00b5L (12,000). - **Hematocrit (Hct)**: 43% (which is within the normal range). - **Sodium**: 138 mEq/L (normal). - **Potassium**: 4.5 mEq/L (normal). The APACHE II score requires each variable to be scored individually, then summed, plus the age category and the chronic health points. Let\u2019s approach this step by step. ### Step 1: Calculate Mean Arterial Pressure (MAP) The patient's blood pressure is 135/75 mm Hg. The formula for MAP is: MAP = [2 (Diastolic) + Systolic] / 3. The APACHE II scoring for MAP is as follows: - MAP < 70: 4 - 70 \u2264 MAP \u2264 109: 0 - MAP > 109: 2 ### Step 2: Score the PaO2 We have the A-a gradient and FiO2. The formula for APACHE II to calculate PaO2 score is based on the ratio of PaO2/FiO2. However, without the actual PaO2 value, this might be tricky. Alternatively, the A-a gradient may be used, but we need to convert it or take a guess. The APACHE II scoring for PaO2/FiO2 ratio is categorized as: - PaO2/FiO2 \u2264 200 \u2192 4 points - 200 < PaO2/FiO2 \u2264 300 \u2192 3 points - 300 < PaO2/FiO2 \u2264 400 \u2192 2 points - 400 < PaO2/FiO2 \u2264 500 \u2192 1 point - PaO2/FiO2 > 500 \u2192 0 points ### Step 3: pH and PaCO2 Scoring The APACHE II scoring for pH is: - pH < 7.10 \u2192 4 - 7.10\u20137.24 \u2192 3 - 7.25\u20137.34 \u2192 2 - 7.35\u20137.45 \u2192 0 - 7.46\u20137.55 \u2192 1 - 7.56\u20137.65 \u2192 3 - > 7.65 \u2192 4 The APACHE II scoring for PaCO2 is: - PaCO2 < 4.3 kPa \u2192 0 - 4.3\u20136.0 kPa \u2192 1 - 6.1\u20138.0 kPa \u2192 2 - 8.1\u20139.3 kPa \u2192 3 - > 9.3 kPa \u2192 4 ### Step 4: Creatinine Scoring The APACHE II creatinine scoring is: - < 1.5 mg/dL \u2192 0 - 1.5\u20131.9 \u2192 1 - 2.0\u20132.9 \u2192 2 - 3.0\u20133.9 \u2192 3 - 4.0\u20134.9 \u2192 4 - \u2265 5 \u2192 5 ### Step 5: WBC Scoring The APACHE II scoring for WBC is: - < 4,000/\u00b5L \u2192 3 - 4,000\u201310,000 \u2192 0 - 10,001\u201320,000 \u2192 1 - > 20,000 \u2192 3 ### Step 6: Body Temperature The APACHE II temperature scoring is: - < 35.0\u00b0C \u2192 3 - 35.0\u201336.0 \u2192 2 - 36.1\u201338.0 \u2192 0 - 38.1\u201339.0 \u2192 1 - > 39.0 \u2192 3 ### Step 7: Heart Rate The APACHE II heart rate scoring is: - < 50 bpm \u2192 3 - 50\u201369 \u2192 1 - 70\u2013109 \u2192 0 - 110\u2013129 \u2192 1 - 130\u2013149 \u2192 2 - \u2265 150 \u2192 3 ### Step 8: Glasgow Coma Scale (GCS) The APACHE II GCS scoring is: - GCS \u2264 8 \u2192 4 - 9\u201313 \u2192 3 - 14\u201315 \u2192 0 Other laboratory variables (Sodium, Potassium, Hematocrit) are scored as 0 when within normal limits. For **age**, APACHE II assigns additional points based on age category. For **chronic health**, the presence of any one of malignancy, AIDS, chronic renal failure, diabetes with complications, hepatic disease, immunosuppression, or metastatic solid tumor adds 1 point (maximum of 1).", "Ground Truth Answer": "36", "Ground Truth Explanation": "The patient's current APACHE II score is 0 points.\nThe patient is 60.0 years old. The patient is reported to have an organ failure of immunocompromise with a surgery type being classified as Nonoperative. Because the patient's age is between 55 and 64, 3 points are added to the total, making the current total, 0 + 3 = 3.\nThe patient's FiO2 percentage is 55.0 %. Because the patent's FiO2 percentrage is greater than 50%, we need to examine the A-a-gradient to compute the APACHE II score. The patient's A-a-gradient is 364. Because the patient's A-a gradient is between 350 and 500, we add 3 points to the total, making the current total 6.\nThe patient's temperature is 37.2 degrees fahrenheit. To convert to degrees celsius, apply the formula 5/9 * [temperature (degrees fahrenheit) - 32]. This means that the patient's temperature is 5/9 * 5.200000000000003 = 2.889 degrees celsius. \nBecause the patient's temperature is below 30 degrees Celsius, 4 points are added to the score, making the current total, 6 + 4 = 10.\nThe mean average pressure is computed by the formula 2/3 * (diastolic blood pressure) + 1/3 * (systolic blood pressure). Plugging in the values, we get 2/3 * 75.0 mm Hg + 1/3 * 135.0 mm Hg = 95.0 mm Hg.\nHence, the patient's mean arterial pressure is 95.0 mm Hg.\nBecause the patient's Mean Arterial Pressure is between 70 and 109 mmHg, 0 points are added to the patient's score, keeping the total at 10.\nBecause the patient's heart rate is between 70 and 109 beats per minute, 0 points are added to the patient's score, keeping the total at 10.\nBecause the patient's respiratory rate is between 12 and 24 breaths per minute, 0 points are added to the patient's score, keeping the total at 10.\nBecause the patient's sodium level is between 130 and 149 mmol/L, 0 points are added to the patient's score, keeping the total at 10. Because the patient's potassium level is between 3.5 and 5.4 mmol/L, 0 points are added to the patient's score, keeping the total at 10. Because the patient has acute renal failure and a creatinine level above 3.5, 8 points are added to the score, making the current total 10 + 8 = 18.\nBecause the patient's hemocratit is between 30% and 45%, 0 points are added to the patient's score, keeping the total at 18. Because the patient's white blood cell count is above 40 x10^9/L, 4 points are added to the score, making the current total 18 + 4 = 22.\nThe patient's Glasgow Coma Score is 14.0, and so we add 14.0 points to the total making the current total 14.0 + 22 = 36.0. Hence, the patient's APACHE II score is 36.0.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the APACHE II (Acute Physiology and Chronic Health Evaluation II ) score for the patient, I need to follow the APACHE II scoring system which considers acute physiological derangements in the first 24 hours , the Glasgow Coma Scale, age, and the presence of chronic health issues. The score helps predict mortality in critically ill patients. First, I'll list all the provided data points and map them to the appropriate APACHE II variables.  \n1. **Age**: 60 years old.  \n2. **Glasgow Coma Scale (GCS)**: 14.  \n3. **Acute Physiology (APACHE II) variables**: The variables include:  \n   - **Temperature** (37.2\u00b0C)  \n   - **Heart Rate** (95 bpm)  \n   - **Respiratory Rate** (19 bpm), but in APACHE II, respiratory rate is part of the PaCO2 (partial pressure of carbon dioxide) measurement, so I need to check the arterial blood gas (ABG) results for PaCO2.  \n   - **Mean Arterial Pressure** (MAP) calculated from BP 135/75 mmHg.  \n   - **PaO2** (from the ABG and A-a gradient, but maybe using FiO2 and PaO2? Wait, the A-a gradient is given as 364 with FiO2 of 55%. To convert this into PaO2 scoring.)  \n   - **pH**: 7.32.  \n   - **Creatinine**: 3.8 mg/dL.  \n   - **White blood cell count (WBC)**: 12,000/\u00b5L (12,000).  \n   - **Hematocrit (Hct)**: 43% (which is within the normal range).  \n   - **Sodium**: 138 mEq/L (normal).  \n   - **Potassium**: 4.5 mEq/L (normal).  \n\nThe APACHE II score requires each variable to be scored individually, then summed, plus the age category and the chronic health points. Let\u2019s approach this step by step.\n\n### Step 1: Calculate Mean Arterial Pressure (MAP)  \nThe patient's blood pressure is 135/75 mm Hg.  \nThe formula for MAP is: MAP = [2 (Diastolic) + Systolic] / 3.  \nThe APACHE II scoring for MAP is as follows:  \n- MAP < 70: 4  \n- 70 \u2264 MAP \u2264 109: 0  \n- MAP > 109: 2  \n\n### Step 2: Score the PaO2  \nWe have the A-a gradient and FiO2. The formula for APACHE II to calculate PaO2 score is based on the ratio of PaO2/FiO2. However, without the actual PaO2 value, this might be tricky. Alternatively, the A-a gradient may be used, but we need to convert it or take a guess.  \nThe APACHE II scoring for PaO2/FiO2 ratio is categorized as:  \n- PaO2/FiO2 \u2264 200 \u2192 4 points  \n- 200 < PaO2/FiO2 \u2264 300 \u2192 3 points  \n- 300 < PaO2/FiO2 \u2264 400 \u2192 2 points  \n- 400 < PaO2/FiO2 \u2264 500 \u2192 1 point  \n- PaO2/FiO2 > 500 \u2192 0 points  \n\n### Step 3: pH and PaCO2 Scoring  \nThe APACHE II scoring for pH is:  \n- pH < 7.10 \u2192 4  \n- 7.10\u20137.24 \u2192 3  \n- 7.25\u20137.34 \u2192 2  \n- 7.35\u20137.45 \u2192 0  \n- 7.46\u20137.55 \u2192 1  \n- 7.56\u20137.65 \u2192 3  \n- > 7.65 \u2192 4  \n\nThe APACHE II scoring for PaCO2 is:  \n- PaCO2 < 4.3 kPa \u2192 0  \n- 4.3\u20136.0 kPa \u2192 1  \n- 6.1\u20138.0 kPa \u2192 2  \n- 8.1\u20139.3 kPa \u2192 3  \n- > 9.3 kPa \u2192 4  \n\n### Step 4: Creatinine Scoring  \nThe APACHE II creatinine scoring is:  \n- < 1.5 mg/dL \u2192 0  \n- 1.5\u20131.9 \u2192 1  \n- 2.0\u20132.9 \u2192 2  \n- 3.0\u20133.9 \u2192 3  \n- 4.0\u20134.9 \u2192 4  \n- \u2265 5 \u2192 5  \n\n### Step 5: WBC Scoring  \nThe APACHE II scoring for WBC is:  \n- < 4,000/\u00b5L \u2192 3  \n- 4,000\u201310,000 \u2192 0  \n- 10,001\u201320,000 \u2192 1  \n- > 20,000 \u2192 3  \n\n### Step 6: Body Temperature  \nThe APACHE II temperature scoring is:  \n- < 35.0\u00b0C \u2192 3  \n- 35.0\u201336.0 \u2192 2  \n- 36.1\u201338.0 \u2192 0  \n- 38.1\u201339.0 \u2192 1  \n- > 39.0 \u2192 3  \n\n### Step 7: Heart Rate  \nThe APACHE II heart rate scoring is:  \n- < 50 bpm \u2192 3  \n- 50\u201369 \u2192 1  \n- 70\u2013109 \u2192 0  \n- 110\u2013129 \u2192 1  \n- 130\u2013149 \u2192 2  \n- \u2265 150 \u2192 3  \n\n### Step 8: Glasgow Coma Scale (GCS)  \nThe APACHE II GCS scoring is:  \n- GCS \u2264 8 \u2192 4  \n- 9\u201313 \u2192 3  \n- 14\u201315 \u2192 0  \n\nOther laboratory variables (Sodium, Potassium, Hematocrit) are scored as 0 when within normal limits.\n\nFor **age**, APACHE II assigns additional points based on age category.  \nFor **chronic health**, the presence of any one of malignancy, AIDS, chronic renal failure, diabetes with complications, hepatic disease, immunosuppression, or metastatic solid tumor adds 1 point (maximum of 1)."}
{"Row Number": 981, "Calculator Name": "Target weight", "Calculator ID": "61", "Category": "physical", "Note ID": "14", "Patient Note": "Patient has a height of 77 in and their target BMI is 19.7 kg/m^2.", "Question": "Based on the patient's height and target BMI, what is the patient's target weight in kg?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "75.35", "LLM Explanation": "To find the patient's target weight given their height and target BMI, follow these steps:\\n1. Convert the height from inches to meters.\\n - The height is 77 inches.\\n - Conversion factor: 1 inch = 0.0254 meters.\\n - Height in meters = 77 * 0.0254 = 1.9558 meters.\\n2. Use the formula for BMI to find the target weight.\\n - The formula for BMI is: BMI = Weight (kg) / (Height (m))^2.\\n - Rearrange the formula to solve for weight: Weight (kg) = BMI * (Height (m))^2.\\n - The target BMI is 19.7 kg/m^2.\\n - The height squared is (1.9558 m)^2.\\n - Calculate (1.9558)^2 \u2248 3.825.\\n3. Plug in the values into the rearranged formula:\\n - Weight (kg) = 19.7 * 3.825.\\n4. Perform the multiplication:\\n - 19.7 * 3.825 = 19.7 * (3.8 + 0.025).\\n - Distribute the multiplication:\\n - 19.7 * 3.8 = (19.7 * 3) + (19.7 * 0.8).\\n - 19.7 * 3 = 59.1.\\n - 19.7 * 0.8 = 15.76.\\n - Add these results: 59.1 + 15.76 = 74.86.\\n - Now calculate 19.7 * 0.025.\\n - 19.7 * 0.025 = 0.4925.\\n - Add the two results together: 74.86 + 0.4925 = 75.3525.\\nThus, the target weight is approximately 75.35 kg.", "LLM Thinking": "First, we need to convert the given patient's height from inches to meters since the BMI formula uses height in meters. The conversion factor between inches to meters is 1 inch = 0 .0254 meters. 1. Convert the height from inches to meters: \\[ \\text{ Height in meters} = 77 \\, \\text{inches } \\times 0.0254 \\, \\text{( meters per inch)} \\] Let's calculate this: \\[ \\text { Height in meters } = 77 * 0.02 54 = 1.9558 \\, \\text{ meters} \\] Next, use the BMI formula to find the target weight in kg. The formula for BMI is \\[ \\text{BMI} = \\frac{\\text{Weight (kg)}}{\\text{Height ( m)}^2} \\] We need to solve for weight, so rearrange the formula: \\[ \\text{Weight (kg)} = \\ text{BMI} \\times \\text{Height (m)}^2 \\] The patient\u2019s target BMI is 19.7 kg/m \u00b2, so plug in the values: \\[ \\text{Weight} = 19.7 \\, \\text{ kg/m}^2 * ( 1.9558 \\, \\text{ meters })^2 \\] First, compute the square of the height in meters : \\[ 1.9558^2 = 3. 8251 \\, (approximately) \\] Now plug this squared height into the formula to find the target weight: \\[ \\text{Weight (kg)} = 19.7 * 3.82 51 \\] Perform the multiplication: 19.7 * 3 .8251 \\[ 19.7 * 3 = 59.1 \\] \\[ 19.7 * 0.8 = (19.7 * 0. 8) = 15.76 \\] \\[ 19 .7 * 0.02 = 0.394 \\] Wait, perhaps it's better to compute this step by step: Let me calculate 19.7 * 3.82 51 more accurately. Using direct multiplication: \\[ 19.7 * 3. 8251 = 19.7 * 3.8 251 \\approx 19.7 * 3.8 25 \\] Let me compute 19.7 * 3 .825: First, 20 * 3.8 25 = 76.5. Then subtract 0.3 *3.825 (since 20-0.3 =19.7): 0.3 * 3.82 5 = 1.1475. Now subtract: 7 6.5 - 1.1475 = 75 .3525. Wait, that gives around 75. 35 kg. Alternatively, perhaps I should compute directly: Let me use distribution method: \\[ 19.7 * 3. 8 2 51 = 19.7 * (3 + 0 .8 +0.02 +0.0051) \\] Now distribute: \\[ (19.7 * 3 ) + ( 19 .7 * 0. 8) + ( 19.7 * 0.0 2) + ( 19.7 * 0.0 05 1) \\] Calculate these separately. 1. \\( 19 . 7 * 3 = 59.1 \\) 2. \\( 19.7 * 0.8 = 15 . 76 \\) 3. \\( 19.7 * 0 .02 = 0.394 \\) 4. \\( 19.7 * 0.00 5 1 \\) = To make it easier: \\(0.0051 * 20 =0.102, so subtract 0 .0051*(0.3) = 0.0 0153 from that (since 20-0.3 =19.7)\\) Approximate: \\[ 0.0 051 * 19.7 \u2248 0.0 051*(20 -0.3) = 0 .0 051 (20)-(0.0 0 51 *0.3) = 0.102 - 0.0015 3 \\approx 0. 102 -0.0 015 = 0 . 100 5 kg (approximately) \\] Now add up: \\[ 19.7 * 3. 8 2 51 = 59.1 + 15 . 76 + 0.394 + 0. 1 005 \\] Add 59.1 +15. 76 =74.86 Add 0.39 4 \u2192 74.86 +0.394= 75.254 Add 0.1005 \u2192 75.254 +0.1005 = approx 75.35 45 However, maybe the calculation can be done more accurately. Let's use a direct multiplication: 19.7*\\((77*0.0254)^2\\) Compute \\(77 * 0.02 54\\): 77 *0.0254: First, 7 7 *2.54 (because 0.0254 = 2.54*0.01) 77* 2.54 = 77*2 + 77 * 0.54 = 154 + 41.5 8 =195.58 Now, 195 .58 cm is the height (since 1 m = 1 00 cm, so 1.9558 m = 195. 58 cm) Now let's calculate \\(19.7 * (1.9558)^2\\) Compute \\((1.9558)^2\\) first: 1.9 558 * 1.9 558: Let me compute this: First, 2 * 2 = 4 Now (1.9 5 5 8) *2 = 3.9116 Let's do precise calculation: 1.9558 * 1.9 558: Let me write it as (2 -0.0442)*(2-0.0442) = (2)^2 - 2*(2)*(0.0442) + (0.0442)^2 4 - 0.1768 + 0.00195264 \u2248 3.82515264 Alternatively, 1.9558^2 \u2248 3.825 Thus, if I take 3.825 as the squared height, then 19.7 * 3.825: Let me compute 19.7 *3.83 (approximating for simplicity): 19.7 * 3 =59.1 19.7 *0.8 =15.76 19.7 *0.03=0.591 Add them all: 59.1 +15.76 +0.591 = 75.451 Let\u2019s take 3.825 instead of 3.83: 19.7 * 3.8 = 74.86 19.7 * 0.02 = 0.394 19.7 * 0.005 = 0.0985 Add: 74.86 + 0.394 + 0.0985 = 75.3525 To calculate the target weight based on the given height (77 inches) and target BMI (19.7 kg/m\u00b2), follow these steps: 1. Convert height from inches to meters: \\(77 \\text{ inches} \\times 0.0254 \\frac{\\text{m}}{\\text{inch}} = 1.9558 \\text{ meters}\\). 2. Calculate the squared height: \\((1.9558 \\text{ m})^2 \\approx 3.825 \\text{ m}^2\\). 3. Apply the BMI formula: \\(\\text{Target Weight} = \\text{BMI} \\times \\text{Height}^2 = 19.7 \\frac{\\text{kg}}{\\text{m}^2} \\times 3.825 \\text{ m}^2.\\) Now perform the multiplication:", "Ground Truth Answer": "75.371", "Ground Truth Explanation": "The patient's target bmi is 19.7 kg/m^2. The patient's height is 77 in, which is 77 in * 0.0254 m / in = 1.956 m. From this, the patient's target weight is 19.7 kg/m^2 * 1.956 m * 1.956 m = 75.371 kg. ", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to convert the given patient's height from inches to meters since the BMI formula uses height in meters.  \nThe conversion factor between inches to meters is 1 inch = 0 .0254 meters.  \n1. Convert the height from inches to meters:\n\n\\[ \\text{ Height in meters} = 77 \\, \\text{inches } \\times 0.0254 \\, \\text{( meters per inch)} \\]\n\nLet's calculate this:\n\n\\[ \\text { Height in meters } = 77 * 0.02 54 = 1.9558 \\, \\text{ meters} \\]\n\nNext, use the BMI formula to find the target weight in kg. The formula for BMI is \n\n\\[ \\text{BMI} = \\frac{\\text{Weight (kg)}}{\\text{Height ( m)}^2} \\]\n\nWe need to solve for weight, so rearrange the formula:\n\n\\[ \\text{Weight (kg)} = \\ text{BMI} \\times \\text{Height (m)}^2 \\]\n\nThe patient\u2019s target BMI is 19.7 kg/m \u00b2, so plug in the values:\n\n\\[ \\text{Weight} = 19.7 \\, \\text{ kg/m}^2 * ( 1.9558 \\, \\text{ meters })^2 \\]\n\nFirst, compute the square of the height in meters :\n\n\\[ 1.9558^2 = 3. 8251 \\, (approximately) \\]\n\nNow plug this squared height into the formula to find the target weight:\n\n\\[ \\text{Weight (kg)} = 19.7 * 3.82 51 \\]\n\nPerform the multiplication:\n\n19.7 * 3 .8251\n\n\\[ 19.7 * 3 = 59.1 \\]\n\n\\[ 19.7 * 0.8 =  (19.7 * 0. 8) = 15.76 \\]\n\n\\[ 19 .7 * 0.02 = 0.394 \\]\n\nWait, perhaps it's better to compute this step by step: Let me calculate 19.7 * 3.82 51 more accurately. Using direct multiplication:\n\n\\[ 19.7 * 3. 8251 = 19.7 * 3.8 251 \\approx 19.7 * 3.8 25 \\]\n\nLet me compute 19.7 * 3 .825:  \nFirst, 20 * 3.8 25 = 76.5. Then subtract 0.3 *3.825 (since 20-0.3 =19.7):  \n0.3 * 3.82 5 = 1.1475.  \nNow subtract: 7 6.5 - 1.1475 = 75 .3525.  \nWait, that gives around 75. 35 kg. Alternatively, perhaps I should compute directly:  \n\nLet me use distribution method:\n\n\\[ 19.7 * 3. 8 2 51 = 19.7 * (3 + 0 .8 +0.02 +0.0051) \\]\n\nNow distribute:\n\n\\[ (19.7 * 3 ) + ( 19 .7 * 0. 8) + ( 19.7 * 0.0 2) + ( 19.7 * 0.0 05 1) \\]\n\nCalculate these separately.\n\n1. \\( 19 . 7 * 3 = 59.1 \\)  \n2. \\( 19.7 * 0.8 =  15 . 76 \\)  \n3. \\( 19.7 * 0 .02 = 0.394 \\)  \n4. \\( 19.7 * 0.00 5 1 \\) =   \nTo make it easier: \\(0.0051 * 20 =0.102, so subtract 0 .0051*(0.3) = 0.0 0153 from that (since 20-0.3 =19.7)\\)  \nApproximate:  \n\\[ 0.0 051 * 19.7 \u2248 0.0 051*(20 -0.3) = 0 .0 051 (20)-(0.0 0 51 *0.3) = 0.102 - 0.0015 3 \\approx 0. 102 -0.0 015 = 0 . 100 5 kg (approximately) \\]\n\nNow add up:  \n\\[ 19.7 * 3. 8 2 51 = 59.1 + 15 . 76 + 0.394 + 0. 1 005 \\]  \nAdd 59.1 +15. 76 =74.86  \nAdd 0.39 4 \u2192 74.86 +0.394= 75.254  \nAdd 0.1005 \u2192 75.254 +0.1005 = approx 75.35 45  \n\nHowever, maybe the calculation can be done more accurately. Let's use a direct multiplication: 19.7*\\((77*0.0254)^2\\)\n\nCompute \\(77 * 0.02 54\\):\n\n77 *0.0254:  \nFirst, 7 7 *2.54 (because 0.0254 = 2.54*0.01)  \n77* 2.54 = 77*2 + 77 * 0.54 = 154 + 41.5 8 =195.58  \nNow, 195 .58 cm is the height (since 1 m = 1 00 cm, so 1.9558 m = 195. 58 cm)\n\nNow let's calculate \\(19.7 * (1.9558)^2\\)  \nCompute \\((1.9558)^2\\) first:\n\n1.9 558 *  1.9 558:  \nLet me compute this:  \nFirst, 2 * 2 = 4  \nNow (1.9 5 5 8) *2 = 3.9116  \nLet's do precise calculation:\n\n1.9558 * 1.9 558:  \nLet me write it as (2 -0.0442)*(2-0.0442) = (2)^2 - 2*(2)*(0.0442) + (0.0442)^2  \n4 - 0.1768 + 0.00195264 \u2248 3.82515264  \n\nAlternatively, 1.9558^2 \u2248 3.825  \n\nThus, if I take 3.825 as the squared height, then 19.7 * 3.825:\n\nLet me compute 19.7 *3.83 (approximating for simplicity):  \n19.7 * 3 =59.1  \n19.7 *0.8 =15.76  \n19.7 *0.03=0.591  \nAdd them all: 59.1 +15.76 +0.591 = 75.451  \n\nLet\u2019s take 3.825 instead of 3.83:  \n19.7 * 3.8 = 74.86  \n19.7 * 0.02 = 0.394  \n19.7 * 0.005 = 0.0985  \nAdd: 74.86 + 0.394 + 0.0985 = 75.3525  \n\nTo calculate the target weight based on the given height (77 inches) and target BMI (19.7 kg/m\u00b2), follow these steps:\n\n1. Convert height from inches to meters:  \n   \\(77 \\text{ inches} \\times 0.0254 \\frac{\\text{m}}{\\text{inch}} = 1.9558 \\text{ meters}\\).  \n2. Calculate the squared height:  \n   \\((1.9558 \\text{ m})^2 \\approx 3.825 \\text{ m}^2\\).  \n3. Apply the BMI formula:  \n   \\(\\text{Target Weight} = \\text{BMI} \\times \\text{Height}^2 = 19.7 \\frac{\\text{kg}}{\\text{m}^2} \\times 3.825 \\text{ m}^2.\\)  \n\nNow perform the multiplication:"}
{"Row Number": 32, "Calculator Name": "CKD-EPI Equations for Glomerular Filtration Rate", "Calculator ID": "3", "Category": "lab", "Note ID": "pmc-7983145-1", "Patient Note": "A 38-year-old female was admitted to the emergency ward with altered sensorium and anuria. She had off and on constitutional symptoms of disease such as general malaise, myalgia, polyarthralgia (mainly involved knee, elbow, and ankle joints), anorexia, weight loss, headache, and pyrexia from the last 4 years. She also had a history of recurrent blood-stained nasal discharge, epistaxis, nasal crusting, nasal ulceration, cough, breathlessness, stridor, and wheeze from the last 3 years. She had a history of pedal edema 3 months back. She also complained of diminution of vision with redness of eyes from 3 months. The patient had a history of ulcers on lips and tongue from the past 4 days and decreased frequency of urination from 3 days. There is no history of hematuria, hemoptysis, or cardiovascular manifestations. On examination, her vitals were deranged; she had tachycardia (120/bpm) and hypotension (100/60 mm of Hg). She also had pallor and bilateral pedal edema. There was high suspicion of GPA with acute renal failure or rapidly progressive glomerulonephritis associated with systemic small-vessel vasculitis. Keeping these two main diagnoses in mind, the investigations were ordered accordingly.\nIt is based on a combination of clinical manifestations of systemic disease, positive ANCA serology, and histological evidence of necrotizing vasculitis, necrotizing glomerulonephritis, or granulomatous inflammation of affected organs such as skin, lung, or kidney.\nA trucut biopsy was taken from the right kidney of the patient and detailed analysis was done. On light microscopy, there was focal segmental necrotizing glomerulonephritis involving more than 60% glomeruli associated with extracapillary proliferation with pauci-immune crescent formation. Electron microscopic examination showed fibrinoid deposition in the glomerular basement membrane. In biochemistry, serum sodium (159 mmol/L) and serum potassium levels (17 mmol/L) were deranged. In kidney panel, serum urea (155.8 mg/dL) and serum creatinine levels (8.9 mg/dL) were highly increased suggesting severe form of disease.\nOn performing ANCA serology, her serum showed a predominantly diffuse, granular cytoplasmic ANCA (c-ANCA) staining pattern on indirect immunofluorescence. By direct enzyme-linked immunosorbent assay, there were high titers of ANCA directed against proteinase-3 (PR-3). PR-3 (1:100 with 1+ intensity) was highly raised and confirmed the diagnosis of granulomatosis with polyangiitis associated with c-ANCA positivity.\nThe patient underwent two sessions of hemodialysis with a 2-day interval with packed red cell transfusion. Following that, serum urea and creatinine levels were controlled. Due to high levels of circulating c-ANCA autoantibodies, TPE was planned in addition to the standard therapy. GPA comes under category I, Grade 1A; American Society for Apheresis guidelines 2016.[] TPE sessions were started on the 4thday of admission. A total of seven cycles was performed with 1.3 total plasma volumes exchanged on every alternate day. Fresh frozen plasma (FFP) and normal saline were used as replacement fluids. During the third cycle of TPE after 5 units of FFP transfusion, the patient developed allergic reaction in the form of severe itching all over the body. To treat allergic reaction, oral pheniramine maleate 5 mg and injection hydrocortisone 100 mg intravenous (i.v.) were given, and after 20 min, procedure was restarted and completed successfully. Rest six cycles of TPE was done uneventfully. Simultaneously, standard induction therapy was also started that comprised of combination of cyclophosphamide (500 mg, i.v.) and methylprednisolone 1000 mg, i.v. daily for 3 days followed by oral prednisolone 60 mg daily for at least 4 weeks. Mesna 200 mg slow i.v. over 2 h was also given to prevent cyclophosphamide-induced hemorrhagic cystitis. Regular monitoring of full blood count, serum proteins, renal function, liver function, urine cytology, and clinical symptoms were done. After seven cycles of TPE, the patient was improved clinically as indicated by her renal function tests and ANCA serology and hence TPE was stopped. The patient's recovery was faster due to the timely intervention of TPE along with standard immunosuppression therapy. The total hospital stay of patient was 18 days which was lesser in comparison to the patient who were treated with standard therapy alone. After that, the patient was on maintenance therapy with azathioprine (2 mg/kg/body weight) at least for 12 months and advised for monthly follow-up.", "Question": "Using the 2021 CKD-EPI Creatinine equation, what is the patient's Glomerular Filtration Rate (GFR) in terms of mL/min/1.73 m\u00b2?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "5", "LLM Explanation": "Step 1: Use the provided serum creatinine value to calculate the GFR. The note states serum creatinine is 8.9 mg/dL.\\nStep 2: The CKD-EPI equation for females to estimate GFR is:\\n\\[ \\\\text{GFR (mL/min/1.73 m}^2\\\\text{)} = 144 \\\\times (\\\\min(\\\\text{SCr}/\\\\kappa,1))^{\\\\alpha} \\\\times \\\\max(\\\\text{SCr}/\\\\kappa,1)^{-1.209} \\\\times 0.993^{\\\\text{age}} \\\\times 1.018 \\\\]\\nWhere:\\n- SCr is the serum creatinine in mg/dL.\\n- For females: \u03ba = 0.7, \u03b1 = \u20130.329\\nStep 3: Plug in the values. SCr = 8.9 mg/dL. First, calculate SCr/\u03ba: 8.9 / 0.7 \u2248 12.7143. Since this is greater than 1, the min function will use 1 for the first term and max(SCr/\u03ba, 1) uses 12.7143.\\nStep 4: Compute \\\\(\\\\min(\\\\text{SCr}/0.7,1)=1\\\\), so first part is \\\\(1^{-0.329}=1\\\\). Compute \\\\(\\\\max(\\\\text{SCr}/0.7,1)^{-1.209}\\\\): \\\\(12.7143^{-1.209}.\\\\)\\nStep 5: Calculate \\\\(12.7143^{-1.209}\\\\). Let\u2019s approximate this value. Using a calculator,\\n\\[12.7143^{-1.209} \\\\approx e^{\\\\ln(12.7143)\\\\times(-1.209)}\\\\]\\nCompute \\\\(\\\\ln(12.7143)\\\\approx2.543\\\\). Multiply by \u20131.209: 2.543\u00d7(\u20131.209)\u2248\u20133.08. Exponentiate:\\n\\[e^{-3.08}\\\\approx0.0462.\\\\]\\nSo, \\\\(12.7143^{-1.209}\\\\approx0.0462.\\\\)\\nStep 6: Multiply all parts: \\\\(144\\\\times1\\\\times0.0462\\\\times0.993^{\\\\text{age}}\\\\times1.018\\\\). But we need the patient\u2019s age. The note says she is 38 years old.\\nLet\u2019s calculate \\\\(0.993^{38}.\\\\)\\nUsing the approximation: \\\\(\\\\ln(0.993)\\\\approx-0.007\\\\) then\\n\\\\[\\\\ln(0.993^{38})\\\\approx-0.007\\\\times38\\\\approx-0.266,\\\\]\\nand exponentiating,\\n\\\\[0.993^{38}\\\\approx e^{-0.266}\\\\approx0.767.\\\\]\\nStep 7: Plugging in all calculated values now, we get:\\n\\\\[GFR\\\\approx144\\\\times0.0462\\\\times0.767\\\\times1.018.\\\\]\\nWe will compute step by step:\\nFirst, \\\\(144\\\\times0.0462\\\\approx144\\\\times0.04=5.76;\\\\quad144\\\\times0.0062\\\\approx0.8928.\\\\) Total \u2248 5.76+0.8928\u22486.65.\\nNow do \\\\(6.65\\\\times0.767\\\\):\\n\\\\[6.65\\\\times0.767\\\\approx6.65\\\\times0.8-(6.65\\\\times0.033).\\\\]\\nCompute \\\\(6.65\\\\times0.8=5.32.\\\\)\\nCompute \\\\(6.65\\\\times0.033\\\\approx0.219.\\\\)\\nSo 5.32\u20130.219\u22485.101.\\nNow multiply by 1.018:\\n\\\\(5.101\\\\times1.018\\\\approx5.101+5.101\\\\times0.018\\\\approx5.101+0.0918\\\\approx5.1928.\\\\)\\nAfter performing the calculations step by step, the estimated GFR is approximately 5.19 mL/min/1.73 m\u00b2.\\nThus, the final answer is approximately 5 mL/min/1.73 m\u00b2.", "LLM Thinking": "Step 1: Use the provided serum creatinine value to calculate the GFR. The note states serum creatinine is 8.9 mg/dL. Step 2: The CKD-EPI equation for females to estimate GFR is: \\[ \\text{GFR (mL/min/1.73 m}^2\\text{)} = 144 \\times \\text{Serum Creatinine}^{-a} \\times e^{(\\text{age})} \\times 0.993^{(\\text{year} - 2009.5)} \\] However, for simplicity, the CKD-EPI Creatinine equation for females is: \\[ \\text{GFR} = 144 \\times (\\min(\\text{SCr}/\\kappa,1))^{\\alpha} \\times \\max(\\text{SCr}/\\kappa,1)^{-1.209} \\times 0.993^{\\text{age}} \\times 1.018 \\] Where: - SCr is the serum creatinine in mg/dL. - For females: \u03ba = 0.7, \u03b1 = \u20130.329 Step 3: Plug in the values. SCr = 8.9 mg/dL. First, calculate SCr/\u03ba: 8.9 / 0.7 \u2248 12.7143. Since this is greater than 1, the min function will use 1 for the first term and max(SCr/\u03ba, 1) uses 12.7143. Step 4: Compute \\(\\min(\\text{SCr}/0.7,1)=1\\), so first part is \\(1^{-0.329}=1\\). Compute \\(\\max(\\text{SCr}/0.7,1)^{-1.209}\\): \\(12.7143^{-1.209}.\\) Step 5: Calculate \\(12.7143^{-1.209}\\). Let\u2019s approximate this value. Using a calculator, \\[12.7143^{-1.209} \\approx e^{\\ln(12.7143)\\times(-1.209)}\\] Compute \\(\\ln(12.7143)\\approx2.543\\). Multiply by \u20131.209: 2.543\u00d7(\u20131.209)\u2248\u20133.08. Exponentiate: \\[e^{-3.08}\\approx0.0462.\\] So, \\(12.7143^{-1.209}\\approx0.0462.\\) Step 6: Multiply all parts: \\(144\\times1\\times0.0462\\times0.993^{\\text{age}}\\times1.018\\). But we need the patient\u2019s age. The note says she is 38 years old. Let\u2019s calculate \\(0.993^{38}.\\) Using the approximation: \\(\\ln(0.993)\\approx-0.007\\) then \\[\\ln(0.993^{38})\\approx-0.007\\times38\\approx-0.266,\\] and exponentiating, \\[0.993^{38}\\approx e^{-0.266}\\approx0.767.\\] Step 7: Plugging in all calculated values now, we get: \\[GFR\\approx144\\times0.0462\\times0.767\\times1.018.\\] We will compute step by step: First, \\(144\\times0.0462\\approx144\\times0.04=5.76;\\quad144\\times0.0062\\approx0.8928.\\) Total \u2248 5.76+0.8928\u22486.65. Now do \\(6.65\\times0.767\\): \\[6.65\\times0.767\\approx6.65\\times0.8-(6.65\\times0.033).\\] Compute \\(6.65\\times0.8=5.32.\\) Compute \\(6.65\\times0.033\\approx0.219.\\) So 5.32\u20130.219\u22485.101. Now multiply by 1.018: \\(5.101\\times1.018\\approx5.101+5.101\\times0.018\\approx5.101+0.0918\\approx5.1928.\\)", "Ground Truth Answer": "5.366", "Ground Truth Explanation": "The formula for computing GFR is 142 x (Scr/A)**B x 0.9938**age x (gender_coeffcient), where the ** indicates an exponent operation, Scr is the concentration of serum creatinine in mg/dL and gender_coefficient is 1.012 if the patient is female, else the coeffient is 1. The coefficients A and B are dependent on the patient's gender and the patient's creatinine concentration.\nThe patient is 38 years old. The patient's gender is Female, and so the patient's gender coefficient is 1.012.\nThe concentration of Serum Creatinine is 8.9 mg/dL. Because the patient's gender is female and the creatinine concentration is greater than or equal to 0.7 mg/dL, A = 0.7 and B = -1.2.\nPlugging in these values, we get 142 * (8.9/0.7)**-1.2 * 0.9938**38 * 1.012 = 5.366.\nHence, the GFR value is 5.366 ml/min/1.73 m\u00b2.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: Use the provided serum creatinine value to calculate the GFR. The note states serum creatinine is 8.9 mg/dL.\n\nStep 2: The CKD-EPI equation for females to estimate GFR is:\n\n\\[ \\text{GFR (mL/min/1.73 m}^2\\text{)} = 144 \\times \\text{Serum Creatinine}^{-a} \\times e^{(\\text{age})} \\times 0.993^{(\\text{year} - 2009.5)} \\]\n\nHowever, for simplicity, the CKD-EPI Creatinine equation for females is:\n\n\\[ \\text{GFR} = 144 \\times (\\min(\\text{SCr}/\\kappa,1))^{\\alpha} \\times \\max(\\text{SCr}/\\kappa,1)^{-1.209} \\times 0.993^{\\text{age}} \\times 1.018 \\]\n\nWhere:\n- SCr is the serum creatinine in mg/dL.\n- For females: \u03ba = 0.7, \u03b1 = \u20130.329\n\nStep 3: Plug in the values. SCr = 8.9 mg/dL. First, calculate SCr/\u03ba: 8.9 / 0.7 \u2248 12.7143. Since this is greater than 1, the min function will use 1 for the first term and max(SCr/\u03ba, 1) uses 12.7143.\n\nStep 4: Compute \\(\\min(\\text{SCr}/0.7,1)=1\\), so first part is \\(1^{-0.329}=1\\). Compute \\(\\max(\\text{SCr}/0.7,1)^{-1.209}\\): \\(12.7143^{-1.209}.\\)\n\nStep 5: Calculate \\(12.7143^{-1.209}\\). Let\u2019s approximate this value. Using a calculator,\n\n\\[12.7143^{-1.209} \\approx e^{\\ln(12.7143)\\times(-1.209)}\\]\n\nCompute \\(\\ln(12.7143)\\approx2.543\\). Multiply by \u20131.209: 2.543\u00d7(\u20131.209)\u2248\u20133.08. Exponentiate:\n\n\\[e^{-3.08}\\approx0.0462.\\]\n\nSo, \\(12.7143^{-1.209}\\approx0.0462.\\)\n\nStep 6: Multiply all parts: \\(144\\times1\\times0.0462\\times0.993^{\\text{age}}\\times1.018\\). But we need the patient\u2019s age. The note says she is 38 years old.\n\nLet\u2019s calculate \\(0.993^{38}.\\)\n\nUsing the approximation: \\(\\ln(0.993)\\approx-0.007\\) then\n\n\\[\\ln(0.993^{38})\\approx-0.007\\times38\\approx-0.266,\\]\n\nand exponentiating,\n\n\\[0.993^{38}\\approx e^{-0.266}\\approx0.767.\\]\n\nStep 7: Plugging in all calculated values now, we get:\n\n\\[GFR\\approx144\\times0.0462\\times0.767\\times1.018.\\]\n\nWe will compute step by step:\n\nFirst, \\(144\\times0.0462\\approx144\\times0.04=5.76;\\quad144\\times0.0062\\approx0.8928.\\) Total \u2248 5.76+0.8928\u22486.65.\n\nNow do \\(6.65\\times0.767\\):\n\n\\[6.65\\times0.767\\approx6.65\\times0.8-(6.65\\times0.033).\\]\n\nCompute \\(6.65\\times0.8=5.32.\\)\n\nCompute \\(6.65\\times0.033\\approx0.219.\\)\n\nSo 5.32\u20130.219\u22485.101.\n\nNow multiply by 1.018:\n\n\\(5.101\\times1.018\\approx5.101+5.101\\times0.018\\approx5.101+0.0918\\approx5.1928.\\)"}
{"Row Number": 449, "Calculator Name": "FeverPAIN Score for Strep Pharyngitis", "Calculator ID": "33", "Category": "diagnosis", "Note ID": "pmc-8610453-1", "Patient Note": "A 77-year-old male with a past medical history significant for hypertension, stroke, and prostate cancer presented to the emergency department for accidental ingestion with nausea and vomiting. Approximately 90 minutes prior to arrival, the patient had gone to the refrigerator for water and had mistaken a bottle of 35% hydrogen peroxide for water, subsequently ingesting approximately 150 milliliters (mL). The patient immediately felt a burning sensation in his mouth and throat, followed by nausea and vomiting. He reportedly vomited several times, mostly dry heaving, but at one point had a small amount of blood in the vomitus. He otherwise denied any other complaints.\nThe patient was in no acute distress upon arrival. His blood pressure was elevated at 157/84 millimeters of mercury, respiratory rate 20 breaths per minute, pulse 65 beats per minute, and arterial oxygen saturation was 98% on room air. Complete physical examination was negative for posterior oropharyngeal erythema, abdominal tenderness, rebound, or guarding. Laboratory results were significant for an elevated leukocyte count of 18.9 \u00d7 103 thousand per millimeters cubed (K/mm3) (reference range: 4.5\u201311.0 K/mm3), hemoglobin of 16.4 grams per deciliter (g/dL) (12.0\u201316.0 g/dL), creatinine of 1.7 milligrams (mg)/dL (0.5\u20131.4 mg/dL), and lipase of 844 U/L (73\u2013393 U/L). Initial imaging via computed tomography (CT) of the abdomen and pelvis with contrast revealed gastric pneumatosis extending into the distal esophagus with extensive portal venous air, diverticulosis, multiple left renal cysts, and a 5.8-centimeter (cm) adrenal myolipoma ().\nGiven the patient\u2019s presenting symptoms combined with the CT findings of gastric pneumatosis, the poison center and gastroenterology were consulted. The patient was admitted for observation with plans for an endoscopy; however, upon surgical consultation, he was emergently transferred to a tertiary care hospital due to concerns for a potential perforation and necrosis of the gastric body and distal esophagus, which may have necessitated a total gastrectomy as well as distal esophagectomy. The patient had been placed on a nothing-by-mouth restriction on admission and was hemodynamically stable on intravenous (IV) fluids, pantoprazole IV drip, and piperacillin-tazobactam at time of transfer.\nUpon arrival at the tertiary center, the patient reported overall improvement of his abdominal pain and sore mouth. Esophagogastroduodenoscopy performed there confirmed moderate to severe distal esophagitis and severe pangastritis but no evidence of necrosis, linear ulcerations along the lesser curvature, or mild bulbar duodenitis. Gastric biopsy later demonstrated fundic type gastric mucosa with acute inflammation and epithelial erosion. Following his endoscopy, the patient tolerated clear liquids and had his diet advanced to surgical soft. He remained pain-free and was deemed stable for discharge on the third day with recommendations for a repeat endoscopy in two to three months.", "Question": "What is the patient's FeverPAIN score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "4", "LLM Explanation": "To calculate the FeverPAIN score, we need to evaluate each component based on the patient's information from the note. Here's the breakdown: - **F (Fever):** The note does not mention a fever. Therefore, this component is 0. - **E (Elevated WBC):** The white blood cell count is 18.9 K/mm\u00b3, which is above the reference range of 4.5\u201311.0 K/mm\u00b3. Therefore, this component is 1. - **Ver (Vomiting):** The patient experienced vomiting and dry heaving, with some blood in the vomitus. Therefore, this component is 1. - **P (Peritoneal signs):** The physical examination did not reveal any signs of peritoneal irritation (no tenderness, rebound, or guarding). Therefore, this component is 0. - **A (Age > 50):** The patient is 77 years old, which is greater than 50. Therefore, this component is 1. - **I (Immunocompromise):** There is no explicit mention of the patient being immunocompromised. Therefore, this component is 0. - **N (No recent upper GI bleed):** The patient had some blood in the vomitus, but this appears to be related to the ingestion of hydrogen peroxide rather than a pre-existing upper GI bleed. Therefore, we can consider this component as 1, assuming the bleed is due to the current event and not a recent, pre-existing upper GI bleed. Now, sum up the scores for each component: 0 (F) + 1 (E) + 1 (Ver) + 0 (P) + 1 (A) + 0 (I) + 1 (N) = 4. Thus, the FeverPAIN score is 4.", "LLM Thinking": "Step 1: To calculate the FeverPAIN score, we need to consider the elements associated with it. The FeverPAIN score is often used in the context of abdominal pain. The acronym \"FeverPAIN\" stands for: - **F**: Fever - **E**: Elevated white blood cell count (Elevated WBC) - **Ver**: Vomiting - **P**: Peritoneal signs - **A**: Age > 50 - **I**: Immunocompromise - **N**: No (recent) upper GI bleed We need to analyze the given patient note to determine whether each component is present or not: 1. **F** for Fever: We need to check for fever. The note doesn't explicitly mention the patient having a fever. The temperature isn't recorded in the vital signs listed (BP, RR, Pulse, SpO2), so we assume there was no mention of fever. 2. **E** for Elevated WBC: The WBC is 18.9 K/mm\u00b3, which is above the reference range of 4.5\u201311.0. 3. **Ver** (Vomiting): The patient experienced vomiting, including several episodes with dry heaving and some blood. 4. **P** (Peritoneal signs): The physical exam notes that the abdomen was negative for tenderness, rebound, or guarding. Thus, peritoneal signs (indicative of peritonitis) are not present. 5. **A** (Age > 50): The patient is 77 years old. 6. **I** (Immunocompromise): The patient has a history of hypertension, stroke, and prostate cancer; however, there is no explicit indication of being immunocompromised or immune\u2010suppressed (no current immunosuppressive treatments mentioned). 7. **N** (No recent upper GI bleed): The patient did have vomiting with some blood (hematemesis), but this occurred within the context of recent ingestion of a toxin (hydrogen peroxide), which might not be considered a \"recent upper GI bleed\" in the traditional sense unless specified as such over an episode not related to the ingestion. However, the note mentions \"at one point had a small amount of blood in the vomitus.\" Since the vomiting is related to the ingestion, this may not be considered a pre-existing, ongoing upper GI bleed unrelated to the poison ingestion. However, the \"N\" component is about absence of recent upper GI bleed, so if the bleed is due to the current ingestion, it may not qualify as a recent bleed that would have occurred before the ingestion incident. However, this is a bit ambiguous. However, the standard criteria for FeverPAIN exclude patients with recent upper GI bleed (like within 2 weeks), but in this case, the bleed is directly due to the ingestion, so perhaps the \"N\" is still considered as \"No\" (i.e., the patient doesn't have a history of a recent GI bleed outside of this event). Now we tally up the score: - **F**: 0 (No fever) - **E**: 1 - **Ver**: 1 - **P**: 0 (no peritoneal signs) - **A**: 1 - **I**: 0 - **N**: 1 (assuming the GI bleed is part of the current event, so no previous)", "Ground Truth Answer": "1", "Ground Truth Explanation": "The patient's current FeverPain score is 0.\nWhether the patient has a fever in the past 24 hours is not reported and so we assume that it is absent for the patient. Because of this, we do not increment the score, keeping the current total at 0.\n'The patient is reported to have an absence of cough or coryza and so we increment the score by 1, making the current total 0 + 1 = 1.\nWhether the patient has a symptom onset \u22643 days is not reported and so we assume that it is absent for the patient. Because of this, we do not increment the score, keeping the current total at 1.\nThe patient is reported to not have purulent tonsils and so we do not increment the score, keeping the current total at 1.\nThe patient is reported to not have severe tonsil inflammation and so we do not increment the score, keeping the current total at 1.\nThe patient's FeverPain score is 1 points.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the FeverPAIN score, we need to consider the elements associated with it.  \nThe FeverPAIN score is often used in the context of abdominal pain.  \nThe acronym \"FeverPAIN\" stands for:\n\n- **F**: Fever  \n- **E**: Elevated white blood cell count (Elevated WBC)  \n- **Ver**: Vomiting  \n- **P**: Peritoneal signs  \n- **A**: Age > 50  \n- **I**: Immunocompromise  \n- **N**: No (recent) upper GI bleed  \n\nWe need to analyze the given patient note to determine whether each component is present or not:\n\n1. **F** for Fever: We need to check for fever. The note doesn't explicitly mention the patient having a fever. The temperature isn't recorded in the vital signs listed (BP, RR, Pulse, SpO2), so we assume there was no mention of fever.  \n2. **E** for Elevated WBC: The WBC is 18.9 K/mm\u00b3, which is above the reference range of 4.5\u201311.0.  \n3. **Ver** (Vomiting): The patient experienced vomiting, including several episodes with dry heaving and some blood.  \n4. **P** (Peritoneal signs): The physical exam notes that the abdomen was negative for tenderness, rebound, or guarding. Thus, peritoneal signs (indicative of peritonitis) are not present.  \n5. **A** (Age > 50): The patient is 77 years old.  \n6. **I** (Immunocompromise): The patient has a history of hypertension, stroke, and prostate cancer; however, there is no explicit indication of being immunocompromised or immune\u2010suppressed (no current immunosuppressive treatments mentioned).  \n7. **N** (No recent upper GI bleed): The patient did have vomiting with some blood (hematemesis), but this occurred within the context of recent ingestion of a toxin (hydrogen peroxide), which might not be considered a \"recent upper GI bleed\" in the traditional sense unless specified as such over an episode not related to the ingestion. However, the note mentions \"at one point had a small amount of blood in the vomitus.\" Since the vomiting is related to the ingestion, this may not be considered a pre-existing, ongoing upper GI bleed unrelated to the poison ingestion. However, the \"N\" component is about absence of recent upper GI bleed, so if the bleed is due to the current ingestion, it may not qualify as a recent bleed that would have occurred before the ingestion incident. However, this is a bit ambiguous. However, the standard criteria for FeverPAIN exclude patients with recent upper GI bleed (like within 2 weeks), but in this case, the bleed is directly due to the ingestion, so perhaps the \"N\" is still considered as \"No\" (i.e., the patient doesn't have a history of a recent GI bleed outside of this event).\n\nNow we tally up the score:  \n- **F**: 0 (No fever)  \n- **E**: 1  \n- **Ver**: 1  \n- **P**: 0 (no peritoneal signs)  \n- **A**: 1  \n- **I**: 0  \n- **N**: 1 (assuming the GI bleed is part of the current event, so no previous)"}
{"Row Number": 199, "Calculator Name": "QTc Bazett Calculator", "Calculator ID": "11", "Category": "physical", "Note ID": "20", "Patient Note": "Patient has a heart rate of 46 bpm and a QT interval of 330 msec.", "Question": "Using the Bazett Formula for corrected QT interval, what is the patient's corrected QT interval in msec?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "289", "LLM Explanation": "To calculate the corrected QT interval using the Bazett formula, we use the formula: \\[ \\text{QTcB} = \\frac{\\text{QT}}{\\sqrt{\\text{RR}}} \\] where QT is the measured QT interval (330 msec), and RR is the RR interval in seconds. The heart rate is 46 bpm. To find the RR interval in seconds, we use the formula: \\[ \\text{RR} = \\frac{60}{\\text{Heart Rate}} = \\frac{60}{46} \\approx 1.3043 \\text{ seconds}. \\] Next, we take the square root of the RR interval: \\[ \\sqrt{\\text{RR}} = \\sqrt{1.3043} \\approx 1.142. \\] Now, we plug the values into the Bazett formula: \\[ \\text{QTcB} = \\frac{330}{1.142} \\approx 289.39. \\] Rounding this to the nearest whole number gives us approximately 289 msec.", "LLM Thinking": "Okay, so I need to calculate the corrected QT interval using the Baz ett formula for this patient. The Bazett formula corrects the QT interval for heart rate and is given by the formula: \\[ \\text{QTc} = \\frac{\\ text{QT} \\text{ (in msec)}}{\\sqrt{\\text {RR interval}}} \\] where the RR interval is the time between two consecutive QRS complexes, which can be derived from the heart rate. Wait , right, the RR interval is the reciprocal of the heart rate in beats per minute when expressed in seconds (because 1 second = 10 00 msec). Let me think. The heart rate is given as 46 bpm. First, let\u2019s convert this heart rate into seconds (because the Bazett formula involves the square root of the RR interval, which is in seconds). So, the heart rate (HR) is 46 beats per minute. The RR interval in seconds (representing the time between successive heartbe ats) is calculated as 60 seconds divided by the heart rate. \\[ \\text{RR}_\\text{interval(seconds)} = \\ frac{60}{\\text{Heart rate (bpm)}} \\ ] Given the heart rate is 46 bpm, \\[ \\text {RR} = 60 / 46 \u2248 1 .3043 seconds \\] Then, the square root of this RR interval is \\[ \\sqrt{\\text{RR}} = \\sqrt {1.3043} \u2248 1.14 2 \\] Now, the QT interval given is 330 msec . According to Bazett's formula, the corrected QT interval (QTcB ) is: \\[ \\text{QTcB} = \\frac{ QT}{\\sqrt{RR}} \\] Plugging in the values: \\[ \\text{QTcB} = \\frac{33 0 \\text{ msec}}{1.14 2} \ufffd \\] Now let\u2019s do the math: \\[ \\text{QTc B} \u2248 \\frac{ 330}{1.1 42} \\] Let me calculate that. 330 divided by 1.142. Let me see, 1. 142 times 288 is about 329. 6.", "Ground Truth Answer": "288.985", "Ground Truth Explanation": "The corrected QT interval using the Bazett formula is computed as  QTc = QT interval / \u221a (RR interval), where the QT interval is in msec, and RR interval is given as 60/(heart rate).\nThe patient's heart rate is 46 beats per minute.\nThe QT interval is 330 msec.\nThe RR interval is computed as 60/(heart rate), and so the RR interval is 60/46 = 1.304.\nHence, plugging in these values, we will get 330/\u221a(1.304) = 288.985.\nThe patient's corrected QT interval (QTc) is 288.985 msec. ", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to calculate the corrected QT interval using the Baz ett formula for this patient. The Bazett formula corrects the QT interval for heart rate and is given by the formula:\n\n\\[ \\text{QTc} = \\frac{\\ text{QT} \\text{ (in msec)}}{\\sqrt{\\text {RR interval}}} \\]\n\nwhere the RR interval is the time between two consecutive QRS complexes, which can be derived from the heart rate. Wait , right, the RR interval is the reciprocal of the heart rate in beats per minute when expressed in seconds (because 1 second = 10 00 msec). Let me think. The heart rate is given as 46 bpm. First, let\u2019s convert this heart rate into seconds (because the Bazett formula involves the square root of the RR interval, which is in seconds). So, the heart rate (HR) is 46 beats per minute. The RR interval in seconds (representing the time between successive heartbe ats) is calculated as 60 seconds divided by the heart rate. \\[ \\text{RR}_\\text{interval(seconds)} = \\ frac{60}{\\text{Heart rate (bpm)}} \\ ] Given the heart rate is 46 bpm, \\[ \\text {RR} = 60 / 46 \u2248 1 .3043 seconds \\]\n\nThen, the square root of this RR interval is \n\n\\[ \\sqrt{\\text{RR}} = \\sqrt {1.3043} \u2248 1.14 2 \\]\n\nNow, the QT interval given is 330 msec . According to Bazett's formula, the corrected QT interval (QTcB ) is:\n\n\\[ \\text{QTcB} = \\frac{ QT}{\\sqrt{RR}} \\]\n\nPlugging in the values: \\[ \\text{QTcB} = \\frac{33 0 \\text{ msec}}{1.14 2} \ufffd \\]\n\nNow let\u2019s do the math:\n\n\\[ \\text{QTc B} \u2248 \\frac{ 330}{1.1 42} \\]\n\nLet me calculate that. 330 divided by 1.142. Let me see, 1. 142 times 288 is about 329. 6."}
{"Row Number": 425, "Calculator Name": "HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)", "Calculator ID": "31", "Category": "lab", "Note ID": "pmc-4864000-2", "Patient Note": "A 14 year old Hispanic female with a 3 year history of type 2 diabetes on once-daily DPP-4 inhibitor Sitagliptin presented for evaluation of morbid obesity with asthma, obstructive sleep apnea, reflux, and irregular menses. She was overweight since preschool age. Family history was notable for type 2 diabetes, obesity, hypertension, hyperlipidemia, and cholelithiasis.\nAt initial preoperative evaluation for bariatric surgery, weight was 129.3kg, height was 154.5cm, and BMI was 54.2kg/m2. Laboratory values were consistent with type 2 diabetes with HbA1c 10.7%, FG 210mg/dL, and 2 hour glucose 378mg/dL, and metabolic syndrome with TG 138mg/dL, HDL 39mg/dL, WC 142cm and elevated BP 120/83 (96th percentile diastolic). Despite Sitagliptin100mg daily, Lantus 28 units daily and Metformin XR 1000mg, HbA1c remained between 9.9% and 10.3% for 6 months. She refused further increase in Metformin dose given gastrointestinal complaints. Sitagliptin was stopped and Exenatide 2mg QW was initiated as adjuvant treatment to Lantus 28 units and Metformin 1000mg daily at weight 131.1kg, BMI 54.4kg/m2, HbA1c 10.2%, and FG 163mg/dl. Within two months of treatment, HbA1c improved to 7.9%. After 6 months, she had sustained glycemic control with HbA1c 8.3% and notable improvements in cardiometabolic parameters including FG (\u221217mg/dl), insulin (\u221226uIU/ml), and TG (\u221212mg/dl). Patient\u2019s weight was 131.5kg on day of gastric sleeve resection surgery with Exenatide QW discontinued following surgery due to normalization of blood glucose levels (HbA1c 5.8%) and weight 118.9kg noted at 2 months postoperatively.", "Question": "What is the patient's HOMA-IR score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "name 'N' is not defined", "LLM Explanation": "name 'N' is not defined", "LLM Thinking": "To calculate HOMA-IR (Homeostatic Model Assessment \u2013 Ins ulin Resistance), we need the fasting glucose (FG) and fasting insulin levels . The formula is HOMA-IR = (FG (mg/dL ) \u00d7 Insulin (\u00b5U/mL)) / 22.5 . Looking at the patient note, the fasting glucose (FG) is given at various points, but fasting insulin is not directly provided. The note mentions \"insulin (\u221226uIU/ml)\" after 6 months of treatment, but this seems to be a change from baseline , not the actual fasting insulin level. Without the actual fasting insulin value, we can\u2019t compute HOMA- IR. The question might be testing if I recognize that the necessary data is missing. Wait, let me check again. The text states \"insulin (\u221226uIU/ml)\" which appears to be the change in insulin level after 6 months of treatment. However, without the baseline insulin value, we can\u2019t determine the actual fasting insulin level needed for HOMA-IR. Since the note doesn\u2019t provide the fasting insulin value at any point, it 's impossible to calculate the HOMA-IR score with the given information . Alternatively, maybe I missed a part where insulin is mentioned? Let's approach this step by step. 1. Identify the needed parameters for HOMA-IR: Fasting Glucose (FG) and F asting Insulin (FINS). The formula is \\( \\text{HOMA-IR} = \\ frac{\\text{(FG } (mg/dL)\\times \\text{ FINS} (\\mu U/mL)\\ ) } { 22. 5 } \\). 2. Check the patient note for FG and FINS values. From the note: - We have several fasting glucose values: - FG at initial presentation: 210 mg/dl (at the time of bariatric surgery evaluation) - After stopping Sitagliptin and initiating Exenatide (over 2 months): FG 1 63 mg/dl - After 6 months of Exen atide: FG decreased by 17 mg/dl from the previous value (so 163-17=146 mg /dl ?) - At surgery day: FG not mentioned, but might have improved further as HbA1c is 5.8 %, which implies good FBG - However, we don't have any direct fasting insulin value in the note. The only insulin-related data we have is \"insulin (\u221226uIU/ml)\" after 6 months of treatment, implying a decrease of 26 units from some baseline , but the baseline isn't provided. Since the note doesn't state the actual fasting insulin level at any time point , the calculation can\u2019t be done.", "Ground Truth Answer": "13.481", "Ground Truth Explanation": "The formula for computing HOMA-IR score is (insulin (\u00b5IU/mL) * glucose mg/dL)/405.\nThe concentration of insulin is 26.0 \u00b5IU/mL.\nThe concentration of glucose is 210.0 mg/dL. \nPlugging into the formula will give us 26.0 * 210.0/405 = 13.481. Hence, the patient's HOMA-IR score is 13.481. ", "Result": "Incorrect"}
{"Row Number": 108, "Calculator Name": "Calcium Correction for Hypoalbuminemia", "Calculator ID": "7", "Category": "lab", "Note ID": "pmc-8342167-1", "Patient Note": "A 26-year-old African American female with a medical history of SLE, ESRD due to LN, remote history of Steven\u2013Johnson Syndrome due to sulfa allergy, and resistant hypertension presented to the emergency department with painful, peeling, blistering, rash and fever. She reported that the rash developed over a period of 3 months with an intermittent response to prednisone therapy. Three weeks prior to presentation, the rash became progressively worse. She developed fevers came on one week prior to presentation. The rash started on her arms and progressively spread. She admitted associated shortness of breath accompanied by a productive cough with green, bloody sputum, as well as nausea and vomiting. Patient reported compliance with her home dose of prednisone but may have not taken her mycophenolate mofetil regularly. She missed two sequential hemodialysis sessions due to pain with walking from the blistering rash on her soles of the feet.\nHer physical exam was significant for fever of 100.6\u00b0F and tachycardia with heart rate of 130 beats per minute. Skin exam was evident for brown plaques on the forehead and bilateral cheeks with sparing of the nasolabial folds, with erosions and hemorrhagic crust involving the philtrum, ears, forehead, nose, chin, and lips. There were dark brown plaques with few erosions and atrophic scars on bilateral forearms and lower legs with deep red to violaceous painful targetoid lesions on the palms and plantar surfaces (Figures and ). The skin over the trunk had pink eroded macules, and there were pink patches on the back within a background of dusky necrotic plaques. There were multiple full-thickness epidermal necroses with large areas of bleeding with the denuded skin on the arms and chest in the sun exposed distribution (). Oral mucosae were negative for any oral lesions.\nPatient was found to be pancytopenic with white blood cell count (WBC) 2.03 (Ref: 3.4\u201310.8 \u00d7 103/UL), absolute neutrophil count (ANC) of 1.25 (Ref: 1.4\u20137.0 \u00d7 103/UL), hemoglobin (Hb) 8.8 g/dL (Ref: 11.1\u201315.9 g/dL), hematocrit (Hct) 28.9% (Ref: 34\u201346%), platelet 69 (150\u2013450 \u00d7 103/UL), sodium 138 mmol/L, potassium 3.9 mmol/L, chloride 98 mmol/L, CO2 21 mmol/L, BUN 41 mg/dL (Ref: 6\u201320 mg/dL), Cr 5.49 mg/dL (Ref: 0.57\u20131.0 mg/dL), calcium 7.2 mg/dL (8.7\u201310.2 mg/dL), albumin 3.2 g/dL, phosphorous 5.0 mg/dL (Ref: 1.2\u20132.2 mg/dL), AST 286 IU/L (Ref 0\u201340 IU/L), ALT 31 IU/L (0\u201332 IU/L), total bilirubin 0.5 mg/dL, alkaline phosphatase 136 IU/L, CK 91 U/L, serum lactate was 0.80 mmol/L, and ferritin was 5885 ng/mL (Ref: 15\u201350 ng/mL). Electrocardiogram was consistent with sinus tachycardia. Chest X-ray did not show any lung infiltrates or effusions. Ultrasound of the abdomen did not show an acute abdominal process, and the liver demonstrated normal echogenicity, echotexture, and size; the spleen was not enlarged. Sputum gram stain and cultures were unremarkable. Blood cultures were negative for bacteria and yeast. Patient was anuric due to chronic dialysis. Evaluation of lupus activity showed double-stranded DNA (dsDNA) antibody 42 IU/mL (Ref: 0\u20139 IU/L). Complement 3 (C3) was 43 mg/dL (Ref: 90\u2013180 mg/dL) and complement 4 (C4) was 9 mg/dL (Ref: 10\u201340 mg/dL). Rheumatoid factor was negative. Sjogren's anti-SSA was >8.0 AI (Ref: 0\u20130.9 AI) and Sjogren's anti-SSB was <0.2 AI (Ref: 0\u20130.9 AI). HIV screen was negative, and viral hepatitis panels for hepatitis A, B, and C were negative. Skin biopsies showed focal interface changes, and periodic acid Schiff (PAS) stain was negative for fungal microorganisms. Gram stain highlighted surface cocci bacteria. VZV and herpes I/II immunostains were negative. The direct immunofluorescence revealed that finely granular deposition of C3, IgM, and fibrinogen is consistent with lupus.\nGiven her presentation of a fever, shortness of breath, and productive cough, there was a concern for postinfectious erythema multiforme. The nucleic acid amplification tests for multiple respiratory pathogens such as Mycoplasma, influenza A, influenza H1, influenza H3, influenza A virus H1 2009, influenza B, respiratory syncytial virus, parainfluenza virus type 1, 2, 3, 4, human metapneumovirus, rhinovirus/enterovirus, adenovirus, Chlamydia pneumoniae, and Mycoplasma pneumoniae were negative. Blood cultures did not grow any bacteria or fungal organisms. Skin wound cultures were also negative for any organisms except for skin flora. Historically, there were no preceding infections reported. Our presumptive primary diagnosis was acute on chronic cutaneous lupus with epidermal necrolysis due to noncompliance with medications; differentials included Rowell syndrome, bullous lupus, Steven\u2013Johnsons syndrome, and toxic epidermal necrolysis (TEN). Hemophagocytic lymphohistiocytosis/mast cell activation syndrome (HLH/MAS) was also a concern given pancytopenia, fevers, elevated transaminases, and elevated ferritin. However, after further evaluation by hematology, HLH/MAS was less likely given halving of ferritin after first dose of intravenous steroids, lack of hepatosplenomegaly, lack of elevation in bilirubin and triglycerides, patient did not have persistent fevers, and soluble IL-2 receptor was 2021 pg/mL (Ref: 175.3\u2013858.2 pg/mL), needed to be greater than 2400 pg/mL (greater than 2 standard deviations of reference range) to meet criteria, and clinical picture was also not as critical as usually seen. The clinical picture of atypical EM-like lesions, presence of chilblains, speckled ANA pattern, elevated anti-Ro/SSA, and absence of infectious or pharmacologic triggers in a patient with SLE confirmed our suspicion for Rowell syndrome.\nDue to the extensive skin surface area involvement, the patient was treated with vancomycin intravenously for primary and secondary skin infection. Gram-negative coverage was held due to severe allergy to penicillin and cephalosporin antibiotics. The pancytopenia was suspected due to an acute flare of systemic lupus erythematosus, and the patient was initially started on methylprednisolone 1.5 mg/kg intravenously daily. Given more than 60% of body surface area (BSA) involvement, the patient was transferred to the burn unit for extensive debridement and multifaceted wound care. Mycophenolate mofetil was held given the elevated transaminases. Pulse doses of intravenous methylprednisolone were escalated to 1000 mg intravenous daily for three days given the concern for acute cutaneous lupus erythematosus with epidermal necrosis and concomitant MAS. After normalization of transaminases, negative testing for latent tuberculosis and hepatitis B and C, and negative blood cultures, the patient was given rituximab 375 mg/m2 intravenously at day 0 and day 15 with excellent maintenance of remission of skin disease and cytopenias. This dose was chosen by the treating provider, given patient being dialysis dependent, thus more immunosuppressed state at baseline and recent elevation in transaminases.\nIt was reassuring that early suspicion for MAS appeared steroid-responsive to pulse intravenous methylprednisolone. The soluble IL-2 receptor alpha measurement was not elevated, and serum ferritin halved after the first dose of pulse steroids. Despite the improvements in serum and systemic symptoms, the skin manifestations were slow to respond. During 2-week and 12-week follow-up of the patient, there has been maintenance of clear skin without any active cutaneous lupus manifestations. Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) was 0 at 12-week follow-up.", "Question": "Using the Calcium Correction for Hypoalbuminemia formula, what is the patient's corrected calcium in mg/dL? Your may set your normal albumin concentration to be 4 g/dL.", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "7.84", "LLM Explanation": "Step 1: Identify the blood calcium level and the albumin level from the patient note. From the patient's lab results, we have the following values: - Calcium: 7.2 mg/dL - Albumin: 3.2 g/dL The normal albumin concentration is given as 4 g/dL for the correction formula. The formula to calculate the corrected calcium level in cases of hypoalbuminemia is: Corrected Calcium = Measured Calcium + 0.8 * (Normal Albumin - Patient's Albumin) Plugging in the values: Corrected Calcium = 7.2 + 0.8 * (4.0 - 3.2) Step 2: Perform the calculation inside the parenthesis first: 4.0 - 3.2 = 0.8 Step 3: Multiply 0.8 by 0.8: 0.8 * 0.8 = 0.64 Step 4: Add this result to the measured calcium: Corrected Calcium = 7.2 + 0.64 = 7.84 mg/dL So, the corrected calcium level is 7.84 mg/dL.", "LLM Thinking": "Step 1: Identify the blood calcium level and the albumin level from the patient note. From the patient's lab results, we have the following values: - Calcium: 7.2 mg/dL - Album in: 3.2 g/dL The normal albumin concentration is given as 4 g/dL for the correction formula. The formula to calculate the corrected calcium level in cases of hypoalbuminemia is: Corrected Calcium = Measured Calcium + 0.8 * (Normal Albumin - Patient's Albumin) Plugging in the values : Corrected Calcium = 7.2 + 0.8 * (4.0 - 3.2) Step 2: Perform the calculation inside the parenthesis first: 4.0 - 3.2 = 0.8 Step 3: Multiply 0.8 by 0.8: 0.8 * 0.8 = 0.64 Step 4: Add this result to the measured calcium:", "Ground Truth Answer": "7.84", "Ground Truth Explanation": "To compute the patient's correct calcium level in mg/dL, the formula is  (0.8 * (Normal Albumin (in g/dL) - Patient's Albumin (in g/dL))) + Serum Calcium (in mg/dL).\nThe patient's normal albumin level is 4.0 g/dL.\nThe concentration of Albmumin is 3.2 g/dL. \nThe concentration of Calcium is 7.2 mg/dL. \nPlugging these values into the formula, we get (0.8 * (4.0 g/dL - 3.2 g/dL)) + 7.2 mg/dL = 7.84 mg/dL.\nThe patient's corrected calcium concentration 7.84 mg/dL.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: Identify the blood calcium level and the albumin level from the patient note.\n\nFrom the patient's lab results, we have the following values:\n\n- Calcium: 7.2 mg/dL\n- Album in: 3.2 g/dL\n\nThe normal albumin concentration is given as 4 g/dL for the correction formula. The formula to calculate the corrected calcium level in cases of hypoalbuminemia is:\n\nCorrected Calcium = Measured Calcium + 0.8 * (Normal Albumin - Patient's Albumin)\n\nPlugging in the values :\n\nCorrected Calcium = 7.2 + 0.8 * (4.0 - 3.2)\n\nStep 2: Perform the calculation inside the parenthesis first:\n\n4.0 - 3.2 = 0.8\n\nStep 3: Multiply 0.8 by 0.8:\n\n0.8 * 0.8 = 0.64\n\nStep 4: Add this result to the measured calcium:"}
{"Row Number": 712, "Calculator Name": "Adjusted Body Weight", "Calculator ID": "62", "Category": "physical", "Note ID": "pmc-7509996-1", "Patient Note": "A 55-year-old man who suffered from hematochezia for 3 mo consulted our hospital in July 2016 (Figure ).\nThe pathological diagnosis following biopsy showed \u201cmoderately differentiated adenocarcinoma of the sigmoid colon\u201d (Figure ). Abdominal enhanced computed tomography (CT) showed mesenteric lymph node metastasis and multiple low-density lesions in the liver. The capecitabine plus oxaliplatin (XELOX) scheme was recommended for the neoadjuvant therapy regimen for three cycles. However, even with therapy, the evaluation was progressive disease (PD) given that lymph node and liver lesions continued to grow; thus, surgery was excluded.\nFrom February 2 to October 14, 2017, folinic acid, fluorouracil, and irinotecan (FOLFIRI) plus bevacizumab was implemented for 12 cycles, and the classification was stable disease (SD); bevacizumab plus S-1 was offered as the maintenance treatment. On March 30, 2018, CT indicted disease progression. Due to intestinal obstruction, the patient underwent laparoscopic intestinal adhesion lysis and transverse colostomy on May 30, 2018.\nThe patient had no medical history of past illness.\nThe patient neither smoke tobacco nor consume alcohol. There was no notable family medical history, such as cancer.\nThe height and weight of the patient were 160 cm and 56.8 kg, respectively. On July 15, 2018, the performance status (PS) was 1 for this patient, with a body temperature of 36.3 \u00b0C, pulse rate of 86 beats/min, and blood pressure of 152/96 mmHg.\nIn July 2016, immunohistochemistry (IHC) and polymerase chain reaction (PCR) were performed to guide therapy at diagnosis. Kirsten rat sarcoma 2 viral oncogene homolog (KRAS), neuroblastoma RAS Viral Oncogene Homolog (NRAS), and v-raf murine sarcoma viral oncogene homolog B1 (BRAF) were wild-type, and mismatch repair proteins were proficient. On May 29, 2018, a peripheral blood sample was assessed for circulating tumor DNA (ctDNA) using next-generation sequencing (NGS) with an array of 189 genes to determine whether ras-rat sarcoma viral oncogene homolog/v-raf-murine sarcoma viral oncogene homolog (RAS/RAF) status changed during the past 2 years and EGFR monoclonal antibody could be used as the third-line therapy. The test results showed that KRAS, NRAS, and BRAF were still wild-type. Interestingly, high-level amplification of HER2 (absolute copy number: 63.67) (Figure ) was identified at the same time, which was reported as the resistance mechanism of anti-EGFR therapy previously[-]. Also, adenomatous polyposis coli (APC) and tumor protein 53 (TP53) alterations were detected, with a mutant allele frequency (MAF) of 7.3% and 9.3%, respectively. IHC for HER2 showed a score of 3+ based on the tumor tissue biopsy obtained on July 22, 2016 (Figure ), while fluorescence in situ hybridization (FISH) showed high-level amplification of HER2 (Figure ); thus, the two tests confirmed the results of ctDNA.\nOn March 30, 2018, CT showed that most of the liver lesions were increased compared to January 17, 2018, while new, multiple lesions were detected in the lung. Thus, the classification was PD, and the patient failed to respond to two lines of therapy.", "Question": "Using the adjusted body weight formula, what is the patient's adjusted body weight in terms of kg?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "56.8", "LLM Explanation": "To calculate the adjusted body weight for the patient, we first need to determine the ideal body weight (IBW). We have the patient's height (160 cm) and weight (56.8 kg). Using the formula for IBW for males: IBW = 50 + 0.9 * (height in cm - 152), we get: \\nIBW = 50 + 0.9 * (160 - 152) = 50 + 0.9 * 8 = 50 + 7.2 = 57.2 kg.\\nSince the patient's actual weight is 56.8 kg, which is slightly below the calculated IBW of 57.2 kg, the patient is not overweight. Therefore, the adjusted body weight is the same as the actual body weight because the adjustment formula is typically used for overweight patients.\\n\\nTo further confirm, I used other formulas for IBW such as the Hamwi and Devine formulas.\\nUsing the Hamwi formula for men: 48 kg + 2.7 kg for each inch over 5 feet. The patient's height is approximately 5 feet 3 inches (since 160 cm is about 62.99 inches). The calculation is: 48 + 3 * 2.7 = 48 + 8.1 = 56.1 kg.\\nUsing the Devine formula for men: 50 + 2.3 kg for each inch over 5 feet. The calculation is: 50 + 3 * 2.3 = 50 + 6.9 = 56.9 kg.\\nWith these formulas, the IBW ranges from 56.1 kg to 56.9 kg. The patient's actual weight of 56.8 kg is very close to these IBW values.\\nSince the patient is not significantly overweight, the adjusted body weight is taken as the actual body weight, which is 56.8 kg.", "LLM Thinking": "First, we need to calculate the adjusted body weight for the patient. However, to do so, we need to know the patient's height and weight, as well as whether they are underweight, normal weight, or overweight. The adjusted body weight formula is usually used in the context of medications, and it varies based on the patient's actual weight relative to their ideal weight. However, a common formula used to adjust body weight, particularly for medication dos ing in obese patients, is: Adjusted Body Weight (ABW) = Ideal Body Weight (IBW) + 0.4 * ( Actual Body Weight - Ideal Body Weight). For males, the ideal body weight (IBW) can be calculated by the formula IBW = 50 + 0.9 * ( height in cm - 152). Let's go step by step. 1. Calculate the ideal body weight (IBW) using the formula for males: IBW = 5 0 + 0.9 * (height in cm - 15 2). The patient's height is 160 cm. \\[ IBW = 50 + 0.9 * ( 160 - 152 ) = 50 + 0.9 * 8 = 50 + 7.2 = 5 7.2 kg \\] 2. The patient's actual weight is 56.8 kg. Since the actual weight is less than the IBW (56.8 kg vs. 57.2 kg), the patient is not considered obese or overweight. Therefore, the adjusted body weight would be the same as the actual weight in this case because the ABW formula is typically applied when the actual weight exceeds IBW. Wait, but the question mentions \"adjusted body weight in terms of kg.\" The standard formula applies when someone is above IBW, so if the actual weight is below IBW, the adjusted weight is just taken as the actual weight. Since the actual weight here is just slightly below the calculated IBW (5 6.8 vs 57.2), the ABW would be taken as the actual weight, since there is no \"adjustment needed for underweight or normal.\" Wait, but I need to double-check the formulas and assumptions since we used a specific height-based formula for ideal body weight. Let's use another common height-based method to calculate IBW for men : the Hamwi formula, which is 48 kg + 2 .7 kg for each inch over 5 feet, and also the Dev ine formula, which is 50 + 2.3 kg per inch over 5 feet. Let me confirm the patient's height in inches for this. Since the patient's height is 160 cm, converting to feet and inches: 160 cm / 2. 54 = approx 62.99 inches, which is about 5 feet 3 inches (since 60 inches is 5 feet, hence 63 inches are 5 feet 3 inches). Using Hamwi for men: 48 kg + 2.7 kg per inch over 5 feet. So 3 inches over: 48 + 3*2.7 = 48 + 8.1 = 56.1 kg. Then actual weight is 56.8 kg. So in this case, actual weight is slightly above IBW by 0.7 kg, so maybe the patient is considered at IBW or just slightly over. Then ABW would be close to actual weight unless we use the adjustment for overweight patients. Alternatively, using Devine formula: 50 + 2. 3 kg per inch over 5 feet: 50 + 3 *2.3 = 50 + 6.9 = 56.9 kg. The actual weight is 56. 8, which is very close to that IBW. So in this case , the actual weight is just under or just over depending on the formula. Since the adjustments for overweight usually apply when weight is significantly above IBW , the adjusted body weight should still be considered approximately the actual weight for this purpose since the excess is minimal.", "Ground Truth Answer": "56.849", "Ground Truth Explanation": "The patient's gender is Male.\nThe patient's height is 160.0 cm, which is 160.0 cm * 0.393701 in/cm = 62.992 in. \nFor males, the ideal body weight (IBW) is calculated as follows:\nIBW = 50 kg + 2.3 kg * (height (in inches) - 60)\nPlugging in the values gives us 50 kg + 2.3 kg * (62.992 (in inches) - 60) = 56.882 kg.\nHence, the patient's IBW is 56.882 kg.The patient's weight is 56.8 kg. To compute the ABW value, apply the following formula: ABW = IBW + 0.4 * (weight (in kg) - IBW (in kg)). ABW = 56.882 kg + 0.4 * (56.8 kg  - 56.882 kg) = 56.849 kg. The patient's adjusted body weight is 56.849 kg.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the adjusted body weight for the patient.  \nHowever, to do so, we need to know the patient's height and weight, as well as whether they are underweight, normal weight, or overweight.  \nThe adjusted body weight formula is usually used in the context of medications, and it varies based on the patient's actual weight relative to their ideal weight.  \nHowever, a common formula used to adjust body weight, particularly for medication dos ing in obese patients, is: Adjusted Body Weight (ABW) = Ideal Body Weight (IBW) + 0.4 * ( Actual Body Weight - Ideal Body Weight).  \nFor males, the ideal body weight (IBW) can be calculated by the formula IBW = 50 + 0.9 * ( height in cm - 152).  \nLet's go step by step.\n\n1. Calculate the ideal body weight (IBW) using the formula for males: IBW = 5 0 + 0.9 * (height in cm - 15 2).  \nThe patient's height is 160 cm.\n\n\\[\nIBW = 50 + 0.9 * ( 160 - 152 ) = 50 + 0.9 * 8 = 50 + 7.2 = 5 7.2 kg\n\\]\n\n2. The patient's actual weight is 56.8 kg.  \nSince the actual weight is less than the IBW (56.8 kg vs. 57.2 kg), the patient is not considered obese or overweight.  \nTherefore, the adjusted body weight would be the same as the actual weight in this case because the ABW formula is typically applied when the actual weight exceeds IBW.  \n\nWait, but the question mentions \"adjusted body weight in terms of kg.\"  \nThe standard formula applies when someone is above IBW, so if the actual weight is below IBW, the adjusted weight is just taken as the actual weight.  \nSince the actual weight here is just slightly below the calculated IBW (5 6.8 vs 57.2), the ABW would be taken as the actual weight, since there is no \"adjustment needed for underweight or normal.\"  \n\nWait, but I need to double-check the formulas and assumptions since we used a specific height-based formula for ideal body weight.  \nLet's use another common height-based method to calculate IBW for men : the Hamwi formula, which is 48 kg + 2 .7 kg for each inch over 5 feet, and also the Dev ine formula, which is 50 + 2.3 kg per inch over 5 feet.  \nLet me confirm the patient's height in inches for this.  \n\nSince the patient's height is 160 cm, converting to feet and inches: 160 cm / 2. 54 = approx 62.99 inches, which is about 5 feet 3 inches (since 60 inches is 5 feet, hence 63 inches are 5 feet 3 inches).  \nUsing Hamwi for men: 48 kg + 2.7 kg per inch over 5 feet.  \nSo 3 inches over: 48 + 3*2.7 = 48 + 8.1 = 56.1 kg.  \nThen actual weight is 56.8 kg.  \nSo in this case, actual weight is slightly above IBW by 0.7 kg, so maybe the patient is considered at IBW or just slightly over.  \nThen ABW would be close to actual weight unless we use the adjustment for overweight patients.  \nAlternatively, using Devine formula: 50 + 2. 3 kg per inch over 5 feet: 50 + 3 *2.3 = 50 + 6.9 = 56.9 kg.  \nThe actual weight is 56. 8, which is very close to that IBW.  \nSo in this case , the actual weight is just under or just over depending on the formula.  \nSince the adjustments for overweight usually apply when weight is significantly above IBW , the adjusted body weight should still be considered approximately the actual weight for this purpose since the excess is minimal."}
{"Row Number": 1021, "Calculator Name": "Estimated of Conception", "Calculator ID": "68", "Category": "date", "Note ID": "14", "Patient Note": "The patient's last menstrual period was on 02/08/2024. Her cycle length is 25 days.", "Question": "Based on the patient's last menstrual period and cycle length, what is the the patient's estimated date of conception? Your answer should be in the format of M/D/Y (ie 08/31/2023, 07/03/2000) with just the date and not other text. ", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "02/19/2024", "LLM Explanation": "To find the estimated date of conception, we need to determine the ovulation date. The patient's cycle length is 25 days, and her last menstrual period (LMP) was on 02/08/2024. Ovulation typically occurs about 14 days before the next expected period. First, calculate the next expected period: 02/08/2024 + 25 days. February has 29 days in 2024 (leap year). Adding 25 days to 02/08/2024: 29 - 8 = 21 days remaining in February after February 8. So, 21 days from February 8 brings us to February 29. We have 25 - 21 = 4 more days to add, which takes us into March. Adding 4 more days to February 29 brings us to March 4. Therefore, the next expected period is March 4, 2024. Now, to find the ovulation date, we subtract 14 days from March 4, 2024. March 4 - 14 days: March 4 - 4 days = March 0 (which doesn't exist), so we go back to February. March 4 is the same as February 29 + 4 days. Subtracting 14 days from March 4: March 4 - 14 = February 19 (since March has 31 days, and 4 - 14 = -10, so we go back 10 days from the end of February. Since February has 29 days in 2024, 29 - 10 = 19. Thus, 14 days before March 4 is February 19. Therefore, the estimated date of conception is February 19, 2024.", "LLM Thinking": "Step 1: To find the estimated date of conception, we need to determine the approximate time in the menstrual cycle when conception is likely to have occurred. Conception typically occurs around the time of ovulation. Ovulation generally happens about 14 days before the start of the next menstrual period for a 28-day cycle, but since the patient has a cycle length of 25 days, ovulation will occur approximately 11 days after the LMP (since 25 \u2212 14 = 11, so ovulation is 11 days after the LMP for a 25-day cycle). Step 2: The patient's last menstrual period (LMP) was on 02/08/2024. To find the date of ovulation (and hence the estimated date of conception), we will add 11 days to the LMP date of 02/08/2024. Step 3: Let's add 11 days to 02/08/2024. If we start from February 8, 2024 and add 11 days: - 02/08/2024 - Day 1: 02/08 (since LMP is day 1 of the cycle) - Day 2: 02/09 - Day 3: 02/10 - Day 4: 02/11 - Day 5: 02/12 - Day 6: 02/13 - Day 7: 02/14 - Day 8: 02/15 - Day 9: 02/16 - Day 10: 02/17 - Day 11: 02/18 Wait, that's only 11 days from the LMP (including the LMP as day 1). Wait, perhaps my counting is off. Let me try again. To get the date 11 days after February 8, 2024: - 02/08 + 11 days = 02/19? Let\u2019s see: 8 + 11 = 19. This means 11 days after 02/08 would be 02/19. Wait, but if LMP is on 02/08, then day 1 is that date. So ovulation occurs on day 11 of the cycle, which would be 02/18 (since 8 + 10 days is 18, because day 1 is the 8th). So day 11 would be 02/18. Wait, let\u2019s clarify: Cycle day 1: LMP is 02/08. To find the 11th cycle day: Day 1: February 8. Add 10 more days: 10 days after February 8 is February 18 (because 2/8 + (11 \u2212 1) = 02/18; since day 0 is 02/07 and day 1 is 02/08). Wait, but I need to confirm the calculation one more time. The Last Menstrual Period (LMP) is 02/08/2024. The cycle length is 25 days. Ovulation occurs approximately 14 days prior to the next expected period. So the next menstrual period would be LMP + cycle length. The next expected LMP (which is the period date after this cycle) = 02/08 + 25 days. Calculating the next period date: 02/08/2024 + 25 days. Let\u2019s break that down: February has 29 days in 2024 (because 2024 is a leap year). So let\u2019s add 25 days to February 8, 2024. - From February 8 to February 29: February 8 + (29 \u2212 8 = 21 days) brings us to February 29. - So 21 days from 02/08 is 02/29. Then we have 25 \u2212 21 = 4 more days to add, so 29 + 4 = March 4. Wait, so 25 days after February 8 is March 4. Therefore, the next period is expected to start on March 4, 2024. Ovulation occurs 14 days before that, which is March 4 minus 14 days. Calculating 14 days before March 4, 2024 by subtracting step-wise: - March 4 - March 3 - March 2 - March 1 (3 days subtracted so far) - February 29 (4 days) - February 28 (5) - February 27 (6) - February 26 (7) - February 25 (8) - February 24 (9) - February 23 (10) - February 22 (11) - February 21 (12) - February 20 (13) - February 19 (14)", "Ground Truth Answer": "02/22/2024", "Ground Truth Explanation": "The patient's estimated date of conception based on their last period is computed by adding to 2 weeks to the patient's last menstrual period date. The patient's last menstrual period was 02/08/2024. \nThe estimated date of conception after adding 2 weeks to the patient's last menstrual period date is 02-22-2024. ", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To find the estimated date of conception, we need to determine the approximate time in the menstrual cycle when conception is likely to have occurred.  \nConception typically occurs around the time of ovulation.  \nOvulation generally happens about 14 days before the start of the next menstrual period for a 28-day cycle, but since the patient has a cycle length of 25 days, ovulation will occur approximately 11 days after the LMP (since 25 \u2212 14 = 11, so ovulation is 11 days after the LMP for a 25-day cycle).  \n\nStep 2: The patient's last menstrual period (LMP) was on 02/08/2024.  \nTo find the date of ovulation (and hence the estimated date of conception), we will add 11 days to the LMP date of 02/08/2024.  \n\nStep 3: Let's add 11 days to 02/08/2024.  \n\nIf we start from February 8, 2024 and add 11 days:  \n- 02/08/2024  \n- Day 1: 02/08 (since LMP is day 1 of the cycle)  \n- Day 2: 02/09  \n- Day 3: 02/10  \n- Day 4: 02/11  \n- Day 5: 02/12  \n- Day 6: 02/13  \n- Day 7: 02/14  \n- Day 8: 02/15  \n- Day 9: 02/16  \n- Day 10: 02/17  \n- Day 11: 02/18  \n\nWait, that's only 11 days from the LMP (including the LMP as day 1). Wait, perhaps my counting is off. Let me try again. To get the date 11 days after February 8, 2024:  \n- 02/08 + 11 days = 02/19? Let\u2019s see: 8 + 11 = 19. This means 11 days after 02/08 would be 02/19.  \n\nWait, but if LMP is on 02/08, then day 1 is that date. So ovulation occurs on day 11 of the cycle, which would be 02/18 (since 8 + 10 days is 18, because day 1 is the 8th). So day 11 would be 02/18. Wait, let\u2019s clarify:  \nCycle day 1: LMP is 02/08.  \nTo find the 11th cycle day: Day 1: February 8. Add 10 more days: 10 days after February 8 is February 18 (because 2/8 + (11 \u2212 1) = 02/18; since day 0 is 02/07 and day 1 is 02/08).  \n\nWait, but I need to confirm the calculation one more time.  \n\nThe Last Menstrual Period (LMP) is 02/08/2024. The cycle length is 25 days. Ovulation occurs approximately 14 days prior to the next expected period. So the next menstrual period would be LMP + cycle length. The next expected LMP (which is the period date after this cycle) = 02/08 + 25 days. Calculating the next period date: 02/08/2024 + 25 days.  \n\nLet\u2019s break that down:  \nFebruary has 29 days in 2024 (because 2024 is a leap year). So let\u2019s add 25 days to February 8, 2024.  \n- From February 8 to February 29: February 8 + (29 \u2212 8 = 21 days) brings us to February 29.  \n- So 21 days from 02/08 is 02/29. Then we have 25 \u2212 21 = 4 more days to add, so 29 + 4 = March 4. Wait, so 25 days after February 8 is March 4. Therefore, the next period is expected to start on March 4, 2024. Ovulation occurs 14 days before that, which is March 4 minus 14 days.  \n\nCalculating 14 days before March 4, 2024 by subtracting step-wise:  \n- March 4  \n- March 3  \n- March 2  \n- March 1 (3 days subtracted so far)  \n- February 29 (4 days)  \n- February 28 (5)  \n- February 27 (6)  \n- February 26 (7)  \n- February 25 (8)  \n- February 24 (9)  \n- February 23 (10)  \n- February 22 (11)  \n- February 21 (12)  \n- February 20 (13)  \n- February 19 (14)"}
{"Row Number": 993, "Calculator Name": "Morphine Milligram Equivalents (MME) Calculator", "Calculator ID": "49", "Category": "dosage", "Note ID": "6", "Patient Note": "The patient takes 60 mg of OxyCODONE 1 time a day, 70 mg of HYDROmorphone 2 times a day, and 10 mg of Codeine 2 times a day.", "Question": "Based on the number of doses per day and the quantity of different doses, what is the patient's daily Morphine Miligram Equivalents (MME)?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "622", "LLM Explanation": "To calculate the Morphine Milligram Equivalent (MME) for the given patient's medications, we need to convert each of the opioids mentioned into their MME equivalents and then sum them up for the daily total. Here are the standard conversion factors (as per CDC guidelines):\\n\\n- OXY CODONE: 1 mg is equivalent to 1 mg of morphine \\n- HYDROMORPHONE: 1 mg is equivalent to 4 mg of morphine \\n- CODEINE: 1 mg is equivalent to 0.1 mg of morphine\\n\\nNow, let's break down the patient's medications:\\n\\n1. **OxyCODONE**: The patient takes 60 mg, 1 time a day. Since it's already equivalent to morphine, the MME contribution is :\\n\\n2. **HYDROmorphone**: The patient takes 70 mg, 2 times a day. The total daily dose is 70 mg times 2 = 140 mg/day. Converted to MME:\\n\\n3. **Codeine**: The patient takes 10 mg, 2 times a day. Total daily dose is 10 mg x 2 = 20 mg/day. Converted to MME:\\n\\nNext, we sum up all the MMEs from the different medications to get the total daily MME.\\n\\nLet's calculate each one step by step.\\n\\n1. For OxyCODONE:\\n - The patient takes 60 mg once a day.\\n - Since 1 mg of OxyCODONE is equivalent to 1 mg of morphine, the MME for OxyCODONE is:\\n \\\\[ 60 \\\\, \\\\text{mg/day} \\\\times 1 = 60 \\\\, \\\\text{MME/day}.\\\\]\\n\\n2. For HYDROmorphone:\\n - The patient takes 70 mg, 2 times a day.\\n - The total daily dose is \\( 70 \\\\, \\\\text{mg/dose} \\\\times 2 \\\\, \\\\text{doses/day} = 140 \\\\, \\\\text{mg/day}.\\\\)\\n - Since 1 mg of HYDROmorphone is equivalent to 4 mg of morphine, the MME for HYDROmorphone is:\\n \\\\[ 140 \\\\, \\\\text{mg/day} \\\\times 4 = 560 \\\\, \\\\text{MME/day}.\\\\]\\n\\n3. For Codeine:\\n - The patient takes 10 mg, 2 times a day.\\n - The total daily dose is \\( 10 \\\\, \\\\text{mg/dose} \\\\times 2 \\\\, \\\\text{doses/day} = 20 \\\\, \\\\text{mg/day}.\\\\)\\n - Since 1 mg of Codeine is equivalent to 0.1 mg of morphine, the MME for Codeine is:\\n \\\\[ 20 \\\\, \\\\text{mg/day} \\\\times 0.1 = 2 \\\\, \\\\text{MME/day}.\\\\]\\n\\nNow, we add up the MMEs from all three medications to get the total daily MME:\\n\\n\\\\[ \\\\text{Total MME/day} = 60 \\\\, \\\\text{(from OxyCODONE)} + 560 \\\\, \\\\text{(from HYDROmorphone)} + 2 \\\\, \\\\text{(from Codeine)} = 622 \\\\, \\\\text{MME/day}.\\\\]\\n\\nSo, the patient's daily Morphine Milligram Equivalents (MME) is 622.", "LLM Thinking": "To calculate the Morphine Milligram Equivalent (MME) for the given patient's medications, we need to convert each of the opioids mentioned into their MME equivalents and then sum them up for the daily total. Here are the standard conversion factors (as per CDC guidelines): - OXY CODONE: 1 mg is equivalent to 1 mg of morphine - HYDROMORPHONE: 1 mg is equivalent to 4 mg of morphine - CODEINE: 1 mg is equivalent to 0.1 mg of morphine Now, let's break down the patient's medications: 1. **OxyCODONE**: The patient takes 60 mg, 1 time a day. Since it's already equivalent to morphine, the MME contribution is : 2. **HYDROmorphone**: The patient takes 70 mg, 2 times a day. The total daily dose is 70 mg times 2 = 140 mg/day. Converted to MME: 3. **Codeine**: The patient takes 10 mg, 2 times a day. Total daily dose is 10 mg x 2 = 20 mg/day. Converted to MME: Next, we sum up all the MMEs from the different medications to get the total daily MME.", "Ground Truth Answer": "793", "Ground Truth Explanation": "The curent Morphine Milligram Equivalents (MME) is 0 MME per day.\nThe patient's dose of OxyCODONE is 60 mg. The patient takes 1 doses/day of OxyCODONE. This means that the patient takes 60 mg/dose OxyCODONE * 1 dose/day = 60 mg/day. To convert to mme/day of OxyCODONE, multiply the 60 mg/day by the mme conversion factor, 1.5 mme/mg, giving us 90.0 mme/day. Adding the mme/day of OxyCODONE to the total mme/day gives us 0 + 90.0 = 90.0 mme/day.\nThe patient's dose of HYDROmorphone is 70 mg. The patient takes 2 doses/day of HYDROmorphone. This means that the patient takes 70 mg/dose HYDROmorphone * 2 dose/day = 140 mg/day. To convert to mme/day of HYDROmorphone, multiply the 140 mg/day by the mme conversion factor, 5 mme/mg, giving us 700 mme/day. Adding the mme/day of HYDROmorphone to the total mme/day gives us 90.0 + 700 = 790.0 mme/day.\nThe patient's dose of Codeine is 10 mg. The patient takes 2 doses/day of Codeine. This means that the patient takes 10 mg/dose Codeine * 2 dose/day = 20 mg/day. To convert to mme/day of Codeine, multiply the 20 mg/day by the mme conversion factor, 0.15 mme/mg, giving us 3.0 mme/day. Adding the mme/day of Codeine to the total mme/day gives us 790.0 + 3.0 = 793.0 mme/day.\nThe patient's mme/day is 793.0 mme/day.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the Morphine Milligram Equivalent (MME) for the given patient's medications, we need to convert each of the opioids mentioned into their MME equivalents and then sum them up for the daily total. Here are the standard conversion factors (as per CDC guidelines):\n\n- OXY CODONE: 1 mg is equivalent to 1 mg of morphine  \n- HYDROMORPHONE: 1 mg is equivalent to 4 mg of morphine  \n- CODEINE: 1 mg is equivalent to 0.1 mg of morphine\n\nNow, let's break down the patient's medications:\n\n1. **OxyCODONE**: The patient takes 60 mg, 1 time a day. Since it's already equivalent to morphine, the MME contribution is :\n\n2. **HYDROmorphone**: The patient takes 70 mg, 2 times a day. The total daily dose is 70 mg times 2 = 140 mg/day. Converted to MME:\n\n3. **Codeine**: The patient takes 10 mg, 2 times a day. Total daily dose is 10 mg x 2 = 20 mg/day. Converted to MME:\n\nNext, we sum up all the MMEs from the different medications to get the total daily MME."}
{"Row Number": 159, "Calculator Name": "MDRD GFR Equation", "Calculator ID": "9", "Category": "lab", "Note ID": "pmc-4227449-1", "Patient Note": "A 73-year-old African American woman with diabetes mellitus, hypertension, and recently diagnosed immunoglobulin G MM, presented with 2 days\u2019 history of fever, nausea, vomiting and dizziness. She was found to be obtunded in our Emergency department and was intubated for airway protection. She was febrile (39.33\u00b0C, 102.8\u00b0F), but hemodynamically stable. She demonstrated mild respiratory distress, had rales and wheezes on auscultation, and edema in both lower extremities. Initial laboratory results (Table ) revealed pancytopenia, elevated creatinine and corrected calcium of 7.3mg/dL, other electrolytes were within normal limits. A chest radiograph revealed cardiomegaly and pulmonary edema. Ten days prior to admission she received one dose of ZA, three doses of bortezomib, and seven doses of daily lenalidomide in addition to weekly dexamethasone. A clinical diagnosis of neutropenic fever, acute renal failure and severe hypocalcemia was made. Treatment was started with intravenous vancomycin and cefepime. She was also given calcium gluconate boluses for her hypocalcemia.\nEven after 24 hours of treatment, her mental status did not improve. She remained febrile, her kidney functions worsened, and her calcium level became undetectable (<5mg/dL) and ionized calcium was 0.66mmol/L (see Table ). She was started on continuous intravenous calcium gluconate infusion in addition to boluses, which still did not increase her calcium levels. We then tested for vitamin D levels which were found to be low (13ng/mL). The value of vitamin D was measured on the day in which renal function was most impaired (creatinine 8mg/dL). Intravenous paricalcitol was initiated, which did improve her calcium level, but, it did not revert to normal. Despite aggressive calcium replacement she remained persistently hypocalcemic and eventually developed tonic\u2013clonic seizures. An electrocardiogram revealed a QT interval of 500ms using Bazett\u2019s formula. Her neuroimaging, however, was normal except for several small calvarium lytic lesions (Figure ). Her family eventually made the decision to focus on comfort measures only, following which, she had a cardiac arrest and died on hospital day 17.", "Question": "Using the MDRD GFR equation, what is the patient's Glomerular Filtration Rate (GFR) in terms of mL/min/1.73 m\u00b2?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "6", "LLM Explanation": "To calculate the patient's GFR using the MDRD equation, we use the following information: the patient is a 73-year-old African American woman, and the serum creatinine level is 8 mg/dL (as given when renal function was most impaired). The MDRD equation is: GFR (mL/min/1.73 m\u00b2) = 175 x (Serum Creatinine)^-1.154 x (Age)^-0.203 x [if female, multiply by 0.742] x [if African American, multiply by 1.212]. Let's break this down step by step. 1. Serum Creatinine = 8 mg/dL. 2. Age = 73 years. 3. The patient is female, so we multiply by 0.742. 4. The patient is African American, so we multiply by 1.212. Now, let's calculate each part of the equation. Step 1: Calculate (Serum Creatinine)^-1.154. (8)^-1.154 \u2248 0.089. Step 2: Calculate (Age)^-0.203. (73)^-0.203 \u2248 0.419. Step 3: Multiply these results by 175. 175 * 0.089 * 0.419 \u2248 6.527. Step 4: Apply the female correction factor (0.742). 6.527 * 0.742 \u2248 4.840. Step 5: Apply the African American correction factor (1.212). 4.840 * 1.212 \u2248 5.87. Thus, the GFR is approximately 5.87 mL/min/1.73 m\u00b2, which rounds to about 6 mL/min/1.73 m\u00b2.", "LLM Thinking": "First, we need to use the given information from the patient note to calculate the Glomerular Filtration Rate (GFR) using the M DRD (Modification of Diet in Renal Disease) equation. The MDRD equation requires several parameters: serum creatinine, age, sex, and race. The patient is a 73-year-old African-American woman. We need the serum creatinine level. The note mentions \"elevated creatinine and corrected calcium of 7 .3mg/dL.\" Wait, the creatinine is listed as part of the acute renal failure, but the value is not directly given in the text. However, the note mentions \"her kidney functions worsened, and her creatinine level became [unspecified], but mentions it was measured on the day when creatinine was 8mg/dL. Wait, looking again: \"The value of vitamin D was measured on the day in which renal function was most impaired (creatinine 8 mg /dL).\" So the highest creatinine is 8 mg/dL, which seems to represent the creatinine levels on the day of renal failure. But the MDRD equation requires the serum creatinine at the time of GFR estimation. However, the question is asking for the GFR based on the MDRD equation. Since the note mentions \"elevated creatinine and corrected calcium of 7.3mg/dL\" in initial labs, but then later , when the renal function was most impaired, creatinine was 8 mg /dL. However, the problem is to calculate the GFR using the MDRD equation. Since the note might be asking for the GFR based on the most recent or the highest creatinine value (as that would be the most relevant for the acute situation), but perhaps the initial creatinine was 7.3 , and then later 8. The question is not entirely clear, but perhaps the key is to use the creatinine value from the initial labs ( since the task says \"using the MDRD GFR equation, what is the patient's GFR in terms of mL/min/1.7 3 m\u00b2?\" without specifying a particular timepoint, so maybe the initial labs are the ones to use. Wait, the initial labs mentioned \"e levated creatinine and corrected calcium of 7 . 3 mg/dL\", but this seems like the creatinine for corrected calcium and not serum creatinine. Wait, the wording is ambiguous. Let me read again: \"Initial laboratory results (Table ) revealed pancy topenia, ** elevated creatinine and corrected calcium of 7 . 3 mg/dL, other electrolytes were within normal limits.\" Wait, perhaps \"corrected calcium of 7.3mg/dL\" is the corrected calcium level, and the elevated creatinine is a separate value, but the actual creatinine value isn't listed here. Wait, this is confusing since we don\u2019t have the serum creatinine directly mentioned except for the later part where it says \"creatinine 8 mg/dL\" when vitamin D levels were checked (representing the day renal function was most impaired). So the problem might be expecting us to use the creatinine of 8 mg/dL for the calculation since it seems to be the creatinine value at the time when the patient's renal function was most severely affected, which would be the relevant point for calculating GFR. Alternatively, maybe the initial creatinine was 7.3, but that might be the corrected calcium, not creatinine; the elevated creatinine is mentioned separately without the value, so perhaps the 8 mg/dL is the only creatinine value provided in the text that can be used. Assuming that the creat inine value to use is 8 mg/dL, let's proceed. The MDRD equation is: GFR (mL/min/1 .73 m\u00b2) = 175 x (Serum Creatinine)^-1.154 x (Age)^-0 .203 x [if female, multiply by 0.7 42] x [if African American, multiply by 1.2 12] First, convert the serum creatinine from mg/dL to mg/dL because the MDRD equation uses serum creatinine in mg /dL. The serum creatinine given is 8 mg/dL. Now we apply the MDRD formula with: - creatinine = 8 mg/dL - age = 73 years - female (so we multiply by 0.7 4 2) - African American (so we multiply by 1.212). Let's calculate step by step. 1. Calculate (Serum Creat inine)^-1.154: (8)^-1 .154 Using a calculator: (8)^-1 .154 \u2248 (1 / 8^1.1 54) First compute 8^1.154. Let me approximate: Natural logarithm of 8 is ln(8)=2 .079. 1.154 * ln(8 )=1.154*2.079\u22482. 414 Now exponentiate to get 8^1.1 54\u2248 e^2.414\u224811.2 (since e^2=7.389, e^2 .4\u224811.02, so approx 11. 2). Thus, 1/11.2\u22480 . 0893. So (8)^-1.154 \u22480.0893. 2. Multiply by 1 75: 175 * (8)^- 1.1 54 \u2248 175 * 0 .0 8 93 \u2248 15.6. Now multiply by Age factor , which is age^-0.203. For the age of 7 3: (7 3)^- 0. 203 Take natural log: ln(73)=4. 290 Multiply by -0.203: 4 .2 9* (-0. 20 3) \ufffd \u2248 -0. 871 Exponentiate: e^- 0. 871. Using exponentials, e^-0 . 8 = 0.449 e^- 0 .8 7 1 \u2248 (e^-0. 8 7 ) = e^-0 .8 * e^-0.07\u22480. 449 *0.932\u22480.4 17. So, (7 3 )^-0. 20 3 \u22480. 41 7. Now multiply this to previous value: 15.6 * 0.4 1 7 \u2248 6.50. Next multiply by the correction factor for sex (female), which is 0 .7 4 2: 6.50 * 0.7 4 2 \u2248 4.82. Then multiply by the race factor ( African American), which is 1. 21 2: 4 .8 2 * 1.212 \u2248 5 .84. The steps to confirm: Wait, but let me check the formula again. The correct MDRD formula is: GFR in ml/min/ 1.73 m\u00b2 = 175 \u00d7 [ (Serum creatinine / mg/dL) ] ^{-1.154} \u00d7 [ Age in years ] ^{-0.203} \u00d7 0.742 (if female) \u00d7 1.212 (if African American) Wait, so the formula has (Serum creatinine) raised to power -1.154, multiplied by age to the -0.203, then multiplied by the sex and race factors. Let me recalculate with more accurate exponentiation: First, serum creatinine C = 8 mg/dL. Calculate C^-1.154 = 8^-1.154. Let me compute this more accurately: Using logarithms: ln(8)=2.079. Thus ln(C^-1.154)= -1.154*2.079\u2248-2.413. Exponentiate: e^-2.413\u22480.089. So 8^-1.154 \u22480.089. Now multiply it by 175: 175 x 0.089 \u224815.575. Now apply the age factor: 73^-0.203. Using logs: ln(73)=4.29;4.29 x (-0.203) \u2248 -0.870; exponentiate: e^-0.87\u22480.419. Now multiply 15.575 x 0.419\u22486.527. Now apply female factor: 6.527 x 0.742\u22484.840. Now apply race factor: 4.84 x1.212\u22485.87.", "Ground Truth Answer": "5.978", "Ground Truth Explanation": "The patient is 73 years old. The concentration of Creatinine is 8.0 mg/dL. \nThe patient is Black, so the race coefficient is 1.212.\nThe patient is female, so the gender coefficient is 0.742.\nThe patient's estimated GFR is calculated using the MDRD equation as:\nGFR = 175 * creatinine^(-1.154) * age^(-0.203) * race_coefficient * gender_coefficient. The creatinine concentration is mg/dL.\nPlugging in these values will give us: 175 * 8.0^(-1.154) * 73^(-0.203) * 1.212 * 0.742=5.978.\nHence, the patient's GFR is 5.978 mL/min/1.73m\u00b2.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to use the given information from the patient note to calculate the Glomerular Filtration Rate (GFR) using the M DRD (Modification of Diet in Renal Disease) equation. The MDRD equation requires several parameters: serum creatinine, age, sex, and race.\n\nThe patient is a 73-year-old African-American woman. We need the serum creatinine level. The note mentions \"elevated creatinine and corrected calcium of 7 .3mg/dL.\" Wait, the creatinine is listed as part of the acute renal failure, but the value is not directly given in the text. However, the note mentions \"her kidney functions worsened, and her creatinine level became [unspecified], but mentions it was measured on the day when creatinine was 8mg/dL. Wait, looking again: \"The value of vitamin D was measured on the day in which renal function was most impaired (creatinine 8 mg /dL).\" So the highest creatinine is 8 mg/dL, which seems to represent the creatinine levels on the day of renal failure. But the MDRD equation requires the serum creatinine at the time of GFR estimation. However, the question is asking for the GFR based on the MDRD equation. Since the note mentions \"elevated creatinine and corrected calcium of 7.3mg/dL\" in initial labs, but then later , when the renal function was most impaired, creatinine was 8 mg /dL. However, the problem is to calculate the GFR using the MDRD equation. Since the note might be asking for the GFR based on the most recent or the highest creatinine value (as that would be the most relevant for the acute situation), but perhaps the initial creatinine was 7.3 , and then later 8. The question is not entirely clear, but perhaps the key is to use the creatinine value from the initial labs ( since the task says \"using the MDRD GFR equation, what is the patient's GFR in terms of mL/min/1.7 3 m\u00b2?\" without specifying a particular timepoint, so maybe the initial labs are the ones to use. Wait, the initial labs mentioned \"e levated creatinine and corrected calcium of 7 . 3 mg/dL\", but this seems like the creatinine for corrected calcium and not serum creatinine. Wait, the wording is ambiguous. Let me read again:\n\n\"Initial laboratory results (Table ) revealed pancy topenia, ** elevated creatinine and corrected calcium of 7 . 3 mg/dL, other electrolytes were within normal limits.\" Wait, perhaps \"corrected calcium of 7.3mg/dL\" is the corrected calcium level, and the elevated creatinine is a separate value, but the actual creatinine value isn't listed here. Wait, this is confusing since we don\u2019t have the serum creatinine directly mentioned except for the later part where it says \"creatinine 8 mg/dL\" when vitamin D levels were checked (representing the day renal function was most impaired). So the problem might be expecting us to use the creatinine of 8 mg/dL for the calculation since it seems to be the creatinine value at the time when the patient's renal function was most severely affected, which would be the relevant point for calculating GFR. Alternatively, maybe the initial creatinine was 7.3, but that might be the corrected calcium, not creatinine; the elevated creatinine is mentioned separately without the value, so perhaps the 8 mg/dL is the only creatinine value provided in the text that can be used.\n\nAssuming that the creat inine value to use is 8 mg/dL, let's proceed. The MDRD equation is:\n\nGFR (mL/min/1 .73 m\u00b2) = 175 x (Serum Creatinine)^-1.154 x (Age)^-0 .203 x [if female, multiply by 0.7 42] x [if African American, multiply by 1.2 12]\n\nFirst, convert the serum creatinine from mg/dL to mg/dL because the MDRD equation uses serum creatinine in mg /dL.\n\nThe serum creatinine given is 8 mg/dL. Now we apply the MDRD formula with:\n\n- creatinine = 8 mg/dL \n- age = 73 years \n- female (so we multiply by 0.7 4 2) \n- African American (so we multiply by 1.212). Let's calculate step by step.\n\n1. Calculate (Serum Creat inine)^-1.154: \n\n(8)^-1 .154 \n\nUsing a calculator: \n\n(8)^-1 .154 \u2248 (1 / 8^1.1 54)\n\nFirst compute 8^1.154. Let me approximate:\n\nNatural logarithm of 8 is ln(8)=2 .079. \n\n1.154 * ln(8 )=1.154*2.079\u22482. 414 \n\nNow exponentiate to get 8^1.1 54\u2248 e^2.414\u224811.2 (since e^2=7.389, e^2 .4\u224811.02, so approx 11. 2). \n\nThus, 1/11.2\u22480 . 0893. So (8)^-1.154 \u22480.0893. \n\n2. Multiply by 1 75:\n\n175 * (8)^- 1.1 54 \u2248 175 * 0 .0 8 93 \u2248 15.6.\n\nNow multiply by Age factor , which is age^-0.203. For the age of 7 3:\n\n(7 3)^- 0. 203 \n\nTake natural log: ln(73)=4. 290 \n\nMultiply by -0.203: 4 .2 9* (-0. 20 3) \ufffd \u2248 -0. 871 \n\nExponentiate: e^- 0. 871. Using exponentials, e^-0 . 8 = 0.449 \n\ne^- 0 .8 7 1 \u2248 (e^-0. 8 7 ) = e^-0 .8 * e^-0.07\u22480. 449 *0.932\u22480.4 17. \n\nSo, (7 3 )^-0. 20 3 \u22480. 41 7.\n\nNow multiply this to previous value:\n\n15.6 * 0.4 1 7 \u2248 6.50.\n\nNext multiply by the correction factor for sex (female), which is 0 .7 4 2:\n\n6.50 * 0.7 4 2 \u2248 4.82.\n\nThen multiply by the race factor ( African American), which is 1. 21 2:\n\n4 .8 2 * 1.212 \u2248 5 .84.\n\nThe steps to confirm:\n\nWait, but let me check the formula again. The correct MDRD formula is:\n\n GFR in ml/min/ 1.73 m\u00b2 = 175 \u00d7 [ (Serum creatinine / mg/dL) ] ^{-1.154} \u00d7 [ Age in years ] ^{-0.203} \u00d7 0.742 (if female) \u00d7 1.212 (if African American)\n\nWait, so the formula has (Serum creatinine) raised to power -1.154, multiplied by age to the -0.203, then multiplied by the sex and race factors. Let me recalculate with more accurate exponentiation:\n\nFirst, serum creatinine C = 8 mg/dL.\n\nCalculate C^-1.154 = 8^-1.154.\n\nLet me compute this more accurately:\n\nUsing logarithms: ln(8)=2.079.\n\nThus ln(C^-1.154)= -1.154*2.079\u2248-2.413.\n\nExponentiate: e^-2.413\u22480.089.\n\nSo 8^-1.154 \u22480.089.\n\nNow multiply it by 175: 175 x 0.089 \u224815.575.\n\nNow apply the age factor: 73^-0.203.\n\nUsing logs: ln(73)=4.29;4.29 x (-0.203) \u2248 -0.870; exponentiate: e^-0.87\u22480.419.\n\nNow multiply 15.575 x 0.419\u22486.527.\n\nNow apply female factor: 6.527 x 0.742\u22484.840.\n\nNow apply race factor: 4.84 x1.212\u22485.87."}
{"Row Number": 378, "Calculator Name": "Sodium Correction for Hyperglycemia", "Calculator ID": "26", "Category": "lab", "Note ID": "pmc-2803813-1", "Patient Note": "A 16-year-old Egyptian boy was referred to our department in 2008. He was comatose with serial fits, and had an acute onset of renal failure for which one session of dialysis was done. His relatives reported an acute onset of disturbed conscious level with serial fits and low grade fever four days earlier. His past medical and drug history were unremarkable.\nAt presentation, he was febrile (temperature 38.0\u00b0C) and hypertensive (blood pressure 170/100 mmHg). Central venous pressure (CVP) was 13 mmHg and urine output (UOP) was 100 cc. Otherwise, in general, his neurological examination was normal except for serial fits.\nInitial laboratory tests included a white blood cell count of 13.7 (4.0-11.0 \u00d7 103/\u03bcL) with predominant lymphocytosis, hemoglobin 15.5 (13.5-17.5 g/dL), platelets 200 (150-400 \u00d7 103/\u03bcL), aspartate aminotransferase (AST) 1003 (20-57 IU/L), alanine aminotransferase (ALT) 1200 (21-72 IU/L), total bilirubin 1.1 (0.0-1.5 mg/dL), direct bilirubin 0.6 (0.0-0.8 mg/dL), alkaline phosphatase 120 (30-136 IU/L), international normalized ratio (INR) 1 and prothrombin time 11 (10.0-13.5 s), serum albumin 4 (3.5-6 mg/dL), random blood sugar 250 (140-199 mg/dL), creatinine 10 (0.6-1.2 mg/dL), urea 330 (15-45 mg/dL), Na+ 136 (135-145 mmol/L), K+ 3.6 (3.5-5), and calcium 9 (9-11 mg/dL). For acute hepatitis A IgM, hepatitis B surface antigen and anti-HB core antibody, and HCV-antibodies by third generation enzyme linked immunosorbent assay (ELISA), hepatitis C RNA by polymerase chain reaction (PCR) as well as HIV-antibodies, serologies were negative. Also, an autoimmune screen, anti-double stranded DNA, pANCA and cANCA, anti-nuclear antibody, and anti-smooth muscle antibody, were all negative. A surface echocardiogram revealed an ejection fraction of 75-80.\nSerum, liver and renal biochemistry was normal 4 days earlier (AST 32 IU/L, ALT 40 IU/L, total bilirubin 0.5 mg/dL) when the patient was admitted to the fever hospital. He was receiving ceftriaxone 2 g intravenously every 24 hours, phenytoin 100 mg intravenously every 8 hours, and paracetamol 0.5 g every 6 hours.\nAn abdominopelvic ultrasound was unremarkable, and chest X-ray was normal. Brain computed tomography (CT) scan without contrast revealed mild brain edema (Figure ), magnetic resonance imaging revealed an encephalitic pattern (Figure ), and electroencephalography (EEG) revealed an encephalitic pattern (Figure ). Cerebrospinal fluid examination returned the following results: glucose 160 mg/dL, protein 20 (20-40 mg/dL), chlorides 717 (720-750 mg/dL), and cells 70/mm3, which were mainly lymphocytes.\nSerology tests were negative for influenza A and B, respiratory syncytial virus (RSV), Mycoplasma pneumoniae, chlamydia, Coxiella burnetii, adenovirus, enterovirus, and antistreptolysin O titer (ASOT). A serology test for EBV by PCR was also negative. A serology test for CMV confirmed acute infection, with a 10-fold rise in CMV-specific IgM. Polymerase chain reaction (PCR) for (CMV) was also positive in the serum and the CSF.\nBecause of the impaired renal function, the patient was started on acyclovir 10 mg/day. Lamotrigine was chosen as antiepileptic drug as it is safe to use in patients with elevated liver enzymes, in addition to other supportive measures such as glycerol as a cerebral dehydrating measure, and antibiotics.\nOver the next three days, fits were controlled. On the third day, the patient started to regain consciousness and became fully conscious by day 11. Renal function returned to normal (without dialysis) after 17 days. Liver enzymes returned to normal after 20 days. A follow-up EEG revealed no abnormality (Figure ). The patient left hospital and made a complete recovery with no residual effects (Table ).", "Question": "What is the patient's corrected sodium concentration in terms of mEq/L?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "136", "LLM Explanation": "To calculate the corrected sodium concentration, we need to use the formula for correcting sodium levels based on serum albumin: Corrected Sodium = Measured Sodium + (2.5 \u00d7 (Normal Albumin Level - Patient's Albumin Level)). The patient's measured sodium is 136 mEq/L. The patient's albumin is listed as 4 (3.5-6 mg/dL), which seems incorrect because it's given in mg/dL instead of the usual g/dL. Assuming it's a typo and the correct unit is g/dL, the patient's albumin is 4 g/dL, and the normal range is 3.5-6 g/dL. Since the patient's albumin (4 g/dL) is within the normal range, no correction is needed. Therefore, the corrected sodium concentration is the same as the measured sodium concentration.", "LLM Thinking": "To calculate the corrected sodium concentration, we need to use the formula for correcting sodium levels when there are elevated or decreased levels of albumin or other factors like the presence of hyponatremia with hypoalbuminemia or hypernatremia with hyperalbuminemia. The correct formula for sodium correction based on serum albumin is: Corrected Sodium = Measured Sodium + (2.5 \u00d7 (Normal Albumin Level - Patient's Albumin Level)) The normal serum albumin level is typically between 3.5 to 5.0 g/dL. In the provided lab results, the patient's serum albumin is 4 mg/dL. Wait, let me check the units again. The note says \"serum albumin 4 (3.5- 6 mg/dL)\", which seems unusual because serum albumin levels are typically reported in g/dL, not mg/dL. The normal range here is written as 3.5-6 mg/dL, but that might be a typo. Wait, 3.5 -6 mg/dL would be extremely low because normal albumin is around 3.5-5.0 g/dL. Let's convert mg/dL to g/dL if this value is indeed meant to be in mg/dL; 4 mg/dL is 0.004 g/dL because (1 g = 1000 mg). That would be way below normal. That can\u2019t be right. Alternatively, maybe it's a typo and should be 4.0 g/dL. Given that the normal range is given as 3.5 -6 mg/dL, that would be impossible because albumin levels in g/dL are usually 3.5-5.0. So let's assume the lab value (serum albumin 4 mg/dL) is likely incorrect or there was a mistake in notation. They might have meant that the albumin is reported in grams per deciliter, so the normal range is 3.5-6 g/dL, but the patient's level is 4 g/dL, which is low. Wait, the problem states: \"serum albumin 4 (3.5 - 6 mg/dL).\" It's possible that the units are actually in g/dL, but the abbreviation for it got mixed up. Let's assume the patient's serum albumin is 4 g/dL (with the normal range 3.5 -6 g/dL), since that makes sense. The lab value listed as 4 (3.5-6 mg/dL) likely translates to serum albumin 4 g/dL. Now, the patient's measured sodium (Na+) is 136 mmol/L or mEq/L (because 1 mmol/L = 1 mEq/L for Na+). Since sodium is measured at 136, which is within the normal range of 135-145. However, if the albumin is low, then the corrected sodium would be higher than the measured sodium since sodium tends to bind to albumin. The formula is used when albumin is low (hypoalbuminemia) to correct for the fact that sodium is lower than it actually is because albumin can't bind with sodium, making it appear low. The formula is: Corrected Na = Measured Na + (2.5 x (Normal Albumin - Patient Albumin)) Normal albumin is 4 g/dL (midpoint of 3.5-6, but actually the standard normal is 3.5-5.0). Let's take the lower normal limit as 3.5 or the midpoint, but the formula often uses a normal albumin of 4 g/dL. Wait, the formula usually uses a normal albumin level of 4 g/dL to correct for low albumin. For each 1 g/dL below 4, sodium decreases by approximately 2.5 mEq/L. But in this case, the patient's albumin is 4, which is within or at the upper end of the normal range (assuming 3.5-5.0). So the difference between normal albumin (let's say 4) and patient's albumin (4) is 0. Therefore, the correction would be 0. Wait, but in the problem, the patient's albumin is listed as 4 (3.5-6 mg/dL), which if incorrect notation translates to serum albumin 4 g/dL, then the normal range is 3.5-6, so the patient's albumin is exactly at the lower end of the normal range, but not below normal. Since it's not below the normal range by a significant amount, we wouldn 't correct it greatly unless it's way below normal. However, if the albumin was 2, then correction would be needed. Alternatively, if the albumin was in mg/dL, but that would be a very low level, making the corrected sodium much higher, but that's probably not the case. But let me check again the data given in the note. The note says : \"serum albumin 4 (3.5-6 mg/dL)\" - perhaps the units are actually grams per dL but written as mg/dL by mistake. If it's 4 g/dL, then the albumin is normal (as 3.5-6 is the range), so correction isn \u2019t needed.", "Ground Truth Answer": "139.6", "Ground Truth Explanation": "The formula for Sodium Correction for Hyperglycemia is Measured sodium + 0.024 * (Serum glucose - 100), where Measured Sodium is the sodium concentration in mEq/L and the Serum glucose is the concentration of glucose in mg/dL.\nThe concentration of sodium is 136.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of sodium from mmol to mEq. The mass of sodium is 136.0 mmol. The compound, sodium, has a valence of 1, and so multiply the valence by the value of mmol to get, 136.0 mmol * 1 mEq/mmol = 136.0 mEq sodium. The volume units is L so no volume conversion is needed. Hence, the concentration value of 136.0 mmol sodium/L converts to 136.0 mEq sodium/L. \nThe concentration of glucose is 250.0 mg/dL. \nPlugging in these values into the formula gives us 136.0 mEq/L + 0.024 * (250.0 - 100) = 139.6 mEq/L.\nHence, the patient's corrected concentration of sodium is 139.6 mEq/L.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the corrected sodium concentration, we need to use the formula for correcting sodium levels when there are elevated or decreased levels of albumin or other factors like the presence of hyponatremia with hypoalbuminemia or hypernatremia with hyperalbuminemia.  \nThe correct formula for sodium correction based on serum albumin is:  \nCorrected Sodium = Measured Sodium + (2.5 \u00d7 (Normal Albumin Level - Patient's Albumin Level))  \n  \nThe normal serum albumin level is typically between 3.5 to 5.0 g/dL.  \nIn the provided lab results, the patient's serum albumin is 4 mg/dL.  \nWait, let me check the units again.  \nThe note says \"serum albumin 4 (3.5- 6 mg/dL)\", which seems unusual because serum albumin levels are typically reported in g/dL, not mg/dL.  \nThe normal range here is written as 3.5-6 mg/dL, but that might be a typo.  \nWait, 3.5 -6 mg/dL would be extremely low because normal albumin is around 3.5-5.0 g/dL.  \nLet's convert mg/dL to g/dL if this value is indeed meant to be in mg/dL; 4 mg/dL is 0.004 g/dL because (1 g = 1000 mg).  \nThat would be way below normal.  \nThat can\u2019t be right.  \nAlternatively, maybe it's a typo and should be 4.0 g/dL.  \nGiven that the normal range is given as 3.5 -6 mg/dL, that would be impossible because albumin levels in g/dL are usually 3.5-5.0.  \nSo let's assume the lab value (serum albumin 4 mg/dL) is likely incorrect or there was a mistake in notation.  \nThey might have meant that the albumin is reported in grams per deciliter, so the normal range is 3.5-6 g/dL, but the patient's level is 4 g/dL, which is low.  \nWait, the problem states: \"serum albumin 4 (3.5 - 6 mg/dL).\"  \nIt's possible that the units are actually in g/dL, but the abbreviation for it got mixed up.  \nLet's assume the patient's serum albumin is 4 g/dL (with the normal range 3.5 -6 g/dL), since that makes sense.  \nThe lab value listed as 4 (3.5-6 mg/dL) likely translates to serum albumin 4 g/dL.  \nNow, the patient's measured sodium (Na+) is 136 mmol/L or mEq/L (because 1 mmol/L = 1 mEq/L for Na+).  \nSince sodium is measured at 136, which is within the normal range of 135-145.  \nHowever, if the albumin is low, then the corrected sodium would be higher than the measured sodium since sodium tends to bind to albumin.  \nThe formula is used when albumin is low (hypoalbuminemia) to correct for the fact that sodium is lower than it actually is because albumin can't bind with sodium, making it appear low.  \nThe formula is:  \nCorrected Na = Measured Na + (2.5 x (Normal Albumin - Patient Albumin))  \nNormal albumin is 4 g/dL (midpoint of 3.5-6, but actually the standard normal is 3.5-5.0).  \nLet's take the lower normal limit as 3.5 or the midpoint, but the formula often uses a normal albumin of 4 g/dL.  \nWait, the formula usually uses a normal albumin level of 4 g/dL to correct for low albumin.  \nFor each 1 g/dL below 4, sodium decreases by approximately 2.5 mEq/L.  \nBut in this case, the patient's albumin is 4, which is within or at the upper end of the normal range (assuming 3.5-5.0).  \nSo the difference between normal albumin (let's say 4) and patient's albumin (4) is 0.  \nTherefore, the correction would be 0.  \n  \nWait, but in the problem, the patient's albumin is listed as 4 (3.5-6 mg/dL), which if incorrect notation translates to serum albumin 4 g/dL, then the normal range is 3.5-6, so the patient's albumin is exactly at the lower end of the normal range, but not below normal.  \nSince it's not below the normal range by a significant amount, we wouldn 't correct it greatly unless it's way below normal.  \nHowever, if the albumin was 2, then correction would be needed.  \nAlternatively, if the albumin was in mg/dL, but that would be a very low level, making the corrected sodium much higher, but that's probably not the case.  \n  \nBut let me check again the data given in the note.  \nThe note says : \"serum albumin 4 (3.5-6 mg/dL)\" - perhaps the units are actually grams per dL but written as mg/dL by mistake.  \nIf it's 4 g/dL, then the albumin is normal (as 3.5-6 is the range), so correction isn \u2019t needed."}
{"Row Number": 766, "Calculator Name": "Delta Ratio", "Calculator ID": "64", "Category": "lab", "Note ID": "pmc-3403404-1", "Patient Note": "A 53-year-old white female with the past medical history of type II diabetes mellitus, hypertension, hyperlipidemia, depression, coronary artery disease after RCA stent, and peripheral vascular disease after bilateral stents to the common iliac arteries was transferred to our hospital after being diagnosed to have osteomyelitis of right great toe and methicillin-sensitive staphylococcus aureus bacteremia from an outside hospital. She was started on ertapenem for bacteremia before getting transferred to our hospital. The baseline laboratory values done on an outpatient evaluation basis just 10 days prior to the admission were WBC 12.5, hemoglobin 13.4, haematocrit 39, platelets 564, BUN 22, creatinine 1.5, glucose 222, sodium 138 meq/L, potassium 4.2 meq/L, chloride 101 meq/L, bicarbonate 25 meq/L, bilirubin total-0.3 mg/dL, bilirubin direct 0.1 mg/dL, alanine transaminase (ALT)-8 IU/L, aspartate transaminase (AST) 9 IU/L, alkaline phosphatase (ALP) 78 IU/L, direct albumin, 3.8 gm/dL, protein total 7.80 gm/dL, PT-10.2 s, INR 1.0, PTT 28 s, and sedimentation rate 72 h; blood culture showed no growth even after 5 days. On admission, physical examination findings were unremarkable except for her right great toe which was swollen and oozing; pedal pulses were not palpable. Laboratory showed an increase in leukocytes 16,300/uL; reference range (4500\u20138500), platelets 775 thousand/cu\u00b7mm reference (140\u2013440), glucose 300 mg/dL (70\u2013105), creatinine 2 mg/dL (0.6\u20131.1), low glomerular filtration rate (gfr) 26 mL/min, normal PT 16.4 s (9.0\u201312.0), PTT 42 s (25\u201335), and INR 1.6. Blood culture done two times showed no growth even after 5 days. X-ray right foot showed osteomyelitis of right great toe; ertapenem was discontinued and was started on nafcillin 12 gram/day. The day nafcillin started was considered as day 1. Surgery was done under general anesthesia on day 4 for the amputation of right great toe. Abdominal aortogram was performed on day 10 and was found to have mild narrowing at the level of tibioperoneal trunk with areas of stenosis the dorsalis pedis artery was occluded. The patient underwent right second toe amputation and percutaneous angioplasty for worsening of her osteomyelitis. On day 15, she was found to be jaundiced with mild disorientation; her liver function showed elevated total and direct bilirubin, alkaline phosphatase (ALP), and gamma glutamyl transpeptidase (GGTP) levels (bilirubin total (T)-9.6; direct (D)-7.3; ALP-388 IU/L; AST-67 IU/L; ALT-24 IU/L; GGTP-878 IU/L, with decreased creatinine clearance 30 mL/min/24 hr reference range (72\u2013141 mL/min/24 hr). Pharmacy was consulted for drug-related hepatic injury, and nafcillin was discontinued immediately. A mild, transient drop in the levels of AST, ALT, ALP, and GGTP was noted immediately after stopping nafcillin. Further workup for hepatitis and jaundice was done to rule out other causes of hepatotoxicity. Workup included a negative direct coombs, and antibody screening, negative ANCA test for MPO and PR3 antibodies, rheumatoid factor, antismooth muscle antibody, antinuclear antibody, and HLA B27 were also negative. Levels of C3 and C4 complements were normal; liver-kidney microsomal antibody, alpha fetoprotein, and antithyroid peroxidase were also normal. Abdominal ultrasound showed a heterogenous appearance of liver parenchyma, and MRI abdomen was normal. The patient had an elevated GGTP, ALP, and bilirubin, mostly direct bilirubin () before being discharged to transitional care unit for rehabilitation.\nOn day 36, her jaundice worsened, and she was admitted at a liver transplant center for further evaluation. Her workup included elevated AST 152 IU/L, ALT 85 IU/L, ALP >1800 IU/L, GGT >1500 IU/L, and total bilirubin 11.5 mg/dL, repeat ultrasound abdomen showed no intra- and extrahepatic biliary obstruction; MRCP was unremarkable; liver biopsy showed diffuse hepatocanalicular cholestasis with focal centrizonal bile infarct, periportal hepatocellular swelling and mild nodular hyperplasia like changes. Diagnosis of cholestatic jaundice secondary to nafcillin was made and Ursodiol 10 mg/kg was started. There was no evidence of fulminant hepatic failure, coagulopathy, or encephalopathy. The patient was discharged to home. The patient was followed as an outpatient with regular blood tests for LFT. The GGTP and ALP both remained elevated >1500 IU/L.\nOn day 54, she was readmitted to the ER for abdominal pain and hematuria. Her workup revealed bilirubin (T-28.7 mg/dL, D-21.3 mg/dL), ALP >1884 IU/L, ALT 24 IU/L, ammonia 45 ug/dL (reference 31\u2013123), creatinine 1.6, INR 5.4, PT 58.5, haemoglobin 7.5 gm/dL (reference 11.5\u201316.0), and haematocrit 21% (reference 37\u201347); urinalysis showed blood in urine, and blood culture remained negative. She was transfused two units of blood and was hemodynamically stabilized. She was monitored closely in the hospital. On day 84, she redeveloped an abdominal pain and was shifted to the liver transplant centre for further evaluation, where she went into respiratory arrest and succumbed to her underlying disease conditions.", "Question": "What is the patient's delta ratio?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "0.83", "LLM Explanation": "To calculate the patient's delta ratio, we use the formula: Delta Ratio = GGT / ALP. From the patient note, on day 36, the values were GGT > 1500 IU/L and ALP > 1800 IU/L. Using these values, the delta ratio is approximately 1500 / 1800 = 0.83. This gives us the delta ratio as approximately 0.83.", "LLM Thinking": "83%", "Ground Truth Answer": "0", "Ground Truth Explanation": "The formula for computing the delta ratio is delta gap (mEq/L)/(24 - bicarbonate mEq/L).\nTo compute the formula of the delta gap, the formula is anion gap (in mEq/L) - 12. The first step is to compute the patient's anion gap.\nThe formula for computing a patient's anion gap is: sodium (mEq/L) - (chloride (mEq/L)+ bicarbonate (mEq/L)).\nThe concentration of sodium is 138.0 mEq/L. \nThe concentration of chloride is 101.0 mEq/L. \nThe concentration of bicarbonate is 25.0 mEq/L. \nPlugging in these values into the anion gap formula gives us 138.0 mEq/L - (101.0 mEq/L + 25.0 mEq/L) = 12.0 mEq/L. Hence, The patient's anion gap is 12.0 mEq/L.\nPlugging in 12.0 mEq/L for the delta gap formula, we get 12.0 - 12 = 0 mEq/L. Hence, the patient's delta gap is 0 mEq/L.\nPlugging in the delta gap and the bicarbonate concentration for the delta ratio formula, we get 0 mEq/L / -1.0 mEq/L = 0. The patient's delta ratio is 0.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "83%"}
{"Row Number": 790, "Calculator Name": "Albumin Corrected Delta Gap", "Calculator ID": "66", "Category": "lab", "Note ID": "pmc-6467431-1", "Patient Note": "A 45-year-old woman with a substantial past medical history of squamous cell cancer (SCC) was treated with laryngectomy and offered tracheostomy. She presented in the emergency department with complaints of shortness of breath (SOB). Her shortness of breath was getting progressively worse starting two days prior to admission. She denied any fevers, chills, sick contacts, nausea, abdominal pain, or diarrhea. She specified that she had actually been drinking a lot more water than regular prior to admission.\nOn admission, her vital signs revealed a blood pressure of 101/73 mmHg, a heart rate of 91 beats/min, a temperature of 37.4 degree Celsius, and a respiratory rate of 26 breaths/min. Her body mass index (BMI) was 18.6 kg/m2. Physical examination revealed a sick-appearing woman in severe respiratory distress using accessory muscles. She had a dry mucous membrane with poor skin turgor. The rest of the physical examination was unremarkable.\nOn laboratory assessment, the hemoglobin was 11.9 mg/dl, leukocyte count 3.6/mm3, serum creatinine 0.8 mg/dl, potassium 3.3 mmol/L, chloride 110 mmol/L, sodium 148 mmol/L, and bicarbonate 6 mmol/L. She had high anion gap metabolic acidosis (AGMA), (anion gap (AG) = 22). Her serum albumin on admission was 4.2 g/L, urine analysis revealed 80 mg/dl ketones, and serum lactate was 1.9 mmol/L. Furthermore, her liver enzymes revealed aspartate aminotransferase (AST) = 48 units/l, alanine aminotransferase (ALT) = 82 units/l, and alkaline phosphatase 199 units/l. Additionally, her blood glucose level was 133 mg/dl, salicylates = 6.8 mg/dl, and acetaminophen level was <2.0 ug/ml. Her blood alcohol level was normal and chest X-ray (CXR) on admission did not show any sign of acute cardiopulmonary problems.\nBased on the initial evaluation, she received stoma suctioning and was placed on high O2 via a tracheostomy mask. Her history of laryngeal cancer, mild tachycardia and hypoxia raised the suspicion of pulmonary embolism, so a chest computed tomography angiography (CTA) was ordered. The chest CTA was negative for pulmonary embolism but showed mild emphysema.\nIn addition to that, an arterial blood gas (ABG) test was done, which revealed a high anion gap metabolic acidosis (HAGMA) as presented in Table . The patient continued to hyperventilate to compensate for the acidosis and was subsequently intubated.\nDifferential diagnoses including carbon monoxide poisoning, aminoglycoside toxicity, methanol, uremia, diabetic ketoacidosis (DKA), alcoholic ketosis, acetaminophen toxicity, iron ingestion, lactic acidosis, ethanol toxicity, salicylate toxicity, and aspirin ingestion were investigated. However, given the patient's normal acetaminophen, salicylate, lactic acid, and ethanol levels, these etiologies were ruled out. Furthermore, serum osmolality was normal and the osmolal gap was less than 10. Our differential diagnosis was further narrowed due to the presence of elevated ketones. Given the patient's malnourished state, the most likely cause of HAGMA in this patient was starvation ketosis. The patient was started on 5% dextrose water and sodium bicarbonate drip, and tube feeds. The ABG level swiftly improved within three days and she was extubated.\nAfter four days of intensive care unit (ICU) course, she was downgraded and later on discharged after detailed counseling from a nutritionist regarding a balanced diet and avoiding fasting. She was followed up after three weeks of discharge with significant improvement on repeat basic metabolic panel with bicarbonate of 25 mmol/L, sodium 138 mmol/L, potassium 3.8 mmol/L, and chloride 102 mmol/L.", "Question": "What is the patient's albumin corrected delta gap in mEq/L?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "9.5", "LLM Explanation": "To calculate the albumin-corrected delta gap, we first need the measured anion gap (AG), which is given as 22 mEq/L. The formula to correct the anion gap for albumin is: \\[ \\text{Corrected AG} = \\text{Measured AG} + 2.5 \\times (4.0 - \\text{serum albumin}) \\]. The serum albumin level is 4.2 g/dL. Plugging in the values, we get: \\[ \\text{Corrected AG} = 22 + 2.5 \\times (4.0 - 4.2) = 22 + 2.5 \\times (-0.2) = 22 - 0.5 = 21.5 \\, \\text{mEq/L}.\\] The normal anion gap is typically around 8-12 mEq/L; we'll use the upper limit of the normal range, which is 12 mEq/L, to calculate the delta gap. The albumin-corrected delta gap is the difference between the corrected AG and the normal AG: \\[ \\text{Albumin-corrected Delta Gap} = \\text{Corrected AG} - \\text{Normal AG} = 21.5 - 12 = 9.5 \\, \\text{mEq/L}. \\]", "LLM Thinking": "First, we need to calculate the Anion Gap (AG) and the Albumin-Corrected Delta Gap. The standard anion gap is given by the formula: \\[ \\text{Anion Gap (AG)} = \\text{[Na]} - [\\text{Cl} + \\text {HCO}_3^-] \\] From the patient's lab results provided in the note: - Sodium (\\[ \\text{Na} \\]) = 148 mEq/L - Chloride (\\[ \\text{Cl} \\]) = 110 mEq/L \u2013 Bicarbonate (\\[ \\text{HCO}_3^- \\]) = 6 mEq/L Using the formula for the Anion Gap: \\[ \\text{AG} = 148 - [110 + 6] \\] Wait, actually the note mentions that the anion gap is already calculated as 22. Now we need to calculate the albumin-corrected delta gap. The delta gap is the difference between the measured anion gap and the normal reference range for the anion gap. The standard reference range for the anion gap is typically between 8\u201312 mEq/L, so the normal AG is considered to be around 10\u201312 mEq/L. However, when albumin levels are low, the anion gap can be adjusted to account for the effect of hypoalbuminemia (since serum albumin has a negative charge and therefore contributes to the anion gap). The formula for the albumin-corrected anion gap is: \\[ \\text{Albumin-corrected AG} = \\text{Measured AG} + 2.5 \\times (4.0 - \\text{serum albumin in g/dL}) \\] where 2.5 accounts for the contributions of albumin to the anion gap. The patient\u2019s serum albumin level is 4.2 g/dL. Using the albumin-corrected AG formula: \\[ \\text{Corrected AG} = 22 + 2.5 \\times (4.0 - 4.2) \\] Calculating the term inside the parenthesis: 4.0 - 4.2 = -0.2 Then multiply by 2.5: 2.5 \u00d7 (-0.2) = -0.5 To calculate the \"albumin corrected delta gap,\" we compare the albumin-corrected Anion gap with the normal anion gap. The delta gap is the difference between the corrected AG and the normal AG (assumed to be around 10\u201312). However, sometimes the delta gap is defined as the measured AG minus the normal AG. But since the question asks for the albumin corrected delta gap, perhaps it's the delta gap calculated after adjusting for albumin. The normal reference range for anion gap is approximately 8\u201316 mEq/L, and a typical midpoint for the normal range is around 12. Therefore the corrected delta gap will be: \\[ \\text{Albumin-corrected Delta Gap} = \\text{Albumin-corrected AG} - \\text{Normal AG} \\] If the normal AG is considered to be 12, Wait, but sometimes the delta gap is just taken as the difference between the measured AG and the normal AG before any albumin correction. But the question specifies \"albumin corrected delta gap,\" which implies that the albumin correction has already been applied to the standard calculation of delta GAP. Let's take the approach to calculate the albumin corrected delta gap: the delta gap is the corrected AG minus the normal AG. So, in this case, the albumin-corrected AG is 21.5. The normal AG is 10\u201312, so using the upper limit for normal anion gap for safety let's use 12. However, sometimes the delta gap is just the measured AG minus normal, but since the AG has been corrected for albumin, the term is the albumin corrected delta gap. But maybe the question wants just the albumin-corrected AG, which is 21.5, but the question says \"albumin corrected delta gap.\" If the question means \"correct for albumin and calculate the delta gap from the normal,\" then the answer is 9.5. Alternatively, maybe the term is different. Let me confirm the formula. Wait, perhaps the albumin-corrected delta gap is the same as the albumin-corrected AG minus the normal AG. Yes, it makes sense because that's how you assess whether there is an abnormal elevation in the anion gap after adjusting for albumin. Since the normal AG is around 10\u201312, the corrected AG here is 21.5, so the delta is 21.5 \u2013 12 (if we take the upper limit of the normal range as 12). So in this context, the albumin-corrected delta gap is the difference between the corrected AG and the upper limit of normal AG.", "Ground Truth Answer": "28.95", "Ground Truth Explanation": "To compute the formula of albumin corrected delta gap, the formula is albumin corrected anion gap (in mEq/L) - 12.\nThe formula for computing a patient's albumin corrected anion gap is: anion_gap (in mEq/L) + 2.5 * (4 - albumin (in g/dL)).\nThe formula for computing a patient's anion gap is: sodium (mEq/L) - (chloride (mEq/L)+ bicarbonate (mEq/L)).\nThe concentration of sodium is 148.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of sodium from mmol to mEq. The mass of sodium is 148.0 mmol. The compound, sodium, has a valence of 1, and so multiply the valence by the value of mmol to get, 148.0 mmol * 1 mEq/mmol = 148.0 mEq sodium. The volume units is L so no volume conversion is needed. Hence, the concentration value of 148.0 mmol sodium/L converts to 148.0 mEq sodium/L. \nThe concentration of chloride is 110.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of chloride from mmol to mEq. The mass of chloride is 110.0 mmol. The compound, chloride, has a valence of 1, and so multiply the valence by the value of mmol to get, 110.0 mmol * 1 mEq/mmol = 110.0 mEq chloride. The volume units is L so no volume conversion is needed. Hence, the concentration value of 110.0 mmol chloride/L converts to 110.0 mEq chloride/L. \nThe concentration of bicarbonate is 6.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of bicarbonate from mmol to mEq. The mass of bicarbonate is 6.0 mmol. The compound, bicarbonate, has a valence of 1, and so multiply the valence by the value of mmol to get, 6.0 mmol * 1 mEq/mmol = 6.0 mEq bicarbonate. The volume units is L so no volume conversion is needed. Hence, the concentration value of 6.0 mmol bicarbonate/L converts to 6.0 mEq bicarbonate/L. \nPlugging in these values into the anion gap formula gives us 148.0 mEq/L - (110.0 mEq/L + 6.0 mEq/L) = 32.0 mEq/L. Hence, The patient's anion gap is 32.0 mEq/L.\nThe concentration of albumin is 4.2 g/L. We need to convert the concentration to g/dL. The mass units of the source and target are the same so no conversion is needed. The current volume unit is L and the target volume unit is dL. The conversion factor is 10.0 dL for every unit of L. Our next step will be to divide the mass by the volume conversion factor of 10.0 to get the final concentration in terms of g/dL. This will result to 4.2 g albumin/10.0 dL = 0.42 g albumin/dL. The concentration value of 4.2 g albumin/L converts to 0.42 g albumin/dL. Plugging in these values into the albumin corrected anion gap formula, we get 32.0 (mEq/L) + 2.5 * (4 - 0.42 (in g/dL)) = 40.95 mEq/L. Hence, the patient's albumin corrected anion gap is 40.95 mEq/L.\nPlugging in 40.95 mEq/L for the anion gap into the albumin corrected delta gap formula, we get 40.95 - 12 = 28.95 mEq/L. Hence, the patient's albumin corrected delta gap is 28.95 mEq/L.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the Anion Gap (AG) and the Albumin-Corrected Delta Gap.  \nThe standard anion gap is given by the formula:  \n\\[ \\text{Anion Gap (AG)} = \\text{[Na]} - [\\text{Cl} + \\text {HCO}_3^-] \\]  \nFrom the patient's lab results provided in the note:  \n- Sodium (\\[ \\text{Na} \\]) = 148 mEq/L  \n- Chloride (\\[ \\text{Cl} \\]) = 110 mEq/L \u2013 Bicarbonate (\\[ \\text{HCO}_3^- \\]) = 6 mEq/L  \n\nUsing the formula for the Anion Gap:  \n\\[ \\text{AG} = 148 - [110 + 6] \\]  \n\nWait, actually the note mentions that the anion gap is already calculated as 22.  \n\nNow we need to calculate the albumin-corrected delta gap. The delta gap is the difference between the measured anion gap and the normal reference range for the anion gap.  \nThe standard reference range for the anion gap is typically between 8\u201312 mEq/L, so the normal AG is considered to be around 10\u201312 mEq/L.  \nHowever, when albumin levels are low, the anion gap can be adjusted to account for the effect of hypoalbuminemia (since serum albumin has a negative charge and therefore contributes to the anion gap).  \n\nThe formula for the albumin-corrected anion gap is:  \n\\[ \\text{Albumin-corrected AG} = \\text{Measured AG} + 2.5 \\times (4.0 - \\text{serum albumin in g/dL}) \\]  \nwhere 2.5 accounts for the contributions of albumin to the anion gap.  \n\nThe patient\u2019s serum albumin level is 4.2 g/dL.  \n\nUsing the albumin-corrected AG formula:  \n\\[ \\text{Corrected AG} = 22 + 2.5 \\times (4.0 - 4.2) \\]  \nCalculating the term inside the parenthesis: 4.0 - 4.2 = -0.2  \nThen multiply by 2.5: 2.5 \u00d7 (-0.2) = -0.5  \n\nTo calculate the \"albumin corrected delta gap,\" we compare the albumin-corrected Anion gap with the normal anion gap.  \nThe delta gap is the difference between the corrected AG and the normal AG (assumed to be around 10\u201312).  \nHowever, sometimes the delta gap is defined as the measured AG minus the normal AG.  \nBut since the question asks for the albumin corrected delta gap, perhaps it's the delta gap calculated after adjusting for albumin.  \nThe normal reference range for anion gap is approximately 8\u201316 mEq/L, and a typical midpoint for the normal range is around 12.  \n\nTherefore the corrected delta gap will be:  \n\\[ \\text{Albumin-corrected Delta Gap} = \\text{Albumin-corrected AG} - \\text{Normal AG} \\]  \nIf the normal AG is considered to be 12,  \n\nWait, but sometimes the delta gap is just taken as the difference between the measured AG and the normal AG before any albumin correction.  \nBut the question specifies \"albumin corrected delta gap,\" which implies that the albumin correction has already been applied to the standard calculation of delta GAP.  \n\nLet's take the approach to calculate the albumin corrected delta gap: the delta gap is the corrected AG minus the normal AG.  \nSo, in this case, the albumin-corrected AG is 21.5. The normal AG is 10\u201312, so using the upper limit for normal anion gap for safety let's use 12.  \nHowever, sometimes the delta gap is just the measured AG minus normal, but since the AG has been corrected for albumin, the term is the albumin corrected delta gap.  \nBut maybe the question wants just the albumin-corrected AG, which is 21.5, but the question says \"albumin corrected delta gap.\"  \nIf the question means \"correct for albumin and calculate the delta gap from the normal,\" then the answer is 9.5.  \nAlternatively, maybe the term is different. Let me confirm the formula.  \n\nWait, perhaps the albumin-corrected delta gap is the same as the albumin-corrected AG minus the normal AG.  \nYes, it makes sense because that's how you assess whether there is an abnormal elevation in the anion gap after adjusting for albumin.  \nSince the normal AG is around 10\u201312, the corrected AG here is 21.5, so the delta is 21.5 \u2013 12 (if we take the upper limit of the normal range as 12).  \nSo in this context, the albumin-corrected delta gap is the difference between the corrected AG and the upper limit of normal AG."}
{"Row Number": 615, "Calculator Name": "QTc Fridericia Calculator", "Calculator ID": "56", "Category": "physical", "Note ID": "8", "Patient Note": "Patient has a heart rate of 164 bpm and a QT interval of 330 msec.", "Question": "Using the Fridericia Formula for corrected QT interval, what is the patient's corrected QT interval in terms of msec?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "236", "LLM Explanation": "To calculate the corrected QT interval using the Fridericia formula, we use the formula: QTc = QT / cube_root(Heart Rate / 60). Given the QT interval is 330 msec and the heart rate is 164 bpm, we first calculate the value inside the cube root: Heart Rate / 60 = 164 / 60 \u2248 2.7333. Next, we find the cube root of 2.7333. Using a calculator, $\\sqrt[3]{2.7333} \\approx 1.400$. Now, we plug this into the Fridericia formula: QTc = 330 / 1.400 \u2248 235.71. Rounding this to the nearest whole number gives us approximately 236 msec.", "LLM Thinking": "Step 1: To calculate the corrected QT interval, we will use the Fridericia formula: QTc = QT / cube_root(Heart Rate / 60), where QT is in milliseconds, and the Heart Rate is in bpm. Step 2: We have the QT interval = 330 msec and the heart rate = 164 bpm . Step 3: We must calculate the QTc using the Frider icia formula. First, compute the cube root of (HR / 60). Step 4: HR / 60 = 164 / 60 \u2248 2.7333. The cube root of this value is $\\sqrt[3]{2.73 33} \u2248 1.400. Step 5 : Now, apply the Fridericia formula: QTc = \\frac {QT}{\\text{cube root (HR / 60)} } = 330 / 1.400 \u2248 235.71 msec. Wait, let \u2019s recompute the cube root (164 / 60): 164 divided by 60 is exactly 2.7 333...; the cube root of approximately $ 2.7 333 is actually closer to 1.400. Let me verify the cube of 1.4: 1.4^ 3 = 1.4 * 1.4 * 1. 4 = 1.96 * 1.4 = 2 .744. Ah, that\u2019s very close to 2. 7 33; thus, $\\sqrt[3]{2.7 333}$ is slightly less than 1.4, maybe around 1.39.", "Ground Truth Answer": "461.339", "Ground Truth Explanation": "The corrected QT interval using the Fredericia formula is computed as  QTc = QT interval / (RR interval)**(1/3), where ** denotes an exponent, QT interval is in msec, and RR interval is given as 60/(heart rate).\nThe patient's heart rate is 164 beats per minute.\nThe QT interval is 330 msec.\nThe RR interval is computed as 60/(heart rate), and so the RR interval is 60/164 = 0.366.\nHence, plugging in these values, we will get 330/\u221a(0.366) = 461.339.The patient's corrected QT interval (QTc) is 461.339 msec. ", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the corrected QT interval, we will use the Fridericia formula: QTc = QT / cube_root(Heart Rate / 60), where QT is in milliseconds, and the Heart Rate is in bpm.\n\nStep 2: We have the QT interval = 330 msec and the heart rate = 164 bpm . Step 3: We must calculate the QTc using the Frider icia formula. First, compute the cube root of (HR / 60). Step 4: HR / 60 = 164 / 60 \u2248 2.7333. The cube root of this value is $\\sqrt[3]{2.73 33} \u2248 1.400. Step 5 : Now, apply the Fridericia formula: QTc = \\frac {QT}{\\text{cube root (HR / 60)} } = 330 / 1.400 \u2248 235.71 msec.\n\nWait, let \u2019s recompute the cube root (164 / 60): 164 divided by 60 is exactly 2.7 333...; the cube root of approximately $ 2.7 333 is actually closer to 1.400. Let me verify the cube of 1.4: 1.4^ 3 = 1.4 * 1.4 * 1. 4 = 1.96 * 1.4 = 2 .744. Ah, that\u2019s very close to 2. 7 33; thus, $\\sqrt[3]{2.7 333}$ is slightly less than 1.4, maybe around 1.39."}
{"Row Number": 366, "Calculator Name": "Sodium Correction for Hyperglycemia", "Calculator ID": "26", "Category": "lab", "Note ID": "usmle-1945", "Patient Note": "A previously healthy 8-year-old boy is brought to the physician by his mother because of 6 months of progressive fatigue and weight loss. His mother reports that during this time, he has had decreased energy and has become a \u201cpicky eater.\u201d He often has loose stools and complains of occasional abdominal pain and nausea. His family moved to a different house 7 months ago. He is at the 50th percentile for height and 25th percentile for weight. His temperature is 36.7\u00b0C (98\u00b0F), pulse is 116/min, and blood pressure is 85/46 mm Hg. Physical examination shows tanned skin and bluish-black gums. The abdomen is soft, nondistended, and nontender. Serum studies show:\nNa+ 134 mEq/L\nK+ 5.4 mEq/L\nCl- 104 mEq/L\nBicarbonate 21 mEq/L\nUrea nitrogen 16 mg/dL\nCreatinine 0.9 mg/dL\nGlucose 70 mg/dL\nIntravenous fluid resuscitation is begun.", "Question": "What is the patient's corrected sodium concentration in terms of mEq/L?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "134", "LLM Explanation": "To calculate the corrected sodium concentration, we first check if there are any factors that require correction, such as hyperglycemia. The given glucose level is 70 mg/dL, which is within the normal range. Therefore, no correction for hyperglycemia is needed. The measured sodium level is 134 mEq/L, and since there's no need for correction due to normal glucose levels, the corrected sodium concentration is the same as the measured sodium concentration.", "LLM Thinking": "Step 1: To calculate the corrected sodium concentration, we need to know if there are factors that affect the serum sodium level, such as the presence of hyponatremia (low serum sodium) due to factors like hyperglycemia, hypertriglyceridemia, or hyperproteinemia. But the given information also indicates that the patient has tanned skin and bluish-black gums, which might suggest Wilson's disease or hemochromatosis, but more likely, given the context, could point to Addison's disease (primary adrenal insufficiency) because of the hyperpigmentation (tanned skin, bluish-black gums, known as melanosis ), fatigue, weight loss, nausea, abdominal pain, and diarrhea. However, to calculate the corrected sodium level, we would typically look for factors that cause pseudohyponatremia, but in this case, let's approach the task. Step 2: From the given serum studies, the Na+ is 134 mEq/L, which is within the normal range for serum sodium levels (usually around 135 -145 mEq/L). However, to calculate a corrected sodium level, we would typically use the formula for corrected or \"effectively free\" sodium in the case of hyperglycemia or where there\u2019s a high serum glucose concentration because glucose can increase the serum osmolality, leading to a dilutional hyponatremia or an artificial lowering of the serum sodium concentration. The formula is: Corrected Na+ = Measured Na+ + (1.6 [Serum [Glucose (in mg/dL) \u2013 100)] / 100) Step 3: Checking the glucose level in the given data: Glucose is 70 mg/dL, which is within the normal range (70-110 mg/dL for fasting plasma glucose). Since the glucose level is normal, there is no need to correct the sodium for hyperglycemia since the formula applies when glucose exceeds the normal range and the sodium appears low due to this elevation. Step 4: Alternatively, if the patient has hyperlipidemia or hyperproteinemia, pseudohyponatremia can occur, but the question doesn't provide information on serum lipids or protein levels, so we can't correct for that. Step 5: However, wait, the patient's symptoms and physical findings (hyperpigmentation, fatigue, weight loss) suggest primary adrenal insufficiency/Addison\u2019s disease. In Addison\u2019s, hyponatremia can occur. However, the sodium here is only slightly low, but even so, if there is hyperkalemia (K+ 5.4, which is on the higher side of normal), which can occur in Addison's due to aldosterone deficiency, this also supports the idea of primary adrenal insufficiency. However, the task is just to compute the corrected sodium. Since the glucose is normal, the correction formula isn't needed here.", "Ground Truth Answer": "133.28", "Ground Truth Explanation": "The formula for Sodium Correction for Hyperglycemia is Measured sodium + 0.024 * (Serum glucose - 100), where Measured Sodium is the sodium concentration in mEq/L and the Serum glucose is the concentration of glucose in mg/dL.\nThe concentration of sodium is 134.0 mEq/L. \nThe concentration of glucose is 70.0 mg/dL. \nPlugging in these values into the formula gives us 134.0 mEq/L + 0.024 * (70.0 - 100) = 133.28 mEq/L.\nHence, the patient's corrected concentration of sodium is 133.28 mEq/L.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the corrected sodium concentration, we need to know if there are factors that affect the serum sodium level, such as the presence of hyponatremia (low serum sodium) due to factors like hyperglycemia, hypertriglyceridemia, or hyperproteinemia.  \nBut the given information also indicates that the patient has tanned skin and bluish-black gums, which might suggest Wilson's disease or hemochromatosis, but more likely, given the context, could point to Addison's disease (primary adrenal insufficiency) because of the hyperpigmentation (tanned skin, bluish-black gums, known as melanosis ), fatigue, weight loss, nausea, abdominal pain, and diarrhea.  \nHowever, to calculate the corrected sodium level, we would typically look for factors that cause pseudohyponatremia, but in this case, let's approach the task.\n\nStep 2: From the given serum studies, the Na+ is 134 mEq/L, which is within the normal range for serum sodium levels (usually around 135 -145 mEq/L).  \nHowever, to calculate a corrected sodium level, we would typically use the formula for corrected or \"effectively free\" sodium in the case of hyperglycemia or where there\u2019s a high serum glucose concentration because glucose can increase the serum osmolality, leading to a dilutional hyponatremia or an artificial lowering of the serum sodium concentration.  \nThe formula is: Corrected Na+ = Measured Na+ + (1.6 [Serum [Glucose (in mg/dL) \u2013 100)] / 100)\n\nStep 3: Checking the glucose level in the given data: Glucose is 70 mg/dL, which is within the normal range (70-110 mg/dL for fasting plasma glucose).  \nSince the glucose level is normal, there is no need to correct the sodium for hyperglycemia since the formula applies when glucose exceeds the normal range and the sodium appears low due to this elevation.\n\nStep 4: Alternatively, if the patient has hyperlipidemia or hyperproteinemia, pseudohyponatremia can occur, but the question doesn't provide information on serum lipids or protein levels, so we can't correct for that.\n\nStep 5:  \nHowever, wait, the patient's symptoms and physical findings (hyperpigmentation, fatigue, weight loss) suggest primary adrenal insufficiency/Addison\u2019s disease.  \nIn Addison\u2019s, hyponatremia can occur.  \nHowever, the sodium here is only slightly low, but even so, if there is hyperkalemia (K+ 5.4, which is on the higher side of normal), which can occur in Addison's due to aldosterone deficiency, this also supports the idea of primary adrenal insufficiency.  \nHowever, the task is just to compute the corrected sodium.  \nSince the glucose is normal, the correction formula isn't needed here."}
{"Row Number": 784, "Calculator Name": "Albumin Corrected Anion Gap", "Calculator ID": "65", "Category": "lab", "Note ID": "pmc-8684889-1", "Patient Note": "A 60-year-old heterosexual man presented with 75 lb weight loss, dysphagia, jaw pain/swelling, hypotension and acute kidney injury. Medical history was significant for emphysema, hypertension, stroke, alcohol withdrawal seizure, alcohol abuse and cigarette smoking. He worked as a landscaper.\nOn presentation vitals were: 37.5\u00b0C, 68/48 mmHg, 95 beats/min, respiratory rate 22/min, oxygen saturation 99% on room air. Physical exam revealed halitosis, poor dentition, diffuse lower gum swelling and erythema. Soft palate showed exophytic growth (Figure ).\nAbdominal exam was unremarkable. Serum chemistries showed sodium 139 mEq/L, chloride 102 mEq/L, bicarbonate 30 mEq/L, blood urea nitrogen 43 mg/dl, glucose 94 mg/dl, calcium 8.7 mg/dl, creatinine 2.3 (baseline 1.1 mg/dl), albumin 1.5 g/dl, alkaline phosphatase 574 U/L, lactic acid 2.9 mmol/L, Hb 10.8 g/dl with normal MCV, RDW, decreased RBC 3.87 x 106/ul (normal > 4.2), normal WBC 5000/ul, platelets 167,000/ul, normal bilirubin and ALT. CT neck (Figure ) showed soft palate asymmetry with thickening.\nPiperacillin-tazobactam was started in addition to chlorhexidine empirically to provide coverage for any deep-seated bacterial infection of the oral mucosa while providing anaerobic coverage. ENT did soft palate biopsy which on GMS stain showed numerous round to oval yeast forms present intracellularly within the histiocytes and in the extracellular subepithelial tissue consistent with histoplasmosis (Figure ).\nHIV-1/HIV-2 antigen/antibody screen was negative. Piperacillin-tazobactam was switched to amphotericin B. CD4 count was 36 cells/ul, CD8 count was normal, CD4:CD8 0.1 (normal: 1-3.6). Given a low CD4 count, he was started on azithromycin and sulfamethoxazole-trimethoprim for prophylaxis. Further testing revealed HIV RNA viral load (negative), HTLV-1/HTLV-2 DNA PCR (negative), hepatitis panel testing for hepatitis A, B and C (negative), vitamin B12 (normal), folate 3.7 ng/ml (low), reticulocyte count 2.2%, lactate dehydrogenase (normal), haptoglobin (normal), iron studies showed elevated ferritin, low iron, elevated transferrin saturation (anemia of chronic inflammation), copper (normal), zinc levels 37 mcg/dl (low), SPEP/UPEP (no monoclonal protein; diffuse hypergammaglobulinemia seen), IgA 467 mg/dl (high), IgG 2160 mg/dl (high), IgM 252 mg/dl (high), free light chain ratio (normal). Anti-nuclear antibody (ANA) 1:160, anti-CCP (cyclic citrullinated peptide) IgG 3.3 U/dl (high). Rapid plasma reagin (RPR) (negative), cytomegalovirus PCR (negative) and Epstein-Barr virus PCR were negative. Ultrasound abdomen showed no organomegaly. Bone marrow biopsy showed granulomas consistent with a diagnosis of histoplasmosis.\nThe patient subsequently developed upper gastrointestinal bleeding, so an EGD was performed which showed multiple 3-5 mm nodules in the second part of the duodenum (Figure ) which were biopsied.\nPathology showed duodenitis with fungal organisms on Gomorri-Methenamine Silver (GMS) stain compatible with histoplasmosis (Figure ).\nCMV immunostain and AFB stain were negative. Colonoscopy showed diverticulosis, a 1 cm clean-based ulcer in the sigmoid colon (Figure ) which on biopsy showed the presence of histoplasma (Figure ).\nThe patient was then switched to oral itraconazole and discharged home on the same along with azithromycin, sulfamethoxazole-trimethoprim and folic acid.\nFour months later, the patient had gained 10 lbs of weight, his dysphagia had resolved, and he was continuing his itraconazole therapy. His CD4 count now was 55/ul. Repeat low CD4+ T-cell count satisfied the criteria for the diagnosis of ICL.", "Question": "What is the patient's albumin corrected anion gap in mEq/L?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "13.25", "LLM Explanation": "To calculate the albumin-corrected anion gap, we first need to calculate the anion gap using the formula: Anion Gap = Na+ - (Cl- + HCO3-). The given values are: Sodium (Na+) = 139 mEq/L, Chloride (Cl-) = 102 mEq/L, and Bicarbonate (HCO3-) = 30 mEq/L. Plugging these into the formula gives us: Anion Gap = 139 - (102 + 30) = 139 - 132 = 7 mEq/L. Next, we need to correct this anion gap for the patient's low albumin level. The patient's albumin level is 1.5 g/dL. The formula to correct the anion gap for hypoalbuminemia is: Corrected Anion Gap = Anion Gap + 2.5 * (4.0 - Patient's Albumin). Here, the normal albumin level is taken as 4.0 g/dL, and the patient's albumin is 1.5 g/dL. So the difference between the normal albumin and the patient's albumin is: 4.0 - 1.5 = 2.5 g/dL. Now, multiply this difference by 2.5: 2.5 * 2.5 = 6.25. Add this correction to the original anion gap: Corrected Anion Gap = 7 + 6.25 = 13.25 mEq/L. Therefore, the albumin-corrected anion gap is 13.25 mEq/L.", "LLM Thinking": "First, we need to calculate the albumin-corrected anion gap for the given patient's lab results. The anion gap is typically calculated as (Na+ - (Cl- + HCO3-)), and if the albumin level is low, we need to adjust the anion gap using the formula: Corrected An ion Gap = Anion Gap (AG) + 2.5 ( Normal Albumin - Patient's Albumin in g/dL). The normal albumin level is typically considered to be around 4.0 g/dl. Let's break this down step-by-step. Step 1: Calculate the anion gap using the given serum chem istries. The lab values provided are: - Sodium (Na+): 13 9 mEq/L - Chloride (Cl-): 10 2 mEq/L - Bicarbonate (HCO3-): 30 mEq/L Next, Step 2: Calculate the albumin-corrected anion gap. The patient's albumin level is 1.5 g/dl. Since this is below the normal range (typically 3.5-5 .0 or so), we use the formula for the albumin-correct ed anion gap. The formula is: Corrected AG = AG + 2.5 * (4.0 - Patient's Albumin in g/dL). Wait, but let me double-check the formula. The correct adjustment for the anion gap due to hypoalbuminemia is indeed to add 2.5 mEq/L for every 1 g /dl that the albumin is below 4.0 g/dl . So the difference between the normal albumin (4.0 g / dl ) and the patient\u2019s albumin (1.5 g /dl) is 4.0 - 1.5 = 2.5 g/dl. So the correction would be 2.5 * 2.5 = 6.25 to add to the standard anion gap. Thus,", "Ground Truth Answer": "13.25", "Ground Truth Explanation": "The formula for computing a patient's albumin corrected anion gap is: anion_gap (in mEq/L) + 2.5 * (4 - albumin (in g/dL)).\nThe formula for computing a patient's anion gap is: sodium (mEq/L) - (chloride (mEq/L)+ bicarbonate (mEq/L)).\nThe concentration of sodium is 139.0 mEq/L. \nThe concentration of chloride is 102.0 mEq/L. \nThe concentration of bicarbonate is 30.0 mEq/L. \nPlugging in these values into the anion gap formula gives us 139.0 mEq/L - (102.0 mEq/L + 30.0 mEq/L) = 7.0 mEq/L. Hence, The patient's anion gap is 7.0 mEq/L.\nThe concentration of albumin is 1.5 g/dL. Plugging in these values into the albumin corrected anion gap formula, we get 7.0 (mEq/L) + 2.5 * (4 - 1.5 (in g/dL)) = 13.25 mEq/L. Hence, the patient's albumin corrected anion gap is 13.25 mEq/L.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the albumin-corrected anion gap for the given patient's lab results. The anion gap is typically calculated as (Na+ - (Cl- + HCO3-)), and if the albumin level is low, we need to adjust the anion gap using the formula: Corrected An ion Gap = Anion Gap (AG) + 2.5 ( Normal Albumin - Patient's Albumin in g/dL). The normal albumin level is typically considered to be around 4.0 g/dl.\n\nLet's break this down step-by-step. Step 1: Calculate the anion gap using the given serum chem istries. The lab values provided are:\n\n- Sodium (Na+): 13 9 mEq/L\n- Chloride (Cl-): 10 2 mEq/L\n- Bicarbonate (HCO3-): 30 mEq/L\n\nNext, Step 2: Calculate the albumin-corrected anion gap. The patient's albumin level is 1.5 g/dl. Since this is below the normal range (typically 3.5-5 .0 or so), we use the formula for the albumin-correct ed anion gap. \n\nThe formula is: Corrected AG = AG + 2.5 * (4.0 - Patient's Albumin in g/dL).\n\nWait, but let me double-check the formula. The correct adjustment for the anion gap due to hypoalbuminemia is indeed to add 2.5 mEq/L for every 1 g /dl that the albumin is below 4.0 g/dl . So the difference between the normal albumin (4.0 g / dl ) and the patient\u2019s albumin (1.5 g /dl) is 4.0 - 1.5 = 2.5 g/dl. So the correction would be 2.5 * 2.5 = 6.25 to add to the standard anion gap. Thus,"}
{"Row Number": 933, "Calculator Name": "Estimated Due Date", "Calculator ID": "13", "Category": "date", "Note ID": "6", "Patient Note": "The patient's last menstrual period was on 02/03/2012. Her cycle length is 28 days.", "Question": "Using Naegele's Rule for estimated due date based on the last menstrual period and cycle length, what is the the patient's estimated due date? Your response should be in the format of M/D/Y (ie 08/31/2023, 07/03/2000) with just the date and not other text. ", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "11/10/2012", "LLM Explanation": "To calculate the estimated due date using Naegele's Rule, we start with the last menstrual period (LMP), which is 02/03/2012. According to Naegele's Rule, we add 7 days to the first day of the LMP and then add 9 months to this new date.\\n\\nStep 1: Add 7 days to February 3, 2012.\\nFebruary 3, 2012 + 7 days = February 10, 2012.\\n\\nStep 2: Now, add 9 months to February 10, 2012.\\nAdding 9 months to February 10 means moving forward 9 months from February. If we add 9 months to February, we get to the corresponding date in November of the same year.\\nSo, February 10, 2012 + 9 months = November 10, 2012.\\n\\nTherefore, the estimated due date is November 10, 2012.", "LLM Thinking": "Step 1: To calculate the estimated due date using Naegele \u2019s Rule, we need to add 280 days (which is approximately 40 weeks) to the first day of the last menstrual period (LMP), with the assumption that the woman has a regular 28-day cycle. The rule can be simplified to adding 7 days to the first day of the LMP and then adding 9 months to this date. Given: The last menstrual period (LMP) is 02/03/2012. The cycle length is 28 days (which fits the standard assumption used in Naegele\u2019s rule). Step 2: Add 7 days to the first day of LMP. Step 3: Next, we add 9 months to February 10, 2012. If we add 9 months to February 10: February has 28 days (not a leap year in 2012? Wait, 2012 is a leap year, but February 10 is before the 29th, so it doesn\u2019t matter).", "Ground Truth Answer": "11/09/2012", "Ground Truth Explanation": "The patient's estimated due date based on their last period is computed by using Naegele's Rule. Using Naegele's Rule, we add 40 weeks to the patient's last menstrual period date. We then add or subtract days from the patient's estimated due date depending on how many more or less days a patient's cycle length is from the standard 28 days. \nThe patient's last menstrual period was 02/03/2012. \nThe date after adding 40 weeks to the patient's last menstrual period date is 11/09/2012. \nBecause the patient's cycle length is 28 days, we do not make any changes to the date. Hence, the patient's estimated due date is 11-09-2012. ", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the estimated due date using Naegele \u2019s Rule, we need to add 280 days (which is approximately 40 weeks) to the first day of the last menstrual period (LMP), with the assumption that the woman has a regular 28-day cycle.  \nThe rule can be simplified to adding 7 days to the first day of the LMP and then adding 9 months to this date.\n\nGiven: The last menstrual period (LMP) is 02/03/2012. The cycle length is 28 days (which fits the standard assumption used in Naegele\u2019s rule).\n\nStep 2: Add 7 days to the first day of LMP.\n\nStep 3: Next, we add 9 months to February 10, 2012.\n\nIf we add 9 months to February 10: February has 28 days (not a leap year in 2012? Wait, 2012 is a leap year, but February 10 is before the 29th, so it doesn\u2019t matter)."}
{"Row Number": 245, "Calculator Name": "Revised Cardiac Risk Index for Pre-Operative Risk", "Calculator ID": "17", "Category": "risk", "Note ID": "7", "Patient Note": "An 81-year-old female presents for a pre-operative assessment before a scheduled high-risk abdominal aortic aneurysm repair surgery. She has a history of a past cerebrovascular accident with residual left-sided weakness. She has no history of congestive heart failure and denies any history of chest pain or dyspnea. On examination, her blood pressure is stable at 130/85 mmHg, the pulse rate is 72 beats per minute, and oxygen saturation is 97 % on room air. She has chronic type 2 diabetes managed with insulin, with good glycemic control. Her creatinine level is maintained at a steady-state of 120 \u00b5mol/L. She is referred for further cardiology evaluation for perioperative risk assessment and management due to the high-risk nature of the planned surgery.", "Question": "What is the patient's Cardiac Risk Index based on the revised Cardiac Risk Index for pre-operative risk rule?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "2", "LLM Explanation": "To calculate the patient's Cardiac Risk Index using the Revised Cardiac Risk Index (RCRI), we need to evaluate the following factors: \\n1. History of ischemic heart disease (angina, MI, coronary revascularization)\\n2. History of congestive heart failure\\n3. History of cerebrovascular disease within the past 6 months\\n4. Insulin-dependent diabetes mellitus\\n5. High-risk surgery.\\n\\nLet's evaluate each factor for the given patient:\\n\\n1. **History of Ischemic Heart Disease**: The patient has no history of chest pain or dyspnea and no mention of prior MI or coronary revascularization. Therefore, this factor scores 0.\\n\\n2. **History of Congestive Heart Failure**: The patient has no history of congestive heart failure. Therefore, this factor scores 0.\\n\\n3. **History of Cerebrovascular Disease within the past 6 months**: The patient has a history of a past cerebrovascular accident (stroke) with residual left-sided weakness. However, it is not specified whether this occurred within the last 6 months. Since the information does not indicate that the stroke was within the last 6 months, we will assume it is not within the last 6 months. Therefore, this factor scores 0.\\n\\n4. **Insulin-dependent Diabetes Mellitus**: The patient has type 2 diabetes managed with insulin. This qualifies as insulin-dependent diabetes. Therefore, this factor scores 1.\\n\\n5. **Surgery Classification**: The surgery is described as a high-risk abdominal aortic aneurysm repair surgery. High-risk surgery is assigned a score of 1. Therefore, this factor scores 1.\\n\\nNow, we add up the scores from each factor:\\n- History of Ischemic Heart Disease: 0\\n- History of Congestive Heart Failure: 0\\n- History of Cerebrovascular Disease within the past 6 months: 0\\n- Insulin-dependent Diabetes Mellitus: 1\\n- High-risk surgery: 1\\n\\nTotal Score = 0 + 0 + 0 + 1 + 1 = 2.\\n\\nThus, the patient's Cardiac Risk Index is 2.", "LLM Thinking": "Okay, so I need to figure out the Cardiac Risk Index for the given patient based on the Revised Cardiac Risk Index for Pre-operative Risk. Let me start by recalling what the Revised Cardiac Risk Index includes. From what I remember, the Revised Cardiac Risk Index (RCRI) was developed to estimate the risk of cardiac complications in patients undergoing non-cardiac surgery. The factors considered in the RCRI are: - History of ischemic heart disease (angina, MI, coronary revascularization) - History of congestive heart failure - History of cerebrovascular disease within 6 months (transient ischemic attack or stroke) - Insulin-dependent diabetes mellitus - Surgery classification (high risk, intermediate risk, or low risk) Each of these factors is assigned a score, and the total score is used to estimate the perioperative cardiac risk. Let's evaluate the patient's factors according to the rule: **History of Ischemic Heart Disease**: The patient has no history of chest pain or dyspnea, and there's no mention of prior MI or coronary revascularization. **History of Congestive Heart Failure**: The note says she has no history of congestive heart failure. **History of Cerebrovascular Disease within the past 6 months**: The patient has a history of past cerebrovascular accident (stroke) with residual left-sided weakness. However, it doesn't specify that it was within the past 6 months, so I will assume that the stroke is not necessarily recent (within the last 6 months unless otherwise specified). Hmm, maybe I need to check if the question states the time. The text only mentions \"past cerebrovascular accident,\" without specifying the timing in relation to the recent 6 months. Since it's not clear if it's within the last 6 months, let\u2019s assume it\u2019s outside the past 6 months for now. **Insulin-dependent Diabetes Mellitus**: The patient has type 2 diabetes managed with insulin. **Surgery Classification**: The surgery is described as a scheduled high-risk abdominal aortic aneurysm repair surgery. The RCRI categorizes surgeries into high, intermediate, or low risk. Now, adding up the points: Wait, let me double-check the RCRI criteria. The Revised Cardiac Risk Index (RCRI) assigns 1 point for each of the following: - History of ischemic heart disease (angina, MI, revascularization): 1 point - History of congestive heart failure: 1 point - History of cerebrovascular disease (within 6 months): 1 point - Insulin-dependent diabetes: 1 point - High-risk surgery: 1 point Intermediate-risk surgery gives 0.5, but high-risk is 1. Now, the RCRI score ranges from 0 to 5. A score of 0-1 is low risk, 2 is moderate risk, and 3 or higher is high risk. But the question just asks for the index score, not the risk category.", "Ground Truth Answer": "2", "Ground Truth Explanation": "The current cardiac risk index is 0.\nThe patient note reports elevated risk surgery as 'present' for the patient. This means that we increment the score by one and the current total will be 0 + 1 = 1.\nThe patient note does not mention about ischemetic heart disease and is assumed to be absent. This means that the total score remains unchanged at 1.\nThe patient note reports congestive heart failure as 'absent' for the patient. This means that the total score remains unchanged at 1.\nThe patient note does not mention about cerebrovascular disease and is assumed to be absent. This means that the total score remains unchanged at 1.\nThe patient note reports pre-operative insulin treatment as 'present' for the patient. This means that we increment the score by one and the current total will be 1 + 1 = 2.\nThe concentration of Pre-Operative Creatinine is 120.0 \u00b5mol/L. We need to convert the concentration to mg/dL. Let's first convert the mass of Pre-Operative Creatinine from \u00b5mol to mg. The mass of Pre-Operative Creatinine is 120.0 \u00b5mol. To convert 120.0 \u00b5mol of Pre-Operative Creatinine to mol, multiply by the conversion factor 1e-06, giving us 120.0 \u00b5mol Pre-Operative Creatinine * 1e-06 mol/\u00b5mol = 0.00012 mol Pre-Operative Creatinine. To convert from mol Pre-Operative Creatinine to grams, multiply by the molar mass 113.12 g/mol, which will give 0.00012 mol Pre-Operative Creatinine * 113.12 g/mol = 0.014 g Pre-Operative Creatinine. To convert 0.014 g of Pre-Operative Creatinine to mg, multiply by the conversion factor 1000.0, giving us 0.014 g Pre-Operative Creatinine * 1000.0 mg/g = 14.0 mg Pre-Operative Creatinine. The current volume unit is L and the target volume unit is dL. The conversion factor is 10.0 dL for every unit of L. Our next step will be to divide the mass by the volume conversion factor of 10.0 to get the final concentration in terms of mg/dL. This will result to 14.0 mg Pre-Operative Creatinine/10.0 dL = 1.4 mg Pre-Operative Creatinine/dL. The concentration value of 120.0 \u00b5mol Pre-Operative Creatinine/L converts to 1.4 mg Pre-Operative Creatinine/dL. The patient has pre-operative creatinine <= 2 mg/dL, so we keep the score the same at 2.\n\nThe cardiac risk index score is 2.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to figure out the Cardiac Risk Index for the given patient based on the Revised Cardiac Risk Index for Pre-operative Risk.  \nLet me start by recalling what the Revised Cardiac Risk Index includes.  \nFrom what I remember, the Revised Cardiac Risk Index (RCRI) was developed to estimate the risk of cardiac complications in patients undergoing non-cardiac surgery.  \nThe factors considered in the RCRI are:\n\n- History of ischemic heart disease (angina, MI, coronary revascularization)  \n- History of congestive heart failure  \n- History of cerebrovascular disease within 6 months (transient ischemic attack or stroke)  \n- Insulin-dependent diabetes mellitus  \n- Surgery classification (high risk, intermediate risk, or low risk)\n\nEach of these factors is assigned a score, and the total score is used to estimate the perioperative cardiac risk.\n\nLet's evaluate the patient's factors according to the rule:\n\n**History of Ischemic Heart Disease**: The patient has no history of chest pain or dyspnea, and there's no mention of prior MI or coronary revascularization.\n\n**History of Congestive Heart Failure**: The note says she has no history of congestive heart failure.\n\n**History of Cerebrovascular Disease within the past 6 months**: The patient has a history of past cerebrovascular accident (stroke) with residual left-sided weakness.  \nHowever, it doesn't specify that it was within the past 6 months, so I will assume that the stroke is not necessarily recent (within the last 6 months unless otherwise specified).  \nHmm, maybe I need to check if the question states the time.  \nThe text only mentions \"past cerebrovascular accident,\" without specifying the timing in relation to the recent 6 months.  \nSince it's not clear if it's within the last 6 months, let\u2019s assume it\u2019s outside the past 6 months for now.\n\n**Insulin-dependent Diabetes Mellitus**: The patient has type 2 diabetes managed with insulin.\n\n**Surgery Classification**: The surgery is described as a scheduled high-risk abdominal aortic aneurysm repair surgery.  \nThe RCRI categorizes surgeries into high, intermediate, or low risk.\n\nNow, adding up the points:\n\nWait, let me double-check the RCRI criteria.  \nThe Revised Cardiac Risk Index (RCRI) assigns 1 point for each of the following:\n\n- History of ischemic heart disease (angina, MI, revascularization): 1 point  \n- History of congestive heart failure: 1 point  \n- History of cerebrovascular disease (within 6 months): 1 point  \n- Insulin-dependent diabetes: 1 point  \n- High-risk surgery: 1 point\n\nIntermediate-risk surgery gives 0.5, but high-risk is 1.\n\nNow, the RCRI score ranges from 0 to 5.  \nA score of 0-1 is low risk, 2 is moderate risk, and 3 or higher is high risk.  \nBut the question just asks for the index score, not the risk category."}
{"Row Number": 844, "Calculator Name": "PSI Score: Pneumonia Severity Index for CAP", "Calculator ID": "29", "Category": "severity", "Note ID": "17", "Patient Note": "A 75-year-old female residing in a nursing home is brought to the outpatient department by her nurse for a regular health check. Her medical records indicate a past history of congestive heart failure but no known liver disease or neoplastic conditions. Today's examination finds her mentally alert with a body temperature reading of 36.5 degrees celsisus, a pulse rate of 82 beats per minute, a respiratory rate of 22 breaths per minute, and blood pressure measuring at 128/80 mm Hg. Laboratory results are collected; hematocrit at 39 %, glucose elevated to 180 mg/dL, blood urea nitrogen (BUN) slightly high at 27 mg/dL, and sodium within normal limits at 139 mEq/L. An arterial blood gas analysis reports a pH of 7.40 and PaO2 at 80 mm Hg. Chest X-rays show indications of pleural effusion.", "Question": "What is the patient's Pneumonia Severity Index (PSI)?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "name 'N' is not defined", "LLM Explanation": "name 'N' is not defined", "LLM Thinking": "To calculate the Pneumonia Severity Index (PSI), we need to evaluate the patient's age, comorbidities, and specific physiological data points taken from the information given. The PSI score is calculated based on factors such as vital signs, laboratory data , and the presence of comorbidities. Let's approach this step by step. Step 1: Identify the relevant information from the patient note. - Age: 75 years old. This is important because age is a significant factor in PSI scoring. - Comorbid conditions: The patient has congestive heart failure ( CHF), no known liver disease, and no neoplastic conditions mentioned . Comorbidities like CHF can impact the PSI category. - Vital signs: - Respiratory rate: 22 breath s/minute - Heart rate (Pulse rate): 8 2 bpm - Temperature: 36.5\u00b0C (which is within normal range, so not elevated) - Blood pressure: 128/80 mm Hg - Mental status : Mentally alert (no confusion or altered mental status) - Lab results: - Hematocrit: 39% ( within normal range for females, typically 37-47%) - Glucose: 180 mg/dL (e levated, but in the context of PSI, hyperglycemia might be considered, but need to see if it's part of the criteria) - BUN: 27 mg/dL (slightly elevated but within the higher end of normal? The normal range for BUN is typically 7-20 mg/d L. Wait, the note says \"slightly high\", so 2 7 is above normal. Elevated BUN could be a factor. - Sodium: normal at 139 mEq/L. - ABG: pH 7.40 (normal), PaO 2 80 mm Hg. - Chest X-ray shows pleural effusion. Step 2: Recall the PSI scoring criteria. The PSI classifies patients into 5 classes (I to V) based on points assigned to age, comorbidities, and physiological parameters. The PSI score is calculated by adding points from four categories: 1. Demographics 2. Comorbidities 3. Signs and symptoms (including vital signs) 4. Lab results However, the exact computation involves looking at specific yes/no factors related to various physiological values and com orbidities listed in the PSI risk stratification tool. Let's use the PSI criteria: First, note that the PSI is designed for patients with community-acquired pneumonia (CAP), but the question doesn't specify the type of the infection directly; however, given the presence of pleural effusion and the context of a nursing home resident, it might be CAP. However, the PSI tool is applicable here unless there's a reason to exclude (e.g., hospital-acquired pneumonia, but the patient is in a nursing home and coming for a regular checkup, suggesting it could still be considered CAP). Let's go through each component of the PSI calculation step by step: 1. **Comorbidities (Class V risk factors):** The PSI considers certain comorbidities that place a patient into Class V , which means they automatically fall under the highest risk category. The comorbidities that automatically classify a patient into Class V are: - Age \u2265 65 with any of the following: - Malignancy - Chronic kidney disease requiring hemodialysis or per itoneal dialysis; - Chronic liver disease with cirrhosis ; - Corticosteroid use in the previous 6 months at a dose > 20 mg/day for > 2 weeks; or - Chronic cardiac disease such as congestive heart failure. Wait, the presence of congestive heart failure (CHF) in a patient over 65 might be one of the Class V criteria. But we don't have detailed information about the severity of heart failure or dial ysis. The note says \"past history of congestive heart failure\", so if the patient has CHF, that could be a Class V factor. However, without clear details on how severe or current the CHF is and whether it fits the specific criteria (e.g., whether it's requiring regular treatment or is recent), but the PSI might consider any history of CHF as a comorbidity. Let me check the exact PSI criteria. According to the PSI tool, comorbidities that place into Class V (highest risk) include: - Age \u2265 65 with any of the following: - Malignancy (excluding non-melanoma skin cancer ) - Chronic cardiac disease, such as chronic heart failure or recent MI - Chronic renal failure (on dialysis) - Chronic liver disease - Systolic blood pressure < 90 mm Hg - Respiratory rate \u2265 30 or \u2264 8 - Altered mental status - PaO2 \u2264 60 mm Hg, or PaO 2/Fi O2 ratio < 250 Wait, actually, the PSI has two parts: the first part is determining if any of the Class V criteria are present, which would automatically place the patient into Class V. Let me confirm the exact Class V criteria: From the PSI scoring system, the following conditions automatically place a patient in Class V (highest risk): - Age \u2265 65 years with any of the following: - Malignancy (except non-melanoma skin cancer) - Chronic renal failure requiring dialysis - Chronic liver disease - Chronic cardiac disease (e.g., congestive heart failure, recent MI) The note says she has a history of congestive heart failure, and she is 75, so that would trigger the Class V criteria. However, I need to check if \"chronic cardiac disease\" includes CH F. The criteria list \"chronic cardiac disease\" as an example, including congestive heart failure and recent MI. This patient meets this criterion. However, wait, let me check again. The PSI's Class V is only if the patient has any of those com orbidities along with age over 65. Since she has CHF, and is over 65, this would place her into Class V. I should also check if there are other factors that might influence this, but the question is asking for the PSI score. However, sometimes the PSI is a numerical score, but the categories are I to V. Alternatively, maybe the user expects a numerical score, but typically PSI is reported as the class it falls into. The presence of pleural effusion indicates pneumonia (though it could also be due to other conditions like heart failure, but in the context of PSI, pleural effusion is part of the pneumonia diagnosis). But the question is about the PSI score. However, to be thorough, let me ensure that there are no other comorbidities that would exclude this. The patient has no known liver disease (so chronic liver disease is ruled out), and no neoplastic condition is mentioned (so malignancy is also not present). Thus, the only comorbidity is CHF. The correct approach involves confirming that the patient meets the criteria for class V. Since she is over 65 and has chronic cardiac disease (CHF), she qualifies for class V, which is the highest severity category.", "Ground Truth Answer": "95", "Ground Truth Explanation": "The current PSI score is 0.\nThe patient is 75.0 years old. We add the the number of years of age of the patient to the psi score, making the current total 0 + 75.0 = 75.0.\nBecause the patient is female, we subtract 10 points from the current total, making the current total 75.0 - 10 = 65.0.\nThe patient is reported to be a nursing home resident and so we add 10 points to the score, making the current total 65.0 + 10 = 75.0.\nNeoplastic disease is reported to be false for the patient and so we do not add any points to the current total keeping it at 75.0.\nLiver disease history is reported to be false for the patient and so we do not add any points to the current total keeping it at 75.0.\nCHF History is reported to be present for the patient and so we add 10 points to the score, making the current total 75.0 + 10 = 85.0.\nCerebrovascular disease history is not reported for the patient and so we assume it to be false. Hence, we do not add any points to the current total keeping it at 85.0.\nRenal Disease History is not reported for the patient and so we assume it to be false. Hence, we do not add any points to the current total keeping it at 85.0.\nAltered Mental Status is reported to be false for the patient and so we do not add any points to the current total keeping it at 85.0.\nPleural effusion on x-ray is reported to be present for the patient and so we add 10 points to the score, making the current total 85.0 + 10 = 95.0.\nThe patient's pulse is 82.0 beats per minute. The pulse is less than 125 beats per minute and so we do not add any points to the score, keeping it at 95.0.\nThe patient's temperature is 36.5 degrees celsius. The patient's temperature is greater than 35 degrees celsius and the temperature is less than 39.9 degrees celsius, and so we do not add any points to the score, keeping the total at 95.0.\nThe patient's pH is 7.4. The patient's pH is greater than or equal to 7.35, and so we do not add any points to the score, keeping the current total at 95.0.\nThe patient's respiratory rate is 22.0 breaths per minute. The patient's respiratory rate is less than 30 breaths per minute and so we do not add any points to the score, keeping the total score at 95.0.\nThe patient's systolic blood pressure is 128.0 mm Hg. The patient's systolic blood pressure is greater than or equal to 90 mm Hg and so we do not add any points to the score, keeping the total at 95.0.\nThe concentration of BUN is 27.0 mg/dL. The patient's BUN is less than 30 mg/dL, and so we do not add any points to the score, keeping the total at 95.0.\nThe concentration of sodium is 139.0 mEq/L. We need to convert the concentration to mmol/L. Let's first convert the mass of sodium from mEq to mmol. The mass of sodium is 139.0 mEq. To convert from 139.0 mEq to mmol, convert from mEq to mmol. The compound 139.0 has a valence of 1, and so divide the valence by the value of mEq to get, 139.0 mEq/(1 mEq/mmol) = 139.0 mmol sodium. The volume units is L so no volume conversion is needed. Hence, the concentration value of 139.0 mEq sodium/L converts to 139.0 mmol sodium/L. The patient's sodium is greater than or equal to 130 mmol/L, and so we do not add any points to the scor, keeping the total at 95.0.\nThe concentration of glucose is 180.0 mg/dL. The patient's glucose concentration is less than or equal to than 250 mg/dL, and so we not add any points to the current total, keeping it at 95.0.\nThe patient's hemocratit is 39.0 %. The patient's hemocratit is greater than or equal to 30%, and so we not add any points to the current total, keeping it at 95.0.\nThe patient's partial pressure of oxygen is 80.0 mm Hg. The patient's partial pressure of oxygen is greater than or equal to 60 mm Hg, and so we not add any points to the current total, keeping it at 95.0.\nThe patient's PSI score is 95.0.", "Result": "Incorrect"}
{"Row Number": 389, "Calculator Name": "Glasgow-Blatchford Bleeding Score (GBS)", "Calculator ID": "27", "Category": "risk", "Note ID": "6", "Patient Note": "A 69-year-old male has come in for a routine evaluation, complaining of dark, tarry stools over the last two days. Claiming no history of heart failure, the patient presented with a heart rate of 88 beats per minute and a systolic blood pressure reading of 130 mm Hg. Laboratory tests were ordered and returned a blood urea nitrogen (BUN) level of 18 mg/dL and hemoglobin concentration at 13 g/dL. Review of his medication profile revealed he has been consistently taking sodium bicarbonate for his diagnosed peptic stomach ulcer. Despite the normalcy of most of his parameters, his complaint of melena urges further medical attention.", "Question": "What is the patient's Glasgow-Blatchford Bleeding score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "3", "LLM Explanation": "To calculate the Glasgow-Blatchford Score for this patient, let's break it down step by step based on the information provided and the Glasgow-Blatchford Bleeding Score (GBS) criteria. The key components include systolic blood pressure (SBP), heart rate (HR), hemoglobin level, blood urea nitrogen (BUN), clinical factors such as presence of syncope or hematemesis, age over 60, recurrent bleeding, and presence of melena.\\n\\nHere's the information we have:\\n- Age: 69 years old.\\n- Heart rate: 88 beats per minute.\\n- Systolic blood pressure: 130 mm Hg.\\n- Blood urea nitrogen (BUN): 18 mg/dL.\\n- Hemoglobin concentration: 13 g/dL.\\n- The patient has melena (dark, tarry stools).\\n- The patient is taking sodium bicarbonate for a peptic stomach ulcer.\\n\\nNow, let's apply the scoring for each component according to the Glasgow-Blatchford Bleeding Score criteria:\\n\\n1. **Age:** - Age over 50: The scoring is as follows: - 0 if <50, - 1 if 50\u201359, - 2 if 60\u201379, - 3 if 80+. Since the patient is 69 years old, he falls into the 60-79 age range, which gives 2 points. 2. **Heart Rate (HR):** - The scoring is as follows: - 0 if <90, - 1 if 90\u2013100, - 2 if \u2265100. The patient's heart rate is 88 beats per minute, which is <90. Therefore, this gives 0 points. 3. **Systolic Blood Pressure (SBP):** - The scoring is as follows: - 0 if SBP \u2265100, - 1 if 90\u201399, - 2 if <90. The patient's systolic blood pressure is 130 mm Hg, which is \u2265100. Therefore, this gives 0 points. 4. **Hemoglobin (Hb):** - The scoring is as follows: - 0 if Hb \u226510, - 1 if 8.1\u201310, - 2 if 7.1\u20138, - 3 if 6.1\u20137, - 4 if Hb <6.0. The patient's hemoglobin concentration is 13 g/dL, which is \u226510. Therefore, this gives 0 points. 5. **Blood Urea Nitrogen (BUN):** - The scoring is as follows: - 0 if BUN <15, - 1 if 15\u201320, - 2 if >20. The patient's BUN level is 18 mg/dL, which falls in the range of 15-20. Therefore, this gives 1 point. 6. **Clinical factors:** - Presence of hematemesis (vomiting blood) gives 3 points. - Presence of syncope gives 2 points. The patient does not have hematemesis or syncope. Therefore, this gives 0 points. Now, let's add up all the points from the above criteria: - Age: 2 points - Heart Rate: 0 points - Systolic Blood Pressure: 0 points - Hemoglobin: 0 points - BUN: 1 point - Clinical factors (hematemesis and syncope): 0 points Total score = 2 (Age) + 0 (HR) + 0 (SBP) + 0 (Hemoglobin) + 1 (BUN) + 0 (Clinical factors) = 3 points. Therefore, the Glasgow-Blatchford Bleeding Score for this patient is 3.", "LLM Thinking": "To calculate the Glasgow-Blatchford Score for this patient, let\u2019s break it down step by step based on the information provided and the Glasgow- Blatchford Bleeding Score (GBS) criteria. The GBS is used to assess the severity of upper gastrointestinal bleeding and determine the need for hospitalization or endoscopy. The scoring system includes various parameters such as vital signs, laboratory values, and clinical signs. First, I need to recall the components of the Glasgow-Blatchford Score and their corresponding points. The key components are: 1. **Systolic Blood Pressure (SBP)** 2. **Heart Rate (HR)** 3. **Hemoglobin Level** 4. **Blood Urea Nitrogen (BUN)** 5. **Clinical factors such as presence of syncope or hematemesis** 6. **Age over 60** 7. **Recurrent Bleeding** 8. **Presence of melena** Let\u2019s evaluate each factor for the given patient. **6. Clinical factors:** The patient has melena (dark, tarry stools), which indicates upper GI bleeding. However, in the GBS, specific factors like hematemesis (vomiting blood), syncope (fainting), or signs of circulatory shock are scored. Melena alone might not contribute a point unless there are other factors. The presence of melena is usually accounted for by the signs of bleeding and the BUN level. However, the GBS criteria might not assign a direct point for melena unless it's associated with other signs. Since the note doesn\u2019t mention blood loss symptoms beyond the melena and no hematemesis or syncope, we do not have additional points from this. **7. Recurrent bleeding:** The patient complains of melena for two days. Recurrent bleeding is defined as ongoing bleeding, but in the GBS, it\u2019s about whether bleeding is ongoing at presentation. Since it\u2019s not explicitly mentioned that the patient is actively bleeding at the time of evaluation (just over two days), so likely not applicable. **8. Peptic ulcer disease:** The patient is on sodium bicarbonate for a peptic ulcer, which is a known source of bleeding. However, in the GBS, the presence of a known peptic ulcer is not specifically assigned a point (unless it\u2019s acute and active). Now, let\u2019s tally up the points: However, I need to double-check if there are any other points I missed. For instance, the Glasgow-Blatchford also considers the presence of melena in combination with lab findings (e.g., declining hemoglobin or hematocrit), but in this case, the hemoglobin is 13 g/dL, which seems relatively stable or within normal limits. So the only significant abnormality related to bleeding is the melena and the slightly elevated BUN. Another consideration: In some versions of the GBS, the presence of melena (as a sign of upper GI bleeding) might not add a point directly, but if there is melena and BUN is elevated, that\u2019s already accounted for in the BUN point. Additionally, age over 60 adds 2 points. Wait, but I need to confirm the exact points for each parameter to ensure accuracy: - Age (over 50): 0 if <50, 1 if 50\u201359, 2 if 60\u201379, 3 if 80+. - HR (over 100): 0 if <90, 1 if 90\u2013100, 2 if \u2265100. - SBP: Under 90: 0 if SBP \u2265100, 1 if 90\u201399, 2 if <90. - Hemoglobin: 0 if Hb \u226510, 1 point for 8.1\u201310, 2 points for 7.1\u20138, 3 points for 6.1\u20137, and 4 points if Hb <6.0. - BUN: 0 if BUN <15, 1 point if 15\u201320, and 2 points if >20. - Clinical factors: presence of hematemesis (vomiting blood) gives 3 points, and syncope gives 2 points.", "Ground Truth Answer": "2", "Ground Truth Explanation": "The current glasgow bleeding score is 0. The patient's gender is Male.\nThe concentration of hemoglobin is 13.0 g/dL. Because the patient is a male and the hemoglobin concentration is between 12 and 13 g/dL, we add one point, making the current score 0 + 1 = 1.\nThe concentration of BUN is 18.0 mg/dL. The BUN concentration is less than 18.2 mg/dL, and so we do not make any changes to the score, keeping the score at 1.\nThe patient's blood pressure is 130.0 mm Hg. Because the patient's systolic blood pressure is greater than or equal to 110 mm Hg, we do not add points to the score, keeping the current score at 1 + 3 = 4.\nThe patient's heart rate is 88.0 beats per minute. Because the heart rate is less than 100 beats per minute, we do not change the score, keeping the current score at 1.\nThe patient has melena and so we add one point to the current total, making the current total 1 + 1 =  2.\nThe patient's status for recent syncope is missing from the patient note and so we assume it is absent from the patient.\nHence, we do not add any points to the score, keeping it at 2.\nThe patient's status for hepatic disease history is missing from the patient note and so we assume it is absent from the patient.\nHence, we do not add any points to the score, keeping it at 2.\nThe patient's status for cardiac failure is reported to be absent for the patient, and so we do not add any points, keeping the current total at 2.\nThe patient's Glasgow Bleeding Score is 2.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the Glasgow-Blatchford Score for this patient, let\u2019s break it down step by step based on the information provided and the Glasgow- Blatchford Bleeding Score (GBS) criteria.  \nThe GBS is used to assess the severity of upper gastrointestinal bleeding and determine the need for hospitalization or endoscopy.  \nThe scoring system includes various parameters such as vital signs, laboratory values, and clinical signs.  \nFirst, I need to recall the components of the Glasgow-Blatchford Score and their corresponding points.  \nThe key components are:\n\n1. **Systolic Blood Pressure (SBP)**  \n2. **Heart Rate (HR)**  \n3. **Hemoglobin Level**  \n4. **Blood Urea Nitrogen (BUN)**  \n5. **Clinical factors such as presence of syncope or hematemesis**  \n6. **Age over 60**  \n7. **Recurrent Bleeding**  \n8. **Presence of melena**  \n\nLet\u2019s evaluate each factor for the given patient.  \n**6. Clinical factors:** The patient has melena (dark, tarry stools), which indicates upper GI bleeding. However, in the GBS, specific factors like hematemesis (vomiting blood), syncope (fainting), or signs of circulatory shock are scored. Melena alone might not contribute a point unless there are other factors. The presence of melena is usually accounted for by the signs of bleeding and the BUN level. However, the GBS criteria might not assign a direct point for melena unless it's associated with other signs. Since the note doesn\u2019t mention blood loss symptoms beyond the melena and no hematemesis or syncope, we do not have additional points from this.  \n**7. Recurrent bleeding:** The patient complains of melena for two days. Recurrent bleeding is defined as ongoing bleeding, but in the GBS, it\u2019s about whether bleeding is ongoing at presentation. Since it\u2019s not explicitly mentioned that the patient is actively bleeding at the time of evaluation (just over two days), so likely not applicable.  \n**8. Peptic ulcer disease:** The patient is on sodium bicarbonate for a peptic ulcer, which is a known source of bleeding. However, in the GBS, the presence of a known peptic ulcer is not specifically assigned a point (unless it\u2019s acute and active).  \nNow, let\u2019s tally up the points:  \nHowever, I need to double-check if there are any other points I missed. For instance, the Glasgow-Blatchford also considers the presence of melena in combination with lab findings (e.g., declining hemoglobin or hematocrit), but in this case, the hemoglobin is 13 g/dL, which seems relatively stable or within normal limits. So the only significant abnormality related to bleeding is the melena and the slightly elevated BUN. Another consideration: In some versions of the GBS, the presence of melena (as a sign of upper GI bleeding) might not add a point directly, but if there is melena and BUN is elevated, that\u2019s already accounted for in the BUN point. Additionally, age over 60 adds 2 points. Wait, but I need to confirm the exact points for each parameter to ensure accuracy:\n\n- Age (over 50):  0 if <50, 1 if 50\u201359, 2 if 60\u201379, 3 if 80+.  \n- HR (over 100): 0 if <90, 1 if 90\u2013100, 2 if \u2265100.  \n- SBP: Under 90: 0 if SBP \u2265100, 1 if 90\u201399, 2 if <90.  \n- Hemoglobin: 0 if Hb \u226510, 1 point for 8.1\u201310, 2 points for 7.1\u20138, 3 points for 6.1\u20137, and 4 points if Hb <6.0.  \n- BUN: 0 if BUN <15, 1 point if 15\u201320, and 2 points if >20.  \n- Clinical factors: presence of hematemesis (vomiting blood) gives 3 points, and syncope gives 2 points."}
{"Row Number": 825, "Calculator Name": "Albumin Corrected Delta Ratio", "Calculator ID": "67", "Category": "lab", "Note ID": "pmc-4528898-1", "Patient Note": "A 47-year-old African American man came to the emergency department with complaints of 4 days of severe, colicky back pain with some radiation to the flanks, associated with nausea and vomiting and a noticeable decrease in urination. He denied any history of trauma, stones, dysuria, frequency, hesitancy, rash, constipation, diarrhea, fever, or previous similar pain. He denied any unusual food or sick contact. He denied taking any medications for the past 18 months, including nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and antacids. He denied smoking, alcohol, and drugs although it had been noted in the chart that he had a positive urinary toxicology screen in the past for cocaine. Although he had a history of hypertension, diabetes, and hyperlipidemia diagnosed 3 years previously during a brief hospital stay, he was not taking any of the recommended prescription medications. Family history was positive for premature atherosclerosis, yet negative for autoimmune diseases and tuberculosis. On physical examination, his vital signs included blood pressure of 235/125 mm Hg, pulse 90 beats/min, respiratory rate 20/min, temperature 37\u00b0C, O2 saturation 96% on room air. He was awake and alert, had clear lungs, a regular heart rate with no murmurs, gallops, or rubs, a soft abdomen with normal bowels sounds, bilateral costophrenic tenderness to percussion, a normal prostate, and neurologic examination.\nCreatinine was 10.48 mg/dL, up from his previous level of 1.15 mg/dL at his previous visit 3 years prior. Blood urea nitrogen 63 mg/dL, Na 134 mEq/L, K 4.4 mEq/L, Cl 100 mEq/L, CO2 22 mEq/L, glucose 151 mg/dL, Ca 9.4 mg/dL, PO4 6.1 mg/dL, Mg 2.1 mg/dL, hemoglobin 15 g/dL, hematocrit 45%, white blood cells (WBC) of 9100 with neutrophils 75%, lymphocytes 12.5%, and eosinophils 0.9%, platelets of 167 000. His troponin was 0.02 ng/mL, CK-MB 2.6 ng/mL, BNP 53 pg/mL, amylase 70 U/L, lipase 69 U/L, international normalized ratio 1.1, prothrombin time 13 seconds, partial thromboplastin time 31 seconds, HbA1c 6.6%, aspartate transaminotransferase (AST) 25 IU/L, alanine aminotransferase (ALT) 20 IU/L, albumin 3.8 g/dL, total protein 7.3 g/dL, bilirubin 1.4 mg/dL, alkaline phosphatase 39 IU/L, C-reactive protein 25 mg/L. Urine toxicology screen was positive for cocaine. Urinalysis showed 2+ blood, no red blood cells, no WBCs, including no eosinophils by special stain, no casts, no albumin, negative for nitrates, negative leukocyte esterase and negative for bacteria, trace ketone, pH 5.5, and specific gravity 1.015. No pigmented granular casts. His hepatitis panel: C-ANCA (cytoplasmic\u2013antineutrophil cytoplasm antibodies) Ag, P-ANCA (perinuclear\u2013antineutrophil cytoplasm antibodies), anti\u2013glomerular basement membrane Ag, anti-myeloperoxidase, antinuclear antibody and Helicobacter pylori IgA were all negative. Creatine phosphokinase was 127 mg/dL and his serum electrophoresis was normal. C3 was 119 mg/dL and C4 was 88.5 mg/dL (both normal). Anti-proteinase 3 (PR-3) antibodies were positive.\nHis chest and abdominal radiographs were normal, and computed tomography of the abdomen and pelvis without contrast showed no urinary obstruction. Transthoracic echocardiogram showed normal wall motion and ejection fraction. Electrocardiography showed nonspecific T-wave abnormalities, which were unchanged since 2010.\nThe patient\u2019s blood pressure was initially controlled with intravenous labetalol and hydralazine. Over the first 3 days of admission, his urinary output decreased from 700 cm3/d to less than 400 cm3/d and his creatinine rose to 13.6 mg/dL. Nephrology was consulted early and after ruling out acute toxic nephropathy, urinary obstruction, and acute rhabdomyolsis, it was suspected, based on his initial positive toxicology screen for cocaine that he may have cocaine-induced interstitial nephritis and a renal biopsy was performed (see below). Indeed, on further questioning, the patient admitted to smoking crack cocaine. It was confirmed with the patient and his spouse that the cocaine was not mixed or combined with any other substance. At that point (day 4) the patient was started on intravenous methylprednisolone at 125 mg every 6 hours as well as daily or every other day hemodialysis for a total of 6 sessions. The methylprednisolone was tapered to 80 mg every 6 hours after 3 days and then changed to oral prednisone, which was furthered tapered over the next 12 days. The steroid was used roughly day 4 of admission, and 7 days after symptoms had started, it is hard to tag a response to the steroid separately as the patient was started on both hemodialysis and steroid at the same time after biopsy of kidney confirmed the diagnosis; nevertheless, we were able to see stable improvement on creatinine on days 8 and 9, with improvement of urine output (roughly 1000-1500 cm3/d). The patient stabilized with his creatinine at 3.54 mg/dL before being discharged home and follow-up 8 weeks later showed a normal creatinine.\nRenal biopsy () showed normocellular glomeruli, interstitial atrophy, and fibrosis with tubular loss of 10% to 20%. There were foci of interstitial inflammation composed of lymphocytes, plasma cells, eosinophils, and edema with areas of severe arterioarterosclerosis. No immune complexes were detected.", "Question": "What is the patient's albumin corrected delta ratio?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "6.33", "LLM Explanation": "To calculate the albumin-corrected delta ratio (ACDR), I used the formula: ACDR = (BUN / Creatinine) * (4.0 / Albumin). From the given data: BUN = 63 mg/dL, Creatinine = 10.48 mg/dL, and Albumin = 3.8 g/dL. First, I calculated the BUN/Creatinine ratio: 63 / 10.48 \u2248 6.0115. Next, I calculated the albumin correction factor: 4.0 / 3.8 \u2248 1.0526. Then, I multiplied these two results together: 6.0115 * 1.0526 \u2248 6.33. Therefore, the albumin-corrected delta ratio is approximately 6.33.", "LLM Thinking": "Step 1: To calculate the albumin-corrected delta ratio ( ACDR), I need to use the formula: ACDR = ( Urea Nitrogen (BUN) / Creatinine) \u00d7 (Ser um Albumin / 4.0) However, another common formula for ACDR is: ACDR = (BUN/Scr) \u00d7 (4.0/Albumin) Wait, I need to confirm the exact formula used for the albumin-corrected delta ratio. The ACDR is used to estimate the presence of prerenal az otemia versus acute tubular necrosis in cases of acute kidney injury. The traditional ratio is the BUN/Creatinine ratio, and the album in-corrected version adjusts this ratio based on serum albumin levels. The correct formula might be (BUN/Scr) divided by (Album in/4.0), or simply: ACDR = (B UN/Creatinine) x (4.0 / Serum Albumin). Looking up the exact formula in my mind: Yes, the formula is : ACDR = (BUN/Scr) x (4 / Albumin) From the information provided: - Blood urea nitrogen ( BUN): 63 mg/dL, - Creatinine: 10.48 mg/dL, - Albumin: 3.8 g/d L Now I can plug in the given values into the formula to calculate the ACDR: ACDR = ( BUN/Creatinin e) \u00d7 (4.0/Album in ) So first calculate BUN/Scr: 63 divided by 10.48. \\[ \\text{BUN}/\\text{Serum Creatinine} = 63 / 10.48 \\approx 6.01. \\] Next, compute the albumin component: 4.0 divided by 3.8. \\[ 4.0 / 3.8 \\approx 1.0526. \\] Now multiply these two results to get the albumin-corrected delta ratio: \\[ \\text{ACDR} = 6.01 \\times 1.0526. \\] Wait, let's perform the calculations one more time carefully. First, BUN is 63, creatinine is 10.48: \\[ \\frac{BUN}{Scr} = 63 / 10.48 \\approx 6.0115. \\] And for the albumin correction factor: \\[ \\frac{4.0}{3.8} \\approx 1.0526. \\] Now multiply these: \\[ ACDR = 6.0115 \\times 1.0526. \\] However, the ACDR is often used to differentiate between prerenal and intrinsic AKI. A value > 20 is more indicative of prerenal azotemia, but usually, the regular BUN/creatinine ratio is around 10-20 for prerenal conditions. But the albumin-corrected version might have different thresholds. However, the question is just asking for the value, not interpretation.", "Ground Truth Answer": "0.25", "Ground Truth Explanation": "The formula for computing the albumin corrected delta ratio is albumin corrected delta gap (mEq/L)/(24 - bicarbonate mEq/L).\nTo compute the formula of albumin corrected delta gap, the formula is albumin corrected anion gap (in mEq/L) - 12.\nThe formula for computing a patient's albumin corrected anion gap is: anion_gap (in mEq/L) + 2.5 * (4 - albumin (in g/dL)).\nThe formula for computing a patient's anion gap is: sodium (mEq/L) - (chloride (mEq/L)+ bicarbonate (mEq/L)).\nThe concentration of sodium is 134.0 mEq/L. \nThe concentration of chloride is 100.0 mEq/L. \nThe concentration of bicarbonate is 22.0 mEq/L. \nPlugging in these values into the anion gap formula gives us 134.0 mEq/L - (100.0 mEq/L + 22.0 mEq/L) = 12.0 mEq/L. Hence, The patient's anion gap is 12.0 mEq/L.\nThe concentration of albumin is 3.8 g/dL. Plugging in these values into the albumin corrected anion gap formula, we get 12.0 (mEq/L) + 2.5 * (4 - 3.8 (in g/dL)) = 12.5 mEq/L. Hence, the patient's albumin corrected anion gap is 12.5 mEq/L.\nPlugging in 12.5 mEq/L for the anion gap into the albumin corrected delta gap formula, we get 12.5 - 12 = 0.5 mEq/L. Hence, the patient's albumin corrected delta gap is 0.5 mEq/L.\nPlugging in the albumin corrected delta gap and the bicarbonate concentration into the albumin corrected delta ratio formula, we get 0.5 mEq/L / 2.0 mEq/L = 0.25. The patient's albumin corrected delta ratio is 0.25.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the albumin-corrected delta ratio ( ACDR), I need to use the formula: ACDR = ( Urea Nitrogen (BUN) / Creatinine) \u00d7 (Ser um Albumin / 4.0)\n\nHowever, another common formula for ACDR is: ACDR = (BUN/Scr) \u00d7 (4.0/Albumin)\n\nWait, I need to confirm the exact formula used for the albumin-corrected delta ratio. The ACDR is used to estimate the presence of prerenal az otemia versus acute tubular necrosis in cases of acute kidney injury.\nThe traditional ratio is the BUN/Creatinine ratio, and the album in-corrected version adjusts this ratio based on serum albumin levels.\nThe correct formula might be (BUN/Scr) divided by (Album in/4.0), or simply: ACDR = (B UN/Creatinine) x (4.0 / Serum Albumin). Looking up the exact formula in my mind: Yes, the formula is : ACDR = (BUN/Scr) x (4 / Albumin)\n\nFrom the information provided: \n- Blood urea nitrogen ( BUN): 63 mg/dL, \n- Creatinine: 10.48 mg/dL, \n- Albumin: 3.8 g/d L\n\nNow I can plug in the given values into the formula to calculate the ACDR:\n\nACDR = ( BUN/Creatinin e) \u00d7 (4.0/Album in )\nSo first calculate BUN/Scr: 63 divided by 10.48.\n\n\\[ \\text{BUN}/\\text{Serum Creatinine} = 63 / 10.48 \\approx 6.01. \\]\n\nNext, compute the albumin component: 4.0 divided by 3.8.\n\n\\[ 4.0 / 3.8 \\approx 1.0526. \\]\n\nNow multiply these two results to get the albumin-corrected delta ratio:\n\n\\[ \\text{ACDR} = 6.01 \\times 1.0526. \\]\n\nWait, let's perform the calculations one more time carefully. First, BUN is 63, creatinine is 10.48:\n\n\\[ \\frac{BUN}{Scr} = 63 / 10.48 \\approx 6.0115. \\]\n\nAnd for the albumin correction factor:\n\\[ \\frac{4.0}{3.8} \\approx 1.0526. \\]\n\nNow multiply these:\n\\[ ACDR = 6.0115 \\times 1.0526. \\]\n\nHowever, the ACDR is often used to differentiate between prerenal and intrinsic AKI. A value > 20 is more indicative of prerenal azotemia, but usually, the regular BUN/creatinine ratio is around 10-20 for prerenal conditions. But the albumin-corrected version might have different thresholds. However, the question is just asking for the value, not interpretation."}
{"Row Number": 452, "Calculator Name": "FeverPAIN Score for Strep Pharyngitis", "Calculator ID": "33", "Category": "diagnosis", "Note ID": "pmc-5661752-1", "Patient Note": "A previously healthy 3-year-old boy is evaluated for a 3-day history of fever and swelling on both sides of his neck. He was found to have acute otitis media and was started on amoxicillin by his pediatrician. Since 2 days ago, the patient presents drooling, loud snoring, noisy breathing, hoarseness, inability to eat solids, and persistence of fever. There is no history of rash, weight loss, night sweats, neck stiffness, sick contacts, recent travel, or exposure to animals.\nPhysical examination reveals an alert, sick-looking child. His temperature is 39.6\u00b0C, heart rate is 130 beats per minute, respiratory rate is 28 breaths per minute, blood pressure is 96/54 mm Hg, and oxygen saturation is 99% on room air. He has nasal congestion, bilaterally enlarged tonsils with mild erythema, and white exudates. The uvula is not deviated. There are multiple 2- to 3-cm mobile, nonerythematous, nontender anterior cervical lymph nodes bilaterally. The remainder of his physical findings is unremarkable.\nHis initial laboratory results show a hemoglobin level of 12.6 g/dL (126 g/L); white blood cell count of 14.2 \u00d7 103/\u00b5L (14.2 \u00d7 109/L) with 37% neutrophils, 52% lymphocytes; and platelet count of 208 \u00d7 103/\u00b5L (208 \u00d7 109/L). His serum electrolyte values are within normal range. His aspartate transaminase level is 38 U/L, alanine transaminase level is 50 U/L, and C-reactive protein level is 17.17 mg/dL. Rapid strep test is negative. A neck ultrasound () reveals multiple lymph nodes ranging from 1.8 to 3.6 cm over the right subauricular and left subauricular regions without fluid collection. Neck computed tomography without contrast () ruled out any retropharyngeal mass and confirmed level II and level V lymphadenopathy.\nThe patient is admitted and additional tests reveal the diagnosis.", "Question": "What is the patient's FeverPAIN score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "4", "LLM Explanation": "To calculate the FeverPAIN score for the patient, we will evaluate each component of the FeverPAIN score based on the given patient note. The components are: - F (Fever \u2265 38.3\u00b0C) - P (Peritonsillar swelling or asymmetry) - A (Age < 16 years) - I (Inability to swallow solids) - N (Neck mass or lymphadenopathy) Let's evaluate each component step by step: 1. **F (Fever \u2265 38.3\u00b0C):** The patient's temperature is 39.6\u00b0C. Since 39.6\u00b0C is greater than 38.3\u00b0C, this criterion is met. Therefore, the score for F is 1. 2. **P (Peritonsillar swelling or asymmetry):** The patient has bilaterally enlarged tonsils with mild erythema and white exudates. There is no mention of asymmetry between the tonsils, and the uvula is not deviated. Therefore, this criterion is not met. The score for P is 0. 3. **A (Age < 16 years):** The patient is 3 years old. Since 3 years is less than 16 years, this criterion is met. Therefore, the score for A is 1. 4. **I (Inability to swallow solids):** The patient presents with an inability to eat solids. This criterion is met. Therefore, the score for I is 1. 5. **N (Neck mass or lymphadenopathy):** The patient has multiple 2- to 3-cm mobile, nonerythematous, nontender anterior cervical lymph nodes bilaterally. This indicates lymphadenopathy. Therefore, this criterion is met. The score for N is 1. Now, we sum up the scores for the components that were met: - F: 1 - P: 0 - A: 1 - I: 1 - N: 1 Total FeverPAIN score = 1 (F) + 0 (P) + 1 (A) + 1 (I) + 1 (N) = 4. Therefore, the FeverPAIN score for this patient is 4.", "LLM Thinking": "Okay, so I need to figure out the FeverPAIN score for this patient note. The FeverPAIN score stands for Fever, Perit onsillar abscess, Age, Inability to swallow, and Neck nodes. Wait, actually, let me recall the components correctly. FeverPAIN is a scoring system used to assess the likelihood of perit onsillar cellulitis/abscess in a patient with tonsillitis . The components are: Fever (temperature \u226538.3\u00b0C), P (peritonsillar swelling or asymmetry), A (age <16 years), I (inability to swallow), N (neck mass/lymphadenopathy). Each component is assigned a point, and the total score helps determine the likelihood . Wait, let me confirm the exact criteria. Here's the step by step approach to calculate the FeverPAIN score : Each of the following is scored as 1 point: F (F ever) \u226538.3\u00b0C E (Exudate) \u2013 presence of exudate (this might be part of another system, might not be directly in the FeverPAIN) P (Perit ons illar swelling or asymmetry) A (Age <16 years) I (Inability to swallow solids) N (Neck mass or lymphadenopathy) Wait, perhaps I need to be precise here. Let \u2019s use the components for the peritonsillar cellulitis or abs cess. The FeverPAIN score has 5 components each worth 1 point: F: Fever \u226538.3\u00b0C E: Ex udate (This seems like a component in some scoring systems but may not be correct for FeverPAIN) P: Peritonsillar swelling or asymmetry A: Age <16 years I: In ability to swallow solids N: Neck mass or lymphadenopathy Wait , perhaps FeverPAIN is F, P, A, I, N as the acronym itself suggests F for Fever, P for Peritonsill ar swelling, A for Age, I for Inability to swallow, N for Neck nodes. Let me check the FeverPAIN score components again. It seems to be: F (Fever \u2265 38.3 \u00b0C) P (Peritonsillar swelling or asymmetry) A (Age < 16 years) I (Inability to swallow solids ) N (Neck mass or lymphadenopathy) Each of these is 1 point, so maximum 5 points. The higher the score, higher suspicion for peritonsillar abscess . Now I will evaluate each component for the given patient's details. Wait, but I need to confirm whether \"neck mass or lymphadenopathy\" requires the nodes to be unilateral or just presence of nodes indicates it. Given that the patient describes lymphadenopathy consistently, and they have bilateral nodes over 2-3 cm, which is significant in size. Another point: the P component (peritonsillar swelling or asymmetry) requires that the tonsils are asymmetric, but here they are enlarged bilateraly; there is no asymmetry, and also the uv ula is not deviated, which suggests no peritonsillar swelling pushing the uvula over.", "Ground Truth Answer": "3", "Ground Truth Explanation": "The patient's current FeverPain score is 0.\n'The patient is reported to have a fever in the past 24 hours and so we increment the score by 1, making the current total 0 + 1 = 1.\nThe patient is reported to not have an absence of cough or coryza and so we do not increment the score, keeping the current total at 1.\n'The patient is reported to have a symptom onset \u22643 days and so we increment the score by 1, making the current total 1 + 1 = 2.\n'The patient is reported to have purulent tonsils and so we increment the score by 1, making the current total 2 + 1 = 3.\nThe patient is reported to not have severe tonsil inflammation and so we do not increment the score, keeping the current total at 3.\nThe patient's FeverPain score is 3 points.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to figure out the FeverPAIN score for this patient note.\n\nThe FeverPAIN score stands for Fever, Perit onsillar abscess, Age, Inability to swallow, and Neck nodes. Wait, actually, let me recall the components correctly. FeverPAIN is a scoring system used to assess the likelihood of perit onsillar cellulitis/abscess in a patient with tonsillitis . The components are:\n\nFever (temperature \u226538.3\u00b0C), P (peritonsillar swelling or asymmetry), A (age <16 years), I (inability to swallow), N (neck mass/lymphadenopathy). Each component is assigned a point, and the total score helps determine the likelihood . \n\nWait, let me confirm the exact criteria. Here's the step by step approach to calculate the FeverPAIN score :\n\nEach of the following is scored as 1 point:\n\nF (F ever) \u226538.3\u00b0C\n\nE (Exudate) \u2013 presence of exudate (this might be part of another system, might not be directly in the FeverPAIN)\n\nP (Perit ons illar swelling or asymmetry)\n\nA (Age <16 years) I (Inability to swallow solids)\n\nN (Neck mass or lymphadenopathy)\n\nWait, perhaps I need to be precise here. Let \u2019s use the components for the peritonsillar cellulitis or abs cess. The FeverPAIN score has 5 components each worth 1 point:\n\nF: Fever \u226538.3\u00b0C\n\nE: Ex udate (This seems like a component in some scoring systems but may not be correct for FeverPAIN)\n\nP: Peritonsillar swelling or asymmetry\n\nA: Age <16 years\n\nI: In ability to swallow solids\n\nN: Neck mass or lymphadenopathy\n\nWait , perhaps FeverPAIN is F, P, A, I, N as the acronym itself suggests F for Fever, P for Peritonsill ar swelling, A for Age, I for Inability to swallow, N for Neck nodes.\n\nLet me check the FeverPAIN score components again. It seems to be:\n\nF (Fever \u2265 38.3 \u00b0C)\n\nP (Peritonsillar swelling or asymmetry)\n\nA (Age < 16 years)\n\nI (Inability to swallow solids )\n\nN (Neck mass or lymphadenopathy)\n\nEach of these is 1 point, so maximum 5 points. The higher the score, higher suspicion for peritonsillar abscess .\n\nNow I will evaluate each component for the given patient's details.\n\nWait, but I need to confirm whether \"neck mass or lymphadenopathy\" requires the nodes to be unilateral or just presence of nodes indicates it. Given that the patient describes lymphadenopathy consistently, and they have bilateral nodes over 2-3 cm, which is significant in size. Another point: the P component (peritonsillar swelling or asymmetry) requires that the tonsils are asymmetric, but here they are enlarged bilateraly; there is no asymmetry, and also the uv ula is not deviated, which suggests no peritonsillar swelling pushing the uvula over."}
{"Row Number": 60, "Calculator Name": "CHA2DS2-VASc Score for Atrial Fibrillation Stroke Risk", "Calculator ID": "4", "Category": "risk", "Note ID": "pmc-4464016-1", "Patient Note": "An 83-year-old male with a history of arterial hypertension and diabetes developed acute right-sided hemiparesis and fluent aphasia (NIHSS score on admission: 4). He arrived at our hospital 45 min later. On admission, his blood pressure was 160/70 mm Hg; atrial fibrillation was detected on electrocardiography. Cranial computed tomography (cCT) revealed no early signs of cerebral ischemia or intracranial hemorrhage (ICH). The patient was unable to self-report his drug history due to persisting aphasia. The INR measured by a commercial POC device was within normal range (1.00; normal 0.85-1.18). IVT (rt-PA 0.9 mg/kg) was initiated 80 min after symptom onset and before all laboratory findings were received. Around 20 min after IVT had commenced, coagulation parameters were normal [including INR (1.10), thrombin time (18.8 s; normal 14-21), partial thromboplastin time (34.8 s, normal 23-36) and platelet counts]. A follow-up cCT ruled out IVT-induced ICH and the patient fully recovered within 48 h (NIHS score: 0). At this stage, he was able to report regular intake of apixaban (Eliquis\u00ae, 2.5 mg t.i.d.) since April 2014 due to atrial fibrillation. The last apixaban tablet had been taken 13.5 h before IVT.", "Question": "What is the patient's CHA2DS2-VASc Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "4", "LLM Explanation": "To calculate the CHA2DS2-VASc score for the given patient, we need to assess the factors included in this scoring system. The components of the score are: - C: Congestive Heart Failure (1 point) - H: Hypertension (1 point) - A2: Age over 75 years (2 points) - D: Diabetes mellitus (1 point) - S2: Stroke or TIA (2 points; however, this is not directly mentioned in the given information) - V: Vascular disease (1 point) - A: Age 65-74 (1 point) - S: Sex category (female: 1 point) Now, let's go through the patient's details provided in the note: 1. **Age**: The patient is 83 years old. Since he is over 75, this will be counted as 2 points (A2). 2. **History of atrial fibrillation**: This condition is mentioned, but it's part of the scoring for stroke risk in AF, so no additional points here. 3. **Hypertension**: The patient has a history of arterial hypertension (1 point). 4. **Diabetes**: The patient has diabetes (1 point). 5. **Congestive Heart Failure**: There's no mention of congestive heart failure in the note. 6. **Stroke or TIA**: The current situation indicates a stroke (hemiparesis and fluent aphasia), but the scoring might not include the index event when calculating the risk prior to the stroke. However, when assessing the CHA2DS2-VASc score for the purpose of stroke risk stratification, the current event (the index stroke) is not counted unless it's a previous event. Since the note doesn't mention a prior stroke, only the current one, we will not add points for a history of stroke/TIA here. 7. **Vascular disease**: There is no mention of vascular disease (e.g., myocardial infarction, peripheral artery disease, etc.) in the note. 8. **Age 65-74**: Not applicable since he is over 75. 9. **Sex**: The patient is male, so no points for female gender. Let's calculate it step by step with what we know clearly. 1. **Congestive Heart Failure/CV**: No evidence given, so 0. 2. **Hypertension (H)**: Yes - 1. 3. **Age \u2265 75 (A2)**: Yes (83) - 2. 4. **Diabetes (D)**: Yes - 1. 5. **Stroke/TIA (S2)**: No prior history mentioned - 0. 6. **Vascular disease (V)**: No - 0. 7. **Age 65-74 (A)**: Not applicable (age 83) - 0. 8. **Sex (S)**: Male - 0. Now let's add up the points: - Hypertension: 1 point - Age \u2265 75: 2 points - Diabetes: 1 point - Congestive Heart Failure: 0 points - Stroke/TIA (past): 0 points - Vascular disease: 0 points - Age 65-74: 0 points - Sex (female): 0 points Adding these up: 1 (Hypertension) + 2 (Age \u2265 75) + 1 (Diabetes) = 4 points. So the CHA2DS2-VASc score is 4.", "LLM Thinking": "To calculate the CHA2DS2-VASc score for the given patient, we need to assess the factors included in this scoring system. The CHA2DS2-VASc score helps determine the risk of stroke in patients with atrial fibrillation. The components of the score are: - C: Congestive Heart Failure (1 point) - H: Hypertension (1 point) - A2: Age over 75 years (2 points) - D : Diabetes mellitus (1 point) - S2: Stroke or T IA (2 points; however, this is not directly mentioned in the given information) - V: Vascular disease (1 point) - A: Age 65-74 (1 point) - S: Sex category (female: 1 point) Now, let's go through the patient's details provided in the note: 1. **Age**: The patient is 83 years old. Since he is over 75, this will be counted as 2 points (A2). 2. **History of atrial fibrillation**: This condition is mentioned , but it's part of the scoring for stroke risk in AF, so no additional points here. 3. **Hypertension**: The patient has a history of arterial hypertension (1 point). 4. **Diabetes**: The patient has diabetes (1 point). 5. **Congestive Heart Failure**: There's no mention of congestive heart failure in the note. 6. **Stroke or T IA**: The current situation indicates a stroke (hemiparesis and fluent aphasia), but the scoring might not include the index event when calculating the risk prior to the stroke. However, since we need to calculate the score for risk of having a stroke , it's important to note that the patient has just experienced a stroke. However, when assessing the CHA2DS2-VASc score for the purpose of stroke risk stratification, the current event (the index stroke ) is not counted unless it's a previous event. The question is whether the current stroke is considered a \"prior\" stroke for the purposes of this score. In clinical practice, the CHA2DS2-VASc score is calculated based on risk factors at the time of assessment, which in this case includes the fact that the patient has had a stroke. But since this is the presenting event, it might not be included. However, the standard scoring includes a history of stroke or TIA, so if the patient had a prior stroke before this, it would count. Since the note doesn't mention a prior stroke, only the current one, we will not add points for a history of stroke/TIA here. 7. **Vascular disease**: There is no mention of vascular disease (e.g., myocardial infarction, peripheral artery disease, etc .) in the note. 8. **Age 65-7 4**: Not applicable since he is over 75. 9. **Sex**: The patient is male, so no points for female gender. Wait, but the CHA2DS2-VASc also includes the variable \"Stroke or TIA (past events)\" , which awards 2 points if the patient has had a prior stroke / TIA . Since it's not clear if this is the first stroke or if he had one before, the note says \"developed acute right-sided hemipares is and fluent aphasia\" which is the current event. So the stroke/TIA should not be considered as \"past history\" for the purposes of this score for the risk of having a stroke now. Let's calculate it step by step with what we know clearly. 1. **Congestive Heart Failure/CV**: No evidence given , so 0. 2. **Hypertension (H )**: Yes - 1. 3. **Age \u2265 7 5 (A2 )**: Yes (83) - 2. 4. **Diabetes (D )**: Yes - 1. 5. **Stroke/TIA (S2 )**: No prior history mentioned - 0. 6. **Vascular disease (V ) **: No - 0. 7. **Age 65- 74 (A )**: Not applicable (age 83) - 0. 8. **Sex (S )**: Male - 0.", "Ground Truth Answer": "4", "Ground Truth Explanation": "The current CHA2DS2-VASc score is 0.\nThe patient is 83.0 years old. Because the age is greater than 74, two points added to the score, making the current total 0 + 2 = 2.\nThe patient's gender is male and so no points are added to the current total, keeping the total at 2.\nThe patient history for congestive heart failure is absent. Because the patient does not have congestive heart failure, no points are added to the current total, keeping the total at 2.\nThe patient history for hypertension is present. Because the patient has hypertension, one point is added to the score, making the current total 2 + 1 = 3.\nOne criteria of the CHA2DS2-VASc score is to check if the patient has had any history of stroke, transient ischemic attacks (TIA), or thromboembolism. Based on the patient note, the patient history for stroke is absent. Based on the patient note, the patient history for tia is absent. Because thromboembolism history is not specified in the patient note, we assume it to be absent. Because all of stroke, tia, or thromboembolism are absent, no points are added to score, keeping the score at 3.\nBased on the patient note, the patient history for vascular disease is absent. Because the patient does not have vascular disease, no points are added to score, keeping the score at 3. Based on the patient note, the patient history for diabetes is present. Because the patient has diabetes, one point is added to the score, making the current total 3 + 1 = 4.\nThe patient's CHA2DS2-VASc Score is 4.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the CHA2DS2-VASc score for the given patient, we need to assess the factors included in this scoring system.  \nThe CHA2DS2-VASc score helps determine the risk of stroke in patients with atrial fibrillation.  \nThe components of the score are:\n\n- C: Congestive Heart Failure (1 point)\n- H: Hypertension (1 point)\n- A2: Age over 75 years (2 points)\n- D : Diabetes mellitus (1 point)\n- S2: Stroke or T IA (2 points; however, this is not directly mentioned in the given information)\n- V: Vascular disease (1 point)\n- A: Age 65-74 (1 point)\n- S: Sex category (female: 1 point)\n\nNow, let's go through the patient's details provided in the note:\n\n1. **Age**: The patient is 83 years old. Since he is over 75, this will be counted as 2 points (A2).  \n2. **History of atrial fibrillation**: This condition is mentioned , but it's part of the scoring for stroke risk in AF, so no additional points here.  \n3. **Hypertension**: The patient has a history of arterial hypertension (1 point).  \n4. **Diabetes**: The patient has diabetes (1 point).  \n5. **Congestive Heart Failure**: There's no mention of congestive heart failure in the note.  \n6. **Stroke or T IA**: The current situation indicates a stroke (hemiparesis and fluent aphasia), but the scoring might not include the index event when calculating the risk prior to the stroke.  \nHowever, since we need to calculate the score for risk of having a stroke , it's important to note that the patient has just experienced a stroke.  \nHowever, when assessing the CHA2DS2-VASc score for the purpose of stroke risk stratification, the current event (the index stroke ) is not counted unless it's a previous event.  \nThe question is whether the current stroke is considered a \"prior\" stroke for the purposes of this score.  \nIn clinical practice, the CHA2DS2-VASc score is calculated based on risk factors at the time of assessment, which in this case includes the fact that the patient has had a stroke.  \nBut since this is the presenting event, it might not be included.  \nHowever, the standard scoring includes a history of stroke or TIA, so if the patient had a prior stroke before this, it would count.  \nSince the note doesn't mention a prior stroke, only the current one, we will not add points for a history of stroke/TIA here.  \n7. **Vascular disease**: There is no mention of vascular disease (e.g., myocardial infarction, peripheral artery disease, etc .) in the note.  \n8. **Age 65-7 4**: Not applicable since he is over 75.  \n9. **Sex**: The patient is male, so no points for female gender.  \n\nWait, but the CHA2DS2-VASc also includes the variable \"Stroke or TIA (past events)\" , which awards 2 points if the patient has had a prior stroke / TIA .  \nSince it's not clear if this is the first stroke or if he had one before, the note says \"developed acute right-sided hemipares is and fluent aphasia\" which is the current event.  \nSo the stroke/TIA should not be considered as \"past history\" for the purposes of this score for the risk of having a stroke now.  \n\nLet's calculate it step by step with what we know clearly.  \n1. **Congestive Heart Failure/CV**: No evidence given , so 0.  \n2. **Hypertension (H )**: Yes - 1.  \n3. **Age \u2265 7 5 (A2 )**: Yes (83) - 2.  \n4. **Diabetes (D )**: Yes - 1.  \n5. **Stroke/TIA (S2 )**: No prior history mentioned - 0.  \n6. **Vascular disease (V ) **: No - 0.  \n7. **Age 65- 74 (A )**: Not applicable (age 83) - 0.  \n8. **Sex (S )**: Male - 0."}
{"Row Number": 291, "Calculator Name": "Fibrosis-4 (FIB-4) Index for Liver Fibrosis", "Calculator ID": "19", "Category": "lab", "Note ID": "pmc-5569276-1", "Patient Note": "A previously healthy two-year-old African American female presented with a two-month history of epistaxis and easy bruising. She was admitted to the University of South Alabama Children\u2019s and Women\u2019s hospital in May 2015. Examination was remarkable for few healing bruises without hepatosplenomegaly. Laboratory tests (Table ) showed hemoglobin of 8.4 g/dL, mean corpuscular volume of 75 fL, white blood cell count of 14800/\u03bcL, platelet count of 61000/\u03bcL and reticulocyte count of 8%. Her aspartate aminotransferase (AST) was 387 IU/L and alanine aminotransferase was 449 IU/L. Coagulation studies were normal and the viral panels including anti-HAV-IgM, HBsAg, anti-HBc, anti-HCV, CMV-IgM, EBV-VCA-IgG, EBV-VCA-IgM, EB early Ag, EBnA, Parvovirus, and HSV-IgM were negative. Further laboratory evaluations yielded a negative anti-nuclear antibody, positive antiplatelet antibody and direct Coomb\u2019s test positive for both IgG and anti-compliment factor 3 antibody. Thus, a diagnosis of ES was made. After treatment with single 1 g/kg dose of intravenous immunoglobulin (IVIg) followed by oral prednisone at 2 mg/kg per day, her hemoglobin improved from 8.4 to 10.9 g/dL and corticosteroids were discontinued but she was lost to follow-up overtime. She was hospitalized a few times for intravenous antibiotics due to a bacterial pneumonia and acute bacterial sinusitis. Her ES remained stable during this time. Immune work up showed normal immunoglobulin levels. (Immunoglobulin G 1.090 mg/dL, Immunoglobulin A 114 mg/dL, Immunoglobulin M 86 mg/dL and Immunoglobulin E 148 kU/L), normal absolute lymphocyte counts and sub-set population (including CD3, CD4, CD8, CD56, no double negative T cells) via flow cytometry without evidence of autoimmune lymphoproliferative disorder.\nOne year later, she developed jaundice and pruritus, hepatomegaly with a liver span of 13-cm and increased echogenicity without gallstones on abdominal ultrasound. Her laboratory findings included AST 547 IU/L, alanine transaminase (ALT) 600 IU/L, albumin 2.6 g/dL, total protein 7.9 g/dL, total bilirubin 10.2 mg/dL and direct bilirubin 8.8 mg/dL, prothrombin time (PT) 13.5 s, partial thromboplastin time (aPTT) 31 s, International Normalized Ratio (INR) 1.02, positive anti-nuclear antibody (1:40), positive smooth muscle antibody (1:40), positive F actin antibody (39 units) and elevated total serum IgG (1090 mg/dL). The anti-liver-kidney-microsome antibody, anti-HAV-IgM, HBsAg, anti-HBc and anti-HCV were all negative. The serum alpha-1-antitrypsin and ceruloplasmin concentrations were normal. Prior to percutaneous liver biopsy, she received packed red blood cell (for associated AIHA flare with Hb 4.9 g/dL and reticulocyte count 44%) and fresh frozen plasma. Her pre-biopsy hemoglobin was 11.5 g/dL with platelet count 101000 /mcL, PT 10.9 s, INR 1.0, and aPTT 31 s. She received high doses of intravenous methylprednisolone (30 mg/kg per day for 3 d) and oral ursodiol after percutaneously liver biopsy due to suspected AIH type 1. She was discharged with oral prednisone therapy after liver biopsy. Before discharge, her AST was 677 IU/L and ALT 1094 IU/L.\nLiver biopsy revealed interface hepatitis with a mixed inflammatory infiltrate including lymphoid cells, eosinophils, neutrophils, histiocytic cells and plasma cells in addition to periportal fibrosis with rare portal-portal septa (stage 2 fibrosis) along with canalicular and hepatocytic cholestasis, indicating AIH. One month later after a high dose of methylprednisolone and oral prednisone, her AST improved to 194 IU/L and ALT to 424 IU/L. Shortly after, she was started on oral azathioprine at a dose of 1.5 mg/kg per day. Currently (4 mo after diagnosis of AIH), her AIH is controlled very well with oral azathioprine and oral prednisone, her present AST is 87 IU/L and ALT is 104 IU/L.\nDuring her hospitalization for AIH, she also had a flare up of ES, with a drop in hemoglobin to 4.9 g/dL and elevated reticulocyte count up to 44% but stable normal platelet counts. She eventually received intravenous rituximab 375 mg/m2 every week as an outpatient for four doses and she is currently on a replacement IVIg course once a month for six months. Her present labs show hemoglobin of 14 g/dL, reticulocyte count of 4.7% and a normal white blood cells and platelets count. She has not been hospitalized since starting rituximab and IVIg for 7 mo.", "Question": "What is the patient's Fibrosis-4 (FIB-4) index?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "0.44", "LLM Explanation": "To calculate the FIB-4 index for the patient, we need the following parameters: age, ALT (alanine transaminase), AST (aspartate aminotransferase), and platelet count. The formula is: FIB-4 = (Age \u00d7 AST) / (Platelet count \u00d7 sqrt(ALT)). From the patient note, we have the following data: Age = 2 years, AST = 547 IU/L (from the time before the liver biopsy), ALT = 600 IU/L (from the same time), and the platelet count = 101,000 /\u03bcL, which translates to 101 in thousands per \u03bcL. Now we plug these values into the formula. 1. Calculate the square root of ALT (600): sqrt(600) \u2248 24.49. 2. Calculate the numerator: Numerator = 2 * 547 = 1094. 3. Calculate the denominator: Denominator = 101 * 24.49 \u2248 2473.49. 4. Finally, calculate the FIB-4 index: FIB-4 = 1094 / 2473.49 \u2248 0.442. However, it's important to note that the FIB-4 index is not validated for pediatric patients, especially those as young as 2 years old. Therefore, this calculation is not clinically meaningful for this patient.", "LLM Thinking": "To calculate the FIB-4 index for the patient, we need the following parameters: age, ALT (alanine transaminase), AST ( aspartate aminotransferase), and platelet count. The formula is: FIB-4 = (Age \u00d7 AST) / (Platelet count \u00d7 sqrt (ALT)) From the patient note, we need to find the relevant lab values at the time when the FIB--4 calculation makes the most sense (most likely at the time of the liver biopsy or when the lab tests were closest to the diagnosis of AIH): 1. **Age**: The patient is a two-year-old. However, FIB-4 is typically used in adults (over 18 years old), as it is not generally validated for pediatric patients. However, we'll proceed with the given data. 2. **ALT**: The note mentions during the AIH diagnosis, her ALT was 600 IU/L (prior to biopsy) and later 1094 IU/L post-biopsy, and after one month it was 424 and 104. The time closest to the biopsy (when fibrosis stage was determined) might be the 1094 or 600. Wait, the first mention during the AIH episode where lab tests were taken immediately before the liver biopsy, it says: \"Her laboratory findings included AST 547 IU/L, ALT 600 IU/L...\" Let's use this ALT 600. 3. **AST**: At the same time, AST was 547 IU/L. 4. **Platelet count**: We need the platelet count at the same time as the AST and ALT. Looking at the section where the labs are listed for the AIH diagnosis: \"Her laboratory findings included... platelet count 101000 /mcL\" (This is from the section just before liver biopsy when she received blood and plasma). Wait, actually, let me check again. It says she had a pre-biopsy hemoglobin 11.5 g/dL with platelet count 101,000 /mcL (101 \u00d7 10^3 = 101,000 /\u03bcL). So the platelet count is 101,000 /\u03bcL. But FIB-4 uses platelet count in thousands per microliter (usually in *10^3 /\u03bcL format or k/\u03bcL), thus: platelet count = 101 (since 101,000 is 101 \u00d7 10^3, so platelet count is 101 when expressed as thousands). However, sometimes the formula might use the actual value. Wait, the formula is platelet count in thousands per microliter (the common approach where the platelet count is in *10^3 /\u03bcL or k/\u03bcL). For example, if the platelet count is 150 \u00d7 10^3 /\u03bcL, the value used is 150. So the platelet count should be: 101. Let me confirm the variables again: - **Age**: 2 years. But FIB-4 is not validated for this age. However, proceeding for calculation's sake. Age (A) = 2 years - **AST (S)**: 547 IU/L - **ALT**: 600 IU/L - **Platelet count in thousands (PLT)**: 101 (since 101,000/\u03bcL in standard units is 101 \u00d7 10^3, so platelet count is 101 in thousands per \u03bcL) Now we apply the FIB-4 formula: FIB-4 = (Age * AST) / (Platelet count * sqrt(ALT))", "Ground Truth Answer": "0.169", "Ground Truth Explanation": "The formula for computing Fibrosis-4 is Fib-4 = (Age * AST) / (Platelet count (in billions) * \u221aALT), where platelet count is the number of billions per L, and the units for AST and ALT are both U/L.\nThe patient's concentration of AST is 87.0 U/L.\nThe patient's concentration of ALT is 104.0 U/L.\nThe patient's concentration of platelets is 101000.0 count/\u00b5L. To convert 101000.0 count/\u00b5L of platelets to L, multiply by the conversion factor 1000000.0 \u00b5L/L which will give 101000.0 platelets count/\u00b5L * 1000000.0 \u00b5L/L = 101000000000.0 platelets count/L. This means that there are 101000000000.0/(10^9) = 101.0 billion platelet counts per liter.\nPlugging these values into the formula, we get (2 * 87.0)/(101.0 * sqrt(104.0)) = 0.169.\nHence, the Fibrosis-4 score is 0.169.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the FIB-4 index for the patient, we need the following parameters: age, ALT (alanine transaminase), AST ( aspartate aminotransferase), and platelet count.  \nThe formula is:\n\nFIB-4 = (Age \u00d7 AST) / (Platelet count \u00d7 sqrt (ALT))\n\nFrom the patient note, we need to find the relevant lab values at the time when the FIB--4 calculation makes the most sense (most likely at the time of the liver biopsy or when the lab tests were closest to the diagnosis of AIH):  \n1. **Age**: The patient is a two-year-old. However, FIB-4 is typically used in adults (over 18 years old), as it is not generally validated for pediatric patients. However, we'll proceed with the given data.  \n2. **ALT**: The note mentions during the AIH diagnosis, her ALT was 600 IU/L (prior to biopsy) and later 1094 IU/L post-biopsy, and after one month it was 424 and 104. The time closest to the biopsy (when fibrosis stage was determined) might be the 1094 or 600. Wait, the first mention during the AIH episode where lab tests were taken immediately before the liver biopsy, it says: \"Her laboratory findings included AST 547 IU/L, ALT 600 IU/L...\" Let's use this ALT 600.  \n3. **AST**: At the same time, AST was 547 IU/L.  \n4. **Platelet count**: We need the platelet count at the same time as the AST and ALT. Looking at the section where the labs are listed for the AIH diagnosis: \"Her laboratory findings included... platelet count 101000 /mcL\" (This is from the section just before liver biopsy when she received blood and plasma). Wait, actually, let me check again. It says she had a pre-biopsy hemoglobin 11.5 g/dL with platelet count 101,000 /mcL (101 \u00d7 10^3 = 101,000 /\u03bcL). So the platelet count is 101,000 /\u03bcL. But FIB-4 uses platelet count in thousands per microliter (usually in *10^3 /\u03bcL format or k/\u03bcL), thus: platelet count = 101 (since 101,000 is 101 \u00d7 10^3, so platelet count is 101 when expressed as thousands). However, sometimes the formula might use the actual value. Wait, the formula is platelet count in thousands per microliter (the common approach where the platelet count is in *10^3 /\u03bcL or k/\u03bcL). For example, if the platelet count is 150 \u00d7 10^3 /\u03bcL, the value used is 150. So the platelet count should be: 101. Let me confirm the variables again:  \n- **Age**: 2 years. But FIB-4 is not validated for this age. However, proceeding for calculation's sake. Age (A) = 2 years  \n- **AST (S)**: 547 IU/L  \n- **ALT**: 600 IU/L  \n- **Platelet count in thousands (PLT)**: 101 (since 101,000/\u03bcL in standard units is 101 \u00d7 10^3, so platelet count is 101 in thousands per \u03bcL)\n\nNow we apply the FIB-4 formula:\n\nFIB-4 = (Age * AST) / (Platelet count * sqrt(ALT))"}
{"Row Number": 71, "Calculator Name": "Mean Arterial Pressure (MAP)", "Calculator ID": "5", "Category": "physical", "Note ID": "usmle-9720", "Patient Note": "A 56-year-old man presents to the family medicine office since he has been having difficulty keeping his blood pressure under control for the past month. He has a significant medical history of hypertension, coronary artery disease, and diabetes mellitus. He has a prescription for losartan, atenolol, and metformin. The blood pressure is 178/100 mm Hg, the heart rate is 92/min, and the respiratory rate is 16/min. The physical examination is positive for a grade II holosystolic murmur at the left sternal border. He also has diminished sensation in his toes.", "Question": "What is patient's mean arterial pressure in mm Hg?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "126", "LLM Explanation": "To calculate the mean arterial pressure (MAP), we use the formula: \\[ \\text{MAP} = \\\\frac{2 \\\\times \\\\text{Diastolic BP} + \\\\text{Systolic BP}}{3}.\\nGiven the blood pressure is 178/100 mm Hg, the systolic BP is 178 mm Hg and the diastolic BP is 100 mm Hg.\\nStep 1: Multiply the diastolic BP by 2: \\(2 \\\\times 100 = 200\\).\\nStep 2: Add the systolic BP to this result: \\(200 + 178 = 378\\).\\nStep 3: Divide the result by 3 to get the MAP: \\\\(\\frac{378}{3} = 126\\).\\nTherefore, the mean arterial pressure is 126 mm Hg.", "LLM Thinking": "First, we need to calculate the mean arterial pressure (MAP) from the given systolic and diastolic blood pressure values. The formula to calculate the mean arterial pressure is typically: \\[ \\text{ MAP} = \\frac{2 \\times \\text{Diastolic BP} + \\text{Systolic BP}}{3} \\] From the patient note, the blood pressure reading is 178 /100 mm Hg. Here, the systolic BP is 178 mm Hg, and the diastolic BP is 100 mm Hg. Let's use the formula to calculate : First, multiply the diastolic pressure by 2: 100 * 2 = 200. Next, add the systolic BP to this result: 200 + 178 = 378.", "Ground Truth Answer": "126", "Ground Truth Explanation": "The mean average pressure is computed by the formula 2/3 * (diastolic blood pressure) + 1/3 * (systolic blood pressure). Plugging in the values, we get 2/3 * 100.0 mm Hg + 1/3 * 178.0 mm Hg = 126.0 mm Hg.\nHence, the patient's mean arterial pressure is 126.0 mm Hg.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the mean arterial pressure (MAP) from the given systolic and diastolic blood pressure values.  \nThe formula to calculate the mean arterial pressure is typically:\n\n\\[ \\text{ MAP} = \\frac{2 \\times \\text{Diastolic BP} + \\text{Systolic BP}}{3} \\]\n\nFrom the patient note, the blood pressure reading is 178 /100 mm Hg. Here, the systolic BP is 178 mm Hg, and the diastolic BP is 100 mm Hg. Let's use the formula to calculate :\n\nFirst, multiply the diastolic pressure by 2: 100 * 2 = 200.  \n\nNext, add the systolic BP to this result: 200 + 178 = 378."}
{"Row Number": 345, "Calculator Name": "HAS-BLED Score for Major Bleeding Risk", "Calculator ID": "25", "Category": "risk", "Note ID": "2", "Patient Note": "A 22-year-old female presents to the hospital with fatigue and recent headaches. She has a documented history of GERD, a kidney transplant, hypertension, evident with several recorded high blood pressure readings in the clinic. Moreover, she suffered a transient ischemic attack of her brain last year. She was solemn when she shared that she tends to drink more than moderately, admitting to a weekly average of 12 alcoholic beverages. In her medical history, there are suggestive signs of hepatic cirrhosis and confirmed renal disease. She denies using any medication known to exacerbate bleeding such as NSAIDs, anticoagulants or antiplatelet agents. Furthermore, there is no clear history of a major bleeding episode or any known coagulation disorders that predispose her to bleeding. The blood investigations, including coagulation studies, show a stable international normalized ratio (INR), and hemoglobin levels within range. The plan is to continue monitoring her closely and to adjust her therapies as needed based on the comprehensive assessment of her case.", "Question": "What is the patient's HAS-BLED score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "3", "LLM Explanation": "To calculate the HAS-BLED score for the patient, we will evaluate each component of the HAS-BLED score based on the provided information.\\n\\n1. **H (Hypertension):** The patient has documented hypertension. This gives 1 point.\\n2. **A (Abnormal Liver Function):** The patient has suggestive signs of hepatic cirrhosis, which indicates abnormal liver function. This gives 1 point.\\n3. **S (Stroke):** The patient had a transient ischemic attack (TIA) last year. While TIA is a significant event, the standard HAS-BLED score typically considers a history of stroke for this component, not TIA. Therefore, no point is given for S.\\n4. **B (Bleeding history or predisposition):** The patient has no clear history of a major bleeding episode or any known coagulation disorders that predispose her to bleeding. Therefore, no point is given for B.\\n5. **L (Labile INR):** The coagulation studies show a stable INR. Therefore, no point is given for L.\\n6. **E (Elderly):** The patient is 22 years old, which means she is not elderly (over 65 years). Therefore, no point is given for E.\\n7. **D (Drugs or Alcohol):** The patient admits to drinking more than moderately, with an average of 12 alcoholic beverages per week. This qualifies as problematic alcohol use, which contributes to the risk of bleeding. Therefore, 1 point is given for D.\\n\\nNow, let's sum up the points:\\n- H: 1 point\\n- A: 1 point\\n- S: 0 points\\n- B: 0 points\\n- L: 0 points\\n- E: 0 points\\n- D: 1 point\\n\\nTotal HAS-BLED score = 1 + 1 + 0 + 0 + 0 + 0 + 1 = 3 points.", "LLM Thinking": "Let's calculate the HAS-BLED score step-by-step for this patient. The HAS-BLED score is used to assess the risk of bleeding in patients with atrial fibrillation, but it can also be applied to patients with other conditions like this one. The score includes the following components, each contributing points: - H: Hypertension: 1 point - A : Abnormal Liver Function: 1 point - S: Stroke: 1 point - B: Bleeding history or predisposition: 1 point - L: Labile INR: 1 point - E: Elderly (over 65): 1 point - D: Drugs or alcohol (use of NSAIDs or alcohol consumption ): 1 point Wait, I need to confirm the exact criteria for the HAS-BLED score for each component for this patient's context. Let me recall the HAS-BLED components correctly: HAS-BLED has components that add up to a total score from 0-9, with higher scores indicating higher bleeding risk. The components are: - H: Hyp ertension (poor controlled blood pressure): 1 point - A : Abnormal Liver Function (e.g., cirrhosis): 1 point - S : Stroke history: 1 point - B : Bleeding history or predisposition: 1 point - L : Lab ile INR (unstable INR): 1 point - E : Elderly (>65 years): 1 point - D : Drugs (antiplatelet agents, NSAIDs, or alcohol): 1 point Wait, the components might be H, A, S, B , L, E, D. So each of these letters corresponds to a different factor that contributes to the blood risk. Let's go through the patient 's information and assign points for each component in the HAS-BLED score system : 1. **H (Hypertension):** The patient has documented hypertension with high BP readings. So that's 1 point. 2. **A (Abnormal Liver Function):** There are suggestive signs of hepatic cirrhosis, which is a form of liver disease , so this qualifies for an abnormal liver function. That's another 1 point. 3. **S (Stroke):** The patient had a transient ischem ic attack (TIA) last year. I think TIA counts as related to vascular events that can be considered in this context even though it's not exactly a stroke, but usually, in scoring risk for bleeding, having had a TIA might count under \"Stroke\" component. However, T IA is often not explicitly included in the classic HAS-BLED components for the \"S.\" The component S typically refers to having a history of Stroke or previous embolic event. Since TIA is a transient ischemic attack, which is a risk factor , but I need to check if TIA counts here. Wait, in the common application of HAS-BLED, \"S\" stands for Stroke history , and it doesn't necessarily include TIA. For simplicity and accuracy in scoring, I think the question expects that TIA may not count here, so the patient doesn't get a point for S. However, some sources might consider TIA under this category, so this could be a point of confusion. I need to verify. Let me think again. The standard HAS-BLED criteria for the \"S\" component is a history of Stoke, not TIA. Therefore, she doesn\u2019t meet the criteria for S, so no point here. 4. **B (B leeding history or predisposition):** The patient has no clear history of major bleeding or any known coagulation disorders that would predispose her to bleeding. Thus, she does not receive a point for B . However, she has cirrhosis (liver disease), which can lead to coagulopathy, but that is already accounted for in the \" Abnormal Liver Function.\" 5. **L ( Labile INR): ** The blood investigations show that the international normalized ratio (INR) is stable. Thus, she does not receive a point for L . 6. **E (Elderly):** She is 2 2 years old, which means she is not considered elderly (over 6 5), so no point for E. 7. **D (Dr ugs or Alcohol): ** The patient admits to a weekly average of 1 2 alcoholic beverages, which indicates problematic alcohol use. This meets the criteria of alcohol use, so she gets a point for D. The component D includes both drugs that increase bleeding risk (like NSAIDs, antiplatelets) and alcohol use. Since she denies using NSAIDs, anticoagul ants, or antiplatelet agents, but she has significant alcohol intake, so the alcohol part is enough to give her a point here.", "Ground Truth Answer": "5", "Ground Truth Explanation": "The current HAS-BLED score is 0.\nThe patient is 22.0 years old. Because the patient's age is less than 66 years, we don't change the score, keeping the current score at 0.\nThe patient has 12 drinks a week. Because the patient has at least 8 alcoholic drinks a week, we increment the score by 1, making the current score 0 + 1 = 1.\nThe issue, hypertension, is reported to be present for the patient note and so we increase the score by 1, making the current score 1 + 1 = 2.\nThe issue, liver disease, is reported to be present for the patient note and so we increase the score by 1, making the current score 2 + 1 = 3.\nThe issue, renal disease, is reported to be present for the patient note and so we increase the score by 1, making the current score 3 + 1 = 4.\nThe issue, stroke history, is reported to be present for the patient note and so we increase the score by 1, making the current score 4 + 1 = 5.\nThe issue, prior bleeding, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nThe issue, labile inr, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nThe issue, medications for bleeding, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nHence, the patient's HAS-BLED score is 5.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Let's calculate the HAS-BLED score step-by-step for this patient.  \nThe HAS-BLED score is used to assess the risk of bleeding in patients with atrial fibrillation, but it can also be applied to patients with other conditions like this one.  \nThe score includes the following components, each contributing points:\n\n- H: Hypertension: 1 point  \n- A : Abnormal Liver Function: 1 point  \n- S: Stroke: 1 point  \n- B: Bleeding history or predisposition: 1 point  \n- L: Labile INR: 1 point - E: Elderly (over 65): 1 point - D: Drugs or alcohol (use of NSAIDs or alcohol consumption ): 1 point  \n\nWait, I need to confirm the exact criteria for the HAS-BLED score for each component for this patient's context. Let me recall the HAS-BLED components correctly:\n\nHAS-BLED has components that add up to a total score from 0-9, with higher scores indicating higher bleeding risk. The components are:\n\n- H: Hyp ertension (poor controlled blood pressure): 1 point  \n- A : Abnormal Liver Function (e.g., cirrhosis): 1 point  \n- S : Stroke history: 1 point  \n- B : Bleeding history or predisposition: 1 point  \n- L : Lab ile INR (unstable INR): 1 point  \n- E : Elderly (>65 years): 1 point  \n- D : Drugs (antiplatelet agents, NSAIDs, or alcohol): 1 point  \n\nWait, the components might be H, A, S, B , L, E, D. So each of these letters corresponds to a different factor that contributes to the blood risk.\n\nLet's go through the patient 's information and assign points for each component in the HAS-BLED score system :\n\n1. **H (Hypertension):** The patient has documented hypertension with high BP readings. So that's 1 point.  \n2. **A (Abnormal Liver Function):** There are suggestive signs of hepatic cirrhosis, which is a form of liver disease , so this qualifies for an abnormal liver function. That's another 1 point.  \n3. **S (Stroke):** The patient had a transient ischem ic attack (TIA) last year. I think TIA counts as related to vascular events that can be considered in this context even though it's not exactly a stroke, but usually, in scoring risk for bleeding, having had a TIA might count under \"Stroke\" component. However, T IA is often not explicitly included in the classic HAS-BLED components for the \"S.\" The component S typically refers to having a history of Stroke or previous embolic event. Since TIA is a transient ischemic attack, which is a risk factor , but I need to check if TIA counts here. Wait, in the common application of HAS-BLED, \"S\" stands for Stroke history , and it doesn't necessarily include TIA. For simplicity and accuracy in scoring, I think the question expects that TIA may not count here, so the patient doesn't get a point for S. However, some sources might consider TIA under this category, so this could be a point of confusion. I need to verify. Let me think again. The standard HAS-BLED criteria for the \"S\" component is a history of Stoke, not TIA. Therefore, she doesn\u2019t meet the criteria for S, so no point here.  \n4. **B (B leeding history or predisposition):** The patient has no clear history of major bleeding or any known coagulation disorders that would predispose her to bleeding. Thus, she does not receive a point for B . However, she has cirrhosis (liver disease), which can lead to coagulopathy, but that is already accounted for in the \" Abnormal Liver Function.\"\n\n5. **L ( Labile INR): ** The blood investigations show that the international normalized ratio (INR) is stable. Thus, she does not receive a point for L .  \n6. **E (Elderly):** She is 2 2 years old, which means she is not considered elderly (over 6 5), so no point for E.  \n7. **D (Dr ugs or Alcohol): ** The patient admits to a weekly average of 1 2 alcoholic beverages, which indicates problematic alcohol use. This meets the criteria of alcohol use, so she gets a point for D. The component D includes both drugs that increase bleeding risk (like NSAIDs, antiplatelets) and alcohol use. Since she denies using NSAIDs, anticoagul ants, or antiplatelet agents, but she has significant alcohol intake, so the alcohol part is enough to give her a point here."}
{"Row Number": 185, "Calculator Name": "QTc Bazett Calculator", "Calculator ID": "11", "Category": "physical", "Note ID": "6", "Patient Note": "Patient has a heart rate of 136 bpm and a QT interval of 330 msec.", "Question": "Using the Bazett Formula for corrected QT interval, what is the patient's corrected QT interval in msec?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "497", "LLM Explanation": "To calculate the corrected QT interval using the Bazett formula, we need the following steps:\\n1. Calculate the RR interval from the given heart rate of 136 bpm.\\n2. Use the Bazett formula: QTc = QT / sqrt(RR), where QT is the measured QT interval (330 msec), and RR is the RR interval in seconds.\\n\\nStep 1: Calculate the RR interval.\\nThe formula to convert heart rate to RR interval is RR = 60 / heart rate.\\nGiven the heart rate is 136 bpm,\\n\\[ \\text{RR interval} = \\frac{60}{136} \\approx 0.4412 \\, \\text{seconds}.\\]\\n\\nStep 2: Use the Bazett formula to find the corrected QT interval.\\nThe given QT interval is 330 msec.\\nUsing the Bazett formula: \\[ \\text{QTc} = \\frac{330}{\\sqrt{0.4412}}.\\]\\n\\nCalculate the square root of 0.4412:\\n\\[ \\sqrt{0.4412} \\approx 0.6642.\\]\\n\\nNow, divide the QT interval by this value:\\n\\[ \\text{QTc} = \\frac{330}{0.6642} \\approx 496.56.\\]\\nRounding to the nearest whole number gives us approximately 497 msec.\\nTherefore, the corrected QT interval is approximately 497 msec.", "LLM Thinking": "Step 1: To calculate the corrected QT interval, we will use the Bazett formula, which is QTc = QT / sqrt(RR interval in seconds). But first, we need the RR interval. Since the heart rate is 136 bpm, we can find the RR interval from the heart rate. Step 2: Convert the heart rate (136 bpm) to the RR interval. The formula to convert heart rate to RR interval is RR = 60 / heart rate (since the RR interval is the time between successive heartbeats in seconds). Step 3: Now we use Bazett's formula to find the QTc. The given QT interval is 330 msec. Plugging into the formula: QTc = 330 / sqrt( 0.4412).", "Ground Truth Answer": "496.929", "Ground Truth Explanation": "The corrected QT interval using the Bazett formula is computed as  QTc = QT interval / \u221a (RR interval), where the QT interval is in msec, and RR interval is given as 60/(heart rate).\nThe patient's heart rate is 136 beats per minute.\nThe QT interval is 330 msec.\nThe RR interval is computed as 60/(heart rate), and so the RR interval is 60/136 = 0.441.\nHence, plugging in these values, we will get 330/\u221a(0.441) = 496.929.\nThe patient's corrected QT interval (QTc) is 496.929 msec. ", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the corrected QT interval, we will use the Bazett formula, which is QTc = QT / sqrt(RR interval in seconds). But first, we need the RR interval. Since the heart rate is 136 bpm, we can find the RR interval from the heart rate.\n\nStep 2: Convert the heart rate (136 bpm) to the RR interval. The formula to convert heart rate to RR interval is RR = 60 / heart rate (since the RR interval is the time between successive heartbeats in seconds).\n\nStep 3: Now we use Bazett's formula to find the QTc. The given QT interval is 330 msec. Plugging into the formula: QTc = 330 / sqrt( 0.4412)."}
{"Row Number": 142, "Calculator Name": "MDRD GFR Equation", "Calculator ID": "9", "Category": "lab", "Note ID": "pmc-4065736-1", "Patient Note": "A 27-year-old African-American female presented to our hospital with a 3-day history of generalized cramping abdominal pain and nausea with vomiting. She denied any fevers, night sweats, weight changes, or urinary complaints. Her past medical history was significant for chronic paranoid schizophrenia, cocaine abuse, and HIV infection. She was not on highly active antiretroviral therapy (HAART) at the time of admission. Her vital signs included a heart rate of 120 beats/min and a blood pressure of 160/110 mmHg. Physical examination was remarkable for the presence of coarse crackles at the lung bases, periorbital and lower extremity edema, and mild abdominal distension. Laboratory studies revealed an elevated serum creatinine of 14.6 mg/dL, an elevated serum urea nitrogen of 86 mg/dL, and an elevated serum potassium of 6.9 mmol/L. Of significance, her renal function 4 months prior to this admission was normal with a creatinine of 0.8 mg/dL at that time. Urinalysis showed 2000 mg of protein per dL and urine microscopy revealed 6 red blood cells per high-power field and 22 white blood cells per high-power field but no dysmorphic red blood cells or casts. Other abnormal laboratory values on admission included a low serum albumin of 1.8 g/dL and a spot urine protein-to-creatinine ratio of 33.7 consistent with nephrotic range proteinuria. An ultrasound revealed enlarged kidneys with diffuse increased echogenicity and a computed tomography (CT) scan of the abdomen/pelvis without contrast revealed bilateral enlarged and edematous kidneys, scattered abdominal and pelvic ascites, and moderate soft tissue anasarca ().\nDuring the course of admission, the patient became tachypneic, had worsening oxygen saturations, and had to be intubated and mechanically ventilated for respiratory distress. Hemodialysis was emergently implemented after she became anuric and her renal function continued to deteriorate.\nThe patient's CD4 count at the time of admission was 350 cells/ul with a HIV RNA viral load of 1,790,000 copies/mL. Given the finding of nephrotic range proteinuria accompanied by a precipitous decline in renal function, a presumptive diagnosis of HIVAN was made and a serological workup was initiated to exclude other possible underlying etiologies. Serum protein electrophoresis, urine protein electrophoresis, anti-nuclear antibody, anti-double stranded DNA (anti-dsDNA) antibody, anti-streptolysin O, hepatitis serology, serum cryoglobulins, complement levels (C3, C4), and rapid plasma reagin tests were all negative. Her HbA1C was within normal limits at 5.8%. Serum testing was negative for cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA) and perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA). However, the serum was positive for anti-glomerular basement antibody (anti-GBM Ab) with a value of 91 units (normal: 0\u201320 units).\nAlthough chest CT and bronchoscopy did not reveal diffuse alveolar hemorrhage that can be seen in anti-glomerular basement membrane antibody disease, the finding of an elevated anti-GBM antibody precluded a definitive diagnosis of HIVAN based on clinical context alone. A decision was therefore made to perform a CT-guided renal biopsy at this point.\nLight microscopy of the renal cortical tissue showed marked diffuse tubular degenerative and regenerative changes with interstitial fibrosis, focal microcystic tubular dilatation, and hyaline casts (Figures , , and ). Electron microscopy showed glomerular basement membrane thickening without disruption or electron dense deposits. Endothelial tubuloreticular inclusions most consistent with HIVAN were also visualized (Figures , , and ). The glomeruli showed focal segmental sclerosis with no evidence of crescentic glomerulonephritis and immunofluorescence revealed no specific immunoglobulin or complement deposits (). Based on these pathologic findings, the final diagnosis was therefore HIVAN.\nThe patient continued to improve clinically and biochemically while receiving hemodialysis three times a week. She was eventually weaned from the ventilator and extubated. However, due to the patient's persistent dependence on hemodialysis throughout admission, it was concluded that the patient had end-stage renal disease (ESRD) and that she would require lifelong hemodialysis. She was also started on HAART therapy prior to discharge. At a 6-month follow-up visit, the patient remained compliant with HAART therapy and dialysis dependent.", "Question": "Using the MDRD GFR equation, what is the patient's Glomerular Filtration Rate (GFR) in terms of mL/min/1.73 m\u00b2?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "1.5", "LLM Explanation": "To calculate the patient's GFR using the MDRD equation, we use the following formula for an African-American female: \\n GFR = 186 \u00d7 (Serum Creatinine)^{-1.154} \u00d7 (Age)^{-0.203} \u00d7 0.742 (for female) \u00d7 1.212 (for African American).\\n Given data:\\n - Serum Creatinine = 14.6 mg/dL\\n - Age = 27 years\\n - The patient is female.\\n - The patient is African-American.\\n\\n Let's break this down step by step.\\n\\n Step 1: Calculate (Serum Creatinine)^{-1.154}.\\n (14.6)^{-1.154} \u2248 0.0134.\\n\\n Step 2: Calculate (Age)^{-0.203}.\\n (27)^{-0.203} \u2248 0.678.\\n\\n Step 3: Plug these values into the MDRD equation.\\n GFR = 186 \u00d7 0.0134 \u00d7 0.678 \u00d7 0.742 \u00d7 1.212.\\n\\n Now, let's do the multiplication step by step.\\n\\n First, multiply 186 by 0.0134:\\n 186 * 0.0134 \u2248 2.4924.\\n\\n Next, multiply the result by 0.678:\\n 2.4924 * 0.678 \u2248 1.692.\\n\\n Then, multiply the result by 0.742:\\n 1.692 * 0.742 \u2248 1.254.\\n\\n Finally, multiply the result by 1.212:\\n 1.254 * 1.212 \u2248 1.518.\\n\\n Therefore, the estimated GFR is approximately 1.5 mL/min/1.73 m\u00b2.", "LLM Thinking": "To solve this problem step by step, we need to use the MDR D (Modification of Diet in Renal Disease) equation to calculate the patient 's Glomerular Filtration Rate (GFR) in mL/min /1.73 m\u00b2. The MDRD equation requires specific variables: serum creatinine, age, gender, and race. The given information includes: - Patient's age : 27 years old. - Patient's race: African-American . - Patient's serum creatinine: 14.6 mg / dL. First, I need to recall the MDRD formula for GFR. The standard MDRD equation for non-African Americans is : GFR = 186 \u00d7 (Serum Creatinine)^ {-1.154} \u00d7 (Age)^{-0.2 03} \u00d7 [0.742 if female] \u00d7 [ 1.212 if African American] Since this patient is African American , the multiplier for race is 1.212 instead of the default (assuming not African American, which would be 1 for non -black and non-African American). The patient is female, so the gender multiplier is 0.74 2. The serum creatinine is 14.6 mg/d L. But the MDRD equation requires serum creatinine in mg/d L, which we already have. The patient's age is 27 , so we plug that into the age term. Let me compute each part step by step. First, compute (Serum Creatinine)^ {-1.154}: 14.6 raised to the power of -1.154. To compute this, first , take the natural logarithm (ln) of 14.6 , multiply by -1.154, then exponentiate. Alternatively, we can directly calculate it: \\( ( 14. 6)^{-1.154} \\approx 0.0 134 \\). Wait, let me verify this calculation more accurately. Using a calculator, \\( (14.6)^{-1. 154} \\approx (1 / 14. 6 )^{1. 154}.\\) Taking it to the calculator, \\( ( 14. 6)^{-1.1 54 } \\approx 0.01337.\\) Next, compute the age term: (27)^{-0. 203} Now calculate (27) raised to the power of -0.203. Again, let's compute this: Using the calculator, \\( (27)^{-0. 2 03 } \\approx 0.678.\\) Now, we have all the components to plug into the MDRD formula. The formula becomes: \\[ \\text{GFR} = 18 6 \\times ( \\text{serum creatinine} )^{-1 .1 5 4 } \\times ( \\text{age}) ^{-0.20 3} \\times [ 0. 7 42 (for female)] \\times [ 1. 212 (for African American)] \\] Plugging in the values : \\[ \\text{GFR} = 186 \\ times (14. 6)^{-1. 15 4} \\times (27)^{-0. 2 0 3 } \\times 0.7 42 \\times 1 .212.\\] Using the earlier computed values: \\( (1 4. 6)^{-1.1 5 4} \\ approx 0.0 1337\\), and \\( ( 27)^{-0.20 3} \\approx 0 .6 7 8.\\) Now substitute these values back into the equation: GFR = 186 \u00d7 0.01 337 \u00d7 0.678 \u00d7 0.7 4 2 \u00d7 1.212 I'll compute this step by step. Step 1: Compute \\( 18 6 \\times 0.01 3 3 7.\\): \\[ 186 \\times 0. 0 1 3 37 = (1 8 6 * 0 .0 1 33 7) \\approx 2. 4 8 7 \\] Step 2: Multiply by 0 .6 7 8: \\[ 2. 4 8 7 * 0 .67 8 = 1. 689\\] (approximating) Step 3: Now multiply by 0 .7 42: \\[ 1. 6 89 * 0 .7 42 = 1. 2 5 3.\\] Finally, multiply by 1 . 2 1 2 \\[ 1.2 5 3 * 1 .2 12 = approximately, 1. 5 17 .\\]", "Ground Truth Answer": "3.654", "Ground Truth Explanation": "The patient is 27 years old. The concentration of Creatinine is 14.6 mg/dL. \nThe patient is Black, so the race coefficient is 1.212.\nThe patient is female, so the gender coefficient is 0.742.\nThe patient's estimated GFR is calculated using the MDRD equation as:\nGFR = 175 * creatinine^(-1.154) * age^(-0.203) * race_coefficient * gender_coefficient. The creatinine concentration is mg/dL.\nPlugging in these values will give us: 175 * 14.6^(-1.154) * 27^(-0.203) * 1.212 * 0.742=3.654.\nHence, the patient's GFR is 3.654 mL/min/1.73m\u00b2.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To solve this problem step by step, we need to use the MDR D (Modification of Diet in Renal Disease) equation to calculate the patient 's Glomerular Filtration Rate (GFR) in mL/min /1.73 m\u00b2. The MDRD equation requires specific variables: serum creatinine, age, gender, and race. \n\nThe given information includes:\n\n- Patient's age : 27 years old. \n- Patient's race: African-American . - Patient's serum creatinine: 14.6 mg / dL.\n\nFirst, I need to recall the MDRD formula for GFR. The standard MDRD equation for non-African Americans is :\n\nGFR = 186 \u00d7 (Serum Creatinine)^ {-1.154} \u00d7 (Age)^{-0.2 03} \u00d7 [0.742 if female] \u00d7 [ 1.212 if African American]\n\nSince this patient is African American , the multiplier for race is 1.212 instead of the default (assuming not African American, which would be 1 for non -black and non-African American). The patient is female, so the gender multiplier is 0.74 2. \n\nThe serum creatinine is 14.6 mg/d L. But the MDRD equation requires serum creatinine in mg/d L, which we already have. The patient's age is 27 , so we plug that into the age term. \n\nLet me compute each part step by step. \n\nFirst, compute (Serum Creatinine)^ {-1.154}:\n\n14.6 raised to the power of -1.154. \n\nTo compute this, first , take the natural logarithm (ln) of 14.6 , multiply by -1.154, then exponentiate. Alternatively, we can directly calculate it: \n\n\\( ( 14. 6)^{-1.154} \\approx 0.0 134 \\). Wait, let me verify this calculation more accurately. Using a calculator,\n\n\\( (14.6)^{-1. 154} \\approx (1 / 14. 6 )^{1. 154}.\\)\n\nTaking it to the calculator,\n\n\\( ( 14. 6)^{-1.1 54 } \\approx 0.01337.\\) Next, compute the age term: (27)^{-0. 203}\n\nNow calculate (27) raised to the power of -0.203. \n\nAgain, let's compute this: Using the calculator,\n\n\\( (27)^{-0. 2 03 } \\approx 0.678.\\)\n\nNow, we have all the components to plug into the MDRD formula. The formula becomes:\n\n\\[ \\text{GFR} = 18 6 \\times ( \\text{serum creatinine} )^{-1 .1 5 4 } \\times ( \\text{age}) ^{-0.20 3} \\times [ 0. 7 42 (for female)] \\times [ 1. 212 (for African American)] \\]\n\nPlugging in the values :\n\n\\[ \n\\text{GFR} = 186 \\ times (14. 6)^{-1. 15 4} \\times (27)^{-0. 2 0 3 } \\times 0.7 42 \\times 1 .212.\\]\n\nUsing the earlier computed values:\n\n\\( (1 4. 6)^{-1.1 5 4} \\ approx 0.0 1337\\),\n\nand \\( ( 27)^{-0.20 3} \\approx 0 .6 7 8.\\)\n\nNow substitute these values back into the equation:\n\nGFR = 186 \u00d7 0.01 337 \u00d7 0.678 \u00d7 0.7 4 2 \u00d7 1.212\n\nI'll compute this step by step.\n\nStep 1: Compute \\( 18 6 \\times 0.01 3 3 7.\\): \\[ 186 \\times 0. 0 1 3 37 = (1 8 6 * 0 .0 1 33 7) \\approx 2. 4 8 7 \\]\n\nStep 2: Multiply by 0 .6 7 8:\n\n\\[ 2. 4 8 7 * 0 .67 8 = 1. 689\\] (approximating)\n\nStep 3: Now multiply by 0 .7 42:\n\n\\[ 1. 6 89 * 0 .7 42 = 1. 2 5 3.\\]\n\nFinally, multiply by 1 . 2 1 2\n\n\\[ 1.2 5 3 * 1 .2 12 = approximately, 1. 5 17 .\\]"}
{"Row Number": 979, "Calculator Name": "Target weight", "Calculator ID": "61", "Category": "physical", "Note ID": "12", "Patient Note": "Patient has a height of 145 cm and their target BMI is 18.5 kg/m^2.", "Question": "Based on the patient's height and target BMI, what is the patient's target weight in kg?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "38.9", "LLM Explanation": "To find the target weight, we use the formula for BMI: BMI = weight (kg) / (height (m))^2. Rearranging this to solve for weight gives us: weight = BMI * (height)^2. The patient's height is 145 cm, which converts to 1.45 m. The target BMI is 18.5 kg/m^2. Now we plug in the values: weight = 18.5 * (1.45)^2. First, calculate (1.45)^2: 1.45 * 1.45 = 2.1025. Next, multiply this result by the target BMI: weight = 18.5 * 2.1025. Performing the multiplication: 18.5 * 2.1025 = 38.89625. Therefore, the target weight is approximately 38.9 kg.", "LLM Thinking": "First, we need to calculate the target weight using the formula for BMI: BMI = weight (kg) / (height (m))^2. The patient's height is 145 cm, which is 1. 45 m (since 1 m = 100 cm), and the target BMI is 18.5 kg/m^2. Next, rearrange the formula to solve for weight: weight = BMI * (height)^2. Now, plug in the known values: Height = 1.45 m Target BMI = 18. 5 Weight = 18.5 * (1.45 )^2 First, square the height: 1.45 * 1.45 = 2.1025 Then , multiply this result by the target BMI: weight = 18. 5 * 2.1025 Now, calculate 1 8.5 * 2.1025. 18. 5 * 2 = 37.0, and 18 .5 * 0.1 = 1.85, and 18. 5 * 0.02 = 0 .37, and 18.5 * 0.0 05 = 0.0925. Now sum: 37.0 + (1.85 + 0. 37) = 37.0 + 2.22 = 39.22. Then add the remaining 0. 0925: 39.22 + 0. 0925 = 39. 3125. However, the question doesn 't specify the required degree of precision, so we use the precise calculation.", "Ground Truth Answer": "38.896", "Ground Truth Explanation": "The patient's target bmi is 18.5 kg/m^2. The patient's height is 145 cm, which is 145 cm * 1 m / 100 cm = 1.45 m. From this, the patient's target weight is 18.5 kg/m^2 * 1.45 m * 1.45 m = 38.896 kg. ", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the target weight using the formula for BMI: BMI = weight (kg) / (height (m))^2. The patient's height is 145 cm, which is 1. 45 m (since 1 m = 100 cm), and the target BMI is 18.5 kg/m^2. Next, rearrange the formula to solve for weight: weight = BMI * (height)^2.\n\nNow, plug in the known values:\n\nHeight = 1.45 m\nTarget BMI = 18. 5\n\nWeight = 18.5 * (1.45 )^2 \n\nFirst, square the height: 1.45 * 1.45 = 2.1025\n\nThen , multiply this result by the target BMI: weight = 18. 5 * 2.1025\n\nNow, calculate 1 8.5 * 2.1025.\n\n18. 5 * 2 = 37.0, and 18 .5 * 0.1 = 1.85, and 18. 5 * 0.02 = 0 .37, and 18.5 * 0.0 05 = 0.0925. \n\nNow sum: 37.0 + (1.85 + 0. 37) = 37.0 + 2.22 = 39.22. Then add the remaining 0. 0925: 39.22 + 0. 0925 = 39. 3125.\n\nHowever, the question doesn 't specify the required degree of precision, so we use the precise calculation."}
{"Row Number": 491, "Calculator Name": "Anion Gap", "Calculator ID": "39", "Category": "lab", "Note ID": "pmc-7544303-1", "Patient Note": "We present the case of a 45-year-old gentleman, known diabetic for 6 years on metformin 1 g, twice a day, with reasonable control (hemoglobin A1c 6.4%). He was admitted to our emergency feeling unwell with 2 days\u2019 history of vomiting and watery diarrhea, also associated crampy periumbilical pain. He denied a history of similar complaints in his companions, no change in his dietary habits preceding symptoms\u2019 onset. He drinks alcohol occasionally; the last drink was 6 months before the presentation\u2014no illicit drug use history. The initial vital signs were normal. Soon later, he became tachycardic with heart rate reaching 120 bpm, blood pressure 127/70 mmHg, and a normal temperature. He looked dehydrated; otherwise, his examination was unremarkable.\nLaboratory workup was significant for initially low glucose 2.5 mmol/L (3.3\u20135.5 mmol/L), high serum creatinine 632 \u03bcmol/L (62\u2013106 umol/L), and high blood urea nitrogen of 21 mmol/L (2.8\u20138 mmol/L). Serum electrolytes were as follows: potassium (K+) 6.3 mmol/L (3.5\u20135.1 mmol/L), sodium (NA) 144 mmol/L (135\u2013145mmol/L), bicarbonate (HCO3) 5.8 mmol/L (23\u201329 mmol/L), and serum chloride 99 mmol/L (99\u2013107 mmol/L). Serum aminotransferases were normal (ALT 31 U/L, AST 27 U/L). He had significant high AG metabolic acidosis with PH of 6.8 (7.35\u20137.45) and AG of 40, lactic acid (LA) strikingly high reaching up to 24 mmol/L (0.5\u20132.2 mmol/L). With LA of 19 mmol/L, his OG measured 20 with serum osmolarity of 340 mmol/kg (275\u2013295 mmol/kg). Toxicology screening, including serum ethanol, acetaminophen, salicylate, and urine for oxalate crystal, was negative.\nAcidosis failed to respond to initial fluid hydration, including intravenous bicarbonate. Thus, the patient underwent 2 sessions of sustained low-efficiency hemodialysis (HD). After HD, his electrolyte disturbances improved, and intravenous fluid hydration continued. Acute kidney injury (AKI) workup, including antinuclear antibodies (ANA), antinuclear cytoplasmic antibodies, creatinine kinase level, and sepsis workup were unremarkable. Starting day 3, the patient was in a polyuric phase, suggestive of acute tubular necrosis (ATN), producing between 3 and 6 L per day, and his serum creatinine was decreasing. He was discharged after 8 days of hospitalization in good condition with a serum creatinine of 140 \u03bcmol/L (62\u2013106 \u03bcmol/L). Figure shows serum creatinine trend during the hospitalization, Figure depicts serum lactic acid clearance during hospitalization.\nOur patient had an AKI with significant lactic acidosis and an OG. Given the significant level of lactic acid, MALA was the likely diagnosis. Our patient was on metformin for a long time, and he did not attempt an overdose; hence, we think that MALA was likely precipitated by dehydration leading to prerenal insult and AKI. Eventually, his prerenal insult led to acute tubular necrosis, as evident by the polyuric phase the patient exhibited on day three.", "Question": "What is the patient's anion gap in terms of mEq/L?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "39.2", "LLM Explanation": "To calculate the anion gap, we use the formula: Anion Gap = Na+ - (Cl- + HCO3-). From the patient note, the values are: Na = 144 mmol/L, Cl = 99 mmol/L, and HCO3 = 5.8 mmol/L. Plugging these values into the formula gives us: Anion Gap = 144 - (99 + 5.8) = 144 - 104.8 = 39.2 mmol/L. Since mEq/L is numerically the same as mmol/L for these ions, the anion gap is 39.2 mEq/L.", "LLM Thinking": "Step 1: To calculate the anion gap, we need the following electrolyte values: sodium (Na+), potassium (K+), chloride (Cl-), and bicarbonate (HCO3-). The formula is Anion Gap = Na+ - (Cl- + H CO3-). Step 2: From the patient note, the provided electrolytes are : Na 144 mmol/L, K 6.3 mmol/L, HCO3 5.8 mmol/L, Cl 99 mmol/L. Step 3: Plug the values into the formula: 144 - (99 + 5.8) = 144 - 104.8 = 39.2. The question asks for the anion gap in mEq/L, which is interchangeable with mmol/L since for these ions, the milliequival ents (mEq) are numerically equal to the millimoles ( mmol).", "Ground Truth Answer": "39.2", "Ground Truth Explanation": "The formula for computing a patient's anion gap is: sodium (mEq/L) - (chloride (mEq/L)+ bicarbonate (mEq/L)).\nThe concentration of sodium is 144.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of sodium from mmol to mEq. The mass of sodium is 144.0 mmol. The compound, sodium, has a valence of 1, and so multiply the valence by the value of mmol to get, 144.0 mmol * 1 mEq/mmol = 144.0 mEq sodium. The volume units is L so no volume conversion is needed. Hence, the concentration value of 144.0 mmol sodium/L converts to 144.0 mEq sodium/L. \nThe concentration of chloride is 99.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of chloride from mmol to mEq. The mass of chloride is 99.0 mmol. The compound, chloride, has a valence of 1, and so multiply the valence by the value of mmol to get, 99.0 mmol * 1 mEq/mmol = 99.0 mEq chloride. The volume units is L so no volume conversion is needed. Hence, the concentration value of 99.0 mmol chloride/L converts to 99.0 mEq chloride/L. \nThe concentration of bicarbonate is 5.8 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of bicarbonate from mmol to mEq. The mass of bicarbonate is 5.8 mmol. The compound, bicarbonate, has a valence of 1, and so multiply the valence by the value of mmol to get, 5.8 mmol * 1 mEq/mmol = 5.8 mEq bicarbonate. The volume units is L so no volume conversion is needed. Hence, the concentration value of 5.8 mmol bicarbonate/L converts to 5.8 mEq bicarbonate/L. \nPlugging in these values into the anion gap formula gives us 144.0 mEq/L - (99.0 mEq/L + 5.8 mEq/L) = 39.2 mEq/L. Hence, The patient's anion gap is 39.2 mEq/L.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the anion gap, we need the following electrolyte values: sodium (Na+), potassium (K+), chloride (Cl-), and bicarbonate (HCO3-).  \nThe formula is Anion Gap = Na+ - (Cl- + H CO3-).  \nStep 2: From the patient note, the provided electrolytes are : Na 144 mmol/L, K 6.3 mmol/L, HCO3 5.8 mmol/L, Cl 99 mmol/L.  \nStep 3: Plug the values into the formula: 144 - (99 + 5.8) = 144 - 104.8 = 39.2.  \nThe question asks for the anion gap in mEq/L, which is interchangeable with mmol/L since for these ions, the milliequival ents (mEq) are numerically equal to the millimoles ( mmol)."}
{"Row Number": 661, "Calculator Name": "QTc Hodges Calculator", "Calculator ID": "58", "Category": "physical", "Note ID": "14", "Patient Note": "Patient has a heart rate of 154 bpm and a QT interval of 330 msec.", "Question": "Using the Hodges Formula for corrected QT interval, what is the patient's corrected QT interval in terms of msec?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "330", "LLM Explanation": "To calculate the corrected QT interval using the Hodges formula, we use the formula: QTc = QT + 0.154 \u00d7 (RR - 0.6), where RR is the R-R interval in seconds. Given the heart rate (HR) is 154 bpm and the QT interval is 330 msec, we first calculate the RR interval: RR = 60 / 154 \u2248 0.3896 seconds. Next, we plug in the values into the Hodges formula: QTc = 330 + 0.154 \u00d7 (0.3896 - 0.6). Calculate the term inside the parenthesis: 0.3896 - 0.6 = -0.2104. Then multiply this by 0.154: 0.154 \u00d7 (-0.2104) \u2248 -0.0324. Finally, add this result to the original QT: QTc = 330 + (-0.0324) \u2248 329.97 msec. Rounding this to the nearest whole number gives us approximately 330 msec.", "LLM Thinking": "Step 1: To calculate the corrected QT interval, we will use the Hodges formula for the corrected QT interval (QTc_Hodges). The formula is: QTc (corrected QT interval) = QT + (QT \u00d7 (Heart Rate - 60)) Wait, that doesn \u2019t seem right - the Hodges formula appears to have been incorrectly recalled by me. Let me check again. The actual Hodges formula is different. It is written as: \\[QTc = \\frac{QT \\text { interval}}{\\sqrt{(RR \\text{ interval in seconds})}} \\] However, the RR interval is the time between two consecutive R waves, which is the reciprocal of the heart rate. Since heart rate (HR) is in beats per minute (bpm), the RR interval in seconds can be calculated as \\( \\frac{60}{HR} \\). So the formula using heart rate becomes: \\[ QTc_Hodges = \\frac{QT}{\\sqrt{\\frac{HR}{60 \\times 1000}}} \\] Wait, maybe I need to clarify correct formulas for different methods to calculate the corrected QT intervals. Another common approach is the Bazett's formula, Fridericia's formula, and the Framingham formula, among others. However, the question specifically asks for the Hodges formula. Let's use the correct Hodges formula: The Hodges formula for QTc is calculated as: QTc = QT + 0.154 \u00d7 (RR interval - 0.6) where the RR interval (in seconds) can be given as RR = 60 / HR. Wait, perhaps I need to confirm the exact formula. Alternatively, according to some sources, the Hodges formula is actually the same as the Bazett\u2019s formula for calculating QTc: QTc = QT / (RR)^0.5 where RR is the cycle length in seconds (i.e., the reciprocal of the heart rate in seconds). However, Hodges formula might not be the same as Bazett's. It may refer to a correction method not commonly used or known by the same name. Alternatively, perhaps the user is referring to the Hodges formula as: QTc = QT + (HR - 60) \u00d7 0.003 (for HR in the range of 40\u2013120 bpm). Wait, this is confusing. Since I need to be precise, I should look up the exact formula for Hodges or take a commonly used approach unless otherwise specified. Let's use the Bazett's formula as it is one of the oldest methods and it is widely used: Bazett's correction is given by: \\[ QTc_Bazett = QT / \\sqrt{(RR)} \\] where RR is the R-R interval in seconds. However, the problem states to use the Hodges formula. It seems there might be confusion because \"Hodges's formula for Correction of QT interval\" is not a standard or widely accepted formula like Bazett, Fridericia, or Framingham. It's possible that the question refers to a different method. Alternatively, maybe it's a typo and they meant \"Bazett\" or Fridericia's formula. Alternatively, maybe it's the Hodges formula as per the paper from 1957? Wait, according to some sources, the Hodges formula is actually: QTc = QT + 0.154 \u00d7 (RR - 0.6) where RR is in seconds. Let me verify this. Alternatively, according to some references, the Hodges formula corrects the QT interval based on the relationship between heart rate and QT interval using the following equation: QTc = QT + 0.154*(RR in seconds - 0.6) Let's use that formula. First, we need to calculate RR interval in seconds. Since the heart rate is 154 bpm, the RR interval is: \\[ RR = \\frac{60}{HR} = \\frac{60}{154} \\text{ seconds} \\] Calculating this: \\[ RR = \\frac{60}{154} \\approx 0.3896 \\text{ seconds}.\\] Now, using the Hodges formula to calculate the corrected QT interval: \\[QTc = QT + 0.154 \\times (RR - 0.6).\\] The given QT interval (QT) = 330 msec, and we have calculated RR = 0.3896 s. Plugging in the values: \\[QTc = 330 + 0.154 \\times (0.3896 - 0.6 )\\] First compute the term (RR - 0.6): 0.3896 - 0.6 = -0.2104. Now multiply this by 0.154: \\[0.154 \\times (-0.2104) = -0.0324\\] Then add this to the original QT: Wait, that seems odd. Because with a higher heart rate (tachycardia), the QT interval normally shortens so the correction should account for that. But here, the result is very close to the original QT. However, the Hodges formula might have a different approach. Another common approach is the Bazett's formula, which takes into account the square root of RR interval. Let me check again. Alternatively, maybe the Hodges formula is: QTc = QT / (RR)^0.5, but that is Bazett's formula. Alternatively, perhaps the question is referring to the Hodges formula as described in some sources where the formula is: QTc = QT + 0.154*(RR - 0.6) where RR is in seconds. Wait, perhaps I made a mistake in the units. The original QT is in msec, and the RR is in seconds, so when we multiply 0.154 (which is in msec per second) times the term in seconds, it should have units of msec. The calculation gives a very small adjustment, so the QTc is almost the same as the original QT due to the high heart rate making the RR very short (approximately 0.389 s, clearly much shorter than 0.6 s), thus subtracting a negative term from the original QT. Wait, but that would mean that the corrected QT is slightly less than the original QT by about 0.03 msec. It does not make sense because when heart rate increases, the QT shortens, so the correction should make the QT longer to standardize it to the rate at which the QT interval would be if the heart were beating at a certain standard rate. If the question is referencing a typical approach like Bazett Correction, which is QTc = QT / sqrt(RR), then let's see what that would give: Using Bazett's formula: First, RR in seconds = 60/HR = 60/154 \u2248 0.3896 s. Then, the corrected QT would be: Wait, that would be very high, but with a high heart rate, the QT is short, so when corrected to a lower heart rate (e.g., 60 bpm), the QT appears corrected to a higher value (because at high heart rates, the QT shortens, so the correction would estimate what it would be at a slower rate). However, the user specifically asked for Hodges formula. Since the Hodges formula is not a standard formula, perhaps there is confusion or the question has a typo. The Bazett correction is one of the common methods, but if the user insists on Hodges, perhaps the formula they have in mind is different. Let me see another source. Another common approach is the Fridericia formula, which takes into account: QTc = QT/(RR)^1/3. Alternatively, perhaps they meant the Framingham formula, which is: QTc = QT in msec + 1.75 \u00d7 (HR - 60). But that would be for HR < 60. Wait, perhaps the Hodges formula used in the context given in certain papers is actually the Bazett\u2019s or Fridericia. Alternatively, maybe the formula is: \\[ QTc = QT + 0.154 \\times (RR - 0.6) \\] As per some references, this is indeed the Hodges formula. Let me re-calculate with that. Given RR = 0.3896 s: (0.3896 - 0.6) = -0.2104 s Multiply by 0.154: 0.154 \u00d7 -0.2104 = -0.0324 msec Finally add this to the original QT of 330 msec That seems odd because when the heart rate is high, the QT shortens, so the correction should account for that by giving a longer QTc. For example, at higher heart rates, the measured QT is shorter, so the corrected QT should be longer to reflect what it would be at a normal heart rate. However, according to this formula, the correction is minimal here, since the heart rate is quite high (making the RR very small compared to 0.6 s), and the correction term adds a very small negative value (so the corrected QT is slightly less than the original QT). This might be because the formula is not designed for such high heart rates, or the correction it applies is quite sensitive to the difference between the RR and 0.6 s.", "Ground Truth Answer": "494.231", "Ground Truth Explanation": "The corrected QT interval using the Hodges formula is computed as  QTc = QT interval + 1.75 * [(60 /rr_interval_sec) - 60], where QT interval is in msec, and RR interval is given as 60/(heart rate).\nThe patient's heart rate is 154 beats per minute.\nThe QT interval is 330 msec.\nThe RR interval is computed as 60/(heart rate), and so the RR interval is 60/154 = 0.39.\nHence, plugging in these values, we will get 330 + 1.75 * [(60/0.39) - 60] = 494.231.\nThe patient's corrected QT interval (QTc) is 494.231 msec.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the corrected QT interval, we will use the Hodges formula for the corrected QT interval (QTc_Hodges).  \nThe formula is:  \nQTc (corrected QT interval) = QT + (QT \u00d7 (Heart Rate - 60))  \n\nWait, that doesn \u2019t seem right - the Hodges formula appears to have been incorrectly recalled by me.  \nLet me check again.  \nThe actual Hodges formula is different. It is written as:  \n\\[QTc = \\frac{QT \\text { interval}}{\\sqrt{(RR \\text{ interval in seconds})}} \\]  \n\nHowever, the RR interval is the time between two consecutive R waves, which is the reciprocal of the heart rate.  \nSince heart rate (HR) is in beats per minute (bpm), the RR interval in seconds can be calculated as \\( \\frac{60}{HR} \\).  \nSo the formula using heart rate becomes:  \n\\[ QTc_Hodges = \\frac{QT}{\\sqrt{\\frac{HR}{60 \\times 1000}}} \\]  \n\nWait, maybe I need to clarify correct formulas for different methods to calculate the corrected QT intervals.  \nAnother common approach is the Bazett's formula, Fridericia's formula, and the Framingham formula, among others.  \nHowever, the question specifically asks for the Hodges formula.  \n\nLet's use the correct Hodges formula:  \nThe Hodges formula for QTc is calculated as:  \nQTc = QT + 0.154 \u00d7 (RR interval - 0.6)  \nwhere the RR interval (in seconds) can be given as RR = 60 / HR.  \n\nWait, perhaps I need to confirm the exact formula.  \nAlternatively, according to some sources, the Hodges formula is actually the same as the Bazett\u2019s formula for calculating QTc:  \nQTc = QT / (RR)^0.5  \nwhere RR is the cycle length in seconds (i.e., the reciprocal of the heart rate in seconds).  \nHowever, Hodges formula might not be the same as Bazett's.  \nIt may refer to a correction method not commonly used or known by the same name.  \nAlternatively, perhaps the user is referring to the Hodges formula as:  \nQTc = QT + (HR - 60) \u00d7 0.003 (for HR in the range of 40\u2013120 bpm).  \n\nWait, this is confusing.  \nSince I need to be precise, I should look up the exact formula for Hodges or take a commonly used approach unless otherwise specified.  \n\nLet's use the Bazett's formula as it is one of the oldest methods and it is widely used: Bazett's correction is given by:  \n\\[ QTc_Bazett = QT / \\sqrt{(RR)} \\]  \nwhere RR is the R-R interval in seconds.  \n\nHowever, the problem states to use the Hodges formula.  \nIt seems there might be confusion because \"Hodges's formula for Correction of QT interval\" is not a standard or widely accepted formula like Bazett, Fridericia, or Framingham.  \nIt's possible that the question refers to a different method.  \nAlternatively, maybe it's a typo and they meant \"Bazett\" or Fridericia's formula.  \nAlternatively, maybe it's the Hodges formula as per the paper from 1957?  \n\nWait, according to some sources, the Hodges formula is actually:  \nQTc = QT + 0.154 \u00d7 (RR - 0.6)  \nwhere RR is in seconds.  \nLet me verify this.  \n\nAlternatively, according to some references, the Hodges formula corrects the QT interval based on the relationship between heart rate and QT interval using the following equation:  \nQTc = QT + 0.154*(RR in seconds - 0.6)  \nLet's use that formula.  \n\nFirst, we need to calculate RR interval in seconds.  \nSince the heart rate is 154 bpm, the RR interval is:  \n\\[ RR = \\frac{60}{HR} = \\frac{60}{154} \\text{ seconds} \\]  \nCalculating this:  \n\\[ RR = \\frac{60}{154} \\approx 0.3896 \\text{ seconds}.\\]  \n\nNow, using the Hodges formula to calculate the corrected QT interval:  \n\\[QTc = QT + 0.154 \\times (RR - 0.6).\\]  \nThe given QT interval (QT) = 330 msec, and we have calculated RR = 0.3896 s.  \nPlugging in the values:  \n\\[QTc = 330 + 0.154 \\times (0.3896 - 0.6 )\\]  \n\nFirst compute the term (RR - 0.6):  \n0.3896 - 0.6 = -0.2104.  \nNow multiply this by 0.154:  \n\\[0.154 \\times (-0.2104) = -0.0324\\]  \nThen add this to the original QT:  \n\nWait, that seems odd.  \nBecause with a higher heart rate (tachycardia), the QT interval normally shortens so the correction should account for that.  \nBut here, the result is very close to the original QT.  \nHowever, the Hodges formula might have a different approach.  \n\nAnother common approach is the Bazett's formula, which takes into account the square root of RR interval.  \nLet me check again.  \nAlternatively, maybe the Hodges formula is:  \nQTc = QT / (RR)^0.5, but that is Bazett's formula.  \nAlternatively, perhaps the question is referring to the Hodges formula as described in some sources where the formula is:  \nQTc = QT + 0.154*(RR - 0.6)  \nwhere RR is in seconds.  \n\nWait, perhaps I made a mistake in the units.  \nThe original QT is in msec, and the RR is in seconds, so when we multiply 0.154 (which is in msec per second) times the term in seconds, it should have units of msec.  \nThe calculation gives a very small adjustment, so the QTc is almost the same as the original QT due to the high heart rate making the RR very short (approximately 0.389 s, clearly much shorter than 0.6 s), thus subtracting a negative term from the original QT.  \n\nWait, but that would mean that the corrected QT is slightly less than the original QT by about 0.03 msec.  \nIt does not make sense because when heart rate increases, the QT shortens, so the correction should make the QT longer to standardize it to the rate at which the QT interval would be if the heart were beating at a certain standard rate.  \n\nIf the question is referencing a typical approach like Bazett Correction, which is QTc = QT / sqrt(RR), then let's see what that would give:  \nUsing Bazett's formula:  \nFirst, RR in seconds = 60/HR = 60/154 \u2248 0.3896 s.  \n\nThen, the corrected QT would be:  \n\nWait, that would be very high, but with a high heart rate, the QT is short, so when corrected to a lower heart rate (e.g., 60 bpm), the QT appears corrected to a higher value (because at high heart rates, the QT shortens, so the correction would estimate what it would be at a slower rate).  \n\nHowever, the user specifically asked for Hodges formula.  \nSince the Hodges formula is not a standard formula, perhaps there is confusion or the question has a typo.  \nThe Bazett correction is one of the common methods, but if the user insists on Hodges, perhaps the formula they have in mind is different.  \nLet me see another source.  \nAnother common approach is the Fridericia formula, which takes into account: QTc = QT/(RR)^1/3.  \nAlternatively, perhaps they meant the Framingham formula, which is: QTc = QT in msec + 1.75 \u00d7 (HR - 60).  \nBut that would be for HR < 60.  \nWait, perhaps the Hodges formula used in the context given in certain papers is actually the Bazett\u2019s or Fridericia.  \nAlternatively, maybe the formula is:  \n\\[ QTc = QT + 0.154 \\times (RR - 0.6) \\]  \nAs per some references, this is indeed the Hodges formula.  \nLet me re-calculate with that.  \nGiven RR = 0.3896 s:  \n(0.3896 - 0.6) = -0.2104 s  \nMultiply by 0.154:  \n0.154 \u00d7 -0.2104 = -0.0324 msec  \nFinally add this to the original QT of 330 msec  \n\nThat seems odd because when the heart rate is high, the QT shortens, so the correction should account for that by giving a longer QTc.  \nFor example, at higher heart rates, the measured QT is shorter, so the corrected QT should be longer to reflect what it would be at a normal heart rate.  \nHowever, according to this formula, the correction is minimal here, since the heart rate is quite high (making the RR very small compared to 0.6 s), and the correction term adds a very small negative value (so the corrected QT is slightly less than the original QT).  \nThis might be because the formula is not designed for such high heart rates, or the correction it applies is quite sensitive to the difference between the RR and 0.6 s."}
{"Row Number": 102, "Calculator Name": "Calcium Correction for Hypoalbuminemia", "Calculator ID": "7", "Category": "lab", "Note ID": "pmc-6323504-1", "Patient Note": "A 73-year-old male veteran presented with recurrent syncope and falls. He had decreased appetite, thirst, and urine output in the setting of progressive abdominal distention, pruritus, and painless jaundice in the prior month. His past medical history was significant for obesity (BMI=40.1), hypertension, and benign prostatic hyperplasia (BPH) with pertinent medications of ibuprofen (200 mg QID), furosemide (40 mg BID), losartan, doxazosin, and finasteride. A detailed dietary history prior to admission was lacking. Physical exam was notable for diffuse jaundice, abdominal distention, and severe mid-thoracic back pain later confirmed to be T6/T7 vertebral fractures.\nInitial laboratory results showed stage 3 AKI with serum creatinine (SCr) elevated to 8.98 mg/dL from a baseline of 1.04 mg/dL. Supporting laboratory findings included elevations in phosphorus (7.6 mg/dL), parathyroid hormone (319.7 pg/mL), and low calcium (7.6 mg/dL), ionized calcium (0.93 mmol/L), albumin (2.8 g/dL), and 25-hydroxy vitamin D (16.4 ng/mL). There was an anion gap (21 mEq/L) with pH= 7.145 confirmed with arterial blood gas. Jaundice workup revealed an obstructive pattern with elevated total bilirubin (5.4 mg/dL), direct bilirubin (3.7 mg/dL), AST (79 U/L), ALT (140 U/L), alkaline phosphatase (392 U/L), GGT (214 U/L), and lipase (690 U/L). Soon after admission, he developed hypotension necessitating vasopressors and broad-spectrum antibiotics for presumed septic shock. AKI workup revealed deteriorating kidney function and development of anuria, requiring intermittent hemodialysis.\nThe etiology of renal failure remained unclear. Urine testing showed nephrotic range proteinuria, many bacteria, no red blood cells, no crystals, few hyaline casts, and no granular casts. A renal biopsy was performed and showed diffuse calcium oxalate crystal deposition with severe acute tubular injury (ATN) and mild interstitial fibrosis (). An evident cause of oxalate nephropathy was unclear, although it was suspected that pancreatic insufficiency leading to fat malabsorption and increased intestinal absorption of oxalate were responsible. Fecal elastase returned low at 54 \u03bcg Elastase/g stool to support pancreatic insufficiency while abdominal computed tomography (CT) without contrast showed exocrine atrophy of the pancreas. Serum oxalate was 3.6 mmol/L (normal range 1.0-3.0 mmol/L). A low-fat, low-oxalate diet with calcium citrate and pancrelipase supplementation was started.\nConcurrently, a jaundice workup began with abdominal ultrasound which showed hepatomegaly, splenomegaly, numerous gallstones, and no inferior vena cava or portal circulation thrombosis. Of note, the common bile duct was not visibly dilated, raising concern for an upstream malignant stricture. MRCP showed marked dilation of the left intrahepatic biliary tree with abrupt termination and mild dilation of the right intrahepatic biliary tree, further raising suspicion of malignancy. ERCP with stenting to the right intrahepatic biliary tree duct was performed. Cytology, a markedly elevated CA 19-9, and imaging confirmed the diagnosis of cholangiocarcinoma (Klatskin tumor). Medical oncology discussed chemotherapy and radiation as alternative treatments, but the patient elected to enter hospice. His kidney function ultimately improved with return of nonoliguric urine output, cessation of dialysis, and improved creatinine to 2.45mg/dL and eGFR of 26 ml/min/1.73m3 at discharge.", "Question": "Using the Calcium Correction for Hypoalbuminemia formula, what is the patient's corrected calcium in mg/dL? Your may set your normal albumin concentration to be 4 g/dL.", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "8.56", "LLM Explanation": "To calculate the corrected calcium using the Calcium Correction for Hypoalbuminemia formula, we use the formula: Corrected Ca = Measured Ca + (4 - Albumin) * 0.8. The given values are: Measured Ca = 7.6 mg/dL and Albumin = 2.8 g/dL. Let's plug these values into the formula step by step.\\n\\nStep 1: Calculate the difference between the normal albumin concentration (4 g/dL) and the patient's albumin level (2.8 g/dL).\\n4 - 2.8 = 1.2 g/dL.\\n\\nStep 2: Multiply this difference by 0.8.\\n1.2 * 0.8 = 0.96.\\n\\nStep 3: Add this result to the measured calcium level.\\n7.6 + 0.96 = 8.56 mg/dL.\\n\\nTherefore, the corrected calcium is 8.56 mg/dL.", "LLM Thinking": "First, we need to calculate the corrected calcium using the Calcium Correction for Hyp oalbuminemia formula. The formula is: Corrected Ca = Measured Ca + (4 - Albumin) * 0.8. The patient's measured calcium level is 7.6 mg/dL, and the albumin level is 2.8 g/dL. The normal albumin concentration we are given is 4 g/dL. The formula adjustment factor is 0.8 mg/dL per g/d L of albumin deviation from the normal albumin concentration. Let's plug in the numbers into the formula: Corrected Ca = Measured Ca + (4 - Albumin) * 0.8 Corrected Ca = 7.6 + (4 - 2.8) * 0.8 Now let's calculate step by step. Step 1: Calculate the difference between the normal albumin level and the patient's albumin level: 4 - 2.8 = 1.2 g/dL Step 2: Multiply this difference by 0.8. 1.2 * 0.8 = 0.96 Step 3: Add this result to the measured calcium: 7.6 + 0.96 = 8.56", "Ground Truth Answer": "8.56", "Ground Truth Explanation": "To compute the patient's correct calcium level in mg/dL, the formula is  (0.8 * (Normal Albumin (in g/dL) - Patient's Albumin (in g/dL))) + Serum Calcium (in mg/dL).\nThe patient's normal albumin level is 4.0 g/dL.\nThe concentration of Albmumin is 2.8 g/dL. \nThe concentration of Calcium is 7.6 mg/dL. \nPlugging these values into the formula, we get (0.8 * (4.0 g/dL - 2.8 g/dL)) + 7.6 mg/dL = 8.56 mg/dL.\nThe patient's corrected calcium concentration 8.56 mg/dL.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the corrected calcium using the Calcium Correction for Hyp oalbuminemia formula. The formula is: Corrected Ca = Measured Ca + (4 - Albumin) * 0.8. \n\nThe patient's measured calcium level is 7.6 mg/dL, and the albumin level is 2.8 g/dL. The normal albumin concentration we are given is 4 g/dL. The formula adjustment factor is 0.8 mg/dL per g/d L of albumin deviation from the normal albumin concentration. Let's plug in the numbers into the formula:\n\nCorrected Ca = Measured Ca + (4 - Albumin) * 0.8  \nCorrected Ca = 7.6 + (4 - 2.8) * 0.8  \n\nNow let's calculate step by step.\n\nStep 1: Calculate the difference between the normal albumin level and the patient's albumin level: 4 - 2.8 = 1.2 g/dL  \n\nStep 2: Multiply this difference by 0.8.  \n\n1.2 * 0.8 = 0.96  \n\nStep 3: Add this result to the measured calcium: 7.6 + 0.96 = 8.56"}
{"Row Number": 747, "Calculator Name": "Delta Gap", "Calculator ID": "63", "Category": "lab", "Note ID": "pmc-3094288-1", "Patient Note": "A 17-year-old Caucasian female presented to local hospital with a history of acute alcohol intoxication and ingestion of large quantities of acetaminophen. The patient complained of nausea for 2 days and subjective increase in thirst and urine output for a day. She did not notice any dysuria, abdominal pain or change in the colour of her urine. She did however report a remarkable increase in lower back pain that she had attributed to strenuous exercise.\nTwo days prior to her presentation to the emergency department, the young lady had attended a party where she consumed over 300 mL of vodka and ingested twenty 500 mg tablets of acetaminophen later that night.\nPast medical history revealed that she had experienced an episode of rash after having taken liquid acetaminophen as a child. She had not taken acetaminophen since infancy and also denied regular use of any other analgesic. Family history was non-contributory for relevant physiological and psychological illness. The patient reported feeling stressed due to a recent slip in school grades, however denied any suicidal ideation.\nPhysical examination in the emergency department revealed blood pressure of 140/92 mmHg, pulse 80 bpm, temperature 36.9\u00b0C, respiratory rate of 16 breaths per minute and oxygen saturation of 100% at room air. Height and weight were recorded at 170 cm and 63 kg. Physical examination was otherwise unremarkable. No rash, joint swelling or sign of dehydration was detected.\nInitial renal function tests at the local hospital revealed serum creatinine and BUN levels of 1.6 mg/dL and 19.3 mg/dL, respectively. Other laboratory results included: glucose 112 mg/dL, sodium 141 mEq/L, potassium 4.3 mEq/L, chloride 104 mEq/L, bicarbonate 29 mEq/L, albumin 43 g/L, aspartate transaminase 20 IU/L, alkaline phosphate 66 IU/L and total bilirubin 1.11 mg/dL. Her INR was reported to be normal at 0.9. Toxicity screens on admission showed acetaminophen level at 9.06 \u03bcg/mL. Urine dipstick showed trace amount of blood and 2 plus protein. Microscopy revealed 25 red blood cells per high power field and was otherwise non-contributory. Abdominal ultrasound revealed increased hepatic echogenicity and the kidneys were normal in appearance.\nAt the outside hospital, she was given morphine, ondansetron and lansoprazole for her back pain and gastrointestinal symptoms. Acetylcysteine was not administered as the patient presented more than 24 hours after the ingestion of acetaminophen.\nRenal function tests were repeated later that evening and monitored frequently thereafter. Over the course of 36 hours, the patient's serum creatinine and BUN levels elevated from 1.6 mg/dL and 19.3 mg/dL to 5.7 mg/dL and 49.6 mg/dL, respectively. Urine output was reported to be 2.7 mL/kg/hour. At this time, the patient was transferred to our Children's Hospital for rapidly progressive renal insufficiency.\nPhysical examination upon admission showed normal vital signs: blood pressure 115/74 mmHg, pulse 60 bpm, temperature 36.6\u00b0C, respiratory rate 16 breaths per minute and 100% oxygen saturation at room air. Serum creatinine and BUN levels were measured at 6.3 mg/dL and 52.4 mg/dL, respectively. Furthermore, her electrolytes were recorded as follows: random glucose 86 mg/dL, sodium 134 mEq/L, potassium 5.7 mEq/L, chloride 104 mEq/L and bicarbonate 22 mEq/L. Coagulation study revealed an INR of 1.0 and an APTT of 28 seconds. Other investigations including blood counts and liver functions tests were within normal range. The patient's daily urine output was 3.3 mL/kg/hour at this time. Urinalysis revealed small amounts of protein and blood in her urine. Staining for eosinophils on the random urine sample was positive.\nRenal biopsy was performed to further delineate the underlying cause of rapidly progressive renal insufficiency. Figure depicts the histological findings. The biopsy showed no evidence of glomerulonephritis. The interstitium was mildly edematous with small aggregates of inflammatory cells, mainly lymphocytes and eosinophils. Immunofluorescence and electron microscopy were both negative for immune deposits. The histological findings were compatible with acute interstitial nephritis.\nThe patient was managed supportively by careful monitoring of fluid intake and output. Corticosteroids therapy was considered if no improvement of her renal function was observed. However, her serum creatinine and BUN levels peaked at 7.0 mg/dL and 60 mg/dL two days after admission then began to improve without further medical intervention. Her serum creatinine and BUN levels upon discharge were 4.7 mg/dL and 48 mg/dL respectively. Outpatient follow-up at two weeks after discharge showed that she had completely recovered; her creatinine was 1 mg/dL and BUN was 18 mg/dL.", "Question": "What is the patient's delta gap in mEq/L?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "name 'N' is not defined", "LLM Explanation": "name 'N' is not defined", "LLM Thinking": "To solve this problem step by step, we need to calculate the serum an ion gap and then the delta gap. Step 1: Find the serum electrolyte results where we can calculate the anion gap. From the laboratory results upon admission to the children's hospital: The anion gap is calculated as: Anion Gap = (Na+) - (Cl- + HCO3-) Plugging in the numbers: Now we need to calculate the delta gap. The term \"delta gap \" typically refers to the difference between the measured anion gap and the normal reference range for the anion gap. However, \"delta gap\" usually means the difference between the serum anion gap and the serum bicarbonate level in cases of metabolic acidosis. The formula for calculating the delta gap is: Delta Gap = Anion Gap - Normal Anion Gap + (Serum Bicarbonate - Normal B icarbonate) The normal range for the anion gap is typically 8 to 12 mEq/L, and the normal range for serum bic arbonate (depending on the lab) is generally around 24 mEq /L. But the delta gap calculation is a bit different. It's used to categorize the mechanism in certain types of metabolic acidosis and the formula used in that context is: Delta Gap = Anion Gap - 8 Delta B (or \u0394bicarb) = 24 - Bicarbonate Then, if the Delta Gap is greater than or proportional to the Delta B, it suggests that there's a mixed acid osis. Wait, perhaps the question is asking for the delta between the an ion gap and the bicarbonate level, a typical approach for classifying metabolic acidosis. However, without clear context on what the task considers the \u201cdelta gap\u201d, perhaps it's the difference between the measured anion gap and the normal value? Or perhaps the \"delta gap\" refers to the difference between the anion gap and the bicarbonate level. Let's try both approaches. Alternatively, the term \"delta gap\" might be a typo or mis interpretation or might refer to a specific task in this case. The delta gap in some sources is calculated as (Anion Gap - 12) and the Delta B as 24 - Bicarbonate Let's see: Anion Gap is 8, which is below the normal range (8-12), so the anion gap is actually within the normal range or low. The delta gap is calculated as (Anion gap - 12 ), but here the anion gap is 8, If the question is asking for the delta gap as per the formula (Anion Gap - 12 ), that would be -4, but that might not be the case. Alternatively, perhaps the \"delta gap\" refers to the difference between the anion gap and the normal value of the anion gap. But that's not a standard term. Alternatively, maybe it\u2019s asking for the difference in the Anion Gap between different time points, but the question says \"delta gap in mEq/L\" without specifying, so perhaps the standard anion gap calculation is required. However the question specifically asks for delta gap, not the anion gap. It seems the question might want to know the difference between the Anion Gap at the presentation and some reference (possibly either normal reference or change over time, which we do not have time-wise data for clearly). Alternatively, maybe it\u2019s the difference between the anion gap and the bic arbonate (like delta gap = AG - (24 - HCO3) since AG - (24 - HCO3) is like AG - delta B (since delta B is 24 - HCO3) Let's try this: In some textbooks, the delta gap is calculated as (AG - (24 - HCO3)) or (AG - delta B). The delta gap is compared to the delta B to determine if it's high anion gap acidosis or normal anion gap acidosis or mixed. The formula is: Delta AG = AG - (24 - HCO3) But the question is asking for the delta gap, which may refer to this value or the difference between the AG now and earlier. But in the given data, the only time points with electrolytes are the initial labs at the outside hospital (which had HCO3 of 29) and upon admission to the children's hospital (with HCO3 of 22). Wait, let me check the data again. To calculate the anion gap from the local hospital's initial results, we need the Na, K, Cl, and HCO3 levels; however, these are not directly provided in the given data. Now \u201cdelta gap\u201d could be the change between these two anion gaps,", "Ground Truth Answer": "-4", "Ground Truth Explanation": "To compute the formula of the delta gap, the formula is anion gap (in mEq/L) - 12. The first step is to compute the patient's anion gap.\nThe formula for computing a patient's anion gap is: sodium (mEq/L) - (chloride (mEq/L)+ bicarbonate (mEq/L)).\nThe concentration of sodium is 134.0 mEq/L. \nThe concentration of chloride is 104.0 mEq/L. \nThe concentration of bicarbonate is 22.0 mEq/L. \nPlugging in these values into the anion gap formula gives us 134.0 mEq/L - (104.0 mEq/L + 22.0 mEq/L) = 8.0 mEq/L. Hence, The patient's anion gap is 8.0 mEq/L.\nPlugging in 8.0 mEq/L for the delta gap formula, we get 8.0 - 12 = -4.0 mEq/L. Hence, the patient's delta gap is -4.0 mEq/L.", "Result": "Incorrect"}
{"Row Number": 550, "Calculator Name": "CURB-65 Score for Pneumonia Severity", "Calculator ID": "45", "Category": "risk", "Note ID": "usmle-187", "Patient Note": "A 62-year-old man is brought to the emergency department with fatigue, dry cough, and shortness of breath for 3 days. He reports a slight fever and has also had 3 episodes of watery diarrhea earlier that morning. Last week, he attended a business meeting at a hotel and notes some of his coworkers have also become sick. He has a history of hypertension and hyperlipidemia. He takes atorvastatin, hydrochlorothiazide, and lisinopril. He appears in mild distress. His temperature is 102.1\u00b0F (38.9\u00b0C), pulse is 56/min, respirations are 16/min, and blood pressure is 150/85 mm Hg. Diffuse crackles are heard in the thorax. Examination shows a soft and nontender abdomen. Laboratory studies show:\nHemoglobin 13.5 g/dL\nLeukocyte count 15,000/mm3\nPlatelet count 130,000/mm3\nSerum\nNa+ 129 mEq/L\nCl- 100 mEq/L\nK+ 4.6 mEq/L\nHCO3- 22 mEq/L\nUrea nitrogen 14 mg/dL\nCreatinine 1.3 mg/dL\nAn x-ray of the chest shows infiltrates in both lungs.", "Question": "What is the patient's CURB-65 score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "0", "LLM Explanation": "Step 1: Evaluate each component of the CURB-65 score for the patient.\\n\\n1. Confusion: The patient appears in mild distress but there is no mention of confusion. Therefore, CONFUSION = 0.\\n2. Urea Level: The BUN is 14 mg/dL. The threshold for CURB-65 is a urea level \u22657 mmol/L (approximately 20 mg/dL). Since 14 mg/dL is below 20 mg/dL, UREA = 0.\\n3. Respiratory Rate: The respiratory rate is 16 breaths/min. The threshold is \u226530 breaths/min. Since 16 is below 30, RESPIRATORY RATE = 0.\\n4. Blood Pressure: The blood pressure is 150/85 mm Hg. The criteria require a systolic BP \u226490 mm Hg or diastolic BP \u226460 mm Hg. Since the systolic BP is 150 (above 90), BLOOD PRESSURE = 0.\\n5. Age 65 or older: The patient is 62 years old, so AGE 65+ = 0.\\n\\nAdding up the scores from each component: 0 (Confusion) + 0 (Urea) + 0 (Respiratory Rate) + 0 (Blood Pressure) + 0 (Age 65+) = 0.\\nTherefore, the CURB-65 score is 0.", "LLM Thinking": "Step 1: Let\u2019s break down the components necessary to calculate the CURB-65 score for this patient. The CURB-65 score is used to assess the severity of community -acquired pneumonia (CAP) and determine the appropriate setting for treatment. The components are: Confusion, Urea level, Respiratory rate, Blood pressure, and Age 65 years old or more. Let's evaluate the patient against each component: 1. Confusion: This refers to whether the patient is oriented to time, person, place. The note mentions that the patient \"appears in mild distress.\" It does not mention any signs of confusion (e.g., altered mental status). Therefore, we will consider Confusion as NOT present unless there's specific information indicating it. Since no information about confusion appears in the note, we assume CONFUSION = 0 (not present). 2. Urea Level (Blood Urea Nitrogen): The laboratory data shows the blood urea nitrogen (BUN) to be 14 mg/dL. The threshold for CURB-65 is a urea level \u22657 mmol/L (which is approximately 20 mg/dL). Since the patient's urea (BUN) is 14 mg/dL, which is below 20, this component is NOT met. So UREA = 0. 3. Respiratory Rate: The note states the patient's respiratory rate is 16 breaths/min. The threshold for this component is a respiratory rate \u226530 breaths per minute. Since the respiratory rate is 16, it is below the threshold of 30. Thus, RESPIRATORY RATE = 0. 4. Blood Pressure: The blood pressure is recorded as 150/85 mm Hg. The criteria require a systolic blood pressure \u2264 90 mm Hg or diastolic blood pressure \u2264 60 mm Hg. The patient's systolic BP is 150, which is well above 90. Therefore, BLOOD PRESSURE = 0. 5. Age 65 or older: The patient's age is 62, which is under 65. Thus, AGE 65+ = 0.", "Ground Truth Answer": "0", "Ground Truth Explanation": "The Curb-65 score is current at 0 points.\nThe patient is 62.0 years old. The patient's age is less than 65 years, and so we add 0 points to the score, keeping the current total at 0.\nWhether the patient has confusion is not reported in the note. Hence, we assume this to be false, and so 0 points are added to the score, making the current total 0.\nThe concentration of BUN is 14.0 mg/dL. The patient's BUN concentration is less than or equal to 19 mg/dL and so 0 points are added to score, keeping the current total at 0.\nThe patient's respiratory rate is 16 breaths per minute. Because the respiratory rate is greater than 30 breaths per minute, 0 points are added to the score, keeping the current total at 0.\nThe patient's systiolic blood pressure is 150 mm Hg. The patient's diastolic blood pressure is 85 mm Hg. For a point a point to be added, the systiolic blood pressure must be less than 90 mm Hg or the diastolic blood pressure must be less than or equal to 60 mm Hg. Because neither of these statements are true, 0 points are added to score, keeping the current total to 0.\nThe patient's Curb-65 score is 0.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: Let\u2019s break down the components necessary to calculate the CURB-65 score for this patient. The CURB-65 score is used to assess the severity of community -acquired pneumonia (CAP) and determine the appropriate setting for treatment. The components are: Confusion, Urea level, Respiratory rate, Blood pressure, and Age 65 years old or more.\n\nLet's evaluate the patient against each component:\n\n1. Confusion: This refers to whether the patient is oriented to time, person, place. The note mentions that the patient \"appears in mild distress.\" It does not mention any signs of confusion (e.g., altered mental status). Therefore, we will consider Confusion as NOT present unless there's specific information indicating it. Since no information about confusion appears in the note, we assume CONFUSION = 0 (not present).\n\n2. Urea Level (Blood Urea Nitrogen): The laboratory data shows the blood urea nitrogen (BUN) to be 14 mg/dL. The threshold for CURB-65 is a urea level \u22657 mmol/L (which is approximately 20 mg/dL). Since the patient's urea (BUN) is 14 mg/dL, which is below 20, this component is NOT met. So UREA = 0.\n\n3. Respiratory Rate: The note states the patient's respiratory rate is 16 breaths/min. The threshold for this component is a respiratory rate \u226530 breaths per minute. Since the respiratory rate is 16, it is below the threshold of 30. Thus, RESPIRATORY RATE = 0.\n\n4. Blood Pressure: The blood pressure is recorded as 150/85 mm Hg. The criteria require a systolic blood pressure \u2264 90 mm Hg or diastolic blood pressure \u2264 60 mm Hg. The patient's systolic BP is 150, which is well above 90. Therefore, BLOOD PRESSURE = 0.\n\n5. Age 65 or older: The patient's age is 62, which is under 65. Thus, AGE 65+ = 0."}
{"Row Number": 307, "Calculator Name": "Centor Score (Modified/McIsaac) for Strep Pharyngitis", "Calculator ID": "20", "Category": "severity", "Note ID": "usmle-6356", "Patient Note": "A 19-year-old male with a past medical history of surgical repair of a torn anterior cruciate ligament and seasonal allergies presents to the emergency department with a rash. He reports that he first noticed the rash on his torso when he woke up this morning, and it has spread down his legs over the last few hours. He also endorses fatigue, malaise, and sore throat for four days. The patient reports that he was seen yesterday at his college\u2019s student health clinic for similar symptoms and was prescribed amoxicillin. He also reports that his younger sister was recently diagnosed with streptococcal pharyngitis, and his mother has psoriatic arthritis. He is a sophomore on the men\u2019s soccer team, but he has had to sit out of practice for the last several days. His home medications include cetirizine and fluticasone nasal spray. He has no known drug allergies. His temperature is 100.8\u00b0F (38.2\u00b0C), blood pressure is 122/76 mmHg, pulse is 97/min, and respirations are 16/min. On physical exam, he has an erythematous oropharynx with posterior cervical lymphadenopathy. His rash can be seen in Figure A.", "Question": "What is the patient's Centor Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "2", "LLM Explanation": "No Explanation", "LLM Thinking": "Let\u2019s calculate the Centor Score step-by-step for this patient. The Centor Score helps determine the likelihood of streptococcal ph aryngitis and is based on the following clinical criteria: 1. Abs ence of cough. 2. Swollen/tender anterior cervical lymph nodes. 3. T enderness of the tonsils with exudate or pus. 4. History of fever (reported by the patient). 5. Age (less than 15 years old is given a point for strep throat likelihood, while being over 45 reduces the points). Let\u2019s evaluate each criterion for the given patient's information. 1. **Absence of cough**: The patient endorses fatig e, malaise, and sore throat but there's no mention of a cough. 2. **Swollen/tender cervical lymph nodes**: The physical exam notes \"posterior cervical lymphadenopathy\", which indicates swollen lymph nodes in the neck. However, the Centor Score specifically refers to anterior cervical lymph nodes. Wait, the note says \"posterior cervical lymphadenopathy\". The traditional Centor Score requires swollen/tender **anterior** cervical lymph nodes. If it's posterior, that might not count. But since many medical texts can interpret this in a broader sense or possibly indicate that the posterior lymphadenopathy also implies some lymphatic involvement that could be clinically similar or associated with upper respiratory symptoms including strep throat, we need to confirm. However, the strict Centor criteria require anterior nodes. Since it specifically says posterior cervical lymphadenopathy, this criterion does not meet the requirement. But for the sake of common medical practice where lymphadenopathy close to the head and neck area is often a marker, if the context suggests enlargement in lymph nodes that might be clinically significant (often considered equivalent), I\u2019ll assume it has the same clinical significance here, so we'll say it's satisfied. Hmm, this is a bit ambiguous. Let me double-check. The Centor criteria specifically state \"swollen anterior cervical lymph nodes\". The posterior cervical nodes are less likely to be associated with streptococ cal pharyngitis. 3. **Tonsillar exudate or swelling**: The physical exam mentions \"erythematous oropharynx\" but no specific mention of tonsillar exudate or pus. 4. **Fever history**: The patient has a current temperature of 100.8\u00b0F, so they have a fever. The Centor criteria consider reported fever (by the patient) as a point. 5. **Age**: The Centor criteria give +1 point if under 15, 0 if between 15-44, and subtract 1 point if over 44. However, maybe the description of \"posterior cervical lymphadenopathy\" is somewhat common or associated with upper respiratory symptoms generally, but let's strictly follow the Centor criteria. Wait, but let me check again. The patient was described as having \"an erythematous orophary nx\", which suggests that the tonsils might be erythemous, and possibly has inflammation but not necessarily tonsillar exudate or pus.", "Ground Truth Answer": "2", "Ground Truth Explanation": "The current Centor score is 0.\nThe patient is 19.0 years old. Because the age is in between 15 and 44 years, the score does not change, keeping the score at 0.\nThe patient's temperature is 100.8 degrees fahrenheit. To convert to degrees celsius, apply the formula 5/9 * [temperature (degrees fahrenheit) - 32]. This means that the patient's temperature is 5/9 * 68.8 = 38.222 degrees celsius. The patient's temperature is greater than 38 degrees Celsius, and so we add one point to the score, making the current score 0 + 1 = 1.\nThe patient note does not mention details about 'cough absent' and so we assume it to be absent. Hence, we do not change the score, keeping the current score at 1.\nThe patient note reports 'tender/swollen anterior cervical lymph nodes' as present for the patient. Hence, we increase the score by 1, making the current score 1 + 1 = 2.\nThe patient note does not mention details about 'exudate or swelling on tonsils' and so we assume it to be absent. Hence, we do not change the score, keeping the current score at 2.\nHence, the Centor score for the patient is 2.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Let\u2019s calculate the Centor Score step-by-step for this patient. The Centor Score helps determine the likelihood of streptococcal ph aryngitis and is based on the following clinical criteria:\n\n1. Abs ence of cough.  \n2. Swollen/tender anterior cervical lymph nodes.  \n3. T enderness of the tonsils with exudate or pus.  \n4. History of fever (reported by the patient).  \n5. Age (less than 15 years old is given a point for strep throat likelihood, while being over 45 reduces the points).\n\nLet\u2019s evaluate each criterion for the given patient's information.  \n1. **Absence of cough**: The patient endorses fatig e, malaise, and sore throat but there's no mention of a cough.  \n2. **Swollen/tender cervical lymph nodes**: The physical exam notes \"posterior cervical lymphadenopathy\", which indicates swollen lymph nodes in the neck. However, the Centor Score specifically refers to anterior cervical lymph nodes. Wait, the note says \"posterior cervical lymphadenopathy\". The traditional Centor Score requires swollen/tender **anterior** cervical lymph nodes. If it's posterior, that might not count. But since many medical texts can interpret this in a broader sense or possibly indicate that the posterior lymphadenopathy also implies some lymphatic involvement that could be clinically similar or associated with upper respiratory symptoms including strep throat, we need to confirm. However, the strict Centor criteria require anterior nodes. Since it specifically says posterior cervical lymphadenopathy, this criterion does not meet the requirement. But for the sake of common medical practice where lymphadenopathy close to the head and neck area is often a marker, if the context suggests enlargement in lymph nodes that might be clinically significant (often considered equivalent), I\u2019ll assume it has the same clinical significance here, so we'll say it's satisfied. Hmm, this is a bit ambiguous. Let me double-check. The Centor criteria specifically state \"swollen anterior cervical lymph nodes\". The posterior cervical nodes are less likely to be associated with streptococ cal pharyngitis.\n\n3. **Tonsillar exudate or swelling**: The physical exam mentions \"erythematous oropharynx\" but no specific mention of tonsillar exudate or pus.  \n4. **Fever history**: The patient has a current temperature of 100.8\u00b0F, so they have a fever. The Centor criteria consider reported fever (by the patient) as a point.  \n5. **Age**: The Centor criteria give +1 point if under 15, 0 if between 15-44, and subtract 1 point if over 44.\n\nHowever, maybe the description of \"posterior cervical lymphadenopathy\" is somewhat common or associated with upper respiratory symptoms generally, but let's strictly follow the Centor criteria.\n\nWait, but let me check again. The patient was described as having \"an erythematous orophary nx\", which suggests that the tonsils might be erythemous, and possibly has inflammation but not necessarily tonsillar exudate or pus."}
{"Row Number": 585, "Calculator Name": "PERC Rule for Pulmonary Embolism", "Calculator ID": "48", "Category": "diagnosis", "Note ID": "pmc-3883470-1", "Patient Note": "A 57-year-old Caucasian man with a smoking habit who had a history of hypertension and dyslipidemia as well as a family history of thoracic aortic dissection presented to a community hospital complaining of sudden onset of chest discomfort and dyspnea. He was diaphoretic, with blood pressure of 114/60mmHg and no pulse deficit, heart rate of 114 beats per minute and respiratory rate of 20 breaths per minute. In addition, he required oxygen by nasal cannula to maintain oxygen saturation above 90%. He had a large-volume central pulse, no extra heart sounds and soft systolic and early diastolic murmurs over the aortic valve. His jugular venous pressure was 4cm above the sternal angle, and he had crackles at both lung bases. There were no features suggestive of Marfan syndrome or connective tissue diseases. The initial emergency work-up included an electrocardiogram (EKG), which showed left ventricular hypertrophy with repolarization abnormalities; a chest X-ray with increased interstitial markings suggesting acute pulmonary edema; a troponin I level of 0.41\u03bcg/L; and a brain natriuretic peptide level of 487ng/L.\nOn the basis of the patient\u2019s abrupt onset of symptoms, family history of aortic dissection and findings consistent with acute aortic insufficiency (large-volume pulse, early diastolic murmur and heart failure), an emergent contrast-enhanced CT scan was obtained (Figure ). This scan showed a 5cm aortic root aneurysm but no aortic dissection. The patient was treated medically for acute coronary syndrome and heart failure, including dual anti-platelet therapy and anti-coagulation. He was subsequently transferred to a tertiary care hospital. Because of the high clinical suspicion of an acute aortic dissection based on his family history, sudden onset chest discomfort and findings of acute aortic insufficiency and heart failure [], a transesophageal echocardiogram was taken, even in light of the negative CT scan (Figure ). This test demonstrated an aortic dissection flap confined to the aortic root, superior to the aortic valve and associated with severe aortic insufficiency. The patient underwent successful repair of his Stanford type A aortic dissection with a 27mm mechanical valved conduit 21 hours after his initial presentation to the community hospital. The pathology report showed a structurally normal trileaflet native valve and cystic medial necrosis of the wall of the aortic root. Specialist cardiovascular radiologists who reviewed the initial CT scan post hoc reprocessed the raw data and correctly identified the dissection above the aortic valve (Figure ). The dissection flap had initially been misinterpreted as a combination of normal aortic valve apparatus and motion artefact.", "Question": "What are the number of criteria met for the PERC Rule for Pulmonary Embolism (PE)?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "2", "LLM Explanation": "To approach this question step-by-step, we must first recall the criteria of the PERC (Pulmonary Embolism Rule-out Criteria) rule for PE exclusion. The PERC rule includes the following 8 clinical criteria: \\n\\n1. Age \u226550 years\\n2. Oral contraceptive use or pregnancy\\n3. Hemoptysis\\n4. Recent surgery or trauma within 4 weeks\\n5. Heart rate >100 bpm\\n6. Unilateral leg swelling\\n7. Prior PE or DVT\\n8. Malignancy (active or treated within the last 6 months)\\n\\nNow, we need to evaluate the patient note for each of these criteria and count how many are met.\\n\\nFirst, the patient is a 57-year-old male. That meets the age \u226550 years (criterion 1). His sex is not female, and there is no mention of oral contraceptive use or pregnancy, so criterion 2 is not met.\\n\\nNext, the patient presents with dyspnea and chest discomfort, but there's no mention of hemoptysis (coughing up blood), so criterion 3 is not met.\\n\\nThe note mentions that he had a history of hypertension and dyslipidemia, but there is no mention of recent surgery or trauma within the last four weeks; therefore, criterion 4 is not met. His heart rate is 114 bpm, which exceeds 100, so criterion 5 (heart rate >100) is met.\\n\\nThere is no mention of leg swelling, unilateral or otherwise, so criterion 6 is not met. The patient has a family history of thoracic aortic dissection, but no personal history of PE or DVT is mentioned, so criterion 7 is not met.\\n\\nThe note also doesn\u2019t mention any history of malignancy, so criterion 8 is not met.\\n\\nThus, the criteria that are met are:\\n- Age \u226550 years (met)\\n- Heart rate >100 bpm (met)\\n\\nSo, two criteria are met: age \u226550 years and heart rate >100 bpm.", "LLM Thinking": "To approach this question step-by-step, we must first recall the criteria of the PERC (Pulmonary Embolism Rule-out Criteria) rule for PE exclusion. The PERC rule includes the following 8 clinical criteria: 1. Age \u226550 years 2. Oral contraceptive use or pregnancy 3. Hemoptysis 4. Recent surgery or trauma within 4 weeks 5. Heart rate >100 bpm 6. Unilateral leg swelling 7. Prior PE or DVT 8. Malign ancy (active or treated within the last 6 months) Now, we need to evaluate the patient note for each of these criteria and count how many are met. First, the patient is a 57-year-old male . That meets the age \u226550 years (criterion 1). His sex is not female, and there is no mention of oral contraceptive use or pregnancy, so criterion 2 is not met. Next, the patient presents with dyspnea and chest discomfort, but there's no mention of hemoptysis (coughing up blood), so criterion 3 is not met. The note mentions that he had a history of hypertension and dyslipidemia, but there is no mention of recent surgery or trauma within the last four weeks; therefore, criterion 4 is not met. His heart rate is 114 bpm, which exceeds 1 00, so criterion 5 (heart rate >100) is met. There is no mention of leg swelling, unilateral or otherwise, so criterion 6 is not met. The patient has a family history of thoracic aortic dissection, but no personal history of PE or D VT (deep vein thrombosis) is mentioned, so criterion 7 is not met. The note also doesn\u2019t mention any history of malignancy , so criterion 8 is not met. Wait, but I need to double-check each point carefully . Let me go through again. 1. Age 57: yes. 2. No contrace ptives or pregnancy: no. 3. No hemoptysis: no. 4. No recent surgery or trauma: no. 5 . Heart rate 114: yes. 6. No leg swelling : no. 7. No prior PE or DVT: no. 8. No malignancy: no.", "Ground Truth Answer": "3", "Ground Truth Explanation": "The current count of PERC criteria met is 0.\nThe patient is 57.0 years old. The patient's age is greater than or equal to 50 years, and so we increment the perc critieria met by 1, making the current total 0 + 1 = 1.\nThe patient's heart rate is 114.0 beats per minute. The patient's heart rate is greater than or equal to 100 beats per minute, and so we increment the perc critieria met by 1, making the current total 1 + 1 = 2.\nThe saturated oxygen percentage in the room is 90.0 percent. The saturated oxygen is less than 95%, and so we increment the perc critieria met by 1, making the current total 2 + 1 = 3.\nThe patient note reports 'unilateral leg swelling' to be absent in the patient and so we do not increment the criteria count. The current total remains at 3.\nThe patient note reports 'hemoptysis' to be absent in the patient and so we do not increment the criteria count. The current total remains at 3.\nThe patient note reports 'recent surgery or trauma' to be absent in the patient and so we do not increment the criteria count. The current total remains at 3.\nThe patient must be diagnosed with at least one of deep vein thrombosis or pulmonary embolism in the past for a PERC rule criteria to be met. The patient is not reported to have been diagnosed with deep vein thrombosis in the past. The patient is not reported to have been diagnosed with pulmonary embolism in the past. Neither criteria is met and so we do increment the criteria count, keep the current total at 3.\nThe patient note does not report a status on 'hormonal use'. Hence, we assume it to be absent, and so we do not increment the criteria count. The current total remains at 3.\nHence, the number of PERC rule criteria met by the patient is 3.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To approach this question step-by-step, we must first recall the criteria of the PERC (Pulmonary Embolism Rule-out Criteria) rule for PE exclusion. The PERC rule includes the following 8 clinical criteria:\n\n1. Age \u226550 years\n2. Oral contraceptive use or pregnancy\n3. Hemoptysis\n4. Recent surgery or trauma within 4 weeks 5. Heart rate >100 bpm\n6. Unilateral leg swelling \n7. Prior PE or DVT \n8. Malign ancy (active or treated within the last 6 months)\n\nNow, we need to evaluate the patient note for each of these criteria and count how many are met.\n\nFirst, the patient is a 57-year-old male . That meets the age \u226550 years (criterion 1). His sex is not female, and there is no mention of oral contraceptive use or pregnancy, so criterion 2 is not met.\n\nNext, the patient presents with dyspnea and chest discomfort, but there's no mention of hemoptysis (coughing up blood), so criterion 3 is not met.\n\nThe note mentions that he had a history of hypertension and dyslipidemia, but there is no mention of recent surgery or trauma within the last four weeks; therefore, criterion 4 is not met. His heart rate is 114 bpm, which exceeds 1 00, so criterion 5 (heart rate >100) is met.\n\nThere is no mention of leg swelling, unilateral or otherwise, so criterion 6 is not met. The patient has a family history of thoracic aortic dissection, but no personal history of PE or D VT (deep vein thrombosis) is mentioned, so criterion 7 is not met.\n\nThe note also doesn\u2019t mention any history of malignancy , so criterion 8 is not met.\n\nWait, but I need to double-check each point carefully . Let me go through again. 1. Age 57: yes. \n2. No contrace ptives or pregnancy: no. \n3. No hemoptysis: no. \n4. No recent surgery or trauma: no. \n5 . Heart rate 114: yes. \n6. No leg swelling : no. \n7. No prior PE or DVT: no. \n8. No malignancy: no."}
{"Row Number": 322, "Calculator Name": "Maintenance Fluids Calculations", "Calculator ID": "22", "Category": "physical", "Note ID": "usmle-8221", "Patient Note": "A healthy 22-year-old male participates in a research study you are leading to compare the properties of skeletal and cardiac muscle. You conduct a 3-phased experiment with the participant. In the first phase, you get him to lift up a 2.3 kg (5 lb) weight off a table with his left hand. In the second phase, you get him to do 20 burpees, taking his heart rate to 150/min. In the third phase, you electrically stimulate his gastrocnemius with a frequency of 50 Hz. You are interested in the tension and electrical activity of specific muscles as follows: Biceps in phase 1, cardiac muscle in phase 2, and gastrocnemius in phase 3.", "Question": "Based on the patient's weight, what is the patient's maintenance fluid in mL/hr?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "name 'N' is not defined", "LLM Explanation": "name 'N' is not defined", "LLM Thinking": "First, we need to calculate the maintenance fluid requirements for a 22 -year-old male, but the note doesn\u2019t directly provide the weight of this patient. The problem mentions a 2.3 kg weight in phase 1, but that's an object, not the patient's weight. Since the note doesn\u2019t provide the patient\u2019s weight, I can't directly compute the fluid rate. Maintenance fluids are typically calculated based on body weight using formulas like the 4-2-1 rule (4 mL/kg/hr for first 10 kg, 2 mL/kg/hr for next 10 kg, and 1 mL/kg/hr for each kg beyond 20 kg). Without the patient's actual weight, the calculation isn\u2019t possible. The question might be a trick to check if I recognize missing data. The task asks to calculate the maintenance fluid rate without providing necessary information. Wait, the user says \"Based on the patient's weight\" but the weight isn't given. Hmm, maybe I overlooked something? The text only mentions that the patient is a \"healthy 22 year old male\" and provides information about the task being conducted (lifting weights, doing burpees, etc.), but there is no explicit mention of the patient\u2019s own weight. So without that, it's impossible to compute. Alternatively, maybe the 2.3 kg is a distractor. Let's break it down step by step: Step 1. Identify necessary parameters: To calculate maintenance fluids in mL/hr for adults, usually the standard rate is 30\u201335 mL/kg/hr for infants and decreases for adults to about approximately 0.8 mL/kg per hour. Wait, actually, for adults, the maintenance fluid is generally around 30\u201340 mL/kg/day, not per hour. Wait, for hourly maintenance fluid for infants, the typical rule of thumb is: Infants (0\u201310 kg): 4 mL/kg/hr; 10\u201320 kg: 2 mL/kg/hr; over 20 kg: 1 mL/kg/hr. But for adults, the maintenance fluid requirement is typically around 1.5 mL/kg/hr or 30\u201340 mL/kg/day. But maybe the question is expecting to use a standard formula. The correct approach for adults is usually around 1 mL/kg/hr for maintenance, but I need to confirm. Alternatively, maybe the question is expecting to use the \"4-2-1\" rule but that applies to pediatric patients, not adults. Since the patient is 22 years old, he is an adult. For adult patients, the maintenance fluid rate is approximately 1 mL/kg/hr for the first 10 kg, 0.5 mL/kg/hr for the next 20 kg, and 0.2 mL/kg/hr for any weight above 30 kg. Wait, but that might vary. Alternatively, some sources say 30 mL/kg/day for adults, which would be about 1.25 mL/kg/hr (since 30 mL/kg/day divided by 24 hours is ~1.25 mL/kg/hr). But without the patient's weight, even if I knew the formula, I can't compute it. The problem states: \"Based on the patient's weight\", but the weight is not provided in the patient note. The only weight mentioned is the 2.3 kg weight he lifted, which is irrelevant here.", "Ground Truth Answer": "9.2", "Ground Truth Explanation": "The patient's weight is 2.3 kg. For patient's with weight less than 10 kg, the rule for computing maintenance fluid is to multiply their weight by 4 mL/kg/hr to get the maintenance fluids per hour. Hence, the patient's maintenance fluid is 2.3 kg * 4 mL/kg/hr = 9.2 mL/hr.\nHence, the patient's fluid maintenance is 9.2 mL/hr.", "Result": "Incorrect"}
{"Row Number": 855, "Calculator Name": "Glasgow Coma Score (GCS)", "Calculator ID": "21", "Category": "severity", "Note ID": "8", "Patient Note": "A 60-year-old male was found unconscious at home by his neighbor and brought to the emergency department by Emergency Medical Services. Vital signs on arrival were heart rate 65 bpm, blood pressure 100/70 mmHg, respiratory rate 14 per minute, and oxygen saturation 98 % on room air. Upon being assessed by the medical staff, there were no immediate signs of trauma or medical alert bracelets. When subjected to a sternal rub, his eyes slightly opened and his limbs were noted to hesitatingly reflex into an extension movement. However, despite repeated attempts, the patient remained nonverbal and not responsive to questions or requests. The initial clinical impression was a possible stroke or major neurological event. Blood tests were run, including coagulation profile, cardiac troponins, glucose, and complete blood count. An urgent CT scan was ordered and he was transferred to the Stroke Unit for further care.", "Question": "What is the patient's Glasgow Coma Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "5", "LLM Explanation": "No Explanation", "LLM Thinking": "Okay, so I need to figure out the Glasgow Coma Score ( GCS) for this patient based on the information provided in the note. The GCS consists of three components: Eye opening, Verbal response, and Motor response. Each of these has a scoring system. 1. **Eye Opening (E Eye)** - 4 = spontaneous - 3 = to speech - 2 = to pain - 1 = none 2. **Verbal Response (V Verbal):** - 5 = oriented - 4 = confused - 3 = words, but not coherent - 2 = sounds only - 1 = none 3. **Motor Response ( M Motor):** - 6 = obeys commands - 5 = localizing pain - 4 = flexion (withdrawal) to pain - 3 = abnormal flexion (decorticate) to pain - 2 = abnormal extension (decerebrate) to pain - 1 = no response to pain Now, looking at the details from the patient note: 1. **Eye Opening:** The note states that when the patient was subjected to a sternal rub, his eyes \"slightly opened.\" This suggests that the eye opening is not spontaneous, but in response to pain (since a sternal rub is a painful stimulus). 2. **Verbal Response:** The note mentions that the patient \"remained nonverbal and not responsive to questions or requests.\" This means there's no verbal response at all. 3. **Motor Response:** The note says that upon sternal rub, the limbs \"hesitatingly reflex into an extension movement.\" The extension movement in response to pain is considered a decerebrate posture.", "Ground Truth Answer": "6", "Ground Truth Explanation": "The current glasgow coma score is 0.\nBased on the patient note, the best eye response for the patient is 'eye opening to pain', and so we add 2 points making the current total 0 + 2 = 2.\nBased on the patient note, the best verbal response for the patient is 'no verbal response', and so we add 1 point making the current total 2 + 1 = 3.\nBased on the patient note, the best verbal response for the patient is 'no verbal response', and so we add 1 point making the current total 3 + 1 = 4.\nBased on the patient note, the best motor response for the patient is 'extension to pain', and so we add 2 points making the current total 4 + 2 = 6.\nHence, the patient's glasgow coma score is 6.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to figure out the Glasgow Coma Score ( GCS) for this patient based on the information provided in the note.  \nThe GCS consists of three components: Eye opening, Verbal response, and Motor response. Each of these has a scoring system.  \n1. **Eye Opening (E Eye)**  \n- 4 = spontaneous  \n- 3 = to speech  \n- 2 = to pain  \n- 1 = none  \n\n2. **Verbal Response (V Verbal):**  \n- 5 = oriented  \n- 4 = confused  \n- 3 = words, but not coherent  \n- 2 = sounds only  \n- 1 = none  \n\n3. **Motor Response ( M Motor):**  \n- 6 = obeys commands  \n- 5 = localizing pain  \n- 4 = flexion (withdrawal) to pain  \n- 3 = abnormal flexion (decorticate) to pain  \n- 2 = abnormal extension (decerebrate) to pain  \n- 1 = no response to pain  \n\nNow, looking at the details from the patient note:  \n\n1. **Eye Opening:**  \nThe note states that when the patient was subjected to a sternal rub, his eyes \"slightly opened.\" This suggests that the eye opening is not spontaneous, but in response to pain (since a sternal rub is a painful stimulus).  \n\n2. **Verbal Response:**  \nThe note mentions that the patient \"remained nonverbal and not responsive to questions or requests.\" This means there's no verbal response at all.  \n\n3. **Motor Response:**  \nThe note says that upon sternal rub, the limbs \"hesitatingly reflex into an extension movement.\" The extension movement in response to pain is considered a decerebrate posture."}
{"Row Number": 908, "Calculator Name": "Caprini Score for Venous Thromboembolism (2005)", "Calculator ID": "36", "Category": "risk", "Note ID": "1", "Patient Note": "A 63 year old female a history of prior DVT is being evaluated at a rehabilitation facility following multiple traumas sustained in a motor vehicle collision. She was transferred to the facility 1 day ago following discharge from the hospital with injuries including multiple rib fractures, a left femoral shaft fracture, and a traumatic brain injury. There was no spinal cord damage or paralysis bhe patient remains confined to bed due to her injuries. The patient denies history of heart failure, any recent infections or sepsis, stroke, pulmonary embolism, inflammatory bowel disease, coronary artery disease, chronic obstructive pulmonary disease, or malignancy. Prior coagulability workup in the patient revealed elevated serum homocysteine, and was otherwise negative for factor V Leiden, prothrombin 20210A, lupus anticoagulant, and anticardiolipin antibody. Heparin has been administered throughout the hospitalization with no complications and the patient has no other history of congenital or acquired thrombophilia. The patient's mother had a DVT/PE in her 50's. The patient's BMI is 27.1 kg/m^2. Physical exam of the lower extremities is notable for a well-healed surgical incision over the left femoral shaft with no signs of infection. There patient has varicose veins bilaterally. There is no lower extremity edema. Range of motion of the left hip and knee are limited due to pain and immobilization. The patient will continue rehabilitation with physical and occupational therapy at the facility to optimize functional recovery.", "Question": "What is the patient's Caprini Score for Venous Thromboembolism?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "13", "LLM Explanation": "No Explanation", "LLM Thinking": "To calculate the Caprini Risk Score for Venous Thromboemb olism (VTE) for this patient, I need to go through the Caprini scoring system step by step and assign points based on the patient's characteristics as described in the patient note. The Caprini score includes factors such as age, surgery, immobilization, trauma, cancer, and other risk factors like hormone therapy, prior VTE, active malignancy , etc. First, let me recall the Caprini scoring system : 1. **Major Surgeries:** - Hip or Knee surgery : 5 points - Abdominal, thoracic, or urologic surgery: 5 points - Gynecologic or vascular surgery: 3 points - General surgery: 1 point - Minor surgery: 1 point 2. **Trauma :** - Hip fracture: 5 points - Multiple trauma or long bone fracture: 3 points 3. **Bed Rest or Immobilization:** - Bed rest > 3 days or in patient surgical or medical hospitalization (over 3 days): 5 points - Bed rest 3 days or less, or nonhospitalized bed rest: 2 points 4. **Malignancy:** (being treated or with history (metastatic or previous): 5 points 5. **Obesity (BMI > 30 kg/m 2): 1 point 6. **Congestive Heart Failure ( NYHA III/IV): 1 point 7. **Cere bral Vascular Accident (CVA): 1 point 8. ** Varicose Veins: 1 point 9. **Prior V TE: 1 point 10. **Age over 40 :** - 40 - 49 yrs: 1 point - 50-59: 2 points - 60 - 69: 3 points - >70: 4 points I'll analyze each factor based on the patient note. 1. **Age:** The patient is 63 years old. According to the scoring, age 60 -69 years gives 3 points. 2. **Surgery:** The patient was admitted to a rehabilitation facility after sustaining traumas including a left femoral shaft fracture (not a surgery , but the femoral fracture is part of the trauma). The note mentions a well-healed surgical incision over the left femoral shaft, which suggests she had surgery for the femoral fracture. However, femoral shaft fracture is a trauma, so maybe the trauma category might be more appropriate here. 3. **Trauma**: The patient sustained multiple traumas from a motor vehicle collision, which included multiple rib fractures and a left femoral shaft fracture (long bone fracture). The long bone fracture qualifies for the \"multiple trauma or long bone fracture category \" which is 3 points. 4. **Immobilization/Bed rest**: The patient remains in bed due to her injuries and has been in a rehabilitation facility since being transferred 1 day ago; however, given her ongoing recovery and immobilization for more than 3 days (since she was in the hospital before transfer), so \"bed rest >3 days\" would be 5 points. 5. **History of prior DVT:** The patient has a history of prior deep venous thrombosis (DVT). The scoring gives 1 point for prior VTE. 6. **Obesity or BMI:** The patient has a BMI of 27. 1. The cutoff for obesity in Caprini is BMI >30 , so this doesn't add a point. 7. **Varicose veins:** The patient has bilateral varic ose veins. This gives 1 point. 8. **Other factors:** The patient has a family history of D VT/PE (mother's history), but this is not one of the criteria in the standard Caprini risk stratification, so it doesn\u2019t directly contribute to the score. 9. **Malignancy:** The patient has no history of malign ancy, so no points here. 10. **Other conditions like heart failure, COPD, etc., are not present.** Now, let me tally the points: - Age 63: 3 points - Multiple trauma with long bone fracture (femoral): 3 points - Bed rest >3 days: 5 points - Prior VTE (history of prior DVT): 1 point - Var icose veins: 1 point", "Ground Truth Answer": "6", "Ground Truth Explanation": "The patient's current caprini score is 0.\nThe patient's gender is Female.\nThe patient is 63.0 years old. Because the patient's age is between 61 and 74, we add two points to the current total, making the current total, 0 + 2 = 2.\nThe patient's surgery type is reported to be 'major'. Hence, we add 2 points to the total, making the current total 2 + 2 = 4.\n The patient does not report anything about ('major surgery in the last month', 1) and so we assume this to be false. Hence, 0 points are added to the score, keeping the total at 4. The patient does not report anything about ('congestive heart failure in the last month', 1) and so we assume this to be false. Hence, 0 points are added to the score, keeping the total at 4. The patient's has does not have sepsis in the last month. Hence, 0 points are added to the score, keeping the total at 4.\nThe patient's has does not have pneumonia in the last month. Hence, 0 points are added to the score, keeping the total at 4.\nThe patient does not report anything about ('immobilizing plaster cast in the last month', 2) and so we assume this to be false. Hence, 0 points are added to the score, keeping the total at 4. The patient's has hip, pelvis, or leg fracture in the last month. Hence, we add 5 to the total, making the current total 5 + 4 = 9.\n The patient does not report anything about ('stroke in the last month', 5) and so we assume this to be false. Hence, 0 points are added to the score, keeping the total at 4. The patient does not report anything about ('multiple trauma in the last month', 5) and so we assume this to be false. Hence, 0 points are added to the score, keeping the total at 4. The patient does not report anything about ('acute spinal cord injury causing paralysis in the last month', 5) and so we assume this to be false. Hence, 0 points are added to the score, keeping the total at 4. The patient's has varicose veins. Hence, we add 1 to the total, making the current total 1 + 4 = 5.\n The patient does not report anything about ('current swollen legs', 1) and so we assume this to be false. Hence, 0 points are added to the score, keeping the total at 4. The patient does not report anything about ('current central venuous access', 2) and so we assume this to be false. Hence, 0 points are added to the score, keeping the total at 4. The patient's has previous DVT documented. Hence, we add 3 to the total, making the current total 3 + 4 = 7.\n The patient's has does not have previous pulmonary embolism documented. Hence, 0 points are added to the score, keeping the total at 4.\nThe patient's has family history of thrombosis. Hence, we add 3 to the total, making the current total 3 + 4 = 7.\n The patient's has does not have Positive Factor V Leiden. Hence, 0 points are added to the score, keeping the total at 4.\nThe patient's has does not have Positive prothrombin 20210A. Hence, 0 points are added to the score, keeping the total at 4.\nThe patient's has elevated serum homocysteine. Hence, we add 3 to the total, making the current total 3 + 4 = 7.\n The patient's has does not have positive lupus anticoagulant. Hence, 0 points are added to the score, keeping the total at 4.\nThe patient's has does not have elevated anticardiolipin antibody. Hence, 0 points are added to the score, keeping the total at 4.\nThe patient's has does not have heparin-induced thrombocytopenia. Hence, 0 points are added to the score, keeping the total at 4.\nThe patient's has does not have 0ther congenital or acquired thrombophilia. Hence, 0 points are added to the score, keeping the total at 4.\nThe patient's mobility status is 'confined to bed >72 hours'. Hence, we add 2 points to the total, making the current total 2 + 4 = 6.\n The patient's has does not have history of inflammatory bowel disease. Hence, 0 points are added to the score, keeping the total at 6.\nThe patient's has does not have acute Myocardial infarction. Hence, 0 points are added to the score, keeping the total at 6.\nThe patient's has does not have chronic Obstructive Pulmonary Disease. Hence, 0 points are added to the score, keeping the total at 6.\nThe patient's has does not have malignancy. Hence, 0 points are added to the score, keeping the total at 6.\nThe patient does not report anything about bmi and so we assume this to be false. Hence, 0 points are added to the score, keeping the total at 6. ", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the Caprini Risk Score for Venous Thromboemb olism (VTE) for this patient, I need to go through the Caprini scoring system step by step and assign points based on the patient's characteristics as described in the patient note. The Caprini score includes factors such as age, surgery, immobilization, trauma, cancer, and other risk factors like hormone therapy, prior VTE, active malignancy , etc.\n\nFirst, let me recall the Caprini scoring system :\n\n1. **Major Surgeries:**\n   - Hip or Knee surgery : 5 points\n   - Abdominal, thoracic, or urologic surgery: 5 points\n   - Gynecologic or vascular surgery: 3 points \n   - General surgery: 1 point - Minor surgery: 1 point\n\n2. **Trauma :**\n   - Hip fracture: 5 points\n   - Multiple trauma or long bone fracture: 3 points \n\n3. **Bed Rest or Immobilization:**\n   - Bed rest > 3 days or in patient surgical or medical hospitalization (over 3 days): 5 points - Bed rest 3 days or less, or nonhospitalized bed rest: 2 points\n\n4. **Malignancy:** (being treated or with history (metastatic or previous): 5 points\n\n5. **Obesity (BMI > 30 kg/m 2): 1 point\n\n6. **Congestive Heart Failure ( NYHA III/IV): 1 point\n\n7. **Cere bral Vascular Accident (CVA): 1 point\n\n8. ** Varicose Veins: 1 point\n\n9. **Prior V TE: 1 point\n\n10. **Age over 40 :**\n   - 40 - 49 yrs: 1 point\n   - 50-59: 2 points - 60 - 69: 3 points - >70: 4 points\n\nI'll analyze each factor based on the patient note.\n\n1. **Age:** The patient is 63 years old. According to the scoring, age 60 -69 years gives 3 points.  \n2. **Surgery:** The patient was admitted to a rehabilitation facility after sustaining traumas including a left femoral shaft fracture (not a surgery , but the femoral fracture is part of the trauma). The note mentions a well-healed surgical incision over the left femoral shaft, which suggests she had surgery for the femoral fracture. However, femoral shaft fracture is a trauma, so maybe the trauma category might be more appropriate here.  \n\n3. **Trauma**: The patient sustained multiple traumas from a motor vehicle collision, which included multiple rib fractures and a left femoral shaft fracture (long bone fracture). The long bone fracture qualifies for the \"multiple trauma or long bone fracture category \" which is 3 points.  \n4. **Immobilization/Bed rest**: The patient remains in bed due to her injuries and has been in a rehabilitation facility since being transferred 1 day ago; however, given her ongoing recovery and immobilization for more than 3 days (since she was in the hospital before transfer), so \"bed rest >3 days\" would be 5 points.  \n5. **History of prior DVT:** The patient has a history of prior deep venous thrombosis (DVT). The scoring gives 1 point for prior VTE.  \n6. **Obesity or BMI:** The patient has a BMI of 27. 1. The cutoff for obesity in Caprini is BMI >30 , so this doesn't add a point.  \n7. **Varicose veins:** The patient has bilateral varic ose veins. This gives 1 point.  \n8. **Other factors:** The patient has a family history of D VT/PE (mother's history), but this is not one of the criteria in the standard Caprini risk stratification, so it doesn\u2019t directly contribute to the score.  \n9. **Malignancy:** The patient has no history of malign ancy, so no points here.  \n10. **Other conditions like heart failure, COPD, etc., are not present.**  \n\nNow, let me tally the points:\n\n- Age 63: 3 points  \n- Multiple trauma with long bone fracture (femoral): 3 points  \n- Bed rest >3 days: 5 points  \n- Prior VTE (history of prior DVT): 1 point  \n- Var icose veins: 1 point"}
{"Row Number": 679, "Calculator Name": "QTc Rautaharju Calculator", "Calculator ID": "59", "Category": "physical", "Note ID": "12", "Patient Note": "Patient has a heart rate of 79 bpm and a QT interval of 330 msec.", "Question": "Using the Rautaharju Formula for corrected QT interval, what is the patient's corrected QT interval in terms of msec?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "346", "LLM Explanation": "To calculate the corrected QT interval using the Rautaharju formula, we use the formula: \\[ \\text{QTc} = \\text{QT} + \\left(0.154 \\times \\text{QT} \\times \\left(\\frac{\\text{HR} - 60}{60}\\right)\\right). \\] Given: QT = 330 msec and HR = 79 bpm. First, calculate \\(\\frac{\\text{HR} - 60}{60} = \\frac{79 - 60}{60} = \\frac{19}{60}.\\) Next, calculate \\(0.154 \\times \\text{QT} = 0.154 \\times 330.\\) Let's break this down: \\(0.1 \\times 330 = 33,\\) \\(0.05 \\times 330 = 16.5,\\) and \\(0.004 \\times 330 = 1.32.\\) Adding these together gives us \\(33 + 16.5 + 1.32 = 50.82.\\) Now multiply this result by \\(\\frac{19}{60}.\\) So, \\(50.82 \\times \\frac{19}{60}.\\) First, calculate \\(50.82 \\times 19 = 965.58.\\) Then divide by 60: \\(\\frac{965.58}{60} \\approx 16.093.\\) Therefore, the term to add to the original QT is approximately 16.093. Now add this to the original QT: \\[ \\text{QTc} = 330 + 16.093 \\approx 346.093.\\] Rounding to the nearest whole number, the corrected QT interval is approximately 346 msec.", "LLM Thinking": "Okay, so I need to calculate the corrected QT interval using the R autaharju Formula for the given patient note. The patient's heart rate (HR) is 79 bpm and the QT interval is 330 msec. Let me recall the Rautaharju formula for the corrected QT interval (QTc): The Rautahar ju formula is one of several methods to correct the QT interval for heart rate , and it is formulated as: \\[ \\text{QTc}_{\\text{Rautaharju}} = \\text{QT} + \\frac{(0.154 \\times \\text{QT}) \\times [ \\text{HR} - 60 ]}{60} \\] Wait, let me make sure I have the exact formula right. I think different sources might present it slightly differently. Alternatively, maybe it's something like: QTc = QT + 0.154 \u00d7 (QT \u00d7 (HR - 60)) / 60 ? Hmm, I need to confirm the exact formula. Alternatively, perhaps the Rautaharju formula is actually: QTc = QT + (0.154 \u00d7 QT \u00d7 (HR - 60)) Wait, no, that might be another version. Alternatively, maybe it's the same as Bazett's but with different coefficients? Wait, no, Bazett uses the square of the RR interval. Let's approach this step by step. The formula I will use is: \\[ \\text{QTc} = QT + 0.154 \\cdot QT \\cdot \\left(\\frac{\\text{HR}}{60} - 1 \\right) \\] But it seems to be a bit confusing, so let's use one common approach for Rautaharju, which takes into account: \\[ \\text{QTc} = QT + 0.154 \\cdot QT \\cdot \\left(\\frac{\\text{HR}}{60} - 1 \\right) \\] Alternatively, perhaps the formula is: \\[ QTc = QT + \\left( \\frac{QT \\times (HR - 60)}{60} \\times 0.154 \\right) \\] Wait, perhaps I should look up the exact Rautaharju formula to be precise, but since I can't do that, I'll have to go with my best recollection. Another approach: some sources state that the Rautaharju formula is: \\[ \\text{QTc} = \\text{QT} + \\frac{0.154 \\times \\text{QT} \\times (\\text{HR} - 60)}{\\text{HR}} \\] Wait, that might be another version. Alternatively, perhaps the correct formula is: QTc = QT + (0.154 \u00d7 QT \u00d7 (HR - 60) / 60) Let me try to think of the formula as follows: \\[ QTc = QT + (0.154 \\times QT) \\times \\left(\\frac{HR - 60}{60}\\right) \\] Yes, that seems plausible. Let me plug in the numbers step by step. Given: QT = 330 msec HR = 79 bpm First, let\u2019s calculate the term inside the multiplication: \\[ \\frac{HR - 60}{60} = \\frac{79 - 60}{60} = \\frac{19}{60} \\] Now, multiply this with 0.154 and QT. So we get \\(0.154 \\times QT \\times \\frac{19}{60} = 0.154 \\times 330 \\times \\frac{19}{60}\\). Now let\u2019s calculate this term in steps: First, \\(0.154 \\times 330 =\\) let's compute: 0.1 \u00d7 330 = 33.0 0.05 \u00d7 330 = 16.5 0.004 \u00d7 330 = 1.32 Breakdown: 0.1 \u00d7 330 = 33 0.05 \u00d7 330 = \\(330/20 = 16.5\\) 0.004 \u00d7 330 = \\(0.001 \u00d7 330 \u00d7 4 = 0.33 \u00d7 4 = 1.32\\) Now add up: 33 + 16.5 = 49.5, plus 1.32 gives 50.82. So that term is 50.82. Now multiply that by \\(\\frac{19}{60}\\). Compute \\(\\frac{19}{60} \\approx 0.3167.\\) So we have \\(50.82 \\times 0.3167.\\) Let me compute that: 0.3 \u00d7 50.82 = 15.246 0.0167 \u00d7 50.82 \u2248 0.848 Adding together: 15.246 + 0.848 \u2248 16.094 Therefore, the term to add to the original QT is approximately 16. Wait, but I need to check my calculations again because maybe I messed up in the long computations. Let's try another approach for final simplicity and accuracy. Let me compute step by step with exact numbers: Compute \\(0.154 \\times 330\\): 0.1 \u00d7 330 = 33 0.05 \u00d7 330 = 16.5 0.004 \u00d7 330 = 1.32 Adding them: 33 + 16.5 = 49.5, plus 1.32 = 50.82 Now multiply by \\(\\frac{HR - 60}{60}\\) where HR = 79: \\(\\frac{19}{60} \\approx 0.3167\\) \\(50.82 \\times 0.3167\\) Break down: 0.3 \u00d7 50.82 = 15.246 0.0167 \u00d7 50.82 \u2248 0.848 Total \u2248 15.246 + 0.848 = 16.094 Thus the addition term is \u2248 16. Wait, but let me do the exact multiplication using the fraction form: \\(\\frac{0.154 \\times 330 \\times 19}{60}\\) First, \\(0.154 \\times 330 = 50.82\\) Then multiply by 19: 50.82 \u00d7 19 = 50.82 \u00d7 (20 \u2212 1) = 1016.4 \u2212 50.82 = 965.58 Now divide by 60: 965.58 / 60 = 16.093 Thus the addition term is \u2248 16.", "Ground Truth Answer": "364.833", "Ground Truth Explanation": "The corrected QT interval using the Rautajarju formula is computed as  QTc = QT interval x (120 + HR) / 180, where QT interval is in msec, and HR is the heart rate in beats per minute.\nThe QT interval is 330 msec.\nThe patient's heart rate is 79 beats per minute.\nHence, plugging in these values, we will get 330 x (120 + 79) / 180 = 364.833.\nThe patient's corrected QT interval (QTc) is 364.833 msec.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to calculate the corrected QT interval using the R autaharju Formula for the given patient note.  \nThe patient's heart rate (HR) is 79 bpm and the QT interval is 330 msec.  \nLet me recall the Rautaharju formula for the corrected QT interval (QTc):  \n\nThe Rautahar ju formula is one of several methods to correct the QT interval for heart rate , and it is formulated as:  \n\n\\[ \\text{QTc}_{\\text{Rautaharju}} = \\text{QT} + \\frac{(0.154 \\times \\text{QT}) \\times [ \\text{HR} - 60 ]}{60} \\]  \n\nWait, let me make sure I have the exact formula right.  \nI think different sources might present it slightly differently.  \nAlternatively, maybe it's something like:  \nQTc = QT + 0.154 \u00d7 (QT \u00d7 (HR - 60)) / 60 ?  \n\nHmm, I need to confirm the exact formula.  \nAlternatively, perhaps the Rautaharju formula is actually:  \nQTc = QT + (0.154 \u00d7 QT \u00d7 (HR - 60))  \n\nWait, no, that might be another version.  \nAlternatively, maybe it's the same as Bazett's but with different coefficients? Wait, no, Bazett uses the square of the RR interval.  \nLet's approach this step by step.  \n\nThe formula I will use is:  \n\\[ \\text{QTc} = QT + 0.154 \\cdot QT \\cdot \\left(\\frac{\\text{HR}}{60} - 1 \\right) \\]  \n\nBut it seems to be a bit confusing, so let's use one common approach for Rautaharju, which takes into account:  \n\\[ \\text{QTc} = QT + 0.154 \\cdot QT \\cdot \\left(\\frac{\\text{HR}}{60} - 1 \\right) \\]  \n\nAlternatively, perhaps the formula is:  \n\\[ QTc = QT + \\left( \\frac{QT \\times (HR - 60)}{60} \\times 0.154 \\right) \\]  \n\nWait, perhaps I should look up the exact Rautaharju formula to be precise, but since I can't do that, I'll have to go with my best recollection.  \nAnother approach: some sources state that the Rautaharju formula is:  \n\\[ \\text{QTc} = \\text{QT} + \\frac{0.154 \\times \\text{QT} \\times (\\text{HR} - 60)}{\\text{HR}} \\]  \n\nWait, that might be another version.  \nAlternatively, perhaps the correct formula is:  \nQTc = QT + (0.154 \u00d7 QT \u00d7 (HR - 60) / 60)  \n\nLet me try to think of the formula as follows:  \n\\[ QTc = QT + (0.154 \\times QT) \\times \\left(\\frac{HR - 60}{60}\\right) \\]  \n\nYes, that seems plausible.  \nLet me plug in the numbers step by step.  \n\nGiven:  \nQT = 330 msec  \nHR = 79 bpm  \n\nFirst, let\u2019s calculate the term inside the multiplication:  \n\\[ \\frac{HR - 60}{60} = \\frac{79 - 60}{60} = \\frac{19}{60} \\]  \n\nNow, multiply this with 0.154 and QT.  \nSo we get \\(0.154 \\times QT \\times \\frac{19}{60} = 0.154 \\times 330 \\times \\frac{19}{60}\\).  \n\nNow let\u2019s calculate this term in steps:  \n\nFirst, \\(0.154 \\times 330 =\\) let's compute:  \n0.1 \u00d7 330 = 33.0  \n0.05 \u00d7 330 = 16.5  \n0.004 \u00d7 330 = 1.32  \n\nBreakdown:  \n0.1 \u00d7 330 = 33  \n0.05 \u00d7 330 = \\(330/20 = 16.5\\)  \n0.004 \u00d7 330 = \\(0.001 \u00d7 330 \u00d7 4 = 0.33 \u00d7 4 = 1.32\\)  \n\nNow add up: 33 + 16.5 = 49.5, plus 1.32 gives 50.82.  \n\nSo that term is 50.82.  \n\nNow multiply that by \\(\\frac{19}{60}\\).  \nCompute \\(\\frac{19}{60} \\approx 0.3167.\\)  \n\nSo we have \\(50.82 \\times 0.3167.\\) Let me compute that:  \n0.3 \u00d7 50.82 = 15.246  \n0.0167 \u00d7 50.82 \u2248 0.848  \n\nAdding together: 15.246 + 0.848 \u2248 16.094  \n\nTherefore, the term to add to the original QT is approximately 16.  \n\nWait, but I need to check my calculations again because maybe I messed up in the long computations.  \n\nLet's try another approach for final simplicity and accuracy. Let me compute step by step with exact numbers:  \n\nCompute \\(0.154 \\times 330\\):  \n0.1 \u00d7 330 = 33  \n0.05 \u00d7 330 = 16.5  \n0.004 \u00d7 330 = 1.32  \nAdding them: 33 + 16.5 = 49.5, plus 1.32 = 50.82  \n\nNow multiply by \\(\\frac{HR - 60}{60}\\) where HR = 79:  \n\\(\\frac{19}{60} \\approx 0.3167\\)  \n\\(50.82 \\times 0.3167\\)  \n\nBreak down:  \n0.3 \u00d7 50.82 = 15.246  \n0.0167 \u00d7 50.82 \u2248 0.848  \n\nTotal \u2248 15.246 + 0.848 = 16.094  \n\nThus the addition term is \u2248 16.  \n\nWait, but let me do the exact multiplication using the fraction form:  \n\\(\\frac{0.154 \\times 330 \\times 19}{60}\\)  \n\nFirst, \\(0.154 \\times 330 = 50.82\\)  \nThen multiply by 19:  \n50.82 \u00d7 19 = 50.82 \u00d7 (20 \u2212 1) = 1016.4 \u2212 50.82 = 965.58  \nNow divide by 60:  \n965.58 / 60 = 16.093  \n\nThus the addition term is \u2248 16."}
{"Row Number": 651, "Calculator Name": "QTc Hodges Calculator", "Calculator ID": "58", "Category": "physical", "Note ID": "4", "Patient Note": "Patient has a heart rate of 161 bpm and a QT interval of 330 msec.", "Question": "Using the Hodges Formula for corrected QT interval, what is the patient's corrected QT interval in terms of msec?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "346", "LLM Explanation": "To calculate the corrected QT interval using the Hodges formula, I used the formula: QTc = QT + 0.154 \u00d7 (HR - 60). Given the patient's heart rate (HR) is 161 bpm and the measured QT interval is 330 msec. First, calculate the difference between the heart rate and 60: 161 - 60 = 101. Next, multiply this difference by 0.154: 0.154 * 101 = 15.554. Finally, add this result to the measured QT interval: 330 + 15.554 = 345.554, which rounds to approximately 346 msec.", "LLM Thinking": "Step 1: To solve this problem using the Hodges formula for the corrected QT interval, first, we need to know the Hodges formula. The Hodges formula is used to correct the QT interval based on the heart rate. The standard formula for correcting the QT interval is usually the Bazett\u2019s formula $QT_c = \\frac{QT}{\\sqrt{RR}}$, but since the problem specifies the Hodges formula, let\u2019s recall its exact form. Step 2: After checking, I recall that the corrected QT interval according to the Hodges formula is defined as: \\[ QT_c = QT + (1.75 \\times \\text{(Heart Rate - 60)}) \\] where QT is the measured QT interval in milliseconds, and the heart rate is in beats per minute (bpm). The formula adjusts the QT interval based on deviations from a heart rate of 60 bpm. Step 3: Given the patient's heart rate is 161 bpm, and the measured QT interval is 330 msec. Now we will apply the Hodges formula to calculate the corrected QT interval. Using the formula: \\[ QT_c = QT + 1.75 \\times (\\text{Heart Rate} - 60) \\] Plug in the given values: \\[ QT = 330 \\, msec \\] \\[ \\text{Heart Rate} = 161 \\, bpm \\] Compute the difference in heart rate: \\[ \\text{Heart Rate} - 60 = 161 - 60 = 101. \\] Now, multiply this difference by 1.75: \\[ 1.75 \\times 101 = 176.75. \\] Now add this to the measured QT interval to get the corrected QT: Wait, this seems unusually high. Let me double-check the formula because a corrected QT of over 500 msec from the Hodges formula doesn\u2019t sound right. Perhaps I made a mistake in recalling the formula. The correct formula for the corrected QT interval according to Hodges is generally given as: \\[ QT_c = \\frac{QT}{\\sqrt{RR}} \\] but usually, the RR interval must be derived from the heart rate. Alternatively, Hodges formula might have a different expression. Let\u2019s use the Bazett\u2019s formula to calculate the corrected QT interval since Hodges might be a different approach. Alternatively, maybe the Hodges formula is: \\[ QT_c = QT + 0.154 \\times (HR - 60) \\] Wait, that\u2019s the Fridericia\u2019s formula is similar to: \\[ QT_c = QT / (RR)^{1/3} \\] Wait, perhaps I got the Hodges formula wrong. The correct approach for the question likely uses a standard approach like Bazett or Fridericia, but the user specified Hodges, so I need to clarify the correct formula that should be applied in standard contexts. Alternatively, perhaps the Hodges formula is defined as: \\[ QT_c = QT + (1.75 (HR \u2013 60)) \\] It seems like a linear approach to correct for heart rate. But the result of 506.75 msec is indeed incorrect because the corrected QT (QTc) should fall within a normal range (typically between 350 to 440 msec for males and up to 460 for females, depending on the formula). So getting over 500 is likely an error. Therefore, I must have made an error in the Hodges formula. Let me verify again. Wait, perhaps the Hodges formula is different. Another source suggests that the Hodges formula is: \\[ QT_c = QT + 0.154 \\times (HR - 60) \\] Let me check that. Let\u2019s plug in the numbers again with that formula: \\[ QT_c = 330 + 0.154 \\times (161 - 60) \\] 1. Calculate (HR \u2013 60): \\[ 161 - 60 = 101. \\] 2. Now multiply this with 0.154: \\[ 0.154 \\times 101 = 15.554. \\] 3. Add to the QT: This is plausible. So perhaps I confused the coefficients. Since the problem states \u201cHodges formula,\u201d I need to confirm the exact formula. However, the user might be referring to a different version. Since I initially thought of the formula with 1.75 but it led to an unrealistic result, it\u2019s more likely that the correct Hodges formula uses a coefficient like 0.154. Alternatively, maybe the formula is: \\[ QT_c = \\frac{QT}{\\sqrt{\\tfrac{\\text{Heart Rate}}{60}}}. \\] Let me try that. First, the RR interval in seconds is 60 / heart rate. So the R\u2013R interval is 60 / 161 \u2248 0.3727 seconds. Using Bazett\u2019s correction (because it might have been meant as a different formula): QTc = QT / \u221aRR So, RR = 60 / HR (because 1 second = 60 / HR seconds per beat) Therefore, RR in seconds is RR = 60 / 161 \u2248 0.372 seconds Then, \u221aRR is \u221a0.3727 \u2248 0.610. Now apply Bazett\u2019s formula \\[ QT_c = \\frac{330}{0.610} \\] But this also gives a very high QTc. Wait, but if the heart rate is high, the QT interval shortens, so a high HR would lead to a lower QTc. So let\u2019s now try Fridericia\u2019s formula to get a better idea: Fridericia: QTc = QT / (RR)^(1/3) where RR in seconds is 0.3727. So (RR)^(1/3) = (0.3727)^(1/3) \u2248 0.72. Then QTc = 330 / 0.72 That\u2019s within normal limits. Hmm. Alternatively, perhaps the Hodges formula is actually the same as Bazett or something else. Let\u2019s try the Hodges formula: According to some sources, the Hodges formula is: \\[ QTc = QT + 0.154 \\times (HR - 60) \\] This is also known as the Hodges\u2013Franklin correction. Let me confirm this. Yes, according to some sources, the formula is: QTc = QT + 0.154 \u00d7 (HR \u2013 60) So with that formula, let\u2019s recalculate: QT = 330 ms HR = 161 0.154 \u00d7 (161\u201360) = 0.154 \u00d7 101 = 15.554 Thus, the corrected QT by the Hodges formula is:", "Ground Truth Answer": "506.501", "Ground Truth Explanation": "The corrected QT interval using the Hodges formula is computed as  QTc = QT interval + 1.75 * [(60 /rr_interval_sec) - 60], where QT interval is in msec, and RR interval is given as 60/(heart rate).\nThe patient's heart rate is 161 beats per minute.\nThe QT interval is 330 msec.\nThe RR interval is computed as 60/(heart rate), and so the RR interval is 60/161 = 0.373.\nHence, plugging in these values, we will get 330 + 1.75 * [(60/0.373) - 60] = 506.501.\nThe patient's corrected QT interval (QTc) is 506.501 msec.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To solve this problem using the Hodges formula for the corrected QT interval, first, we need to know the Hodges formula.  \nThe Hodges formula is used to correct the QT interval based on the heart rate.  \nThe standard formula for correcting the QT interval is usually the Bazett\u2019s formula $QT_c = \\frac{QT}{\\sqrt{RR}}$, but since the problem specifies the Hodges formula, let\u2019s recall its exact form.  \n\nStep 2: After checking, I recall that the corrected QT interval according to the Hodges formula is defined as:\n\n\\[ QT_c = QT + (1.75 \\times \\text{(Heart Rate - 60)}) \\]\n\nwhere QT is the measured QT interval in milliseconds, and the heart rate is in beats per minute (bpm).  \nThe formula adjusts the QT interval based on deviations from a heart rate of 60 bpm.  \n\nStep 3: Given the patient's heart rate is 161 bpm, and the measured QT interval is 330 msec.  \n\nNow we will apply the Hodges formula to calculate the corrected QT interval. Using the formula:\n\n\\[ QT_c = QT + 1.75 \\times (\\text{Heart Rate} - 60) \\]\n\nPlug in the given values:\n\n\\[ QT = 330 \\, msec \\]  \n\\[ \\text{Heart Rate} = 161 \\, bpm \\]\n\nCompute the difference in heart rate:\n\n\\[ \\text{Heart Rate} - 60 = 161 - 60 = 101. \\]\n\nNow, multiply this difference by 1.75:\n\n\\[ 1.75 \\times 101 = 176.75. \\]\n\nNow add this to the measured QT interval to get the corrected QT:\n\nWait, this seems unusually high. Let me double-check the formula because a corrected QT of over 500 msec from the Hodges formula doesn\u2019t sound right. Perhaps I made a mistake in recalling the formula.  \nThe correct formula for the corrected QT interval according to Hodges is generally given as:\n\n\\[ QT_c = \\frac{QT}{\\sqrt{RR}} \\]\n\nbut usually, the RR interval must be derived from the heart rate.  \nAlternatively, Hodges formula might have a different expression. Let\u2019s use the Bazett\u2019s formula to calculate the corrected QT interval since Hodges might be a different approach. Alternatively, maybe the Hodges formula is:\n\n\\[ QT_c = QT + 0.154 \\times (HR - 60) \\]\n\nWait, that\u2019s the Fridericia\u2019s formula is similar to:\n\n\\[ QT_c = QT / (RR)^{1/3} \\]\n\nWait, perhaps I got the Hodges formula wrong. The correct approach for the question likely uses a standard approach like Bazett or Fridericia, but the user specified Hodges, so I need to clarify the correct formula that should be applied in standard contexts. Alternatively, perhaps the Hodges formula is defined as:\n\n\\[ QT_c = QT + (1.75 (HR \u2013 60)) \\]\n\nIt seems like a linear approach to correct for heart rate. But the result of 506.75 msec is indeed incorrect because the corrected QT (QTc) should fall within a normal range (typically between 350 to 440 msec for males and up to 460 for females, depending on the formula). So getting over 500 is likely an error. Therefore, I must have made an error in the Hodges formula. Let me verify again.\n\nWait, perhaps the Hodges formula is different. Another source suggests that the Hodges formula is:\n\n\\[ QT_c = QT + 0.154 \\times (HR - 60) \\]\n\nLet me check that. Let\u2019s plug in the numbers again with that formula:\n\n\\[ QT_c = 330 + 0.154 \\times (161 - 60) \\]\n\n1. Calculate (HR \u2013 60):\n\\[ 161 - 60 = 101. \\]\n\n2. Now multiply this with 0.154:\n\\[ 0.154 \\times 101 = 15.554. \\]\n\n3. Add to the QT:\n\nThis is plausible. So perhaps I confused the coefficients. Since the problem states \u201cHodges formula,\u201d I need to confirm the exact formula. However, the user might be referring to a different version. Since I initially thought of the formula with 1.75 but it led to an unrealistic result, it\u2019s more likely that the correct Hodges formula uses a coefficient like 0.154. Alternatively, maybe the formula is:\n\n\\[ QT_c = \\frac{QT}{\\sqrt{\\tfrac{\\text{Heart Rate}}{60}}}. \\]\n\nLet me try that.\n\nFirst, the RR interval in seconds is 60 / heart rate. So the R\u2013R interval is 60 / 161 \u2248 0.3727 seconds. Using Bazett\u2019s correction (because it might have been meant as a different formula):\n\nQTc = QT / \u221aRR\n\nSo, RR = 60 / HR (because 1 second = 60 / HR seconds per beat)\n\nTherefore, RR in seconds is\n\nRR = 60 / 161 \u2248 0.372 seconds\n\nThen, \u221aRR is \u221a0.3727 \u2248 0.610.\n\nNow apply Bazett\u2019s formula\n\n\\[ QT_c = \\frac{330}{0.610} \\]\n\nBut this also gives a very high QTc. Wait, but if the heart rate is high, the QT interval shortens, so a high HR would lead to a lower QTc.\n\nSo let\u2019s now try Fridericia\u2019s formula to get a better idea:\n\nFridericia: QTc = QT / (RR)^(1/3)\n\nwhere RR in seconds is 0.3727.\n\nSo (RR)^(1/3) = (0.3727)^(1/3) \u2248 0.72.\n\nThen QTc = 330 / 0.72\n\nThat\u2019s within normal limits. Hmm.\n\nAlternatively, perhaps the Hodges formula is actually the same as Bazett or something else.\n\nLet\u2019s try the Hodges formula: According to some sources, the Hodges formula is:\n\n\\[ QTc = QT + 0.154 \\times (HR - 60) \\]\n\nThis is also known as the Hodges\u2013Franklin correction. Let me confirm this.\n\nYes, according to some sources, the formula is:\n\nQTc = QT + 0.154 \u00d7 (HR \u2013 60)\n\nSo with that formula, let\u2019s recalculate:\n\nQT = 330 ms  \nHR = 161  \n\n0.154 \u00d7 (161\u201360) = 0.154 \u00d7 101 = 15.554  \n\nThus, the corrected QT by the Hodges formula is:"}
{"Row Number": 77, "Calculator Name": "Mean Arterial Pressure (MAP)", "Calculator ID": "5", "Category": "physical", "Note ID": "pmc-3691896-2", "Patient Note": "A 65-year-old African American woman was rushed to the hospital by ambulance following an episode of syncope at a community supermarket. She regained consciousness within a few minutes. There was no tongue biting, urinary incontinence, or postictal confusion. She reported some premonitory symptoms of warmth and sweating and gave a history of light-headedness, weakness, and fatigue over the last 2 weeks. She denied palpitations, chest pain, shortness of breath, fever, dizziness, or visual changes. She denied headache or weakness.\nOver the last couple of months, she had multiple episodes of fall but no loss of consciousness. The falls were increasing in frequency over the last 2 weeks. She lived alone and had a history of hypertension for almost thirteen years for which she was noncompliant with her medications. She did not smoke, drink alcohol, or use any illicit drugs. Her mother had hypertension and died at the age of 80 years from heart disease.\nOn examination, her temperature was 37\u00b0C, the respiratory rate was 24 breaths per minute, and blood pressure while supine was 89/52 mm Hg, with a heart rate of 52 beats per minute; on standing, her blood pressure fell to 69/40 mm Hg, with a heart rate of 74 beats per minute. Her blood glucose level was 120 mg per deciliter. Oxygen saturation was 100 percent on 2 liters of oxygen via nasal cannula.\nPhysical evaluation showed no signs of head trauma. Her respiratory, cardiovascular, and abdominal examinations were unremarkable. Neurological examination showed decreased sensation to light touch in a stocking and glove distribution. Upper limb reflexes were brisk and lower limb reflexes were absent. Vibratory sensation and position sense were decreased in both upper and lower limbs. An extensor plantar response was noted bilaterally and Romberg's test was positive. There was hyperpigmentation of both palms with dark discoloration of the nails (). Axillary and pubic hair was normal in distribution and density. She was admitted to the hospital for further investigation and workup.\nContrast computed tomography (CT) of the head showed no obvious lesion. An electrocardiogram revealed sinus bradycardia at a rate of 50 beats per minute with no ST or T wave changes. A 24-hour holter monitoring was performed which revealed sinus bradycardia without other arrhythmias.\nHer laboratory studies were as shown in .\nSerum alcohol levels were undetectable and urine toxicology was negative. Esophagogastro-dudodenoscopy was performed and the gastric biopsy was suggestive of chronic atrophy of the body and fundus. The endoscopic findings were further reinforced by high serum levels of antibodies to intrinsic factor and gastric parietal cells confirming malabsorption of vitamin B12 due to lack of intrinsic factor. Thus, the diagnosis of pernicious anemia was established.\nThe patient was started on intramuscular injection of vitamin B12 (1,000 \u03bcg) daily for one week, then weekly for one month. She was later lost to followup, and posttreatment evaluation of the skin hyperpigmentation and neurological evaluation could not be done.", "Question": "What is patient's mean arterial pressure in mm Hg?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "49.7", "LLM Explanation": "To calculate the mean arterial pressure (MAP), we use the formula: MAP = Diastolic + (Systolic - Diastolic)/3. The patient has two sets of blood pressure readings: one while supine (89/52 mm Hg) and one while standing (69/40 mm Hg). Given the context of the patient's syncope and symptoms of light-headedness, the standing position is likely more relevant.\\n\\nFor the standing position:\\nSystolic = 69 mm Hg,\\nDiastolic = 40 mm Hg.\\n\\nUsing the formula for MAP:\\nMAP = 40 + (69 - 40)/3.\\n\\nCalculate the difference between systolic and diastolic:\\n69 - 40 = 29.\\n\\nNow divide this difference by 3:\\n29 / 3 \u2248 9.67.\\n\\nAdd this result to the diastolic pressure:\\nMAP = 40 + 9.67 \u2248 49.67 mm Hg.\\n\\nTherefore, the mean arterial pressure while standing is approximately 49.67 mm Hg.", "LLM Thinking": "First, we need to calculate the mean arterial pressure (MAP) from the provided blood pressure readings. The question doesn't specify whether to use the supine or standing blood pressure , so I will calculate both to determine the appropriate one for the mean arterial pressure (though it\u2019s common to use both and/or context to decide which might be more significant in the clinical scenario. The patient\u2019s supine blood pressure is 89/52 mm Hg. The formula for calculating mean arterial pressure (MAP) is: \\[ \\text{MAP} = \\text{Diastolic BP } + \\frac{(\\text{Systolic BP} - \\ text{Diastolic BP})}{3}\\] For the supine position: Systolic (SP) = 89, Di astolic (DP) = 52 Using the formula, we get: 52 + (89-52)/3 = 52 + 37/3 \u2248 52 + 12.33 = 64.33 mm H g Alternatively, sometimes the MAP is approximated as (2*Di astolic + Systolic)/3. Let me check that method as well. For supine blood pressure, MAP supine = (2 * 52 + 89) / 3 = (1 04 + 89) / 3 = 193 / 3 \u2248 64.33 mmHg. Since the question doesn't specify which blood pressure reading to use, but MAP is typically calculated for a specific measurement. The problem might be asking for the supine position since that's the first mentioned. Alternatively, maybe the standing BP is also required? However, the question asks for the patient's mean arterial pressure, and it 's common to report MAP in a specific position, but the problem may expect the mean arterial pressure under resting (supine) condition unless specified otherwise. Since the question doesn't specify, but in clinical settings, MAP is often taken while supine as the standard measurement to evaluate hemodynamic stability. Alternatively, maybe they want it for the standing position as that might be significant given the context of the patient 's syncope and orthostatic hypotension. However, the question seems to seek the MAP without a specific context hinting which MAP to use . The problem states \"patient's mean arterial pressure in mm Hg\" without specifying the position. However, in the note, the blood pressure is given in both supine and standing positions and in the context given (especially considering the symptoms like syn cope and light-headedness), the orthostatic hypotension is a critical factor hence the standing MAP (representative of the MAP when the patient is in an upright position and experiencing symptoms) might be more relevant. However, without explicit instruction, perhaps the question expects the supine MAP since that is the standard position for blood pressure measurement. The question might be testing knowledge of MAP calculation using one of the provided readings . The problem mentions \"blood pressure while supine was 89/5 2 mm Hg\" and also mentions a drop on standing to 6 9/40. Since the question is just asking for the patient's MAP, perhaps they expect us to calculate both and see which is needed, but maybe the question is simpler, just taking one of the BP readings given . Alternatively, maybe it\u2019s the mean of both? Unlikely. Since the note provides both, perhaps the question is expecting the supine MAP , which is higher, but the key is to use the correct formula. Let's take the MAP from the supine position which is 8 9/52.", "Ground Truth Answer": "64.333", "Ground Truth Explanation": "The mean average pressure is computed by the formula 2/3 * (diastolic blood pressure) + 1/3 * (systolic blood pressure). Plugging in the values, we get 2/3 * 52.0 mm Hg + 1/3 * 89.0 mm Hg = 64.333 mm Hg.\nHence, the patient's mean arterial pressure is 64.333 mm Hg.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the mean arterial pressure (MAP) from the provided blood pressure readings.  \nThe question doesn't specify whether to use the supine or standing blood pressure , so I will calculate both to determine the appropriate one for the mean arterial pressure (though it\u2019s common to use both and/or context to decide which might be more significant in the clinical scenario.  \nThe patient\u2019s supine blood pressure is 89/52 mm Hg.\n\nThe formula for calculating mean arterial pressure (MAP) is: \\[ \\text{MAP} = \\text{Diastolic BP } + \\frac{(\\text{Systolic BP} - \\ text{Diastolic BP})}{3}\\]\n\nFor the supine position:  \nSystolic (SP) = 89, Di astolic (DP) = 52\n\nUsing the formula, we get: 52 + (89-52)/3 = 52 + 37/3 \u2248 52 + 12.33 = 64.33 mm H g\n\nAlternatively, sometimes the MAP is approximated as (2*Di astolic + Systolic)/3. Let me check that method as well.\n\nFor supine blood pressure,  \n\nMAP supine = (2 * 52 + 89) / 3 = (1 04 + 89) / 3 = 193 / 3 \u2248 64.33 mmHg. Since the question doesn't specify which blood pressure reading to use, but MAP is typically calculated for a specific measurement.  \nThe problem might be asking for the supine position since that's the first mentioned. Alternatively, maybe the standing BP is also required?  \nHowever, the question asks for the patient's mean arterial pressure, and it 's common to report MAP in a specific position, but the problem may expect the mean arterial pressure under resting (supine) condition unless specified otherwise.  \nSince the question doesn't specify, but in clinical settings, MAP is often taken while supine as the standard measurement to evaluate hemodynamic stability.  \nAlternatively, maybe they want it for the standing position as that might be significant given the context of the patient 's syncope and orthostatic hypotension.  \nHowever, the question seems to seek the MAP without a specific context hinting which MAP to use .  \nThe problem states \"patient's mean arterial pressure in mm Hg\" without specifying the position.  \nHowever, in the note, the blood pressure is given in both supine and standing positions and in the context given (especially considering the symptoms like syn cope and light-headedness), the orthostatic hypotension is a critical factor hence the standing MAP (representative of the MAP when the patient is in an upright position and experiencing symptoms) might be more relevant.  \nHowever, without explicit instruction, perhaps the question expects the supine MAP since that is the standard position for blood pressure measurement.  \nThe question might be testing knowledge of MAP calculation using one of the provided readings .  \nThe problem mentions \"blood pressure while supine was 89/5 2 mm Hg\" and also mentions a drop on standing to 6 9/40.  \nSince the question is just asking for the patient's MAP, perhaps they expect us to calculate both and see which is needed, but maybe the question is simpler, just taking one of the BP readings given .  \nAlternatively, maybe it\u2019s the mean of both? Unlikely.  \nSince the note provides both, perhaps the question is expecting the supine MAP , which is higher, but the key is to use the correct formula.  \nLet's take the MAP from the supine position which is 8 9/52."}
{"Row Number": 193, "Calculator Name": "QTc Bazett Calculator", "Calculator ID": "11", "Category": "physical", "Note ID": "14", "Patient Note": "Patient has a heart rate of 72 bpm and a QT interval of 330 msec.", "Question": "Using the Bazett Formula for corrected QT interval, what is the patient's corrected QT interval in msec?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "361", "LLM Explanation": "To calculate the corrected QT interval using the Bazett formula, we use the formula: QTc = QT / \u221a(RR interval in seconds). Given the heart rate is 72 bpm and the QT interval is 330 msec, we first need to find the RR interval in seconds. The RR interval is calculated as 60 / heart rate. Therefore, RR = 60 / 72 = 0.8333 seconds. Next, we take the square root of the RR interval: \u221a(0.8333) \u2248 0.9128. Now we apply the Bazett formula: QTc = 330 / 0.9128 \u2248 361.44 msec. Rounding this to the nearest whole number gives us 361 msec.", "LLM Thinking": "Okay, so I need to calculate the corrected QT interval using the Bazett formula for this patient. The Bazett formula corrects the QT interval for heart rate and is given by the formula: QTc = QT / \u221a(RR interval in seconds), where the RR interval (representing the heart rate) can be derived from the heart rate. Given: - Heart rate = 72 bpm - QT interval = 330 msec First, I have to remember that the RR interval is the time between two consecutive R waves in an Electrocardiogram (ECG), and it corresponds to the heart rate. Since the heart rate is given in beats per minute (bpm), we can convert it to the RR interval in seconds. The formula to convert heart rate (HR) to RR interval (in seconds) is RR = 60 / HR. So, let\u2019s calculate the RR interval: \\[ \\text{RR interval} = \\frac{60}{\\text{Heart rate}} = \\frac{60}{72} \\] Wait, 60 divided by 72. Let me compute that. \\[ \\text{RR interval} = \\frac{60}{72} = \\approx 0.8333 \\text{ seconds} \\] Then, the square root of the RR interval is: \\[ \\sqrt{\\text{RR interval}} = \\sqrt{0.8333} \\approx \\sqrt{0.8333} \\] Using a calculator, \\[ \\sqrt{0.8333} \\approx 0.913. \\] Now we use the Bazett formula: The corrected QT interval (QTc) is calculated by dividing the measured QT interval by the square root of the RR interval: \\[ \\text{QTc} = \\frac{QT}{\\sqrt{RR}} \\] Plugging the numbers: \\[ QTc = \\frac{330 \\text{ msec}}{0.913} \\approx \\frac{330}{0.913} \\] Now, let's calculate \\( \\frac{330}{0.913} \\): \\[ \\frac{330}{0.913} \\approx 361.2048 \\] Wait, but let me check again the calculations step by step to ensure accuracy. Wait, let me recalculate the square root part more precisely. \\[ RR interval = \\frac{60}{72} = \\frac{5}{6} \\approx 0.833333. \\] Taking the square root: \\[ \\sqrt{\\frac{5}{6}} = \\sqrt{0.833333...} \\approx 0.9128 \\text{ (approximately)} \\] Now using this in the Bazett formula, \\[ QTc = \\frac{330}{0.9128} \\approx 361.44. \\]", "Ground Truth Answer": "361.569", "Ground Truth Explanation": "The corrected QT interval using the Bazett formula is computed as  QTc = QT interval / \u221a (RR interval), where the QT interval is in msec, and RR interval is given as 60/(heart rate).\nThe patient's heart rate is 72 beats per minute.\nThe QT interval is 330 msec.\nThe RR interval is computed as 60/(heart rate), and so the RR interval is 60/72 = 0.833.\nHence, plugging in these values, we will get 330/\u221a(0.833) = 361.569.\nThe patient's corrected QT interval (QTc) is 361.569 msec. ", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to calculate the corrected QT interval using the Bazett formula for this patient.  \nThe Bazett formula corrects the QT interval for heart rate and is given by the formula: QTc = QT / \u221a(RR interval in seconds), where the RR interval (representing the heart rate) can be derived from the heart rate.\n\nGiven:  \n- Heart rate = 72 bpm  \n- QT interval = 330 msec\n\nFirst, I have to remember that the RR interval is the time between two consecutive R waves in an Electrocardiogram (ECG), and it corresponds to the heart rate.  \nSince the heart rate is given in beats per minute (bpm), we can convert it to the RR interval in seconds.  \nThe formula to convert heart rate (HR) to RR interval (in seconds) is RR = 60 / HR.\n\nSo, let\u2019s calculate the RR interval:\n\n\\[ \\text{RR interval} = \\frac{60}{\\text{Heart rate}} = \\frac{60}{72} \\]\n\nWait, 60 divided by 72. Let me compute that.\n\n\\[ \\text{RR interval} = \\frac{60}{72} = \\approx 0.8333 \\text{ seconds} \\]\n\nThen, the square root of the RR interval is:\n\n\\[ \\sqrt{\\text{RR interval}} = \\sqrt{0.8333} \\approx \\sqrt{0.8333} \\]\n\nUsing a calculator,\n\n\\[ \\sqrt{0.8333} \\approx 0.913. \\]\n\nNow we use the Bazett formula:\n\nThe corrected QT interval (QTc) is calculated by dividing the measured QT interval by the square root of the RR interval:\n\n\\[ \\text{QTc} = \\frac{QT}{\\sqrt{RR}} \\]\n\nPlugging the numbers:\n\n\\[ QTc = \\frac{330 \\text{ msec}}{0.913} \\approx \\frac{330}{0.913} \\]\n\nNow, let's calculate \\( \\frac{330}{0.913} \\):\n\n\\[ \\frac{330}{0.913} \\approx 361.2048 \\]\n\nWait, but let me check again the calculations step by step to ensure accuracy.\n\nWait, let me recalculate the square root part more precisely.\n\n\\[ RR interval = \\frac{60}{72} = \\frac{5}{6} \\approx 0.833333. \\]\n\nTaking the square root:\n\n\\[ \\sqrt{\\frac{5}{6}} = \\sqrt{0.833333...} \\approx 0.9128 \\text{ (approximately)} \\]\n\nNow using this in the Bazett formula,\n\n\\[ QTc = \\frac{330}{0.9128} \\approx 361.44. \\]"}
{"Row Number": 87, "Calculator Name": "Body Mass Index (BMI)", "Calculator ID": "6", "Category": "physical", "Note ID": "pmc-7475287-1", "Patient Note": "A 33-year-old woman was referred to a university hospital for the evaluation of secondary amenorrhea for 4 months. The patient had spontaneous thelarche at age 11 years and menarche at age 13 years. She denied experiencing vasomotor symptoms. A human chorionic gonadotropin (hCG) urine test was negative. The results of the physical examination were as follows: height 165.0 cm, weight 60.2 kg, systolic blood pressure 132 mmHg, and diastolic blood pressure 77 mmHg. Breast development and pubic hair growth were both stage 5 according to the Tanner staging system. Basal hormonal tests revealed highly elevated serum FSH and luteinizing hormone (LH) levels (52.7 IU/L and 33.2 IU/L, respectively), a low estradiol (E2) level (17.8 pg/mL), and high AMH level (5.04 ng/mL). Serum levels of prolactin, thyroid-stimulating hormone, and free T4 were all normal. A transvaginal ultrasound revealed a normal-sized uterus with polycystic ovarian morphology (> 20 antral follicles measuring 2\u20139 mm) observed in the right ovary ().\nThe patient was unmarried and wanted to preserve her fertility; therefore, she was advised to visit an infertility hospital for oocyte cryopreservation. The repeated basal hormonal tests were unchanged, and serum levels of androgens including total testosterone, free testosterone, 17\u03b1-hydroxyprogesterone, and dehydroepiandrosterone sulfate were all normal. Induction of superovulation was attempted with a starting dose of 150 IU recombinant FSH (Follitrope\u00ae; LG, Iksan, Korea) daily for oocyte cryopreservation. The dose of recombinant FSH was increased to 225 IU after one week because follicular development was not observed on ultrasound. However, follicular development was not observed despite the increase in FSH dose, and cycle cancellation was determined at that time. Further evaluation included karyotype, FMR1 premutation, and 21-hydroxylase antibody tests. The karyotype analysis revealed 47,XXX[1]/46,XX[29]; however, it was read as a normal variant by the specialist in laboratory medicine. The FMR1 premutation test revealed no abnormal CGG trinucleotide repeat expansion. The patient tested negative for 21-hydroxylase antibodies. In addition, anti-thyroglobulin antibodies and anti-thyroid peroxidase antibodies were negative. She was prescribed oral contraceptives (Yaz\u00ae) for hypoestrogenism associated with POI.", "Question": "What is the patient's body mass mass index (BMI)? Your answer should be in terms of kg/m\u00b2.", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "22.11", "LLM Explanation": "To calculate the BMI, we use the formula: BMI = weight (kg) / (height (m))^2. The given weight is 60.2 kg and the height is 165.0 cm. First, convert the height from cm to meters: 165.0 cm / 100 = 1.65 m. Next, we square the height in meters: (1.65)^2 = 2.7225. Now, plug the values into the BMI formula: BMI = 60.2 / 2.7225 \u2248 22.11. Therefore, the patient's BMI is approximately 22.11 kg/m\u00b2.", "LLM Thinking": "First, we need to calculate the BMI using the given height and weight of the patient. The formula for BMI is weight (kg) divided by height (m) squared. The patient's weight is 60.2 kg and the height is 165.0 cm. Step 1: Convert the height from centimeters to meters. Since 1 meter = 100 cm, Step 2: Use the BMI formula: BMI = (weight in kg) / (height in meters)^2. So, BMI = 60.2 / ( 1.65)^2. Now we calculate 1.6 5^2: Then divide 60.2 by 2 .7225.", "Ground Truth Answer": "22.112", "Ground Truth Explanation": "The formula for computing the patient's BMI is (weight)/(height * height), where weight is the patient's weight in kg and height is the patient's height in m.\nThe patient's height is 165.0 cm, which is 165.0 cm * 1 m / 100 cm = 1.65 m. The patient's weight is 60.2 kg. The patient's bmi is therefore 60.2 kg / (1.65 m * 1.65 m) = 22.112 kg/m^2.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the BMI using the given height and weight of the patient. The formula for BMI is weight (kg) divided by height (m) squared. The patient's weight is 60.2 kg and the height is 165.0 cm.\n\nStep 1: Convert the height from centimeters to meters. Since 1 meter = 100 cm,\n\nStep 2: Use the BMI formula: BMI = (weight in kg) / (height in meters)^2.\n\nSo, BMI = 60.2 / ( 1.65)^2. \n\nNow we calculate 1.6 5^2: \n\nThen divide 60.2 by 2 .7225."}
{"Row Number": 458, "Calculator Name": "FeverPAIN Score for Strep Pharyngitis", "Calculator ID": "33", "Category": "diagnosis", "Note ID": "pmc-3034928-1", "Patient Note": "A 28-year-old man presented with severe neck pain mainly on the left side with painful swallowing for 5 days. The patient initially had asked for medical advice at a primary health care facility and was treated with antibiotics and anti-inflammatory drugs, but there was no improvement and the pain was increasing in severity. On detailed history, the patient reported that he had an attack of choking and coughing, while he was eating chicken during dinner one day before the onset of symptoms.\nOn examination, there was a low-grade fever and tenderness in the left side of the neck, and the pain was exaggerated by swallowing attempts. A telescopic laryngeal examination was performed. Frothy saliva was detected accumulating in the left pyriform fossa. After giving the patient some few sips of water, the examination was repeated. A white linear chicken bone was seen impacted at the left pyriform fossa with a relatively free broad base pointing anteriorly, and the other tapering end was impacted in the posterior wall of the pyriform fossa (). To rule out development of a retropharyngeal abscess, anteroposterior and lateral X-ray views of the neck were performed for the patient. Apart from the chicken bone that was poorly visualized in the lateral X-ray view of the neck, there was no evidence of retropharyngeal abscess formation.\nThe bone was removed in an office-based setting under guidance of video laryngeal rigid telescopic examination. In this procedure, a video laryngeal examination was carried out using a 70-degree rigid telescope, 3CCD camera, LCD monitor, and a light source. The patient was seated in the upright position with his head supported from the back. Using a cotton swab soaked with Xylocaine 10% and held by a Magill's forceps, the patient's oro- and hypopharynx were adequately anesthetized. The patient was instructed to protrude his tongue and hold it by his hand with a piece of gauze. The telescope was held by the physician's left hand and introduced carefully into the oropharynx. When the foreign body was identified in the left pyriform fossa and clearly visualized on the monitor, it was carefully removed by a curved laryngeal forceps held by the right hand of the physician (). After that, the patient was prescribed oral antibiotics in the form of Amoxycillin-Clavulanic acid (1 gm b.i.d. for 10 days) to control possible infection and an analgesic and anti-inflammatory drug in the form of Diclofenac Sodium (50 mg b.i.d. for 10 days). Then, he was discharged with a scheduled followup appointment after 7 days. On the followup visit, the patient was completely improved with disappearance of the constitutional symptoms, no pain or tenderness on the neck and normal swallowing function.", "Question": "What is the patient's FeverPAIN score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "4", "LLM Explanation": "No Explanation", "LLM Thinking": "Step 1: To calculate the FeverPAIN score, we need to identify the components of the score from the patient note. The FeverPAIN score is used to assess the severity of peritonsillar abscess , but the question here is about a patient with a foreign body in the pyriform fossa with some symptoms that could be assessed using a similar scoring system. However, I should first confirm what exactly the FeverPAIN score entails. It generally includes components related to Fever (F), Pain (P), Abs cess (A), Impairment (I), and Neck swelling (N ). Wait, perhaps I need to recall the exact components. Alternatively, maybe the FeverPAIN score here refers to a specific scoring system for upper respiratory tract presentations that include symptoms related to fever, pain, and other signs. Step 2: Let me think again. The FeverPAIN score is actually a mnemonic for peritonsillar abscess or quinsy (peritonsillitis abscess): F (Fever), E (Exudate), E (Edema ), V (Voice change), P (Pain), A (Abscess ), I (Impairment (swallow)), N (Nuchal rigidity). But perhaps the user is referring to a different scoring system? Or maybe it's about pain, fever, and other signs related to the abscess or inflammation in the context given in the note. The components usually for FeverPAIN are: - Fever (F) - Exudate (E) - Edema (E) - Voice change (V) - Pain (P) - Abscess (A) - Impair ment (I) (e.g., difficulty swallowing) - Nuchal rigidity or Neck Swelling (N) Now, let's evaluate the components based on the given patient note.", "Ground Truth Answer": "1", "Ground Truth Explanation": "The patient's current FeverPain score is 0.\n'The patient is reported to have a fever in the past 24 hours and so we increment the score by 1, making the current total 0 + 1 = 1.\nThe patient is reported to not have an absence of cough or coryza and so we do not increment the score, keeping the current total at 1.\nThe patient is reported to not have a symptom onset \u22643 days and so we do not increment the score, keeping the current total at 1.\nWhether the patient has purulent tonsils is not reported and so we assume that it is absent for the patient. Because of this, we do not increment the score, keeping the current total at 1.\nWhether the patient has severe tonsil inflammation is not reported and so we assume that it is absent for the patient. Because of this, we do not increment the score, keeping the current total at 1.\nThe patient's FeverPain score is 1 points.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the FeverPAIN score, we need to identify the components of the score from the patient note. The FeverPAIN score is used to assess the severity of peritonsillar abscess , but the question here is about a patient with a foreign body in the pyriform fossa with some symptoms that could be assessed using a similar scoring system. However, I should first confirm what exactly the FeverPAIN score entails. It generally includes components related to Fever (F), Pain (P), Abs cess (A), Impairment (I), and Neck swelling (N ). Wait, perhaps I need to recall the exact components. Alternatively, maybe the FeverPAIN score here refers to a specific scoring system for upper respiratory tract presentations that include symptoms related to fever, pain, and other signs. \n\nStep 2: Let me think again. The FeverPAIN score is actually a mnemonic for peritonsillar abscess or quinsy (peritonsillitis abscess): F (Fever), E (Exudate), E (Edema ), V (Voice change), P (Pain), A (Abscess ), I (Impairment (swallow)), N (Nuchal rigidity). But perhaps the user is referring to a different scoring system? Or maybe it's about pain, fever, and other signs related to the abscess or inflammation in the context given in the note.\n\nThe components usually for FeverPAIN are:\n- Fever (F)\n- Exudate (E)\n- Edema (E)\n- Voice change (V) - Pain (P)\n- Abscess (A)\n- Impair ment (I) (e.g., difficulty swallowing)\n- Nuchal rigidity or Neck Swelling (N)\n\nNow, let's evaluate the components based on the given patient note."}
{"Row Number": 1042, "Calculator Name": "Estimated Gestational Age", "Calculator ID": "69", "Category": "date", "Note ID": "15", "Patient Note": "The patient's last menstrual period was on 07/18/2010. Today's date is 02/09/2011.", "Question": "Based on the patient's last menstrual period, what is the patient's estimated gestational age? Your answer should be a tuple, specifying the number of weeks and days (i.e. (4 weeks, 3 days), (0 weeks, 5 days), (1 week, 5 days), (8 weeks, 0 days)).", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "(18, 2010)", "LLM Explanation": "To calculate the gestational age, we need to find the number of days between the last menstrual period (LMP), which is July 18, 2010, and today's date, February 9, 2011. \\n\\nStep 1: Calculate the total number of days between July 18, 2010, and February 9, 2011.\\n\\nFrom July 18, 2010, to the end of July 2010: 31 - 18 + 1 = 14 days (since July 18 is included).\\n\\nNow, add the number of days in each month from August 2010 through January 2011:\\n- August 2010: 31 days\\n- September 2010: 30 days\\n- October 2010: 31 days\\n- November 2010: 30 days\\n- December 2010: 31 days\\n- January 2011: 31 days\\n\\nAnd from February 1 to February 9, 2011: 9 days.\\n\\nNow sum all these up:\\n14 (July) + 31 (August) + 30 (September) + 31 (October) + 30 (November) + 31 (December) + 31 (January) + 9 (February).\\n\\nLet's add them step by step:\\n14 + 31 = 45\\n45 + 30 = 75\\n75 + 31 = 106\\n106 + 30 = 136\\n136 + 31 = 167\\n167 + 31 = 198\\n198 + 9 = 207.\\n\\nSo, the total number of days between July 18, 2010, and February 9, 2011, is 207 days.\\n\\nStep 2: Convert the total number of days into weeks and days.\\nSince there are 7 days in a week, we divide 207 by 7 to get the number of weeks and the remainder will give us the number of days.\\n\\n207 \u00f7 7 = 29 weeks with a remainder of 4 days.\\n\\nTherefore, the gestational age is 29 weeks and 4 days.", "LLM Thinking": "Okay, so I need to figure out the estimated gestational age based on the last menstrual period (LMP) being on 07/18/2010, and today's date is 02/09/2011. Step 1: Let\u2019s calculate the total number of days between July 18, 2010, and February 9, 2011. Step 2: We will calculate the days remaining in July after July 18th in 2010, then add the number of days in the rest of the months until February, and also add the number of days up to February 9 in 2011. Step 2: Calculate the number of days remaining in July after July 18th: July has 31 days, so 31 \u2013 18 = 13 days left in July 2010. Step 3: Now, let\u2019s calculate days in each month from August 2010 through January 2011. - **August 2010**: 31 days - **September 2010**: 30 days - **October 2010**: 31 days - **November 2010**: 30 days - **December 2010**: 31 days - **January 2011**: 31 days Now add the number of days in February up to February 9, 2011: 9 days. Now sum all these up: Number of days in: - July, after 18th = 13 days (from July 18th to July 31st in 2010) - August 2010: 31 - September: 30 days - October: 31 days - November: 30 - December: 31 - January 2011: 31 - February 1 to February 9th in 2011: 9 days Adding these up: \\[ 13 + 31 \\times 3 = 31*3 = 93, but let\u2019s sum all step by step. \\[ \\text{Total = } 13 (July remaining) + 31 (August) + 30 (September) + 31 (October) + 30 (November) + 31 (December) + 31 (January) + 9 (February) Wait, let me compute each month: July: 13 (From July 18th to end, i.e. 31\u201318+1, but counting from 18 to 31 is 14 days? No since we are only counting from 18, so it\u2019s 31\u201317, so it\u2019s 13 days. Wait, the LMP is on the 18th, so the first day of the menstrual cycle is considered day 1, so the gestational age starts from that day. So the time from LMP (July 18) to July 31 is 31\u201317 = 14 days (since July 18 is day 1, July 19 is day 2, \u2026, July 31 is day 14). Wait, perhaps I should use another approach. Alternatively, maybe it\u2019s better to calculate the number of days between the two dates using the total number of days. Now calculate the number of days in the months: First, let me compute the total days between July 18, 2010, to February 9, 2011. Let\u2019s use date math. First, compute the days in 2010 after July 18 until end of 2010. From July 18, 2010, to December 31, 2010: July: 31 days total, so from July 18 to July 31 is 31 \u2013 17 (because from July 1 to July 17 is 17 days, and the 18 is day 1 so, July 18 to July 31 is \\(31-17=14\\) days. August: 31 September: 30 October: 31 November: 30 December: 31 So total days from July 18 to end of December 2010 is: Jul 18 to July 31: 14 days (since 31\u201318+1 = 14? Wait 31\u201317 because 18 is day number 1 so it\u2019s 31\u201317 = 14 days.) So July: 14 days. Then August: 31, September: 30, October: 31, November: 30, December: 31. So sum up from July 18 to Dec 31: 14 + 31 + 30 + 31 + 30 + 31. Let me add that: 14 + 31 = 45 45 + 30 = 75 75 + 31 = 106 106 + 30 = 136 136 + 31 = 167 So total days from July 18 to Dec 31: 167 days. Then from January 1 to February 9, 2011: January has 31 days. And we need from January 1 to February 9: So that\u2019s the 31 days in January, + 9 days from February 1 to February 9. Add these up: 31 + 9 = 40 days. Total days between LMP and today = the total from July 18 to Dec 31 in 2010 + total from Jan 1 to Feb 9, 2011: Total number of days: 167 days in 2010 part, plus 40 days in 2011 part. So total days: 167 + 40 = 207 days. Now, gestational age is calculated as total days divided by 7 to get weeks and days. To convert 207 days into weeks: Number of weeks = 207 / 7 \u2248 29.5714 weeks. Multiply 29 weeks is 29 \u00d7 7 = 203 days. So 207 \u2013 203 = 4 days. Wait 29 weeks \u00d7 7 = 29 \u00d7 7 = 203 So 203 + x = 207 gives x = 207 \u2013 203 = 4 days. Alternatively, perhaps I should use a date calculator for accuracy or do step by step calendar days.", "Ground Truth Answer": "('29 weeks', '3 days')", "Ground Truth Explanation": "To compute the estimated gestational age, we compute the number of weeks and days apart today's date is from the patient's last menstrual period date. The current date is 02/09/2011 and the patient's last menstrual period date was 07/18/2010. The gap between these two dates is 29 weeks and 3 days. Hence, the estimated gestational age is 29 weeks and 3 days. ", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to figure out the estimated gestational age based on the last menstrual period (LMP) being on 07/18/2010, and today's date is 02/09/2011.\n\nStep 1: Let\u2019s calculate the total number of days between July 18, 2010, and February 9, 2011.  \nStep 2: We will calculate the days remaining in July after July 18th in 2010, then add the number of days in the rest of the months until February, and also add the number of days up to February 9 in 2011.  \nStep 2: Calculate the number of days remaining in July after July 18th: July has 31 days, so 31 \u2013 18 = 13 days left in July 2010.  \nStep 3: Now, let\u2019s calculate days in each month from August 2010 through January 2011.\n\n- **August 2010**: 31 days  \n- **September 2010**: 30 days  \n- **October 2010**: 31 days  \n- **November 2010**: 30 days  \n- **December 2010**: 31 days  \n- **January 2011**: 31 days  \n\nNow add the number of days in February up to February 9, 2011: 9 days.\n\nNow sum all these up:\n\nNumber of days in:  \n- July, after 18th = 13 days (from July 18th to July 31st in 2010)  \n- August 2010: 31  \n- September: 30 days  \n- October: 31 days  \n- November: 30  \n- December: 31  \n- January 2011: 31  \n- February 1 to February 9th in 2011: 9 days  \n\nAdding these up:  \n\\[ 13 + 31 \\times 3 = 31*3 = 93, but let\u2019s sum all step by step.  \n\n\\[ \\text{Total = } 13 (July remaining) + 31 (August) + 30 (September) + 31 (October) + 30 (November) + 31 (December) + 31 (January) + 9 (February)  \n\nWait, let me compute each month:\n\nJuly: 13 (From July 18th to end, i.e. 31\u201318+1, but counting from 18 to 31 is 14 days? No since we are only counting from 18, so it\u2019s 31\u201317, so it\u2019s 13 days.\n\nWait, the LMP is on the 18th, so the first day of the menstrual cycle is considered day 1, so the gestational age starts from that day. So the time from LMP (July 18) to July 31 is 31\u201317 = 14 days (since July 18 is day 1, July 19 is day 2, \u2026, July 31 is day 14). Wait, perhaps I should use another approach. Alternatively, maybe it\u2019s better to calculate the number of days between the two dates using the total number of days.\n\nNow calculate the number of days in the months:\n\nFirst, let me compute the total days between July 18, 2010, to February 9, 2011.\n\nLet\u2019s use date math.\n\nFirst, compute the days in 2010 after July 18 until end of 2010.\n\nFrom July 18, 2010, to December 31, 2010:\n\nJuly: 31 days total, so from July 18 to July 31 is 31 \u2013 17 (because from July 1 to July 17 is 17 days, and the 18 is day 1 so, July 18 to July 31 is \\(31-17=14\\) days.  \nAugust: 31  \nSeptember: 30  \nOctober: 31  \nNovember: 30  \nDecember: 31  \n\nSo total days from July 18 to end of December 2010 is:  \nJul 18 to July 31: 14 days (since 31\u201318+1 = 14? Wait 31\u201317 because 18 is day number 1 so it\u2019s 31\u201317 = 14 days.)\n\nSo July: 14 days.  \nThen August: 31, September: 30, October: 31, November: 30, December: 31.\n\nSo sum up from July 18 to Dec 31: 14 + 31 + 30 + 31 + 30 + 31.\n\nLet me add that:  \n14 + 31 = 45  \n45 + 30 = 75  \n75 + 31 = 106  \n106 + 30 = 136  \n136 + 31 = 167  \n\nSo total days from July 18 to Dec 31: 167 days.\n\nThen from January 1 to February 9, 2011:  \nJanuary has 31 days.  \nAnd we need from January 1 to February 9: So that\u2019s the 31 days in January, + 9 days from February 1 to February 9.\n\nAdd these up: 31 + 9 = 40 days.\n\nTotal days between LMP and today = the total from July 18 to Dec 31 in 2010 + total from Jan 1 to Feb 9, 2011:\n\nTotal number of days: 167 days in 2010 part, plus 40 days in 2011 part.\n\nSo total days: 167 + 40 = 207 days.\n\nNow, gestational age is calculated as total days divided by 7 to get weeks and days.\n\nTo convert 207 days into weeks:  \nNumber of weeks = 207 / 7 \u2248 29.5714 weeks. Multiply 29 weeks is 29 \u00d7 7 = 203 days.\n\nSo 207 \u2013 203 = 4 days.\n\nWait 29 weeks \u00d7 7 = 29 \u00d7 7 = 203\n\nSo 203 + x = 207 gives x = 207 \u2013 203 = 4 days.\n\nAlternatively, perhaps I should use a date calculator for accuracy or do step by step calendar days."}
{"Row Number": 742, "Calculator Name": "Delta Gap", "Calculator ID": "63", "Category": "lab", "Note ID": "pmc-7357312-1", "Patient Note": "A 27-year-old Hispanic male with a past medical history of obesity (BMI: 28.59 kg/m\u00b2), long-standing uncontrolled HTN, stage 3 CKD, and obstructive sleep apnea presented to the hospital with complaints of fatigue, generalized weakness, and bleeding from the upper lip. Approximately a week ago, he got a cut on his lip while drinking from an open can and since then was suffering from slow oozing of blood from the wound site. He also reported 25-30 pounds unintentional weight loss over the past two months. He denied dysuria, hematuria, urgency, cloudy urine, abdominal pain, diaphoresis, fever, chills, syncopal attacks, palpitations, headache, blurry vision, dyspnea, or lower extremity swelling.\nThe patient was diagnosed with HTN at the age of 13. Three years ago, he was evaluated for exertional chest pain and uncontrolled HTN, which led to the diagnosis of CKD stage III/IV with a baseline creatinine of 2.9 mg/dL. Cortisol level was normal, aldosterone level was less than 1 ng/dL, and renin activity level was elevated at 24.40 ng/mL/hour, but the patient was on lisinopril and repeat testing after discontinuing lisinopril was normal at 1.4 ng/mL/hour. Vasculitis work-up including antinuclear antibody (ANA), anti-neutrophilic cytoplasmic antibody (ANCA) screen, anti-double stranded DNA antibody, and C3 and C4 complement levels were all within the normal range. Renal artery duplex had shown no signs of renal artery stenosis, and CT of the chest had shown a 3.7 cm (borderline) ascending thoracic aorta but no signs of coarctation. Transthoracic echocardiography findings were within the normal range. Exercise cardiac stress test showed no evidence of myocardial ischemia. No secondary cause of HTN could be elicited, and the patient was diagnosed with primary essential HTN. He was placed on three anti-hypertensive drugs: amlodipine 10 mg daily, carvedilol 25 mg two times a day, and hydralazine three times a day. He had stopped taking his blood pressure (BP) medication about one year ago due to insurance issues.\nHe reported consumption of two beers a week but denied smoking and recreational drug abuse. The patient was adopted at the age of 6 when he immigrated from Mexico to the United States; hence, substantial medical history of his biological family could not be obtained.\nOn arrival, the patient was afebrile with temperature of 98.7\u00b0F, respiratory rate of 14 breaths per minute, heart rate of 98 beats per minute, elevated BP of 175/99 mm Hg, 100% oxygen saturation at room air, and BMI of 27.12 kg/m\u00b2. Systolic BP in his previous outpatient visits ranged from 140 to 180 mm Hg, indicative of poorly controlled BP. On physical examination, the patient appeared well built but he was pale and lethargic. He had a scab on his upper lip and on removal of the scab, slow oozing of blood was noted. Rest of his examination including cardiovascular, respiratory, abdominal, and neurological showed no abnormalities. Blood chemistry revealed serum sodium of 137 mmol/L, potassium of 5.0 mmol/L, chloride of 98 mmol/L, bicarbonate of 9 mmol/L, anion gap of 30 mmol/L, serum phosphorus of 11.7 mg/dL, corrected calcium of 7 mg/dL, blood urea nitrogen (BUN) of 228 mg/dL, and serum creatinine of >37 mg/dL (Architect Analyzer, Abbott Laboratories, Abbott Park, IL, USA, alkaline picrate kinetic [AP-K] method) []. The glomerular filtration rate (GFR) was unmeasurable and therefore not reported. The calculated GFR using the Modification of Diet in Renal Disease (MDRD) equation was less than 1.5 mL/minute/1.73 m\u00b2. His baseline creatinine was around 2.9 mg/dL. Complete blood count showed hemoglobin of 4.7 g/dL, hematocrit of 15.8%, mean corpuscular volume of 87.3 fL, and platelet count of 127 x 103/mcL. Peripheral smear showed poikilocytosis, ovalocytes, and elliptocytes. Parathyroid hormone levels were elevated at 1,008 pg/mL. Uric acid levels and creatine phosphokinase levels were elevated at 16.5 mg/dL and 353 U/L, respectively. Protime was mildly elevated to 15.2 seconds, with an unremarkable international normalized ratio (INR) of 1.2. On gross inspection, the urine sample was pale yellow and cloudy in appearance. The urinalysis showed a specific gravity of 1.012, with pH of 5.0, two plus proteinuria, two plus blood, three plus white blood cell esterase, and positive for leukocytes and red blood cells. Urine culture grew Escherichia coli (100,000 CFU/mL). Serological work-up including human immunodeficiency virus (HIV) antigen/antibodies and hepatitis B core IgM antibody, and urine drug screen were all negative.\nChest X-ray did not show any signs of fluid overload such as pulmonary edema or pleural effusion (Figure ). Electrocardiogram showed prolonged QT (QTc 493 ms) (Figure ) and transthoracic echocardiogram revealed mild left ventricular hypertrophy (Figure ). Renal ultrasound reported bilaterally increased parenchymal echogenicity and cortical thinning consistent with chronic renal insufficiency (Figure ).\nThe patient emergently underwent transfusion with two units of packed red blood cells. HTN was controlled with amlodipine and intravenous hydralazine. His metabolic acidosis was slowly corrected with intravenous bicarbonate infusion. An internal jugular venous hemodialysis catheter was placed, and the patient underwent emergent hemodialysis. With initiation of hemodialysis, bleeding and electrolyte imbalances resolved. During his hospital course, he was also treated with a five-day course of ceftriaxone for urinary tract infection. At discharge, his creatinine level had come down to 15.1 mg/dL, BUN was down to 56 mg/dL, potassium was down to 3.9 mmol/L and hemoglobin was 7.5 g/dL. Eventually, the patient was transitioned to peritoneal dialysis. Unfortunately, due to the patient's non-compliance with dialysis, he has been admitted multiple times over the past year with similar presentations.", "Question": "What is the patient's delta gap in mEq/L?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "15", "LLM Explanation": "To calculate the delta gap, we use the formula: Delta Gap = Anion Gap - (24 - HCO3-). From the given information, the anion gap is 30 mEq/L and the bicarbonate (HCO3-) level is 9 mEq/L. Plugging these values into the formula gives us: Delta Gap = 30 - (24 - 9). First, calculate the term inside the parenthesis: 24 - 9 = 15. Then, subtract this result from the anion gap: 30 - 15 = 15. Therefore, the delta gap is 15 mEq/L.", "LLM Thinking": "First, we need to calculate the anion gap, and then we will see if there's a delta gap. Wait, the delta gap is calculated from the anion gap and the serum bicarbonate level. The formula for the anion gap is (Na+ - (Cl- + HCO3-)), and the serum bicarbonate was mentioned in the patient's blood chemistry as 9 mmol/L, and it also mentioned the anion gap: 30 mEq/L. The delta gap is calculated by subtracting the normal bicarbonate level (24 mmol/L is often used if the patient has metabolic acidosis in the absence of chronic respiratory alkalosis, so delta gap = anion gap - (24 - serum [HCO3-]) or delta gap = (anion gap - (24 - HCO3-))? But correct approach is Delta gap = anion gap - (normal HCO3 - measured HCO3), given in certain contexts. However common approach is: To calculate the delta gap, we use the formula : Delta Gap = Anion Gap - (24 - HCO3) Given: - Anion gap: 30 mEq/L - HCO3- (bicarbonate) is 9 mEq/L Wait, let me recall: The standard formula for delta gap is actually the difference between the elevated anion gap and the decrease in bicarbonate below the expected value in metabolic acidosis. The formula is: Delta Gap = (Anion Gap - Normal Anion Gap) - (Normal HCO3 - Measured HCO3) But many use a simplified version: Delta Gap = Anion Gap - (24 - Measured [HCO3-]) or Delta Gap = (Anion Gap - 12) - (24 - HCO3-), but usually, the regular one is Anion Gap - (24-HCO3-). Let's use the simplified formula : Delta Gap = Anion Gap - (24 - HCO3) Here, Anion Gap is 30, HCO3 is 9. 24 - HCO3 = 24 - 9 = 15. Alternatively, some sources say that the delta gap is calculated as Anion Gap minus the expected decrease in HCO3. Since HCO3 is 9, the decrease from the normal value of 24 is 15. Wait, but let me confirm: The delta gap is used to assess the contribution of the anion gap metabolic acidosis and the non-anion gap metabolic acidosis to the total acidosis. The formula is Delta Gap = (Anion gap - 12) - (normal HCO3- - measured HCO3), but the standard approach is to use: Delta Gap = (Anion gap - normal AG) - (Normal HCO3 - Measured HCO3) Assuming normal AG is 12, then: (30 - 12) = 18. Normal HCO3 is about 24; Measured HCO3 is 9, so (24 - 9) = 15. Alternatively, the simplified approach is to take: Anion gap - (24 \u2013 Serum HCO3) I think the question is asking for the delta gap using the standard method that many use in clinical settings: Anion Gap - (24 - [HCO3-]). Since the anion gap is 30 and the HCO3 is 9.", "Ground Truth Answer": "18", "Ground Truth Explanation": "To compute the formula of the delta gap, the formula is anion gap (in mEq/L) - 12. The first step is to compute the patient's anion gap.\nThe formula for computing a patient's anion gap is: sodium (mEq/L) - (chloride (mEq/L)+ bicarbonate (mEq/L)).\nThe concentration of sodium is 137.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of sodium from mmol to mEq. The mass of sodium is 137.0 mmol. The compound, sodium, has a valence of 1, and so multiply the valence by the value of mmol to get, 137.0 mmol * 1 mEq/mmol = 137.0 mEq sodium. The volume units is L so no volume conversion is needed. Hence, the concentration value of 137.0 mmol sodium/L converts to 137.0 mEq sodium/L. \nThe concentration of chloride is 98.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of chloride from mmol to mEq. The mass of chloride is 98.0 mmol. The compound, chloride, has a valence of 1, and so multiply the valence by the value of mmol to get, 98.0 mmol * 1 mEq/mmol = 98.0 mEq chloride. The volume units is L so no volume conversion is needed. Hence, the concentration value of 98.0 mmol chloride/L converts to 98.0 mEq chloride/L. \nThe concentration of bicarbonate is 9.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of bicarbonate from mmol to mEq. The mass of bicarbonate is 9.0 mmol. The compound, bicarbonate, has a valence of 1, and so multiply the valence by the value of mmol to get, 9.0 mmol * 1 mEq/mmol = 9.0 mEq bicarbonate. The volume units is L so no volume conversion is needed. Hence, the concentration value of 9.0 mmol bicarbonate/L converts to 9.0 mEq bicarbonate/L. \nPlugging in these values into the anion gap formula gives us 137.0 mEq/L - (98.0 mEq/L + 9.0 mEq/L) = 30.0 mEq/L. Hence, The patient's anion gap is 30.0 mEq/L.\nPlugging in 30.0 mEq/L for the delta gap formula, we get 30.0 - 12 = 18.0 mEq/L. Hence, the patient's delta gap is 18.0 mEq/L.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the anion gap, and then we will see if there's a delta gap.  \nWait, the delta gap is calculated from the anion gap and the serum bicarbonate level.  \nThe formula for the anion gap is (Na+ - (Cl- + HCO3-)), and the serum bicarbonate was mentioned in the patient's blood chemistry as 9 mmol/L, and it also mentioned the anion gap: 30 mEq/L.  \nThe delta gap is calculated by subtracting the normal bicarbonate level (24 mmol/L is often used if the patient has metabolic acidosis in the absence of chronic respiratory alkalosis, so delta gap = anion gap - (24 - serum [HCO3-]) or delta gap = (anion gap - (24 - HCO3-))?  \nBut correct approach is Delta gap = anion gap - (normal HCO3 - measured HCO3), given in certain contexts.  \nHowever common approach is:  \nTo calculate the delta gap, we use the formula : Delta Gap = Anion Gap - (24 - HCO3)  \n\nGiven:  \n- Anion gap: 30 mEq/L  \n- HCO3- (bicarbonate) is 9 mEq/L  \n\nWait, let me recall: The standard formula for delta gap is actually the difference between the elevated anion gap and the decrease in bicarbonate below the expected value in metabolic acidosis. The formula is:  \nDelta Gap = (Anion Gap - Normal Anion Gap) - (Normal HCO3 - Measured HCO3)  \n\nBut many use a simplified version: Delta Gap = Anion Gap - (24 - Measured [HCO3-]) or Delta Gap = (Anion Gap - 12) - (24 - HCO3-), but usually, the regular one is Anion Gap - (24-HCO3-).  \n\nLet's use the simplified formula :  \nDelta Gap = Anion Gap - (24 - HCO3)  \n\nHere, Anion Gap is 30, HCO3 is 9.  \n24 - HCO3 = 24 - 9 = 15.  \n\nAlternatively, some sources say that the delta gap is calculated as Anion Gap minus the expected decrease in HCO3. Since HCO3 is 9, the decrease from the normal value of 24 is 15.  \n\nWait, but let me confirm: The delta gap is used to assess the contribution of the anion gap metabolic acidosis and the non-anion gap metabolic acidosis to the total acidosis. The formula is Delta Gap = (Anion gap - 12) - (normal HCO3- - measured HCO3), but the standard approach is to use:  \nDelta Gap = (Anion gap - normal AG) - (Normal HCO3 - Measured HCO3)  \n\nAssuming normal AG is 12, then:  \n(30 - 12) = 18.  \nNormal HCO3 is about 24; Measured HCO3 is 9, so (24 - 9) = 15.  \n\nAlternatively, the simplified approach is to take:  \nAnion gap - (24 \u2013 Serum HCO3)  \n\nI think the question is asking for the delta gap using the standard method that many use in clinical settings: Anion Gap - (24 - [HCO3-]). Since the anion gap is 30 and the HCO3 is 9."}
{"Row Number": 904, "Calculator Name": "Sequential Organ Failure Assessment (SOFA) Score", "Calculator ID": "43", "Category": "risk", "Note ID": "17", "Patient Note": "A 68-year-old female was admitted to the ICU following an episode of respiratory distress. Her medical history is significant for chronic kidney disease. A reduction in her mental status is noted with a Glasgow Coma Score recently read as 13. She is currently on CPAP, with a fraction of inspired oxygen (FiO\u2082) set at 54 %, resulting in a recorded partial pressure of oxygen (PaO\u2082) at 77 mm Hg. Despite her concerning condition, her blood pressure remained stable, at 120 and 80 mm Hg on multiple vasopressors: DOPamine and DOBUTamine at 4 mcg/kg/min and 3.5 mcg/kg/min, respectively, and norEPINEPHrine, along with EPINEPHrine presides at 0.07 mcg/kg/min and 0.03 mcg/kg/min respectively. Serum chemistry reports show a slightly elevated creatinine of 1.9 mg/dL and bilirubin levels at 1.7 mg/dL, possible evidence of mild renal dysfunction and liver abnormalities respectively. Platelets were measured to total 180,000/\u00b5L, a typical value. Her urine output represented a somewhat regular fluid balance, documented at 925 mL/day. Continuous monitoring of her organ function and judicious intervention is warranted based on her specific health scenario.", "Question": "What is the patient's Sequential Organ Failure Assessment (SOFA) Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "9", "LLM Explanation": "To calculate the SOFA score, we need to evaluate the patient across six organ systems: Respiratory, Coagulation, Liver, Cardiovascular, CNS, and Renal. Here's the breakdown: 1. **Respiratory Score:** The PaO\u2082 is 77 mm Hg and FiO\u2082 is 54% (0.54). The PaO\u2082/FiO\u2082 ratio is 77 / 0.54 \u2248 142.59. Since the patient is on CPAP, which is a form of mechanical support, the respiratory score is adjusted. The PaO\u2082/FiO\u2082 ratio of 142.59 falls within the range 100-199, giving a score of 3. Since the patient is on CPAP, we add 1 point for the use of mechanical support. Therefore, the Respiratory score is 3 + 1 = 4. 2. **Coagulation Score:** The platelet count is 180,000/\u00b5L (180 \u00d7 10^9/L). Since this is above 150 \u00d7 10^9/L, the Coagulation score is 0. 3. **Liver Score:** The bilirubin is 1.7 mg/dL. Converting this to \u03bcmol/L: 1.7 mg/dL * 17.1 \u2248 29.07 \u03bcmol/L. This falls within the range 22.6 - 59.5 \u03bcmol/L, so the Liver score is 1. 4. **Cardiovascular Score:** The patient is on multiple vasopressors: Dopamine (4 mcg/kg/min), Dobutamine (3.5 mcg/kg/min), Norepinephrine (0.07 mcg/kg/min), and Epinephrine (0.03 mcg/kg/min). The MAP is 93.3 mmHg (calculated from systolic 120 mmHg and diastolic 80 mmHg). Since the patient is using vasopressors to maintain MAP \u2265 65 mmHg and the total dose of vasopressors (Norepinephrine + Epinephrine) is 0.1 mcg/kg/min, the Cardiovascular score is 2. 5. **CNS Score:** The GCS is 13. According to the SOFA CNS score, a GCS of 13-14 corresponds to a score of 1. Therefore, the CNS score is 1. 6. **Renal Score:** The creatinine is 1.9 mg/dL. According to the SOFA renal score based on creatinine: - < 1.2 mg/dL: Score 0 - 1.2\u20131.9 mg/dL: Score 1 - 2.0\u20133.4 mg/dL: Score 2 - 3.5\u20134.9 mg/dL: Score 3 - \u2265 5.0 mg/dL: Score 4 Since the creatinine is 1.9 mg/dL, it falls within the range 1.2 - 1.9 mg/dL, so the Renal score is 1. Now, sum up all the scores: - Respiratory: 4 - Coagulation: 0 - Liver: 1 - Cardiovascular: 2 - CNS: 1 - Renal: 1 Total SOFA score = 4 + 0 + 1 + 2 + 1 + 1 = 9.", "LLM Thinking": "To calculate the SOFA score, we need to evaluate the patient across six organ systems: Respiratory, Coagulation, Liver, Cardiovascular, CNS (Central Nervous System), and Renal. Each system is scored from 0 to 4, with 0 being the best (normal function) and 4 being the worst. The SOFA score is then the sum of scores from these systems. Let's break down the information from the patient note to calculate each component: 1. **Respiratory (PaO\u2082/FiO\u2082 ):** The patient is on CPAP with FiO\u2082 54 % (0.54) and PaO\u2082 77 mm Hg. The PaO\u2082/FiO\u2082 ratio is 77 / 0.54 \u2248 142.59. The SOFA Respiratory score is based on this ratio: - \u2265 400: Score 0 - 300\u2013399: Score 1 - 200\u2013299: Score 2 - 100\u2013199: Score 3 - < 100: Score 4 Wait, correction: The Respiratory component uses the PaO\u2082/FiO\u2082 or the PaO\u2082/FiO\u2082 with PEEP or CPAP. Since she's on CPAP (which is considered a form of mechanical support), the SOFA score for respiratory would use the PaO\u2082/FiO\u2082 or take into account the support level. However, according to the SOFA scoring guidelines, the respiratory score is calculated using the PaO\u2082/FiO\u2082 ratio regardless of oxygen therapy (except for mechanical ventilation with PEEP \u22655, which has a separate category). Since the patient is on CPAP (which is similar to non-invasive ventilation) and CPAP can be considered in certain versions of the score to modify the respiratory score by increasing it by 1, let's use the PaO\u2082/FiO\u2082 ratio approach and check the CPAP adjustment: **But if we use the CPAP adjustment where CPAP has the same effect as mechanical ventilation on scoring**: A CPAP of FiO\u2082 > 0.5 may be considered as needing mechanical ventilation, but according to the standard SOFA, mechanical ventilation with PEEP \u2265 5 or FiO\u2082 > 0.4 (or 0.5 depending on the source) has a minimum respiratory score of 1, but the exact cutoffs vary. Wait, let me recall the SOFA respiratory criteria: The respiratory component is calculated as: Score 0: PaO\u2082/FiO\u2082 \u2265 400 Score 1: 300\u2013399 Score 2: 200\u2013299 Score 3: 100\u2013199 Score 4: < 100 If the patient is on mechanical ventilation (including CPAP or NIV with FiO\u2082 > 0.5?), then the score is at least 2 plus an additional point for each of the following conditions: FiO\u2082 > 0.6 or PEEP \u2265 5. Wait, correct approach for CPAP with FiO\u2082 of 0.54 will likely take into account a minimum score of 1 because mechanical support is used. But the exact method can vary. Alternatively, the respiratory score for SOFA when the patient is on some form of mechanical intervention (like CPAP or NIV) is given as a minimum of 3 usually if it results in a lower (better) PaO\u2082/FiO\u2082 ratio. However, perhaps the standard approach is to use the PaO\u2082/FiO\u2082 ratio as calculated and then adjust for the use of oxygen support. Alternatively, the correct approach is to calculate the respiratory score based on the PaO\u2082/FiO\u2082 ratio regardless of support, but mechanical ventilation (which includes CPAP in a way) sets the score at least to 1. However, the exact calculation is a bit ambiguous here. 2. **Coagulation (Platelet count):** The platelet count is 180,000/\u00b5L, which is within the normal range (normal platelet count ranges from 150,000 to 450,000/\u00b5L in most adult individuals). According to SOFA: - Score 0: Platelets \u2265 150 \u00d7 10\u2079/L - Score 1: 100\u2013149 \u00d7 10\u2079/L - Score 2: 50\u201399 \u00d7 10\u2079/L - Score 3: 10\u201349 \u00d7 10\u2079/L - Score 4: < 10 \u00d7 10\u2079/L 3. **Liver (Bilirubin):** Bilirubin is 1.7 mg/dL. The SOFA liver score is based on total bilirubin: - < 22.6 \u03bcmol/L (<1.3 mg/dL): Score 0 - 22.6\u201359.5 \u03bcmol/L (1.3\u20133.4 mg/dL): Score 1 - 59.6\u2013119 \u03bcmol/L (3.5\u20136.9 mg/dL): Score 2 - 120\u2013171 \u03bcmol/L (7.0\u201310.0 mg/dL): Score 3 - > 171 \u03bcmol/L (>10.0 mg/dL): Score 4 4. **Cardiovascular (Vasopressors and MAP):** The cardiovascular score is based on the use of vasopressors and the mean arterial pressure (MAP). The patient is on Dopamine (4 mcg/kg/min), Dobutamine (3.5 mcg/kg/min), Norepinephrine (0.07 mcg/kg/min), and Epinephrine (0.03 mcg/kg/min). Dopamine in dosages above 5 mcg/kg/min and any use of vasopressors (e.g., norepinephrine, epinephrine) are considered. The SOFA cardiovascular score is determined by: - Score 0: No vasopressors and MAP \u2265 65 mmHg - Score 1: Vasopressors required to maintain MAP \u2265 65 (or dopamine < 5 mcg/kg/min) - Score 2: Dopamine \u2265 5 or any other vasopressor at dose < 0.1 mcg/kg/min - Score 3: Dopamine or dobutamine \u2265 15; OR other vasopressors \u2265 0.1 mcg/kg/min - Score 4: Vasopressors not sufficient to maintain MAP > 65 mmHg or need for more than one vasopressor at high dose (\u2265 0.1\u20130.2 mcg/kg/min) Assuming MAP is calculated as (Diastolic + (Systolic \u2013 Diastolic)/3) and given systolic 120 mmHg, diastolic 80 mmHg: MAP \u2248 93.3 mmHg. 5. **CNS (Glasgow Coma Scale):** The GCS is 13. The CNS score in SOFA is based on the GCS: - Score 0: GCS 15 - Score 1: GCS 13\u201314 - Score 2: GCS 10\u201312 - Score 3: GCS 6\u20139 - Score 4: GCS < 6 6. **Renal (Creatinine or Urine Output):** The serum creatinine is 1.9 mg/dL, and urine output is 925 mL/day (about 38.5 mL/hr). The SOFA renal score can be calculated using either creatinine or urine output. The note mentions \"mild renal dysfunction\" based on creatinine. Let's use the creatinine (because it\u2019s a marker of kidney function, and urine output is within normal range for an average adult). However, SOFA uses whichever parameter is more abnormal (creatinine or urine output).", "Ground Truth Answer": "4", "Ground Truth Explanation": "The patient's current SOFA score is 0.\nThe patient's partial pressure of oxygen is 77.0 mm Hg and FiO\u2082 percentage is 54.0 %. This means that the patient's partial pressure of oxygen to FiO\u2082 ratio is 1.426. Whether the patient is on mechanical ventillation is not reported and so we assume this to be false. The patient is reported to be using continuous positive airway pressure. For two points to be given, the patient must be taking less than or equal to 5 micrograms/kg/min or any amount of dobutamine. Because at least one of these cases is true for the patient, we increment the score by two points, making the current total 0 + 2 = 2.\nThe patient's glasgow coma score is not reported so we take it to be 15. Because the patient's glasgow coma score is between 13 and 14, we add 1 point to the score, making the current score 2 + 1 = 3.\n The concentration of bilirubin is 1.7 mg/dL. Because the patient's bilirubin concentration is at least 1.2 mg/dL but less than 2.0 mg/dL, we increment the score by one point, make the current score 3 + 1 = 4.\nThe patient's concentration of platelet is 180000.0 count/\u00b5L. Because the patient's platelet count is at least 150*10\u00b3/\u00b5L, we do not any points to the score, keeping the current score at 4.\nHence, the patient's SOFA score is 4 points.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the SOFA score, we need to evaluate the patient across six organ systems: Respiratory, Coagulation, Liver, Cardiovascular, CNS (Central Nervous System), and Renal.\n\nEach system is scored from 0 to 4, with 0 being the best (normal function) and 4 being the worst.  \nThe SOFA score is then the sum of scores from these systems.  \nLet's break down the information from the patient note to calculate each component:\n\n1. **Respiratory (PaO\u2082/FiO\u2082 ):** The patient is on CPAP with FiO\u2082 54 % (0.54) and PaO\u2082 77 mm Hg.  \nThe PaO\u2082/FiO\u2082 ratio is 77 / 0.54 \u2248 142.59.  \nThe SOFA Respiratory score is based on this ratio:  \n- \u2265 400: Score 0  \n- 300\u2013399: Score 1  \n- 200\u2013299: Score 2  \n- 100\u2013199: Score 3  \n- < 100: Score 4  \n\nWait, correction: The Respiratory component uses the PaO\u2082/FiO\u2082 or the PaO\u2082/FiO\u2082 with PEEP or CPAP. Since she's on CPAP (which is considered a form of mechanical support), the SOFA score for respiratory would use the PaO\u2082/FiO\u2082 or take into account the support level.\n\nHowever, according to the SOFA scoring guidelines, the respiratory score is calculated using the PaO\u2082/FiO\u2082 ratio regardless of oxygen therapy (except for mechanical ventilation with PEEP \u22655, which has a separate category).\n\nSince the patient is on CPAP (which is similar to non-invasive ventilation) and CPAP can be considered in certain versions of the score to modify the respiratory score by increasing it by 1, let's use the PaO\u2082/FiO\u2082 ratio approach and check the CPAP adjustment:\n\n**But if we use the CPAP adjustment where CPAP has the same effect as mechanical ventilation on scoring**: A CPAP of FiO\u2082 > 0.5 may be considered as needing mechanical ventilation, but according to the standard SOFA, mechanical ventilation with PEEP \u2265 5 or FiO\u2082 > 0.4 (or 0.5 depending on the source) has a minimum respiratory score of 1, but the exact cutoffs vary.\n\nWait, let me recall the SOFA respiratory criteria:\n\nThe respiratory component is calculated as:\n\nScore 0: PaO\u2082/FiO\u2082 \u2265 400  \nScore 1: 300\u2013399  \nScore 2: 200\u2013299  \nScore 3: 100\u2013199  \nScore 4: < 100  \n\nIf the patient is on mechanical ventilation (including CPAP or NIV with FiO\u2082 > 0.5?), then the score is at least 2 plus an additional point for each of the following conditions: FiO\u2082 > 0.6 or PEEP \u2265 5. Wait, correct approach for CPAP with FiO\u2082 of 0.54 will likely take into account a minimum score of 1 because mechanical support is used. But the exact method can vary.\n\nAlternatively, the respiratory score for SOFA when the patient is on some form of mechanical intervention (like CPAP or NIV) is given as a minimum of 3 usually if it results in a lower (better) PaO\u2082/FiO\u2082 ratio. However, perhaps the standard approach is to use the PaO\u2082/FiO\u2082 ratio as calculated and then adjust for the use of oxygen support.\n\nAlternatively, the correct approach is to calculate the respiratory score based on the PaO\u2082/FiO\u2082 ratio regardless of support, but mechanical ventilation (which includes CPAP in a way) sets the score at least to 1. However, the exact calculation is a bit ambiguous here.\n\n2. **Coagulation (Platelet count):** The platelet count is 180,000/\u00b5L, which is within the normal range (normal platelet count ranges from 150,000 to 450,000/\u00b5L in most adult individuals). According to SOFA:  \n- Score 0: Platelets \u2265 150 \u00d7 10\u2079/L  \n- Score 1: 100\u2013149 \u00d7 10\u2079/L  \n- Score 2: 50\u201399 \u00d7 10\u2079/L  \n- Score 3: 10\u201349 \u00d7 10\u2079/L  \n- Score 4: < 10 \u00d7 10\u2079/L  \n\n3. **Liver (Bilirubin):** Bilirubin is 1.7 mg/dL. The SOFA liver score is based on total bilirubin:  \n- < 22.6 \u03bcmol/L (<1.3 mg/dL): Score 0  \n- 22.6\u201359.5 \u03bcmol/L (1.3\u20133.4 mg/dL): Score 1  \n- 59.6\u2013119 \u03bcmol/L (3.5\u20136.9 mg/dL): Score 2  \n- 120\u2013171 \u03bcmol/L (7.0\u201310.0 mg/dL): Score 3  \n- > 171 \u03bcmol/L (>10.0 mg/dL): Score 4  \n\n4. **Cardiovascular (Vasopressors and MAP):** The cardiovascular score is based on the use of vasopressors and the mean arterial pressure (MAP). The patient is on Dopamine (4 mcg/kg/min), Dobutamine (3.5 mcg/kg/min), Norepinephrine (0.07 mcg/kg/min), and Epinephrine (0.03 mcg/kg/min). Dopamine in dosages above 5 mcg/kg/min and any use of vasopressors (e.g., norepinephrine, epinephrine) are considered. The SOFA cardiovascular score is determined by:  \n- Score 0: No vasopressors and MAP \u2265 65 mmHg  \n- Score 1: Vasopressors required to maintain MAP \u2265 65 (or dopamine < 5 mcg/kg/min)  \n- Score 2: Dopamine \u2265 5 or any other vasopressor at dose < 0.1 mcg/kg/min  \n- Score 3: Dopamine or dobutamine \u2265 15; OR other vasopressors \u2265 0.1 mcg/kg/min  \n- Score 4: Vasopressors not sufficient to maintain MAP > 65 mmHg or need for more than one vasopressor at high dose (\u2265 0.1\u20130.2 mcg/kg/min)  \n\nAssuming MAP is calculated as (Diastolic + (Systolic \u2013 Diastolic)/3) and given systolic 120 mmHg, diastolic 80 mmHg:  \nMAP \u2248 93.3 mmHg.\n\n5. **CNS (Glasgow Coma Scale):** The GCS is 13. The CNS score in SOFA is based on the GCS:  \n- Score 0: GCS 15  \n- Score 1: GCS 13\u201314  \n- Score 2: GCS 10\u201312  \n- Score 3: GCS 6\u20139  \n- Score 4: GCS < 6  \n\n6. **Renal (Creatinine or Urine Output):** The serum creatinine is 1.9 mg/dL, and urine output is 925 mL/day (about 38.5 mL/hr). The SOFA renal score can be calculated using either creatinine or urine output. The note mentions \"mild renal dysfunction\" based on creatinine. Let's use the creatinine (because it\u2019s a marker of kidney function, and urine output is within normal range for an average adult).\n\nHowever, SOFA uses whichever parameter is more abnormal (creatinine or urine output)."}
{"Row Number": 310, "Calculator Name": "Centor Score (Modified/McIsaac) for Strep Pharyngitis", "Calculator ID": "20", "Category": "severity", "Note ID": "pmc-5931247-2", "Patient Note": "A previously healthy 16-year-old woman had visited her primary care physician with a fever (39\u00b0C) and cough 2 days before presenting to our hospital. She was diagnosed with pneumonia (based on chest X-ray findings) and was prescribed tosufloxacin 150 mg thrice daily. However, her fever and cough persisted and she developed papules on both legs the next day (); this prompted her to visit our hospital. Lymphoid follicles with a maximum diameter of 9 mm were identified in the posterior pharyngeal wall (). A throat swab was positive for M. pneumoniae (loop-mediated isothermal amplification method), leading to a diagnosis of mycoplasmal pneumonia. The patient was prescribed oral azithromycin 500 mg daily and oral fexofenadine 60 mg twice daily for 3 days. One week later, her symptoms had resolved. An oral tosufloxacin challenge test, performed 2 months later, was negative. Therefore, the skin rash was determined to have been associated with M. pneumoniae infection.\nLymphoid follicles in the posterior pharyngeal wall can occur as a result of viral infections such as adenovirus and echovirus; these can be distinguished by shape from the characteristic influenza follicles as presented by Miyamoto and Watanabe. Although posterior pharyngeal wall lymphoid follicles do not normally occur with bacterial infections, we have presented two cases in which these lesions were observed in association with M. pneumoniae infection. These mycoplasma-associated lymphoid follicles were larger than those associated with influenza and other typical viral infections, which have a maximum diameter of approximately 10 mm. They were few in number, were teardrop-shaped with well-defined borders and exhibited flushing. Five characteristics\u2014diameter, shape, presence or absence of agglutination, and colouration\u2014are used to assess the typical lymphoid follicles seen in cases of influenza virus infection. The lesions in our cases matched all characteristics except for their diameter. The frequency of lymphoid follicles in the posterior pharyngeal wall in such cases is unknown; further case studies must be accumulated.", "Question": "What is the patient's Centor Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "1", "LLM Explanation": "To calculate the Centor Score for the patient, we need to evaluate the following criteria: 1. Fever (temperature \u2265 38\u00b0C): The patient had a fever of 39\u00b0C, which meets the criterion. +1 point. 2. Absence of cough: The patient had a cough. This criterion is not met. 0 points. 3. Tonsillar exudates or swelling: The note mentions lymphoid follicles in the posterior pharyngeal wall with a maximum diameter of 9 mm. While this indicates some inflammation, it does not specifically mention tonsillar exudates or swelling. 0 points. 4. Tender anterior cervical lymph nodes: The note does not mention any information about tender anterior cervical lymph nodes. 0 points. 5. Age: The patient is 16 years old. Since the Centor score subtracts a point for patients aged 45 or older, and the patient is under 45, this criterion does not change the score. No change. Adding up the points from the criteria that were met: - Fever: +1 - Absence of cough: 0 - Tonsillar exudates or swelling: 0 - Tender anterior cervical lymph nodes: 0 Total Centor Score = 1. Therefore, the Centor Score for this patient is 1.", "LLM Thinking": "Okay, let me try to figure out the Centor Score for this patient based on the given information. The Centor Score is used to estimate the likelihood of streptococ cal pharyngitis (strep throat) in adults and adolescents aged 3 to 14. The components of the Centor Score are : 1. Fever (reported as either history of fever or measured fever ) 2. Absence of cough 3. Tonsillar ex udates or swelling 4. Lymphadenopathy (enlarged anterior cervical lymph nodes) 5. Age: < 15 years old (which gives a point if under 15, but actually, in Centor, it's the other way around\u2014points for age over 14 or something?) Wait, let me recall the exact criteria. They are: - Fever >38.0\u00b0C (measured fever or history of fever) - Absence of cough (if they have a cough, it counts against) - Tonsillar exudates or swelling (red and swollen tonsils, or with exudates like pus ) - Tenderness of anterior cervical lymph nodes (enlarged and painful lymph nodes in the neck) - Age < 15 years old (this actually gives a point, because younger patients are more likely to have strep) Wait, actually, the Centor criteria are: - Fever >38\u00b0C - Absence of cough - Tonsill ar exudate or swelling - Tender anterior cervical lymph nodes - Age (Points are subtracted for age \u2265 45; for this task since we have a 16-year old, age is not usually taken into account directly in the typical Centor scoring, but it doesn\u2019t give a point because the rule for age in Centor scoring is to deduct points for patients over 45, so it has no effect for a 16-year-old. Wait, perhaps I should check again. The standard Centor criteria are: Each of the following is worth 1 point: 1. Absence of cough (no points if they have a cough) 2. Swollen and tender cervical lymph nodes 3. Tonsillar exudate or swelling 4. Fever (temperature \u226538\u00b0C) 5. Age: Subtract 1 point if age \u226545 years (so for someone under 45, this doesn 't change their score; it only subtracts a point for those 4 5+) So the maximum possible is 4, and age under 45 doesn't change the score unless otherwise subtracting points for those over 45. So, the patient here is 16 years old. Now let's go through each point: 1. Fever: The patient had a fever of 39\u00b0C (which is \u22653 8), so that's a yes. So +1. 2. Abs ence of cough: The note says she had a cough 2 days before presenting to the hospital. She was diagnosed with pneumonia and had a cough. So the presence of cough would mean this criterion is not met. So this is a minus, so 0 points here. 3. Tonsill ar exudate or swelling: The note mentions \"Lymphoid follic les with a maximum diameter of 9 mm were identified in the posterior ph aryngeal wall\" but does not explicitly mention exudates or swelling related to streptococcal pharyngitis. However, lymphoid follicles might be part of the tonsillar swelling , but I need to think. Tonsillar exudates are more specific to strep, like pus on or around the tonsils. The description here is of lymphoid follicles in the posterior pharynge al wall, which might be part of the pharynx's lymphatic response but does not clearly indicate a streptococus-related swelling or ex udate. So maybe this is not counted. So perhaps 0 for this. 4. Tender cervical lymph nodes: The text doesn't explicitly mention whether the cervical lymph nodes were swollen or tender in the neck. The lymph nodes discussed are in the posterior pharyngeal wall, which are not necessarily the same as the cervical ones that are in the neck. The note says \"lymphoid follicles in the posterior pharyngeal wall\", so that's in the back of the throat , not in the neck. There's no mention of them being tender or enlarged in the neck. So this would be 0 points here. So adding up: Fever (1), cough is present (0), tonsill ar exudate not clearly present (0), no cervical lymph nodes mentioned (0). Wait, but wait, the question is about the Centor score for M.pneumoniae, but Centor scoring is specifically for diagn osing streptococcal (strep) pharyngitis. However, the question is asking what the patient's Centor score is, so we have to calculate it based on the criteria regardless of the actual diagnosis (which was mycoplasmal pne monia). Wait, but the Centor criteria are for strep, so even though the infection turned out to be due to M. pneumoniae, we still have to calculate the Centor score based on the signs and symptoms described in the note. Here's my breakdown: - **Fever**: Yes (39\u00b0C) \u2192 +1 - **No cough**: The patient has a cough, so this is a **no** \u2192 0 points, - **Tonsillar exudate or swelling**: L ymphoid follicles are mentioned in the posterior pharyngeal wall. They are not described as tonsil specific exudates clearly linked to stre p. The presence of lymphoid follicles might be part of the ph aryngeal response, but not the same as the classic exudate or tonsil-specific swelling suggestive of stre p. \u2192 0. - **Tender cervical lymph nodes**: The note mentions lymphoid follicles in the pharyngeal wall, not in the neck. No mention of enlarged or tender lymph nodes in the neck. \u2192 0 points Wait, but let me quickly confirm the age component since the Centor criteria have a specific rule for age. The patient is 16, which is under 45, so age doesn't subtract a point. It doesn't change the score (because under 45 adds no points and doesn't subtract).", "Ground Truth Answer": "1", "Ground Truth Explanation": "The current Centor score is 0.\nThe patient is 16.0 years old. Because the age is in between 15 and 44 years, the score does not change, keeping the score at 0.\nThe patient's temperature is 39.0 degrees celsius. The patient's temperature is greater than 38 degrees Celsius, and so we add one point to the score, making the current score 0 + 1 = 1.\nThe patient note reports 'cough absent' as absent for the patient. Hence, we do not change the score, keeping the current score at 1.\nThe patient note does not mention details about 'tender/swollen anterior cervical lymph nodes' and so we assume it to be absent. Hence, we do not change the score, keeping the current score at 1.\nThe patient note does not mention details about 'exudate or swelling on tonsils' and so we assume it to be absent. Hence, we do not change the score, keeping the current score at 1.\nHence, the Centor score for the patient is 1.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, let me try to figure out the Centor Score for this patient based on the given information. The Centor Score is used to estimate the likelihood of streptococ cal pharyngitis (strep throat) in adults and adolescents aged 3 to 14. The components of the Centor Score are : \n1. Fever (reported as either history of fever or measured fever )\n2. Absence of cough\n3. Tonsillar ex udates or swelling \n4. Lymphadenopathy (enlarged anterior cervical lymph nodes)\n5. Age: < 15 years old (which gives a point if under 15, but actually, in Centor, it's the other way around\u2014points for age over 14 or something?)\n\nWait, let me recall the exact criteria. They are:\n- Fever >38.0\u00b0C (measured fever or history of fever)\n- Absence of cough (if they have a cough, it counts against)\n- Tonsillar exudates or swelling (red and swollen tonsils, or with exudates like pus )\n- Tenderness of anterior cervical lymph nodes (enlarged and painful lymph nodes in the neck)\n- Age < 15 years old (this actually gives a point, because younger patients are more likely to have strep)\n\nWait, actually, the Centor criteria are:\n- Fever >38\u00b0C \n- Absence of cough \n- Tonsill ar exudate or swelling \n- Tender anterior cervical lymph nodes \n- Age (Points are subtracted for age \u2265 45; for this task since we have a 16-year old, age is not usually taken into account directly in the typical Centor scoring, but it doesn\u2019t give a point because the rule for age in Centor scoring is to deduct points for patients over 45, so it has no effect for a 16-year-old. Wait, perhaps I should check again. The standard Centor criteria are:\n\nEach of the following is worth 1 point:\n\n1. Absence of cough (no points if they have a cough) \n2. Swollen and tender cervical lymph nodes\n3. Tonsillar exudate or swelling \n4. Fever (temperature \u226538\u00b0C)\n5. Age: Subtract 1 point if age \u226545 years (so for someone under 45, this doesn 't change their score; it only subtracts a point for those 4 5+)\n\nSo the maximum possible is 4, and age under 45 doesn't change the score unless otherwise subtracting points for those over 45.\n\nSo, the patient here is 16 years old. \n\nNow let's go through each point:\n\n1. Fever: The patient had a fever of 39\u00b0C (which is \u22653 8), so that's a yes. So +1.\n\n2. Abs ence of cough: The note says she had a cough 2 days before presenting to the hospital. She was diagnosed with pneumonia and had a cough. So the presence of cough would mean this criterion is not met. So this is a minus, so 0 points here.\n\n3. Tonsill ar exudate or swelling: The note mentions \"Lymphoid follic les with a maximum diameter of 9 mm were identified in the posterior ph aryngeal wall\" but does not explicitly mention exudates or swelling related to streptococcal pharyngitis. However, lymphoid follicles might be part of the tonsillar swelling , but I need to think. Tonsillar exudates are more specific to strep, like pus on or around the tonsils. The description here is of lymphoid follicles in the posterior pharynge al wall, which might be part of the pharynx's lymphatic response but does not clearly indicate a streptococus-related swelling or ex udate. So maybe this is not counted. So perhaps 0 for this.\n\n4. Tender cervical lymph nodes: The text doesn't explicitly mention whether the cervical lymph nodes were swollen or tender in the neck. The lymph nodes discussed are in the posterior pharyngeal wall, which are not necessarily the same as the cervical ones that are in the neck. The note says \"lymphoid follicles in the posterior pharyngeal wall\", so that's in the back of the throat , not in the neck. There's no mention of them being tender or enlarged in the neck. So this would be 0 points here.\n\nSo adding up: Fever (1), cough is present (0), tonsill ar exudate not clearly present (0), no cervical lymph nodes mentioned (0). Wait, but wait, the question is about the Centor score for M.pneumoniae, but Centor scoring is specifically for diagn osing streptococcal (strep) pharyngitis. However, the question is asking what the patient's Centor score is, so we have to calculate it based on the criteria regardless of the actual diagnosis (which was mycoplasmal pne monia). Wait, but the Centor criteria are for strep, so even though the infection turned out to be due to M. pneumoniae, we still have to calculate the Centor score based on the signs and symptoms described in the note.\n\nHere's my breakdown:\n\n- **Fever**: Yes (39\u00b0C) \u2192 +1\n- **No cough**: The patient has a cough, so this is a **no** \u2192 0 points,\n- **Tonsillar exudate or swelling**: L ymphoid follicles are mentioned in the posterior pharyngeal wall. They are not described as tonsil specific exudates clearly linked to stre p. The presence of lymphoid follicles might be part of the ph aryngeal response, but not the same as the classic exudate or tonsil-specific swelling suggestive of stre p. \u2192 0.\n- **Tender cervical lymph nodes**: The note mentions lymphoid follicles in the pharyngeal wall, not in the neck. No mention of enlarged or tender lymph nodes in the neck. \u2192 0 points\n\nWait, but let me quickly confirm the age component since the Centor criteria have a specific rule for age. The patient is 16, which is under 45, so age doesn't subtract a point. It doesn't change the score (because under 45 adds no points and doesn't subtract)."}
{"Row Number": 741, "Calculator Name": "Delta Gap", "Calculator ID": "63", "Category": "lab", "Note ID": "pmc-2791737-1", "Patient Note": "Near midday an 87-year-old woman activated 911 complaining of shortness of breath. The patient\u2019s past history was significant for myocardial infarction. A recent echocardiogram showed left ventricular hypokinesis consistent with an ischemic cardiomyopathy with an ejection fraction of 20 to 25%. Previous magnetic resonance imaging showed a 9x11x16 mm meningioma, without metastasis, edema or hydrocephalus. Her medications included verapamil, timolol, and diazepam.\nThe initial assessment by paramedics at 1320 described an alert and appropriate patient with pupils equal, round and reactive; the breathing was not labored, lungs were clear, and finger stick glucose was 139. The rhythm was ventricular tachycardia. Paramedics gave 50mg lidocaine intravenous (IV) push, with resolution of the tachycardia to a narrow complex sinus rhythm at a rate of 80 beats per minute. The rhythm was stable for one to two minutes, then recurred. They administered a second dose of lidocaine 50mg IV push, resulting in resolution of the tachycardia to a sinus rate of 78 beats per minute. The patient reported a decrease in shortness of breath and some mild dizziness. Paramedic personnel initiated a lidocaine drip at 2mg/minute for transport to the emergency department (ED).\nIn the primary ED, 28 minutes later, the patient had a ventricular rate of 152 beats per minute. She received a third 50mg dose of lidocaine IV. Her electrocardiogram (EKG) revealed normal sinus rhythm with left ventricular hypertrophy and an anteroseptal infarct of indeterminate age. At 1413 the physician increased the lidocaine drip to 4mg/minute, and administered aspirin 325mg by mouth. Shortly thereafter, the patient received a loading dose of amiodarone 150mg IV, followed by an amiodarone drip at 1mg/minute. She then came via EMS to our hospital.\nEn route emergency medical service personnel noted the patient to be in normal sinus rhythm with ventricular ectopy. The lidocaine drip remained at 4mg/minute and the amiodarone drip at 1mg/minute. The IV pump delivering amiodarone failed 20 minutes into the transfer and the medication discontinued. During transfer the report notes that the patient complained of \u201cbeing sleepy\u201d but was alert and appropriate. Six minutes prior to arrival the patient\u2019s mental status changed abruptly. She became non-verbal, her eyes remained open with a fixed gaze, but she was able to flex her hands on command.\nUpon arrival to our ED the patient\u2019s vitals signs were: heart rate 76 beats/min, respiratory rate 22 per minute, blood pressure 135/65, tympanic temperature 96.4\u00b0F, and oxygen saturation 92% on 15-liter flow nonrebreather mask. Her weight was 49 kilograms. Her airway was patent. The EKG monitor showed normal sinus rhythm. The patient was unresponsive to painful stimuli with pupils 4mm and nonreactive with intact gag reflex. Plantar reflexes were neutral. Given the patient\u2019s abrupt change in mental status, brainstem stroke was considered and we consulted neurology. We ordered an expedited computerized tomographic scan (CT) of the head 19 minutes after arrival. Two minutes later she received 0.4mg naloxone intraveniously and the lidocaine drip was discontinued. The patient\u2019s National Institute of Health (NIH) stroke score was 24, indicating severe neurologic impairment.\nInitial imaging studies included a chest x-ray with the only abnormality being an enlarged cardiac silhouette. CT scan of the head revealed mild microvascular ischemic changes. An 11 mm partially calcified right falcine mass was consistent with a stable meningioma. CT angiography examination in the ED 51 minutes after arrival demonstrated no evidence of vaso-occlusive change affecting the cervical or intracranial arterial vessels. Laboratory values drawn 19 minutes after arrival at our facility were as follows: Sodium 135 mmol/L, potassium 3.7 mmol/L, chloride 103 mmol/L, bicarbonate 19 mmol/L, creatinine 0.7 mg/dL, blood urea nitrogen 19 mg/dL, glucose 164 mg/dL, Mg 1.6 mg/dL, phosphorus 4.8 mg/dL, ionized calcium 1.10 mmol/L (reference 1.17\u20131.33 mmol/L). Cardiac enzymes, creatinine kinase (CK), CKMB and Troponin-T were normal. The initial arterial blood gas obtained on room air showed a pH of 7.28; the pCO2 was 44 mmHg, pO2 63 mmHg, and oxygen saturation 87%. The serum lidocaine level drawn 51 minutes after arrival, 30 minutes after the lidocaine drip was discontinued, resulted 7.9 mg/L with a reference range in our laboratory of 1.5\u20136.0 mg/L.\nFollowing termination of the lidocaine drip the patient\u2019s mental status gradually and steadily improved. By 60 minutes after termination of the drip her NIH stroke scale score was three, indicative of minimal impairment. During the ensuing hospitalization no more abnormalities of mental status or other neurologic complaints were encountered.", "Question": "What is the patient's delta gap in mEq/L?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "1", "LLM Explanation": "To calculate the patient's delta gap, we first need to calculate the anion gap (AG). The formula for the anion gap is: AG = [Na] - ([Cl] + [HCO3]). From the given lab values, we have: [Na] = 135 mmol/L, [Cl] = 103 mmol/L, and [HCO3] = 19 mmol/L. Plugging these values into the formula gives us: AG = 135 - (103 + 19) = 135 - 122 = 13 mEq/L. The normal anion gap is approximately 12 mEq/L. The delta gap is calculated as the difference between the measured anion gap and the normal anion gap. Therefore, the delta gap = Measured AG - Normal AG = 13 - 12 = 1 mEq/L.", "LLM Thinking": "First, we need to calculate the anion gap, and then the delta gap. The anion gap (AG) is calculated using the following formula : AG = [Na] - ([Cl] + [HCO3 ]). The delta gap is calculated by subtracting the normal AG of approximately 12 mEq/L from the measured AG. Looking at the lab values provided in the patient's note, the sodium (Na) is 135 mmol/L, chloride (Cl) is 103 mmol/L, and bicarbonate (HCO3) is 19 mmol/L. Let's calculate the anion gap: AG = [Na] - ([Cl] + [HCO3 ]) Next, the normal anion gap is typically around 12 +/- 4 mEq/L, meaning a normal range of about 8-16. However, to compute the delta gap, the difference between the measured AG and the normal AG (usually 12) is used. Therefore, the delta gap is measured AG - normal AG.", "Ground Truth Answer": "1", "Ground Truth Explanation": "To compute the formula of the delta gap, the formula is anion gap (in mEq/L) - 12. The first step is to compute the patient's anion gap.\nThe formula for computing a patient's anion gap is: sodium (mEq/L) - (chloride (mEq/L)+ bicarbonate (mEq/L)).\nThe concentration of sodium is 135.0 mEq/L. \nThe concentration of chloride is 103.0 mEq/L. \nThe concentration of bicarbonate is 19.0 mEq/L. \nPlugging in these values into the anion gap formula gives us 135.0 mEq/L - (103.0 mEq/L + 19.0 mEq/L) = 13.0 mEq/L. Hence, The patient's anion gap is 13.0 mEq/L.\nPlugging in 13.0 mEq/L for the delta gap formula, we get 13.0 - 12 = 1.0 mEq/L. Hence, the patient's delta gap is 1.0 mEq/L.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the anion gap, and then the delta gap.  \nThe anion gap (AG) is calculated using the following formula : AG = [Na] - ([Cl] + [HCO3 ]).  \nThe delta gap is calculated by subtracting the normal AG of approximately 12 mEq/L from the measured AG.  \n\nLooking at the lab values provided in the patient's note, the sodium (Na) is 135 mmol/L, chloride (Cl) is 103 mmol/L, and bicarbonate (HCO3) is 19 mmol/L.  \nLet's calculate the anion gap:\n\nAG = [Na] - ([Cl] + [HCO3 ])\n\nNext, the normal anion gap is typically around 12 +/- 4 mEq/L, meaning a normal range of about 8-16.  \nHowever, to compute the delta gap, the difference between the measured AG and the normal AG (usually 12) is used.\n\nTherefore, the delta gap is measured AG - normal AG."}
{"Row Number": 870, "Calculator Name": "APACHE II Score", "Calculator ID": "28", "Category": "risk", "Note ID": "3", "Patient Note": "A 73-year-old male is admitted to the emergency department following an acute abdominal pain that started suddenly 8 hours ago. He has a known history of hypertension, type 2 diabetes, for which he takes insulin daily, and liver cirrhosis. The patient denies any history of cerebrovascular events or ischemic heart disease. On physical examination, his blood pressure is 138/92 mmHg, heart rate is 107 beats per minute, respiratory rate is 35 breaths per minute, and he is afebrile with a temperature of 37.2\u00b0C. Auscultation of the chest reveals no rales, S3 gallop, or signs of congestive heart failure. His Glasgow Coma Scale score is 15, indicating full consciousness. Laboratory results show a creatinine level of 4.58 mg/dL, indicating impaired renal function, and a sodium level of 143.21 mmol/L and a potassium level of 3.68 mmol/L. His fraction of inspired air is 63 %.  His arterial blood gas analysis reveals a pH of 7.29, a PaO2 of 78 mm Hg, and an A-a gradient of 331 mm Hg while on room air. Hematocrit is at 41 %, and white blood cell count is 15,105 cells/\u00b5L. Given his acute presentation, history of diabetes managed with insulin, and laboratory findings, a thorough evaluation including imaging and further laboratory tests is warranted to assess the severity and underlying cause of his symptoms.", "Question": "What is the patient's APACHE II score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "20", "LLM Explanation": "To calculate the APACHE II score for the patient, we need to evaluate various physiological parameters and chronic health factors according to the APACHE II scoring system. Here's the step-by-step process: 1. **Age**: The patient is 73 years old. The APACHE II score awards points based on age categories: - 70-79 years: 5 points. 2. **Respiratory System**: - Respiratory rate is 35 breaths/min. - For respiratory rate > 35: 3 points. - PaO\u2082 = 78 mmHg, FiO\u2082 = 0.63. - PaO\u2082/FiO\u2082 = 78 / 0.63 \u2248 123.81. - For PaO\u2082/FiO\u2082 < 200: 4 points. We take the higher score between respiratory rate and PaO\u2082/FiO\u2082. - Respiratory rate gives 3 points. - PaO\u2082/FiO\u2082 gives 4 points. - Therefore, the higher score is 4 points for the respiratory system. 3. **Cardiovascular System**: - Heart Rate (HR): 107 bpm. - 60\u2013109: 0 points. - So, HR gives 0 points. - Systolic Blood Pressure (SBP): 138 mmHg. - 110\u2013200: 0 points. - So, SBP gives 0 points. 4. **Neurological System**: - GCS = 15. - GCS 15: 0 points. - So, GCS gives 0 points. 5. **Temperature**: - Temperature is 37.2\u00b0C, which is within the normal range (36.0\u201338.0\u00b0C). - So, temperature gives 0 points. 6. **Creatinine**: - Creatinine = 4.58 mg/dL. - 4.0\u20134.9: 4 points. - So, creatinine gives 4 points. 7. **WBC**: - WBC = 15.1 \u00d7 10\u00b3/\u00b5L. - 12.0\u201319.9: 1 point. - So, WBC gives 1 point. 8. **pH**: - pH = 7.29. - 7.25\u20137.29: 2 points. - So, pH gives 2 points. 9. **Serum Sodium**: - Sodium = 143.21 mmol/L. - 135\u2013145: 0 points. - So, sodium gives 0 points. 10. **Serum Potassium**: - Potassium = 3.68 mmol/L. - Normal range is 3.5\u20135.0 mmol/L. Since it is within the normal range, it gives 0 points. 11. **Hematocrit (HCT)**: - HCT = 41%. - 35\u201344.9%: 1 point. - So, HCT gives 1 point. Now, let's sum up the acute physiology points from the above calculations: - Respiratory: 4 points - Cardiovascular (HR + SBP): 0 + 0 = 0 points - Neurological (GCS): 0 points - Temperature: 0 points - Creatinine: 4 points - WBC: 1 point - pH: 2 points - Sodium: 0 points - Potassium: 0 points - HCT: 1 point Total acute physiology points = 4 (respiratory) + 0 (cardiovascular) + 0 (neurological) + 0 (temperature) + 4 (creatinine) + 1 (WBC) + 2 (pH) + 0 (sodium) + 0 (potassium) + 1 (HCT) = 12 points. Now add the age points: Age points = 5 points. Now add the chronic health points: The patient has cirrhosis, which adds 3 points for chronic health. So the total APACHE II score = Acute physiology points + Age points + Chronic health points = 12 + 5 + 3 = 20.", "LLM Thinking": "To calculate the APACHE II (Acute Physiology and Chronic Health Evaluation II ) score for the patient, we need to evaluate various physiological parameters and chronic health factors according to the APACHE II scoring system. The APACHE II score includes components such as age, acute physiology, and chronic health conditions. Here\u2019s the step-by-step process: 1. **Age**: The patient is 73 years old. The APACHE II score awards points based on age categories: - 70-79 years: 5 points. 2. **Physiological Parameters**: - **Respiratory System**: - Need to calculate the PaO\u2082/FiO\u2082 ratio or A-a gradient (Alveolar-Arterial oxygen difference) or respiratory rate. Given: The patient has an A-a gradient of 331 mmHg and is on room air (FiO\u2082 for room air is approximately 0.21). However, the A-a gradient is not directly used in APACHE II. Instead, APACHE II uses PaO\u2082/FiO\u2082 ratio. However, in the note, PaO\u2082 is 78 mmHg and FiO\u2082 is 63% (0.63). Let\u2019s calculate the PaO\u2082/FiO\u2082 ratio. The APACHE II scoring for PaO\u2082/FiO\u2082 ratio is categorized as: - < 200: 4 points - 200\u2013300: 3 points - 300\u2013400: 2 points - > 400: 1 point However, note that APACHE II uses the PaO\u2082/FiO\u2082 ratio or the respiratory rate. The respiratory rate is 35 breaths/min, which is above 24. For respiratory rate, the points are: - 12\u201324: 0 points - < 12 or > 35: 3 points - 25\u201334: 1 point However, APACHE II uses the higher of PaO\u2082/FiO\u2082 ratio or respiratory rate. - **Cardiovascular System**: This includes systolic blood pressure and heart rate. - **Heart Rate (HR): 107 bpm** For HR: - < 40 or > 129: 3 points - 40\u201350 or 120\u2013129: 2 points - 50\u201360 or 110\u2013119: 1 point - 60\u2013109: 0 points - **Systolic Blood Pressure (SBP)**: Not given directly, but we can use the given blood pressure: 138/92 mmHg. The SBP is 138 mmHg. APACHE II uses SBP: - < 70: 4 points - 70\u201379: 3 points - 80\u201389: 2 points - 90\u2013109: 1 point - 110\u2013200: 0 points - > 200: 3 points - **Neurological System**: Glasgow Coma Scale (GCS) score = 15 The APACHE II scoring for GCS is: - < 3: 6 points - 3\u20134: 5 points - 5\u20136: 4 points - 7\u20138: 3 points - 9\u201310: 2 points - 11\u201314: 1 point - 15: 0 points - **Temperature**: The patient\u2019s body temperature is 37.2 \u00b0C, which is normal (36.0\u201338.0 \u00b0C in APACHE). - **Mean Arterial Pressure (MAP) / Urine Output / Creatinine**: We have given creatinine level = 4.58 mg/dL The APACHE II uses creatinine in its scoring: - < 0.5 mg/dL: \u20132 points - 0.5\u20130.9: 0 points - 1.0\u20131.9: 1 point - 2.0\u20132.9: 2 points - 3.0\u20133.9: 3 points - 4.0\u20134.9: 4 points - \u2265 5.0: 5 points For urine output over 24 hours/use of dialysis is not provided, so we can\u2019t score this. Since the creatinine is elevated, we use that. - **White Blood Cell Count (WBC)**: WBC is 15.1 \u00d7 10\u00b3/\u00b5L APACHE II scoring for WBC: - < 1.0: 3 points - 1.0\u20131.9: 2 points - 2.0\u201311.9: 0 points - 12.0\u201319.9: 1 point - \u2265 20.0: 2 points - **pH**: The pH is 7.29, which is below 7.3. The APACHE II scoring for arterial pH is: - < 7.20: 4 points - 7.20\u20137.24: 3 points - 7.25\u20137.29: 2 points - 7.30\u20137.34: 1 point - \u2265 7.35: 0 points - **Serum Sodium**: Sodium level is 143.21 mmol/L. The reference range is typically 135\u2013145 mmol/L. - < 120: 4 points - 120\u2013124: 3 points - 125\u2013129: 2 points - 130\u2013134: 1 point - 135\u2013145: 0 points - 146\u2013154: 1 point - \u2265 155: 2 points - **Serum Potassium**: 3.68 mmol/L. Normal is 3.5\u20135.0. - **Hematocrit (HCT)**: 41%. The APACHE II scoring for hematocrit is: - < 20%: 4 points - 20\u201329.9%: 3 points - 30\u201334.9%: 2 points - 35\u201344.9%: 1 point - \u2265 45%: 0 points 3. **Chronic Health Conditions**: The patient has cirrhosis, which is considered a chronic health condition in APACHE II scoring. For chronic health, cirrhosis adds 3 points (under the category of \"Other chronic diseases\" or \"Cirrhosis\"). Now, summing up all the points: Wait, but in the APACHE II scoring, the chronic health points are adjusted differently based on whether the patient is intubated or not and other factors? Or is it a separate addition? Let\u2019s sum the acute physiology score first: APACHE II Score = (sum of acute physiology points) + (age points) + (chronic health points). The chronic health points are added if the patient has any of the chronic conditions (like cirrhosis, cancer, etc.), and each condition adds points (cirrhosis = 3 in this case). So the total would be:", "Ground Truth Answer": "41", "Ground Truth Explanation": "The patient's current APACHE II score is 0 points.\nThe patient is 73.0 years old. The patient is reported to have an organ failure of immunocompromise with a surgery type being classified as Nonoperative . Because the patient's age is between 65 and 74, 5 points are added to the total, making the current total, 0 + 5 = 5.\nThe patient's FiO2 percentage is 63.0 %. Because the patent's FiO2 percentrage is greater than 50%, we need to examine the A-a-gradient to compute the APACHE II score. The patient's A-a-gradient is 331.0. Because the patient's A-a gradient is between 200 and 349, we add 2 points to the total, making the current total 7.\nThe patient's temperature is 37.2 degrees fahrenheit. To convert to degrees celsius, apply the formula 5/9 * [temperature (degrees fahrenheit) - 32]. This means that the patient's temperature is 5/9 * 5.200000000000003 = 2.889 degrees celsius. \nBecause the patient's temperature is below 30 degrees Celsius, 4 points are added to the score, making the current total, 7 + 4 = 11.\nThe mean average pressure is computed by the formula 2/3 * (diastolic blood pressure) + 1/3 * (systolic blood pressure). Plugging in the values, we get 2/3 * 92.0 mm Hg + 1/3 * 138.0 mm Hg = 107.333 mm Hg.\nHence, the patient's mean arterial pressure is 107.333 mm Hg.\nBecause the patient's Mean Arterial Pressure is between 70 and 109 mmHg, 0 points are added to the patient's score, keeping the total at 11.\nBecause the patient's heart rate is between 70 and 109 beats per minute, 0 points are added to the patient's score, keeping the total at 11.\nBecause the patient's respiratory rate is between 35 and 49 breaths per minute, 3 points are added to the score, making the current total, 11 + 3 = 14.\nBecause the patient's sodium level is between 130 and 149 mmol/L, 0 points are added to the patient's score, keeping the total at 14. Because the patient's potassium level is between 3.5 and 5.4 mmol/L, 0 points are added to the patient's score, keeping the total at 14. Because the patient has acute renal failure and a creatinine level above 3.5, 8 points are added to the score, making the current total 14 + 8 = 22.\nBecause the patient's hemocratit is between 30% and 45%, 0 points are added to the patient's score, keeping the total at 22. Because the patient's white blood cell count is above 40 x10^9/L, 4 points are added to the score, making the current total 22 + 4 = 26.\nThe patient's Glasgow Coma Score is 15.0, and so we add 15.0 points to the total making the current total 15.0 + 26 = 41.0. Hence, the patient's APACHE II score is 41.0.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the APACHE II (Acute Physiology and Chronic Health Evaluation II ) score for the patient, we need to evaluate various physiological parameters and chronic health factors according to the APACHE II scoring system.  \nThe APACHE II score includes components such as age, acute physiology, and chronic health conditions.  \nHere\u2019s the step-by-step process:\n\n1. **Age**: The patient is 73 years old. The APACHE II score awards points based on age categories:  \n   - 70-79 years: 5 points.\n\n2. **Physiological Parameters**:  \n- **Respiratory System**:  \n  - Need to calculate the PaO\u2082/FiO\u2082 ratio or A-a gradient (Alveolar-Arterial oxygen difference) or respiratory rate.  \n  Given: The patient has an A-a gradient of 331 mmHg and is on room air (FiO\u2082 for room air is approximately 0.21).  \n  However, the A-a gradient is not directly used in APACHE II.  \n  Instead, APACHE II uses PaO\u2082/FiO\u2082 ratio.  \n  However, in the note, PaO\u2082 is 78 mmHg and FiO\u2082 is 63% (0.63). Let\u2019s calculate the PaO\u2082/FiO\u2082 ratio.  \n  The APACHE II scoring for PaO\u2082/FiO\u2082 ratio is categorized as:  \n    - < 200: 4 points  \n    - 200\u2013300: 3 points  \n    - 300\u2013400: 2 points  \n    - > 400: 1 point  \n  However, note that APACHE II uses the PaO\u2082/FiO\u2082 ratio or the respiratory rate.  \n  The respiratory rate is 35 breaths/min, which is above 24.  \n  For respiratory rate, the points are:  \n    - 12\u201324: 0 points  \n    - < 12 or > 35: 3 points  \n    - 25\u201334: 1 point  \n  However, APACHE II uses the higher of PaO\u2082/FiO\u2082 ratio or respiratory rate.\n\n- **Cardiovascular System**: This includes systolic blood pressure and heart rate.  \n- **Heart Rate (HR): 107 bpm**  \n  For HR:  \n    - < 40 or > 129: 3 points  \n    - 40\u201350 or 120\u2013129: 2 points  \n    - 50\u201360 or 110\u2013119: 1 point  \n    - 60\u2013109: 0 points  \n\n- **Systolic Blood Pressure (SBP)**: Not given directly, but we can use the given blood pressure: 138/92 mmHg. The SBP is 138 mmHg.  \n  APACHE II uses SBP:  \n    - < 70: 4 points  \n    - 70\u201379: 3 points  \n    - 80\u201389: 2 points  \n    - 90\u2013109: 1 point  \n    - 110\u2013200: 0 points  \n    - > 200: 3 points  \n\n- **Neurological System**: Glasgow Coma Scale (GCS) score = 15  \n  The APACHE II scoring for GCS is:  \n    - < 3: 6 points  \n    - 3\u20134: 5 points  \n    - 5\u20136: 4 points  \n    - 7\u20138: 3 points  \n    - 9\u201310: 2 points  \n    - 11\u201314: 1 point  \n    - 15: 0 points  \n\n- **Temperature**: The patient\u2019s body temperature is 37.2 \u00b0C, which is normal (36.0\u201338.0 \u00b0C in APACHE).\n\n- **Mean Arterial Pressure (MAP) / Urine Output / Creatinine**:  \n  We have given creatinine level = 4.58 mg/dL  \n  The APACHE II uses creatinine in its scoring:  \n    - < 0.5 mg/dL: \u20132 points  \n    - 0.5\u20130.9: 0 points  \n    - 1.0\u20131.9: 1 point  \n    - 2.0\u20132.9: 2 points  \n    - 3.0\u20133.9: 3 points  \n    - 4.0\u20134.9: 4 points  \n    - \u2265 5.0: 5 points  \n\n  For urine output over 24 hours/use of dialysis is not provided, so we can\u2019t score this.  \n  Since the creatinine is elevated, we use that.\n\n- **White Blood Cell Count (WBC)**: WBC is 15.1 \u00d7 10\u00b3/\u00b5L  \n  APACHE II scoring for WBC:  \n    - < 1.0: 3 points  \n    - 1.0\u20131.9: 2 points  \n    - 2.0\u201311.9: 0 points  \n    - 12.0\u201319.9: 1 point  \n    - \u2265 20.0: 2 points  \n\n- **pH**: The pH is 7.29, which is below 7.3.  \n  The APACHE II scoring for arterial pH is:  \n    - < 7.20: 4 points  \n    - 7.20\u20137.24: 3 points  \n    - 7.25\u20137.29: 2 points  \n    - 7.30\u20137.34: 1 point  \n    - \u2265 7.35: 0 points  \n\n- **Serum Sodium**: Sodium level is 143.21 mmol/L. The reference range is typically 135\u2013145 mmol/L.  \n    - < 120: 4 points  \n    - 120\u2013124: 3 points  \n    - 125\u2013129: 2 points  \n    - 130\u2013134: 1 point  \n    - 135\u2013145: 0 points  \n    - 146\u2013154: 1 point  \n    - \u2265 155: 2 points  \n\n- **Serum Potassium**: 3.68 mmol/L. Normal is 3.5\u20135.0.  \n\n- **Hematocrit (HCT)**: 41%. The APACHE II scoring for hematocrit is:  \n    - < 20%: 4 points  \n    - 20\u201329.9%: 3 points  \n    - 30\u201334.9%: 2 points  \n    - 35\u201344.9%: 1 point  \n    - \u2265 45%: 0 points  \n\n3. **Chronic Health Conditions**: The patient has cirrhosis, which is considered a chronic health condition in APACHE II scoring.  \nFor chronic health, cirrhosis adds 3 points (under the category of \"Other chronic diseases\" or \"Cirrhosis\").  \n\nNow, summing up all the points:  \nWait, but in the APACHE II scoring, the chronic health points are adjusted differently based on whether the patient is intubated or not and other factors? Or is it a separate addition? Let\u2019s sum the acute physiology score first:  \n\nAPACHE II Score = (sum of acute physiology points) + (age points) + (chronic health points). The chronic health points are added if the patient has any of the chronic conditions (like cirrhosis, cancer, etc.), and each condition adds points (cirrhosis = 3 in this case). So the total would be:"}
{"Row Number": 360, "Calculator Name": "HAS-BLED Score for Major Bleeding Risk", "Calculator ID": "25", "Category": "risk", "Note ID": "17", "Patient Note": "A 59-year-old gentleman presents with episodes of dizziness and palpitations. His past medical history is significant for a previous stroke and uncontrolled hypertension (182/111). Blood tests showed a labile INR, with a supra-therapeutic range nearly 80 % of the time. A significant bleeding event that happened following a minor operative procedure is documented and requires careful attention. His lifestyle habits include moderate alcohol consumption, tallying approximately three alcoholic beverages per week. Despite the other complexities, the liver function tests appear normal suggesting no liver disease, and similar is the case with his renal function tests showing no kidney impairment. His case is closely following up considering all the clinically important traits.", "Question": "What is the patient's HAS-BLED score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "4", "LLM Explanation": "Let's calculate the HAS-BLED score step-by-step for this patient. The HAS-BLED score includes the following components: H (Hypertension), A (Abnormal Renal/Liver function), S (Stroke history), B (Bleeding history or predisposition), L (Labile INR), E (Elderly), and D (Drugs/alcohol concurrently). Here's the breakdown based on the patient's information: 1. **Hypertension (H):** The patient has uncontrolled hypertension with a blood pressure of 182/111 mmHg. This meets the criterion for hypertension (systolic BP > 160 mmHg or diastolic BP > 100 mmHg). So, this is 1 point. 2. **Abnormal renal/liver function (A):** The note states that both liver function tests and renal function tests are normal. Therefore, this criterion is not met. So, 0 points. 3. **Stroke history (S):** The patient has a past medical history of a previous stroke. This criterion is met. So, 1 point. 4. **Bleeding history or predisposition (B):** The patient had a significant bleeding event following a minor operative procedure. This indicates a history of bleeding. Therefore, this criterion is met. So, 1 point. 5. **Labile INR (L):** The patient has a labile INR, with it being supra-therapeutic nearly 80% of the time. This criterion is met. So, 1 point. 6. **Elderly (E):** The patient is 59 years old, which is not over 65 years. Therefore, this criterion is not met. So, 0 points. 7. **Drugs/alcohol (D):** The patient consumes approximately three alcoholic beverages per week, which is considered moderate and does not meet the threshold for excessive alcohol intake (more than 8 drinks per week for men). There is no mention of antiplatelet drugs or NSAIDs. Therefore, this criterion is not met. So, 0 points. Now, let's add up the points: - H: 1 point - S: 1 point - B: 1 point - L: 1 point - A: 0 points - E: 0 points - D: 0 points Total HAS-BLED score = 1 + 1 + 1 + 1 = 4 points.", "LLM Thinking": "Let's calculate the HAS-BLED score step-by-step for this patient. The HAS-BLED score is a tool to assess the risk of bleeding in patients with atrial fibrillation or who require anticoagulation. It consists of the following components (with 1 point each for the presence of the risk factor unless otherwise specified): - H: Hypertension ( systolic BP > 160 mmHg or diast olic BP > 100 mmHg) - A: Ab normal Renal/Liver function - S: Stroke history - B : Bleeding history or predisposition - L: Labile INR (INR outside the therapeutic range) - E: Elderly (age > 65 years) - D: Drugs/alcohol concomit antly (antiplatelet drugs or alcohol) First, let's go through each component and see if it applies to this patient based on the given information : 1. **Hypertension (H):** The patient has uncontrolled hypertension with a blood pressure reading of 182/1 11 mmHg. This meets the criterion of systolic BP > 160 or diastolic >100. 2. **Abnormal renal/l iver function (A):** The note says \"liver function tests appear normal suggesting no liver disease, and similar is the case with his renal function tests showing no kidney impairment.\" This means there are no abnormalities in renal or liver function tests. 3. **Stroke history ( S):** The patient has a past medical history of a previous stroke. That's a clear yes. 4. **Bleeding history or predisposition (B):** A significant bleeding event occurred after a minor operative procedure. This qualifies as a history of bleeding. Additionally, predisposition could include factors like alcohol use, but the alcohol consumption here is moderate (3 drinks per week), which may not be considered excessive . However, the bleeding event itself is enough for this point. 5. **Labile INR (L ):** The note mentions that blood tests showed a labile INR, with it being supra-therapeutic nearly 80% of the time . That definitely counts as labile. 6. **Elderly (E):** The patient is 59 years old, which is under 65. 7. **Drugs/ alcohol (D):** The patient has moderate alcohol consumption (3 beverages per week), which might be considered a small alcohol intake. However, the standard for HAS-BLED is \"concurrent use of anti platelet drugs or nonsteroidal anti-inflammatory drugs, or excessive alcohol intake (more than 8 drinks per week in men, 4 per week in women).\" Since the patient is male and has only 3 drinks weekly , it does not meet the 'excessive alcohol intake' threshold for this score. The note does not mention any antiplatelet or NSAID use.", "Ground Truth Answer": "4", "Ground Truth Explanation": "The current HAS-BLED score is 0.\nThe patient is 59.0 years old. Because the patient's age is less than 66 years, we don't change the score, keeping the current score at 0.\nThe patient has 3 drinks a week. Because the patient has less than 8 alcoholic drinks a week, we don't change the score, keeping the current score at 0.\nThe issue, hypertension, is reported to be present for the patient note and so we increase the score by 1, making the current score 0 + 1 = 1.\nThe issue, liver disease, is reported to be absent for the patient and so we do not change the score, keeping the current score at 1.\nThe issue, renal disease, is reported to be absent for the patient and so we do not change the score, keeping the current score at 1.\nThe issue, stroke history, is reported to be present for the patient note and so we increase the score by 1, making the current score 1 + 1 = 2.\nThe issue, prior bleeding, is reported to be present for the patient note and so we increase the score by 1, making the current score 2 + 1 = 3.\nThe issue, labile inr, is reported to be present for the patient note and so we increase the score by 1, making the current score 3 + 1 = 4.\nThe issue, medications for bleeding, is missing from the patient note and so we assume it to be absent and so we do not change the score, keeping the current score at 4.\nHence, the patient's HAS-BLED score is 4.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Let's calculate the HAS-BLED score step-by-step for this patient.  \nThe HAS-BLED score is a tool to assess the risk of bleeding in patients with atrial fibrillation or who require anticoagulation.  \nIt consists of the following components (with 1 point each for the presence of the risk factor unless otherwise specified):\n\n- H: Hypertension ( systolic BP > 160 mmHg or diast olic BP > 100 mmHg)  \n- A: Ab normal Renal/Liver function  \n- S: Stroke history  \n- B : Bleeding history or predisposition  \n- L: Labile INR (INR outside the therapeutic range)  \n- E: Elderly (age > 65 years)  \n- D: Drugs/alcohol concomit antly (antiplatelet drugs or alcohol)\n\nFirst, let's go through each component and see if it applies to this patient based on the given information :\n\n1. **Hypertension (H):** The patient has uncontrolled hypertension with a blood pressure reading of 182/1 11 mmHg.  \nThis meets the criterion of systolic BP > 160 or diastolic >100.\n\n2. **Abnormal renal/l iver function (A):** The note says \"liver function tests appear normal suggesting no liver disease, and similar is the case with his renal function tests showing no kidney impairment.\"  \nThis means there are no abnormalities in renal or liver function tests.\n\n3. **Stroke history ( S):** The patient has a past medical history of a previous stroke.  \nThat's a clear yes.\n\n4. **Bleeding history or predisposition (B):** A significant bleeding event occurred after a minor operative procedure.  \nThis qualifies as a history of bleeding.  \nAdditionally, predisposition could include factors like alcohol use, but the alcohol consumption here is moderate (3 drinks per week), which may not be considered excessive .  \nHowever, the bleeding event itself is enough for this point.\n\n5. **Labile INR (L ):** The note mentions that blood tests showed a labile INR, with it being supra-therapeutic nearly 80% of the time .  \nThat definitely counts as labile.\n\n6. **Elderly (E):** The patient is 59 years old, which is under 65.\n\n7. **Drugs/ alcohol (D):** The patient has moderate alcohol consumption (3 beverages per week), which might be considered a small alcohol intake.  \nHowever, the standard for HAS-BLED is \"concurrent use of anti platelet drugs or nonsteroidal anti-inflammatory drugs, or excessive alcohol intake (more than 8 drinks per week in men, 4 per week in women).\"  \nSince the patient is male and has only 3 drinks weekly , it does not meet the 'excessive alcohol intake' threshold for this score.  \nThe note does not mention any antiplatelet or NSAID use."}
{"Row Number": 614, "Calculator Name": "QTc Fridericia Calculator", "Calculator ID": "56", "Category": "physical", "Note ID": "7", "Patient Note": "Patient has a heart rate of 170 bpm and a QT interval of 330 msec.", "Question": "Using the Fridericia Formula for corrected QT interval, what is the patient's corrected QT interval in terms of msec?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "467", "LLM Explanation": "To calculate the corrected QT interval using the Fridericia formula, we need to follow these steps:\\n\\n1. Convert the heart rate to the RR interval.\\n2. Use the Fridericia formula: QTc = QT / (RR)^(1/3), where QT is the QT interval in milliseconds and RR is the RR interval in seconds.\\n\\nStep 1: Convert the heart rate to the RR interval.\\nThe heart rate is 170 bpm. The formula to convert heart rate to RR interval is:\\nRR interval (seconds) = 60 / heart rate.\\nSo, RR interval = 60 / 170 \u2248 0.3529 seconds.\\n\\nStep 2: Use the Fridericia formula to calculate the corrected QT interval.\\nThe given QT interval is 330 msec.\\nThe Fridericia formula is: QTc = QT / (RR)^(1/3).\\nPlugging in the values, we get:\\nQTc = 330 / (0.3529)^(1/3).\\n\\nNow, calculate the cube root of 0.3529.\\n(0.3529)^(1/3) \u2248 0.7066.\\n\\nNow, plug this value back into the formula:\\nQTc = 330 / 0.7066 \u2248 466.99 msec.\\nRounding to the nearest whole number gives us approximately 467 msec.\\n\\nTherefore, the corrected QT interval is approximately 467 msec.", "LLM Thinking": "Step 1: To calculate the corrected QT interval, we will use the Fridericia formula: QTc = QT / cube root of (RR interval in seconds). But first, we need to convert the heart rate into the RR interval in seconds since we have the heart rate given as 170 bpm and the QT interval as 330 msec. Step 2: The relationship between heart rate and RR (the time between successive heartbeats) is given by RR interval (seconds) = 60 / heart rate (bpm). However, heart rate is beats per minute, so the calculation should be RR interval = 60 / heart rate. Step 3: Pl ugging the heart rate into the formula: RR interval = 60 / 170 bpm. Step 6: Use the Fridericia correction formula to calculate the corrected QT (QTc): QTc = QT / (RR interval)^(1/3) = 330 msec / 0.7066.", "Ground Truth Answer": "466.934", "Ground Truth Explanation": "The corrected QT interval using the Fredericia formula is computed as  QTc = QT interval / (RR interval)**(1/3), where ** denotes an exponent, QT interval is in msec, and RR interval is given as 60/(heart rate).\nThe patient's heart rate is 170 beats per minute.\nThe QT interval is 330 msec.\nThe RR interval is computed as 60/(heart rate), and so the RR interval is 60/170 = 0.353.\nHence, plugging in these values, we will get 330/\u221a(0.353) = 466.934.The patient's corrected QT interval (QTc) is 466.934 msec. ", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the corrected QT interval, we will use the Fridericia formula: QTc = QT / cube root of (RR interval in seconds). But first, we need to convert the heart rate into the RR interval in seconds since we have the heart rate given as 170 bpm and the QT interval as 330 msec.\n\nStep 2: The relationship between heart rate and RR (the time between successive heartbeats) is given by RR interval (seconds) = 60 / heart rate (bpm). However, heart rate is beats per minute, so the calculation should be RR interval = 60 / heart rate. \n\nStep 3: Pl ugging the heart rate into the formula: RR interval = 60 / 170 bpm.\n\nStep 6: Use the Fridericia correction formula to calculate the corrected QT (QTc): QTc = QT / (RR interval)^(1/3) = 330 msec / 0.7066."}
{"Row Number": 50, "Calculator Name": "CHA2DS2-VASc Score for Atrial Fibrillation Stroke Risk", "Calculator ID": "4", "Category": "risk", "Note ID": "pmc-4369977-1", "Patient Note": "A 55-year-old right-handed male presented to the emergency department after a syncopal episode. He was teaching a karate class when a coworker saw him fall to the ground. He spontaneously regained consciousness after a few seconds but was confused for \u223c15\u201320 min. He had no recollection of the event, and was hemodynamically stable and neurologically intact. He denied illicit drug use. Vitals, physical examination and laboratory studies were within normal limits. ECG showed normal sinus rhythm with normal PR and QT intervals and no ST-T wave changes. He was on no AV blocking agents. Head CT showed no intracranial bleed or mass lesion.\nHe had a history of five similar episodes in the past. During the last episode, he had been noted to have sinus arrest on telemetry and underwent single atrial lead pacemaker placement. The pacemaker was programmed to AAI mode. AV conduction was tested and was normal. Coronary angiogram showed no evidence of coronary artery disease. EEG had been minimally abnormal with left temporal theta slowing, suggestive of an area of neurophysiologic dysfunction, but no epileptiform activity was noted. He had no history of febrile seizures, central nervous system infection or cranial trauma.\nThe patient was admitted for further work up. Continuous EEG monitoring was ordered to evaluate for seizure activity. At \u223c7 min and 36 s, the patient started to have recurrent automatisms and became unresponsive, with the EEG showing complex partial seizure activity emanating from the left anterior temporal region with continued post-ictal right temporal delta slowing. The seizure lasted \u223c1 min. The simultaneous ECG lead demonstrated heart rate slowing toward the end of the seizure episode, with the rhythm changing from sinus to atrially paced at 60 beats min\u22121 with 1:1 conduction, to atrially paced with 2:1 AV block, followed by complete heart block for 4 s, followed by resumption of the baseline atrially paced rhythm with 1:1 conduction (Fig. ).\nCardiac electrophysiology recommended treating the seizure episodes before considering upgrade of the pacemaker to a dual-chamber device. The patient was started and subsequently discharged on levetiracetam. More than 15 months later, he has had no seizures or syncopal events.", "Question": "What is the patient's CHA2DS2-VASc Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "0", "LLM Explanation": "To calculate the CHA2DS2-VASc score, we need to evaluate the risk factors for stroke in patients with atrial fibrillation or in this case, the patient's factors that could indicate their stroke risk in general since the score is used for such evaluations. The CHA2DS2-VASc score includes the following factors: Congestive heart failure, Hypertension, Age \u226575 (scored as 2), Diabetes, Stroke / TIA or thrombo embolism history, Vascular disease, Age 65\u201374 (1 point), and Sex category (female gets 1 point). Looking at the patient note, the patient is a 55-year-old male. First, check each component: - Congestive heart failure: The note doesn't mention any history of CHF or heart failure - Hypertension: The patient's vitals and lab studies are within normal limits, and there is no mention of hypertension - Age: The patient is 55 years old. Since the age category is 1 point for 65\u201374 and 2 points for \u2265 75 years old - Diabetes: The note does not indicate diabetes - Stroke/TIA history: The patient has had syncopal episodes but no mention of prior stroke or TIA. However, he had a pacemaker placed due to sinus arrest, but this doesn\u2019t directly indicate a prior stroke - Vascular disease: No mention of peripheral vascular disease, coronary artery disease (though he had a coronary angiogram showing no CAD), or other vascular issues - Age 65\u201374: As the patient is 55, this is not applicable - Sex category: The patient is male Now let's calculate the score step by step: - Congestive heart failure: 0 (not mentioned) - Hypertension: 0 (not mentioned, and vitals are within normal limits) - Age \u226575: 0 (the patient is 55 years old) - Diabetes: 0 (not mentioned) - Stroke/TIA/thromboembolism history: 0 (no mention of prior stroke or TIA) - Vascular disease: 0 (no mention of vascular disease) - Age 65\u201374: 0 (the patient is 55 years old, so not in this age range) - Sex (female): 0 (the patient is male) Adding up these scores: - CHF: 0 - Hypertension: 0 - Age \u226575: 0 - Diabetes: 0 - Stroke/TIA/thromboembolism history: 0 - Vascular disease: 0 - Age 65\u201374: 0 - Sex (female): 0 Thus, the total CHA2DS2-VASc score is 0.", "LLM Thinking": "To calculate the CHA2DS2-VASc score, we need to evaluate the risk factors for stroke in patients with atrial fibrillation or in this case, the patient's factors that could indicate their stroke risk in general since the score is used for such evaluations. The CHA2DS2-VASc score includes the following factors: Congestive heart failure, Hypertension, Age \u226575 ( scored as 2), Diabetes, Stroke / TIA or thrombo embolism history, Vascular disease, Age 65\u201374 (1 point), and Sex category (female gets 1 point). Looking at the patient note, the patient is a 55-year-old male. First, check each component: - Congestive heart failure: The note doesn't mention any history of CHF or heart failure - Hypertension: The patient's vitals and lab studies are within normal limits, and there is no mention of hypertension - Age: The patient is 55 years old. Since the age category is 1 point for 65\u201374 and 2 points for \u2265 75 years old - Diabetes: The note does not indicate diabetes - Stroke/TIA history: The patient has had syncopal episodes but no mention of prior stroke or TIA. However, he had a pacemaker placed due to sinus arrest, but this doesn\u2019t directly indicate a prior stroke - Vascular disease: No mention of peripheral vascular disease, coronary artery disease (though he had a coronary angiogram showing no CAD), or other vascular issues - Age 65\u201374: As the patient is 55, this is not applicable - Sex category: The patient is male", "Ground Truth Answer": "0", "Ground Truth Explanation": "The current CHA2DS2-VASc score is 0.\nThe patient is 55.0 years old. Because the age is less than 65 years, no points are added to the current total, keeping the total at 0.\nThe patient's gender is male and so no points are added to the current total, keeping the total at 0.\nThe patient history for congestive heart failure is absent. Because the patient does not have congestive heart failure, no points are added to the current total, keeping the total at 0.\nBecause hypertension history is not specified in the patient note, we assume that it is absent from the patient. Because the patient does not have hypertension, no points are added to the current total, keeping the total at 0.\nOne criteria of the CHA2DS2-VASc score is to check if the patient has had any history of stroke, transient ischemic attacks (TIA), or thromboembolism. Based on the patient note, the patient history for stroke is absent. Based on the patient note, the patient history for tia is absent. Based on the patient note, the patient history for thromboembolism is absent. Because all of stroke, tia, or thromboembolism are absent, no points are added to score, keeping the score at 0.\nBased on the patient note, the patient history for vascular disease is absent. Because the patient does not have vascular disease, no points are added to score, keeping the score at 0. Because diabetes history is not specified in the patient note, we assume it's value as 'absent'. Because the patient does not have diabetes, no points are added to score, keeping the score at 0.\nThe patient's CHA2DS2-VASc Score is 0.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the CHA2DS2-VASc score, we need to evaluate the risk factors for stroke in patients with atrial fibrillation or in this case, the patient's factors that could indicate their stroke risk in general since the score is used for such evaluations.  \nThe CHA2DS2-VASc score includes the following factors: Congestive heart failure, Hypertension, Age \u226575 ( scored as 2), Diabetes, Stroke / TIA or thrombo embolism history, Vascular disease, Age 65\u201374 (1 point), and Sex category (female gets 1 point).  \nLooking at the patient note, the patient is a 55-year-old male.  \n\nFirst, check each component:  \n- Congestive heart failure: The note doesn't mention any history of CHF or heart failure  \n- Hypertension: The patient's vitals and lab studies are within normal limits, and there is no mention of hypertension  \n- Age: The patient is 55 years old. Since the age category is 1 point for 65\u201374 and 2 points for \u2265 75 years old  \n- Diabetes: The note does not indicate diabetes  \n- Stroke/TIA history: The patient has had syncopal episodes but no mention of prior stroke or TIA. However, he had a pacemaker placed due to sinus arrest, but this doesn\u2019t directly indicate a prior stroke  \n- Vascular disease: No mention of peripheral vascular disease, coronary artery disease (though he had a coronary angiogram showing no CAD), or other vascular issues  \n- Age 65\u201374: As the patient is 55, this is not applicable  \n- Sex category: The patient is male"}
{"Row Number": 200, "Calculator Name": "Child-Pugh Score for Cirrhosis Mortality", "Calculator ID": "15", "Category": "severity", "Note ID": "2", "Patient Note": "A 61 year old male with a history of chronic iron deficiency anemia, type 2 diabetes mellitus, cirrhosis secondary to alpha 1 antitrypsin deficiency, hypertension, and chronic kidney disease presents to the emergency department from a skilled nursing facility for lethargy and confusion. History is limited by confusion, though the patient complains of abdominal pain. The patient is unsure when his last bowel movement was. He denies dysuria, nausea or vomiting. Vitals are as follows: heart rate 102 bpm, blood pressure 127/77, temperature 97.5\u00b0F. The patient is oriented only to self. Asterixis is present. Abdominal exam is notable for decreased bowel sounds, and negative for ascites. Labs are notable for sodium 135 mmol/L, potassium 3.3 mmol/L, BUN 38 mg/dL, creatinine 2.0 mg/dL, albumin 3.1 g/dL, bilirubin 40.2umol/L, ammonia 125 umol/L, TSH 1.83 ulU/mL, WBC 4.3, hemoglobin 8.9 g/dL, and INR 2.1. The patient is admitted to the medical service.", "Question": "What is the patient's Child-Pugh Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "9", "LLM Explanation": "To calculate the Child-Pugh Score for this patient, we need to evaluate several parameters: total bilirubin, serum albumin, prothrombin time (INR), ascites, and hepatic encephalopathy. Here are the steps: 1. Convert the bilirubin from umol/L to mg/dL. The given bilirubin is 40.2 umol/L. Using the conversion factor 1 mg/dL = 17.1 umol/L, we get: \\[ \\text{Bilirubin in mg/dL} = \\frac{40.2}{17.1} \\approx 2.35 \\, \\text{mg/dL}.\\] 2. The serum albumin is given as 3.1 g/dL. 3. The INR is given as 2.1. 4. The patient is negative for ascites, so there is no ascites. 5. The patient is oriented only to self and has asterixis, indicating hepatic encephalopathy. Now, let's score each parameter according to the Child-Pugh criteria: - **Bilirubin (in mg/dL):** - < 1.7 mg/dL = 1 - 1.7 - 3.0 mg/dL = 2 - 3.0 - 6.0 mg/dL = 3 - > 6.0 mg/dL = 4 Since the bilirubin is 2.35 mg/dL, it falls within the range of 1.7 - 3.0 mg/dL. Therefore, the score for bilirubin is 2. - **Albumin (in g/dL):** - \u2265 3.5 = 1 - 2.8 - 3.4 = 2 - 2.1 - 2.7 = 3 - < 2.1 = 4 Since the albumin is 3.1 g/dL, it falls within the range of 2.8 - 3.4 g/dL. Therefore, the score for albumin is 2. - **INR:** - < 1.7 = 1 - 1.7 - 2.3 = 2 - > 2.3 = 3 Since the INR is 2.1, it falls within the range of 1.7 - 2.3. Therefore, the score for INR is 2. - **Ascites:** - None (controlled) = 1 - Mild = 2 - Moderate or refractory = 3 Since the patient is negative for ascites, the score for ascites is 1. - **Hepatic Encephalopathy:** - None = 1 - Grade 1 or 2 = 2 - Grade 3 or 4 = 3 Since the patient is oriented only to self and has asterixis, indicating some degree of hepatic encephalopathy (likely grade 1 or 2), the score for hepatic encephalopathy is 2. Now, we sum up the scores for each parameter: - Bilirubin: 2 - Albumin: 2 - INR: 2 - Ascites: 1 - Hepatic Encephalopathy: 2 Total Child-Pugh Score = 2 + 2 + 2 + 1 + 2 = 9. Therefore, the patient's Child-Pugh Score is 9.", "LLM Thinking": "To calculate the Child-Pugh Score for this patient, we need to evaluate several parameters: total bilirubin, serum albumin, proth rombin time (INR), ascites, and hepatic enceph alopathy. The Child-Pugh score classifies the severity of liver disease into 5 categories (A to D), each with a score from 5 to 15. First, let's gather the relevant lab values and clinical findings from the patient note: 1. **Total Bilirubin**: The given note provides the total bilirubin as 40. 2 umol/L. We need to convert this to mg/dL since the Child-Pugh score typically uses bilirubin in mg/dL. The conversion factor is 1 mg/dL = 17.1 umol/L. \\[ \\text{Bilirubin in mg/dL} = \\frac{40.2 \\, \\umol/L}{ 17.1} \\approx 2.35 \\, \\text{mg/dL}\\] 2. **Serum Albumin**: The lab value for serum albumin given in the note is 3. 1 g/dL. 3. **Prothrombin Time/INR**: The given INR is 2.1. 4. **Ascites**: The abdominal exam mentions \"negative for ascites\", so ascites is absent. 5. **Hepatic Encephalopathy**: The patient is oriented only to self and has asterixis, indicating hepatic enceph alopathy (grade 1 or 2, but even presence counts in Child-Pugh). Now, let's score each parameter: - **Bilirubin**: - < 1.7 mg/dL = 1 - 1.7 - 3.0 mg/dL = 2 - 3.0 - 6.0 mg/dL = 3 - > 6.0 = 4 - **Albumin** (3.1 g/dL): - \u2265 3.5 = 1 - 2.8 - 3.4 = 2 - 2.1 - 2.7 = 3 - < 2.1 = 4 - **INR (Prothrombin Time)**: - < 1.7 = 1 - 1.7 - 2.3 = 2 - > 2.3 = 3 - **Ascites**: - None (controlled) = 1 - Mild = 2 - Moderate or refractory = 3 - **Hepatic Encephalopathy**: - None = 1 - Grade 1 or 2 (confusion / lethargy, asterixis) = 2", "Ground Truth Answer": "8", "Ground Truth Explanation": "The current child pugh score is 0.\nThe patient's INR is 2.1. Because the INR is between 1.7 and 2.3, we add two to the score, making the current total 0 + 2 = 2.\nThe concentration of bilirubin is 40.2 \u00b5mol/L. We need to convert the concentration to mg/dL. Let's first convert the mass of bilirubin from \u00b5mol to mg. The mass of bilirubin is 40.2 \u00b5mol. To convert 40.2 \u00b5mol of bilirubin to mol, multiply by the conversion factor 1e-06, giving us 40.2 \u00b5mol bilirubin * 1e-06 mol/\u00b5mol = 4.02e-05 mol bilirubin. To convert from mol bilirubin to grams, multiply by the molar mass 548.66 g/mol, which will give 4.02e-05 mol bilirubin * 548.66 g/mol = 0.022 g bilirubin. To convert 0.022 g of bilirubin to mg, multiply by the conversion factor 1000.0, giving us 0.022 g bilirubin * 1000.0 mg/g = 22.0 mg bilirubin. The current volume unit is L and the target volume unit is dL. The conversion factor is 10.0 dL for every unit of L. Our next step will be to divide the mass by the volume conversion factor of 10.0 to get the final concentration in terms of mg/dL. This will result to 22.0 mg bilirubin/10.0 dL = 2.2 mg bilirubin/dL. The concentration value of 40.2 \u00b5mol bilirubin/L converts to 2.2 mg bilirubin/dL. Because the Bilirubin concentration is between 2 mg/dL and 3 mg/dL, we add 2 to the score, making the current total 2 + 2 = 4.\nThe concentration of albumin is 3.1 g/dL. Because the Albumin concentration is between 2.8 g/dL and 3.5 g/dL, we add 2 to the score, making the current total 4 + 2 = 6.\nEncephalopathy state is 'Grade 1-2 encephalopathy' and so we add two points to the score, making the current total 6 + 2 = 8.\nThe patient's child pugh score is 8.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the Child-Pugh Score for this patient, we need to evaluate several parameters: total bilirubin, serum albumin, proth rombin time (INR), ascites, and hepatic enceph alopathy. The Child-Pugh score classifies the severity of liver disease into 5 categories (A to D), each with a score from 5 to 15.\n\nFirst, let's gather the relevant lab values and clinical findings from the patient note:\n\n1. **Total Bilirubin**: The given note provides the total bilirubin as 40. 2 umol/L. We need to convert this to mg/dL since the Child-Pugh score typically uses bilirubin in mg/dL. The conversion factor is 1 mg/dL = 17.1 umol/L. \\[ \\text{Bilirubin in mg/dL} = \\frac{40.2 \\, \\umol/L}{ 17.1} \\approx 2.35 \\, \\text{mg/dL}\\]\n\n2. **Serum Albumin**: The lab value for serum albumin given in the note is 3. 1 g/dL.\n\n3. **Prothrombin Time/INR**: The given INR is 2.1.\n\n4. **Ascites**: The abdominal exam mentions \"negative for ascites\", so ascites is absent.\n\n5. **Hepatic Encephalopathy**: The patient is oriented only to self and has asterixis, indicating hepatic enceph alopathy (grade 1 or 2, but even presence counts in Child-Pugh).\n\nNow, let's score each parameter:\n\n- **Bilirubin**:\n  - < 1.7 mg/dL = 1\n  - 1.7 - 3.0 mg/dL = 2\n  - 3.0 - 6.0 mg/dL = 3\n  - > 6.0 = 4\n\n- **Albumin** (3.1 g/dL):\n  - \u2265 3.5 = 1\n  - 2.8 - 3.4 = 2\n  - 2.1 - 2.7 = 3\n  - < 2.1 = 4\n\n- **INR (Prothrombin Time)**:\n  - < 1.7 = 1\n  - 1.7 - 2.3 = 2\n  - > 2.3 = 3\n\n- **Ascites**:\n  - None (controlled) = 1\n  - Mild = 2\n  - Moderate or refractory = 3\n\n- **Hepatic Encephalopathy**:\n  - None = 1\n  - Grade 1 or 2 (confusion / lethargy, asterixis) = 2"}
{"Row Number": 596, "Calculator Name": "SIRS Criteria", "Calculator ID": "51", "Category": "diagnosis", "Note ID": "pmc-4499596-1", "Patient Note": "A 67-year-old man was admitted to our hospital with febrile sensation and cough for 3 days. He had no other underlying chronic disease. He was an ex-smoker (20 pack-years) and did not have a history of alcohol abuse. His vital signs were as follows: blood pressure, 140/82 mm Hg; heart rate, 68 beats per minute; respiratory rate, 20 per minute; and body temperature, 38.5\u2103. Auscultation revealed coarse crackles in both lower lung fields.\nChest radiography showed multiple pulmonary infiltrations in the right lung fields (). White blood cell count was 8,000/mm3 with 76.0% segmented neutrophils, 13.7% lymphocytes, and 1% eosinophils. C-reactive protein and procalcitonin were 23.34 mg/dL and 0.579 mg/dL, respectively. Other routine blood chemistry tests were all normal. Arterial blood gas analysis revealed pH 7.439, PCO2 36.3 mm Hg, PO2 52.4 mm Hg, and HCO3- 24.9 mmol/L.\nA computed tomography (CT) scan of the chest was performed, and revealed multiple pulmonary consolidations, ground-glass opacities, and interstitial septal thickenings in both lower lung fields (). Based on these observations, we made a diagnosis of CAP and initiated antimicrobial therapy of intravenous ceftriaxone 2 g plus azithromycin 500 mg. After treatment of CAP, the clinical findings of the patient stabilized, and the patient was discharged on hospital day 4.\nAfter three months, we performed a routine check-up of the patient. The patient had no definitive symptoms. Follow-up chest radiography showed resolution of multiple pulmonary consolidations throughout most of the lung fields, but a mass-like lesion without the loss of right cardiac borders at the right lower lobe field was observed (). Follow-up CT scans of the chest revealed interval improvements in pneumonic consolidations in both lower lung fields, but an increased mass in the right posterior mediastinum at T6-7 level that we had considered to be pneumonic consolidations on the previous CT scans was visible (). This oval and elongated mass with mild enhancement of soft tissue density without any bone destruction was observed (). Positron emission tomography using 2-[fluorine-18] fluoro-2-deoxy-D-glucose (FDG) imaging and CT scans of the whole body except the brain revealed mild FDG uptake of maximum standardized uptake value 3.4 at the posterior mediastinal mass.\nPercutaneous needle biopsy using ultrasound was performed. Lung ultrasound revealed an ill-defined, hypoechoic subpleural lesion measuring about 5.0 cm\u00d72.7 cm at right paraspinal area of T6-7 level. And microscopic examination showed diffuse infiltrates of polymorphous and asynchronous plasma cells with large and eccentric nuclei, prominent nucleoli, and abundant cytoplasm (). Immunohistochemistry revealed the biopsy was positive for CD138, the cytoplasm was diffusely reactive for monoclonal kappa-light chain (). Based on these findings, the posterior mediastinal mass was diagnosed as a IgG kappa type plasmacytoma.\nWe subsequently investigated the possibility of multiple myeloma. Laboratory tests showed an inverse albumin/globulin ratio (total protein, 10.7 g/dL; albumin, 3.0 g/dL; A/G ratio, 0.38). Serum hemoglobin, creatinine, and total calcium were 11.8 g/dL, 1.4 mg/dL, and 8.5 mg/dL, respectively. Immunofixation of serum showed monoclonal gammopathy of IgG-kappa type. In serum protein electrophoresis, the M spike level was 4.58 g/dL. Serum Ig determination revealed a markedly increased IgG level (6,993.1 mg/dL), and the level of \u03b22-microglobulin was 3,674.2 ng/mL. On bone marrow aspiration and biopsy, plasma cells were increased up to 7.8% of all marrow nucleated cells. Those findings were consistent with monoclonal gammopathy of undetermined significance (MGUS) and insufficient for diagnostic criteria of symptomatic multiple myeloma. The patient was finally diagnosed as a posterior mediastinal plasmacytoma (IgG-kappa type). The patient was referred to the hematology department for proper treatment. This report was approved by the Ethical Review Committee.", "Question": "What is the number of SIRS critiera met by the patient?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "1", "LLM Explanation": "To determine the number of SIRS criteria met by the patient, I will check each of the four SIRS criteria against the given patient data.\\n\\n1. **Temperature**: The patient's body temperature is 38.5\u00b0C. Since this is greater than 38\u00b0C, this criterion is met.\\n\\n2. **Heart Rate**: The patient's heart rate is 68 beats per minute. The criterion requires a heart rate > 90 beats per minute. Since 68 is not greater than 90, this criterion is not met.\\n\\n3. **Respiratory Rate**: The patient's respiratory rate is 20 breaths per minute. The criterion requires a respiratory rate > 20 breaths per minute. Since the respiratory rate is exactly 20, it does not meet the criterion of being greater than 20 breaths per minute. Therefore, this criterion is not met.\\n\\n4. **White Blood Cell Count (WBC)**: The patient's WBC count is 8,000/mm3. The criterion for WBC is either > 12,000/mm3 or < 4,000/mm3, or > 10% immature band forms. The WBC count of 8,000/mm3 is neither > 12,000/mm3 nor < 4,000/mm3. Additionally, there is no information provided about the presence of immature band forms. Therefore, this criterion is not met.\\n\\nIn summary, out of the four SIRS criteria, only the temperature criterion is met.", "LLM Thinking": "Okay, so I need to figure out how many SIRS criteria this patient met. Let me start by recalling what the SIRS criteria are. SIRS stands for Systemic Inflammatory Response Syndrome, and it's used to identify patients with a systemic response that might indicate sepsis or a serious systemic inflammatory condition. The SIRS criteria include: 1. Temperature greater than 38\u00b0C (100.4\u00b0F) or less than 36\u00b0C (96.8\u00b0F). 2. Heart rate > 90 beats/min. 3. Respiratory rate > 20 breaths/min or PaCO2 < 32 mmHg. 4. WBC (white blood cell count) > 12,000 /mm3 or < 4,000/mm3, or > 10% immature band forms (neutrophils). Hmm, the cutoff is >20, so maybe this doesn't count unless we can prove that PaCO2 is < 32 mmHg. Wait, looking at the blood gas, the PaCO2 is 36.3 mm Hg.", "Ground Truth Answer": "2", "Ground Truth Explanation": "The current count of SIRS criteria met is 0.\nThe patient's temperature is 38.5 degrees celsius. Because the temperature is greater than 38 degrees celsius, we increment the criteria count by 1 making the current total 0 + 1 = 1.\nThe patient's heart rate is 68.0 beats per minute. Because the heart rate is less than 90 beats per minute, this does not meet SIRS criteria for heart rate, and so the current total remains at 1.\nThe patient's concentration of white blood cell is 8000.0 count/m^3. Because the white blood cell count is between 4000 and 12000 count per m^3, this does not meet SIRS criteria for white blood cell count, and so the current total remains at 2.\nThe final SIRS criteria is whether the patient has a respiratory rate of more than 20 breaths per minute or if the patient's PaCO\u2082 partial pressure is less than 32 mm Hg. The patient's respiratory rate is 20.0 breaths per minute, which is less or equal to than 20 breaths per min. The patient's PaCO\u2082 partial pressure is 36.3 mm Hg, which is greater or equal to than 32 mm Hg. Neither criteria met and so keep the current total at 2.\nHence, the the number of SIRS criteria met by the patient is 2.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to figure out how many SIRS criteria this patient met.  \nLet me start by recalling what the SIRS criteria are.  \nSIRS stands for Systemic Inflammatory Response Syndrome, and it's used to identify patients with a systemic response that might indicate sepsis or a serious systemic inflammatory condition.  \nThe SIRS criteria include:\n\n1. Temperature greater than 38\u00b0C (100.4\u00b0F) or less than 36\u00b0C (96.8\u00b0F).  \n2. Heart rate > 90 beats/min.  \n3. Respiratory rate > 20 breaths/min or PaCO2 < 32 mmHg.  \n4. WBC (white blood cell count) > 12,000 /mm3 or < 4,000/mm3, or > 10% immature band forms (neutrophils).\n\nHmm, the cutoff is >20, so maybe this doesn't count unless we can prove that PaCO2 is < 32 mmHg.  \nWait, looking at the blood gas, the PaCO2 is 36.3 mm Hg."}
{"Row Number": 966, "Calculator Name": "Steroid Conversion Calculator", "Calculator ID": "24", "Category": "dosage", "Note ID": "19", "Patient Note": "Patient has taken 152.535 mg of Hydrocortisone IV.", "Question": "Based on the patient's dose of Hydrocortisone IV, what is the equivalent dosage in mg of PredniSONE PO? ", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "38.13", "LLM Explanation": "Step 1: Understand the relationship between Hydrocortisone and Prednisone. The conversion ratio between Hydrocortisone and Prednisone is typically 4:1. This means that 4 mg of Hydrocortisone is equivalent to 1 mg of Prednisone. Step 2: Convert the given dose of Hydrocortisone IV to the equivalent dose of Prednisone PO. The patient has received 152.535 mg of Hydrocortisone IV. To find the equivalent amount in Prednisone, we use the conversion ratio. Step 3: Perform the calculation. \\[ \\text{Equivalent Prednisone dose (mg)} = \\frac{\\text{Hydrocortisone dose (mg)}}{4}.\\] Now, let's plug in the given dose of Hydrocortisone: \\[ \\text{Equivalent Prednisone dose (mg)} = \\frac{152.535}{4}.\\] Perform the division: \\[ \\frac{152.535}{4} = 38.13375.\\] So, the equivalent dosage in mg of Prednisone PO for 152.535 mg of Hydrocortisone IV is approximately 38.13375 mg. Rounding to two decimal places, 38.13375 becomes 38.13. Therefore, the equivalent dosage in mg of Prednisone PO is 38.13 mg.", "LLM Thinking": "Step 1: Understand the relationship between Hydrocortisone and Prednisone. The conversion ratio between Hydrocortisone and Prednisone is typically 4:1. This means that 4 mg of Hydrocortisone is equivalent to 1 mg of Prednisone. Step 2: Convert the given dose of Hydrocortisone IV to the equivalent dose of Prednisone PO. The patient has received 152.535 mg of Hydrocortisone IV. To find the equivalent amount in Prednisone, we use the conversion ratio. Step 3: Perform the calculation. \\[ \\text{Equivalent Prednisone dose (mg)} = \\frac{\\text{Hydrocortisone dose (mg)}}{4}.\\]", "Ground Truth Answer": "38.134", "Ground Truth Explanation": "The mass of Hydrocortisone IV is 152.535 mg. To convert from the Hydrocortisone IV to PredniSONE PO, multiply by the conversion factor, 0.25 mg PredniSONE PO/Hydrocortisone IV, giving us 152.535 mg Hydrocortisone IV * 0.25 mg PredniSONE PO/mg Hydrocortisone IV = 38.134 mg PredniSONE PO. 152.535 mg of Hydrocortisone IV is equal to 38.134 mg of PredniSONE PO.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: Understand the relationship between Hydrocortisone and Prednisone.  \nThe conversion ratio between Hydrocortisone and Prednisone is typically 4:1.  \nThis means that 4 mg of Hydrocortisone is equivalent to 1 mg of Prednisone.  \nStep 2: Convert the given dose of Hydrocortisone IV to the equivalent dose of Prednisone PO.  \nThe patient has received 152.535 mg of Hydrocortisone IV.\n\nTo find the equivalent amount in Prednisone, we use the conversion ratio.\n\nStep 3: Perform the calculation.\n\n\\[ \\text{Equivalent Prednisone dose (mg)} = \\frac{\\text{Hydrocortisone dose (mg)}}{4}.\\]"}
{"Row Number": 952, "Calculator Name": "Steroid Conversion Calculator", "Calculator ID": "24", "Category": "dosage", "Note ID": "5", "Patient Note": "Patient has taken 45.802 mg of PredniSONE PO.", "Question": "Based on the patient's dose of PredniSONE PO, what is the equivalent dosage in mg of Hydrocortisone IV? ", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "183.208", "LLM Explanation": "To convert the dose of Prednisone to Hydrocortisone, we use the standard conversion factor that 1 mg of Prednisone is approximately equal to 4 mg of Hydrocortisone. Given the patient's dose is 45.802 mg of Prednisone, we multiply this by 4 to get the equivalent dose in Hydrocortisone. The calculation is: 45.802 * 4 = 183.208 mg of Hydrocortisone.", "LLM Thinking": "Okay, so I need to figure out the equivalent dosage of Hydrocortisone IV based on the patient's Prednisone dose. Let's approach this step by step. Step 1: First, recall the conversion factor between Prednisone (oral) and Hydrocortisone (intravenous or generally). The typical conversion rate is that 1 mg of Prednisone is usually equivalent to about 4 to 5 mg of Hydrocortisone. The commonly used conversion factor is usually around 4 mg of Hydrocortisone per 1 mg of Prednisone, but I should verify if it applies here. So, if 1 mg of Prednisone equals 4 mg Hydrocortisone, then 45.802 mg of Prednisone would be converted to Hydrocortisone as follows: \\[ \\text{Equivalent Hydrocortisone dose} = \\text{Prednisone dose (mg)} \\times 4 \\] Wait, but let me double-check the conversion factor to be sure. Some sources say that the exact conversion can vary slightly. The standard ratio is indeed 1:4. So 1 mg of Prednisone is approximately equal to 4 mg of Hydrocortisone. Step 2: Now, calculate the equivalent dose using the given Prednisone dose. The patient has taken 45.802 mg of Prednisone PO. Using the conversion factor, \\[ \\text{Hydrocortisone} = 45.802 \\times 4 \\] Let me compute that. 45 times 4 is 180, and 0.8 times 4 is 3.2. Then, 0.02 times 4 is 0.08. So, performing the exact calculation: 45.802 \u00d7 4 = ? Let me do the multiplication step by step: 45 \u00d7 4 = 180 0.8 \u00d7 4 = 3.2 \u2192 total so far 183.2 0.02 \u00d7 4 = 0.08 Now add them all together: 180 + 3.2 = 183.2 Add the 0.08 to it: 183.2 + 0.08 = 183.28 Perform the detailed multiplication: \\[ 4 * 45.802 = (4 * 45) + (4 * 0.8) + (4 * 0.002) \\] 4 * 45 = 180 4 * 0.8 = 3.2 4 * 0.002 = 0.008 Adding these results together: 180 (from 4 * 45) + 3.2 (from 4 * 0.8) + 0.008 (from 4 * 0.002) Let's add them stepwise. 180 + 3.2 = 183.2 Then add 0.008: 183.2 + 0.008 = 183.208? Wait a second, maybe I messed up the decimal. I'll do the multiplication a bit differently. Let me write 45.802 as 45.802 and multiply by 4. 45.802 * 4 To make it easier, split it into two: [4 * 45.8 + 4 * 0.002]. [4 * 45.8 = 4*(40 + 5.8)= 160 + 23.2 = 183.2] and [4 * 0.002 = 0.008] Adding both results together: 183.2 + 0.008 = 183.208.", "Ground Truth Answer": "183.162", "Ground Truth Explanation": "The mass of PredniSONE PO is 45.802 mg. To convert from the PredniSONE PO to Hydrocortisone IV, multiply by the conversion factor, 3.999 mg Hydrocortisone IV/PredniSONE PO, giving us 45.802 mg PredniSONE PO * 3.999 mg Hydrocortisone IV/mg PredniSONE PO = 183.162 mg Hydrocortisone IV. 45.802 mg of PredniSONE PO is equal to 183.162 mg of Hydrocortisone IV.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to figure out the equivalent dosage of Hydrocortisone IV based on the patient's Prednisone dose. Let's approach this step by step.\n\nStep 1: First, recall the conversion factor between Prednisone (oral) and Hydrocortisone (intravenous or generally). The typical conversion rate is that 1 mg of Prednisone is usually equivalent to about 4 to 5 mg of Hydrocortisone. The commonly used conversion factor is usually around 4 mg of Hydrocortisone per 1 mg of Prednisone, but I should verify if it applies here.\n\nSo, if 1 mg of Prednisone equals 4 mg Hydrocortisone, then 45.802 mg of Prednisone would be converted to Hydrocortisone as follows:\n\n\\[ \\text{Equivalent Hydrocortisone dose} = \\text{Prednisone dose (mg)} \\times 4 \\]\n\nWait, but let me double-check the conversion factor to be sure. Some sources say that the exact conversion can vary slightly. The standard ratio is indeed 1:4. So 1 mg of Prednisone is approximately equal to 4 mg of Hydrocortisone.\n\nStep 2: Now, calculate the equivalent dose using the given Prednisone dose. The patient has taken 45.802 mg of Prednisone PO.\n\nUsing the conversion factor,\n\n\\[ \\text{Hydrocortisone} = 45.802 \\times 4 \\]\n\nLet me compute that. 45 times 4 is 180, and 0.8 times 4 is 3.2. Then, 0.02 times 4 is 0.08.\n\nSo, performing the exact calculation:\n\n45.802 \u00d7 4 = ? Let me do the multiplication step by step:\n\n45 \u00d7 4 = 180\n\n0.8 \u00d7 4 = 3.2 \u2192 total so far 183.2\n\n0.02 \u00d7 4 = 0.08\n\nNow add them all together: 180 + 3.2 = 183.2\n\nAdd the 0.08 to it: 183.2 + 0.08 = 183.28\n\nPerform the detailed multiplication:\n\n\\[ 4 * 45.802 = (4 * 45) + (4 * 0.8) + (4 * 0.002) \\]\n\n4 * 45 = 180\n\n4 * 0.8 = 3.2\n\n4 * 0.002 = 0.008\n\nAdding these results together: 180 (from 4 * 45) + 3.2 (from 4 * 0.8) + 0.008 (from 4 * 0.002)\n\nLet's add them stepwise.\n\n180 + 3.2 = 183.2 Then add 0.008: 183.2 + 0.008 = 183.208?\n\nWait a second, maybe I messed up the decimal. I'll do the multiplication a bit differently. Let me write 45.802 as 45.802 and multiply by 4.\n\n45.802 * 4\n\nTo make it easier, split it into two: [4 * 45.8 + 4 * 0.002].\n\n[4 * 45.8 = 4*(40 + 5.8)= 160 + 23.2 = 183.2]\n\nand \n[4 * 0.002 = 0.008]\n\nAdding both results together: 183.2 + 0.008 = 183.208."}
{"Row Number": 991, "Calculator Name": "Morphine Milligram Equivalents (MME) Calculator", "Calculator ID": "49", "Category": "dosage", "Note ID": "4", "Patient Note": "The patient takes 60 mg of FentANYL patch 1 time a day, 20 mg of HYDROmorphone 3 times a day, and 30 mg of FentaNYL buccal 2 times a day.", "Question": "Based on the number of doses per day and the quantity of different doses, what is the patient's daily Morphine Miligram Equivalents (MME)?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "6480", "LLM Explanation": "To calculate the patient's daily Morphine Milligram Equivalents (MME), we will convert each medication to its MME and sum them up.\\n\\n1. **Fentanyl Patch (60 mg, once a day):**\\n - Conversion factor: 1 mg Fentanyl patch = 4 mg MME.\\n - MME for the Fentanyl patch: \\( 60 \\, \\text{mg} \\times 4 = 240 \\, \\text{MME}.\\)\\n\\n2. **Hydromorphone (20 mg, 3 times a day):**\\n - Daily dose of Hydromorphone: \\( 20 \\, \\text{mg/dose} \\times 3 \\, \\text{doses/day} = 60 \\, \\text{mg/day}.\\)\\n - Conversion factor: 1 mg Hydromorphone = 4 mg MME.\\n - MME for Hydromorphone: \\( 60 \\, \\text{mg} \\times 4 = 240 \\, \\text{MME}.\\)\\n\\n3. **Fentanyl Buccal (30 mg, 2 times a day):**\\n - Daily dose of Fentanyl buccal: \\( 30 \\, \\text{mg/dose} \\times 2 \\, \\text{doses/day} = 60 \\, \\text{mg/day}.\\)\\n - Conversion factor for Fentanyl buccal: 1 mg Fentanyl buccal = 100 mg MME.\\n - MME for Fentanyl buccal: \\( 60 \\, \\text{mg} \\times 100 = 6000 \\, \\text{MME}.\\)\\n\\nNow, sum up all the MMEs:\\n\\[ \\text{Total MME} = 240 \\, \\text{(from Fentanyl patch)} + 240 \\, \\text{(from Hydromorphone)} + 6000 \\, \\text{(from Fentanyl buccal)} = 6480 \\, \\text{MME}.\\]", "LLM Thinking": "First, we need to convert the given medications and their dosages to their respective Morphine Milligram Equivalents (MMEs). The conversion factors are: - Fentanyl patch: 1 mcg of Fentanyl is equivalent to 0.16 mg of Morphine. However, the Fentanyl patch is a transdermal delivery system, so the total daily dose from the patch needs to be calculated over a 24-hour period. Wait, actually, the Fentanyl patch is applied every 72 hours (3 days), but the daily dose is calculated by dividing the total patch mg by 3. - Hydrocodone or Hydromorphone: Generally, it\u2019s assumed that approximately 1 mg of Hydromorphone is equivalent to 4\u20138 mg of oral morphine. The CDC uses a conversion factor of 4 mg oral morphine per 1 mg of Hydromorphone, but I need to confirm the correct one. - Fentanyl buccal: 100 mcg of buccal (or sublingual) Fentanyl is roughly equivalent to 20 mg oral morphine, i.e., 1 mg Fentanyl = 20 mg MME. Wait, actually the conversion rate is that 1 mcg buccal/IV Fentanyl is equivalent to 0.16 mg oral morphine? Or maybe I\u2019m mixing up with the transdermal? The correct conversion for Fentanyl buccal is closer to having 1 mcg = 1 mg morphine? But commonly it\u2019s about 0.16 mg morphine for every mcg. Let\u2019s convert each component step by step. **1. Fentanyl patch (60 mg):** Conversion rate for transdermal Fentanyl to MME: 1 mcg/hour (which is the transdermal rate) is 0.16 mg morphine per day. Wait, maybe the total mg from the patch needs to be converted to MME in a different way. Let\u2019s see. The standard conversion factor is that 10 mcg/hour from a transdermal fentanyl patch is equivalent to 1 mg Oral Morphine per day. So, the total daily dose from the patch is calculated by first converting the mg to mcg. But the patch delivers over 72 hours. Wait, perhaps I should use the common approach where: The standard approach is that each Fentanyl patch has a certain strength (in mg), and that can be converted to a corresponding MME. The conversion factor for Fentanyl transdermal is 1 mg = 10 mg MME (some sources say 1 mg fentanyl = 25 mg MME, but perhaps CDC uses 1 mg fentanyl = 2.5\u20134 times the mg to convert to oral MME over 24 hours). Alternatively, according to CDC\u2019s MME calculator: The Fentanyl transdermal equivalent to MME factor is 1 mg Fentanyl = 4 mg MME. **2. Hydrocodone/Hydromorphone (20 mg, 3 times a day):** Hydromorphone conversion factor: 1 mg = 4 mg morphine. **3. Fentanyl buccal (30 mg, 2 times per day):** For buccal or sublingual Fentanyl, it\u2019s often considered that 1 mcg = 0.16 mg MME, so 1 mg = 1 000 mcg \u00d7 0.16 mg = 160 mg MME.", "Ground Truth Answer": "451.8", "Ground Truth Explanation": "The curent Morphine Milligram Equivalents (MME) is 0 MME per day.\nThe patient's dose of FentANYL patch is 60 mg. The patient takes 1 doses/day of FentANYL patch. This means that the patient takes 60 mg/dose FentANYL patch * 1 dose/day = 60 mg/day. To convert to mme/day of FentANYL patch, multiply the 60 mg/day by the mme conversion factor, 2.4 mme/mg, giving us 144.0 mme/day. Adding the mme/day of FentANYL patch to the total mme/day gives us 0 + 144.0 = 144.0 mme/day.\nThe patient's dose of HYDROmorphone is 20 mg. The patient takes 3 doses/day of HYDROmorphone. This means that the patient takes 20 mg/dose HYDROmorphone * 3 dose/day = 60 mg/day. To convert to mme/day of HYDROmorphone, multiply the 60 mg/day by the mme conversion factor, 5 mme/mg, giving us 300 mme/day. Adding the mme/day of HYDROmorphone to the total mme/day gives us 144.0 + 300 = 444.0 mme/day.\nThe patient's dose of FentaNYL buccal is 30 \u00b5g.\nThe patient takes 2 doses/day of FentaNYL buccal. This means that the patient takes 30 \u00b5g/dose FentaNYL buccal * 2 dose/day = 60 \u00b5g/day. To convert to mme/day of FentaNYL buccal, multiply the 60 \u00b5g/day by the mme conversion factor, 0.13 mme/\u00b5g, giving us 7.8 mme/day. Adding the mme/day of FentaNYL buccal to the total mme/day gives us 444.0 + 7.8 = 451.8 mme/day.\nThe patient's mme/day is 451.8 mme/day.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to convert the given medications and their dosages to their respective Morphine Milligram Equivalents (MMEs). The conversion factors are:\n\n- Fentanyl patch: 1 mcg of Fentanyl is equivalent to 0.16 mg of Morphine. However, the Fentanyl patch is a transdermal delivery system, so the total daily dose from the patch needs to be calculated over a 24-hour period. Wait, actually, the Fentanyl patch is applied every 72 hours (3 days), but the daily dose is calculated by dividing the total patch mg by 3.  \n- Hydrocodone or Hydromorphone: Generally, it\u2019s assumed that approximately 1 mg of Hydromorphone is equivalent to 4\u20138 mg of oral morphine. The CDC uses a conversion factor of 4 mg oral morphine per 1 mg of Hydromorphone, but I need to confirm the correct one.  \n- Fentanyl buccal: 100 mcg of buccal (or sublingual) Fentanyl is roughly equivalent to 20 mg oral morphine, i.e., 1 mg Fentanyl = 20 mg MME. Wait, actually the conversion rate is that 1 mcg buccal/IV Fentanyl is equivalent to 0.16 mg oral morphine? Or maybe I\u2019m mixing up with the transdermal? The correct conversion for Fentanyl buccal is closer to having 1 mcg = 1 mg morphine? But commonly it\u2019s about 0.16 mg morphine for every mcg.\n\nLet\u2019s convert each component step by step.\n\n**1. Fentanyl patch (60 mg):**  \nConversion rate for transdermal Fentanyl to MME: 1 mcg/hour (which is the transdermal rate) is 0.16 mg morphine per day. Wait, maybe the total mg from the patch needs to be converted to MME in a different way. Let\u2019s see. The standard conversion factor is that 10 mcg/hour from a transdermal fentanyl patch is equivalent to 1 mg Oral Morphine per day. So, the total daily dose from the patch is calculated by first converting the mg to mcg. But the patch delivers over 72 hours. Wait, perhaps I should use the common approach where:\n\nThe standard approach is that each Fentanyl patch has a certain strength (in mg), and that can be converted to a corresponding MME. The conversion factor for Fentanyl transdermal is 1 mg = 10 mg MME (some sources say 1 mg fentanyl = 25 mg MME, but perhaps CDC uses 1 mg fentanyl = 2.5\u20134 times the mg to convert to oral MME over 24 hours). Alternatively, according to CDC\u2019s MME calculator:\n\nThe Fentanyl transdermal equivalent to MME factor is 1 mg Fentanyl = 4 mg MME.\n\n**2. Hydrocodone/Hydromorphone (20 mg, 3 times a day):**  \nHydromorphone conversion factor: 1 mg = 4 mg morphine.\n\n**3. Fentanyl buccal (30 mg, 2 times per day):**  \nFor buccal or sublingual Fentanyl, it\u2019s often considered that 1 mcg = 0.16 mg MME, so 1 mg = 1 000 mcg \u00d7 0.16 mg = 160 mg MME."}
{"Row Number": 548, "Calculator Name": "CURB-65 Score for Pneumonia Severity", "Calculator ID": "45", "Category": "risk", "Note ID": "pmc-7282354-1", "Patient Note": "Here we report a case of a 41-year-old man with past medical history (PMH) of asthma, urinary tract infection (UTI), erectile dysfunction, and diverticulosis with a prior episode of diverticulitis who had presented with left lower quadrant (LLQ) pain and managed for complicated UTI secondary to prostatitis/nephrolithiasis in July 2019, three months prior to the current presentation. Blood and urine cultures did not reveal any growth at that time and CT of abdomen and pelvis demonstrated diverticulitis of descending colon, thickening of bladder wall, and prostatic calcifications, with no liver lesions. He was discharged home on oral levofloxacin and his pain resolved with completion of outpatient course of oral antibiotics.\nHe came to the ER three months later in October 2019 with a two-day history of RUQ pain, 9/10 in intensity, not related to oral intake, and relieved by lying supine. It was associated with anorexia and malaise. He also mentioned a one-week history of fever, rigors, and generalized weakness. Review of systems were remarkable for foul-smelling urine with associated, intermittent LLQ pain. He reported nausea without vomiting. Of note, he denied recent travel and change in dietary habits. He has not been sexually active for the past year and he had an index colonoscopy in 2004.\nOn exam in the ER, his BP was 121/79, pulse 111, temp. 101.7\u00b0F, respiratory rate (RR) 19, saturating at 95% on room air. His mucous membranes were dry, abdomen was tender in RUQ. Chest was clear and rectal exam was negative for mass or active bleeding with a normal sphincter tone. His labs were significant for white blood cell (WBC) of 17.7 with left shift (neutrophil of 85.7 and bands 25%), hemoglobin (Hb) of 12.8, potassium of 3.3, magnesium of 1.5 and lactate of 2.2, blood urea nitrogen (BUN)/creatinine of 21/1.0, alkaline phosphatase of 136, aspartate aminotransferase (AST) 218, alanine transaminase (ALT) 242 and international normalized ratio (INR) of 1.3. Urine analysis (UA) was positive for nitrites, LE 2+, packed field with WBC and many bacteria on urine microscopy.\nChest X-ray (CXR) did not demonstrate any acute cardiopulmonary disease. CT abdomen and pelvis revealed two multilocular, hypoattenuating lesions in the right lobe of the liver which were 7-8 cm in size (Figure ), new as compared to previous CT scan done three months prior (Figure ). Cross-sectional imaging was also suggestive of sigmoid diverticulitis and colo-vesical fistula. At this point, the main focus was on multifocal, metastatic infection to the liver versus primary liver abscesses. The patient was admitted to the ICU for intensive monitoring and management of sepsis secondary to hepatic abscesses/complicated UTI. Blood and urine cultures were taken before the initiation of broad-spectrum, intravenous antibiotics.\nHe underwent percutaneous drainage of both liver collections and fluid analysis was performed. The fluid was tested for ova and parasite with negative results. Cytology was negative for malignant cells. Fluid microscopy revealed abundant neutrophils consistent with abscess. Cultures were positive for S. constellatus. Blood cultures isolated S. constellatus which was concordant with fluid studies. Urine culture was significant for E. coli. Serological testing for Echinococcus antibody was negative. Based on the culture and sensitivity of liver fluid collections, he was started on levofloxacin and metronidazole. The patient was managed for Gram-positive bacteremia and repeat cultures after initiation of parenteral antibiotics were negative. A peripherally inserted central catheter (PICC) line was placed to continue intravenous antibiotics for six weeks.\nFollow-up CT revealed a sigmoid abscess and findings consistent with colo-vesical fistula (Figure ). The sigmoid abscess was drained percutaneously, but not cultured. A diverting loop ileostomy was performed for initial management of colo-vesical fistula with plans for definitive surgery in the future. Work up for inflammatory bowel disease was negative including anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophilic cytoplasmic autoantibody (ANCA). HIV and Hepatitis B and C serologies were negative.\nHe was discharged home with PICC line in place with arrangements for outpatient IV antibiotics. During outpatient follow up, both liver abscess were fully resolved (Figure ). He completed six weeks of IV antibiotics and the PICC line was removed. He will follow up with urology for definitive repair of colovesical fistula.", "Question": "What is the patient's CURB-65 score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "1", "LLM Explanation": "To calculate the CURB-65 score for the patient, we need to check each criterion:\\n1. Confusion: No mention of confusion, so 0 points.\\n2. Urea: BUN is 21 mg/dL, which is > 20 mg/dL, so 1 point.\\n3. Respiratory rate: The respiratory rate is 19, which is less than 30 breaths per minute, so 0 points.\\n4. Blood pressure: The blood pressure is 121/79, which is within the normal range (SBP \u2265 90 mmHg and DBP \u2265 60 mmHg), so 0 points.\\n5. Age: The patient is 41 years old, which is less than 65 years, so 0 points.\\nAdding up the points: 0 (Confusion) + 1 (Urea) + 0 (Respiratory rate) + 0 (Blood pressure) + 0 (Age) = 1.", "LLM Thinking": "To calculate the CURB-65 score for the patient, we need to evaluate the criteria included in the CURB-65 scoring system for assessing the severity of community-acquired pneumonia. However, looking at the provided patient note, the patient's primary issues are related to liver abscess, possible UTI and colovesical fistula . The note does not mention a diagnosis of pneumonia. The CURB-65 score is specifically used for pneumonia severity, so its application here might be questionable unless we assume that the patient presents with a systemic infection or sepsis that may resemble certain aspects of pneumonia. But traditional CURB-65 factors include: Confusion, Urea , Respiratory rate, Blood pressure, and Age \u2265 65. Let's approach this step by step. 1. **Confusion**: There 's no mention of confusion or altered mental status in the patient's presentation. The only mental status mentioned is \"malaise.\" 2. **Urea **: The lab result for Blood Urea Nitrogen (BUN) is provided as 21. (We generally use the BUN level for the urea component in CURB-65, where a BUN > 7 mmol/L (or approximately BUN > 20 mg/dL) qualifies for a point. Since the BUN is 21, which is slightly elevated, this criterion is met.) 3. **Respiratory rate (\u2265 3 0 breaths per minute)**: The respiratory rate (RR) is given as 19, which is within the normal range (typically 1 2-20 breaths per minute for adults), so this criterion is not met. 4. **Blood pressure (SBP < 90 mmHg or DBP < 60 mmHg)**: The patient's BP is 121/79, which is within the normal range for systolic (SBP > 90 mm Hg) and diastolic blood pressure (DBP > 6 0 mmHg), so this criterion is not met. 5. ** Age \u2265 6 5 years old**: The patient is 41 years old, so this is not met. {\"step _by_step_thinking\": \"To calculate the CURB-65 score , the criteria are assessed: Confusion (no), Urea (B UN 21 mg/dL, so 1 point), Respiratory rate <30 (0), Blood pressure normal (0), Age < 65 (0).\\n Adding up the points :\\n Confusion : 0\\n Urea (BUN \u2265 20 mg/d L): 1\\n Respiratory Rate : 0\\n BP (SB P < 90 or DBP < 60): 0 \\n Age \u2265 65 : 0\\n\"} Assistant {\"step_by_step_th inking\": \"To determine the CURB-65 score for the given patient, we evaluate the following criteria:\\n1. **Confusion**: The patient does not exhibit confusion (only malaise mentioned).\\n2. **Urea**: BUN is 21 mg/dL (\u2265 20 mg/dL), so 1 point.\\n3. **Respiratory Rate**: The respiratory rate is 19, which is normal (not over 30), thus 0 points.\\n4. **BP**: Blood pressure is 121/79 (both within normal ranges), so 0 points.\\n5. ** Age**: The patient is 41 years old (under 65 ), so 0 points.\"}", "Ground Truth Answer": "1", "Ground Truth Explanation": "The Curb-65 score is current at 0 points.\nThe patient is 41.0 years old. The patient's age is less than 65 years, and so we add 0 points to the score, keeping the current total at 0.\nWhether the patient has confusion is not reported in the note. Hence, we assume this to be false, and so 0 points are added to the score, making the current total 0.\nThe concentration of BUN is 21.0 mg/dL. The patient's BUN concentration is greater than 19 mg/dL and so we add 1 point to score making the current total 0 + 1 = 1.\nThe patient's respiratory rate is 19 breaths per minute. Because the respiratory rate is greater than 30 breaths per minute, 0 points are added to the score, keeping the current total at 1.\nThe patient's systiolic blood pressure is 121 mm Hg. The patient's diastolic blood pressure is 79 mm Hg. For a point a point to be added, the systiolic blood pressure must be less than 90 mm Hg or the diastolic blood pressure must be less than or equal to 60 mm Hg. Because neither of these statements are true, 0 points are added to score, keeping the current total to 1.\nThe patient's Curb-65 score is 1.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the CURB-65 score for the patient, we need to evaluate the criteria included in the CURB-65 scoring system for assessing the severity of community-acquired pneumonia. However, looking at the provided patient note, the patient's primary issues are related to liver abscess, possible UTI and colovesical fistula . The note does not mention a diagnosis of pneumonia. The CURB-65 score is specifically used for pneumonia severity, so its application here might be questionable unless we assume that the patient presents with a systemic infection or sepsis that may resemble certain aspects of pneumonia. But traditional CURB-65 factors include: Confusion, Urea , Respiratory rate, Blood pressure, and Age \u2265 65. Let's approach this step by step.\n\n1. **Confusion**: There 's no mention of confusion or altered mental status in the patient's presentation. The only mental status mentioned is \"malaise.\"\n\n2. **Urea **: The lab result for Blood Urea Nitrogen (BUN) is provided as 21. (We generally use the BUN level for the urea component in CURB-65, where a BUN > 7 mmol/L (or approximately BUN > 20 mg/dL) qualifies for a point. Since the BUN is 21, which is slightly elevated, this criterion is met.)\n\n3. **Respiratory rate (\u2265 3 0 breaths per minute)**: The respiratory rate (RR) is given as 19, which is within the normal range (typically 1 2-20 breaths per minute for adults), so this criterion is not met.\n\n4. **Blood pressure (SBP < 90 mmHg or DBP < 60 mmHg)**: The patient's BP is 121/79, which is within the normal range for systolic (SBP > 90 mm Hg) and diastolic blood pressure (DBP > 6 0 mmHg), so this criterion is not met.\n\n5. ** Age \u2265 6 5 years old**: The patient is 41 years old, so this is not met.\n\n{\"step _by_step_thinking\": \"To calculate the CURB-65 score , the criteria are assessed: Confusion (no), Urea (B UN 21 mg/dL, so 1 point), Respiratory rate <30 (0), Blood pressure normal (0), Age < 65 (0).\\n Adding up the points :\\n Confusion : 0\\n Urea (BUN \u2265 20 mg/d L): 1\\n Respiratory Rate : 0\\n BP (SB P < 90 or DBP < 60): 0 \\n Age \u2265 65 : 0\\n\"}\n\nAssistant\n{\"step_by_step_th inking\": \"To determine the CURB-65 score for the given patient, we evaluate the following criteria:\\n1. **Confusion**: The patient does not exhibit confusion (only malaise mentioned).\\n2. **Urea**: BUN is 21 mg/dL (\u2265 20 mg/dL), so 1 point.\\n3. **Respiratory Rate**: The respiratory rate is 19, which is normal (not over 30), thus 0 points.\\n4. **BP**: Blood pressure is 121/79 (both within normal ranges), so 0 points.\\n5. ** Age**: The patient is 41 years old (under 65 ), so 0 points.\"}"}
{"Row Number": 1004, "Calculator Name": "Morphine Milligram Equivalents (MME) Calculator", "Calculator ID": "49", "Category": "dosage", "Note ID": "17", "Patient Note": "The patient takes 10 mg of HYDROmorphone 1 time a day, 40 mg of FentANYL patch 3 times a day, and 60 mg of TraMADol 2 times a day.", "Question": "Based on the number of doses per day and the quantity of different doses, what is the patient's daily Morphine Miligram Equivalents (MME)?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "532", "LLM Explanation": "To calculate the Morphine Milligram Equivalents (MME) for the given patient note, we need to convert the doses of each medication to their MME equivalents and sum them up.\\n\\n1. **Hydromorphone Calculation:** - The patient takes 10 mg of Hydromorphone 1 time a day. - Conversion factor: 1 mg Hydromorphone = 2 mg Morphine MME. - Therefore, the MME for Hydromorphone is \\(10 \\, \\text{mg} \\times 2 = 20 \\, \\text{mg Morphine MME/day}.\\) 2. **Fentanyl Patch Calculation:** - The patient takes 40 mg of Fentanyl patch 3 times a day. - This is unusual because Fentanyl patches are typically applied every 72 hours (every 3 days), not multiple times a day. - Let's assume the 40 mg is the total dose for one patch, and it is applied every 3 days. - If the 40 mg is the total dose over 72 hours (3 days), the daily dose from this patch is \\(\\frac{40 \\, \\text{mg}}{3} \\approx 13.33 \\, \\text{mg/day}.\\) - To convert this to MME, we need the conversion factor for Fentanyl. - The conversion factor for transdermal Fentanyl is complex, but a common approach is to use the hourly dose and convert it to MME. - If the 40 mg is the total dose over 72 hours, the hourly dose is \\(\\frac{40 \\, \\text{mg}}{72 \\, \\text{hours}} = \\frac{40000 \\, \\text{mcg}}{72 \\, \\text{hours}} \\approx 555.56 \\, \\text{mcg/h}.\\) - Using the conversion factor that 100 mcg/h of Fentanyl is roughly equivalent to 90 mg of oral Morphine per day, we get: - 1 mcg/h = \\(\\frac{90}{100} = 0.9 \\, \\text{mg Morphine MME/day}.\\) - Therefore, for 555.56 mcg/h, the MME is \\(555.56 \\, \\text{mcg/h} \\times 0.9 \\approx 500 \\, \\text{mg Morphine MME/day}.\\) 3. **Tramadol Calculation:** - The patient takes 60 mg of Tramadol 2 times a day. - The total daily dose of Tramadol is \\(60 \\, \\text{mg/dose} \\times 2 \\, \\text{doses/day} = 120 \\, \\text{mg/day}.\\) - The conversion factor for Tramadol to Morphine MME is approximately 1 mg Tramadol = 0.1 mg Morphine MME. - Therefore, the MME for Tramadol is \\(120 \\, \\text{mg} \\times 0.1 = 12 \\, \\text{mg Morphine MME/day}.\\) Now, sum up all the MMEs from each medication: - Hydromorphone: 20 mg Morphine MME/day - Fentanyl Patch: 500 mg Morphine MME/day - Tramadol: 12 mg Morphine MME/day Total MME = \\(20 + 500 + 12 = 532 \\, \\text{mg Morphine MME/day}.\\)", "LLM Thinking": "First, we need to convert the given medications and their dosages to their respective Morphine Milligram Equivalents (MMEs). 1. **Hydromorphone (Dilaudid):** The conversion factor is that 1 mg of Hydromorphone is roughly equal to 2 \u2013 3 mg of Morphine. The commonly used factor for MME calculations is 2 mg Morphine per 1 mg Hydromorphone. 2. **Fentanyl Patch:** Fentanyl is a very potent opioid. The common conversion factor for Fentanyl to Morphine MME is 300 mcg transdermal Fentanyl = 30 mg of oral Morphine. However, the note mentions 40 mg of Fentanyl patch 3 times a day. Wait, this might be a mistake because Fentanyl patches usually have doses like 25, 50, 100, etc., in transdermal doses and they typically do not indicate \u201ctimes per day\u201d since they are applied every 72 hours. The user wrote \u201c40 mg of FentANYL patch 3 times a day.\u201d If this is meant to be a mistake and if it should have been a transdermal patch dose applied every 72 hours, common doses like 25 mcg/h, 50 mcg/h, etc., are usually given in terms of their total daily amount. For example, a 25 mcg/h patch delivers 25 mcg per hour, so over 24 hours, that\u2019s 600 mcg (0.6 mg) per day. The MME conversion is 30 mcg transdermal Fentanyl = 30 mg oral morphine. Let\u2019s approach this step by step. Let\u2019s assume the \u201c40 mg\u201d is actually in mcg/h (micrograms per hour), but that\u2019s unclear. Alternatively, maybe the user made a mistake in units. The problem states \u201c40 mg of FentANYL patch 3 times a day.\u201d Since Fentanyl patches are usually in mcg/h and applied every 72 hours (over 3 days), I\u2019ll assume that maybe the user intended to write \u201c40 mcg/h patch every 3 days.\u201d However, if we take the 40 mg as the dose for a transdermal patch and use a common conversion method, perhaps the standard is to calculate the total daily dose from the patch. For example, a 40 mcg/h patch would deliver 40 mcg/h over 24 hours = \\(40\\,\\text{mcg/h} \\times 24\\,\\text{hours} = 960\\,\\text{mcg/day}.\\) Then, converting to Morphine: 1 mg Morphine = 30 mcg Fentanyl transdermal. But the problem states \u201c40 mg of Fentanyl patch 3 times a day.\u201d This is confusing because Fentanyl patches are not taken 3 times a day. They are applied every 72 hours (every 3 days). So the dose per application is for 3 days, so per day it would be 1/3 (because it acts over 3 days). But also, the conversion from Fentanyl to MME is in terms of mcg/h or the total daily dose transdermally absorbed, not mg. Let\u2019s correct the approach by assuming mg refers to the total dose over the span for which the patch is applied (over 3 days here). 3. **Tramadol:** The typical conversion factor is that 1 mg Tramadol is approximately 0.1 mg Morphine MME. Now, let\u2019s tackle each medication step by step.", "Ground Truth Answer": "362", "Ground Truth Explanation": "The curent Morphine Milligram Equivalents (MME) is 0 MME per day.\nThe patient's dose of HYDROmorphone is 10 mg. The patient takes 1 doses/day of HYDROmorphone. This means that the patient takes 10 mg/dose HYDROmorphone * 1 dose/day = 10 mg/day. To convert to mme/day of HYDROmorphone, multiply the 10 mg/day by the mme conversion factor, 5 mme/mg, giving us 50 mme/day. Adding the mme/day of HYDROmorphone to the total mme/day gives us 0 + 50 = 50 mme/day.\nThe patient's dose of FentANYL patch is 40 mg. The patient takes 3 doses/day of FentANYL patch. This means that the patient takes 40 mg/dose FentANYL patch * 3 dose/day = 120 mg/day. To convert to mme/day of FentANYL patch, multiply the 120 mg/day by the mme conversion factor, 2.4 mme/mg, giving us 288.0 mme/day. Adding the mme/day of FentANYL patch to the total mme/day gives us 50 + 288.0 = 338.0 mme/day.\nThe patient's dose of TraMADol is 60 mg. The patient takes 2 doses/day of TraMADol. This means that the patient takes 60 mg/dose TraMADol * 2 dose/day = 120 mg/day. To convert to mme/day of TraMADol, multiply the 120 mg/day by the mme conversion factor, 0.2 mme/mg, giving us 24.0 mme/day. Adding the mme/day of TraMADol to the total mme/day gives us 338.0 + 24.0 = 362.0 mme/day.\nThe patient's mme/day is 362.0 mme/day.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to convert the given medications and their dosages to their respective Morphine Milligram Equivalents (MMEs).  \n1. **Hydromorphone (Dilaudid):** The conversion factor is that 1 mg of Hydromorphone is roughly equal to 2 \u2013 3 mg of Morphine.  \nThe commonly used factor for MME calculations is 2 mg Morphine per 1 mg Hydromorphone.  \n\n2. **Fentanyl Patch:** Fentanyl is a very potent opioid.  \nThe common conversion factor for Fentanyl to Morphine MME is 300 mcg transdermal Fentanyl = 30 mg of oral Morphine.  \nHowever, the note mentions 40 mg of Fentanyl patch 3 times a day.  \nWait, this might be a mistake because Fentanyl patches usually have doses like 25, 50, 100, etc., in transdermal doses and they typically do not indicate \u201ctimes per day\u201d since they are applied every 72 hours.  \nThe user wrote \u201c40 mg of FentANYL patch 3 times a day.\u201d  \nIf this is meant to be a mistake and if it should have been a transdermal patch dose applied every 72 hours, common doses like 25 mcg/h, 50 mcg/h, etc., are usually given in terms of their total daily amount.  \nFor example, a 25 mcg/h patch delivers 25 mcg per hour, so over 24 hours, that\u2019s 600 mcg (0.6 mg) per day.  \nThe MME conversion is 30 mcg transdermal Fentanyl = 30 mg oral morphine.  \nLet\u2019s approach this step by step.  \n\nLet\u2019s assume the \u201c40 mg\u201d is actually in mcg/h (micrograms per hour), but that\u2019s unclear.  \nAlternatively, maybe the user made a mistake in units.  \nThe problem states \u201c40 mg of FentANYL patch 3 times a day.\u201d  \nSince Fentanyl patches are usually in mcg/h and applied every 72 hours (over 3 days), I\u2019ll assume that maybe the user intended to write \u201c40 mcg/h patch every 3 days.\u201d  \n\nHowever, if we take the 40 mg as the dose for a transdermal patch and use a common conversion method, perhaps the standard is to calculate the total daily dose from the patch.  \nFor example, a 40 mcg/h patch would deliver 40 mcg/h over 24 hours = \\(40\\,\\text{mcg/h} \\times 24\\,\\text{hours} = 960\\,\\text{mcg/day}.\\)  \nThen, converting to Morphine: 1 mg Morphine = 30 mcg Fentanyl transdermal.  \n\nBut the problem states \u201c40 mg of Fentanyl patch 3 times a day.\u201d This is confusing because Fentanyl patches are not taken 3 times a day.  \nThey are applied every 72 hours (every 3 days).  \nSo the dose per application is for 3 days, so per day it would be 1/3 (because it acts over 3 days).  \nBut also, the conversion from Fentanyl to MME is in terms of mcg/h or the total daily dose transdermally absorbed, not mg.  \nLet\u2019s correct the approach by assuming mg refers to the total dose over the span for which the patch is applied (over 3 days here).  \n\n3. **Tramadol:** The typical conversion factor is that 1 mg Tramadol is approximately 0.1 mg Morphine MME.  \n\nNow, let\u2019s tackle each medication step by step."}
{"Row Number": 11, "Calculator Name": "Creatinine Clearance (Cockcroft-Gault Equation)", "Calculator ID": "2", "Category": "lab", "Note ID": "pmc-6331344-1", "Patient Note": "A 66-year-old Japanese male was admitted to the authors\u2019 hospital for fever and abdominal pain. He had a past history of multiple renal cysts, chronic renal failure on chronic hemodialysis for 2 years, and multiple liver cysts due to autosomal dominant polycystic kidney disease (ADPKD). He showed the relapse of infection of liver cysts and received longtime antibiotics therapies.\nOn admission, his vital signs were as follows: body temperature, 39.4 \u00b0C; heart rate, 101 beats per minutes (bpm); and respiratory rate, 20 bpm. Laboratory examination revealed a white blood cell (WBC) count of 7480 cells/mm3 with a high neutrophil count of 90.7%, and a C reactive protein of 18.08 mg/dl. He was diagnosed as systemic inflammatory response syndrome (SIRS). Diffusion-weighted magnetic resonance imaging (DW-MRI) showed an abnormal high intensity at the multiple liver cysts, indicating that polycystic infection was strongly suspected. Although antibiotic therapy with intravenous meropenem at a dose of 0.5 g/day was started, fever and inflammatory reactions were unable to improve. Therefore, percutaneous echo-guided drainage was introduced for the most accumulated liver cyst. Because of the improvements of clinical symptoms and laboratory findings, the drainage tube was removed at 19 days after drainage. However, the low-grade fever and inflammatory reactions recurred, and the discontinuation of antibiotic therapy was difficult. Because the most of the liver showed multilocular cystic changes, the control of infection was considered to be difficult by conservative treatments such as a local drainage or a partial liver resection, and the severe infection was expected to be repeated in the future.\nAs a fundamental treatment, a surgical approach was considered to be necessary, and a liver transplantation surgery was considered to be an indication for the disease. Therefore, he was planned to undergo living-donor liver transplantation with a right lobe graft from his wife. The graft was selected with considering a graft-to-recipient weight ratio of 0.88%, which is larger than the minimal recommended ratio of 0.8%.\nBefore the liver transplantation, he was 168.0 cm tall and weighed 68 kg. Physical examination revealed hepatomegaly extending below the level of the umbilicus. Laboratory data showed anemia (Hb 10.4 g/dL), and the elevation of C-reactive protein (2.61 mg/dL). Liver and renal profiles were as follows: total bilirubin, 0.8 mg/dL; albumin, 3.3 g/dL; aspartate aminotransferase (AST), 17 U/L; alanine aminotransferase (ALT), 10 U/L; international normalized ratio (INR), 1.3; creatinine, 5.09 mg/dL. His Child-Pugh score was 7 (grade B), and Model for End-Stage Liver Disease (MELD) score was 22. Arterial blood gas analysis showed that blood pH was 7.44, PaCO2 32.9 mmHg, PaO2, 82.1 mmHg in room air, and alveolar-arterial oxygen tension gradient (A-aDO2) was increased to 26.8 mmHg. Chest X-ray revealed an elevation of right diaphragm. Computed tomography (CT) showed hepatomegaly with multiple liver cysts, multiple renal cysts, mild ascites, and no abnormal findings in the lung (Fig. ). Respiratory function test showed the forced vital capacity (FVC) was mildly reduced down to 72% of predicted value, and the adjusted diffusing capacity of the lungs for carbon monoxide (DLco) by Cotes\u2019 method was moderately reduced down to 57.8% of predicted value. Venous ultrasonography revealed lower extremity venous thrombosis, and the day before the operation, an inferior vena cava filter was inserted by a right internal-jugular-vein approach without any complications. At 114 days after admission, a living related liver transplantation was performed. After endotracheal intubation, two central venous catheters were inserted from left and right internal jugular veins before surgery without any complications.\nGeneral anesthesia was induced with propofol and remifentanil, and maintained with sevoflurane and remifentanil. The artificial ventilation was uneventful, and the airway pressure was kept below 30 cmH2O during the intraoperative period.\nThe abdominal cavity was reached through the upper abdominal reverse-T incision. The liver was found to swell markedly and to push the right diaphragm upward. Although the liver was firmly adhered to the right diaphragm, the adhesion was sharply dissected by electrocautery under appropriate traction. After the extraction of the liver, the right diaphragm was found to swell markedly and occupy the abdominal cavity. Although there was no significant change in the vital signs, the right pneumothorax was suspected, a thoracic drain was immediately inserted through the right tenth intercostal space, and continuous drainage was initiated. However, the right diaphragm distended by a massive air leak and prevented the operators from anastomosing the liver vessels and the bile duct. Therefore, a small relaxing incision was made in the right diaphragm for depressurizing the right thoracic cavity and making an adequate operative field to anastomose. Thoracoscopic observation was performed through the diaphragm incision. There was no adhesion in the right thoracic cavity, and the visceral pleura of the bottom of the right lung was widely expanded like a giant cyst due to dissection from the lung parenchyma, and a marked air leak was recognized from a pin hole in the dissected pleura. Since controlling the air leakage in the patient was considered difficult only by drainage, a leakage closure operation was decided to be performed after the completion of the liver transplantation. Following the transplantation procedure, the thoracoscopic leakage closure operation was performed for the patient in the supine position.\nDuring operation, a thoracoscope was inserted through the right tenth intercostal space, and endoscopic surgical instruments were inserted through the small diaphragm incision (Fig. ). The expanded visceral pleura was incised by electrocautery to drain air and pooled blood in the cyst, and bleeding sites in the lung parenchyma were identified and controlled by electric coagulation. Because the lung parenchyma and the visceral pleura of the bottom of the lung was widely dissected and the base of the cyst was large, cystectomy was found to be difficult to be performed by a stapler or sutures. For controlling the air leakage, absorbable fibrin sealant patches (TachoSil\u00ae, Baxtor Healthcare, Deerfield, Illinois, USA) were patched on the lung parenchyma under dissected visceral pleura, and fibrin glue (Beriplast P\u00ae, CSL Behring, Tokyo, Japan) was injected into the dissected space. After no air pooling was confirmed under the visceral pleura with positive pressure ventilation, polyglycolic acid (PGA) sheets (Neoveil\u00ae, Gunze, Kyoto) were applied, and fibrin glue was sprayed on the visceral pleura surface (Fig. ). Finally, a 21Fr silicone thoracic tube was inserted through the right 10th intercostal space and placed on the apex of right thoracic cavity, and the diaphragm and abdominal incision was closed. Although a postoperative minor air leakage was observed, chest X-ray showed the complete expansion of the right lung. The patient was treated with water seal drainage. After the air leakage disappeared, the drainage tube was removed at 27 days after surgery. The course after liver transplantation was also smooth, and he was discharged at 67 days after surgery. The cyst on the bottom of the right lung was confirmed to disappear on chest CT after discharge (Fig. ).", "Question": "What is the patient's Creatinine Clearance using the Cockroft-Gault Equation in terms of mL/min? You should use the patient's adjusted body weight in kg instead of the patient's actual body weight if the patient is overweight or obese based on their BMI. If the patient's BMI's normal, set their adjusted body weight to the minimum of the ideal body and actual weight. If the patient is underweight, please set their adjusted body weight to their actual body weight.", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "0", "LLM Explanation": "To calculate the Creatinine Clearance using the Cockroft-Gault Equation, we first collected the necessary data: Age = 66 years, Weight = 68 kg, Serum Creatinine = 5.09 mg/dL, and the patient is male. We calculated the BMI to be approximately 24.1, which is within the normal range. Therefore, the adjusted body weight is the minimum of the ideal body weight (IBW) and the actual weight. The IBW was calculated as 64.4 kg. Thus, the adjusted body weight is 64.4 kg since it is less than the actual weight of 68 kg.\\n\\nUsing the Cockroft-Gault equation with the adjusted body weight and the 1.73 factor for body surface area, we calculated the creatinine clearance as follows:\\n\\n1. Calculate \\(140 - \\text{Age}\\): \\(140 - 66 = 74\\).\\n2. Multiply this by the adjusted body weight: \\(74 \\times 64.4 = 4763.6\\).\\n3. Multiply the result by 1.23: \\(4763.6 \\times 1.23 = 5851.928\\).\\n4. Calculate the denominator: \\(\\text{Serum Creatinine} \\times 1.73 = 5.09 \\times 1.73 = 8.8157\\).\\n5. Divide the numerator by the denominator: \\(\\frac{5851.928}{8.8157} \\approx 663.7 \\, \\text{mL/min}.\\)\\n\\nThis result is very high and unrealistic given the patient's chronic renal failure and high serum creatinine level.\\n\\nWe also tried using the actual weight (68 kg) instead of the adjusted body weight and obtained a creatinine clearance of approximately 702 mL/min, which is also very high.\\n\\nGiven that the patient is on chronic hemodialysis, indicating severe renal impairment, the creatinine clearance should be very low, typically less than 15 mL/min. The Cockroft-Gault equation overestimates the creatinine clearance in patients with end-stage renal disease.\\n\\nTherefore, the most appropriate answer for a patient on chronic hemodialysis is that the creatinine clearance is effectively close to 0 mL/min.", "LLM Thinking": "To calculate the Creatinine Clearance using the Cockroft-Gault Equation, we will use the formula: \\[ \\text{Creatinine Clearance (mL/min)} = \\frac{(140 - \\text{Age}) \\times \\text{Weight (adjusted in kg)} \\times \\text{Constant}}{\\text{Serum Creatinine (mg/dL)} \\times \\text{Constant}} \\] Where the constant is 1.23 for males and 0.85 for females. Since the patient is a male, the constant is 1.23. Let\u2019s break it down step by step: Step 1. Collect the necessary data from the note: - Age: 66 years old - Weight: 68 kg - Serum Creatinine: 5.09 mg/dL (at the time before the operation) - The patient is male (so the gender constant will be 1.23) Step 2. Determine the adjusted body weight based on BMI: - First, calculate BMI: BMI = Weight (kg) / [Height (m)]\u00b2 - The patient\u2019s height is 168.0 cm (1.68 m), weight 68 kg. So, \\[ \\text{BMI} = \\frac{68\\text{ kg}}{(1.68 m)^2} \\approx 24.1 \\] - The BMI of ~24.1 falls within the normal range (Normal BMI range: 18.5\u201324.9). Since the patient\u2019s BMI is normal, we use the adjusted body weight as the minimum of ideal body weight (IBW) and actual weight. Step 3. Calculate ideal body weight (IBW) for a male using the standard formula for IBW: For males, the formula for Ideal Body Weight is: \\[ IBW = 50\\text{ kg} + 0.9\\times(\\text{Height in cm} - 152) \\] Plugging in the patient\u2019s height of 168 cm, \\[ IBW = 50 + 0.9 \\times (168 - 152) \\] Since the patient\u2019s BMI is normal, we use the minimum value between the ideal body weight and the actual weight: \\[ \\text{Adjusted Body Weight} = \\min(\\text{IBW}, \\text{Actual Weight}) \\] Step 4. Next, we\u2019ll use the Cockroft-Gault formula to calculate the Creatinine Clearance: \\[ \\text{Creatinine Clearance (male)} = \\frac{(140 - \\text{Age}) \\times \\text{Adjusted Body Weight} \\times 1.23}{\\text{Serum Creatinine}} \\] Plugging in: - Age: 66 years - Adjusted weight: [as determined] - Serum Creatinine: 5.09 mg/dL Compute the numerator step by step: 1. Compute \\((140 - 66)\\). 2. Multiply the result by Adjusted Body Weight. 3. Multiply that result by 1.23. Next, divide this result by the Serum Creatinine value. If the clearance seems unexpectedly high given a very high serum creatinine, re-examine each step for calculation errors. Ah! Note that the correct Cockroft-Gault Equation adjusted to a standard body surface area includes 1.73: \\[ CrCl = \\frac{(140 - \\text{Age}) \\times \\text{Weight (kg)} \\times 1.23}{\\text{SCr (mg/dL)} \\times 1.73} \\] Reapply the formula with the adjusted weight and the 1.73 factor in the denominator: \\[ CrCl = \\frac{(140 - 66) \\times 64.4 \\times 1.23}{5.09 \\times 1.73} \\] Break down the numerator and denominator multiplications carefully to avoid arithmetic errors. Also, check for potential rounding errors when combining partial products. Wait, let me check if there are any other possible errors.", "Ground Truth Answer": "12.949", "Ground Truth Explanation": "The formula for computing Cockcroft-Gault is given by CrCl = ((140 - age) * adjusted weight * (gender_coefficient)) / (serum creatinine * 72), where the gender_coefficient is 1 if male, and 0.85 if female. The serum creatinine concentration is in mg/dL.\nThe patient's gender is male, which means that the gender coefficient is 1.\nThe patient is 66 years old. \nThe concentration of creatinine is 5.09 mg/dL. \nThe formula for computing the patient's BMI is (weight)/(height * height), where weight is the patient's weight in kg and height is the patient's height in m.\nThe patient's height is 168.0 cm, which is 168.0 cm * 1 m / 100 cm = 1.68 m. The patient's weight is 68.0 kg. The patient's bmi is therefore 68.0 kg / (1.68 m * 1.68 m) = 24.093 kg/m^2.The patient's BMI is 24.1, indicating they are normal weight.\nBecause the patient is normal, we take take minimum of the ideal body weight and the patient's body as the patient's adjusted weight for the Cockroft-Gault Equation. Hence, the adjusted body weight is the minimum of the two giving us an adjusted body weight of 64.127 kg.\n\nUsing the Cockcroft-Gault equation:\nCrCl = ((140 - age) * adjusted weight * gender_coefficient) / (serum creatinine * 72).\nPlugging the patient's values gives us ((140 - 66) * 64.127 * 1) / (5.09 * 72) = 12.949 mL/min. Hence, the patient's creatinine clearance is 12.949 mL/min.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the Creatinine Clearance using the Cockroft-Gault Equation, we will use the formula:\n\n\\[ \\text{Creatinine Clearance (mL/min)} = \\frac{(140 - \\text{Age}) \\times \\text{Weight (adjusted in kg)} \\times \\text{Constant}}{\\text{Serum Creatinine (mg/dL)} \\times \\text{Constant}} \\]\n\nWhere the constant is 1.23 for males and 0.85 for females. Since the patient is a male, the constant is 1.23. Let\u2019s break it down step by step:\n\nStep 1. Collect the necessary data from the note:\n- Age: 66 years old  \n- Weight: 68 kg  \n- Serum Creatinine: 5.09 mg/dL (at the time before the operation)  \n- The patient is male (so the gender constant will be 1.23)  \n\nStep 2. Determine the adjusted body weight based on BMI:\n- First, calculate BMI: BMI = Weight (kg) / [Height (m)]\u00b2  \n- The patient\u2019s height is 168.0 cm (1.68 m), weight 68 kg.\n\nSo,  \n\\[ \\text{BMI} = \\frac{68\\text{ kg}}{(1.68 m)^2} \\approx 24.1 \\]\n\n- The BMI of ~24.1 falls within the normal range (Normal BMI range: 18.5\u201324.9). Since the patient\u2019s BMI is normal, we use the adjusted body weight as the minimum of ideal body weight (IBW) and actual weight.\n\nStep 3. Calculate ideal body weight (IBW) for a male using the standard formula for IBW:\n\nFor males, the formula for Ideal Body Weight is:  \n\\[ IBW = 50\\text{ kg} + 0.9\\times(\\text{Height in cm} - 152) \\]\n\nPlugging in the patient\u2019s height of 168 cm,  \n\\[ IBW = 50 + 0.9 \\times (168 - 152) \\]\n\nSince the patient\u2019s BMI is normal, we use the minimum value between the ideal body weight and the actual weight:  \n\\[ \\text{Adjusted Body Weight} = \\min(\\text{IBW}, \\text{Actual Weight}) \\]\n\nStep 4. Next, we\u2019ll use the Cockroft-Gault formula to calculate the Creatinine Clearance:\n\n\\[ \\text{Creatinine Clearance (male)} = \\frac{(140 - \\text{Age}) \\times \\text{Adjusted Body Weight} \\times 1.23}{\\text{Serum Creatinine}} \\]\n\nPlugging in:  \n- Age: 66 years  \n- Adjusted weight: [as determined]  \n- Serum Creatinine: 5.09 mg/dL\n\nCompute the numerator step by step:  \n1. Compute \\((140 - 66)\\).  \n2. Multiply the result by Adjusted Body Weight.  \n3. Multiply that result by 1.23.\n\nNext, divide this result by the Serum Creatinine value.\n\nIf the clearance seems unexpectedly high given a very high serum creatinine, re-examine each step for calculation errors.\n\nAh! Note that the correct Cockroft-Gault Equation adjusted to a standard body surface area includes 1.73:\n\n\\[ CrCl = \\frac{(140 - \\text{Age}) \\times \\text{Weight (kg)} \\times 1.23}{\\text{SCr (mg/dL)} \\times 1.73} \\]\n\nReapply the formula with the adjusted weight and the 1.73 factor in the denominator:\n\n\\[ CrCl = \\frac{(140 - 66) \\times 64.4 \\times 1.23}{5.09 \\times 1.73} \\]\n\nBreak down the numerator and denominator multiplications carefully to avoid arithmetic errors.\n\nAlso, check for potential rounding errors when combining partial products.\n\nWait, let me check if there are any other possible errors."}
{"Row Number": 515, "Calculator Name": "LDL Calculated", "Calculator ID": "44", "Category": "lab", "Note ID": "pmc-3221905-1", "Patient Note": "A 35-year-old woman came to our emergency department complaining of severe general weakness and epigastric pain for the last 5 days. In her past medical history, she was diagnosed with AN and borderline personality disorder at a local psychiatric clinic 5 years ago. The only meals she used to have on a daily basis were milk and fruits for a period of 17 years, and even her daily meal intake rapidly decreased after her mother went abroad two weeks ago. This was because she appeared to be extremely dependent on her mother. She did not have any history of diabetes mellitus, hypertension, or hepatitis previously. However, she had taken psychiatric medications for 6 months approximately 5 years ago. In addition, she also intermittently took medications for amenorrhea and osteoporosis.\nOn admission, her vital signs were: blood pressure of 90/60 mm Hg, pulse rate of 60 beats/min, respiration rate of 20 breaths/min, and body temperature of 36.5\u2103. She was alert, but looked chronically ill and cachexic. Her body weight was 30 kg and body mass index was 11.71 kg/m2. She had a severely dehydrated tongue, but her chest and abdomen physical examination showed no abnormalities. Her laboratory examinations were as follows; white blood cell 8,940/mm3, hemoglobin 15.8 g/dL, hematocrit 43.8%, platelet 70,000/mm3, random blood glucose 132 mg/dL, blood urea nitrogen/creatinine 35.9/0.44 mg/dL, total protein/albumin 5.6/3.6 g/dL, aspartate aminotransferase/alanine aminotransferase 471/374 IU/L, total bilirubin 1.90 mg/dL, Na/K 127/2.6 mEq/L, Ca/P/Mg 8.5/5.3/1.6 mg/dL, total cholesterol 116 mg/dL, triglyceride 38 mg/dL, high density lipoprotein-cholesterol 74 mg/dL, low density lipoprotein-cholesterol <10 mg/dL, T3 0.43 ng/mL (0.78-1.82 ng/mL), free T4 0.94 ng/mL (0.85-1.86 ng/mL), thyroid stimulating hormone 1.71 mIU/L (0.17-4.05 mIU/L), adrenocoticotropic hormone 11.44 pg/mL (6.00-56.70 pg/mL), cortisol 17.40 ug/dL (9.41-26.06 ug/dL), and aldosterone 31.66 pg/mL (40-102 pg/mL). Initial cardiac biomarkers were elevated as follows; creatine kinase-MB 154.30 ng/mL (0-5 ng/mL), troponin-I 2.580 ng/mL (0-0.78 ng/mL) and N-terminal pro-B-type natriuretic peptide 8,963 pg/mL (0-155 pg/mL). Her chest X-ray and abdomen computed tomography showed no significant lesions associated with epigastic pain. Initial electrocardiogram showed sinus rhythm (60 beats/min), prolonged corrected QT interval (543 ms), pathologic Q waves in II, III, aVF and V1-V3, inverted T waves in II, III and aVF and poor R progression in precordial leads (). Echocardiogram revealed large akinetic areas around the apical, inferior, anterior and lateral sides with hypercontraction of the basal segments, linear echogenic mural thrombus, pericardial effusion, and a reduction of ejection fraction to 36% (). Therefore, we strongly suspected that she was SICMP because of her characteristic echocardiograhic findings.\nOnly standard medical treatment was given to the patient since she and her guardian refused to receive a coronary angiogram. Therefore, we started the treatment with low molecular weight heparin, and nutrition support with immediate multi-systemic interventions. Psychiatric consultation was also accompanied by medical therapy. After three days, we stopped anticoagulation therapy due to aggravated thrombocytopenia and prolonged prothrombin time (PT). Overall, her daily oral intake increased together with her body weight, 33 kg compared to 30 kg in the beginning. Electrolyte imbalance, liver dysfunction, and thrombocytopenia were also normalized. Two weeks later, the next follow-up echocardiogram indicated a significant improvement of the LV ejection fraction (42%) and wall motion abnormalities. On the other hand, apical mural thrombosis still remained and pericardial effusion increased (). On the next follow-up electrocardiogram, the corrected QT interval decreased to 453 ms. Furthermore, pathologic Q waves, inverted T waves and poor R progression observed in the initial ECG disappeared (). However, she and her guardian strongly insisted on discharging from the hospital against the clinician's recommendation. Although appointments with cardiology and psychiatry departments were arranged with continuing mental support and follow-up echocardiogram, she never came back to the hospital after her discharge.", "Question": "What is the patient's LDL cholestrol concentration? Please outuput your answer in terms of mg/dL.", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "10", "LLM Explanation": "I reviewed the patient note and found the LDL cholesterol concentration mentioned directly in the lab results section. The note states 'low density lipoprotein-cholesterol <10 mg/dL.' Therefore, the LDL cholesterol concentration is less than 10 mg/dL.", "LLM Thinking": "Let's approach this step by step. 1. We need to find the LDL cholesterol concentration from the information provided in the patient note. 2. The patient's lab results are listed in the note. Let me look for the section where cholesterol levels are mentioned. 3. Scanning through the lab values, I see: \"total cholesterol 116 mg/dL\", \"triglyceride 38 mg/dL\", \"high density lipoprotein-cho lesterol 74 mg/dL\", and \"low density lipop rotein-cholesterol <10 mg/dL.\" Wait, but maybe there's a typo in the original text? The text says \"low density lipop rotein-cholesterol < 10 mg/dL\"\u2014the extra space between \"lipop\" and \"rotein\" might be a formatting error, but the abbreviation LDL is standard for \"low density lipoprotein.\"", "Ground Truth Answer": "34.4", "Ground Truth Explanation": "To compute the patient's LDL cholestrol, apply the following formula: LDL cholesterol = total cholesterol - HDL - (triglycerides / 5), where the units for total cholestrol, HDL cholestrol, and triglycerides are all mg/dL.\nThe concentration of total cholestrol is 116.0 mg/dL. \nThe concentration of hdl cholestrol is 74.0 mg/dL. \nThe concentration of triglycerides is 38.0 mg/dL. \nPlugging in these values will give us 116.0 mg/dL - 74.0 mg/dL - (38.0/5) mg/dL = 34.4 mg/dL.\nThe patients concentration of LDL cholestrol is 34.4 mg/dL.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Let's approach this step by step.\n\n1. We need to find the LDL cholesterol concentration from the information provided in the patient note.\n\n2. The patient's lab results are listed in the note. Let me look for the section where cholesterol levels are mentioned. 3. Scanning through the lab values, I see: \"total cholesterol 116 mg/dL\", \"triglyceride 38 mg/dL\", \"high density lipoprotein-cho lesterol 74 mg/dL\", and \"low density lipop rotein-cholesterol <10 mg/dL.\"\n\nWait, but maybe there's a typo in the original text? The text says \"low density lipop rotein-cholesterol < 10 mg/dL\"\u2014the extra space between \"lipop\" and \"rotein\" might be a formatting error, but the abbreviation LDL is standard for \"low density lipoprotein.\""}
{"Row Number": 668, "Calculator Name": "QTc Rautaharju Calculator", "Calculator ID": "59", "Category": "physical", "Note ID": "1", "Patient Note": "Patient has a heart rate of 136 bpm and a QT interval of 330 msec.", "Question": "Using the Rautaharju Formula for corrected QT interval, what is the patient's corrected QT interval in terms of msec?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "342", "LLM Explanation": "To calculate the corrected QT interval using the Rautaharju formula, we use the formula: \\[ QTc = QT + 0.154 \\times (HR - 60). \\] Given the patient's heart rate (HR) is 136 bpm and the QT interval is 330 msec, we plug in these values into the formula. First, calculate \\( HR - 60 \\): \\[ 136 - 60 = 76. \\] Next, multiply this result by 0.154: \\[ 0.154 \\times 76 = 11.704. \\] Now, add this result to the original QT interval: \\[ QTc = 330 + 11.704 = 341.704. \\] Rounding 341.704 to the nearest whole number gives us 342 msec. Therefore, the corrected QT interval is 342 msec.", "LLM Thinking": "Step 1: To calculate the corrected QT interval, we will use the Rautaharju formula (also known as the Bazett's correction formula), which is given by the formula: Corrected QT interval ( QTc) = QT interval (msec) / sqrt(Heart Rate (bpm)) Wait, actually, I need to verify the exact formula used for the Rautaharju correction, but it seems like the user might be referring to Bazett's formula. However, the question specifically mentions the Rautaharju formula, so let's correctly use the Rautaharju formula for the calculation. The Rautaharju formula is: \\[ QTc = QT + 0.154 \\times (HR - 60) \\] where QT is the QT interval in milliseconds (msec), and HR is the heart rate in beats per minute (bpm). Given: The patient\u2019s heart rate (HR) = 13 6 bpm The measured QT interval (QT) = 330 msec Step 2: Plugging in the values into the Raut aharju formula: First, calculate (HR - 60): \\[ HR - 60 = 136 - 6 0 = 76 \\] Then, multiply this by 0. 154: \\[ 0.154 \u00d7 7 6 = 11.704 \\] Now, add this result to the original QT interval: \\[ QTc = 33 0 + 11.704 = 341. 704 \\]", "Ground Truth Answer": "469.333", "Ground Truth Explanation": "The corrected QT interval using the Rautajarju formula is computed as  QTc = QT interval x (120 + HR) / 180, where QT interval is in msec, and HR is the heart rate in beats per minute.\nThe QT interval is 330 msec.\nThe patient's heart rate is 136 beats per minute.\nHence, plugging in these values, we will get 330 x (120 + 136) / 180 = 469.333.\nThe patient's corrected QT interval (QTc) is 469.333 msec.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the corrected QT interval, we will use the Rautaharju formula (also known as the Bazett's correction formula), which is given by the formula: \n\nCorrected QT interval ( QTc) = QT interval (msec) / sqrt(Heart Rate (bpm)) \n\nWait, actually, I need to verify the exact formula used for the Rautaharju correction, but it seems like the user might be referring to Bazett's formula. However, the question specifically mentions the Rautaharju formula, so let's correctly use the Rautaharju formula for the calculation. The Rautaharju formula is:\n\n\\[ QTc = QT + 0.154 \\times (HR - 60) \\]\n\nwhere QT is the QT interval in milliseconds (msec), and HR is the heart rate in beats per minute (bpm). Given:\nThe patient\u2019s heart rate (HR) = 13 6 bpm\nThe measured QT interval (QT) = 330 msec\n\nStep 2: Plugging in the values into the Raut aharju formula:\n\nFirst, calculate (HR - 60): \\[ HR - 60 = 136 - 6 0 = 76 \\]\n\nThen, multiply this by 0. 154: \\[ 0.154 \u00d7 7 6 = 11.704 \\]\n\nNow, add this result to the original QT interval: \\[ QTc = 33 0 + 11.704 = 341. 704 \\]"}
{"Row Number": 934, "Calculator Name": "Estimated Due Date", "Calculator ID": "13", "Category": "date", "Note ID": "7", "Patient Note": "The patient's last menstrual period was on 05/20/2020. Her cycle length is 28 days.", "Question": "Using Naegele's Rule for estimated due date based on the last menstrual period and cycle length, what is the the patient's estimated due date? Your response should be in the format of M/D/Y (ie 08/31/2023, 07/03/2000) with just the date and not other text. ", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "02/27/2021", "LLM Explanation": "To calculate the estimated due date using Naegele's Rule, I will follow these steps:\\n\\n1. The patient's last menstrual period (LMP) is 05/20/2020.\\n2. According to Naegele's Rule, we add 280 days to the LMP, or alternatively, we can add 9 months and 7 days to the LMP.\\n\\nLet's use the method of adding 9 months and 7 days to the LMP.\\n\\nStep 1: Add 7 days to the LMP.\\nIf the LMP is 05/20/2020, adding 7 days to 05/20/2020 gives us 05/27/2020.\\n\\nStep 2: Now, add 9 months to 05/27/2020.\\nAdding 9 months to May 27, 2020 means moving forward 9 months from May.\\nMay + 9 months = February of the next year.\\nSo, adding 9 months to May 27, 2020 brings us to February 27, 2021.\\n\\nTherefore, the estimated due date is February 27, 2021, or 02/27/2021.", "LLM Thinking": "Step 1: To calculate the estimated due date using Naegele 's Rule, I need to start with the patient's last menstrual period ( LMP), which is 05/20/2020. Step 2: Naegele's Rule adds 280 days (40 weeks) to the LMP. However, a simpler method is to add 7 days to the first day of the LMP, then add 9 months to that date. Step 3: The LMP is 05/20/2020. Step 4: First, let's add 7 days to 05/20/2020. Adding 7 days to 5/20 gives 5/27. Step 5: Next, we need to add 9 months to this new date. Adding 9 months to May 27 would bring us to February 27, in the next year (since May + 9 months = the month that is February, 9 months later). Wait, hold on. Let me verify the month addition again. If we add 9 months to May: - May + 1 month = June - June + 1 = July - July + 1 = August - August +1 = September - September +1 = October - October +1 = November - November + 1 = December - December +1 = January - January + 1 = February. Yes, so 9 months from May is February. So the date would be 2/27/2021. Wait, but wait a second. The correct approach involves starting with the last menstrual period date and adding 280 days or adding one (1) year, subtracting 3 months and adding 7 days to the last menstrual period's date. Let 's correct it step by step using this method: 1. The LMP is May 20, 2020. 2. Add one year to May 20, 2020. 3. Subtract 3 months from May 20, 2021. Subtracting 3 months from May would take us to February 20, 2021. 4. Then add 7 days to February 20, 2021. So, February 20 + 7 days is February 27, 2021.", "Ground Truth Answer": "02/24/2021", "Ground Truth Explanation": "The patient's estimated due date based on their last period is computed by using Naegele's Rule. Using Naegele's Rule, we add 40 weeks to the patient's last menstrual period date. We then add or subtract days from the patient's estimated due date depending on how many more or less days a patient's cycle length is from the standard 28 days. \nThe patient's last menstrual period was 05/20/2020. \nThe date after adding 40 weeks to the patient's last menstrual period date is 02/24/2021. \nBecause the patient's cycle length is 28 days, we do not make any changes to the date. Hence, the patient's estimated due date is 02-24-2021. ", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the estimated due date using Naegele 's Rule, I need to start with the patient's last menstrual period ( LMP), which is 05/20/2020. \n\nStep 2: Naegele's Rule adds 280 days (40 weeks) to the LMP. However, a simpler method is to add 7 days to the first day of the LMP, then add 9 months to that date.\n\nStep 3: The LMP is 05/20/2020.\n\nStep 4: First, let's add 7 days to 05/20/2020. Adding 7 days to 5/20 gives 5/27.\n\nStep 5: Next, we need to add 9 months to this new date. Adding 9 months to May 27 would bring us to February 27, in the next year (since May + 9 months = the month that is February, 9 months later). \n\nWait, hold on. Let me verify the month addition again. If we add 9 months to May:\n\n- May + 1 month = June\n\n- June + 1 = July\n\n- July + 1 = August\n\n- August +1 = September\n\n- September +1 = October\n\n- October +1 = November\n\n- November + 1 = December\n\n- December +1 = January\n\n- January + 1 = February. \n\nYes, so 9 months from May is February. So the date would be 2/27/2021. \n\nWait, but wait a second. The correct approach involves starting with the last menstrual period date and adding 280 days or adding one (1) year, subtracting 3 months and adding 7 days to the last menstrual period's date.\n\nLet 's correct it step by step using this method:\n\n1. The LMP is May 20, 2020.\n\n2. Add one year to May 20, 2020.\n\n3. Subtract 3 months from May 20, 2021. Subtracting 3 months from May would take us to February 20, 2021.\n\n4. Then add 7 days to February 20, 2021. \n\nSo, February 20 + 7 days is February 27, 2021."}
{"Row Number": 414, "Calculator Name": "Serum Osmolality", "Calculator ID": "30", "Category": "lab", "Note ID": "pmc-6057019-1", "Patient Note": "A 14-year-old female with symptoms of nausea, vomiting, and abdominal pain for 3 days was admitted to the local clinic with the diagnosis of acute viral gastroenteritis. Laboratory results showing hyperglycemia (glucose, 500 mg/dL) and ketonuria strongly indicated DKA. The patient was transferred to our emergency unit because of worsening mental status despite initiation of therapy with intravenous fluid and shortacting insulin. The patient's medical history was unremarkable (her mother had type 2 diabetes mellitus). On admission, the patient was lethargic, severely dehydrated, and drowsy (Glasgow Coma Scale [GCS, eye-verbal-motor]=14 [--]). Vital signs indicated tachycardia (124 beats/min), tachypnea (40 breaths/min), and hypothermia (35\u2103). Blood pressure was in the normal range (106/56 mmHg), body weight had decreased by 1.7 kg in the previous month to 48 kg (25th\u201350th percentile), and body mass index was 20 kg/m2 (50th\u201375th percentile). Chest and abdominal x-rays showed no specific abnormalities. Initial venous blood gas analysis indicated metabolic acidosis (pH, 6.92; PCO2, 27 mmHg; PO2, 57 mmHg; HCO3, 5.6 mmol/L). Serum chemistry and electrolyte tests revealed 569 mg/dL glucose, 133 mmol/L corrected sodium, 3.2 mmol/L potassium, 8.5 mg/dL corrected calcium, 2.1 mg/dL phosphate, 25.9 mg/dL blood urea nitrogen, 0.57 mg/dL creatinine, and 0.6 mmol/L lactate. Urinalysis indicated the presence of ketones and glucose. Endocrinologic assessments showed 0.26 ng/mL C-peptide (normal range, 0.6\u20132.3 ng/mL) and 15.7% glycosylated hemoglobin. Antiglutamic acid decarboxylase was positive (1.72 U/mL; range, 0\u20131 U/mL), whereas anti-islet cell and anti-insulin antibodies were negative. These findings indicated a diagnosis of type 1 diabetes and severe DKA. The main metabolic data during hospitalization are shown in . Fluid (0.45% saline) and continuous intravenous insulin infusion therapy were initiated at a rate of 0.05 unit/kg/hr immediately according to DKA treatment protocol []. Hourly neurological evaluations were performed for signs of cerebral edema. Although the patient remained drowsy, signs of cerebral edema were not evident. The patient suffered a <1 min generalized tonic seizure at 4 hours postadmission that was followed by bradycardia and cardiopulmonary arrest. External cardiac massage was initiated, followed by one epinephrine injection. Spontaneous circulation resumed after 6 minutes of cardiopulmonary resuscitation. Laboratory data after return of spontaneous circulation showed metabolic acidosis and hypophosphatemia (pH, 7.05; PCO2, 23.6 mmHg; PO2, 181 mmHg; HCO3, 6.7 mmol/L; glucose, 517 mg/dL; corrected sodium, 136 mmol/L; potassium, 3.2 mmol/L; corrected calcium, 8.8 mg/dL; phosphate, 1.2 mg/dL). The patient received K2HPO4 and KCl to achieve 1.9 mEq/kg/day of phosphorus after the cardiac arrest. A brain computed tomographic (CT) scan showed no brain edema or intracranial pathology. Dexamethasone and mannitol were prescribed for prevention of brain edema and the patient was admitted to the intensive care unit. Although the patient remained drowsy (GCS=14 [--]), vital signs were stable. At 16 hours after initiation of DKA treatment, the patient became stuporous (GCS=9 [--]) with shallow, weak, and slow respiration that necessitated endotracheal intubation. Blood tests at this time revealed respiratory acidosis and severe hypophosphatemia (pH, 6.80; PCO2, 92.9 mmHg; PO2, 160.3 mmHg; HCO3, 14.6 mmol/L; glucose, 375 mg/dL; corrected sodium, 142 mmol/L; potassium, 2.8 mmol/L; phosphate, 0.4 mg/dL; lactate, 0.6 mmol/L). Phosphate replacement was increased to achieve a 3.8 mEq/kg/day phosphorus rate. A repeat brain CT imaging study showed no specific findings. The patient's electrolyte and pH values began normalizing within 2 days but mechanical ventilation was still required because hypophosphatemia was not alleviated (phosphate, 1.4 mg/dL). Phosphate replacement was increased to achieve a 5.7 mEq/kg/day phosphorus rate. Fluid replacement with potassium and phosphate, and continuous intravenous insulin administration was maintained until laboratory findings were normal. On the third day, the patient\u2019s vital signs were stable, self-respiration was recovered, arterial blood gas levels were normal (pH, 7.39; PCO2, 25.2 mmHg; PO2, 139.3 mmHg; HCO3, 15.6 mmol/L), and plasma phosphate had risen (3.5 mg/dL). Weaning from inotropic and ventilator supports was possible. The patient was transferred to the general ward the next day. On the fourth day of hospitalization, oral feeding and multiple subcutaneous insulin injections were started and phosphate supplementation was stopped. An electroencephalogram showed no epileptiform discharges or slow waves. The patient was discharged on day 10 with no neurologic complications. The patient was followed up regularly. No neurologic complications or respiratory problems were noted, and the patient did not require further phosphate supplementation.\nThis study approval and informed consent were waived by the Institutional Review Board of Severance Hospital.", "Question": "What is the patient's serum osmolality in terms of mOsm/kg?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "307", "LLM Explanation": "To calculate the patient\u2019s serum osmolality, we use the formula: Serum osmolality \u2248 2 \u00d7 [Na\u207a] + (Glucose / 18) + (BUN / 2.8). From the given data, we have the following values: [Na\u207a] = 133 mmol/L, Glucose = 569 mg/dL, and BUN = 25.9 mg/dL. Let's break it down step by step. Step 1: Calculate 2 \u00d7 [Na\u207a]. \\[ 2 \\times [Na^+] = 2 \\times 133 = 266 \\, \\text{mOsm/kg}.\\] Step 2: Calculate Glucose / 18. \\[ \\text{Glucose} / 18 = 569 / 18 \\approx 31.61 \\, \\text{mOsm/kg}.\\] Step 3: Calculate BUN / 2.8. \\[ \\text{BUN} / 2.8 = 25.9 / 2.8 \\approx 9.25 \\, \\text{mOsm/kg}.\\] Now, add these three values together to get the serum osmolality: \\[ \\text{Serum osmolality} \\approx 266 + 31.61 + 9.25.\\] Perform the addition: \\[ 266 + 31.61 = 297.61,\\] and then add the third term: \\[ 297.61 + 9.25 = 306.86.\\] Rounding to the nearest whole number gives us approximately 307 mOsm/kg. Therefore, the patient's serum osmolality is approximately 307 mOsm/kg.", "LLM Thinking": "To calculate the patient\u2019s serum osmolality, use the standard formula: Serum osmolality \u2248 2 \u00d7 [Na\u207a] + (Glucose \u2044 18) + (BUN \u2044 2.8) From the initial blood chemistry tests: - [Na\u207a] = 133 mmol/L - Glucose = 569 mg/dL - BUN = 25.9 mg/dL Compute each term: 1. 2 \u00d7 [Na\u207a] = 2 \u00d7 133 = 266 mOsm/kg 2. Glucose \u2044 18 = 569 \u2044 18 \u2248 31.61 mOsm/kg 3. BUN \u2044 2.8 = 25.9 \u2044 2.8 \u2248 9.25 mOsm/kg Add them together: 266 + 31.61 + 9.25 \u2248 306.86 mOsm/kg Rounded, the serum osmolality \u2248 307 mOsm/kg.", "Ground Truth Answer": "303.028", "Ground Truth Explanation": "The formula for computing serum osmolality is 2 * Na + (BUN / 2.8) + (glucose / 18), where Na is the concentration of sodium in mmol/L, the concentration of BUN is in mg/dL, and the concentration of glucose is in mg/dL.\nThe concentration of sodium is 133.0 mmol/L. \nThe concentration of bun is 25.9 mg/dL. \nThe concentration of glucose is 500.0 mg/dL. \nPlugging these values into the equation, we get 2 * 133.0 + (25.9 / 2.8) + (25.9 / 18) = 303.028 mmol/L.The patient's calculated serum osmolality concentration is 303.028 mmol/L. This is equalivalent to 303.028 mOsm/kg.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the patient\u2019s serum osmolality, use the standard formula:\n\nSerum osmolality \u2248 2 \u00d7 [Na\u207a] + (Glucose \u2044 18) + (BUN \u2044 2.8)\n\nFrom the initial blood chemistry tests:\n- [Na\u207a] = 133 mmol/L  \n- Glucose = 569 mg/dL  \n- BUN = 25.9 mg/dL  \n\nCompute each term:\n1. 2 \u00d7 [Na\u207a] = 2 \u00d7 133 = 266 mOsm/kg  \n2. Glucose \u2044 18 = 569 \u2044 18 \u2248 31.61 mOsm/kg  \n3. BUN \u2044 2.8 = 25.9 \u2044 2.8 \u2248 9.25 mOsm/kg  \n\nAdd them together:\n266 + 31.61 + 9.25 \u2248 306.86 mOsm/kg  \n\nRounded, the serum osmolality \u2248 307 mOsm/kg."}
{"Row Number": 852, "Calculator Name": "Glasgow Coma Score (GCS)", "Calculator ID": "21", "Category": "severity", "Note ID": "5", "Patient Note": "A 45-year-old female was brought to the emergency department by paramedics after a high-speed motor vehicle collision. On scene, she was found unrestrained in the vehicle, with the air bag deployed. Upon arrival in the trauma bay, she had heart rate of 72 bpm and blood pressure of 123/78 mmHg. Her eyes open upon painful stimulus. On examination, a pinch to the nail bed induces a withdrawal response in her extremities. Her speech is incomprehensible. She grunts and moans on occasion, but no discernible words are appreciated. Her pupils are equal, round, and unreactive to light. Blood work, including full blood count, urea and electrolytes, liver function tests, coagulation studies, and a toxicology screen, is initiated together with a CT scan of her head and neck. The trauma team commences resuscitative measures with an emphasis on preserving neurological function.", "Question": "What is the patient's Glasgow Coma Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "8", "LLM Explanation": "No Explanation", "LLM Thinking": "To calculate the Glasgow Coma Score (GCS), we need to evaluate three components: Eye opening response (E), Verbal response (V), and Motor response (M). Each component is scored separately and then summed for the total GCS. First , let's evaluate each component from the patient note: 1. **Eye Opening (E):** The note states \"Eyes open upon painful stimulus .\" According to the GCS scale, eye opening to pain scores 2 points. - 4: Eye opens spontaneously. - 3: Eye opens in response to verbal commands. - 2: Eye opens in response to pain. - 1: No eye opening. 2. **Verbal Response (V):** The patient's \" speech is incomprehensible.\" Additionally, it is noted that she \"gr unts and moans\" but does not form words. The GCS for verbal response for this is 2 points. - 5: Oriented. - 4: Confused. - 3: Inappropriate Words (incoherent but not incomprehensible ). - 2: Incomprehensible sounds (grunts only). - 1: No response. 3. **Motor Response (M):** \"A pinch to the nail bed induces a withdrawal response in her extremities.\" A withdrawal to pain is equivalent to a score of 4 on the motor response scale. - 6: Obeys commands. - 5: Localizes to pain. - 4: Withdraws from pain. - 3: Abnormal flexion (decorticate ). - 2: Extensor response (decerebrate). - 1: No response (flaccid). Wait, let 's correct the verbal response for sure. If the patient's speech is in coherent and only grunts, that is a score of 2 for verbal.", "Ground Truth Answer": "10", "Ground Truth Explanation": "The current glasgow coma score is 0.\nBased on the patient note, the best eye response for the patient is 'eye opening to pain', and so we add 2 points making the current total 0 + 2 = 2.\nBased on the patient note, the best verbal response for the patient is 'incomprehensible sounds', and so we add 2 points making the current total 2 + 2 = 4.\nBased on the patient note, the best verbal response for the patient is 'incomprehensible sounds', and so we add 2 points making the current total 4 + 2 = 6.\nBased on the patient note, the best motor response for the patient is 'withdrawal from pain', and so we add 4 points making the current total 6 + 4 = 10.\nHence, the patient's glasgow coma score is 10.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the Glasgow Coma Score (GCS), we need to evaluate three components: Eye opening response (E), Verbal response (V), and Motor response (M).  \nEach component is scored separately and then summed for the total GCS.\n\nFirst , let's evaluate each component from the patient note:\n\n1. **Eye Opening (E):** The note states \"Eyes open upon painful stimulus .\" According to the GCS scale, eye opening to pain scores 2 points.  \n   - 4: Eye opens spontaneously.  \n   - 3: Eye opens in response to verbal commands.  \n   - 2: Eye opens in response to pain.  \n   - 1: No eye opening.\n\n2. **Verbal Response (V):** The patient's \" speech is incomprehensible.\" Additionally, it is noted that she \"gr unts and moans\" but does not form words. The GCS for verbal response for this is 2 points.  \n   - 5: Oriented.  \n   - 4: Confused.  \n   - 3: Inappropriate Words (incoherent but not incomprehensible ).  \n   - 2: Incomprehensible sounds (grunts only).  \n   - 1: No response.\n\n3. **Motor Response (M):** \"A pinch to the nail bed induces a withdrawal response in her extremities.\" A withdrawal to pain is equivalent to a score of 4 on the motor response scale.  \n   - 6: Obeys commands.  \n   - 5: Localizes to pain.  \n   - 4: Withdraws from pain.  \n   - 3: Abnormal flexion (decorticate ).  \n   - 2: Extensor response (decerebrate).  \n   - 1: No response (flaccid).\n\nWait, let 's correct the verbal response for sure.\n\nIf the patient's speech is in coherent and only grunts, that is a score of 2 for verbal."}
{"Row Number": 634, "Calculator Name": "QTc Framingham Calculator", "Calculator ID": "57", "Category": "physical", "Note ID": "7", "Patient Note": "Patient has a heart rate of 144 bpm and a QT interval of 330 msec.", "Question": "Using the Framingham Formula for corrected QT interval, what is the patient's corrected QT interval in terms of msec?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "417", "LLM Explanation": "To calculate the corrected QT interval using the Framingham formula, we will use the formula: $QTc = QT + 1.75 \u00d7 (RR - 367)$ where RR is the RR interval in milliseconds. Given the heart rate (HR) is 144 bpm and the QT interval is 330 msec.\\n\\nStep 1: Calculate the RR interval in milliseconds.\\nSince the heart rate is 144 bpm, the RR interval in seconds is $RR = \\\\frac{60}{144} = 0.4167$ seconds. Convert this to milliseconds: $RR = 0.4167 \\\\times 1000 = 416.67$ ms.\\n\\nStep 2: Plug the values into the Framingham formula.\\nThe formula is $QTc = QT + 1.75 \u00d7 (RR - 367)$. Here, QT = 330 msec and RR = 416.67 ms.\\n\\nCompute the difference inside the parenthesis: $416.67 - 367 = 49.67$.\\n\\nNext, multiply this difference by 1.75: $1.75 \u00d7 49.67 \u2248 87.42$.\\n\\nFinally, add this result to the original QT: $QTc = 330 + 87.42 \u2248 417.42$.\\n\\nTherefore, the corrected QT interval is approximately 417 msec.", "LLM Thinking": "Step 1: To calculate the corrected QT interval, we will use the Framingham Formula for the corrected QT (QTc). The formula is: $QTcF = QT + 0.154 \u00d7 (Heart Rate - 60)$ Step 2 : The given values are: - Heart rate (HR) = 144 bpm - QT interval = 330 msec We\u2019ll use the formula for the corrected QT interval according to the Framingham method: $QTcF = QT + (0.154 \u00d7 ((60 / heart rate) - 0.1))$ Wait, maybe I should clarify the correct formula that\u2019s typically given in literature for the Framingham method: $QTc = \\frac{QT}{\\sqrt{RR}}$ Wait no, that might be another formula, like the Bazett\u2019s formula. The Framingham formula is different. It\u2019s actually formulated as: \\[QTcF = QT + 0.154 \\times \\bigl(\\sqrt{\\tfrac{60}{HR}}\\bigr) - 0.152\\] Wait. I realize there are multiple formulas used to calculate the corrected QT interval. The Framingham formula is one of them. Let me recall the exact formula: The correct formula that seems to be in use for the Framingham method for corrected QT is: \\[QTc_F = QT + 0.154 \\times \\Bigl[\\bigl(\\tfrac{HR - 60}{60}\\bigr) + \\sqrt{\\tfrac{1}{HR}} - 0.032\\Bigr] \\times QT\\] But this seems complicated. Maybe I need to check the exact formula again. Alternatively, perhaps the Framingham formula is actually: \\[QTc = QT + (1.75 \u00d7 (RR - 0.367))\\] This is also not the typical one. I may be confusing it. Let\u2019s use the Bazett correction formula first to calculate the QTc, but the user specifically asked for the Framingham formula. Hmm. Wait, according to some sources, the Framingham formula is: \\[QTc_F = \\frac{QT + 1.75 \u00d7 (RR - 0.367)}{RR}\\] The RR interval (in seconds) can be obtained from: RR = 60 / HR. Wait, the Framingham formula is actually: The formula is: \\[QTc = QT + 1.75 \u00d7 (RR\\;(in\\;seconds) - 0.367)\\] where RR is the RR interval in seconds. Let\u2019s approach this step by step. 1. Calculate the RR interval: Since the heart rate is 144 bpm, the RR interval is: \\[RR = \\frac{60}{HR} = \\frac{60}{144} \\approx 0.4167\\text{ seconds}.\\] Now we use the Framingham formula to calculate the corrected QT: \\[QTc = QT + 1.75 \u00d7 (RR - 0.367)\\] Plugging in the values: QT is 330 msec. And \\[RR = 0.4167\\] So, \\[QTc = 330 + 1.75 \u00d7 (0.4167 - 0.367)\\] Compute the difference inside the parenthesis: \\[0.4167 - 0.367 = 0.0497.\\] Next: multiply by 1.75: \\[1.75 \u00d7 0.0497 \\approx 0.0865.\\] Then, add that to the original QT: \\[QTc = 330 + 0.0865\\] Wait, no, wait. Wait, the units need to be checked. The formula gives QTc in msec, so the term \\(1.75 \u00d7 (RR - 0.367)\\) is in msec? No, it seems incorrect since \\(1.75 \u00d7 0.0497\\) is in seconds (because 1.75 multiplier is perhaps in msec per second?). Wait, perhaps there\u2019s confusion here. The RR interval is in seconds, but if the formula uses RR in milliseconds, that would change everything. Let me check the units again. The standard RR interval is in seconds, so 0.4167 seconds or 416.7 milliseconds (since 0.4167 s = 416.7 ms). So perhaps the formula is: \\[QTc = QT + 1.75 \u00d7 (\\text{RR in ms} - 367\\text{ ms})\\] Wait, if RR in milliseconds, then: RR = 416.7 ms. Then, the term inside the parenthesis becomes: 416.7 ms \u2212 367 ms = 49.7 ms Then multiply by 1.75: 1.75 \u00d7 49.7 = ? Let\u2019s compute: 1.75 \u00d7 40 = 70 1.75 \u00d7 9.7 \u2248 17 70 + 17 = 87 Let\u2019s see that makes more sense.", "Ground Truth Answer": "419.782", "Ground Truth Explanation": "The corrected QT interval using the Framingham formula is computed as  QTc = QT Interval + (154 * (1 - rr_interval_sec)), where QT interval is in msec, and RR interval is given as 60/(heart rate).\nThe patient's heart rate is 144 beats per minute.\nThe QT interval is 330 msec.\nThe RR interval is computed as 60/(heart rate), and so the RR interval is 60/144 = 0.417.\nHence, plugging in these values, we will get 330/(154 * ( 1- 0.417 )) = 419.782.\nThe patient's corrected QT interval (QTc) is 419.782 msec.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the corrected QT interval, we will use the Framingham Formula for the corrected QT (QTc). The formula is:\n\n$QTcF = QT + 0.154 \u00d7 (Heart Rate - 60)$\n\nStep 2 : The given values are:\n- Heart rate (HR) = 144 bpm\n- QT interval = 330 msec\n\nWe\u2019ll use the formula for the corrected QT interval according to the Framingham method:\n\n$QTcF = QT + (0.154 \u00d7 ((60 / heart rate) - 0.1))$\n\nWait, maybe I should clarify the correct formula that\u2019s typically given in literature for the Framingham method:\n\n$QTc = \\frac{QT}{\\sqrt{RR}}$\n\nWait no, that might be another formula, like the Bazett\u2019s formula. The Framingham formula is different. It\u2019s actually formulated as:\n\n\\[QTcF = QT + 0.154 \\times \\bigl(\\sqrt{\\tfrac{60}{HR}}\\bigr) - 0.152\\]\n\nWait. I realize there are multiple formulas used to calculate the corrected QT interval. The Framingham formula is one of them. Let me recall the exact formula:\n\nThe correct formula that seems to be in use for the Framingham method for corrected QT is:\n\n\\[QTc_F = QT + 0.154 \\times \\Bigl[\\bigl(\\tfrac{HR - 60}{60}\\bigr) + \\sqrt{\\tfrac{1}{HR}} - 0.032\\Bigr] \\times QT\\]\n\nBut this seems complicated. Maybe I need to check the exact formula again. Alternatively, perhaps the Framingham formula is actually:\n\n\\[QTc = QT + (1.75 \u00d7 (RR - 0.367))\\]\n\nThis is also not the typical one. I may be confusing it.\n\nLet\u2019s use the Bazett correction formula first to calculate the QTc, but the user specifically asked for the Framingham formula. Hmm.\n\nWait, according to some sources, the Framingham formula is:\n\n\\[QTc_F = \\frac{QT + 1.75 \u00d7 (RR - 0.367)}{RR}\\]\n\nThe RR interval (in seconds) can be obtained from: RR = 60 / HR.\n\nWait, the Framingham formula is actually:\n\nThe formula is:\n\n\\[QTc = QT + 1.75 \u00d7 (RR\\;(in\\;seconds) - 0.367)\\]\n\nwhere RR is the RR interval in seconds. Let\u2019s approach this step by step.\n\n1. Calculate the RR interval: Since the heart rate is 144 bpm, the RR interval is:\n\n   \\[RR = \\frac{60}{HR} = \\frac{60}{144} \\approx 0.4167\\text{ seconds}.\\]\n\nNow we use the Framingham formula to calculate the corrected QT:\n\n\\[QTc = QT + 1.75 \u00d7 (RR - 0.367)\\]\n\nPlugging in the values:\n\nQT is 330 msec.\n\nAnd\n\n\\[RR = 0.4167\\]\n\nSo,\n\n\\[QTc = 330 + 1.75 \u00d7 (0.4167 - 0.367)\\]\n\nCompute the difference inside the parenthesis:\n\n\\[0.4167 - 0.367 = 0.0497.\\]\n\nNext: multiply by 1.75:\n\n\\[1.75 \u00d7 0.0497 \\approx 0.0865.\\]\n\nThen, add that to the original QT:\n\n\\[QTc = 330 + 0.0865\\]\n\nWait, no, wait. Wait, the units need to be checked. The formula gives QTc in msec, so the term \\(1.75 \u00d7 (RR - 0.367)\\) is in msec? No, it seems incorrect since \\(1.75 \u00d7 0.0497\\) is in seconds (because 1.75 multiplier is perhaps in msec per second?).\n\nWait, perhaps there\u2019s confusion here. The RR interval is in seconds, but if the formula uses RR in milliseconds, that would change everything. Let me check the units again. The standard RR interval is in seconds, so 0.4167 seconds or 416.7 milliseconds (since 0.4167 s = 416.7 ms). So perhaps the formula is:\n\n\\[QTc = QT + 1.75 \u00d7 (\\text{RR in ms} - 367\\text{ ms})\\]\n\nWait, if RR in milliseconds, then:\n\nRR = 416.7 ms.\n\nThen, the term inside the parenthesis becomes:\n\n416.7 ms \u2212 367 ms = 49.7 ms\n\nThen multiply by 1.75:\n\n1.75 \u00d7 49.7 = ? Let\u2019s compute:\n\n1.75 \u00d7 40 = 70  \n1.75 \u00d7 9.7 \u2248 17  \n70 + 17 = 87\n\nLet\u2019s see that makes more sense."}
{"Row Number": 940, "Calculator Name": "Estimated Due Date", "Calculator ID": "13", "Category": "date", "Note ID": "13", "Patient Note": "The patient's last menstrual period was on 04/09/2021. Her cycle length is 25 days.", "Question": "Using Naegele's Rule for estimated due date based on the last menstrual period and cycle length, what is the the patient's estimated due date? Your response should be in the format of M/D/Y (ie 08/31/2023, 07/03/2000) with just the date and not other text. ", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "01/13/2022", "LLM Explanation": "To calculate the estimated due date using Naegele's Rule, I started with the patient's last menstrual period (LMP), which is April 9, 2021 (04/09/2021), and the cycle length, which is 25 days. \\n\\nStep 1: Using the standard Naegele's Rule for a 28-day cycle, we add 7 days to the LMP (April 9, 2021 + 7 days = April 16, 2021), and then add 9 months to this date. Adding 9 months to April 16, 2021 gives us January 16, 2022.\\n\\nStep 2: Since the cycle length is 25 days (which is 3 days shorter than the standard 28 days), we need to adjust the due date by subtracting the difference (28 - 25 = 3 days) from the due date calculated in Step 1.\\n\\nStep 3: Subtract 3 days from January 16, 2022. January 16, 2022 - 3 days = January 13, 2022.\\n\\nTherefore, the adjusted estimated due date is January 13, 2022.", "LLM Thinking": "Step 1: To calculate the estimated due date using Naegele 's Rule, I need to start with the patient's last menstrual period ( LMP), which is April 9, 2021 ( 04/09/2021), and the cycle length , which is 25 days. Step 2: Nae gele's Rule typically starts with adding 280 days ( or 40 weeks) to the LMP to estimate the due date. However, when the cycle length is not 28 days, we need to adjust the due date based on the cycle length. For a standard 28-day cycle, the rule is to add 7 days to the LMP's start date and then 9 months to get the due date. But, for a non-standard cycle, we adjust the due date by the difference between the cycle length and 28 days. Step 3: First, I'll calculate the estimated due date assuming a standard 28-day cycle using Naegele's Rule and then make the adjustment for the given cycle length, 25 days . Step 4: Applying the standard method: LMP is April 9, 2021. Add 7 days to this date: April 9 + 7 days = April 16, 2021. Then add 9 months: April 16, 2021 + 9 months = January 16, 2022. Step 5: Since the cycle length is shorter than 28 days (25 days), the ovulation and conception might have occurred earlier, so the due date should be adjusted. The adjustment is calculated by subtracting (28 - cycle length) days from the estimated due date. Here, 28 -25 = 3 days. So the cycle is 3 days shorter than the standard 28 days. Therefore, we need to subtract 3 days from the previously calculated due date (January 16, 20 22).", "Ground Truth Answer": "01/17/2022", "Ground Truth Explanation": "The patient's estimated due date based on their last period is computed by using Naegele's Rule. Using Naegele's Rule, we add 40 weeks to the patient's last menstrual period date. We then add or subtract days from the patient's estimated due date depending on how many more or less days a patient's cycle length is from the standard 28 days. \nThe patient's last menstrual period was 04/09/2021. \nThe date after adding 40 weeks to the patient's last menstrual period date is 01/14/2022. \nBecause the patient's cycle length is 25 days, this means that we must subtract 3 days from the patient's estimate due date. Hence, the patient's estimated due date is 01-17-2022. ", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the estimated due date using Naegele 's Rule, I need to start with the patient's last menstrual period ( LMP), which is April 9, 2021 ( 04/09/2021), and the cycle length , which is 25 days. \n\nStep 2: Nae gele's Rule typically starts with adding 280 days ( or 40 weeks) to the LMP to estimate the due date. However, when the cycle length is not 28 days, we need to adjust the due date based on the cycle length. For a standard 28-day cycle, the rule is to add 7 days to the LMP's start date and then 9 months to get the due date.\n\nBut, for a non-standard cycle, we adjust the due date by the difference between the cycle length and 28 days.\n\nStep 3: First, I'll calculate the estimated due date assuming a standard 28-day cycle using Naegele's Rule and then make the adjustment for the given cycle length, 25 days . Step 4: Applying the standard method: LMP is April 9, 2021. Add 7 days to this date: April 9 + 7 days = April 16, 2021. Then add 9 months: April 16, 2021 + 9 months = January 16, 2022.\n\nStep 5: Since the cycle length is shorter than 28 days (25 days), the ovulation and conception might have occurred earlier, so the due date should be adjusted. The adjustment is calculated by subtracting (28 - cycle length) days from the estimated due date.\n\nHere, 28 -25 = 3 days. So the cycle is 3 days shorter than the standard 28 days.\n\nTherefore, we need to subtract 3 days from the previously calculated due date (January 16, 20 22)."}
{"Row Number": 371, "Calculator Name": "Sodium Correction for Hyperglycemia", "Calculator ID": "26", "Category": "lab", "Note ID": "usmle-5401", "Patient Note": "A 32-year-old woman presents to her primary care physician for constant fatigue. The patient states that she is always tired. She claims she is too tired to exercise and has gained 7 pounds recently. She complains of constipation and a decrease in libido as well. She states that she hasn't felt herself lately and is struggling with her relationships. The patient has a past medical history of obesity and diabetes. Her current medications include insulin, lisinopril, metformin, and sodium docusate. Her temperature is 99.5\u00b0F (37.5\u00b0C), blood pressure is 147/98 mmHg, pulse is 90/min, respirations are 17/min, and oxygen saturation is 98% on room air. Laboratory values are obtained and shown below.\n\nHemoglobin: 10.0 g/dL\nHematocrit: 30%\nMCV: 88 fL\nLeukocyte count: 7,500/mm^3 with normal differential\nPlatelet count: 192,000/mm^3\n\nSerum:\nNa+: 139 mEq/L\nCl-: 100 mEq/L\nK+: 4.3 mEq/L\nHCO3-: 25 mEq/L\nBUN: 20 mg/dL\nGlucose: 129 mg/dL\nCreatinine: 1.1 mg/dL\nCa2+: 10.2 mg/dL\nAST: 12 U/L\nALT: 10 U/L\n\nA peripheral blood smear is performed as seen in Figure A.", "Question": "What is the patient's corrected sodium concentration in terms of mEq/L?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "139", "LLM Explanation": "To calculate the corrected sodium concentration, we use the formula for correcting sodium for hyperglycemia since the patient has an elevated glucose level (129 mg/dL). The formula is: Corrected Na+ = Measured Na+ + (0.0155 \u00d7 [Serum glucose (mg/dL) - 100]). Given the measured sodium is 139 mEq/L and the glucose is 129 mg/dL, we plug these values into the formula: Corrected Na+ = 139 + (0.0155 \u00d7 (129 - 100)) Corrected Na+ = 139 + (0.0155 \u00d7 29) Corrected Na+ = 139 + 0.4495 Corrected Na+ \u2248 139.45 mEq/L. Rounding to the nearest whole number gives us approximately 139 mEq/L.", "LLM Thinking": "Step 1: To calculate the corrected sodium concentration, we need to factor in the patient's serum sodium level and adjust it for the patient's serum albumin levels because sodium can be affected by changes in albumin. However, from the lab values provided, serum albumin is not given directly . Wait, the user hasn't provided albumin levels. Another common approach is to correct sodium if there is a known condition like hypo albuminemia or hyperalbuminemia which indirectly affects sodium levels. Alternatively, maybe the question is referring to another correction, such as for hyper glycemia since the patient also has a high glucose level due to diabetes . The formula for correcting serum sodium (Na+) for hyperglycemia is: Corrected Na+ = Measured Na+ + (0. 0155 \u00d7 [Serum glucose (mg/dL) - 100]). Let me check the glucose level. The patient's glucose is 129 mg/dL, which is slightly elevated but not extremely high. The formula requires subtracting 10 0 mg/dL from the glucose level and then applying the correction. Let's apply the correction for hyperglycemia using the given formula : Corrected Na+ = Measured Na+ + (0. 0155 \u00d7 (Glucose - 100)) However, I should verify if this correction is necessary here. The patient has diabetes and is on insulin, so hyperglycemia could affect serum sodium . The formula is typically used when glucose levels are over 100 mg /dL because high glucose causes a shift in osmolality, leading to a fall in the measured serum sodium due to a \"pseudo hyponat remia.\" Now, let's calculate the correction step by step. 1 29-100=29. Multiply by 0. 0155: 0.0155 * 2 9 = 0.4495. But perhaps the formula requires a different approach? Or maybe the question doesn't need further correction because the glucose level is not extremely high. Alternatively, maybe the question is a trick question because the given data has no specific instructions for correction beyond hyperglycemic correction. The question states \"corrected sodium concentration in terms of mEq/L,\" and the only readily available correction for given data is for hyperglycemia .", "Ground Truth Answer": "139.696", "Ground Truth Explanation": "The formula for Sodium Correction for Hyperglycemia is Measured sodium + 0.024 * (Serum glucose - 100), where Measured Sodium is the sodium concentration in mEq/L and the Serum glucose is the concentration of glucose in mg/dL.\nThe concentration of sodium is 139.0 mEq/L. \nThe concentration of glucose is 129.0 mg/dL. \nPlugging in these values into the formula gives us 139.0 mEq/L + 0.024 * (129.0 - 100) = 139.696 mEq/L.\nHence, the patient's corrected concentration of sodium is 139.696 mEq/L.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the corrected sodium concentration, we need to factor in the patient's serum sodium level and adjust it for the patient's serum albumin levels because sodium can be affected by changes in albumin.\nHowever, from the lab values provided, serum albumin is not given directly .\nWait, the user hasn't provided albumin levels.\nAnother common approach is to correct sodium if there is a known condition like hypo albuminemia or hyperalbuminemia which indirectly affects sodium levels.\nAlternatively, maybe the question is referring to another correction, such as for hyper glycemia since the patient also has a high glucose level due to diabetes .\nThe formula for correcting serum sodium (Na+) for hyperglycemia is: Corrected Na+ = Measured Na+ + (0. 0155 \u00d7 [Serum glucose (mg/dL) - 100]).\nLet me check the glucose level.\nThe patient's glucose is 129 mg/dL, which is slightly elevated but not extremely high.\nThe formula requires subtracting 10 0 mg/dL from the glucose level and then applying the correction.\nLet's apply the correction for hyperglycemia using the given formula :\n\nCorrected Na+ = Measured Na+ + (0. 0155 \u00d7 (Glucose - 100))\n\nHowever, I should verify if this correction is necessary here.\nThe patient has diabetes and is on insulin, so hyperglycemia could affect serum sodium .\nThe formula is typically used when glucose levels are over 100 mg /dL because high glucose causes a shift in osmolality, leading to a fall in the measured serum sodium due to a \"pseudo hyponat remia.\"\n\nNow, let's calculate the correction step by step.\n\n1 29-100=29. Multiply by 0. 0155: 0.0155 * 2 9 = 0.4495.\n\nBut perhaps the formula requires a different approach?\nOr maybe the question doesn't need further correction because the glucose level is not extremely high.\nAlternatively, maybe the question is a trick question because the given data has no specific instructions for correction beyond hyperglycemic correction.\nThe question states \"corrected sodium concentration in terms of mEq/L,\" and the only readily available correction for given data is for hyperglycemia ."}
{"Row Number": 410, "Calculator Name": "Serum Osmolality", "Calculator ID": "30", "Category": "lab", "Note ID": "pmc-4720855-1", "Patient Note": "A 66 year-old female patient was admitted to the emergency room for progressive shortness of breath and poor health condition for 1 week. Her blood pressure was 80/50 mmHg and arterial blood gas analysis was pH; 6.98, pCO2; 99 mmHg, pO2; 66 mmHg. She was immediately intubated and transferred to the coronary intensive care unit. Echocardiography revealed massive pericardial effusion with cardiac tamponade (posteriorly 3 cm, anteriorly 2.5 cm, laterally 2 cm and 2.7 cm in adjacency with the right ventricle). The patient had non valvular AF and been receiving dabigatran etexilate 150 mg twice daily for one year. In addition to dabigatran, the other medications included verapamil, budesonide, valsartan, and hydrochlorotiazide. She had a history of chronic obstructive pulmonary disease, hyperthyroidism, hypertension and gastroesophageal reflux disease. Her blood tests performed 1 year ago showed serum creatinine 0.5 mg/dL (normal range 0.5-0.9 mg/dL) and estimated creatinine clearance 136 mL/minute (using the Cock-croft-Gault equation).\nOn admission her blood tests showed blood urea nitrogen 163.9 mg/dL (normal range 16.6-48.5 mg/dL), creatinine 3.99 mg/dL (normal range 0.5-0.9 mg/dL), estimated creatinine clearance 16 mL/minute (using the Cock-croft-Gault equation), fasting glucose 83.9 mg/dL (normal range 74-109 mg/dL), sodium 130 mmol/L (normal range 136-145 mmol/L), potassium 5.3 mmol/L (normal range 3.5-5.1 mmol/L), prothrombin time (PT) 44.5 s (normal range 11.5-15 s), activated partial thromboplastin time (aPTT) 123.7 s (normal range 26-32 s), international normalized ratio (INR) 4.79, white blood cell count 10.59 103/uL (normal range 4.4-11.3 103/uL), hemoglobin 7.7 g/dL (normal range 11.7-16.1 g/dL), hematocrit 25.7% (normal range 35-47%), and platelet count 183 103/uL (normal range 152-396 103/uL).\nUrgent pericardiocentesis was performed with echocardiographic guidance and 1500 mL of hemorrhagic fluid was removed. Pericardial fluid analysis showed hemoglobin 7 g/dL and plasma hemoglobin level of the patient was 7.7 g/dL. Cytologic exam was negative for malignancy. Biochemical tests showed total protein 5.4 mg/dL, lactate dehydrogenase 707 mg/dL and albumin 2.98 mg/dL.\nSix hours after pericardiocentesis, the patients' blood pressure was over 100 mmHg systolic and she began to urinate. Red blood cell and fresh frozen plasma transfusions were made and post-transfusion hemoglobin level was 12 g/dL, PT 36.4 s (normal range 11.5-15 s), aPTT 100.5 s (normal range 26-32 s), and INR 4.1. On the second day after pericardiocentesis, hemorrhagic fluid flow via drainage catheter persisted and additional fresh frozen plasma transfusion was administered. Subsequently, PT was 25.3 s, aPTT 77,5 and INR was 2.3. Pericardial drainage was terminated after achievement of no flow through catheter and no pericardial effusion on control echocardiography.\nLaboratory tests repeated on the fourth day of admission were as follows: blood urea nitrogen 109 mg/dL, creatinine 1.4 mg/dL, INR 1.4 and hemoglobin 12 g/dL. The patient was extubated after improved ventilation parameters. Dabigatran etexilate was omitted and other medications were continued. She was discharged 10 days after admission. Warfarin was initiated and the follow-up was uneventful.", "Question": "What is the patient's serum osmolality in terms of mOsm/kg?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "323", "LLM Explanation": "To calculate the patient's serum osmolality, we use the formula: \\[ \\text{Serum osmolality (mOsm/kg)} = 2 \\times [\\text{Na}^+] + \\frac{\\text{BUN}}{2.8} + \\frac{\\text{Glucose}}{18}. \\] From the admission data, we have the following values: - Sodium (Na): 130 mmol/L - Blood urea nitrogen (BUN): 163.9 mg/dL - Glucose: 83.9 mg/dL Now, let's plug these values into the formula step by step. 1. Calculate \\(2 \\times [\\text{Na}^+]\\): \\[ 2 \\times 130 = 260. \\] 2. Calculate \\(\\frac{\\text{BUN}}{2.8}\\): \\[ \\frac{163.9}{2.8} = 58.5357. \\] 3. Calculate \\(\\frac{\\text{Glucose}}{18}\\): \\[ \\frac{83.9}{18} \\approx 4.6611. \\] Now, add all these values together: \\[ \\text{Serum osmolality} = 260 + 58.5357 + 4.6611. \\] Adding the first two terms: \\[ 260 + 58.5357 = 318.5357. \\] Now add the third term: \\[ 318.5357 + 4.6611 \\approx 323.1968. \\] Rounding to the nearest whole number gives us approximately 323 mOsm/kg.", "LLM Thinking": "First, we need to calculate the serum osmolality using the formula for plasma osmolality: \\[ \\text{Serum osmolality ( mOsm/kg)} = 2 \\times [\\text{Na} ^+] + [\\text{BUN}]/2.8 + [\\text{glucose}]/18 \\] From the given information in the patient note: - **Blood urea nitrogen (BUN ):** 163.9 mg/dL (on admission) or 109 mg/dL on the fourth day. The question asks about the patient's serum osmolality but doesn\u2019t specify a particular point in time. Given that the goal is likely to calculate it for the acute phase when the patient was admitted (since that\u2019s when the major abnormalities were observed), we\u2019ll use the measurements from the admission. The question doesn\u2019t specify, so we need to clarify. But since the task is to compute it based on the provided data, and often in clinical settings, serum osmolality is calculated using values during admission or the acute phase unless otherwise specified, I'll use the data from the admission (BUN 163.9 mg/dL). Wait, let me check again. The correct approach is likely to use the parameters at one of the given time points. Since the question doesn't specify a time, but the admission labs are the earliest and most relevant for an acute picture, we use those values. However, looking at the provided data: But the question might not be tied to a particular time. Alternatively, maybe the question expects using the fourth-day values. Let\u2019s calculate for both and choose the more clinically relevant one. Let's calculate for the **admission** data first : Now, applying the formula: Now let\u2019s calculate for **the fourth-day** data to compare : - Sodium: Not provided on the fourth day. The note only mentions BUN, creatinine, and INR on the fourth day. But if Na remains the same (assuming no significant changes unless specified), let\u2019s see. However, the sodium value is only given once in the admission data. - **Glucose:** Not provided for that day, so I\u2019ll keep it the same for now (83.9 mg/dL) for consistency (because generally, unless there's a change mentioned in the note, lab tests are not repeated unless clinically necessary.) So, if using the fourth-day BUN but same Na and glucose: But the question asks for \"the patient's serum osmolality\" without specifying time. Since the fourth-day values represent a more normalized state (with creatinine also being better), the question might not be tied to a specific time. Alternatively, the question might be asking about the serum osmolality during the acute phase (admission), as that's when the most critical labs were taken. However, the problem is that the user hasn't specified which time point. However, looking back at the note, perhaps the question expects using the admission values since those are the ones that are the most abnormal and relevant to the clinical scenario presented (like the cardiac tamponade and acute renal failure). Additionally, the sodium level is given in the admission data, so it might be assumed it\u2019s the best set to use for this calculation. Thus, the most appropriate (and common clinical practice) would often be to use the admission labs for such calculations unless stated otherwise. They reflect the physiologic state during the acute illness.", "Ground Truth Answer": "323.197", "Ground Truth Explanation": "The formula for computing serum osmolality is 2 * Na + (BUN / 2.8) + (glucose / 18), where Na is the concentration of sodium in mmol/L, the concentration of BUN is in mg/dL, and the concentration of glucose is in mg/dL.\nThe concentration of sodium is 130.0 mmol/L. \nThe concentration of bun is 163.9 mg/dL. \nThe concentration of glucose is 83.9 mg/dL. \nPlugging these values into the equation, we get 2 * 130.0 + (163.9 / 2.8) + (163.9 / 18) = 323.197 mmol/L.The patient's calculated serum osmolality concentration is 323.197 mmol/L. This is equalivalent to 323.197 mOsm/kg.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the serum osmolality using the formula for plasma osmolality:\n\n\\[ \\text{Serum osmolality ( mOsm/kg)} = 2 \\times [\\text{Na} ^+] + [\\text{BUN}]/2.8 + [\\text{glucose}]/18 \\]\n\nFrom the given information in the patient note:\n\n- **Blood urea nitrogen (BUN ):** 163.9 mg/dL (on admission) or 109 mg/dL on the fourth day. The question asks about the patient's serum osmolality but doesn\u2019t specify a particular point in time.\n\nGiven that the goal is likely to calculate it for the acute phase when the patient was admitted (since that\u2019s when the major abnormalities were observed), we\u2019ll use the measurements from the admission.\n\nThe question doesn\u2019t specify, so we need to clarify.\n\nBut since the task is to compute it based on the provided data, and often in clinical settings, serum osmolality is calculated using values during admission or the acute phase unless otherwise specified, I'll use the data from the admission (BUN 163.9 mg/dL).\n\nWait, let me check again. The correct approach is likely to use the parameters at one of the given time points.\n\nSince the question doesn't specify a time, but the admission labs are the earliest and most relevant for an acute picture, we use those values.\n\nHowever, looking at the provided data:\n\nBut the question might not be tied to a particular time. Alternatively, maybe the question expects using the fourth-day values.\n\nLet\u2019s calculate for both and choose the more clinically relevant one.\n\nLet's calculate for the **admission** data first :\n\nNow, applying the formula:\n\nNow let\u2019s calculate for **the fourth-day** data to compare :\n\n- Sodium: Not provided on the fourth day. The note only mentions BUN, creatinine, and INR on the fourth day. But if Na remains the same (assuming no significant changes unless specified), let\u2019s see. However, the sodium value is only given once in the admission data.\n\n- **Glucose:** Not provided for that day, so I\u2019ll keep it the same for now (83.9 mg/dL) for consistency (because generally, unless there's a change mentioned in the note, lab tests are not repeated unless clinically necessary.)\n\nSo, if using the fourth-day BUN but same Na and glucose:\n\nBut the question asks for \"the patient's serum osmolality\" without specifying time.\n\nSince the fourth-day values represent a more normalized state (with creatinine also being better), the question might not be tied to a specific time.\n\nAlternatively, the question might be asking about the serum osmolality during the acute phase (admission), as that's when the most critical labs were taken.\n\nHowever, the problem is that the user hasn't specified which time point.\n\nHowever, looking back at the note, perhaps the question expects using the admission values since those are the ones that are the most abnormal and relevant to the clinical scenario presented (like the cardiac tamponade and acute renal failure).\n\nAdditionally, the sodium level is given in the admission data, so it might be assumed it\u2019s the best set to use for this calculation.\n\nThus, the most appropriate (and common clinical practice) would often be to use the admission labs for such calculations unless stated otherwise.\n\nThey reflect the physiologic state during the acute illness."}
{"Row Number": 446, "Calculator Name": "Charlson Comorbidity Index (CCI)", "Calculator ID": "32", "Category": "risk", "Note ID": "21", "Patient Note": "A 76-year-old gentleman visits the clinic for a follow-up. His impressive journey through life is marked by several health challenges. At the forefront of his medical history is hepatoblastoma that he battled; he has been in remission since the completion of his treatment regimen. Leukemia has also been a significant chapter within his medical narrative, which he's managing with the appropriate therapy. His heart endures the strain of congestive heart failure; ongoing management of this condition has been emphasized by his healthcare team. He has managed to keep his type II diabetes mellitus uncomplicated with diet management and regular exercise. A clinical assessment had led to a diagnosis of dementia, which has progressively been impacting his coping abilities and presenting social challenges for him. He also presented with signs and symptoms suggestive of severe liver disease, contributing to his complicated health status. Status post cerebral vascular accident has been another turning point in his health journey, although he didn\u2019t suffer any significant residual deficits. However, the patient denies having transient ischemic attacks. His experience with autoimmune disorders is punctuated by a diagnosis of connective tissue disease which is being persistently managed. Despite his rich past medical history, he shows no signs of chronic kidney disease, AIDS, any peripheral vascular disease, peptic ulcer disease, or chronic obstructive pulmonary disease. His spirit and engagement towards managing his chronic health conditions have been outstanding, with regular follow-ups and compliance to his multifaceted treatment plan.", "Question": "What is the patient's Charlson Comorbidity Index (CCI)?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "12", "LLM Explanation": "To calculate the Charlson Comorbidity Index (CCI), I identified the relevant comorbid conditions from the patient note and assigned points based on the Charlson Comorbidity Index scoring system. The conditions contributing to the CCI are: \\n\\n1. **Leukemia**: This is an active malignancy and is assigned 6 points.\\n2. **Congestive Heart Failure (CHF)**: This condition is included in the Charlson Comorbidity Index and is assigned 1 point.\\n3. **Dementia**: Dementia is included in the Charlson Comorbidity Index and is assigned 1 point.\\n4. **Severe Liver Disease**: Severe liver disease is included in the Charlson Comorbidity Index and is assigned 3 points.\\n5. **Status Post Cerebral Vascular Accident (CVA)**: A history of stroke (cerebral vascular accident) is included in the Charlson Comorbidity Index and is assigned 1 point.\\n\\nNow, I add up the points for these conditions:\\n- Leukemia: 6 points\\n- Congestive Heart Failure: 1 point\\n- Dementia: 1 point\\n- Severe Liver Disease: 3 points\\n- Status Post Cerebral Vascular Accident: 1 point\\n\\nTotal CCI = 6 + 1 + 1 + 3 + 1 = 12.", "LLM Thinking": "To calculate the Charlson Comorbidity Index (CCI), I will identify each of the comorbid conditions mentioned in the patient note and assign points based on the Charlson Comorbidity Index scoring system. The CCI includes various comorbidities with specific point values, and the total score is the sum of these points. First, I'll list all the conditions the patient has: 1. **Hepatoblastoma**: This is a type of cancer. The Charlson Comorbidity Index includes \"Malignancy\" and usually assigns 6 points for metastatic cancer or 2 points for other cancers . Since the note mentions that he has been in remission after completing the treatment , it's likely that this is a previous cancer. However, cured or past cancer (in remission) may not be included . I need to check if past malignancies in remission count. Typically, the index focuses on current, active conditions. The note says he's been in remission since treatment completion, so maybe this will not factor into the CCI unless otherwise specified as active. However, some sources include cancer (except lymphoma) as 6 points or other cancers as 1-2 points if they are active. Since it's not clear if it's still considered active, I'll set aside this condition for now. 2. **Leukemia**: This is an active malignancy. It usually counts for points. The Charlson index assigns 6 points for lymphoma or leukemia, so leukemia here would be 6 points. Wait, let me confirm. The Charlson index: \"Lymphoma\" is 5 points, and \"Leukemia\" (as a kind of malignancy) is categorized under \"Malignant neoplasms\" which is 1 point (for solid tumors) or higher if it's hematologic. However common approach assigns leukemia as a 6-point malignancy because it is a hematologic malignancy. Wait, I need to recall exact scoring. For \"Active malignancy without metastasis\", if the leukemia is active it might be 2 points, but if it's metastatic it's 6. However, the note says he is managing with appropriate therapy, implying it's an active condition (possibly under control but present). So Leukemia is likely 2 or 6 points. However, according to the Charlson index, \"Malignancy (excluding lymphoma)\" is 6 points if metastatic, 2 otherwise? Wait, maybe I need to recall: The Charlson Comorbidity Index has \"Malignancy\" (other than lymphoma) as 6 points (for metastatic) or 2 points (if non-metastatic and not in remission). However, if the malignancy is in remission, it might not be counted. The note says \"managing with appropriate therapy\", but doesn't specify if it's metastatic or in remission. Hmm, this is ambiguous. However, in the absence of metastasis, leukemia would be considered 2 points since it's in the active therapy phase and not clearly in remission or has metastasis. Let's note it for now (Leukemia = 2 points). 4. **Type II Diabetes Mellitus ( uncomplicated)**: Uncomplicated diabetes is not included in the Charl son Comorbidity Index. It is only counted if it is complicated (with end organ damage like ret inopathy, neuropathy, etc.), which the note states it is uncomp licated. So diabetes here does not contribute to the score. 8. **Connective Tissue Disease / Autoimmune Disorder**: This generally refers to conditions like Lupus, Rheumatoid Arthritis, etc ., which don't have an individual point in the Charlson Comorbidity Index unless it leads to specific complications like renal failure or heart disease, which isn't mentioned here. So, connective tissue disease typically is not given points in CCI unless it's a specific condition like rheumatoid arthritis leading to heart or lung complications (which would fall into other categories). Since it's not complicating (e.g., no indication of heart or lung issues from it), it might not add points. 9. **Other conditions mentioned (no CKD, AIDS, P VD, PUD, COPD, etc.)**: These conditions are excluded as the note states he has none. Hmm. I need to confirm the exact scoring for leukemia in the Charlson index. Looking up the standard CCI: The Charlson Comorbidity Index includes \"Malignancy\" (other than lymphoma) as 6 points (for metastatic) or 2 points (if non-met astatic and not in remission). Leukemia is a hematologic malignancy and is typically considered to have poor prognosis hence assigned higher points (because it is inherently \u201chigh-risk\u201d). The standard approach is that leukemia is counted as 6 points even if in remission because it\u2019s an aggressive, high-risk malignancy that significantly impacts prognosis. Wait, but the note says he is managing with appropriate therapy. However, the Charlson index might not consider remission status for malignancies unless explicitly in remission for a prolonged time. Given that it's in his current medical history as \"managing with appropriate therapy\", it's likely still an active condition; thus, it seems it should be scored. Since it's not clear if leukemia is in remission (though he is managing it), but the note doesn't state remission for leukemia, I will take leukemia at its aggressive nature, which might fall into the 6-point category. However, some sources clarify that leukemia is scored as 6 points regardless of prognosis since its presence in the patient's treatment plan implies current activity and high risk. Let me confirm: According to the original Charlson Index, \"Malignancy\" (other than lymphoma) is scored as 6 points if metast atic or 2 points if not. However, for hematologic malignancies like leukemia or myeloma, they are considered to have a 6 points since their presence in the patient's treatment plan implies current activity and high risk.", "Ground Truth Answer": "11", "Ground Truth Explanation": "The current CCI is value is 0.\nThe patient is 76.0 years old. Because the patient's age is between 70 and 79, we add 3 points to the score, making the current total = 0 + 3 = 3.\nThe issue, 'Myocardial infarction,' is reported to be absent for the patient and so we do not add any points to the score, keeping the current total at 3.\nThe patient's CCI score is 3 points.\n The issue,'Congestive heart failure,' is present for the patient and so we add 1 point to the score, making the current total 3 + 1 = 4.\nThe patient's CCI score is 4 points.\nThe issue, 'Peripheral vascular disease,' is reported to be absent for the patient and so we do not add any points to the score, keeping the current total at 4.\nThe patient's CCI score is 4 points.\nAt least one of transient ischemic attack or cerebral vascular accident must be present in the patient for a point to be added to the current total.\nTransient ischemic attacks is reported to be absent for the patient.\nCerebral vascular accident is reported to be present for the patient.\nBecause at least one of the issues is reported to be present for the patient, we add 1 point to the score, making the current total 4 + 1 = 5.\nThe issue, 'Connective tissue diease,' is reported to be absent for the patient and so we do not add any points to the score, keeping the current total at 5.\nThe patient's CCI score is 5 points.\n The issue,'Dementia,' is present for the patient and so we add 1 point to the score, making the current total 5 + 1 = 6.\nThe patient's CCI score is 6 points.\nThe issue, 'Chronic obstructive pulmonary disease,' is reported to be absent for the patient and so we do not add any points to the score, keeping the current total at 6.\nThe patient's CCI score is 6 points.\nThe issue, 'Hemiplegia,' is reported to be absent for the patient and so we do not add any points to the score, keeping the current total at 6.\nThe patient's CCI score is 6 points.\nThe issue, 'Peptic ulcer disease,' is reported to be absent for the patient and so we do not add any points to the score, keeping the current total at 6.\nThe patient's CCI score is 6 points.\n The issue,'Liver Disease,' is present for the patient and so we add 1 point to the score, making the current total 6 + 1 = 7.\nThe patient's CCI score is 7 points.\n The issue,'Diabetes mellitus,' is present for the patient and so we add 1 point to the score, making the current total 7 + 1 = 8.\nThe patient's CCI score is 8 points.\nThe issue, 'Moderate to severe chronic kidney disease,' is reported to be absent for the patient and so we do not add any points to the score, keeping the current total at 8.\nThe patient's CCI score is 8 points.\n The issue,'Solid tumor,' is present for the patient and so we add 1 point to the score, making the current total 8 + 1 = 9.\nThe patient's CCI score is 9 points.\nThe issue, 'Leukemia,' is reported to be present for the patient and so we add 2 points to the score, making the current total 9 + 2 = 11.\nThe patient's CCI score is 11 points.\nThe issue, 'Lymphoma,' is reported to be absent for the patient and so we do not add any points to the score, keeping the current total at 11.\nThe patient's CCI score is 11 points.\nThe issue, 'AIDS,' is reported to be absent for the patient and so we do not add any points to the score, keeping the current total at 11.\nThe patient's CCI score is 11 points.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the Charlson Comorbidity Index (CCI), I will identify each of the comorbid conditions mentioned in the patient note and assign points based on the Charlson Comorbidity Index scoring system.  \nThe CCI includes various comorbidities with specific point values, and the total score is the sum of these points.  \nFirst, I'll list all the conditions the patient has:  \n\n1. **Hepatoblastoma**: This is a type of cancer. The Charlson Comorbidity Index includes \"Malignancy\" and usually assigns 6 points for metastatic cancer or 2 points for other cancers . Since the note mentions that he has been in remission after completing the treatment , it's likely that this is a previous cancer. However, cured or past cancer (in remission) may not be included . I need to check if past malignancies in remission count. Typically, the index focuses on current, active conditions. The note says he's been in remission since treatment completion, so maybe this will not factor into the CCI unless otherwise specified as active.  \nHowever, some sources include cancer (except lymphoma) as 6 points or other cancers as 1-2 points if they are active.  \nSince it's not clear if it's still considered active, I'll set aside this condition for now.  \n\n2. **Leukemia**: This is an active malignancy. It usually counts for points. The Charlson index assigns 6 points for lymphoma or leukemia, so leukemia here would be 6 points. Wait, let me confirm.  \nThe Charlson index: \"Lymphoma\" is 5 points, and \"Leukemia\" (as a kind of malignancy) is categorized under \"Malignant neoplasms\" which is 1 point (for solid tumors) or higher if it's hematologic. However common approach assigns leukemia as a 6-point malignancy because it is a hematologic malignancy. Wait, I need to recall exact scoring.  \nFor \"Active malignancy without metastasis\", if the leukemia is active it might be 2 points, but if it's metastatic it's 6. However, the note says he is managing with appropriate therapy, implying it's an active condition (possibly under control but present). So Leukemia is likely 2 or 6 points. However, according to the Charlson index, \"Malignancy (excluding lymphoma)\" is 6 points if metastatic, 2 otherwise? Wait, maybe I need to recall: The Charlson Comorbidity Index has \"Malignancy\" (other than lymphoma) as 6 points (for metastatic) or 2 points (if non-metastatic and not in remission). However, if the malignancy is in remission, it might not be counted. The note says \"managing with appropriate therapy\", but doesn't specify if it's metastatic or in remission. Hmm, this is ambiguous. However, in the absence of metastasis, leukemia would be considered 2 points since it's in the active therapy phase and not clearly in remission or has metastasis. Let's note it for now (Leukemia = 2 points).  \n\n4. **Type II Diabetes Mellitus ( uncomplicated)**: Uncomplicated diabetes is not included in the Charl son Comorbidity Index. It is only counted if it is complicated (with end organ damage like ret inopathy, neuropathy, etc.), which the note states it is uncomp licated. So diabetes here does not contribute to the score.  \n\n8. **Connective Tissue Disease / Autoimmune Disorder**: This generally refers to conditions like Lupus, Rheumatoid Arthritis, etc ., which don't have an individual point in the Charlson Comorbidity Index unless it leads to specific complications like renal failure or heart disease, which isn't mentioned here. So, connective tissue disease typically is not given points in CCI unless it's a specific condition like rheumatoid arthritis leading to heart or lung complications (which would fall into other categories). Since it's not complicating (e.g., no indication of heart or lung issues from it), it might not add points.  \n\n9. **Other conditions mentioned (no CKD, AIDS, P VD, PUD, COPD, etc.)**: These conditions are excluded as the note states he has none.  \n\nHmm. I need to confirm the exact scoring for leukemia in the Charlson index. Looking up the standard CCI: The Charlson Comorbidity Index includes \"Malignancy\" (other than lymphoma) as 6 points (for metastatic) or 2 points (if non-met astatic and not in remission). Leukemia is a hematologic malignancy and is typically considered to have poor prognosis hence assigned higher points (because it is inherently \u201chigh-risk\u201d). The standard approach is that leukemia is counted as 6 points even if in remission because it\u2019s an aggressive, high-risk malignancy that significantly impacts prognosis. Wait, but the note says he is managing with appropriate therapy. However, the Charlson index might not consider remission status for malignancies unless explicitly in remission for a prolonged time. Given that it's in his current medical history as \"managing with appropriate therapy\", it's likely still an active condition; thus, it seems it should be scored. Since it's not clear if leukemia is in remission (though he is managing it), but the note doesn't state remission for leukemia, I will take leukemia at its aggressive nature, which might fall into the 6-point category. However, some sources clarify that leukemia is scored as 6 points regardless of prognosis since its presence in the patient's treatment plan implies current activity and high risk. Let me confirm: According to the original Charlson Index, \"Malignancy\" (other than lymphoma) is scored as 6 points if metast atic or 2 points if not. However, for hematologic malignancies like leukemia or myeloma, they are considered to have a 6 points since their presence in the patient's treatment plan implies current activity and high risk."}
{"Row Number": 334, "Calculator Name": "Maintenance Fluids Calculations", "Calculator ID": "22", "Category": "physical", "Note ID": "pmc-5970484-1", "Patient Note": "A 32-year-old Japanese woman with AN and pancytopenia was admitted to the psychiatric department of our hospital. The patient had no other remarkable medical or familial history. There was no occupational history indicating exposure to organic solvents (e.g., benzene).\nThe patient started binge eating and purging at 14 years of age. At 16 years of age, she was diagnosed with AN, and had multiple hospitalizations in this regard. The patient\u2019s first admission to our department was at 26 years of age, at which time her body mass index (BMI) was 9.5 kg/m2 (weight, 22 kg; height, 152 cm). The patient had mild, transient bicytopenia with a low white blood cell (WBC) count (3000 cells/\u03bcL; reference range, 4000\u20139000 cells/\u03bcL) and a low hemoglobin (Hb) level (10.3 g/dL; reference range, 12.0\u201315.2 g/dL). These abnormalities improved with nutritional therapy. At the time of discharge, the patient\u2019s weight had improved, with a BMI of approximately 17 kg/m2.\nAt 32 years of age, the patient\u2019s binge eating and purging behavior worsened again, and she began to lose weight. Five months prior to her eventual hospitalization (BMI, 15.0 kg/m2), no hematological abnormalities were identified. At 46 days prior to the hospitalization, because of ongoing fatigue, she was examined by a hematologist at our hospital. The patient was determined to be underweight, with a body weight of 31.9 kg and a BMI of 13.8 kg/m2. Peripheral blood analysis confirmed pancytopenia with the following findings: low WBC count, 2500 cells/\u03bcL; low neutrophil count, 1010 cells/\u03bcL (reference range: 1600\u20135400 cells/\u03bcL); low eosinophil count, 0 cells/\u03bcL (reference range: 80\u2013610 cells/\u03bcL); low basophil count, 30 cells/\u03bcL (reference range: 0\u2013180 cells/\u03bcL); normal lymphocyte count, 1280 cells/\u03bcL (reference range: 1060\u20134190 cells/\u03bcL); normal monocyte count, 200 cells/\u03bcL (reference range: 90\u2013690 cells/\u03bcL); low reticulocyte count, 14.4 \u00d7 103 cells/\u03bcL (reference range: 35.0\u2013125.0 \u00d7 103 cells/\u03bcL); low Hb level, 6.1 g/dL; high mean corpuscular volume, 113.9 fL (reference range: 80.0\u2013100.0 fL); and low platelet (Plt) count, 10.6 \u00d7 104 cells/dL (reference range: 11.7\u201332.9 \u00d7 104 cells/dL). Blood biochemistry studies showed low serum levels of folate (3.0 ng/mL; reference range: 4.0\u201319.9 ng/mL) but normal serum levels of iron and vitamin B12. The etiology of pancytopenia was tentatively suspected to be folate deficiency, and thus the patient was prescribed folate at 10 mg/day. At 28 days prior to hospitalization, the folate level had recovered within normal limits, but the peripheral blood counts had worsened (low WBC count, 2200 cells/\u03bcL; low Hb level, 2.5 g/dL; and low Plt count, 8.6 \u00d7 104 cells/dL).\nThe patient was temporarily admitted to the hematology department of our hospital for blood transfusions. Laboratory tests yielded negative results for autoimmune disorders (including systemic lupus erythematosus), malignant lymphoma, infectious diseases, hemophagocytic lymphohistiocytosis, and hypersplenism. The patient was offered nutritional therapy to improve her weight but she refused and was therefore discharged following blood transfusions. After discharge, outpatient follow-up was performed by the hematology department. However, the patient\u2019s hematologic condition did not improve. Despite receiving blood transfusions twice monthly, the patient was eventually hospitalized once again for severe anemia. The patient believed that her hematological problems were not related with her eating behavior and persistently refused nutritional therapy. Finally, she was admitted to the psychiatric department to receive both hematologic and psychiatric support.\nOn admission, the patient\u2019s body weight was 30 kg and BMI was 13.0 kg/m2. The vital signs were normal. Physical examination revealed no abnormalities other than bilateral non-pitting edema of the lower legs. The patient received folate (10 mg/day), sertraline (50 mg/day), zolpidem (10 mg/day), and flunitrazepam (2 mg/day). Toxicology analysis was not performed because the patient presented no feature indicating exposure to toxic compounds. Laboratory findings were as follows: low WBC count, 2100 cells/\u03bcL; low reticulocyte count, 9.4 \u00d7 103 cells/\u03bcL; low Hb level, 5.7 g/dL; and low Plt count, 4.1 \u00d7 104 cells/dL. The differential WBC count was normal. Serum levels of iron, folate, vitamin B12, zinc, copper, and ceruloplasmin were within normal ranges. These results did not identify the etiology of the hematological problems. The patient persistently refused nutritional therapy and hoped that some other causes of pancytopenia (other than malnutrition) would be found. On hospitalization day 7, upon obtaining written informed consent from the patient, we performed bone marrow aspiration and biopsy.\nBone marrow aspiration revealed low counts of nucleated cells (5.5 \u00d7 103 cells/\u03bcL; reference range: 100\u2013200 \u00d7 103 cells/\u03bcL) and megakaryocytes (< 15.6 cells/\u03bcL; reference range: 50\u2013150 cells/\u03bcL). Bone marrow biopsy revealed hypoplasia but no dysplasia and confirmed the presence of fatty replacement with no gelatinous material (Fig. ). It was notable that the bone marrow displayed fatty marrow findings without any evidence of GMT, which would generally indicate IAA. Moreover, no chromosomal abnormalities or cell surface abnormalities were found upon bone marrow examination. T1-weighted images from thoracolumbar magnetic resonance imaging confirmed homogenous high signal intensity, characteristic of fatty marrow. Detailed examination of peripheral blood and bone marrow findings indicated IAA. However, despite the absence of bone marrow features typically seen in malnutrition, the patient\u2019s hematological abnormalities manifested after a decrease in body weight. Thus, although the biopsy findings indicated IAA, we considered that the nutritional etiology of pancytopenia could not be thoroughly ruled out.\nAfter bone marrow aspiration and biopsy, the patient accepted nutritional therapy. At the time of admission, she was given 600 kcal/day intravenously. Energy intake was gradually increased, and the patient received oral nutrition amounting to 3200 kcal/day from hospitalization day 14 until discharge. The patient\u2019s caloric intake was strictly managed, which resulted in weight restoration (Table ). The hematological abnormalities began to improve with the gradual increase in caloric intake. By hospitalization day 11, the patient\u2019s condition had improved to the point where she no longer required transfusions. On hospitalization day 28, the patient\u2019s weight was 38.1 kg, and her BMI was 16.5 kg/m2. Pancytopenia had also improved (Table ), and thus the patient was discharged the following day. Bone marrow aspiration and biopsy performed 2 weeks after discharge yielded normal findings. Because both blood and bone marrow findings improved after implementation of nutritional therapy alone, the final diagnosis was pancytopenia secondary to malnutrition.", "Question": "Based on the patient's weight, what is the patient's maintenance fluid in mL/hr?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "57.15", "LLM Explanation": "To calculate the patient's maintenance fluid rate, we use the formula for adults, which is 1.5 mL/kg/hr. The patient's weight is 38.1 kg. Therefore, the maintenance fluid rate is calculated as 1.5 mL/kg/hr * 38.1 kg. This gives us 1.5 * 38.1 = 57.15 mL/hr.", "LLM Thinking": "Step 1: To calculate a patient\u2019s maintenance fluid rate, we need to estimate the total daily maintenance fluid requirement in mLs and then convert it to mL per hour. Step 2: The patient's weight is given at the time of discharge as 38.1 kg. Step 3: The standard formula for maintenance fluids in adults is typically 3 0 mL/kg for the first 10 kg, 20 mL /kg for the next 10 kg, and 10 mL/kg for the remaining weight over 20 kg. This is known as the \"4-2-1 rule.\" Step 4: Applying the formula : For the first 10 kg: Wait, actually, the \"4-2-1 rule\" is common for children, and a simpler approach for adults is often used: for adults, the typical maintenance fluid rate is approximately 30 mL/kg /day for the first 10 kg, 20 mL/kg/day for the next 10 kg, and 10 mL/kg/day for the remaining weight over 20 kg. Alternatively, sometimes a simpler rule is used where the maintenance fluid is estimated at approximately 30 mL /kg/day for the first 20 kg and 20 mL/kg /day for any weight over 20 kg. But another common approach for adults is to use a fixed rate of 1.5 mL/kg/hr , which translates to about 36 mL/kg/day. Alternatively, some sources suggest 30-35 mL/kg/day for basal maintenance requirements. Let's use the rule for adults: Maintenance fluid requirement per day for adults can be calculated as 30 mL/kg for the first 1 0 kg, plus 20 mL/kg for the next 10 kg (up to 20 kg), and 10 mL/kg for any weight over 20 kg. This is similar to the pediatric 4-2-1 rule but in mL/kg/day instead of per hour. Wait, confusion here: in children, 4-2 -1 gives total mL/day, and in adults sometimes 1.5 mL/kg/hr (so 36 mL/kg/day). However, the problem is asking for maintenance fluid in mL/hr, so need to convert the total daily maintenance fluid requirement into an hourly rate afterward. Let's take the approach considering the patient's weight (38. 1 kg): First, calculate total daily requirement: Using the adult formula of 30 mL/kg/day for weight up to 20 kg and 20 mL/kg/day for the remaining weight: First 20 kg = 20 kg (because 38.1 kg is more than 20 kg) Remaining weight: 38.1 kg - 20 kg = 18.1 kg Then, to find mL per hour , we divide the total daily fluid by 24 (since 1 day = 24 hours) Alternatively, if using the 1.5 mL/kg/hr formula: Total daily = 1.5 mL/kg/hr * 2 4 hours * weight in kg (because 1.5 mL/kg/hr * 24 hours = 36 mL/kg/d) Let's compute using 1.5 mL/kg/hr: Total daily = 1 .5 * 38.1 kg * 24 = ? Wait, no, the hourly rate is 1.5 mL/kg , so total daily is 1.5 *38.1 * 24? Wait, no. The formula is: Maintenance mL/hr = 1.5 * kg (because 1. 5 mL/kg /hr) So for 38.1 kg: But this would give a daily total of 5 7.15 mL/hr *24 = around 1,3 71 mL/day, which might be higher than the previous calculation. It may be higher because it is not using the stepwise weight-based approach (which decreases the required volume for heavier individuals). Let's take the second (1.5 mL/kg/hr) approach as the standard for adults, since the stepwise method is more for ped iatrics. However, the problem is in the patient's weight. The correct approach for this question likely assumes a typical approach for adults. Another common approach is: Adults: 30 mL/kg/day for basal maintenance or 1.5 mL/kg/hr So I\u2019ll use the 1.5 mL/kg/hr method here. Calculations: Using 1.5 (mL/kg *hr): For 38. 1 kg: 1. 5 * 3 8.1 (because 38.1 is the weight)", "Ground Truth Answer": "78.1", "Ground Truth Explanation": "The patient's weight is 38.1 kg. For patient's whose weight is greater than 20 kg, the formula for computing the maintenance fluid is 60 mL/hr + 1 mL/kg/hr * (weight (in kilograms) - 10 kilograms). Hence, plugging into this formula, we get 60 mL/hr + 2 mL/kg/hr * (38.1 kg - 10 kg) = 78.1 mL/hr.\nHence, the patient's fluid maintenance is 78.1 mL/hr.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate a patient\u2019s maintenance fluid rate, we need to estimate the total daily maintenance fluid requirement in mLs and then convert it to mL per hour.\n\nStep 2: The patient's weight is given at the time of discharge as 38.1 kg.\n\nStep 3: The standard formula for maintenance fluids in adults is typically 3 0 mL/kg for the first 10 kg, 20 mL /kg for the next 10 kg, and 10 mL/kg for the remaining weight over 20 kg. This is known as the \"4-2-1 rule.\"\n\nStep 4: Applying the formula :\n\nFor the first 10 kg: \n\nWait, actually, the \"4-2-1 rule\" is common for children, and a simpler approach for adults is often used: for adults, the typical maintenance fluid rate is approximately 30 mL/kg /day for the first 10 kg, 20 mL/kg/day for the next 10 kg, and 10 mL/kg/day for the remaining weight over 20 kg. Alternatively, sometimes a simpler rule is used where the maintenance fluid is estimated at approximately 30 mL /kg/day for the first 20 kg and 20 mL/kg /day for any weight over 20 kg.\n\nBut another common approach for adults is to use a fixed rate of 1.5 mL/kg/hr , which translates to about 36 mL/kg/day. Alternatively, some sources suggest 30-35 mL/kg/day for basal maintenance requirements. Let's use the rule for adults:\n\nMaintenance fluid requirement per day for adults can be calculated as 30 mL/kg for the first 1 0 kg, plus 20 mL/kg for the next 10 kg (up to 20 kg), and 10 mL/kg for any weight over 20 kg. This is similar to the pediatric 4-2-1 rule but in mL/kg/day instead of per hour. \n\nWait, confusion here: in children, 4-2 -1 gives total mL/day, and in adults sometimes 1.5 mL/kg/hr (so 36 mL/kg/day). However, the problem is asking for maintenance fluid in mL/hr, so need to convert the total daily maintenance fluid requirement into an hourly rate afterward. Let's take the approach considering the patient's weight (38. 1 kg):\n\nFirst, calculate total daily requirement:\n\nUsing the adult formula of 30 mL/kg/day for weight up to 20 kg and 20 mL/kg/day for the remaining weight:\n\nFirst 20 kg = 20 kg (because 38.1 kg is more than 20 kg)\n\nRemaining weight: 38.1 kg - 20 kg = 18.1 kg\n\nThen, to find mL per hour , we divide the total daily fluid by 24 (since 1 day = 24 hours)\n\nAlternatively, if using the 1.5 mL/kg/hr formula:\n\nTotal daily = 1.5 mL/kg/hr * 2 4 hours * weight in kg (because 1.5 mL/kg/hr * 24 hours = 36 mL/kg/d)\n\nLet's compute using 1.5 mL/kg/hr:\n\nTotal daily = 1 .5 * 38.1 kg * 24 = ? Wait, no, the hourly rate is 1.5 mL/kg , so total daily is 1.5 *38.1 * 24?\n\nWait, no. The formula is:\n\nMaintenance mL/hr = 1.5 * kg (because 1. 5 mL/kg /hr)\n\nSo for 38.1 kg:\n\nBut this would give a daily total of 5 7.15 mL/hr *24 = around 1,3 71 mL/day, which might be higher than the previous calculation. It may be higher because it is not using the stepwise weight-based approach (which decreases the required volume for heavier individuals). Let's take the second (1.5 mL/kg/hr) approach as the standard for adults, since the stepwise method is more for ped iatrics. \n\nHowever, the problem is in the patient's weight. The correct approach for this question likely assumes a typical approach for adults. Another common approach is:\n\nAdults: 30 mL/kg/day for basal maintenance or 1.5 mL/kg/hr\n\nSo I\u2019ll use the 1.5 mL/kg/hr method here. \n\nCalculations: Using 1.5 (mL/kg *hr): \n\nFor 38. 1 kg: 1. 5 * 3 8.1 (because 38.1 is the weight)"}
{"Row Number": 942, "Calculator Name": "Estimated Due Date", "Calculator ID": "13", "Category": "date", "Note ID": "15", "Patient Note": "The patient's last menstrual period was on 03/24/2017. Her cycle length is 30 days.", "Question": "Using Naegele's Rule for estimated due date based on the last menstrual period and cycle length, what is the the patient's estimated due date? Your response should be in the format of M/D/Y (ie 08/31/2023, 07/03/2000) with just the date and not other text. ", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "01/02/2018", "LLM Explanation": "To calculate the estimated due date using Naegele's Rule, we start with the last menstrual period (LMP), which is 03/24/2017. The standard Naegele's Rule involves adding 7 days to the first day of the LMP and then adding 9 months to that date. For a 28-day cycle, this would be: \\n1. Add 7 days to 03/24/2017: 03/24 + 7 days = 03/31, 2017.\\n2. Add 9 months to 03/31, 2017: 03/31 + 9 months = 12/31, 2017.\\nSince the patient has a cycle length of 30 days (which is 2 days longer than the standard 28-day cycle), we need to adjust the due date by adding these 2 extra days to the due date obtained from the standard calculation.\\nSo, 12/31/2017 + 2 days = 01/02, 2018.\\nThus, the estimated due date is January 2, 2018.", "LLM Thinking": "Step 1: To calculate the estimated due date using Naegele 's Rule, we need to add 280 days (which is approximately 40 weeks) to the first day of the last menstrual period (LMP), with the assumption that the woman has a regular 2 8-day cycle. However, since the patient\u2019s cycle length is 30 days, we might need to adjust the due date. Step 2: The L MP given is March 24, 2017. The typical Naegele's Rule suggests adding 280 days to the LMP for a 28-day cycle, but since the cycle here is 30 days, there's an extra 2 days. Therefore, we should add those 2 days to the standard due date to adjust the estimation for a 30-day cycle. Let's calculate step by step. Step 3: First, we 'll calculate the standard due date using Naegele's Rule for a 28-day cycle: - Add 7 days to the first day of the LMP: 03/24 + 7 days = 04/01, 2017. - Then add 9 months to this date: 04/01 , 2017 + 9 months = 01/ 01, 2018. Step 4: Now, adjust for the 3 0-day cycle length. Since the cycle is longer by 2 days, the ovulation and conception would have taken place about 2 extra days after the LMP, compared to the standard 28-day cycle. Therefore, we need to add those 2 days to the standard due date to get the adjusted due date. Wait , correct approach for Naegele's Rule with different cycle length adjustment : Alternatively, some sources state that if the cycle is longer than 2 8 days, add the number of extra days to the resulting due date. Since the cycle is 30 days (2 days longer than 2 8), the due date should be extended by 2 days beyond the standard estimated due date calculated for an average cycle length of 28 days.", "Ground Truth Answer": "12/31/2017", "Ground Truth Explanation": "The patient's estimated due date based on their last period is computed by using Naegele's Rule. Using Naegele's Rule, we add 40 weeks to the patient's last menstrual period date. We then add or subtract days from the patient's estimated due date depending on how many more or less days a patient's cycle length is from the standard 28 days. \nThe patient's last menstrual period was 03/24/2017. \nThe date after adding 40 weeks to the patient's last menstrual period date is 12/29/2017. \nBecause the patient's cycle length is 30 days, this means that we must add 2 days to the patient's estimate due date. Hence, the patient's estimated due date is 12-31-2017. ", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the estimated due date using Naegele 's Rule, we need to add 280 days (which is approximately 40 weeks) to the first day of the last menstrual period (LMP), with the assumption that the woman has a regular 2 8-day cycle. However, since the patient\u2019s cycle length is 30 days, we might need to adjust the due date. \n\nStep 2: The L MP given is March 24, 2017. The typical Naegele's Rule suggests adding 280 days to the LMP for a 28-day cycle, but since the cycle here is 30 days, there's an extra 2 days. Therefore, we should add those 2 days to the standard due date to adjust the estimation for a 30-day cycle. Let's calculate step by step.\n\nStep 3: First, we 'll calculate the standard due date using Naegele's Rule for a 28-day cycle:\n- Add 7 days to the first day of the LMP: 03/24 + 7 days = 04/01, 2017.\n- Then add 9 months to this date: 04/01 , 2017 + 9 months = 01/ 01, 2018.\n\nStep 4: Now, adjust for the 3 0-day cycle length. Since the cycle is longer by 2 days, the ovulation and conception would have taken place about 2 extra days after the LMP, compared to the standard 28-day cycle. Therefore, we need to add those 2 days to the standard due date to get the adjusted due date.\n\nWait , correct approach for Naegele's Rule with different cycle length adjustment : Alternatively, some sources state that if the cycle is longer than 2 8 days, add the number of extra days to the resulting due date. Since the cycle is 30 days (2 days longer than 2 8), the due date should be extended by 2 days beyond the standard estimated due date calculated for an average cycle length of 28 days."}
{"Row Number": 211, "Calculator Name": "Child-Pugh Score for Cirrhosis Mortality", "Calculator ID": "15", "Category": "severity", "Note ID": "13", "Patient Note": "A male patient in his early 70s with alcoholic liver disease and diabetes was brought to the hospital due to extreme confusion and unresponsiveness to verbal stimuli. He has been experiencing a progressively worsening mental state suggestive of stage 3-4 hepatic encephalopathy. Blood investigation revealed an INR of 1.6, suggesting a coagulopathy consistent with liver disease. His bilirubin was 1.9 mg/dL, and albumin 3.3 g/dL, reflecting liver damage. He has been prescribed a low-protein diet with lactulose and rifaximin and has been referred for an immediate assessment for liver transplantation. His HbA1c level was also measured, which showed well-controlled blood-glucose levels at 7 %.", "Question": "What is the patient's Child-Pugh Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "8", "LLM Explanation": "Step 1: Identify the parameters for the Child-Pugh Score: serum bilirubin, serum albumin, INR, presence of ascites, and presence of hepatic encephalopathy.\\nStep 2: Extract the relevant data from the patient note.\\n- Serum Bilirubin: 1.9 mg/dL\\n- Serum Albumin: 3.3 g/dL\\n- INR: 1.6\\n- Ascites: Not mentioned, so we assume None.\\n- Encephalopathy: Stage 3-4 hepatic encephalopathy, which corresponds to Grade 3 or 4.\\nStep 3: Assign points to each parameter.\\n- Bilirubin: 1.9 mg/dL < 2 mg/dL \u2192 1 point.\\n- Albumin: 3.3 g/dL falls between 2.8\u20133.4 \u2192 2 points.\\n- INR: 1.6 < 1.7 \u2192 1 point.\\n- Ascites: None \u2192 1 point.\\n- Encephalopathy: Grade 3 or 4 \u2192 3 points.\\nStep 4: Sum up the points.\\n1 (Bilirubin) + 2 (Albumin) + 1 (INR) + 1 (Ascites) + 3 (Encephalopathy) = 8 points.\\nThus, the Child-Pugh Score is 8.", "LLM Thinking": "Step 1: To calculate the Child-Pugh Score, we need to identify the five parameters: serum bilirubin, serum albumin, INR or prothrombin time, presence of ascites, and presence of hepatic encephalopathy. The Child-Pugh score classifies the stages of liver disease by summing up points allocated for each factor. The scoring system is as follows: - Serum Bilirubin (mg/dL): - 1 point: <2 - 2 points: 2\u20133 - 3 points: >3 - Serum Albumin (g/dL): - 1 point: \u22653.5 - 2 points: 2.8\u20133.4 - 3 points: <2.8 - INR (Prothrombin Time): - 1 point: <1.7 - 2 points: 1.7\u20132.3 - 3 points: >2.3 - Ascites (Yes/No): - 1 point: None - 2 points: Controlled with medication - 3 points: Refractory - Encephalopathy (grade): - 1 point: Grade 0 or None - 2 points: Grade 1 or Grade 2 - 3 points: Grade 3 or Grade 4 Step 2: Now, let's extract the relevant data from the patient note. - Serum Bilirubin: 1.9 mg/dL - Serum Albumin: 3.3 g/dL - INR: 1.6 \u2013 The note mentions stage 3\u20134 hepatic encephalopathy. - Ascites: Not directly mentioned. However, in the absence of any mention of ascites (e.g., no mention of fluid in abdomen, no medications for ascites), we might assume it's \u201cnone\u201d (1 point). But sometimes, advanced liver disease may have ascites not explicitly stated. However, since the note does not mention it, we\u2019ll proceed with \u201cNone.\u201d - Encephalopathy: Grade 3 or 4 (stage 3\u20134 is mentioned, so this would be Grade 3 or 4 for hepatic encephalopathy). Step 3: Assign points to each parameter: 1. Bilirubin: 1.9 mg/dL <2 mg/dL - Points: 1 2. Albumin: 3.3 g/dL falls between 2.8\u20133.4 - Points: 2 3. INR: 1.6 <1.7 - Points: 1 4. Ascites: None - Points: 1 5. Encephalopathy: Grade 3 or 4 - Points: 3 Now we map the total score to the Child-Pugh class. The scoring system is: - Class A: 5\u20136 points - Class B: 7\u20139 points - Class C: 10\u201315 points However, wait, let me double-check the encephalopathy and ascites. The note says \u201cprogressively worsening mental state suggestive of stage 3\u20134 hepatic encephalopathy.\u201d The grading for encephalopathy in Child-Pugh: Grade 0: none; Grade 1: subtle changes (e.g., anxiety, euphoria); Grade 2: lethargy, disorientation, asterixis; Grade 3: somnolence or confusion but responsive to stimuli; Grade 4: coma. The patient is \u201cunresponsive to verbal stimuli,\u201d which might be stage 3 or 4. If it\u2019s stage 4 (comatose), that would be 3 points. The ascites is not mentioned, so assume none. Sometimes the INR is measured as the prothrombin time (PT), and sometimes the values are in INR. Since in the note given, it directly mentions INR, and the INR value is 1.6 which is within the normal range or very close to (because 1.6 <1.7 means it is considered in the lower category). Let\u2019s calculate step by step. 1. Serum Bilirubin: 1.9 \u2192 1 pt 2. Albumin: 3.3 \u2192 2.8\u20133.4 \u2192 2 points 3. INR: 1.6 \u2192 <1.7 \u2192 1 point 4. Ascites: none \u2192 1 point 5. Hepatic Encephalopathy: Grade 3\u20134 \u2192 3 points", "Ground Truth Answer": "8", "Ground Truth Explanation": "The current child pugh score is 0.\nThe patient's INR is 1.6. Because the INR is less than 1.7, we add 1 to the score, making the current total 0 + 1 = 1.\nThe concentration of bilirubin is 1.9 mg/dL. Because the Bilirubin concentration is less than 2 mg/dL, we add 1 to the score, making the current total 1 + 1 = 2.\nThe concentration of albumin is 3.3 g/dL. Because the Albumin concentration is between 2.8 g/dL and 3.5 g/dL, we add 2 to the score, making the current total 2 + 2 = 4.\nThe Ascites state not specified, assuming and so we will assume it to be absent. This means we add 1 point to the score, making the current total 4 + 1 = 5.\nEncephalopathy state is 'Grade 3-4 encephalopathy' and so we add three points to the score, making the current total 5 + 3 = 8.\nThe patient's child pugh score is 8.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the Child-Pugh Score, we need to identify the five parameters: serum bilirubin, serum albumin, INR or prothrombin time, presence of ascites, and presence of hepatic encephalopathy.  \nThe Child-Pugh score classifies the stages of liver disease by summing up points allocated for each factor.  \nThe scoring system is as follows:  \n\n- Serum Bilirubin (mg/dL):  \n  - 1 point: <2  \n  - 2 points: 2\u20133  \n  - 3 points: >3  \n\n- Serum Albumin (g/dL):  \n  - 1 point: \u22653.5  \n  - 2 points: 2.8\u20133.4  \n  - 3 points: <2.8  \n\n- INR (Prothrombin Time):  \n  - 1 point: <1.7  \n  - 2 points: 1.7\u20132.3  \n  - 3 points: >2.3  \n\n- Ascites (Yes/No):  \n  - 1 point: None  \n  - 2 points: Controlled with medication  \n  - 3 points: Refractory  \n\n- Encephalopathy (grade):  \n  - 1 point: Grade 0 or None  \n  - 2 points: Grade 1 or Grade 2  \n  - 3 points: Grade 3 or Grade 4  \n\nStep 2: Now, let's extract the relevant data from the patient note.  \n- Serum Bilirubin: 1.9 mg/dL  \n- Serum Albumin: 3.3 g/dL  \n- INR: 1.6 \u2013 The note mentions stage 3\u20134 hepatic encephalopathy.  \n- Ascites: Not directly mentioned. However, in the absence of any mention of ascites (e.g., no mention of fluid in abdomen, no medications for ascites), we might assume it's \u201cnone\u201d (1 point). But sometimes, advanced liver disease may have ascites not explicitly stated. However, since the note does not mention it, we\u2019ll proceed with \u201cNone.\u201d  \n- Encephalopathy: Grade 3 or 4 (stage 3\u20134 is mentioned, so this would be Grade 3 or 4 for hepatic encephalopathy).  \n\nStep 3: Assign points to each parameter:  \n1. Bilirubin: 1.9 mg/dL <2 mg/dL  \n   - Points: 1  \n2. Albumin: 3.3 g/dL falls between 2.8\u20133.4  \n   - Points: 2  \n3. INR: 1.6 <1.7  \n   - Points: 1  \n4. Ascites: None  \n   - Points: 1  \n5. Encephalopathy: Grade 3 or 4  \n   - Points: 3  \n\nNow we map the total score to the Child-Pugh class. The scoring system is:  \n- Class A: 5\u20136 points  \n- Class B: 7\u20139 points  \n- Class C: 10\u201315 points  \n\nHowever, wait, let me double-check the encephalopathy and ascites. The note says \u201cprogressively worsening mental state suggestive of stage 3\u20134 hepatic encephalopathy.\u201d The grading for encephalopathy in Child-Pugh: Grade 0: none; Grade 1: subtle changes (e.g., anxiety, euphoria); Grade 2: lethargy, disorientation, asterixis; Grade 3: somnolence or confusion but responsive to stimuli; Grade 4: coma. The patient is \u201cunresponsive to verbal stimuli,\u201d which might be stage 3 or 4. If it\u2019s stage 4 (comatose), that would be 3 points. The ascites is not mentioned, so assume none. Sometimes the INR is measured as the prothrombin time (PT), and sometimes the values are in INR. Since in the note given, it directly mentions INR, and the INR value is 1.6 which is within the normal range or very close to (because 1.6 <1.7 means it is considered in the lower category). Let\u2019s calculate step by step.\n\n1. Serum Bilirubin: 1.9 \u2192 1 pt  \n2. Albumin: 3.3 \u2192 2.8\u20133.4 \u2192 2 points  \n3. INR: 1.6 \u2192 <1.7 \u2192 1 point  \n4. Ascites: none \u2192 1 point  \n5. Hepatic Encephalopathy: Grade 3\u20134 \u2192 3 points"}
{"Row Number": 1016, "Calculator Name": "Estimated of Conception", "Calculator ID": "68", "Category": "date", "Note ID": "9", "Patient Note": "The patient's last menstrual period was on 10/11/2020. Her cycle length is 29 days.", "Question": "Based on the patient's last menstrual period and cycle length, what is the the patient's estimated date of conception? Your answer should be in the format of M/D/Y (ie 08/31/2023, 07/03/2000) with just the date and not other text. ", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "10/26/2020", "LLM Explanation": "To find the estimated date of conception, we use the information that the patient's last menstrual period (LMP) was on 10/11/2020 and the cycle length is 29 days. In a typical cycle, ovulation occurs approximately 14 days before the next expected period. For a 29-day cycle, the next period would be expected 29 days after the LMP, i.e., 10/11/2020 + 29 days. To calculate the next period date: 10/11 + 29 days. October has 31 days. From 10/11 to the end of October: 31 - 11 = 20 days. So, after 20 days from 10/11, we reach the end of October (October 31). We have 29 days in total to add. We've already used up 20 out of those 29 days to reach the end of October. So, we have 29 - 20 = 9 more days to add into November. Adding 9 days to November 1 gives us November 9. Therefore, the next expected period is on 11/09/2020. Now, to find the ovulation date, we count 14 days before this next period. 11/09 - 14 days. To calculate this: From November 9, going back 9 days brings us to November 1st. We still need to go back an additional 14 - 9 = 5 days from November 1st. Going back 5 days from November 1st takes us to October 27th. So, the estimated date of ovulation is October 27, 2020. Conception typically occurs around the time of ovulation. Therefore, the estimated date of conception is around October 27, 2020. Alternatively, another approach is to add approximately the midpoint of the cycle to the LMP. Since the cycle is 29 days, ovulation occurs around day 15 of the cycle (29 - 14 = 15). Adding 15 days to the LMP (10/11/2020): 10/11 + 15 days. Adding 15 days to October 11: From October 11 to October 31: There are 20 days in October from the 11th to the 31st. So, adding 15 days to October 11: If we add 20 days to October 11, we exceed the number of days we need to add (15). We don't need to go beyond October since 15 days is within the month of October. To calculate it step by step: October 11 + 15 days: October 11 + 20 days = October 31 (but we only need 15 days). So, adding 15 days to October 11: October 11 + 15 = October 26. Thus, the estimated date of conception using this method is October 26, 2020. Both methods give us close dates: October 27 and October 26. Given the two methods, the estimated date of conception is likely between October 26 and October 27, 2020. Since the first method gave October 27 and the second method gave October 26, and considering the typical approach of using the midpoint for conception, the most common approach is to use the day 14 days before the next expected period. Therefore, the estimated date of conception is October 27, 2020. But since the question asks for the estimated date of conception and both methods are valid, I will take the midpoint approach which gives us October 26. So the final estimated date of conception is 10/26/2020.", "LLM Thinking": "Step 1: To find the estimated date of conception, we need to know the last menstrual period (LMP) and the cycle length. The LMP is given as 10/11/2020 and the cycle length is 29 days. Step 2 : Generally, ovulation occurs about 14 days before the start of the next menstrual period in a typical 28-day cycle. However, since the patient's cycle is 29 days, ovulation would occur approximately 15 days after the LMP (since 29 \u2013 14 = 15, because the next period starts after 29 days from the start of the LMP, ovulation occurs about midway through the cycle, i.e., around day 15 for a 29-day cycle). Step 3: We must calculate the day that is 15 days after the LMP to estimate the day of ovulation or the conception date. Step 4: The LMP was on 10/11/2020. We need to add 14 or 15 days to this date. Let me confirm the exact method for calculating conception date. Since the cycle length is 29 days, ovulation occurs around day 15 after the first day of the LMP (because it\u2019s 29 \u2013 14 = 15). So adding 14 days to LMP gives the date of ovulation, but maybe it's 14 days before the next expected period. But commonly the conceptual date is usually ovulation time + 2 days span when fertilization can happen. However, the standard method for conception date is LMP plus 2 weeks (14 days) to estimate ovulation, but adjusted for cycle length. Wait, let me think again. The typical formula for conception date is LMP plus cycle length minus 14 days. For example, in a 28-day cycle, conception occurs about 2 weeks after the LMP because ovulation is generally in the middle of the cycle. For a 29-day cycle: If the LMP is 10/11, the next period is expected on 11/9 (10/11 + 29 days). The ovulation occurs about 14 days before the next period, which would be 11/9 minus 14 days = 10/26. Therefore, adding 14 days to the LMP (because generally, the date of conception is about 2 weeks after LMP for a 28-day cycle, so for a 29-day cycle, it would be 15 days since the cycle is 1 day longer) is another way to do it. 10/11 + 14 days = 10/25, but adding 15 days would be 10/26. Now let's add 15 days to the LMP. Starting from October 11, adding 15 days: October 11 + 10 days = October 21, then add 5 more days to reach October 21 + 4 (since there are 31 days in October?) Wait, October has 31 days. 11 + 15 = 26. So 10/11 plus 15 days is October 26.", "Ground Truth Answer": "10/25/2020", "Ground Truth Explanation": "The patient's estimated date of conception based on their last period is computed by adding to 2 weeks to the patient's last menstrual period date. The patient's last menstrual period was 10/11/2020. \nThe estimated date of conception after adding 2 weeks to the patient's last menstrual period date is 10-25-2020. ", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To find the estimated date of conception, we need to know the last menstrual period (LMP) and the cycle length.  \nThe LMP is given as 10/11/2020 and the cycle length is 29 days.\n\nStep 2 : Generally, ovulation occurs about 14 days before the start of the next menstrual period in a typical 28-day cycle.  \nHowever, since the patient's cycle is 29 days, ovulation would occur approximately 15 days after the LMP (since 29 \u2013 14 = 15, because the next period starts after 29 days from the start of the LMP, ovulation occurs about midway through the cycle, i.e., around day 15 for a 29-day cycle).\n\nStep 3: We must calculate the day that is 15 days after the LMP to estimate the day of ovulation or the conception date.\n\nStep 4: The LMP was on 10/11/2020. We need to add 14 or 15 days to this date.  \nLet me confirm the exact method for calculating conception date. Since the cycle length is 29 days, ovulation occurs around day 15 after the first day of the LMP (because it\u2019s 29 \u2013 14 = 15).  \nSo adding 14 days to LMP gives the date of ovulation, but maybe it's 14 days before the next expected period.  \nBut commonly the conceptual date is usually ovulation time + 2 days span when fertilization can happen.  \nHowever, the standard method for conception date is LMP plus 2 weeks (14 days) to estimate ovulation, but adjusted for cycle length.\n\nWait, let me think again.  \nThe typical formula for conception date is LMP plus cycle length minus 14 days.  \nFor example, in a 28-day cycle, conception occurs about 2 weeks after the LMP because ovulation is generally in the middle of the cycle.  \nFor a 29-day cycle: If the LMP is 10/11, the next period is expected on 11/9 (10/11 + 29 days).  \nThe ovulation occurs about 14 days before the next period, which would be 11/9 minus 14 days = 10/26.  \nTherefore, adding 14 days to the LMP (because generally, the date of conception is about 2 weeks after LMP for a 28-day cycle, so for a 29-day cycle, it would be 15 days since the cycle is 1 day longer) is another way to do it.  \n10/11 + 14 days = 10/25, but adding 15 days would be 10/26.\n\nNow let's add 15 days to the LMP.  \nStarting from October 11, adding 15 days: October 11 + 10 days = October 21, then add 5 more days to reach October 21 + 4 (since there are 31 days in October?) Wait, October has 31 days. 11 + 15 = 26.  \nSo 10/11 plus 15 days is October 26."}
{"Row Number": 520, "Calculator Name": "LDL Calculated", "Calculator ID": "44", "Category": "lab", "Note ID": "pmc-2803825-1", "Patient Note": "A 68-year-old Caucasian man was referred to our cardiology clinic in February 2008 for further evaluation of a conspicuous new heart murmur. The patient did not have any cardiac complaints and did not suffer from angina pectoris or dyspnoea. The patient had advanced gonarthrosis of the left knee, advanced degeneration of the cervical spine and advanced bilateral omarthrosis. His medical history included kidney stone surgery (1988), diagnosis of ochronosis based on a biopsy of the knee joint (1995), total hip replacement (1997), Miller-Galante II prosthesis of the right knee (1997), periosteal rupture of the left Achilles tendon with transosseous re-fixation (1999), ventral corporectomy at C4 and discectomy at C3/C4 and C4/C5 after cervical spinal canal stenosis with myelopathy at C3-C5, and ventral and dorsal osteochondrosis (2001). Family history revealed that his brother also had ochronosis. The patient was not on any medication.\nOn physical examination, the patient was found to be in a moderately reduced general condition and in a regular nutritional status. His body mass index was 25.8 kg/m2. He had a blood pressure of 130/80 mmHg bilaterally and a pulse rate of 80 beats/min. Dyspnoea, cyanosis and liver skin spots were not observed. Bluish-black pigmentations were found on several parts of the sclera (Figure ). The patient's pupils were of average width and showed prompt response to light. No arcus lipoides, no goitre and no superior vena cava syndrome were noticed. His thorax and chest expansion were symmetrical. Breath sounds were vesicular and percussion resonant, with no crepitations or evidence of a pleural effusion. His heart beat was regular with a grade 2/6 diastolic murmur at the apex and a grade 2/6 systolic murmur over the mitral and tricuspid valves. His abdomen was soft and non-tender to palpation, liver and spleen were not enlarged, and there was no costo-vertebral-angular tenderness. Unilateral oedema on the left ankle was observed. Also, the left foot pulse was absent, while normal central and peripheral pulses were symmetrically palpable.\nResults of the patient's laboratory examination showed 252 mg/dl total cholesterol, 84 mg/dl triglycerides, 66 mg/dl high-density lipoprotein and 72 mg/dl low-density lipoprotein. Inflammatory markers were not elevated and anti-streptolysin O (ASO) titre was not raised. The patient's urine turned brownish black when left standing for some time.\nAn electrocardiogram (ECG) test showed a sinus rhythm of 72 beats/min with left axis deviation (-57 degrees). The patient's depolarisation and repolarisation phases were normal. During an exercise ECG using a treadmill set up to 125 watts workload, his blood pressure increased from 160/90 mmHg to 160/100 mmHg and his pulse rate from 68 to 158 beats/min. When the exercise ECG was stopped at the point of exhaustion, no angina pectoris, dyspnoea, significant ST segment depression or profound dysrhythmia were observed. His blood pressure and pulse rate normalised within 3 minutes of recovery.\nAn echocardiogram revealed that the patient's left atrium was normal in size while his left ventricle was slightly dilated (Figure ). The pumping function of the left heart was normal - there was no evidence of hypertrophy - and the aortic valve had three cusps. A Doppler echocardiogram showed a minor to moderate aortic insufficiency, a combined mitral valve defect with an opening size of 1.6 cm2 with mild to moderate regurgitation, and a mild tricuspid regurgitation. No pericardial effusion was detected. The patient's right heart was normal in size without any signs of stasis.\nA histopathological analysis of the patient revealed brownish deposits between the collagen fibre bundles of a knee joint biopsy sample. The pigment was found both extracellularly and intracellularly. The appearance of the pigment was variable, being coarse, like haemosiderin and fine, like granules. Iron staining was negative and no inflammatory or post-inflammatory changes were observed. Taken together, the patient's histopathology was characteristic for ochronosis.\nBased on cardiac investigations, an alkaptonuria-associated degenerative valve defect with aortic, mitral and tricuspid valve insufficiency was diagnosed. The decision for using conservative therapy was reached and the patient was treated with an angiotensin-converting enzyme (ACE) inhibitor (2.5 mg/day ramipril).\nAt follow-up examinations in April and November 2008, the patient presented in a stable condition. However, in February 2009, the patient was hospitalised because of cardiac decompensation.", "Question": "What is the patient's LDL cholestrol concentration? Please outuput your answer in terms of mg/dL.", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "72", "LLM Explanation": "I reviewed the patient note and found the laboratory examination results section. It directly provides the LDL cholesterol concentration as 72 mg/dL.", "LLM Thinking": "Let's approach this step by step. 1. We need to find the patient's Low-Density Lipoprotein (LDL) cholesterol concentration in the given patient note. 2. The patient note provides several laboratory results for cholesterol. Let me look through the lab section again. The lab results listed in the note are: - Total cholesterol: 2 52 mg/dL - Triglycerides: 84 mg/dL - High-density lipoprotein (HDL): 66 mg/dL - Low-density lipoprotein (LD L): 72 mg/dL The question directly asks for the patient's Low-Density Lipoprotein (LDL) cholesterol concentration.", "Ground Truth Answer": "169.2", "Ground Truth Explanation": "To compute the patient's LDL cholestrol, apply the following formula: LDL cholesterol = total cholesterol - HDL - (triglycerides / 5), where the units for total cholestrol, HDL cholestrol, and triglycerides are all mg/dL.\nThe concentration of total cholestrol is 252.0 mg/dL. \nThe concentration of hdl cholestrol is 66.0 mg/dL. \nThe concentration of triglycerides is 84.0 mg/dL. \nPlugging in these values will give us 252.0 mg/dL - 66.0 mg/dL - (84.0/5) mg/dL = 169.2 mg/dL.\nThe patients concentration of LDL cholestrol is 169.2 mg/dL.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Let's approach this step by step.\n\n1. We need to find the patient's Low-Density Lipoprotein (LDL) cholesterol concentration in the given patient note.\n\n2. The patient note provides several laboratory results for cholesterol. Let me look through the lab section again. The lab results listed in the note are:\n\n- Total cholesterol: 2 52 mg/dL\n- Triglycerides: 84 mg/dL\n- High-density lipoprotein (HDL): 66 mg/dL\n- Low-density lipoprotein (LD L): 72 mg/dL\n\nThe question directly asks for the patient's Low-Density Lipoprotein (LDL) cholesterol concentration."}
{"Row Number": 89, "Calculator Name": "Body Mass Index (BMI)", "Calculator ID": "6", "Category": "physical", "Note ID": "pmc-5371580-1", "Patient Note": "A 37-year-old female patient was referred to Hacettepe University, Pediatric Genetics Department following complaints of atypical facial features. She was the second child of non-consanguineous healthy parents. She was born at term by spontaneous vaginal delivery with a birthweight of 1,500 g (lower than 3rd centile). Her birth length and head circumference were not recorded. The patient had delayed psychomotor development and began to walk and speak after the age of 3 years. She has been able to read and write after attending a rehabilitation program. She was evaluated for developmental delay, short stature, learning disability, recurrent upper respiratory system infections, and constipation in childhood, but no diagnosis was made. Laboratory work-up, including cranial imaging, echocardiography, and blood biochemistry were all normal except for subclinical hypothyroidism and osteoporosis. The patient had generalized anxiety disorder and hypochondriasis since her adolescence and her symptoms had deteriorated over time. She started to suffer from difficulty falling asleep, especially during the last five years. She was described as over-friendly by her family members. On her admission, a physical examination revealed a weight of 42 kg (lower than 3rd centile), a height of 145 cm (lower than 3rd centile), and a head circumference of 52 cm (\u22122 standard deviations). Among the facial features, a long face, a long neck accentuated by sloping shoulders, low-set ears, periorbital fullness, a short nose, a wide mouth, a small jaw, and malar flattening were noted (). She was talkative and gregarious. The patient exhibited prolonged phases of staring into our faces and maintained eye contact throughout the physical examination. Based on these findings, the patient was clinically diagnosed with Williams syndrome. Fluorescence in situ hybridization analysis revealed 46,XX.ish del(7)(q11.2 q11.2) (ELN-), which confirmed the clinical diagnosis (). Genetic counseling was provided to the family and a follow-up plan was created. An informed consent was obtained from the patient.", "Question": "What is the patient's body mass mass index (BMI)? Your answer should be in terms of kg/m\u00b2.", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "20", "LLM Explanation": "To calculate the patient's BMI, we use the formula: BMI = weight (kg) / (height (m))^2. The given weight is 42 kg, and the height is 145 cm. First, convert the height from cm to meters: 145 cm / 100 = 1.45 m. Next, we calculate the square of the height: (1.45 m)^2 = 2.1025 m^2. Now, plug the weight and the squared height into the BMI formula: BMI = 42 kg / 2.1025 m^2 \u2248 19.98 kg/m\u00b2. Therefore, the patient's BMI is approximately 19.98 kg/m\u00b2, which rounds to 20 kg/m\u00b2.", "LLM Thinking": "First, we need to calculate the BMI using the formula: BMI = weight (kg) / (height (m))^2 From the patient note , the weight is 42 kg, and the height is 1 45 cm. To use the formula, we need to convert the height from cm to m. There are 100 cm in 1 m. So, the height in meters is: height in meter = 145 cm / 100 = 1.4 5 m. Now, we can calculate the BMI: \\[ \\text{ BMI} = \\frac{\\text{weight (in kg)}}{\\text {height (in meters)}^2} \\] Plugging in the values: Weight = 42 kg Height = 1.4 5 m So, BMI = 42 / (1.4 5)^2 Let me compute that step by step. First, compute the square of the height: 1.45 squared is 1. 45 * 1.45 = 2.10 25. Now, divide the weight by this value: BMI = 42 / 2.1025 \u2248 1 9. 98. However, it's better to check the calculation again for accuracy. Let me re-calculate: 1.45 * 1.4 5 = 2.1025. Yes. Then 4 2 / 2.1025 \u2248 19. 98. Wait, but the question asks for the answer in terms of kg/m\u00b2, so maybe keep it to two decimal places or one. However, in the note, the height is 145 cm (exactly) and weight is 4 2 kg. So exact calculation: 145 cm = 1. 45 m. 1.45 squared = 1.45 \u00d7 1.45 = 2.1025.", "Ground Truth Answer": "19.976", "Ground Truth Explanation": "The formula for computing the patient's BMI is (weight)/(height * height), where weight is the patient's weight in kg and height is the patient's height in m.\nThe patient's height is 145.0 cm, which is 145.0 cm * 1 m / 100 cm = 1.45 m. The patient's weight is 42.0 kg. The patient's bmi is therefore 42.0 kg / (1.45 m * 1.45 m) = 19.976 kg/m^2.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the BMI using the formula:\n\nBMI = weight (kg) / (height (m))^2\n\nFrom the patient note , the weight is 42 kg, and the height is 1 45 cm.\n\nTo use the formula, we need to convert the height from cm to m. There are 100 cm in 1 m. \n\nSo, the height in meters is:\n\nheight in meter = 145 cm / 100 = 1.4 5 m.\n\nNow, we can calculate the BMI:\n\n\\[ \\text{ BMI} = \\frac{\\text{weight (in kg)}}{\\text {height (in meters)}^2} \\]\n\nPlugging in the values:\n\nWeight = 42 kg\n\nHeight = 1.4 5 m\n\nSo,\n\nBMI = 42 / (1.4 5)^2 \n\nLet me compute that step by step.\n\nFirst, compute the square of the height:\n\n1.45 squared is 1. 45 * 1.45 = 2.10 25.\n\nNow, divide the weight by this value:\n\nBMI = 42 / 2.1025 \u2248 1 9. 98.\n\nHowever, it's better to check the calculation again for accuracy. Let me re-calculate:\n\n1.45 * 1.4 5 = 2.1025. Yes. Then 4 2 / 2.1025 \u2248 19. 98.\n\nWait, but the question asks for the answer in terms of kg/m\u00b2, so maybe keep it to two decimal places or one.\n\nHowever, in the note, the height is 145 cm (exactly) and weight is 4 2 kg. So exact calculation:\n\n145 cm = 1. 45 m.\n\n1.45 squared = 1.45 \u00d7 1.45 = 2.1025."}
{"Row Number": 731, "Calculator Name": "Delta Gap", "Calculator ID": "63", "Category": "lab", "Note ID": "pmc-7748582-1", "Patient Note": "The patient discussed in this case report is a 53-year-old male with a past medical history of hypertension, hyperlipidemia, and diabetes mellitus type 2, managed on metformin and canagliflozin. After undergoing a routine laparoscopic appendectomy, his postoperative course remained uneventful. He started tolerating oral feeds, having bowel movements and remained hemodynamically stable. Therefore, he was discharged two days after the surgery. However, a few hours later, on the day of discharge, he presented to the emergency department with sudden onset generalized abdominal pain, non-exertional shortness of breath, and fever.\nOn presentation, he was febrile (temperature: 100.7\u00b0F), tachycardia (heart rate: 114 bpm), tachypneic (respiratory rate: 30/min), and hypoxic with an oxygen saturation of 87% on room air. His physical examination was benign; lungs were clear to auscultation bilaterally and soft, non-tender abdomen. The surgical site looked clean, without any discharge, and was non-tender to touch.\nThe patient\u2019s initial laboratory measurements were all within normal limits: blood glucose 126 mg/dL, sodium 134 mmol/L, potassium 4.5 mmol/L, chloride 105 mmol/L, bicarbonate 17 mEq/L, blood urea nitrogen (BUN) 11 mg/dL, and creatinine 0.9 mg/dL. The exception was a high anion gap of 20.8 mEq/L and a pH of 7.21. The patient was started on four liters nasal cannula, switched to non-rebreather as he remained hypoxic, and was subsequently admitted to the hospital for further management. A septic workup was initiated, and the patient was placed on empiric antibiotics.\nFurther laboratory results revealed positive serum ketones (beta-hydroxybutyrate 2.69 mmol/L), whereas the urinalysis revealed glucosuria (urine glucose > 1500 mg/dL) and ketonuria and no proteins. A urine culture was negative for any infectious growth. Serum lactate was 13 mg/dL. A computerized axial tomography (CAT) scan of the patient\u2019s chest showed bilateral lower lobe consolidations suggestive of probable pneumonia. A CAT scan of his abdomen showed probable postoperative ileus with no obstruction or abscess. On further questioning, the patient reported having resumed canagliflozin and his regular diet as instructed upon being discharged.\nDue to a high anion gap and positive ketones in the blood with normal blood glucose levels, the patient was diagnosed with euglycemic diabetic ketoacidosis secondary to his SGLT2-inhibitor use. Thus, canagliflozin was stopped, and the patient was started on an insulin drip with 10% dextrose. Subsequently, he was transferred to the intensive care unit (ICU) for closer monitoring. The patient\u2019s condition started improving after the treatment with insulin and dextrose. On day two, following admission, his symptoms improved, and subsequent laboratory results also looked better with a lower anion gap of 16.2 mEq/L. On day three following admission, he was switched from an insulin drip to subcutaneous insulin and sliding scale as his laboratory results approached normal, with an anion gap of 13.2 mEq/L and beta-hydroxybutyrate of 0.81 mmol/L. With symptom resolution, the patient was then returned to the floor. However, his urine glucose remained high (>1500 mg/dL).\nDischarged the next day and advised to continue subcutaneous insulin for a week, the patient was asked to consult his endocrinologist for further management. He was also recommended against resuming canagliflozin.", "Question": "What is the patient's delta gap in mEq/L?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "8.8", "LLM Explanation": "To calculate the delta gap, we use the formula: Delta Gap = Measured Anion Gap - Normal Anion Gap. The measured anion gap is 20.8 mEq/L, and the normal anion gap is typically around 12 mEq/L. Therefore, the delta gap is 20.8 mEq/L - 12 mEq/L = 8.8 mEq/L.", "LLM Thinking": "First, we need to calculate the delta gap. The delta gap refers to the difference between the measured serum anion gap and the expected anion gap . The anion gap is defined as: Anion Gap = Sodium - ( Chloride + Bicarbonate). The delta gap is calculated by subtracting the regular anion gap (usually around 12 mEq/L) from the measured anion gap. However, looking at the provided data, the patient's initial anion gap is given as 20.8 mEq/L. The traditional reference range for anion gap is typically around 8 to 12 mEq/L (with an upper limit usually considered up to 12 mEq/L for a normal anion gap). However, the term \"delta gap\" is sometimes used in the context of evaluating metabolic acidosis to differentiate between high anion gap acidosis and normal anion gap acidosis. The delta gap formula is calculated as (Measured Anion Gap - Normal An ion Gap) divided by 2.5. This ratio is then compared to the change in bicarbonate (\u0394 HCO3-). However, in this case, the question simply asks for the delta gap, which seems to refer to the change in the anion gap during the course of the patient's hospital visit (over time). Let's calculate the change (delta) in the anion gap: The initial anion gap (upon presentation) is 20. 8 mEq/L; the anion gap on Day 2 is 16.2 mEq/L; and on Day 3, the anion gap is 13.2 mEq/L. The change or delta in anion gap from the initial measurement until it improved could be calculated as the difference between the initial value and the later values . But the question doesn't specify a time frame. However, looking back at the problem statement, the user might be asking for the delta between the first anion gap measurement and one of the subsequent ones , but the question says \"delta gap\" without further context. Alternatively, maybe the user is referring to the standard \"delta gap\" formula related to evaluating acid-base imbalances: Delta Gap = (Measured Anion Gap - Normal Anion Gap)/(2.3 or 2.5 ) \u2013 but this is to compare with the \u0394 HCO3-. Let me check the question again: \"What is the patient's delta gap in mEq/L?\" The question is ambiguous unless it refers to the change in anion gap over time. Alternatively, perhaps the term \"delta gap\" here is intended as the difference between the measured anion gap and the normal anion gap.", "Ground Truth Answer": "0", "Ground Truth Explanation": "To compute the formula of the delta gap, the formula is anion gap (in mEq/L) - 12. The first step is to compute the patient's anion gap.\nThe formula for computing a patient's anion gap is: sodium (mEq/L) - (chloride (mEq/L)+ bicarbonate (mEq/L)).\nThe concentration of sodium is 134.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of sodium from mmol to mEq. The mass of sodium is 134.0 mmol. The compound, sodium, has a valence of 1, and so multiply the valence by the value of mmol to get, 134.0 mmol * 1 mEq/mmol = 134.0 mEq sodium. The volume units is L so no volume conversion is needed. Hence, the concentration value of 134.0 mmol sodium/L converts to 134.0 mEq sodium/L. \nThe concentration of chloride is 105.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of chloride from mmol to mEq. The mass of chloride is 105.0 mmol. The compound, chloride, has a valence of 1, and so multiply the valence by the value of mmol to get, 105.0 mmol * 1 mEq/mmol = 105.0 mEq chloride. The volume units is L so no volume conversion is needed. Hence, the concentration value of 105.0 mmol chloride/L converts to 105.0 mEq chloride/L. \nThe concentration of bicarbonate is 17.0 mEq/L. \nPlugging in these values into the anion gap formula gives us 134.0 mEq/L - (105.0 mEq/L + 17.0 mEq/L) = 12.0 mEq/L. Hence, The patient's anion gap is 12.0 mEq/L.\nPlugging in 12.0 mEq/L for the delta gap formula, we get 12.0 - 12 = 0 mEq/L. Hence, the patient's delta gap is 0 mEq/L.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the delta gap.  \nThe delta gap refers to the difference between the measured serum anion gap and the expected anion gap .  \nThe anion gap is defined as: Anion Gap = Sodium - ( Chloride + Bicarbonate).  \nThe delta gap is calculated by subtracting the regular anion gap (usually around 12 mEq/L) from the measured anion gap.  \nHowever, looking at the provided data, the patient's initial anion gap is given as 20.8 mEq/L.  \nThe traditional reference range for anion gap is typically around 8 to 12 mEq/L (with an upper limit usually considered up to 12 mEq/L for a normal anion gap).  \nHowever, the term \"delta gap\" is sometimes used in the context of evaluating metabolic acidosis to differentiate between high anion gap acidosis and normal anion gap acidosis.  \nThe delta gap formula is calculated as (Measured Anion Gap - Normal An ion Gap) divided by 2.5.  \nThis ratio is then compared to the change in bicarbonate (\u0394 HCO3-).  \nHowever, in this case, the question simply asks for the delta gap, which seems to refer to the change in the anion gap during the course of the patient's hospital visit (over time).  \nLet's calculate the change (delta) in the anion gap:  \nThe initial anion gap (upon presentation) is 20. 8 mEq/L; the anion gap on Day 2 is 16.2 mEq/L; and on Day 3, the anion gap is 13.2 mEq/L.  \nThe change or delta in anion gap from the initial measurement until it improved could be calculated as the difference between the initial value and the later values .  \nBut the question doesn't specify a time frame.  \nHowever, looking back at the problem statement, the user might be asking for the delta between the first anion gap measurement and one of the subsequent ones , but the question says \"delta gap\" without further context.  \nAlternatively, maybe the user is referring to the standard \"delta gap\" formula related to evaluating acid-base imbalances: Delta Gap = (Measured Anion Gap - Normal Anion Gap)/(2.3 or 2.5 ) \u2013 but this is to compare with the \u0394 HCO3-.  \nLet me check the question again: \"What is the patient's delta gap in mEq/L?\"  \nThe question is ambiguous unless it refers to the change in anion gap over time.  \nAlternatively, perhaps the term \"delta gap\" here is intended as the difference between the measured anion gap and the normal anion gap."}
{"Row Number": 351, "Calculator Name": "HAS-BLED Score for Major Bleeding Risk", "Calculator ID": "25", "Category": "risk", "Note ID": "8", "Patient Note": "A 67-year-old gentleman finds himself at the health clinic with recurrent bouts of fatigue. His health voyage is blotted with a longstanding diagnosis of hypertension, which despite efforts, seems to be poorly controlled recently. The patient does not take any blood-thinning agents or other medications known to predispose to bleeding. He admits to mild alcohol consumption, quantifying it at about three drinks per week. His medical trajectory also reveals a major bleeding episode that occurred in the past, claiming a substantial amount of hospital time. Simultaneously, liver function tests over the past few months have indicated irreversible, end stage liver fibrosis, necessitating further evaluation and intervention. However, renal pathologies remain absence in his medical dossier as the renal function records show no signs of compromise. His presentation poses several noteworthy elements for his care-continuum, requiring diligent medical management and monitoring.", "Question": "What is the patient's HAS-BLED score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "5", "LLM Explanation": "Let's calculate the HAS-BLED score step-by-step for this patient. The HAS-BLED score is a tool used to evaluate the risk of bleeding in patients with atrial fibrillation who might be considered for anticoagulation therapy. The score includes the following components, each worth 1 point:\\n\\n1. Hypertension (uncontrolled): The patient has longstanding hypertension that's poorly controlled recently.\\n\\n2. Abnormal Renal/Liver function: The patient has end-stage liver fibrosis (which counts as abnormal liver function), and the note mentions that there are no signs of compromised renal function.\\n\\n3. Stroke: There is no mention of a previous stroke in the note.\\n\\n4. Bleeding history: The patient has a history of a major bleeding episode in the past.\\n\\n5. Labile INR: There is no mention of labile International Normalized Ratio (INR),\\n\\n6. Elderly (over 65): The patient is 67 years old,\\n\\n7. Drugs/alcohol: The patient has mild alcohol consumption (3 drinks per week),\\n\\nNow, let's add up the points :\\n\\n1. Hypertension (uncontrolled): 1 point\\n2. Abnormal Liver function (end-stage liver fibrosis): 1 point\\n3. Bleeding history: 1 point (major bleeding episode in the past)\\n4. Elderly (over 65): 1 point (since the patient is 67 years old)\\n5. Alcohol consumption: 1 point (mild alcohol consumption, 3 drinks per week)\\n\\nLet's count the points for each criterion that applies:\\n\\n- Hypertension (uncontrolled): 1 point\\n- Abnormal Liver function: 1 point (due to end-stage liver fibrosis)\\n- Bleeding history: 1 point (major bleeding episode in the past)\\n- Elderly (over 65): 1 point (since the patient is 67 years old)\\n- Alcohol use: 1 point (mild alcohol consumption, 3 drinks per week)\\n\\nNow, let's sum up the points:\\n\\n1 (Hypertension) + 1 (Abnormal Liver function) + 1 (Bleeding history) + 1 (Elderly) + 1 (Alcohol use) = 5 points.\\n\\nSo the HAS-BLED score is 5.", "LLM Thinking": "Let's calculate the HAS-BLED score step-by-step for this patient. The HAS-BLED score is a tool used to evaluate the risk of bleeding in patients with atrial fibrillation who might be considered for anticoag ulation therapy. The score includes the following components, each worth 1 point: 1. Hypertension (uncontrolled): The patient has longstanding hypertension that's poorly controlled recently. 2. Abnormal Renal/Liver function: The patient has end-stage liver fibrosis (which counts as abnormal liver function), and the note mentions that there are no signs of compromised renal function. 3. Stroke: There is no mention of a previous stroke in the note. 4. Bleeding history: The patient has a history of a major bleeding episode in the past. 5. Labile INR: There is no mention of labile International Normalized Ratio (INR), 6. Elderly (over 65): The patient is 67 years old, 7. Drugs/alcohol: The patient has mild alcohol consumption (3 drinks per week), Now, let's add up the points :", "Ground Truth Answer": "4", "Ground Truth Explanation": "The current HAS-BLED score is 0.\nThe patient is 67.0 years old. Because the patient's age is greater than 65 years, we increment the score by 1, making the current score 0 + 1 = 1.\nThe patient has 3 drinks a week. Because the patient has less than 8 alcoholic drinks a week, we don't change the score, keeping the current score at 1.\nThe issue, hypertension, is reported to be present for the patient note and so we increase the score by 1, making the current score 1 + 1 = 2.\nThe issue, liver disease, is reported to be present for the patient note and so we increase the score by 1, making the current score 2 + 1 = 3.\nThe issue, renal disease, is reported to be absent for the patient and so we do not change the score, keeping the current score at 3.\nThe issue, stroke history, is missing from the patient note and so we assume it to be absent and so we do not change the score, keeping the current score at 3.\nThe issue, prior bleeding, is reported to be present for the patient note and so we increase the score by 1, making the current score 3 + 1 = 4.\nThe issue, labile inr, is missing from the patient note and so we assume it to be absent and so we do not change the score, keeping the current score at 4.\nThe issue, medications for bleeding, is reported to be absent for the patient and so we do not change the score, keeping the current score at 4.\nHence, the patient's HAS-BLED score is 4.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Let's calculate the HAS-BLED score step-by-step for this patient. The HAS-BLED score is a tool used to evaluate the risk of bleeding in patients with atrial fibrillation who might be considered for anticoag ulation therapy. The score includes the following components, each worth 1 point:\n\n1. Hypertension (uncontrolled): The patient has longstanding hypertension that's poorly controlled recently.\n\n2. Abnormal Renal/Liver function: The patient has end-stage liver fibrosis (which counts as abnormal liver function), and the note mentions that there are no signs of compromised renal function.\n\n3. Stroke: There is no mention of a previous stroke in the note.\n\n4. Bleeding history: The patient has a history of a major bleeding episode in the past.\n\n5. Labile INR: There is no mention of labile International Normalized Ratio (INR),\n\n6. Elderly (over 65): The patient is 67 years old,\n\n7. Drugs/alcohol: The patient has mild alcohol consumption (3 drinks per week),\n\nNow, let's add up the points :"}
{"Row Number": 219, "Calculator Name": "Child-Pugh Score for Cirrhosis Mortality", "Calculator ID": "15", "Category": "severity", "Note ID": "21", "Patient Note": "A 63-year-old male with recently diagnosed cirrhosis secondary to NAFLD came for a follow-up consultation. During the appointment, he exhibited confusion, asterixis, and slurred speech. Laboratory evaluations were remarkable with an increased INR value at 1.8. Liver function tests showed a total bilirubin count of 1.9 mg/dL and an albumin level of 3.1 g/dL demonstrating compromised liver function. Additional lab tests showed a glucose level at 130 mg/dL, though hemoglobin A1c was within acceptable bounds which indicate fairly well-controlled DM II. The patient was advised to maintain dietary restrictions and adhere to prescribed therapeutic management. Family intervention was also suggested considering his cognitive impairment. He was reassured that they would initiate steps to manage his encephalopathy right away.", "Question": "What is the patient's Child-Pugh Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "9", "LLM Explanation": "No Explanation", "LLM Thinking": "Okay, so I need to figure out the Child-Pugh Score for the given patient based on the information provided in the patient's note. Step 1: I should recall what the Child-Pugh Score is. It 's a scoring system used to assess the severity of chronic liver disease, which uses 5 different criteria: - Total Bilirubin - Serum Albumin - Prothrombin Time (we will use the IN R) - Ascites - Hepatic Encephalopathy For each of these criteria, the patient is scored from 1 to 4 or 1 to 2. The scores are summed up to get the total Child-Pugh score, which then determines the class (A, B , or C) that indicates the prognosis. The scoring system is as follows: Total Bilirubin (mg/d L) - 1: <= 1.2 - 2 : 1.2 to 2.0 - 3: 2.0 to 3.0 - 4: > 3.0 Serum Albumin (g/d L) - 1: >= 3.5 - 2 : 2 .8-3.4 - 3: 2.1 -2.7 - 4: < 2.1 Prothrombin Time (INR) - 1: <= 1.7 - 2: 1.8-2. 3 - 3: 2.4-3.0 - 4: >3.0 Ascites (1 or 2) - 1: none or controlled - 2: present Hepatic Encephalopathy (1 or 2) - 1: none - 2: present Now, let's break down the information given in the patient note and calculate the score for each criterion. Step 1: Total Bilirubin. Step 2: Serum Albumin is 3.1 g/d L. Step 3: Prothrombin Time (INR) is given as 1.8. Step 4: Ascites. The patient note doesn\u2019t mention any ascites specifically, so it's likely \"None or controlled.\" But wait, do I have to check if ascites is present? Since it's not mentioned, maybe I should assume it's not present. However, sometimes in cirrhosis, ascites may be present but not mentioned unless noted otherwise; however, given the standard, if it's not mentioned, it's likely absent or not significant enough to be mentioned. Step 5: Hepatic Encephalopathy. The patient has confusion, asterixis, and slurred speech. These are signs consistent with hepatic encephalopathy. Now, the Child-Pugh classes are as follows: - A: 5- 6 points - B: 7-9 points - C: 10-15 points", "Ground Truth Answer": "9", "Ground Truth Explanation": "The current child pugh score is 0.\nThe patient's INR is 1.8. Because the INR is between 1.7 and 2.3, we add two to the score, making the current total 0 + 2 = 2.\nThe concentration of bilirubin is 1.9 mg/dL. Because the Bilirubin concentration is less than 2 mg/dL, we add 1 to the score, making the current total 2 + 1 = 3.\nThe concentration of albumin is 3.1 g/dL. Because the Albumin concentration is between 2.8 g/dL and 3.5 g/dL, we add 2 to the score, making the current total 3 + 2 = 5.\nThe Ascites state not specified, assuming and so we will assume it to be absent. This means we add 1 point to the score, making the current total 5 + 1 = 6.\nEncephalopathy state is 'Grade 3-4 encephalopathy' and so we add three points to the score, making the current total 6 + 3 = 9.\nThe patient's child pugh score is 9.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to figure out the Child-Pugh Score for the given patient based on the information provided in the patient's note.\n\nStep 1: I should recall what the Child-Pugh Score is. It 's a scoring system used to assess the severity of chronic liver disease, which uses 5 different criteria:\n- Total Bilirubin\n- Serum Albumin \n- Prothrombin Time (we will use the IN R)\n- Ascites\n- Hepatic Encephalopathy\n\nFor each of these criteria, the patient is scored from 1 to 4 or 1 to 2. The scores are summed up to get the total Child-Pugh score, which then determines the class (A, B , or C) that indicates the prognosis. The scoring system is as follows:\n\nTotal Bilirubin (mg/d L)\n- 1: <= 1.2\n- 2 : 1.2 to 2.0\n- 3: 2.0 to 3.0\n- 4: > 3.0\n\nSerum Albumin (g/d L)\n- 1: >= 3.5\n- 2 : 2 .8-3.4 \n- 3: 2.1 -2.7 \n- 4: < 2.1 \n\nProthrombin Time (INR)\n- 1: <= 1.7\n- 2: 1.8-2. 3 \n- 3: 2.4-3.0 \n- 4: >3.0\n\nAscites (1 or 2)\n- 1: none or controlled\n- 2: present\n\nHepatic Encephalopathy (1 or 2)\n- 1: none\n- 2: present\n\nNow, let's break down the information given in the patient note and calculate the score for each criterion.\n\nStep 1: Total Bilirubin.\n\nStep 2: Serum Albumin is 3.1 g/d L.\n\nStep 3: Prothrombin Time (INR) is given as 1.8.\n\nStep 4: Ascites. The patient note doesn\u2019t mention any ascites specifically, so it's likely \"None or controlled.\" But wait, do I have to check if ascites is present? Since it's not mentioned, maybe I should assume it's not present. However, sometimes in cirrhosis, ascites may be present but not mentioned unless noted otherwise; however, given the standard, if it's not mentioned, it's likely absent or not significant enough to be mentioned.\n\nStep 5: Hepatic Encephalopathy. The patient has confusion, asterixis, and slurred speech. These are signs consistent with hepatic encephalopathy.\n\nNow, the Child-Pugh classes are as follows:\n- A: 5- 6 points \n- B: 7-9 points\n- C: 10-15 points"}
{"Row Number": 629, "Calculator Name": "QTc Framingham Calculator", "Calculator ID": "57", "Category": "physical", "Note ID": "2", "Patient Note": "Patient has a heart rate of 81 bpm and a QT interval of 330 msec.", "Question": "Using the Framingham Formula for corrected QT interval, what is the patient's corrected QT interval in terms of msec?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "333", "LLM Explanation": "To calculate the corrected QT interval using the Framingham formula, we use the formula: $QTcF = QT + 0.154 * (HR - 60).$ Given the values: Heart rate (HR) = 81 bpm and QT interval = 330 msec. First, calculate $HR - 60$: $81 - 60 = 21.$ Next, multiply this result by 0.154: $0.154 * 21 = 3.234.$ Now, add this result to the original QT interval: $330 + 3.234 = 333.234.$ Rounding 333.234 to the nearest whole number gives us 333. Therefore, the corrected QT interval is 333 msec.", "LLM Thinking": "Step 1: To calculate the corrected QT interval, we will use the Framingham Formula for the corrected QT (QTc). The formula is: $QTcF = QT + 0.1 54 \u00d7 (Heart Rate - 60)$ Step 2 : The given values are: - Heart rate (HR) = 8 1 bpm - QT interval = 330 msec Let's plug in these values into the Framingham formula for QTc. The formula is: $QTcF = QT + 0.154 \u00d7 (HR - 60)$ Wait, actually, I need to correct my thinking; the Framingham formula is: $QTcF = QT + [Heart Rate - 60] \\times 0 .154$ But a common version of the Framingham formula is : $QTc\\_F = QT + 0.154 * (HR - 60).$ Let's use this formula: First, compute (HR - 60): 81 - 60 = 21 Next, multiply 0.1 54 by this value: $0.154 * 2 1 = 3.234$ Add this to the original QT interval: $QT\\_cF = 330 + 3 .234$ So, $QT_cF = 33 3.234 msec$ Wait, but the question says \"correct ed QT interval in terms of msec\". So rounding is necessary? The Framingham formula's result is typically rounded to one decimal place, but sometimes it's rounded to the nearest whole number. Let me check. The standard approach might be to keep one decimal, but perhaps the question expects us to round it to the nearest integer. Alternatively, maybe it's okay to leave it as is. Let me do both. Wait, but the correct formula for the Framingham method is typically written as follows for easier calculations: $QT\\_cF = \\frac{QT}{\\sqrt {RR}}$ where RR is the R-R interval in seconds, but since the $QT\\_cF$ in bpm also uses a derived formula for convenience $QT\\_cF = QT + 0.15 4*(HR -60).$ Wait, actually, I need to confirm the exact Framingham formula. Let me think again. The Framingham formula is indeed: QTcF = QT + 0 .154 \u00d7 (Heart Rate - 60) Yes, moving on. If the Heart Rate is 81 bpm and the QT is 330, then: First, subtract 60 from the heart rate: 81 - 60 = 21 . Then multiply this by 0.154: $0 . 154 * 21 = 3. 234 $ Finally add this to the QT interval: $330 + 3 .234 = 33 3 .23 4 msec.", "Ground Truth Answer": "369.886", "Ground Truth Explanation": "The corrected QT interval using the Framingham formula is computed as  QTc = QT Interval + (154 * (1 - rr_interval_sec)), where QT interval is in msec, and RR interval is given as 60/(heart rate).\nThe patient's heart rate is 81 beats per minute.\nThe QT interval is 330 msec.\nThe RR interval is computed as 60/(heart rate), and so the RR interval is 60/81 = 0.741.\nHence, plugging in these values, we will get 330/(154 * ( 1- 0.741 )) = 369.886.\nThe patient's corrected QT interval (QTc) is 369.886 msec.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To calculate the corrected QT interval, we will use the Framingham Formula for the corrected QT (QTc). The formula is:\n\n$QTcF = QT + 0.1 54 \u00d7 (Heart Rate - 60)$\n\nStep 2 : The given values are:\n- Heart rate (HR) = 8 1 bpm \n- QT interval = 330 msec\n\nLet's plug in these values into the Framingham formula for QTc.\n\nThe formula is: $QTcF = QT + 0.154 \u00d7 (HR - 60)$\n\nWait, actually, I need to correct my thinking; the Framingham formula is:\n\n$QTcF = QT + [Heart Rate - 60] \\times 0 .154$\n\nBut a common version of the Framingham formula is :\n\n$QTc\\_F = QT + 0.154 * (HR - 60).$\n\nLet's use this formula: First, compute (HR - 60): 81 - 60 = 21\n\nNext, multiply 0.1 54 by this value: $0.154 * 2 1 = 3.234$\n\nAdd this to the original QT interval: $QT\\_cF = 330 + 3 .234$\n\nSo, $QT_cF = 33 3.234 msec$\n\nWait, but the question says \"correct ed QT interval in terms of msec\". So rounding is necessary? The Framingham formula's result is typically rounded to one decimal place, but sometimes it's rounded to the nearest whole number. Let me check. The standard approach might be to keep one decimal, but perhaps the question expects us to round it to the nearest integer. Alternatively, maybe it's okay to leave it as is. Let me do both.\n\nWait, but the correct formula for the Framingham method is typically written as follows for easier calculations:\n\n $QT\\_cF = \\frac{QT}{\\sqrt {RR}}$ where RR is the R-R interval in seconds, but since the $QT\\_cF$ in bpm also uses a derived formula for convenience $QT\\_cF = QT + 0.15 4*(HR -60).$ \n\nWait, actually, I need to confirm the exact Framingham formula. Let me think again. The Framingham formula is indeed:\n\nQTcF = QT + 0 .154 \u00d7 (Heart Rate - 60)\n\nYes, moving on.\n\nIf the Heart Rate is 81 bpm and the QT is 330, then:\n\nFirst, subtract 60 from the heart rate: 81 - 60 = 21 .\n\nThen multiply this by 0.154: $0 . 154 * 21 = 3. 234 $\n\nFinally add this to the QT interval: \n\n$330 + 3 .234 = 33 3 .23 4 msec."}
{"Row Number": 278, "Calculator Name": "HEART Score for Major Cardiac Events", "Calculator ID": "18", "Category": "risk", "Note ID": "pmc-4980942-1", "Patient Note": "A 35-year-old man was hospitalized for acute chest pain and palpitation at rest with a presumed diagnosis of unstable angina. He also described an episode of syncope. He was prescribed chlorpheniramine 4 mg a couple of days ago for symptomatic treatment of upper respiratory tract infection, and he was also on propranolol 20 mg treatment for essential tremor and anxiety disorder for many years. He was used to take propranolol daily. His complaints appeared 1 h after intake of the second dosage of chlorpheniramine together with propranolol. He had no prior history of cardiac arrhythmias, valvular or congenital heart disease, and sudden cardiac death in family history. He smoked regularly up to 20 cigarettes a day. He denied the usage of legal or illegal other medications such as antidepressants and cocaine. Physical examination revealed irregular pulse, low blood pressure of 90/60 mmHg, and altered cloudy consciousness. He had no biochemical abnormality; magnesium and potassium level was in normal range. Electrocardiography (ECG) showed ST-segment depression in inferior leads and isolated ST elevation in leads D1-aVL []. Echocardiography showed normal systolic functions with no segmental wall motion abnormalities. The patient was given 300 mg of acetylsalicylic acid and underwent emergency coronary angiography that revealed normal coronary arteries. Whenever ischemic changes were observed in admission ECG, anti-ischemic therapy was not admitted to the patient due to the result of completely normal coronaries. After all the patient was followed by telemetry at coronary care unit. Control ECG showed ventricular bigeminy and R on T phenomenon. On the 2nd day of admission, the patient had polymorphic ventricular tachycardia (VT) attack which degenerated to ventricular fibrillation, immediately patient was defibrillated and sinus rhythm was restored successfully []. After defibrillation, the patient continued to have frequent premature ventricular beats and couplets on the monitor. On the 3rd day of his admission, an upper rib ECG was performed and showed a pattern of right bundle branch block with ST-segment elevation in leads V3. The present findings were thought to be compatible with Type 3 Brugada syndrome []. An ajmaline challenge test[] was then performed. Although the frequency of ventricular extrasystoles and couplets was increased during the test, no coved-type ECG pattern appeared in the right precordial leads []. Therefore, the diagnosis of Brugada syndrome was abandoned. Electrophysiological study was proposed, but the patient refused the test. Because the patient survived a sudden unexplained cardiac arrest, it was decided to implant an implantable cardioverter defibrillator for secondary prevention. The patient recovered and had no further complaints after implantation and he was discharged.", "Question": "What is the patient's HEART score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "5", "LLM Explanation": "To calculate the HEART score, we need to evaluate the following components: History, ECG, Age, Risk factors, and Troponin. Here's the breakdown for the given patient note: 1. **History**: The patient presented with acute chest pain and palpitations at rest along with syncope. The chest pain at rest and the presence of syncope make the history concerning and not typical of classic angina. Therefore, the history score is 2 (non-anginal chest pain or chest discomfort). 2. **ECG**: The ECG showed ST-segment depression in inferior leads and isolated ST elevation in leads D1-aVL. These changes suggest ischemic changes. Therefore, the ECG score is 2 (significant ischemic changes). 3. **Age**: The patient is 35 years old. According to the HEART score, the age score for someone under 45 years is 0. 4. **Risk factors**: The patient smokes regularly (20 cigarettes/day), which is a risk factor. Therefore, the risk factor score is 1. 5. **Troponin (T)**: There is no mention of elevated troponin levels. Therefore, the troponin score is 0. Now, sum up the scores: - History: 2 - ECG: 2 - Age: 0 - Risk factors: 1 - Troponin: 0 Total HEART score = 2 + 2 + 0 + 1 + 0 = 5.", "LLM Thinking": "To calculate the HEART score, we need to use the factors for the HEART score: History, ECG, Age, Risk factors, and Transectal (Troponin). The HEART score is used to risk stratify patients with possible acute coronary syndrome (ACS). Each component is scored as 0, 1, or 2, with a total score ranging from 0 to 10. Higher scores indicate a higher risk of major adverse cardiac events within 6 weeks. The components are as follows: 1. **History**: The patient's history related to ACS. 2. **ECG**: Presence of significant ECG changes suggestive of ischemia. 3. **Age**: The patient's age. 4. **Risk factors**: Presence of risk factors (smoking, diabetes, obesity, hypertension , hyperlipidemia, family history of premature coronary artery disease). 5. **Troponin (T):** Elevated cardiac troponin. Now, let\u2019s assess the task based on the given patient note : 1. **History**: - The patient presented with chest pain, palpitation, and an episode of syncope. The chest pain was at rest, which is a concerning feature. The patient was on propranolol (a beta-blocker) for essential tremor and anxiety, and had recently started chlorpheniramine. The symptoms appeared shortly after taking a second dose of chlorpheniramine along with propranolol. They have symptoms associated with ACS, such as chest pain and syncope. However, the patient had normal coronary arteries on angiography. However, in the HEART score, the history component is based on the nature and characteristics of the pain (typical / atypical / non-cardiac). The patient's chest pain is at rest, which is more concerning. The History score is typically 2 if the pain is atypical or non-cardiac or associated with exertion (no rest pain), and 0 or 1 for typical ACS. Wait, I need to recall the exact grading for the history: For history, the scoring is as follows: - Typical angina: 0 - Atypical angina-like symptoms: 1 - Non-anginal chest pain or chest discomfort: 2 The patient's history mentions \"acute chest pain and palpitation at rest.\" Chest pain at rest can be typical of ACS, but in the context of this classification, rest pain is typically considered more concerning, and if it's typical angina (crushing, pressure, radiating to arm/neck etc.), then it might be 0. However, the exact description here is \"acute chest pain and palpitation at rest.\" The terms \"acute\", \"palpitation\", and the occurrence at rest suggest it might be more concerning, but the exact classification is needed. Since it includes \"palpitations\" which hint at arrhythmia and not typical angina, the history may be considered \"non-anginal chest pain or chest discomfort.\" Wait, but the patient also had syncope. However, the history component is primarily about the chest pain. The presence of syncope might add to the risk, but for the HEART score, its contribution to the history factor is not immediately clear unless it directly adds to the typology of the chest pain. 2. **ECG**: The ECG showed ST-segment depression in inferior leads and isolated ST elevation in leads D1-aVL. These changes are suggestive of ischemia. The ECG score in HEART is 2 if there is significant ischemic change or previous MI, 1 if it is nonspecific changes/ischemic changes not clearly significant, 0 if normal. Here the presence of ST changes suggestive of ischemia, even though they do not represent classic acute ischemia (ST elevation typical of STEMI), indicates ECG changes associated with ACS. 3. **Age**: The patient is 35 years old. The age component in HEART is 0 for < 45 years, 1 for 45-64, and 2 for \u226565. 4. **Risk factors**: The risk factors are smoking (20 cigarettes/day), which is definitely a risk factor; the patient has no other explicit mentions of diabetes, hypertension, etc. However, in some versions of HEART, the risk factor category may have more detailed categorization including additional medical history such as hypertension, obesity, and family history. However, the note states \"no prior history of ... heart disease...,\" suggesting no history of hypertension/diabetes explicitly mentioned. So the only risk factor is smoking. 5. **Troponin (T)**: The note does not mention elevated blood troponin. The task states \"biochemical abnormality\" was not present, so troponin presumably normalized or was not elevated. Now summing up the components :", "Ground Truth Answer": "5", "Ground Truth Explanation": "The current HEART Score is 0.\nThe value of 'history' in the patient's note is determined to be 'Highly suspicious'. Based on the HEART Score criteria, 2 points are added for 'history', increasing the current total to 0 + 2 = 2.\nThe value of 'electrocardiogram' in the patient's note is determined to be 'Significant ST deviation'. Based on the HEART Score criteria, 2 points are added for 'electrocardiogram', increasing the current total to 2 + 2 = 4.\nThe patient is 35.0 years old. The patient's age is less than 45 years and so keep the current total at 4.\nThe following risk factor(s) are present based on the patient's note: smoking. The following risk factor(s) are mentioned in the patient's note, but these risk factors are noted to be absent from the patient: hypertension, diabetes mellitus, family with cvd, atherosclerotic disease. The following risk factor(s) are missing from the patient's data: hypertension, diabetes mellitus, family with cvd, atherosclerotic disease. We will assume that these are all absent from the patient. Based on the HEART Score risk factors criteria, 1 risk factors are present and so 1 point is added for the risk factors criteria, making the current total, 4 + 1 = 5.\n'initial troponin' is missing from the patient's data and so we assume it's value is less than or equal to normal limit.Based on the HEART Score criteria, 0 points are added for 'initial troponin', keeping the current total at 5.\nBased on the patient's data, the HEART Score is 5.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the HEART score, we need to use the factors for the HEART score: History, ECG, Age, Risk factors, and Transectal (Troponin). The HEART score is used to risk stratify patients with possible acute coronary syndrome (ACS). Each component is scored as 0, 1, or 2, with a total score ranging from 0 to 10. Higher scores indicate a higher risk of major adverse cardiac events within 6 weeks. The components are as follows:\n\n1. **History**: The patient's history related to ACS.  \n2. **ECG**: Presence of significant ECG changes suggestive of ischemia.  \n3. **Age**: The patient's age.  \n4. **Risk factors**: Presence of risk factors (smoking, diabetes, obesity, hypertension , hyperlipidemia, family history of premature coronary artery disease).  \n5. **Troponin (T):** Elevated cardiac troponin.\n\nNow, let\u2019s assess the task based on the given patient note :\n\n1. **History**:  \n   - The patient presented with chest pain, palpitation, and an episode of syncope. The chest pain was at rest, which is a concerning feature. The patient was on propranolol (a beta-blocker) for essential tremor and anxiety, and had recently started chlorpheniramine. The symptoms appeared shortly after taking a second dose of chlorpheniramine along with propranolol. They have symptoms associated with ACS, such as chest pain and syncope. However, the patient had normal coronary arteries on angiography. However, in the HEART score, the history component is based on the nature and characteristics of the pain (typical / atypical / non-cardiac). The patient's chest pain is at rest, which is more concerning. The History score is typically 2 if the pain is atypical or non-cardiac or associated with exertion (no rest pain), and 0 or 1 for typical ACS. Wait, I need to recall the exact grading for the history:\n\nFor history, the scoring is as follows:  \n- Typical angina: 0  \n- Atypical angina-like symptoms: 1  \n- Non-anginal chest pain or chest discomfort: 2  \n\nThe patient's history mentions \"acute chest pain and palpitation at rest.\" Chest pain at rest can be typical of ACS, but in the context of this classification, rest pain is typically considered more concerning, and if it's typical angina (crushing, pressure, radiating to arm/neck etc.), then it might be 0. However, the exact description here is \"acute chest pain and palpitation at rest.\" The terms \"acute\", \"palpitation\", and the occurrence at rest suggest it might be more concerning, but the exact classification is needed. Since it includes \"palpitations\" which hint at arrhythmia and not typical angina, the history may be considered \"non-anginal chest pain or chest discomfort.\"\n\nWait, but the patient also had syncope. However, the history component is primarily about the chest pain. The presence of syncope might add to the risk, but for the HEART score, its contribution to the history factor is not immediately clear unless it directly adds to the typology of the chest pain.\n\n2. **ECG**:  \n   The ECG showed ST-segment depression in inferior leads and isolated ST elevation in leads D1-aVL. These changes are suggestive of ischemia. The ECG score in HEART is 2 if there is significant ischemic change or previous MI, 1 if it is nonspecific changes/ischemic changes not clearly significant, 0 if normal. Here the presence of ST changes suggestive of ischemia, even though they do not represent classic acute ischemia (ST elevation typical of STEMI), indicates ECG changes associated with ACS.\n\n3. **Age**:  \n   The patient is 35 years old. The age component in HEART is 0 for < 45 years, 1 for 45-64, and 2 for \u226565.\n\n4. **Risk factors**:  \n   The risk factors are smoking (20 cigarettes/day), which is definitely a risk factor; the patient has no other explicit mentions of diabetes, hypertension, etc. However, in some versions of HEART, the risk factor category may have more detailed categorization including additional medical history such as hypertension, obesity, and family history. However, the note states \"no prior history of ... heart disease...,\" suggesting no history of hypertension/diabetes explicitly mentioned. So the only risk factor is smoking.\n\n5. **Troponin (T)**:  \n   The note does not mention elevated blood troponin. The task states \"biochemical abnormality\" was not present, so troponin presumably normalized or was not elevated.\n\nNow summing up the components :"}
{"Row Number": 694, "Calculator Name": "Body Surface Area Calculator", "Calculator ID": "60", "Category": "physical", "Note ID": "pmc-6166568-1", "Patient Note": "A fifteen-year-old girl, born at term of normal delivery second of three siblings, initially presented in the Orthopaedics OPD in 2010 with a history of progressive knee deforming of 1month and was referred to an endocrinologist for evaluation of metabolic bone disease. Dietary history was suggestive of adequate calcium and vitamin D intake and adequate sun exposure. No history of malabsorption or renal disorder. On examination, height 150 cm (5\u201310 percentile), weight 32 <5th percentile, US: LS = 0.96, percentile target height: 161.5 cm, genu valgum deformity noted, intermalleolar distance: 10.9 cm, bilateral wrist widening noted.\nBiochemical evaluation revealed serum calcium: 14.2 mg/dl, phosphorus: 3.4 mg/dl, 25(OH) vitamin D: 25.10 nmol/L, iPTH: 1967 pg/ml, alkaline phosphatase: 1400 U/L, 24 hours urinary calcium: 282 mg/24 hours. Imaging: X-ray hand showed features of rickets [Figures -]. CT neck: Features s/o left superior parathyroid adenoma. Lesion in lower pole of left lobe of thyroid Sestamibi scan: S/o functioning parathyroid adenoma on left side. She underwent left inferior parathyroidectomy in May 2010: however, on follow up after 1 year she was found to have elevated parathyroid hormone (PTH) and calcium and was then referred to SGPGI with a diagnosis of persistent hyperparathyroidism (HPT).\nAt evaluation in SGPGI there were no records of previous surgery; repeat methoxy iso butyl isonitrile (MIBI) revealed a superior parathyroid adenoma on left side and was concordant with the ultrasonography (USG) finding of a left superior parathyroid adenoma. Bilateral neck exploration was performed with intraoperative parathyroid hormone (IOPTH) monitoring. At operation, both right parathyroid glands were found to be grossly normal; a left superior parathyroid adenoma was found which was excised (2.2 \u00d7 1.6 \u00d7 1.6 mm, weight 2.2 gm). However, left inferior parathyroid gland could not be found. IOPTH according to Miami criteria was curative, as there was >50% drop from the pre-excision value of 2130 to 231 at 10 minutes. Histophalogical examination was suggestive of parathyroid adenoma. At the last follow up, in 2016, her biochemical parameters including calcium and iPTH were within normal limits and she was free of bone pains, though her genu valgum persisted.", "Question": "What is the patient's body surface area? Please output your answer in terms of m\u00b2.", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "1.155", "LLM Explanation": "To calculate the body surface area (BSA), I used the Mosteller formula: BSA = sqrt((height (cm) * weight (kg)) / 3600). From the patient note, the height is 150 cm and the weight is 32 kg. Plugging these values into the formula gives us the following steps:\\n1. Calculate the product of height and weight: 150 * 32 = 4800.\\n2. Divide this product by 3600: 4800 / 3600 = 1.3333.\\n3. Take the square root of the result from step 2: sqrt(1.3333) \u2248 1.155.\\nTherefore, the BSA is approximately 1.155 m\u00b2.", "LLM Thinking": "First, we need to calculate the body surface area (BSA) for the patient. The common formula used for calculating body surface area is the Mosteller formula: \\[ \\text{BSA (m^2)} = \\sqrt {\\frac{\\text{(height (cm) \\times weight (kg)) }}{3600}} \\] From the patient note, the height is 150 cm. The weight is listed as 3 2 (though it is not specified if it's in kilograms or pounds). The note mentions \"weight 32 <5th percentile,\" so assuming the weight is given in kilograms (since in typical clinical settings, weight in children is often recorded in kg), the weight would be 32 kg . Now we will plug in the height and weight into the Mosteller formula : Height = 150 cm, Weight = 32 kg , BSA = sqrt( (150 * 32) / 3600) Let's calculate this step by step: Step 1: Calculate the product of height and weight. \\[ 150 \\times 32 = 48 00. \\] Step 2: Divide this product by 3 600. \\[ 4800 / 36 00 = 1.3333. \\]", "Ground Truth Answer": "1.155", "Ground Truth Explanation": "For the body surface area computation, the formula is sqrt((weight (in kgs) * height (in cm))/3600, where the units of weight is in kg and the units of height is in cm.\nThe patient's height is 150.0 cm. \nThe patient's weight is 32.0 kg. \nTherefore, the patient's bsa is sqrt((32.0 (in kgs) * 150.0 (in cm))/3600) = 1.155 m^2.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the body surface area (BSA) for the patient. The common formula used for calculating body surface area is the Mosteller formula: \\[ \\text{BSA (m^2)} = \\sqrt {\\frac{\\text{(height (cm) \\times weight (kg)) }}{3600}} \\]\n\nFrom the patient note, the height is 150 cm. The weight is listed as 3 2 (though it is not specified if it's in kilograms or pounds). The note mentions \"weight 32 <5th percentile,\" so assuming the weight is given in kilograms (since in typical clinical settings, weight in children is often recorded in kg), the weight would be 32 kg . Now we will plug in the height and weight into the Mosteller formula :\n\nHeight = 150 cm,\nWeight = 32 kg ,\n\nBSA = sqrt( (150 * 32) / 3600)\n\nLet's calculate this step by step: Step 1: Calculate the product of height and weight. \\[ 150 \\times 32 = 48 00. \\]\n\nStep 2: Divide this product by 3 600. \\[ 4800 / 36 00 = 1.3333. \\]"}
{"Row Number": 897, "Calculator Name": "Sequential Organ Failure Assessment (SOFA) Score", "Calculator ID": "43", "Category": "risk", "Note ID": "10", "Patient Note": "A 58-year-old male was admitted to the ICU following the deterioration of his conscious state; currently, he is rated with a Glasgow Coma Scale score of 10. He is presently on mechanical ventilation, with FiO\u2082 at 54 %, and his arterial blood gas shows a PaO\u2082 of 76 mm Hg. Furthermore, there are ongoing infusions of multiple vasopressors to maintain his hemodynamic stability, including norEPINEPHrine and EPINEPHrine at 0.1 mcg/kg/min each, DOPamine at 7 mcg/kg/min, and DOBUTamine at 1 mcg/kg/min. His systolic and diastolic blood pressure recorded at 120 mm Hg and 75 mm Hg, respectively. Biochemical findings show creatinine measurement at 1.4 mg/dL, indicating a slight deviation in renal function, while the bilirubin level stood at 2.3 mg/dL. His platelet count is 175,000/\u00b5L. Over the past 24-hours, his urine output was 850 mL/day.", "Question": "What is the patient's Sequential Organ Failure Assessment (SOFA) Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "7", "LLM Explanation": "To calculate the Sequential Organ Failure Assessment (SOFA) score for this patient, I will evaluate each organ system's contribution based on the provided data points. Here are the steps: 1. **Respiratory Subscore:** - PaO\u2082 = 76 mmHg - FiO\u2082 = 54% (or 0.54 in decimal form) - PaO\u2082/FiO\u2082 ratio = 76 / 0.54 \u2248 140.7. - The scoring for the Respiratory Subscore is as follows: - PaO\u2082/FiO\u2082 > 400: Score = 0 - 300-400: Score = 1 - 200-299: Score = 2 - 100-199: Score = 3 - <100: Score = 4 Since the PaO\u2082/FiO\u2082 ratio is approximately 140.7, it falls within the range 100-199. Therefore, the Respiratory Subscore is 3. 2. **Coagulation Subscore:** - Platelet count = 175,000/\u00b5L. - The scoring for the Coagulation Subscore is as follows: - Platelets \u2265 150,000/\u00b5L: Score = 0 - 100,000 - 149,000/\u00b5L: Score = 1 - 50,000 - 99,000/\u00b5L: Score = 2 - <50,000/\u00b5L: Score = 4 Since the platelet count is 175,000/\u00b5L, it is above 150,000/\u00b5L. Therefore, the Coagulation Subscore is 0. 3. **Liver Subscore:** - Bilirubin = 2.3 mg/dL. - The scoring for the Liver Subscore is as follows: - <1.7 mg/dL: Score = 0 - 1.7 - 2.9 mg/dL: Score = 1 - 3.0 - 11.9 mg/dL: Score = 2 - \u226512 mg/dL: Score = 3 Since the bilirubin level is 2.3 mg/dL, it falls within the range 1.7 - 2.9 mg/dL. Therefore, the Liver Subscore is 1. 4. **Cardiovascular Subscore:** - The patient is on multiple vasopressors: norepinephrine (0.1 mcg/kg/min), epinephrine (0.1 mcg/kg/min), dopamine (7 mcg/kg/min), and dobutamine (1 mcg/kg/min). - The scoring for the Cardiovascular Subscore is based on the use of vasopressors: - No vasopressors: Score = 0 - Dopamine < 5 mcg/kg/min or dobutamine < 5 mcg/kg/min: Score = 0 - Dopamine \u2265 5 mcg/kg/min or NE/epinephrine < 0.1 mcg/kg/min: Score = 1 - NE/epinephrine 0.1 - 0.49 mcg/kg/min: Score = 2 - NE/epinephrine \u2265 0.5 mcg/kg/min: Score = 3 Since the patient is using both norepinephrine and epinephrine, each at 0.1 mcg/kg/min, the combined dose of norepinephrine and epinephrine is 0.1 + 0.1 = 0.2 mcg/kg/min. This falls within the range 0.1 - 0.49 mcg/kg/min. Therefore, the Cardiovascular Subscore is 2. 5. **Renal Subscore:** - Creatinine = 1.4 mg/dL. - Urine output over the last 24 hours = 850 mL. The scoring for the Renal Subscore is based on the highest value between creatinine and urine output. For creatinine: - <1.2 mg/dL: Score = 0 - 1.2 - 1.9 mg/dL: Score = 1 - 2.0 - 3.4 mg/dL: Score = 2 - 3.5 - 5.0 mg/dL: Score = 3 - >5.0 mg/dL: Score = 4 Since the creatinine is 1.4 mg/dL, it falls within the range 1.2 - 1.9 mg/dL. Therefore, the creatinine-based Renal Subscore is 1. For urine output: - \u2265 2000 mL: Score = 0 - 500 - 1999 mL: Score = 1 - 0.1 - 0.49 L (100 - 499 mL): Score = 2 - <0.1 L (<100 mL): Score = 3 Since the urine output is 850 mL, it falls within the range 500 - 1999 mL. Therefore, the urine output-based Renal Subscore is 1. The Renal Subscore is the maximum of the two scores (creatinine and urine output). Both creatinine and urine output give a score of 1. Therefore, the Renal Subscore is 1. Now, let's sum up all the subscores: - Respiratory Subscore = 3 - Coagulation Subscore = 0 - Liver Subscore = 1 - Cardiovascular Subscore = 2 - Renal Subscore = 1 Adding these together gives the total SOFA score: 3 (Respiratory) + 0 (Coagulation) + 1 (Liver) + 2 (Cardiovascular) + 1 (Renal) = 7. Therefore, the total SOFA score is 7.", "LLM Thinking": "To calculate the Sequential Organ Failure Assessment (SOFA) score for this patient , I need to evaluate each organ system's contribution based on the provided data points. The SOFA score includes six subscores: Respiratory (PaO\u2082 /FiO\u2082 ratio), Coagulation (platelet count), Liver (bilirubin), Cardiovascular (vasopressors and MAP ), Renal (serum creatinine or urine output), and CNS ( not directly scored but Glasgow Coma Scale is sometimes used for brain function). However, SOFA primarily uses blood pressure management, vasopressor support , and MAP for cardiovascular subscore. Let me break down each component step by step. First, the Respiratory Subscore is based on the PaO\u2082/FiO\u2082 ratio: 1. **PaO\u2082** = 76 mmHg , **FiO\u2082** = 54% (0.54 in decimal form). So the ratio is 76 / 0.54 \u2248 140.7. Next, Coagulation Subscore: Platelet count is 175,000/\u00b5L. According to SOFA criteria: - Platelets \u2265 150: Score = 0 - 100 - 149 : Score = 1 - 50 - 99: Score = 2 - <50: Score =4. Liver Subscore: Bilirubin is 2.3 mg/dL. The cutoffs are: - <1.7: 0 - 1.7-2.9: 1 - 3.0-11.9: 2 - \u226512: 3. Cardiovascular Subscore: This is based on the use of vasopressors and MAP. The patient is on multiple vasopressors (norepinephrine, epinephrine, dopamine, dobutamine). However, SOFA primarily considers the highest dose of vasopressors required to keep mean arterial pressure (MAP) at \u2265 65 mmHg. The scoring is: - No vasopressors: 0 \u2013 Dopamine < 5 mcg/kg/min OR dobutamine < 5 mcg/kg/min: 0 - Dopamine \u2265 5 mcg/kg/min or NE/epinephrine < 0.1 mcg/kg/min: 1 - NE/epinephrine 0.1\u20130.49 mcg/kg/min: 2 - NE/epinephrine \u2265 0.5 mcg/kg/min: 3 Here, the patient is using: - Norepinephrine: 0.1 mcg/kg/min - Epinephrine: 0.1 mcg/kg/min - Dopamine: 7 mcg/kg/min - Dobutamine: 1 mcg/kg/min Wait, but in SOFA, the cardiovascular score is based on the vasopressor with the highest dose among those that are considered in the vasopressor scoring. Dopamine and dobutamine are considered differently. For vasopressors like dopamine (at \u2265 5 mcg/kg/min) or dobutamine, they contribute a score of 1. But if the patient is on NE or epinephrine, those are more potent and take higher priority. Since the patient is on both norepinephrine (0.1 mcg/kg/min) and epinephrine (0.1), we will use the combined effect (because generally, the highest needed potent vasopressor is used). However, SOFA specifically looks at the highest dose of NE or epinephrine or the combination. Since each is at 0.1, adding them would be 0.2, but the scoring for NE/epi is based on the total dose? Or is it per vasopressor? The guidelines state that if NE or epinephrine is used, the dose is the total of both. So in this case, total NE + Epi dose = 0.1 + 0.1 = 0.2 mcg/kg/min. Renal Subscore: The criteria are based on creatinine or urine output. The patient has a creatinine of 1.4 mg/dL and has a urine output over the last 24 hours of 850 mL. The renal score is the highest between the two values. For creatinine: - <1.2: Score 0 - 1.2\u20131.9: Score 1 - 2.0\u20133.4: Score 2 - 3.5\u20135.0: Score 3 - >5.0: Score 4 Urine output: The score is based on the urine output over 24 hours: - \u22652000 mL: Score = 0 - 500\u20131999 mL: Score = 1 - 0.1\u20130.49 L: Score = 2 - <0.1 L: Score = 3. CNS Subscore: SOFA does not have a direct subscore for the CNS, but the Glasgow Coma Scale is sometimes used in modified versions, but standard SOFA excludes it. So we will ignore the GCS here. Now summing all the subscores: Wait, but wait, the six systems: Respiratory, Coagulation, Liver, Cardiovascular, Renal, and CNS. Wait, the six components are: Respiratory, Coagulation, Liver, Cardiovascular, Renal, and CNS is usually not scored directly in SOFA. Let me confirm the components: SOFA has six components: Respiratory, Coagulation, Liver, Cardiovascular, Renal, and CNS (but CNS is not part of the standard SOFA score; the original SOFA does not include a CNS component). The standard SOFA score includes the following: Respiratory, Coagulation, Liver, Cardiovascular, Renal, and CNS is sometimes added in some protocols, but in the standard version, it's 6 organs without CNS. Wait, actually, the standard SOFA has six components: Respiratory, Coagulation, Liver, Cardiovascular, Renal, and CNS is not part of standard scoring in the original SOFA.", "Ground Truth Answer": "10", "Ground Truth Explanation": "The patient's current SOFA score is 0.\nThe patient's partial pressure of oxygen is 76.0 mm Hg and FiO\u2082 percentage is 54.0 %. This means that the patient's partial pressure of oxygen to FiO\u2082 ratio is 1.407. The patient is reported to be on mechanical ventillation. Whether the patient is on continuous positive airway pressure is not reported and so we assume this to be false. Because the patient's partial pressure of oxygen to FiO\u2082 ratio is less than 100, and the patient is using at least one of (i) mechanical ventillation or (ii) continious positive airway pressure, we increase the score by four points, makeing the current total 0 + 4 = 4.\nFor two points to be given, the patient must be taking less than or equal to 5 micrograms/kg/min or any amount of dobutamine. Because at least one of these cases is true for the patient, we increment the score by two points, making the current total 4 + 2 = 6.\nThe patient's glasgow coma score is not reported so we take it to be 15. Because the patient's glasgow coma score is between 10 and 12, we add 2 points to the score, making the current score 6 + 2 = 8.\n The concentration of bilirubin is 2.3 mg/dL. Because the patient's bilirubin concentration is at least 2.0 mg/dL but less than 6.0 mg/dL, we increment the score by two points, make the current score 8 + 2 = 10.\nThe patient's concentration of platelet is 175000.0 count/\u00b5L. Because the patient's platelet count is at least 150*10\u00b3/\u00b5L, we do not any points to the score, keeping the current score at 10.\nHence, the patient's SOFA score is 10 points.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the Sequential Organ Failure Assessment (SOFA) score for this patient , I need to evaluate each organ system's contribution based on the provided data points.  \nThe SOFA score includes six subscores: Respiratory (PaO\u2082 /FiO\u2082 ratio), Coagulation (platelet count), Liver (bilirubin), Cardiovascular (vasopressors and MAP ), Renal (serum creatinine or urine output), and CNS ( not directly scored but Glasgow Coma Scale is sometimes used for brain function).  \nHowever, SOFA primarily uses blood pressure management, vasopressor support , and MAP for cardiovascular subscore.  \nLet me break down each component step by step.\n\nFirst, the Respiratory Subscore is based on the PaO\u2082/FiO\u2082 ratio: 1. **PaO\u2082** = 76 mmHg , **FiO\u2082** = 54% (0.54 in decimal form). So the ratio is 76 / 0.54 \u2248 140.7.\n\nNext, Coagulation Subscore: Platelet count is 175,000/\u00b5L. According to SOFA criteria:\n- Platelets \u2265 150: Score = 0\n- 100 - 149 : Score = 1\n- 50 - 99: Score = 2\n- <50: Score =4.\n\nLiver Subscore: Bilirubin is 2.3 mg/dL. The cutoffs are:\n- <1.7: 0\n- 1.7-2.9: 1\n- 3.0-11.9: 2\n- \u226512: 3.\n\nCardiovascular Subscore: This is based on the use of vasopressors and MAP. The patient is on multiple vasopressors (norepinephrine, epinephrine, dopamine, dobutamine). However, SOFA primarily considers the highest dose of vasopressors required to keep mean arterial pressure (MAP) at \u2265 65 mmHg. The scoring is:\n- No vasopressors: 0 \u2013 Dopamine < 5 mcg/kg/min OR dobutamine < 5 mcg/kg/min: 0  \n- Dopamine \u2265 5 mcg/kg/min or NE/epinephrine < 0.1 mcg/kg/min: 1  \n- NE/epinephrine 0.1\u20130.49 mcg/kg/min: 2  \n- NE/epinephrine \u2265 0.5 mcg/kg/min: 3  \n\nHere, the patient is using:\n- Norepinephrine: 0.1 mcg/kg/min  \n- Epinephrine: 0.1 mcg/kg/min  \n- Dopamine: 7 mcg/kg/min  \n- Dobutamine: 1 mcg/kg/min  \n\nWait, but in SOFA, the cardiovascular score is based on the vasopressor with the highest dose among those that are considered in the vasopressor scoring. Dopamine and dobutamine are considered differently. For vasopressors like dopamine (at \u2265 5 mcg/kg/min) or dobutamine, they contribute a score of 1. But if the patient is on NE or epinephrine, those are more potent and take higher priority. Since the patient is on both norepinephrine (0.1 mcg/kg/min) and epinephrine (0.1), we will use the combined effect (because generally, the highest needed potent vasopressor is used). However, SOFA specifically looks at the highest dose of NE or epinephrine or the combination. Since each is at 0.1, adding them would be 0.2, but the scoring for NE/epi is based on the total dose? Or is it per vasopressor? The guidelines state that if NE or epinephrine is used, the dose is the total of both. So in this case, total NE + Epi dose = 0.1 + 0.1 = 0.2 mcg/kg/min.\n\nRenal Subscore: The criteria are based on creatinine or urine output. The patient has a creatinine of 1.4 mg/dL and has a urine output over the last 24 hours of 850 mL. The renal score is the highest between the two values. For creatinine:\n- <1.2: Score 0  \n- 1.2\u20131.9: Score 1  \n- 2.0\u20133.4: Score 2  \n- 3.5\u20135.0: Score 3  \n- >5.0: Score 4  \n\nUrine output: The score is based on the urine output over 24 hours:\n- \u22652000 mL: Score = 0  \n- 500\u20131999 mL: Score = 1  \n- 0.1\u20130.49 L: Score = 2  \n- <0.1 L: Score = 3.  \n\nCNS Subscore: SOFA does not have a direct subscore for the CNS, but the Glasgow Coma Scale is sometimes used in modified versions, but standard SOFA excludes it. So we will ignore the GCS here.\n\nNow summing all the subscores:\n\nWait, but wait, the six systems: Respiratory, Coagulation, Liver, Cardiovascular, Renal, and CNS. Wait, the six components are: Respiratory, Coagulation, Liver, Cardiovascular, Renal, and CNS is usually not scored directly in SOFA.\n\nLet me confirm the components: SOFA has six components: Respiratory, Coagulation, Liver, Cardiovascular, Renal, and CNS (but CNS is not part of the standard SOFA score; the original SOFA does not include a CNS component). The standard SOFA score includes the following: Respiratory, Coagulation, Liver, Cardiovascular, Renal, and CNS is sometimes added in some protocols, but in the standard version, it's 6 organs without CNS. Wait, actually, the standard SOFA has six components: Respiratory, Coagulation, Liver, Cardiovascular, Renal, and CNS is not part of standard scoring in the original SOFA."}
{"Row Number": 214, "Calculator Name": "Child-Pugh Score for Cirrhosis Mortality", "Calculator ID": "15", "Category": "severity", "Note ID": "16", "Patient Note": "A 69-year-old male with a past medical history of hypertension, chronic alcohol use, and cirrhosis presented for a routine check. He was sober and although slight mental slowness and mild asterixis were present on exam, There was no evidence of ascites. The laboratory results revealed an INR of 1.9, increasing the concern for impaired liver function. His serum total bilirubin was 2.0 mg/dL and albumin was 3.2 g/dL, indicating diminished liver function. The patient's blood glucose was 120 mg/dL, raising the suspicion of prediabetes, and his creatinine was 1.0 mg/dL, indicating good renal function. He was ordered to abstain from alcohol consumption, maintain a balanced diet, and monitor his blood glucose regularly. His medications including diuretics and antihypertensives remained unaltered until his next appointment.", "Question": "What is the patient's Child-Pugh Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "9", "LLM Explanation": "No Explanation", "LLM Thinking": "Okay, so I need to figure out the Child-Pugh Score for this patient. Let me recall what the Child-Pugh score entails. It's used to assess liver function in people with cirrhosis, right ? The Child-Pugh score includes five factors: 1. Total Bilir ubin 2. Serum Albumin 3. Prothrombin Time (INR) 4. Ascites 5. Hepatic Encephalopathy Each of these factors is assigned points from 1 to 3, and the total score determines the class (A, B , or C) of liver disease. Here are the scoring criteria: - **Total Bilirubin**: 1: <2 mg/dL 2: 2-3 mg/dL 3: >3 mg /dL - **Albumin**: 1: \u22653.5 g/dL 2: 2.8-3. 4 3: <2.8 Wait, the patient 's albumin is 3.2. So that would be 2 points since it falls in the range: 2.8-3. 4? Wait, wait, the cutoff for albumin's second category is 2.8-3.4? Or maybe 3.5 to 2.8. - **Prothrombin Time (IN R)**: 1: <1.7 2: 1.7-2.3 3: >2 .3 The patient\u2019s INR is 1.9, so that falls into the second category (1.7-2.3), which corresponds to 2 points. - **Ascites**: 1: None 2: Mild (responding to diuretics) 3: Se vere (troublesome, requiring TIPS, etc.) The note says, \"There was no evidence of ascites.\" That means no asc ites. Therefore it\u2019s 1 point. - **Hepatic Encephalopathy**: 1: None 2: Mild (confusion with recovery between episodes) 3: Moderate or severe (persistent confusion, etc.) The patient has \"slight mental slowness and mild asterixis.\" Asterix is (flapping tremor) suggests some impairment, typically linked to hep atic encephalopathy. The question is how severe. The note says \"mild asterixis\" and \"slight mental slowness.\" So that might be considered mild encephalopathy. Thus, it would likely correspond to 2 points for mild hepatic en cephalopathy. Now let me list each parameter and their points: 1. Bilir ubin: 2.0 mg/dL \u2192 2 points ( because the range for 2.0 is within 2-3 mg /dL \u2192 score 2. 2. Albumin: 3 .2 \u2192 between 2.8-3.4 \u2192 2 points 3. INR: 1.9 \u2192 falls in the 1.7-2.3 \u2192 2 points 4. Ascites: none \u2192 1 point 5. Encephalopathy : mild \u2192 2 points Adding them up: 2+2 +2 +1 +2 = 9. Now let's determine the Child-Pugh class from the total score: - A total score of 5-6 corresponds to Class A. - 7-9 corresponds to Class B. - 10 - 15 corresponds to Class C.", "Ground Truth Answer": "6", "Ground Truth Explanation": "The current child pugh score is 0.\nThe patient's INR is 1.9. Because the INR is between 1.7 and 2.3, we add two to the score, making the current total 0 + 2 = 2.\nThe concentration of bilirubin is 2.0 mg/dL. The concentration of albumin is 3.2 g/dL. Because the Albumin concentration is between 2.8 g/dL and 3.5 g/dL, we add 2 to the score, making the current total 2 + 2 = 4.\nEncephalopathy state is 'Grade 1-2 encephalopathy' and so we add two points to the score, making the current total 4 + 2 = 6.\nThe patient's child pugh score is 6.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to figure out the Child-Pugh Score for this patient. Let me recall what the Child-Pugh score entails. It's used to assess liver function in people with cirrhosis, right ? The Child-Pugh score includes five factors: \n\n1. Total Bilir ubin \n2. Serum Albumin \n3. Prothrombin Time (INR) \n4. Ascites \n5. Hepatic Encephalopathy \n\nEach of these factors is assigned points from 1 to 3, and the total score determines the class (A, B , or C) of liver disease. Here are the scoring criteria:\n\n- **Total Bilirubin**: 1: <2 mg/dL \n  2: 2-3 mg/dL \n  3: >3 mg /dL \n\n- **Albumin**: 1: \u22653.5 g/dL \n  2: 2.8-3. 4 \n  3: <2.8 \n\nWait, the patient 's albumin is 3.2. So that would be 2 points since it falls in the range: 2.8-3. 4? Wait, wait, the cutoff for albumin's second category is 2.8-3.4? Or maybe 3.5 to 2.8.\n\n- **Prothrombin Time (IN R)**: 1: <1.7 \n  2: 1.7-2.3 \n  3: >2 .3 \n\nThe patient\u2019s INR is 1.9, so that falls into the second category (1.7-2.3), which corresponds to 2 points. - **Ascites**: 1: None \n  2: Mild (responding to diuretics) \n  3: Se vere (troublesome, requiring TIPS, etc.) \n\nThe note says, \"There was no evidence of ascites.\" That means no asc ites. Therefore it\u2019s 1 point. - **Hepatic Encephalopathy**: 1: None 2: Mild (confusion with recovery between episodes) 3: Moderate or severe (persistent confusion, etc.)\n\nThe patient has \"slight mental slowness and mild asterixis.\" Asterix is (flapping tremor) suggests some impairment, typically linked to hep atic encephalopathy. The question is how severe. The note says \"mild asterixis\" and \"slight mental slowness.\" So that might be considered mild encephalopathy. Thus, it would likely correspond to 2 points for mild hepatic en cephalopathy. Now let me list each parameter and their points:\n\n1. Bilir ubin: 2.0 mg/dL \u2192 2 points ( because the range for 2.0 is within 2-3 mg /dL \u2192 score 2. \n\n2. Albumin: 3 .2 \u2192 between 2.8-3.4 \u2192 2 points\n\n3. INR: 1.9 \u2192 falls in the 1.7-2.3 \u2192 2 points \n\n4. Ascites: none \u2192 1 point \n\n5. Encephalopathy : mild \u2192 2 points \n\nAdding them up: 2+2 +2 +1 +2 = 9.\n\nNow let's determine the Child-Pugh class from the total score: \n\n- A total score of 5-6 corresponds to Class A. \n- 7-9 corresponds to Class B. \n- 10 - 15 corresponds to Class C."}
{"Row Number": 97, "Calculator Name": "Body Mass Index (BMI)", "Calculator ID": "6", "Category": "physical", "Note ID": "pmc-7021465-1", "Patient Note": "The subject was a 14-year-old female patient with EDS hypermobile type. She had perceived her recurrent shoulder dislocation from childhood. She complained of shoulder pain and restriction of activity in daily life (ADL) during shoulder movement due to shoulder instability. There was no abnormal finding from radiological examination. There were no psychiatric diseases. She could dislocate her bilateral shoulder joint voluntarily. Her chief complaint was the bilateral shoulder discomfort and instability during writing motion. On her first examination by a doctor, she was treated conservatively, using the exercise program for 6 months []. On her second examination by a doctor at another hospital, she was also treated conservatively, adding an orthosis for MDI to the exercise program (intervention A) []. The patient received an explanation about this report and provided informed consent that complied with the Declaration of Helsinki.\nThe patient had a slight build with a height of 156 cm and weight of 44 kg. To evaluate her bilateral shoulder function, her active range of motion (ROM) (), sulcus sign, and shoulder instability in each direction were measured on the time point at the beginning of intervention A. Her passive ROM was not able to be measured because her humeral head was dislocated so easily with passive ROM exercise. Muscle strength was also difficult to measure due to dislocation with ease. Although her humeral head dislocated many times during rehabilitation, the doctor allowed her rehabilitation because there was no increase of persistent pain and she could centralize her humeral head voluntarily. The modified Rowe score was measured to evaluate shoulder instability [] ().\nEDS patients usually suffer from many musculoskeletal symptoms, even when they grow up []. On the other hand, it has been demonstrated that patients who have shoulder MDI will recover shoulder function during movement after rehabilitation programs [, ]. However, the prognosis of this patient was challenging because patients with EDS were excluded from the rehabilitation programs.\nThe AB design includes some measurement of outcome variables throughout a baseline control/comparison phase A and then throughout another intervention phase B []. In the early part of rehabilitation, the patient was provided with an exercise program for MDI with orthosis [] (intervention A). The term was continued for 3 months. In summary, she performed shoulder isometric muscle exercises using the TheraBand (Hygenic, Akron, Ohio) for the rotator muscles and scapula stabilizers with supervision by a physical therapist. The program includes five exercises: resistance exercises of shoulder abduction, internal rotation, external rotation, extension, and flexion. Assistance from a physical therapist to stabilize the humeral head was often needed so as not to dislocate it. The resistance during exercise was gradually increased according to her performance regarding shoulder dislocation. A physical therapy session was provided one to two times a week. Each session was 40 minutes. Compliance of home exercises was no more than about twice a week.\nIn the latter part of rehabilitation, the patient was instructed to perform the Watson program for MDI [, , ] (intervention B). The Watson program is an exercise program that aims for coordination of scapular muscles with strengthening rotator cuff and deltoid muscle. This phase also lasted for 3 months. In summary, this program consists of six stages that focus on retraining specific scapular control before any deltoid and rotator cuff exercise. The patient should make progress with exercise into functional and sport-specific ranges. She also received a physical therapy session one to two times a week. Each session was 40 minutes. In the first stage, correction of her humeral head by a physical therapist was effective during shoulder movement. The scapular control exercise was performed with assistance. She could make progress to stage 2 within 1 month. She could finally perform stage 5 exercises after 2 more months of rehabilitation. Compliance of home exercises was more than 3 days a week.\nThe intervention was performed from July 2017 to January 2018. The patient was followed up until July 2018. The active ROM increased, while the passive ROM was not increased, due to easy dislocation (). The sulcus sign was still positive after intervention and at the time point of the final evaluation. The shoulder instability score was improved after intervention B (). She felt no pain and discomfort during writing motion after the time point. She could also control both humeral heads within proper position during ADL. A fair outcome was achieved by the final evaluation.", "Question": "What is the patient's body mass mass index (BMI)? Your answer should be in terms of kg/m\u00b2.", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "18.1", "LLM Explanation": "To calculate the patient's BMI, we use the formula: BMI = weight (kg) / (height (m))^2. The patient's weight is 44 kg and her height is 156 cm. First, convert the height from cm to meters: 156 cm = 1.56 m. Next, we calculate the square of the height: (1.56 m)^2 = 2.4336 m^2. Now, we divide the weight by the squared height: 44 kg / 2.4336 m^2 \u2248 18.1. Therefore, the patient's BMI is approximately 18.1 kg/m\u00b2.", "LLM Thinking": "First, we need to calculate the BMI using the formula: BMI = weight (kg) / (height (m))^2 The patient's weight is given as 44 kg, and her height is 15 6 cm. We need to convert the height from cm to meters. Since 1 meter = 100 cm, 156 cm = 156 / 100 = 1. 56 m. Now we can plug in the weight and height into the BMI formula: Weight = 44 kg, Height = 1. 56 m. BMI = (44 kg) / (1. 56 m)^2. First, calculate the square of the height : 1.56 * 1.56 = 2 .4336 m^2. Now, divide weight by this squared height to get the BMI: 44 kg / 2. 4336 m^2.", "Ground Truth Answer": "18.08", "Ground Truth Explanation": "The formula for computing the patient's BMI is (weight)/(height * height), where weight is the patient's weight in kg and height is the patient's height in m.\nThe patient's height is 156.0 cm, which is 156.0 cm * 1 m / 100 cm = 1.56 m. The patient's weight is 44.0 kg. The patient's bmi is therefore 44.0 kg / (1.56 m * 1.56 m) = 18.08 kg/m^2.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the BMI using the formula:\n\nBMI = weight (kg) / (height (m))^2\n\nThe patient's weight is given as 44 kg, and her height is 15 6 cm. We need to convert the height from cm to meters. Since 1 meter = 100 cm, 156 cm = 156 / 100 = 1. 56 m.\n\nNow we can plug in the weight and height into the BMI formula:\n\nWeight = 44 kg,\nHeight = 1. 56 m.\n\nBMI = (44 kg) / (1. 56 m)^2.\n\nFirst, calculate the square of the height : 1.56 * 1.56 = 2 .4336 m^2.\n\nNow, divide weight by this squared height to get the BMI: 44 kg / 2. 4336 m^2."}
{"Row Number": 79, "Calculator Name": "Mean Arterial Pressure (MAP)", "Calculator ID": "5", "Category": "physical", "Note ID": "trec-ct-2021-46", "Patient Note": "Patient A is a 30-year-old male who was admitted to the hospital after 10 days of cough, profuse nocturnal sweating and loss of appetite. He had traveled to India 1 months ago and has not any positive history of TB vaccination. He is a previously healthy man, working as an engineer in a high tech company. He doesn't smoke o use any illicit drugs. He was febrile (38 c) with heart rate of 115 b/min, respiratory rate of 22, BP of 125/75 mmHg and O2 sat of 97%. Chest X-ray showed infiltrate in the middle of left lung with diameter of 1.8 cm with signs of cavitation. The sputum smear revealed positive sputum culture for Mycobacterium tuberculosis which are sensitive of the first-line TB drugs (isoniazid, streptomycin, rifampicin and ethambutol). Lab study is reported bellow:\nHgb: 13 g/dl\nWBC: 14000 /mm3\nPlt: 300000 /ml\nAST: 13 U/L\nALT: 15 U/L\nAlk P: 53 U/L\nBill total: 0.6 mg/dl\nNa: 137 mEq/l\nK: 4 mEq/l\nCreatinine: 0.5 mg/dl\nBUN: 10 mg/dl\nESR: 120 mm/hr", "Question": "What is patient's mean arterial pressure in mm Hg?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "91.67", "LLM Explanation": "To calculate the mean arterial pressure (MAP), we use the formula: MAP = (Systolic BP + 2 * Diastolic BP) / 3. From the patient note, the blood pressure is given as 125/75 mmHg. Here, the systolic blood pressure (SBP) is 125 mmHg and the diastolic blood pressure (DBP) is 75 mmHg. Plugging these values into the formula gives us: MAP = (125 + 2 * 75) / 3. First, calculate 2 * 75, which equals 150. Then add this to the systolic blood pressure: 125 + 150 = 275. Finally, divide 275 by 3 to get the MAP: 275 / 3 = 91.67 mmHg.", "LLM Thinking": "First, we need to calculate the mean arterial pressure (MAP) from the given systolic and diastolic blood pressure values. The formula to calculate the mean arterial pressure is typically: \\[ \\text{ MAP} = \\frac{\\text{(Systolic BP + 2 x Diastolic BP)}}{3}.\\] From the patient note , the blood pressure (BP) is reported as 125/ 75 mmHg. Here, the systolic blood pressure (SB P) is 125 mmHg, and the diast olic blood pressure (DBP) is 75 mmHg. Plugging the numbers into the formula: SBP = 1 25, DBP = 75. Calculations: First, multiply the diastolic blood pressure by 2: \\[ 2 \\ times 75 = 150.\\] Next, add this value to the systolic blood pressure: \\[ 125 + 150 = 275.\\] Now, divide this sum by 3: \\[ \\text{MAP} = \\frac{ 275}{3 } = 91.67.\\]", "Ground Truth Answer": "91.667", "Ground Truth Explanation": "The mean average pressure is computed by the formula 2/3 * (diastolic blood pressure) + 1/3 * (systolic blood pressure). Plugging in the values, we get 2/3 * 75.0 mm Hg + 1/3 * 125.0 mm Hg = 91.667 mm Hg.\nHence, the patient's mean arterial pressure is 91.667 mm Hg.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the mean arterial pressure (MAP) from the given systolic and diastolic blood pressure values. The formula to calculate the mean arterial pressure is typically:\n\n\\[ \\text{ MAP} = \\frac{\\text{(Systolic BP + 2 x Diastolic BP)}}{3}.\\]\n\nFrom the patient note , the blood pressure (BP) is reported as 125/ 75 mmHg. Here, the systolic blood pressure (SB P) is 125 mmHg, and the diast olic blood pressure (DBP) is 75 mmHg. Plugging the numbers into the formula: \n\nSBP = 1 25, DBP = 75.\n\nCalculations:\n\nFirst, multiply the diastolic blood pressure by 2:\n\n\\[ 2 \\ times 75 = 150.\\]\n\nNext, add this value to the systolic blood pressure:\n\n\\[ 125 + 150 = 275.\\]\n\nNow, divide this sum by 3:\n\n\\[ \\text{MAP} = \\frac{ 275}{3 } = 91.67.\\]"}
{"Row Number": 701, "Calculator Name": "Body Surface Area Calculator", "Calculator ID": "60", "Category": "physical", "Note ID": "pmc-8524955-1", "Patient Note": "A 172-cm tall, 18-year-old man, weight 100 kg, was admitted to our department in January 2020 due to left medial deep ankle pain after stamping the clutch about 10 days ago, who had an extreme liking of seafood, beer and carbonated drinks. During the physical examination, medial ankle tenderness and mild swelling were present, with a VAS score of 6 or 7, but the range of ankle motion was normal. Ankle X-rays, computerized tomography (CT) and magnetic resonance imaging (MRI) scans were conducted and a medial talus osteochondral lesion with subchondral cyst formation was detected (Fig. ). Various laboratory tests detected high levels of uric acid (568 \u00b5mol/L), anti-streptolysin O (130.10 IU/mL), procalcitonin (0.28 ng/mL) and a high level of serum C-reactive protein (39.50 mg/L). The patient\u2019s erythrocyte sedimentation rate, blood cell counts, and other biochemical indexes were all within the normal range. He was primarily diagnosed with a Hepple stage V type talus osteochondral lesion, but the etiology was not clear. An ankle arthroscopy was conducted, and we found a few gouty tophus deposits in the talus articular cartilage and synovial tissue. The medial, central talus articular cartilage was soft, uneven and partially defective, with gouty tophus deposits. A 1.5-mm K-wire was drilled into this site to confirm the talus lesion site under C-arm fluoroscopy. A medial curved incision was made on the medial malleolus and the talus osteochondral lesion was exposed after inverted V-shaped medial malleolus osteotomy and removed with trephine; the removed lesions were found to be gouty tophus (Fig. ), which was further confirmed by the finding of monosodium urate monohydrate (MSU) crystals in postoperative histological sections (Fig. ). After complete debridement of these lesions, the lesion site was not a regular shape, and a very small amount of normal osteochondral tissue was cut with a small osteotome to form a square lesion site. Then an osteochondral block of the same size was harvested from the autologous talus neck and grafted onto the site and fixed with two 2.0 mm bioabsorbable screws. The donor site was filled and tamped with the cancellous bone on the osteotomy surface of the medial malleolus. Then the medial malleolus was fixed with three cannulated screws after reduction. Aceclofenac dispersible tablets and allopurinol were taken by the patient immediately after the operation and he was advised to use his left ankle passively, with no weight-bearing for 5 weeks. At this time his serum uric acid concentration was in the normal range and a good medial malleolus union was revealed by X-ray imaging. Partial weight-bearing was encouraged 2 months postoperatively when the cyst talus osteochondral lesion had disappeared and was replaced with normal bone tissue 6 months postoperatively. The patient could walk with slight pain at this time with a VAS score of 1 and was very satisfied with the outcome. Regular monitoring of serum uric acid concentrations and his modified diet continued, and he has been followed up for 12 months.", "Question": "What is the patient's body surface area? Please output your answer in terms of m\u00b2.", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "2.19", "LLM Explanation": "To calculate the body surface area (BSA), I will use the Mosteller formula: BSA (m^2) = sqrt[(height (cm) * weight (kg)) / 3600]. The patient's height is 172 cm and weight is 100 kg. First, I calculate the product of height and weight: 172 * 100 = 17200. Next, I divide this product by 3600: 17200 / 3600 \u2248 4.7778. Finally, I take the square root of 4.7778, which gives approximately sqrt(4.7778) \u2248 2.186. Rounding this to two decimal places, the BSA is approximately 2.19 m\u00b2.", "LLM Thinking": "First, we need to calculate the body surface area (BSA) for the patient. The common formula used for calculating body surface area is the Mosteller formula: \\[ \\text{BSA (m^2)} = \\sqrt {\\frac{\\text{(height (cm) \\times weight (kg)) }}{3600}} \\] The patient's height is 172 cm and weight is 100 kg. Let \u2019s use these values in the Mosteller formula. Calculating the product of height and weight: 172 cm \u00d7 100 kg = 17,200. Then divide that by 3600: 17,2 00 / 3600 \u2248 4.77 78. Next, we take the square root of 4.7 778.", "Ground Truth Answer": "2.186", "Ground Truth Explanation": "For the body surface area computation, the formula is sqrt((weight (in kgs) * height (in cm))/3600, where the units of weight is in kg and the units of height is in cm.\nThe patient's height is 172.0 cm. \nThe patient's weight is 100.0 kg. \nTherefore, the patient's bsa is sqrt((100.0 (in kgs) * 172.0 (in cm))/3600) = 2.186 m^2.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the body surface area (BSA) for the patient.  \nThe common formula used for calculating body surface area is the Mosteller formula: \\[ \\text{BSA (m^2)} = \\sqrt {\\frac{\\text{(height (cm) \\times weight (kg)) }}{3600}} \\]\n\nThe patient's height is 172 cm and weight is 100 kg. Let \u2019s use these values in the Mosteller formula.  \nCalculating the product of height and weight: 172 cm \u00d7 100 kg = 17,200. Then divide that by 3600: 17,2 00 / 3600 \u2248 4.77 78.  \n\nNext, we take the square root of 4.7 778."}
{"Row Number": 137, "Calculator Name": "Wells' Criteria for Pulmonary Embolism", "Calculator ID": "8", "Category": "risk", "Note ID": "pmc-6020350-1", "Patient Note": "A 43-year old, asymptomatic woman was admitted to our hospital by her family doctor after receiving a chest-x-ray during routine clinical examination. The x-ray showed a mediastinal mass overlapping the aortic arch region (Fig. ). For verification a computed tomography (CT) was performed and revealed incidentally a type B dissection, which was most likely chronic without information of the index date, originating from an aneurysm of a left cervical arch with a maximum diameter of 6 cm (Fig. ). The left renal artery, the coeliac trunc and the main part of the superior mesenteric artery branched from the false lumen without a sign of malperfusion of the organs. Because of the huge diameter and the potential risk of rupture, an urgent surgical repair was planned. Before intervention the patient got a blood pressure adjustment by ACE inhibitor. Betablocker was not necessary because of a resting pulse under 60 beats per minute. For neurological online monitoring, sensitive and motor evoked potentials were monitored. Spinal drainage was installed 1 day before the procedure. Surgical access was carried out through median sternotomy and an additional left lateral thoracic incision through the fourth intercostal space (Hemi-Clemshell). Simultaneously to the preparation of the aneurysm, partial cardiopulmonary bypass was installed in the left groin by cannulation of the femoral artery and vein under echocardiographic guidance. During selective ventilation of the right side, the left lung was mobilized by transsection of the Ligamentum pulmonale and preparation of the perianeurysmatic tissue and adhesions. After identification and preparation of the recurrent and phrenic nerve and the supraaortal branches, the descending aorta was clamped and a distal anastomosis performed with a straight graft (20 mm). The visceral arteries partially branched from the false and true lumen without a sign of malperfusion. Before the final distal anastomosis, we performed a fenestration of the dissection membrane about a length of 5 cm to keep the perfusion of both lumina. The left carotid artery originated from the aortic arch with a distance of only 1 cm from the aneurysm. The left axillary artery branched directly from the aneurysm and was dissected and reimplanted with a separate 8 mm sidegraft to the 20 mm straight graft between the distal arch and proximal descending aorta. (Fig. ). The procedure was performed with partial cardiopulmonary bypass (CPB) of 87 min, aortic clamp time of 62 min under normothermic condition. The patient was extubated on first postoperative day and recovered well.\nBiopsy of aortic tissue showed a picture consistent with arteriosclerosis and loss of smooth muscle cells, rupture of the elastic fibres and fibrosis of the media. The intima could not be visualized in detail.\nThe patient was discharged to cardiac rehabilitation at 13th postoperative day and recovered well. Last follow up with computed tomography was performed 3, 5 years after initial operation with a good and stable result of the dissection membrane and a perfusion of both lumina. The patient is able to resume a normal life without limitations.", "Question": "What is the patient\u2019s score of Wells' criteria for Pulmonary Embolism?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "0.5", "LLM Explanation": "To calculate the Wells' criteria score for Pulmonary Embolism based on the given patient note, I will evaluate each criterion and assign points accordingly. Here's the breakdown: 1. Clinical signs suggestive of DVT (swelling of the leg, pain on palpation of the calf, increased circumference of the leg): No such signs are mentioned. Score = 0 points. 2. Recent surgery or trauma with immobilization: The note mentions surgery but refers to the procedure performed after the diagnosis, not a recent surgery or trauma before the admission. Score = 0 points. 3. Active cancer (treatment within the last 6 months or palliative): No mention of cancer. Score = 0 points. 4. Paralysis or immobilization for over 3 days: No information on this. Since the patient is described as asymptomatic and admitted due to a chest x-ray finding, it doesn't seem she was immobilized before admission. Score = 0 points. 5. Previous DVT or PE: No history of DVT or PE is mentioned. Score = 0 points. 6. Hemoptysis: No mention of hemoptysis. Score = 0 points. 7. Pulsatile or unilateral leg swelling: No such symptoms are described. Score = 0 points. 8. Alternative diagnosis as likely or more likely than PE: The patient has a known aortic dissection, which is a much more likely diagnosis than PE given the context. This criterion applies, and it scores 0.5 points. Adding up the points from the applicable criteria: - Item 8: 0.5 points Thus, the total Wells' criteria score is 0.5 points.", "LLM Thinking": "Okay, let me try to figure this out. The user is asking for the Wells' criteria score for Pulmonary Embolism based on the given patient note. Let's review the Wells' criteria for Pulmonary Emb olism: The Wells\u2019 criteria include the following risk factors: 1. Clinical signs suggestive of DVT (e.g., swelling of the leg, pain on palpation of the calf, increased circumference of the leg) 2. Recent surgery or trauma with immobilization 3. Active cancer (treatment within the last 6 months or palliative) 4. Paralysis or immobilization for over 3 days 5. Previous DVT or PE 6. Hemoptysis 7. Pulsatile or unilateral leg swelling 8. Alternative diagnosis as likely or more than PE Scores are assigned as follows: - 3 points for each of the first five items (1-5) - 1.5 points for items 6 and 7 - 0.5 points for item 8. The total score classifies the patient into high, moderate, or low risk for PE. Now, let's assess each criterion based on the given patient note. The patient note describes a 43-year-old asymptomatic woman admitted due to a chest x-ray that showed a mediastinal mass , leading to a CT that found a type B aortic dissection. The patient was asymptomatic, so there are no symptoms like shortness of breath, chest pain, hemoptysis or clinical signs suggestive of DVT . The note mentions she had surgery (the aortic repair), but the Wells ' criteria are applied before surgery to estimate the preoperative probability of a PE , which the question is asking about. However, the patient's scenario is about aortic dissection, not PE , so none of the Wells criteria factors seem to be present here. Looking at each item: 1. Clinical signs of DVT: The patient is described as asymptomatic, with no mention of leg swelling, calf pain or anything like it. 2. Recent surgery or trauma with immobilization: While she had surgery, the Wells criteria would consider this before the current procedure. It doesn't mention any recent (pre-admission) surgery or immobilization . 3. Active cancer: There's no mention of active cancer. 4. Paralysis or immobilization for over 3 days: No info on that. She was admitted but asymptomatic, so maybe not immobil ized before admission unless that's implied by her clinical course. However, she was asymptomatic so likely not bedridden before admission. 5. Previous DVT or PE: The note doesn't mention any prior history of DVT or PE. It also says nothing about: hemoptysis (item 6), pulsatile swelling (7), or whether another diagnosis is more likely (item 8). The patient's condition is an aortic dissection, which is the primary issue, so item 8 might apply here because the presentation (mediast inal mass) is more likely than PE. But item 8 is whether the alternative diagnosis is more likely than PE. In this case, the alternative diagnosis, aortic dissection, is indeed more likely, so that would contribute 0.5 points. However, the Wells criteria are used when PE is considered as a possible diagnosis , not when it\u2019s already ruled out in favor of another diagnosis like this one. Considering all of this, the task seems to be incorrectly applied since the Wells' criteria are used to assess the clinical probability of PE, and in this case, the patient has a known aortic dissection. However, strictly following the criteria, the only possible point might be item 8 (alternative diagnosis more likely), which gives 0.5 points . But even this is questionable since the suspicion for PE was likely not the primary concern here. But wait, the Wells criteria also have some points for other factors. They are not described in the note such as: - Signs or symptoms of DVT (item 1) \u2013 no. - Surgery/immobil ization within 4 weeks (item 2) \u2013 no recent immobilization before the admission except the surgery, but that's the current procedure. - The key point is that the Wells' criteria are used when PE is considered, which isn't the case here. However, the question is asking for the score based on the note. Let\u2019s calculate it step by step systematically: - ** Item 1: Clinical signs suggestive of DVT (swelling, pain , increased circumference ) \u2013 0 points (no mention)** - ** Item 2: Surgery or trauma with immobilization in past 4 weeks \u2013 0 points (no mention of such event before admission)** - ** Item 3: Active cancer treatment in past 6 months or pall iative care \u2013 0 points (no mention of cancer)** - ** Item 4: Paralysis or immobilization for more than 3 days \u2013 0 points (no info on this, but she was asymptomatic )** - ** Item 5: Previous PE or DVT \u2013 0 points (not stated)** - ** Item 6: Hem optysis \u2013 0 points ( not mentioned in the note)** - ** Item 7: Pulsatile or unilateral leg swelling \u2013 0 points (no mention in the note)** - ** Item 8: Alternative diagnosis at least as likely \u2013 0.5 points** (since the patient's condition is aortic dissection, which is more likely than PE, so this applies) But in the Wells criteria, if the patient is asymptomatic and the alternative diagnosis is more likely, then yes, that 0.5 is the only point that could apply in the strictest sense. However, the Wells criteria are typically used in cases where PE is being considered , which isn't the case here. But the question is asking for the score based on the note's information, so we have to go with what we have.", "Ground Truth Answer": "1.5", "Ground Truth Explanation": "The Well's score for pulmonary embolism is currently 0.\nClinical signs and symptoms of DVT are repoted to be absent and so the total score remains unchanged, keeping the total score at 0. Pulmonary Embolism is not reported to be the #1 diagnosis and so the total score remains unchanged, keeping the total score at 0.\nThe patient's heart rate is 60.0 beats per minute. The heart rate is less than 100 bpm, and so the score remains unchanged, keeping the total score at 0.\nBecause the patient did not have an immobilization for at least 3 days but the patient had a surgery in the past 4 weeks, the score increases to 0 + 1.5 = 1.5.\nThe report does not give an indication on if the patient has previously had pulmonary embolism diagnosed and so we assume this to be false.The report does not give an indication on if the patient has previously been diagnosed with deep vein thrombosis and so we assume this to be false.Because the patient has no previous diagnosis of pulmonary embolism (PE) or deep vein thrombosis (DVT), the score remains at 1.5.\nHemoptysis is reported to be absent and so the total score remains unchanged, keeping the total score at 1.5.\nMalignany with treatment within 6 months or palliative is reported to be absent and so the total score remains unchanged, keeping the total score at 1.5.\nThe patient's Well's score for pulmonary embolism is 1.5.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, let me try to figure this out. The user is asking for the Wells' criteria score for Pulmonary Embolism based on the given patient note. Let's review the Wells' criteria for Pulmonary Emb olism:\n\nThe Wells\u2019 criteria include the following risk factors:\n\n1. Clinical signs suggestive of DVT (e.g., swelling of the leg, pain on palpation of the calf, increased circumference of the leg)\n2. Recent surgery or trauma with immobilization\n3. Active cancer (treatment within the last 6 months or palliative)\n4. Paralysis or immobilization for over 3 days\n5. Previous DVT or PE \n6. Hemoptysis\n7. Pulsatile or unilateral leg swelling\n8. Alternative diagnosis as likely or more than PE\n\nScores are assigned as follows:\n- 3 points for each of the first five items (1-5)\n- 1.5 points for items 6 and 7\n- 0.5 points for item 8. The total score classifies the patient into high, moderate, or low risk for PE.\n\nNow, let's assess each criterion based on the given patient note.\n\nThe patient note describes a 43-year-old asymptomatic woman admitted due to a chest x-ray that showed a mediastinal mass , leading to a CT that found a type B aortic dissection. The patient was asymptomatic, so there are no symptoms like shortness of breath, chest pain, hemoptysis or clinical signs suggestive of DVT . The note mentions she had surgery (the aortic repair), but the Wells ' criteria are applied before surgery to estimate the preoperative probability of a PE , which the question is asking about. However, the patient's scenario is about aortic dissection, not PE , so none of the Wells criteria factors seem to be present here.\n\nLooking at each item:\n\n1. Clinical signs of DVT: The patient is described as asymptomatic, with no mention of leg swelling, calf pain or anything like it.  \n2. Recent surgery or trauma with immobilization: While she had surgery, the Wells criteria would consider this before the current procedure. It doesn't mention any recent (pre-admission) surgery or immobilization .  \n3. Active cancer: There's no mention of active cancer.  \n4. Paralysis or immobilization for over 3 days: No info on that. She was admitted but asymptomatic, so maybe not immobil ized before admission unless that's implied by her clinical course. However, she was asymptomatic so likely not bedridden before admission.  \n5. Previous DVT or PE: The note doesn't mention any prior history of DVT or PE.  \n\nIt also says nothing about: hemoptysis (item 6), pulsatile swelling (7), or whether another diagnosis is more likely (item 8). The patient's condition is an aortic dissection, which is the primary issue, so item 8 might apply here because the presentation (mediast inal mass) is more likely than PE. But item 8 is whether the alternative diagnosis is more likely than PE. In this case, the alternative diagnosis, aortic dissection, is indeed more likely, so that would contribute 0.5 points. However, the Wells criteria are used when PE is considered as a possible diagnosis , not when it\u2019s already ruled out in favor of another diagnosis like this one.\n\nConsidering all of this, the task seems to be incorrectly applied since the Wells' criteria are used to assess the clinical probability of PE, and in this case, the patient has a known aortic dissection. However, strictly following the criteria, the only possible point might be item 8 (alternative diagnosis more likely), which gives 0.5 points . But even this is questionable since the suspicion for PE was likely not the primary concern here.\n\nBut wait, the Wells criteria also have some points for other factors. They are not described in the note such as:\n\n- Signs or symptoms of DVT (item 1) \u2013 no.  \n- Surgery/immobil ization within 4 weeks (item 2) \u2013 no recent immobilization before the admission except the surgery, but that's the current procedure.  \n- The key point is that the Wells' criteria are used when PE is considered, which isn't the case here. However, the question is asking for the score based on the note.\n\nLet\u2019s calculate it step by step systematically:\n\n- ** Item 1: Clinical signs suggestive of DVT (swelling, pain , increased circumference ) \u2013 0 points (no mention)**  \n- ** Item 2: Surgery or trauma with immobilization in past 4 weeks \u2013 0 points (no mention of such event before admission)**  \n- ** Item 3: Active cancer treatment in past 6 months or pall iative care \u2013 0 points (no mention of cancer)**  \n- ** Item 4: Paralysis or immobilization for more than 3 days \u2013 0 points (no info on this, but she was asymptomatic )**  \n- ** Item 5: Previous PE or DVT \u2013 0 points (not stated)**  \n- ** Item 6: Hem optysis \u2013 0 points ( not mentioned in the note)**  \n- ** Item 7: Pulsatile or unilateral leg swelling \u2013 0 points (no mention in the note)**  \n- ** Item 8: Alternative diagnosis at least as likely \u2013 0.5 points** (since the patient's condition is aortic dissection, which is more likely than PE, so this applies)  \n\nBut in the Wells criteria, if the patient is asymptomatic and the alternative diagnosis is more likely, then yes, that 0.5 is the only point that could apply in the strictest sense. However, the Wells criteria are typically used in cases where PE is being considered , which isn't the case here. But the question is asking for the score based on the note's information, so we have to go with what we have."}
{"Row Number": 209, "Calculator Name": "Child-Pugh Score for Cirrhosis Mortality", "Calculator ID": "15", "Category": "severity", "Note ID": "11", "Patient Note": "The patient is a 59-year-old male with a known history of cirrhosis due to chronic Hepatitis B infection. Upon clinical examination, he has jaundice and his abdomen is moderately distended with a noticeable fluid wave on palpation, indicating moderate ascites. He has been experiencing episodes of short-term memory loss and confusion, consistent with grade 1-2 hepatic encephalopathy. His laboratory results reflected impaired coagulation status given INR of 1.9. Overall liver function tests showed albumin level of 2.8 g/dL and total bilirubin 2.5 mg/dL. His hemoglobin level was 12.3 g/dL, and other routine biochemical parameters were within acceptable range. His medication list includes diuretics, lactulose, and antiviral agents for ongoing Hepatitis B infection. The patient and his family have been advised to monitor his cognitive function at home and relay any further deterioration.", "Question": "What is the patient's Child-Pugh Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "9", "LLM Explanation": "No Explanation", "LLM Thinking": "To calculate the Child-Pugh Score for this patient, we need to evaluate five different parameters: albumin, total bilirubin, proth rombin time (INR), ascites, and encephalopathy . Each parameter is assigned points based on their severity. First, let's look at the albumin level. The patient's albumin level is 2.8 g/dL. According to the Child-Pugh criteria, albumin between 2.8 -3.4 g/dL corresponds to 1 point. Next, the total bilirubin is 2.5 mg /dL. The criteria state that bilirubin levels between 2.0- 3.0 mg/dL are assigned 2 points. The prothrombin time (INR) is 1.9 , which falls into the range of 1.2-1.7 , which gives 2 points. For the ascites component, the given information indicates \"moderate ascites ,\" which corresponds to grade 2 (moderate ascites requiring paracent esis or diuretics), giving 2 points. Finally, the patient shows grade 1-2 hepatic encephal opathy , which translates to mild (grade 1 or 2) confusion , so that's 1 point. Adding all these points: 1 (albumin) + 2 ( bilirubin) + 2 (INR) + 2 (ascites) + 1 (encephalopathy).", "Ground Truth Answer": "9", "Ground Truth Explanation": "The current child pugh score is 0.\nThe patient's INR is 1.9. Because the INR is between 1.7 and 2.3, we add two to the score, making the current total 0 + 2 = 2.\nThe concentration of bilirubin is 2.5 mg/dL. Because the Bilirubin concentration is between 2 mg/dL and 3 mg/dL, we add 2 to the score, making the current total 2 + 2 = 4.\nThe concentration of albumin is 2.8 g/dL. Because the Albumin concentration is less than 2.8 g/dL, we add 3 to the score, making the current total 4 + 3 = 7.\nEncephalopathy state is 'Grade 1-2 encephalopathy' and so we add two points to the score, making the current total 7 + 2 = 9.\nThe patient's child pugh score is 9.", "Result": "Correct", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the Child-Pugh Score for this patient, we need to evaluate five different parameters: albumin, total bilirubin, proth rombin time (INR), ascites, and encephalopathy . Each parameter is assigned points based on their severity. First, let's look at the albumin level. The patient's albumin level is 2.8 g/dL. According to the Child-Pugh criteria, albumin between 2.8 -3.4 g/dL corresponds to 1 point. Next, the total bilirubin is 2.5 mg /dL. The criteria state that bilirubin levels between 2.0- 3.0 mg/dL are assigned 2 points. The prothrombin time (INR) is 1.9 , which falls into the range of 1.2-1.7 , which gives 2 points. For the ascites component, the given information indicates \"moderate ascites ,\" which corresponds to grade 2 (moderate ascites requiring paracent esis or diuretics), giving 2 points. Finally, the patient shows grade 1-2 hepatic encephal opathy , which translates to mild (grade 1 or 2) confusion , so that's 1 point. Adding all these points: 1 (albumin) + 2 ( bilirubin) + 2 (INR) + 2 (ascites) + 1 (encephalopathy)."}
{"Row Number": 558, "Calculator Name": "Framingham Risk Score for Hard Coronary Heart Disease", "Calculator ID": "46", "Category": "lab", "Note ID": "usmle-1128", "Patient Note": "A 67-year-old woman comes to the physician with a 4-month history of chest pain that occurs on exertion. The pain is dull, and she experiences retrosternal pressure when she walks up the stairs to her apartment on the fifth floor. The pain disappears shortly after stopping for one minute. She has hypertension, for which she takes lisinopril and metoprolol daily. She does not smoke or drink alcohol. She is 158 cm (5 ft 2 in) tall and weighs 82 kg (180 lb); BMI is 33 kg/m2. Her pulse is 72/min and blood pressure is 140/85 mm Hg. Cardiac examination shows no murmurs, rubs, or gallops. Fasting lipid studies show:\nTotal cholesterol 196 mg/dL\nLDL 110 mg/dL\nHDL 50 mg/dL\nA resting ECG shows no abnormalities. A week after uneventful initiation of aspirin, the patient is started on atorvastatin.", "Question": "What is the patient's Framingham Risk Score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "0.12", "LLM Explanation": "To calculate the patient's Framingham Risk Score, I will use the following information: Age = 67 years, Total Cholesterol = 196 mg/dL, HDL Cholesterol = 50 mg/dL, Systolic Blood Pressure = 140 mm Hg (on medication), Smoking status = No, and Diabetes status = No (not mentioned, so assumed no). I will use the Framingham Risk Score tables for women to find the points for each factor and sum them up.\\n\\n1. **Age (67 years):** For women aged 65-69, the points are 8.\\n2. **Total Cholesterol (196 mg/dL):** Within the range 160-199 mg/dL, the points are 3.\\n3. **HDL Cholesterol (50 mg/dL):** Within the range 50-59 mg/dL, the points are 1.\\n4. **Systolic Blood Pressure (140 mm Hg, on medication):** For systolic BP between 140-159 mm Hg while on treatment, the points are 3.\\n5. **Smoking Status (No):** 0 points.\\n6. **Diabetes (No):** 0 points.\\n\\nNow, sum the points: 8 (Age) + 3 (Total Cholesterol) + 1 (HDL) + 3 (Systolic BP) + 0 (Smoking) + 0 (Diabetes) = 15 points.\\n\\nUsing the Framingham Risk Score table for women, 15 points corresponds to a 10-year risk of approximately 12%.", "LLM Thinking": "Okay, so I need to calculate the patient's Framingham Risk Score. Let me start by recalling what the Framingham Risk Score involves. It is used to estimate the 10-year risk of developing coronary heart disease (CHD) for someone who is currently free of it. The Framingham Risk Score includes several factors such as age, gender, total cholesterol, HDL cholesterol, systolic blood pressure, use of blood pressure medications, smoking status, and diabetes (if any). Since the patient is a woman, I should make sure I'm using the correct scoring system for women, as there are different tables for men and women. The formula can involve looking up specific point values for categories of various risk factors and summing them up to estimate risk in a percentage. However, I will use the provided information to calculate this step by step: Here's the list of variables and their respective values for this patient: 1. **Age:** 67 years old. 2. **Total Cholesterol:** 196 mg/dL 3. **HDL Cholesterol:** 50 mg/dL 4. **Systolic Blood Pressure (SBP):** 140 mm Hg 5. **On BP medication:** Yes (lisinopril and metoprolol) 6. **Smoking status:** No 7. **Diabetes Status:** Not mentioned, so I\u2019ll assume she doesn\u2019t have diabetes unless stated. Let's break it down step by step using the Framingham Risk Score components for women. Let's use the points for each component from the Framingham Risk Score tables (for simplicity in calculation, I'm looking up the points from the standard tables): ### Step-by-Step Calculation **Step 1: Age (67 years)** Looking at the age category for women: For 65-69 years, the points are 8 points (assuming standard tables, but need to confirm exact points). For age 67: - Age 65-69: 8 points (exact value might vary slightly depending on exact age within the range, but standard tables may group by 5-year increments). Let's use 8. **Step 2: Total Cholesterol (196 mg/dL).** For women, the points for total cholesterol are as follows: - 160-199 mg/dL: 3 points (Wait, but 196 is within 160-199, so 3 points? Wait, let me check again. Wait, maybe different ranges.) Let's use the ranges for total cholesterol: - < 160: 0 - 160-199: 3 - 200-239: 6 - 240 or more: 8 Since 196 is within 160-199, the score is 3. **Step 3: HDL Cholesterol (50 mg/dL).** HDL cholesterol points for women are: - 60 or more: 0 points - 50-59: 1 point - 40-49: 2 points - < 40: 3 points. Her HDL is 50, which is in the 50-59 range. So 1 point. **Step 4: Systolic Blood Pressure (140 mm Hg).** For systolic blood pressure, we need to check whether she's on BP medication (because this impacts the score). She takes lisinopril and metoprolol for hypertension. Since she's on blood pressure medication, we use the \u201con treatment\u201d points for systolic BP. For systolic BP on treatment points for women: - < 120: 0 points - 120-129: 1 point - 130-139: 2 points - 140-159: 3 points - \u2265 160: 4 points. Since her SBP is 140, this falls into the 140-159 category. So 3 points. **Step 5: Smoking Status: No.** For non-smokers, the points are 0. **Step 6: Diabetes: Not mentioned, so assume no.** Diabetes adds points (for women, 3 points if present), so since not mentioned, 0. **Now, summing all the points:** Age: 8 points (for 67 years, 65-69 range) Total Cholesterol: 3 points (within 160-199) HDL: 1 point (50) SBP (on meds): 3 points (140 mmHg, 140-159 range, and she is on meds) Smoking: 0 points (Non-smoker) Diabetes: 0 Total points = 8 + 3 + 1 + 3 + 0 + 0 Total points = 15 points Now we need to convert these points into the 10-year risk percentage using the Framingham Risk Score table for women. The conversion table maps total points to estimated 10-year risk of CHD. For a woman with a total score of 15 points: Looking at the Framingham Risk Score table for women: Points | 10-year risk (%) --- | --- 9 | 4% 11 | 6% 13 | 9% 15 | 12% Wait, perhaps I need to recall exact ranges. For approximations: - A total score of around 15 often corresponds roughly to a 10-year risk in certain ranges based on the conversion. Let me think. For example, according to the Framingham tables, a woman with 15 points could correspond to approximately a risk in the range between 10-15% or so. Wait, maybe I need to look up exact points to risk. Alternatively, I can recall that each point adds a certain risk. However, without the exact table, perhaps I can estimate based on the standard tables that 15 points translate to a percentage like this: Looking up standard Framingham Risk Score for women: For example, here's a sample: Points | 10-year risk (%) --- | --- 9 | 4% 11 | 6% 13 | 9% 15 | 12% Alternatively, perhaps the exact value is different. But since common ranges indicate:", "Ground Truth Answer": "0.1", "Ground Truth Explanation": "The patient's gender is Female.\nFor females, the formula for computing the framingham risk score is 31.764001 * ln(age) + 22.465206 * ln(total_cholestrol) - 1.187731 * ln(hdl_cholestrol) + 2.552905 * ln(sys_bp) + 0.420251 * bp_medicine + 13.07543 * smoker + -5.060998 * ln(age) * ln(total_cholestrol) + -2.996945 * ln(age_smoke) * smoker - 146.5933061, where 'bp_medicine' is a binary variable for whether a patient's blood pressure is being treated with medicine, total cholestrol and hdl cholestrol are in mg/dL, and 'smoker' is whether the patient is a smoker or not.\nFrom this, we use the risk score to get likelihood for a patient getting myocardial infraction (MI) or dying in the next 10 years: 1 - 0.9402^exp(risk_score), where risk_score is the value from the formula above.\nThe patient is 67 years old. The patient is not a smoker, making the smoking variable equal to 0.\nThe patient's systolic blood pressure is 140.0 mm Hg.\nThe patient has been specified to take medication for treating their blood pressure, making the bp_medicine variable equal to 1.\nThe concentration of total cholestrol is 196.0 mg/dL. We need to convert the concentration to mmol/L. Let's first convert the mass of total cholestrol from mg to mmol. The mass of total cholestrol is 196.0 mg. To convert 196.0 mg of total cholestrol to g, multiply by the conversion factor 0.001, giving us 196.0 mg total cholestrol * 0.001 g/mg = 0.196 g total cholestrol. To convert from grams of total cholestrol to moles, divide by the molar mass 386.65 g/mol, which will give 0.196 g/(386.65 g total cholestrol/mol) = 0.000507 mol total cholestrol. To convert 0.000507 mol of total cholestrol to mmol, multiply by the conversion factor 1000.0, giving us 0.000507 mol total cholestrol * 1000.0 mmol/mol = 0.507 mmol total cholestrol. The current volume unit is dL and the target volume unit is L. The conversion factor is 0.1 L for every unit of dL. Our next step will be to divide the mass by the volume conversion factor of 0.1 to get the final concentration in terms of mmol/L. This will result to 0.507 mmol total cholestrol/0.1 L = 5.07 mmol total cholestrol/L. The concentration value of 196.0 mg total cholestrol/dL converts to 5.07 mmol total cholestrol/L. \nThe concentration of hdl cholestrol is 50.0 mg/dL. We need to convert the concentration to mmol/L. Let's first convert the mass of hdl cholestrol from mg to mmol. The mass of hdl cholestrol is 50.0 mg. To convert 50.0 mg of hdl cholestrol to g, multiply by the conversion factor 0.001, giving us 50.0 mg hdl cholestrol * 0.001 g/mg = 0.05 g hdl cholestrol. To convert from grams of hdl cholestrol to moles, divide by the molar mass 386.65 g/mol, which will give 0.05 g/(386.65 g hdl cholestrol/mol) = 0.000129 mol hdl cholestrol. To convert 0.000129 mol of hdl cholestrol to mmol, multiply by the conversion factor 1000.0, giving us 0.000129 mol hdl cholestrol * 1000.0 mmol/mol = 0.129 mmol hdl cholestrol. The current volume unit is dL and the target volume unit is L. The conversion factor is 0.1 L for every unit of dL. Our next step will be to divide the mass by the volume conversion factor of 0.1 to get the final concentration in terms of mmol/L. This will result to 0.129 mmol hdl cholestrol/0.1 L = 1.29 mmol hdl cholestrol/L. The concentration value of 50.0 mg hdl cholestrol/dL converts to 1.29 mmol hdl cholestrol/L. \nPlugging in these values will give us the risk score: 31.764001 * ln(67) + 22.465206 * ln(5.07) - 1.187731 * ln(1.29) + 2.552905 * ln(140.0) + 0.420251 * 1 + 13.07543 * 0 + -5.060998 * ln(67) * ln(5.07) + -2.996945 * ln(67) * 0 - 146.5933061 = 1.6.\nPlugging this into the MI risk formula gives us 1 - 0.98767^exp(1.6) = 0.1 %.\nThe patient's percentage of getting MI or dying is 0.1 %.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to calculate the patient's Framingham Risk Score. Let me start by recalling what the Framingham Risk Score involves. It is used to estimate the 10-year risk of developing coronary heart disease (CHD) for someone who is currently free of it.\n\nThe Framingham Risk Score includes several factors such as age, gender, total cholesterol, HDL cholesterol, systolic blood pressure, use of blood pressure medications, smoking status, and diabetes (if any). Since the patient is a woman, I should make sure I'm using the correct scoring system for women, as there are different tables for men and women. The formula can involve looking up specific point values for categories of various risk factors and summing them up to estimate risk in a percentage. However, I will use the provided information to calculate this step by step: Here's the list of variables and their respective values for this patient:\n1. **Age:** 67 years old.\n2. **Total Cholesterol:** 196 mg/dL\n3. **HDL Cholesterol:** 50 mg/dL\n4. **Systolic Blood Pressure (SBP):** 140 mm Hg\n5. **On BP medication:** Yes (lisinopril and metoprolol)\n6. **Smoking status:** No\n7. **Diabetes Status:** Not mentioned, so I\u2019ll assume she doesn\u2019t have diabetes unless stated.\n\nLet's break it down step by step using the Framingham Risk Score components for women. Let's use the points for each component from the Framingham Risk Score tables (for simplicity in calculation, I'm looking up the points from the standard tables):\n\n### Step-by-Step Calculation\n\n**Step 1: Age (67 years)**  \nLooking at the age category for women: For 65-69 years, the points are 8 points (assuming standard tables, but need to confirm exact points). For age 67:  \n- Age 65-69: 8 points (exact value might vary slightly depending on exact age within the range, but standard tables may group by 5-year increments). Let's use 8.\n\n**Step 2: Total Cholesterol (196 mg/dL).**  \nFor women, the points for total cholesterol are as follows:  \n- 160-199 mg/dL: 3 points (Wait, but 196 is within 160-199, so 3 points? Wait, let me check again. Wait, maybe different ranges.)\n\nLet's use the ranges for total cholesterol:  \n- < 160: 0  \n- 160-199: 3  \n- 200-239: 6  \n- 240 or more: 8\n\nSince 196 is within 160-199, the score is 3.\n\n**Step 3: HDL Cholesterol (50 mg/dL).**  \nHDL cholesterol points for women are:  \n- 60 or more: 0 points  \n- 50-59: 1 point  \n- 40-49: 2 points  \n- < 40: 3 points. Her HDL is 50, which is in the 50-59 range. So 1 point.\n\n**Step 4: Systolic Blood Pressure (140 mm Hg).**  \nFor systolic blood pressure, we need to check whether she's on BP medication (because this impacts the score). She takes lisinopril and metoprolol for hypertension. Since she's on blood pressure medication, we use the \u201con treatment\u201d points for systolic BP.\n\nFor systolic BP on treatment points for women:  \n- < 120: 0 points  \n- 120-129: 1 point  \n- 130-139: 2 points  \n- 140-159: 3 points  \n- \u2265 160: 4 points. Since her SBP is 140, this falls into the 140-159 category. So 3 points.\n\n**Step 5: Smoking Status: No.**  \nFor non-smokers, the points are 0.\n\n**Step 6: Diabetes: Not mentioned, so assume no.** Diabetes adds points (for women, 3 points if present), so since not mentioned, 0.\n\n**Now, summing all the points:**\n\nAge: 8 points (for 67 years, 65-69 range)  \nTotal Cholesterol: 3 points (within 160-199)  \nHDL: 1 point (50)  \nSBP (on meds): 3 points (140 mmHg, 140-159 range, and she is on meds)  \nSmoking: 0 points (Non-smoker)  \nDiabetes: 0  \n\nTotal points = 8 + 3 + 1 + 3 + 0 + 0  \n\nTotal points = 15 points\n\nNow we need to convert these points into the 10-year risk percentage using the Framingham Risk Score table for women. The conversion table maps total points to estimated 10-year risk of CHD.\n\nFor a woman with a total score of 15 points: Looking at the Framingham Risk Score table for women:\n\nPoints | 10-year risk (%)  \n--- | ---  \n9  | 4%  \n11 | 6%  \n13 | 9%  \n15 | 12%\n\nWait, perhaps I need to recall exact ranges. For approximations:  \n- A total score of around 15 often corresponds roughly to a 10-year risk in certain ranges based on the conversion. Let me think. For example, according to the Framingham tables, a woman with 15 points could correspond to approximately a risk in the range between 10-15% or so. Wait, maybe I need to look up exact points to risk.\n\nAlternatively, I can recall that each point adds a certain risk. However, without the exact table, perhaps I can estimate based on the standard tables that 15 points translate to a percentage like this:\n\nLooking up standard Framingham Risk Score for women:\n\nFor example, here's a sample:\n\nPoints | 10-year risk (%)  \n--- | ---  \n9  | 4%  \n11 | 6%  \n13 | 9%  \n15 | 12%\n\nAlternatively, perhaps the exact value is different. But since common ranges indicate:"}
{"Row Number": 358, "Calculator Name": "HAS-BLED Score for Major Bleeding Risk", "Calculator ID": "25", "Category": "risk", "Note ID": "15", "Patient Note": "A 70-year-old man presents to the clinic with concerns about recent headaches and breathlessness. His detailed medical history confirms he had suffered a stroke in the past. Additionally, he has been dealing with hypertension for a while now, unfortunately, recent BP measurements reflect a lack of effective control (164/113). The patient denies alcohol consumption, reporting zero drinks per week. There are no predominant signs of renal impairment in his profile, as witnessed by normal creatinine levels and glomerular filtration rate. Coagulation profiles including INR have consistently been within the normal range without noteworthy fluctuations. The patient's history does not note any significant bleeding episodes, suggesting no predisposition to bleeding. Our team is closely following up on his case, preparing for a thorough evaluation of his condition for most appropriate management.", "Question": "What is the patient's HAS-BLED score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "2", "LLM Explanation": "Step 1: Let's calculate the HAS-BLED score for the patient. The HAS-BLED score includes the following components: Hypertension (systolic BP > 160 mmHg), Abnormal liver function, Renal impairment, Bleeding history or predisposition, INR > 3.5, Elderly (age > 65 years), Drugs (concomitant use of NSAIDs or anticoagulants), and Ethanol (> 80 g/day for men).\\nStep 2: Evaluate each component based on the provided information.\\n\\n1. Hypertension: The patient's BP is 164/113 mmHg. Since the systolic BP is >160 mmHg, this criterion is met (1 point).\\n2. Abnormal liver function: No information about abnormal liver function is provided, so this is 0 points.\\n3. Renal impairment: The note mentions normal creatinine and GFR, so no renal impairment (0 points).\\n4. Bleeding history or predisposition: The patient has no significant bleeding episodes, so this is 0 points.\\n5. INR > 3.5: The note states that the INR is within the normal range, so this is 0 points.\\n6. Elderly (age > 65): The patient is 70 years old, so this criterion is met (1 point).\\n7. Drugs (NSAIDs or anticoagulants): No mention of concomitant use of NSAIDs or anticoagulants, so this is 0 points.\\n8. Ethanol (> 80 g/day): The patient denies alcohol consumption (0 drinks per week), so this is 0 points.\\n\\nNow, sum up the points: 1 (Hypertension) + 1 (Elderly) = 2 points.", "LLM Thinking": "Step 1: Let\u2019s calculate the HAS-BLED score for the patient . The HAS-BLED score is used to assess the risk of bleeding in patients , especially those with atrial fibrillation on anticoagulation. It includes 8 factors, each scored 1 point except for lab values which are 1 point each. The components are: - H (Hypertension: systolic blood pressure > 160 mmHg) - A (Abnormal liver function) - S (Renal impairment) - B (Bleeding history or predisposition) - Lab (INR > 3.5) - E (Elderly: age > 65 years) - D (Drugs: concomitant use of drugs, such as NSAIDs or anticoagulants) - E (Ethanol: alcohol > 80 g/day for men) Step 2: Let me go through each component based on the provided note. 1. **Hypertension**: The patient has hypertension that is not well-controlled, with a BP of 164/113 mm Hg. Although the systolic BP is 164, which is above 160, so this criterion is met. 2. **Abnormal liver function**: There is no mention of liver function tests (LFTs) in the note. The note mentions normal creatinine and GFR (renal function) but says nothing about liver function tests like ALT, AST, etc. Therefore, we assume this to be 0. 3. **Renal impairment**: The patient's creatinine and GFR are normal, so there is no renal impairment. 4. **Bleeding history or predisposition**: The note mentions that the patient has no significant bleeding episodes, so this is 0. However, the patient has had a past stroke, but unless it was hemorrhagic, it might not count. The note does not specify the type of stroke. However, the HAS-BLED specifically refers to bleeding history/predisposition. Since it's not mentioned, we assume 0. 5. **Lab (INR > 3.5)**: The coagulation profile, including INR, is reported to be within the normal range. So this is 0. 6. **E (Elderly: age > 65)**: The patient is 70, so yes. 7. **Drugs**: The note does not mention use of NSAIDs or anticoagulants. So we cannot count this unless otherwise specified. 8. **Ethanol**: The patient denies alcohol consumption (0 drinks per week), so this is 0. Now, sum up all the points:", "Ground Truth Answer": "3", "Ground Truth Explanation": "The current HAS-BLED score is 0.\nThe patient is 70.0 years old. Because the patient's age is greater than 65 years, we increment the score by 1, making the current score 0 + 1 = 1.\nThe patient has 0 drinks a week. Because the patient has less than 8 alcoholic drinks a week, we don't change the score, keeping the current score at 1.\nThe issue, hypertension, is reported to be present for the patient note and so we increase the score by 1, making the current score 1 + 1 = 2.\nThe issue, liver disease, is missing from the patient note and so we assume it to be absent and so we do not change the score, keeping the current score at 2.\nThe issue, renal disease, is reported to be absent for the patient and so we do not change the score, keeping the current score at 2.\nThe issue, stroke history, is reported to be present for the patient note and so we increase the score by 1, making the current score 2 + 1 = 3.\nThe issue, prior bleeding, is reported to be absent for the patient and so we do not change the score, keeping the current score at 3.\nThe issue, labile inr, is reported to be absent for the patient and so we do not change the score, keeping the current score at 3.\nThe issue, medications for bleeding, is missing from the patient note and so we assume it to be absent and so we do not change the score, keeping the current score at 3.\nHence, the patient's HAS-BLED score is 3.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: Let\u2019s calculate the HAS-BLED score for the patient . The HAS-BLED score is used to assess the risk of bleeding in patients , especially those with atrial fibrillation on anticoagulation. It includes 8 factors, each scored 1 point except for lab values which are 1 point each. The components are:\n\n- H (Hypertension: systolic blood pressure > 160 mmHg)\n- A (Abnormal liver function)\n- S (Renal impairment)\n- B (Bleeding history or predisposition)\n- Lab (INR > 3.5)\n- E (Elderly: age > 65 years)\n- D (Drugs: concomitant use of drugs, such as NSAIDs or anticoagulants)\n- E (Ethanol: alcohol > 80 g/day for men)\n\nStep 2: Let me go through each component based on the provided note.\n\n1. **Hypertension**: The patient has hypertension that is not well-controlled, with a BP of 164/113 mm Hg. Although the systolic BP is 164, which is above 160, so this criterion is met.\n\n2. **Abnormal liver function**: There is no mention of liver function tests (LFTs) in the note. The note mentions normal creatinine and GFR (renal function) but says nothing about liver function tests like ALT, AST, etc. Therefore, we assume this to be 0.\n\n3. **Renal impairment**: The patient's creatinine and GFR are normal, so there is no renal impairment.\n\n4. **Bleeding history or predisposition**: The note mentions that the patient has no significant bleeding episodes, so this is 0. However, the patient has had a past stroke, but unless it was hemorrhagic, it might not count. The note does not specify the type of stroke. However, the HAS-BLED specifically refers to bleeding history/predisposition. Since it's not mentioned, we assume 0.\n\n5. **Lab (INR > 3.5)**: The coagulation profile, including INR, is reported to be within the normal range. So this is 0.\n\n6. **E (Elderly: age > 65)**: The patient is 70, so yes.\n\n7. **Drugs**: The note does not mention use of NSAIDs or anticoagulants. So we cannot count this unless otherwise specified.\n\n8. **Ethanol**: The patient denies alcohol consumption (0 drinks per week), so this is 0.\n\nNow, sum up all the points:"}
{"Row Number": 789, "Calculator Name": "Albumin Corrected Delta Gap", "Calculator ID": "66", "Category": "lab", "Note ID": "pmc-8056694-1", "Patient Note": "A now four-year-old boy presented at the age of 3 years to our emergency department with a 2-week history of fever (39.5 \u00b0C), vomiting, and watery stools, which had already improved. He also had lower limb oedema and periorbital puffiness for one week. Apart from receiving paracetamol for the fever, there was no history of medication use. He is the offspring of parents in a consanguineous marriage with an unremarkable past medical history. He has one sister and three brothers. One of his brothers was diagnosed with steroid-resistant nephrotic syndrome due to membranous proliferative glomerulonephritis (MPGN) with C3 deposition diagnosed by kidney biopsy at 3 years of age. He reached chronic kidney disease stage 5 at the age of 4 years. Dialysis was considered, but he died in another hospital due to sepsis. No genetic testing was done on his brother.\nOn initial examination, the patient was stable but hypertensive with blood pressure reading of 136/83 mmHg, generalized oedema and a distended abdomen. No other abnormalities detected in systemic examinations. Laboratory investigations were performed and revealed the following: serum creatinine (45 \u00b5mol/L; normal 2.6\u201352.2 \u00b5mol/L), blood urea nitrogen (14.1 mmol/L; normal 1.8\u20136.4 mmol/L), potassium (5.5 mmol/L), sodium (135 mmol/L), chloride (110 mmol/L), bicarbonate (18 mmol/L), albumin (1.2 g/dL; normal 3.4-4.2 g/dL), haemoglobin (Hgb) (5.2 g/dL; normal 11.5\u201314.5 g/dL), white blood cell (WBC) count (9.13 \u00d7 109/L; normal 4\u201312 \u00d7 109/L), platelet count (23 \u00d7 109/L; normal 150\u2013400 \u00d7 109/L), haptoglobin (< 0.058 g/L; normal 0.5\u20132.2 g/L), lactate dehydrogenase (LDH) (1425 U/L; normal 150\u2013500 U/L), complement C3 (C3) (0.550 g/L; normal 0.80\u20131.60 g/L), and complement C4 (C4) (0.109/L; normal 0.16\u20130.48 g/L). The patient also had normal coagulation profile, normal level of ADAMTS13, negative coombs test and peripheral blood smears showed schistocytes. His urine dipstick showed urine protein excretion of > 400 mg/dL and 20\u201350 red blood cells/high power field. Stool cultures and analysis revealed no pathogens (Table ). Due to his uncontrolled hypertension and thrombocytopenia, the patient could not undergo a kidney biopsy.\nThe patient\u2019s clinical picture fit the diagnosis of aHUS, and eculizumab was started within 24 h of the diagnosis. Following the recommendations of the Food and Drug Administration (FDA) and the manufacturer, he was given a 600 mg intravenous (IV) infusion as induction therapy and a 300 mg IV infusion every two weeks as maintenance therapy. After two doses of eculizumab, he started to show clinical and laboratory improvement. His Hgb improved to 9 g/dL; his platelet count increased to 169 \u00d7 109/L; and his C3, haptoglobin, and LDH levels were normalized (Table ). His blood pressure was controlled on amlodipine and lisinopril, and his oedema significantly improved. A genetic panel for aHUS was performed, and the patient showed a homozygous nonsense gene mutation in DGKE p.(Phe250Serfs*3). No mutation was detected in the gene coding regions of ADAMTS13, C3, CD46, CFB, CFH, CFHR1, CFHR2, CFHR3, CFHR5, CFI, MMACHC, PIGA, PLG, THBD, CD59, CR1, CR2, INF2, or MUT.\nSix months after presentation, the patient was stable and in clinical remission on eculizumab 300 mg every other week. His laboratory parameters were within the normal ranges (Hgb 11.8 g/dL, platelet count 543 \u00d7 109/L, C3 0.9 g/L) apart from persistent moderate proteinuria, with urine dipstick 100 mg/dL and serum albumin 2.5 g/dL (Table ). Based on the genetic results and the patient\u2019s general condition, we decided to start increasing the time between eculizumab doses, targeting discontinuation. A 300 mg IV infusion of eculizumab was administered every three weeks instead of every two weeks. Following the first dose after increasing the time between doses, the patient was noticed to be oedematous; his proteinuria in urine dipstick increased to 400 \u2212 300 mg/dL with urine protein/creatinine ratio > 3 mg/mg, his albumin dropped to 1.9 g/dL, and other laboratory parameters, including Hgb and platelet count, were within the normal ranges (Hgb 12.2 g/dl and platelet count 494 \u00d7 109/L) (Table ). His oedema improved after the addition of oral furosemide at 1 mg/kg/dose twice daily. Nevertheless, after 4 months of eculizumab every 3 weeks, the patient\u2019s proteinuria and albumin levels did not improve. The decision was made to try eculizumab every two weeks and observe his proteinuria. Interestingly, his proteinuria improved to 100 mg/dL after only two doses of the two-week regimen, his oedema subsided and serum albumin improved gradually from 1.9 g/L to 2.2 g/L (Table ). Four months later, patient is stable on eculizumab 300 mg IV infusion every two weeks with no oedema and stable proteinuria and Albumin (Table ). Throughout his first year after presentation, apart from proteinuria, his creatinine was within the normal range, and he had no signs of HUS activity after the first remission.", "Question": "What is the patient's albumin corrected delta gap in mEq/L?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "14", "LLM Explanation": "To calculate the albumin-corrected delta gap, we first calculate the uncorrected anion gap (AG) using the formula: AG = [Na+] - ([Cl-] + [HCO3-]). Using the given values: Na+ = 135 mmol/L, Cl- = 110 mmol/L, and HCO3- = 18 mmol/L, we get: AG = 135 - (110 + 18) = 135 - 128 = 7 mEq/L. Next, we apply the albumin correction to the anion gap. The formula for the albumin-corrected anion gap (AGc) is: AGc = AG + 2.5 * (4 - Albumin), where the normal albumin level is 4 g/dL and the patient's albumin level is 1.2 g/dL. Substituting the values, we get: AGc = 7 + 2.5 * (4 - 1.2). Calculate 4 - 1.2, which equals 2.8. Then, multiply 2.8 by 2.5: 2.5 * 2.8 = 7.0. Add this to the uncorrected anion gap: AGc = 7 + 7.0 = 14.0 mEq/L. Therefore, the albumin-corrected anion gap is 14 mEq/L, which we interpret as the 'albumin-corrected delta gap' in this context.", "LLM Thinking": "First, we need to calculate the albumin-corrected anion gap to determine the delta gap. The anion gap (AG) is calculated as (Na+ - (Cl- + HCO3-)). The albumin-corrected AG adjusts for low albumin levels, as albumin contributes to the anion gap indirectly by causing hypoalbuminemia , which decreases the measured AG. The formula for correcting the AG for album in is AGc = AG + (2.5 \u00d7 (1 - albumin/normal albumin)), where the normal albumin is generally taken as 4 g/dL. However, note that the term 'Albumin-corrected delta gap' might refer to the difference between the measured AG and the normal AG, adjusted for the albumin level. Alternatively, sometimes the term 'delta gap' refers to the difference between the measured anion gap and serum sodium minus serum urea (N \u2013 U difference), or the difference between (Na+)-(Cl- + HCO 3-) and the normal range (e.g., 8-16 mEq/L), but the user's question specifically mentions \"albumin corrected delta gap\", which likely refers to the albumin-corrected anion gap itself or the adjustment made to the AG due to low albumin. However, without clear context on what the task considers the \u201cdelta gap\u201d in this context, I'll calculate the albumin-corrected anion gap (AGc) and see if that matches the required answer. Let's use the first set of measurements from the patient's lab results to compute this. Looking at the initial lab results: Sodium (Na+) = 135 mmol/L Chloride (Cl-) = 110 mmol/L bicarbonate (HCO3 -) = 18 mmol/L Albumin = 1. 2 g/dL First, compute the uncorrected anion gap (AG): \\[ AG = [Na+] - [Cl-] + [HCO3-] \\] Wait, actually, the correct formula for the Anion Gap is (Na+) - ([Cl-] + [HCO3-]), So, \\[ AG = Na+ - (Cl- + HCO3-) = 135 - ( 110 + 18) = 135 - 128 = 7 mEq/L \\] The normal an ion gap is generally in the range of 8-16 mEq /L. Next, we must calculate the albumin correction. The common approach for albumin correction involves adding 2.5 \u00d7 (Normal Albumin - Patient Albumin) to the measured AG. The normal albumin is typically 4 g/dL, so: Corrected AG (AGc) = AG + (2.5 \u00d7 (4 - Albumin)) Here, Albumin is 1.2 g/dL, So, AGc = 7 + (2.5 \u00d7 (4 - 1.2)) \\[ 4 - 1.2 = 2.8 \\] 2.5 \u00d7 2.8 = 7.0 The delta gap might refer to the difference between the corrected AG and the normal AG. Since it specifically asks for the 'Albumin-corrected delta gap in mEq/L', and without a specific definition of the \u201cdelta gap\u201d provided in the problem, one possible interpretation is that the \u201cdelta gap\u201d is equivalent to the albumin-corrected anion gap. Wait, but I need to confirm the exact terminology. Sometimes \"delta gap\" refers to the difference between the anion gap and the (Na - (Cl + HCO3)), but here the question is \"albumin corrected delta gap\", which might just be the corrected anion gap. Alternatively, perhaps delta gap is the difference between the measured anion gap and the normal value (e.g., 8-16), but the question says \"albumin corrected delta gap\", so likely the correction is to take into account the albumin value to adjust the gap. Alternatively, let me double-check the definition of \u201cdelta\u201d in medical contexts related to the albumin-corrected anion gap. The delta gap is sometimes the difference between the measured anion gap and the serum sodium minus serum urea (N \u2013 U): \u0394 Gap = AG \u2013 [(Na) - (Cl + HCO3)], but that would be zero. Alternatively, the delta gap might be the difference between the measured AG and the calculated AG based on albumin. Alternatively, perhaps the user is using \"delta gap\" to refer to the correction itself (i.e., the amount added due to low albumin), which is 7 (because AGc - AG = 7). But the question says \"albumin corrected delta gap\", which is ambiguous. However, the standard term for the anion gap corrected for albumin is the albumin-corrected anion gap. Since the question specifies \"in mEq/L\" and the albumin-corrected Anion Gap is the only value in the mEq/L unit, I will assume this is it. So the step by step thinking is: calculate the uncorrected anion gap, apply the albumin correction formula, and arrive at 14.", "Ground Truth Answer": "2", "Ground Truth Explanation": "To compute the formula of albumin corrected delta gap, the formula is albumin corrected anion gap (in mEq/L) - 12.\nThe formula for computing a patient's albumin corrected anion gap is: anion_gap (in mEq/L) + 2.5 * (4 - albumin (in g/dL)).\nThe formula for computing a patient's anion gap is: sodium (mEq/L) - (chloride (mEq/L)+ bicarbonate (mEq/L)).\nThe concentration of sodium is 135.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of sodium from mmol to mEq. The mass of sodium is 135.0 mmol. The compound, sodium, has a valence of 1, and so multiply the valence by the value of mmol to get, 135.0 mmol * 1 mEq/mmol = 135.0 mEq sodium. The volume units is L so no volume conversion is needed. Hence, the concentration value of 135.0 mmol sodium/L converts to 135.0 mEq sodium/L. \nThe concentration of chloride is 110.0 mEq/L. \nThe concentration of bicarbonate is 18.0 mEq/L. \nPlugging in these values into the anion gap formula gives us 135.0 mEq/L - (110.0 mEq/L + 18.0 mEq/L) = 7.0 mEq/L. Hence, The patient's anion gap is 7.0 mEq/L.\nThe concentration of albumin is 1.2 g/dL. Plugging in these values into the albumin corrected anion gap formula, we get 7.0 (mEq/L) + 2.5 * (4 - 1.2 (in g/dL)) = 14.0 mEq/L. Hence, the patient's albumin corrected anion gap is 14.0 mEq/L.\nPlugging in 14.0 mEq/L for the anion gap into the albumin corrected delta gap formula, we get 14.0 - 12 = 2.0 mEq/L. Hence, the patient's albumin corrected delta gap is 2.0 mEq/L.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "First, we need to calculate the albumin-corrected anion gap to determine the delta gap.  \nThe anion gap (AG) is calculated as (Na+ - (Cl- + HCO3-)).  \nThe albumin-corrected AG adjusts for low albumin levels, as albumin contributes to the anion gap indirectly by causing hypoalbuminemia , which decreases the measured AG.  \nThe formula for correcting the AG for album in is AGc = AG + (2.5 \u00d7 (1 - albumin/normal albumin)), where the normal albumin is generally taken as 4 g/dL.  \nHowever, note that the term 'Albumin-corrected delta gap' might refer to the difference between the measured AG and the normal AG, adjusted for the albumin level.  \nAlternatively, sometimes the term 'delta gap' refers to the difference between the measured anion gap and serum sodium minus serum urea (N \u2013 U difference), or the difference between (Na+)-(Cl- + HCO 3-) and the normal range (e.g., 8-16 mEq/L), but the user's question specifically mentions \"albumin corrected delta gap\", which likely refers to the albumin-corrected anion gap itself or the adjustment made to the AG due to low albumin.  \nHowever, without clear context on what the task considers the \u201cdelta gap\u201d in this context, I'll calculate the albumin-corrected anion gap (AGc) and see if that matches the required answer.  \nLet's use the first set of measurements from the patient's lab results to compute this.  \n\nLooking at the initial lab results:  \nSodium (Na+) = 135 mmol/L  \nChloride (Cl-) = 110 mmol/L  \nbicarbonate (HCO3 -) = 18 mmol/L  \nAlbumin = 1. 2 g/dL  \n\nFirst, compute the uncorrected anion gap (AG):  \n\\[ AG = [Na+] - [Cl-] + [HCO3-] \\]  \nWait, actually, the correct formula for the Anion Gap is (Na+) - ([Cl-] + [HCO3-]),  \nSo,  \n\n\\[ AG = Na+ - (Cl- + HCO3-) = 135 - ( 110 + 18) = 135 - 128 = 7 mEq/L \\]  \nThe normal an ion gap is generally in the range of 8-16 mEq /L.  \n\nNext, we must calculate the albumin correction. The common approach for albumin correction involves adding 2.5 \u00d7 (Normal Albumin - Patient Albumin) to the measured AG.  \nThe normal albumin is typically 4 g/dL, so:  \n\nCorrected AG (AGc) = AG + (2.5 \u00d7 (4 - Albumin))  \nHere, Albumin is 1.2 g/dL,  \nSo,  \nAGc = 7 + (2.5 \u00d7 (4 - 1.2))  \n\\[ 4 - 1.2 = 2.8 \\]  \n2.5 \u00d7 2.8 = 7.0  \n\nThe delta gap might refer to the difference between the corrected AG and the normal AG.  \nSince it specifically asks for the 'Albumin-corrected delta gap in mEq/L', and without a specific definition of the \u201cdelta gap\u201d provided in the problem, one possible interpretation is that the \u201cdelta gap\u201d is equivalent to the albumin-corrected anion gap.  \nWait, but I need to confirm the exact terminology. Sometimes \"delta gap\" refers to the difference between the anion gap and the (Na - (Cl + HCO3)), but here the question is \"albumin corrected delta gap\", which might just be the corrected anion gap.  \nAlternatively, perhaps delta gap is the difference between the measured anion gap and the normal value (e.g., 8-16), but the question says \"albumin corrected delta gap\", so likely the correction is to take into account the albumin value to adjust the gap.  \nAlternatively, let me double-check the definition of \u201cdelta\u201d in medical contexts related to the albumin-corrected anion gap. The delta gap is sometimes the difference between the measured anion gap and the serum sodium minus serum urea (N \u2013 U): \u0394 Gap = AG \u2013 [(Na) - (Cl + HCO3)], but that would be zero.  \nAlternatively, the delta gap might be the difference between the measured AG and the calculated AG based on albumin.  \nAlternatively, perhaps the user is using \"delta gap\" to refer to the correction itself (i.e., the amount added due to low albumin), which is 7 (because AGc - AG = 7).  \nBut the question says \"albumin corrected delta gap\", which is ambiguous.  \nHowever, the standard term for the anion gap corrected for albumin is the albumin-corrected anion gap.  \nSince the question specifies \"in mEq/L\" and the albumin-corrected Anion Gap is the only value in the mEq/L unit, I will assume this is it.  \nSo the step by step thinking is: calculate the uncorrected anion gap, apply the albumin correction formula, and arrive at 14."}
{"Row Number": 1017, "Calculator Name": "Estimated of Conception", "Calculator ID": "68", "Category": "date", "Note ID": "10", "Patient Note": "The patient's last menstrual period was on 08/22/2014. Her cycle length is 27 days.", "Question": "Based on the patient's last menstrual period and cycle length, what is the the patient's estimated date of conception? Your answer should be in the format of M/D/Y (ie 08/31/2023, 07/03/2000) with just the date and not other text. ", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "09/04/2014", "LLM Explanation": "To find the estimated date of conception, we need to determine the ovulation date. Given the last menstrual period (LMP) is 08/22/2014 and the cycle length is 27 days, the next menstrual period would be 27 days after 08/22/2014. Adding 27 days to August 22, 2014: \\nAugust 22 + 9 days = August 31.\\nRemaining days to add: 27 - 9 = 18 days.\\nAdding 18 days to September 1 gives us September 19. So the next menstrual period is on September 18, 2014. Ovulation typically occurs about 14 days before the next menstrual period. Therefore, 14 days before September 18, 2014 is September 4, 2014. Thus, the estimated date of conception is September 4, 2014.", "LLM Thinking": "Step 1: To find the estimated date of conception, we need to determine the approximate time in the menstrual cycle when conception is likely to have occurred . Conception typically occurs around the time of ovulation. Ovulation generally happens about 14 days before the start of the next menstrual period, but this can vary based on the woman's cycle length . Step 2: If the cycle is 27 days long, ovulation usually occurs about 14 days before the start of the next menstrual cycle. However, to calculate ovulation from LMP, the formula is LMP + cycle length - ovulation (which generally occurs approximately 14 days before the next menstrual cycle starts for a typical cycle). Step 3: Calculate the date of the next menstrual period after L MP.", "Ground Truth Answer": "09/05/2014", "Ground Truth Explanation": "The patient's estimated date of conception based on their last period is computed by adding to 2 weeks to the patient's last menstrual period date. The patient's last menstrual period was 08/22/2014. \nThe estimated date of conception after adding 2 weeks to the patient's last menstrual period date is 09-05-2014. ", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Step 1: To find the estimated date of conception, we need to determine the approximate time in the menstrual cycle when conception is likely to have occurred . Conception typically occurs around the time of ovulation. Ovulation generally happens about 14 days before the start of the next menstrual period, but this can vary based on the woman's cycle length . Step 2: If the cycle is 27 days long, ovulation usually occurs about 14 days before the start of the next menstrual cycle. However, to calculate ovulation from LMP, the formula is LMP + cycle length - ovulation (which generally occurs approximately 14 days before the next menstrual cycle starts for a typical cycle). Step 3: Calculate the date of the next menstrual period after L MP."}
{"Row Number": 261, "Calculator Name": "HEART Score for Major Cardiac Events", "Calculator ID": "18", "Category": "risk", "Note ID": "pmc-8509094-1", "Patient Note": "A 47-year-old man presented to the emergency department (ED) in April 2021 for altered mental status. His medical history consisted of type 2 diabetes mellitus and hypertension, and there was no history of malignancy. Per Emergency Medical Services, the patient lives at home with a roommate who witnessed a seizure-like episode. He arrived at the ED with glucose in the 700s. Home medications included insulin glargine 25 units twice daily, gabapentin 800 mg three times daily, aspirin 81 mg daily, atorvastatin 40 mg daily, and metoprolol succinate 200 mg daily. He was treated for hyperosmolar hyperglycemic state in the ED and was admitted for further management. The patient was found to be COVID positive on SARS-CoV-2 RNA testing. He left against medical advice two days later.\nApproximately two weeks later, the patient presented with pleuritic chest pain associated with shortness of breath. Vital signs at the time of admission: temperature 37.9\u00b0 Celsius, heart rate 92 beats/minute, blood pressure 117/79 mmHg, respiratory rate 18 breaths/minute, and oxygen saturation 94% on room air. Cardiac examination revealed normal S1 and S2 and no murmurs, rubs, or gallops. Lung auscultation was clear to auscultation bilaterally, without wheezes, rhonchi, or rales. Bilateral 2+ pitting edema was present to the level of his knees. Initial troponin was 0.481 ng/ml (reference <0.012 ng/ml) but subsequently downtrended to <0.02 ng/ml, and pro B-type natriuretic peptide (pro-BNP) was 2800 pg/ml (reference 0-300 pg/ml). Electrocardiography (ECG) showed normal sinus rhythm with low voltages in the limb leads; there were no diffuse ST-segment elevations (Figure ). Transthoracic echocardiogram (TTE) showed a left ventricular ejection fraction of 30% with severe global hypokinesis, increased wall thickness of the right ventricle, and a small circumferential pericardial effusion without evidence of tamponade physiology. Unfortunately, the patient again left against medical advice.\nThree months later, the patient presented to the hospital with shortness of breath and was found to be volume overloaded due to medication noncompliance. TTE showed a large pericardial effusion with diastolic compression of the right atrium, consistent with cardiac tamponade physiology. He underwent pericardiocentesis with the removal of 800 ml serosanguinous fluid that was negative for malignant cytology. Acid-fast bacilli culture and smear of the pericardial fluid were negative. Approximately one month later, the patient saw his cardiologist for follow-up. The patient was referred to the ED for bilateral lower extremity cellulitis. On this most recent ED visit, approximately four months after the initial presentation, the patient agreed to stay in the hospital and undergo a comprehensive diagnostic evaluation.\nIn addition to evaluation of his cellulitis, bedside ultrasonography showed that a moderate to large pericardial effusion had recurred, though without evidence of right ventricular diastolic collapse or right atrial systolic collapse. CT chest also confirmed an incidental large pericardial effusion (Figure ). Blood cultures were negative. Testing of human immunodeficiency virus (HIV) and antinuclear antibody (ANA) serology was negative. His ECG on this admission was unchanged from prior ECGs. Hemoglobin A1c was 8%, and low-density lipoprotein (LDL) was 58 mg/dl. Carcinoembryonic antigen (CEA), alpha fetoprotein (AFP), cancer antigens (CA 19-9), and prostate-specific antigen (PSA) were negative. Repeat TTE showed large pericardial effusion (2.3 cm) and evidence of tamponade physiology (exaggerated respiratory variation in mitral inflow velocity (E) on Doppler echocardiography).\nOf note, a previous left heart catheterization with coronary angiography did not show significant obstructive coronary artery disease. A prior echocardiogram seven months prior revealed an ejection fraction of 65%, without pericardial effusion. The patient underwent placement of a pericardial window, and a chest tube was inserted. Repeat blood cultures were negative. The chest tube drained approximately 165 ml. The patient\u2019s clinical presentation improved, and he was discharged home.", "Question": "What is the patient's HEART score?", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "7", "LLM Explanation": "To calculate the HEART score, we need to use the following elements: History, Electrocardiogram (ECG), Age, Risk factors, and Troponin. Let's go through each component step by step: 1. **History**: The patient presented with pleuritic chest pain associated with shortness of breath. Pleuritic chest pain is more suggestive of pericarditis rather than ischemic heart pain. This suggests a lower likelihood of ACS. The score for History is 1 (atypical chest pain). 2. **ECG**: The ECG showed normal sinus rhythm with low voltages in the limb leads and no diffuse ST-segment elevations. No ischemic changes are mentioned. So, the score for ECG is 0 (no ischemic changes). 3. **Age**: The patient is 47 years old. According to the HEART scoring system, for ages between 45 and 64 years, the score is 2. So, the score for Age is 2. 4. **Risk Factors**: The patient has hypertension and type 2 diabetes mellitus. These are significant risk factors for ACS. The presence of at least one risk factor gives a score of 1. So, the score for Risk Factors is 1. 5. **Troponin**: The initial troponin was elevated (0.481 ng/ml), which is above the normal reference range (<0.012 ng/ml). Even though it subsequently downtrended to <0.02 ng/ml, the initial presentation had an elevated troponin. So, the score for Troponin is 3 (elevated troponin). Now, let's add up all the scores: - History: 1 - ECG: 0 - Age: 2 - Risk Factors: 1 - Troponin: 3 Total HEART score = 1 + 0 + 2 + 1 + 3 = 7.", "LLM Thinking": "To calculate the HEART score, we need to use the following elements of the HEART risk score system (HEART stands for History, Electrocard iogram (ECG), Age, Risk factors, and Troponin ). The score helps assess the likelihood of acute coronary syndrome (ACS). Each component is assigned a score from 0 to 3 points, and the total score ranges from 0 to 12. A higher score indicates a higher risk of ACS. The components are: - **History**: The clinical presentation. - **ECG**: Presence of ischemic changes. - **Age**: The patient's age. - **Risk factors**: Presence of risk factors for ACS. - **Troponin**: Evidence of myocardial injury. Let's go through each component step by step: ### 1. **History** The patient presented with pleuritic chest pain associated with short ness of breath. The chest pain was pleuritic, which is more suggestive of peric arditis rather than ischemic heart pain. This suggests a lower likelihood of ACS. The HEART history component scores are: - **0**: No chest pain. - **1**: Atypical chest pain. - **2**: Typical chest pain. - **3**: Cardiac arrest. ### 2. **Electrocardiogram ( ECG)** The ECG showed normal sinus rhythm with low voltages in the limb leads; there were no diffuse ST-segment elevations. However, if there are non-specific changes like low voltage, it might not count as ischemic. The key here is whether there are signs of ischemia. ### 3. **Age** The patient is 47 years old. - For age less than 45 years: 1 point. - 45-64: 2 points. ### 4. **Risk Factors** The risk factors for ACS generally include: hypertension, diabetes, hyperlipidemia, smoking, family history of CAD, etc. The patient has hypertension and type 2 diabetes mellitus. Each significant risk factor adds to the risk score. However, in the HEART scoring system, the risk factor component is binary: the presence of any major risk factors (at least 2 major risk factors like HTN, DM, hyperlipidemia, smoking, or family history) scores 1. Wait, I need to confirm the exact criteria used in the HEART score: - 0: No risk factors - 1: At least one risk factor. ### 5. **Troponin** The initial troponin was 0.481 (elevated, as the normal reference is <0.012 ng/ml), but it subsequently downtrend ed to <0.02. Elevated troponin is a marker for myocardial injury; however, given it dropped, we must interpret this. The HEART score requires the troponin result. The system considers elevated troponin as a score of 3, normal (within normal limits) as 0. The initial value was elevated but later normalized. But the timing of the test matters. Since the presentation where HEART is applied is when the chest pain occurred (the second presentation where he had pleuritic chest pain and shortness of breath), the troponin at that time was initially elevated (0.481), and it subsequently downtrended, suggesting it was elevated at the onset. - Elevated Troponin: 3 points. - Normal: 0.", "Ground Truth Answer": "5", "Ground Truth Explanation": "The current HEART Score is 0.\nThe value of 'history' in the patient's note is determined to be 'Highly suspicious'. Based on the HEART Score criteria, 2 points are added for 'history', increasing the current total to 0 + 2 = 2.\nThe value of 'electrocardiogram' in the patient's note is determined to be 'Normal'. Based on the HEART Score criteria, 0 points are added for 'electrocardiogram', keeping the current total at 2.\nThe patient is 47.0 years old. The patient's age is between 45 and 65 years and so we increment the current total by 1, making the current total 2 + 1 = 3.\nThe following risk factor(s) are present based on the patient's note: hypertension, diabetes mellitus. The following risk factor(s) are mentioned in the patient's note, but these risk factors are noted to be absent from the patient: atherosclerotic disease. The following risk factor(s) are missing from the patient's data: atherosclerotic disease. We will assume that these are all absent from the patient. Based on the HEART Score risk factors criteria, 2 risk factors are present and so 1 point is added for the risk factors criteria, making the current total, 3 + 1 = 4.\nThe value of 'initial troponin' in the patient's note is determined to be 'between the normal limit or up to three times the normal limit'. Based on the HEART Score criteria, 1 point is added for 'initial troponin', increasing the current total to 4 + 1 = 5.\nBased on the patient's data, the HEART Score is 5.", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "To calculate the HEART score, we need to use the following elements of the HEART risk score system (HEART stands for History, Electrocard iogram (ECG), Age, Risk factors, and Troponin ).  \nThe score helps assess the likelihood of acute coronary syndrome (ACS).  \nEach component is assigned a score from 0 to 3 points, and the total score ranges from 0 to 12.  \nA higher score indicates a higher risk of ACS.  \nThe components are:\n\n- **History**: The clinical presentation.  \n- **ECG**: Presence of ischemic changes.  \n- **Age**: The patient's age.  \n- **Risk factors**: Presence of risk factors for ACS.  \n- **Troponin**: Evidence of myocardial injury.  \nLet's go through each component step by step:\n\n### 1. **History**  \nThe patient presented with pleuritic chest pain associated with short ness of breath.  \nThe chest pain was pleuritic, which is more suggestive of peric arditis rather than ischemic heart pain.  \nThis suggests a lower likelihood of ACS.  \nThe HEART history component scores are:  \n- **0**: No chest pain.  \n- **1**: Atypical chest pain.  \n- **2**: Typical chest pain.  \n- **3**: Cardiac arrest.\n\n### 2. **Electrocardiogram ( ECG)**  \nThe ECG showed normal sinus rhythm with low voltages in the limb leads; there were no diffuse ST-segment elevations.  \nHowever, if there are non-specific changes like low voltage, it might not count as ischemic.  \nThe key here is whether there are signs of ischemia.\n\n### 3. **Age**  \nThe patient is 47 years old.  \n- For age less than 45 years: 1 point.  \n- 45-64: 2 points.\n\n### 4. **Risk Factors**  \nThe risk factors for ACS generally include: hypertension, diabetes, hyperlipidemia, smoking, family history of CAD, etc.  \nThe patient has hypertension and type 2 diabetes mellitus.  \nEach significant risk factor adds to the risk score.  \nHowever, in the HEART scoring system, the risk factor component is binary: the presence of any major risk factors (at least 2 major risk factors like HTN, DM, hyperlipidemia, smoking, or family history) scores 1.  \nWait, I need to confirm the exact criteria used in the HEART score:  \n- 0: No risk factors  \n- 1: At least one risk factor.\n\n### 5. **Troponin**  \nThe initial troponin was 0.481 (elevated, as the normal reference is <0.012 ng/ml), but it subsequently downtrend ed to <0.02.  \nElevated troponin is a marker for myocardial injury; however, given it dropped, we must interpret this.  \nThe HEART score requires the troponin result.  \nThe system considers elevated troponin as a score of 3, normal (within normal limits) as 0.  \nThe initial value was elevated but later normalized.  \nBut the timing of the test matters.  \nSince the presentation where HEART is applied is when the chest pain occurred (the second presentation where he had pleuritic chest pain and shortness of breath), the troponin at that time was initially elevated (0.481), and it subsequently downtrended, suggesting it was elevated at the onset.  \n- Elevated Troponin: 3 points.  \n- Normal: 0."}
{"Row Number": 1044, "Calculator Name": "Estimated Gestational Age", "Calculator ID": "69", "Category": "date", "Note ID": "17", "Patient Note": "The patient's last menstrual period was on 10/01/2022. Today's date is 06/13/2023.", "Question": "Based on the patient's last menstrual period, what is the patient's estimated gestational age? Your answer should be a tuple, specifying the number of weeks and days (i.e. (4 weeks, 3 days), (0 weeks, 5 days), (1 week, 5 days), (8 weeks, 0 days)).", "LLM Name": "BytedTsinghua-SIA/DAPO-Qwen-32B", "LLM Answer": "(1, 2022)", "LLM Explanation": "To calculate the gestational age, I first determined the number of days between the last menstrual period (LMP), which was on October 1, 2022, and today's date, June 13, 2023. I broke this down month by month and summed up the total number of days.\\n\\nFrom October 1, 2022 to December 31, 2022:\\n- October: 31 days (since the LMP is on the 1st, the whole month is counted)\\n- November: 30 days\\n- December: 31 days\\nAdding these up gives: 31 + 30 + 31 = 92 days.\\n\\nFrom January 1, 2023 to June 13, 2023:\\n- January: 31 days\\n- February: 28 days (since 2023 is not a leap year)\\n- March: 31 days\\n- April: 30 days\\n- May: 31 days\\n- June: 13 days (from June 1 to June 13)\\nAdding these up gives: 31 + 28 + 31 + 30 + 31 + 13.\\nLet's add them step by step:\\n31 + 28 = 59\\n59 + 31 = 90\\n90 + 30 = 120\\n120 + 31 = 151\\n151 + 13 = 164.\\n\\nSo the total number of days from January 1, 2023 to June 13, 2023 is 164 days.\\n\\nNow, adding the days from October 1, 2022 to December 31, 2022 (92 days) and the days from January 1, 2023 to June 13, 2023 (164 days), we get:\\n92 + 164 = 256 days.\\n\\nTo convert 256 days into weeks and days, we divide 256 by 7.\\n256 \u00f7 7 = 36 weeks with a remainder of 4 days.\\n\\nTherefore, the gestational age is 36 weeks and 4 days.", "LLM Thinking": "Okay, so I need to figure out the estimated gestational age based on the last menstrual period (LMP) being on 10/01/2022, and today's date is 06/13/2023. Step 1. Calculate the total number of days between the LMP and today's date. First, I'll note the dates: LMP is October 1, 2022; today is June 13, 2023. Wait, let me make sure the dates are correct. The user wrote \"10/01/2022\" which is October 1st, 2022, and \"06/13/2023\" which is June 13th, 2023. Now, I'll calculate the number of days from October 1, 2022 to June 13, 2023. We will break this into calculating the number of days in each month between October 1, 2022, and June 13, 2023. Let me list the months from October 2022 through June 2023 and calculate the number of days in each month from the starting date (October 1, 2022) to the end of each month until we reach June 13, 2023. 1. Days remaining in October 2022: Since the LMP is October 1, so the days in October from the 1st to the end. October has 31 days, so from Oct 1 to Oct 31 is 30 days (since Oct 1 is day 1, so Oct 31 is (31-1) = 30 days after Oct 1? Wait no, the total days including the starting day from Oct 1 to the end of the month is 31 days. But since we are counting from Oct 1 to today, for Oct 1 to Oct 1 is considered the first day. For gestational age calculation, the LMP is counted as week 0, so perhaps each day is counted from the first day. Wait, but actually, the standard method is to count 40 weeks from the LMP. The gestational age is calculated as the number of weeks and days from the first day of the LMP. So the first day is considered week 0 until the end of the first week (6 days later), and the second week starts the 8th day, and so on. But maybe the standard approach is to compute the total days first, then convert to weeks and days. So perhaps the best approach is to calculate the total days between the two dates, then divide by 7 to get weeks, and the remainder will be the number of days within the current week. Let\u2019s compute the total number of days between October 1, 2022 and June 13, 2023: 1. Days in the remaining part of October, 2022: Since the LMP is Oct 1st, the days in October from that day to the end of the month: October has 31 days, so from Oct 1 to Oct 31 is (31 - 1) + 1 = 31 days. But since we are considering the entire month from October 1: the total days in October is 31 days. Wait, but if we count from Oct 1 (which is considered the first day), it\u2019s 31 days. Wait, perhaps I should use a date calculator or the difference directly in terms of year-month-day: - From October 1, 2022 to October 1, 2023 is exactly one year. But since the end date is June 13 in 2023, we need to calculate the period from October 1, 2022 to October 1, 2023 and then subtract the days from October 1, 2023 to June 13, 2023? No, that\u2019s more complicated. Let's simply count the number of days month by month and add them up. Step 2: Calculate total days month by month. Let's go step by step: Starting from October 1, 2022: - October 2022: 31 days (since we start on the 1st, so the entire month counts) Wait, no. Wait, the period from October 1 to October 1 would be 1 day. So, October 1 to Oct 31 is 31 - 1 + 1 = 31 days. So, if LMP is October 1, then the first day is counted as day 0, so each day adds one. But for total days between the two dates, including both start and end dates? Hmm, perhaps it's easier to use a formula. The total number of days between two dates is typically calculated by a date difference function, but since I have to compute manually here. Let me list each month's number of days from October 1, 2022 to the end of that year, and then continue into the next year until we reach June 13, 2023. - Days from October 1, 2022 to December 31, 2022: October: 31 days (since starting on the 1st, so full month) November: 30 days December: 31 days Adding these up gives the total days from October to the end of the year (2022): 31 (Oct) + 30 (Nov) + 31 (Dec) = 92 days Now, from January 1, 2023 to June 13, 2023 (because we already counted till the end of December 2022): - Number of days in each of the months from Jan to June 13: January: 31 days February: Since 2023 is not a leap year, February has 28 days (because 2023 divided by 4 is 505.75), so February has 28 days. March: 31 days April: 30 days May: 31 days June: From the 1st to the 13th is 13 days. Now, add up these days for January through June 13, 2023. - January: 31 days - February: 28 days - March: 31 - April: 30 - May: 31 - June: 13 Total from January 1 to June 13: 31 + 28 = 59 Add March: 59 + 31 = 90 Add April: 90 + 30 = 120 Add May: 120 + 31 = 151 Add June up to the 13th: 151 + 13 = 164 So the total number of days from Jan 1 to June 13, 2023 is 164 days. Therefore, the total days from October 1, 2022 to June 13, 2023 is: (days from October 1 to Dec 31, 2022) + (days from Jan 1 to June 13, 2023) That is 92 + 164 = 256 days. Now, let's convert this into weeks and days: To convert 256 days into weeks and days: We divide by 7 to get the number of weeks: 256 \u00f7 7 = 36 weeks with remainder 4 days Because 36 \u00d7 7 = 252, and 256 - 252 = 4. So the remainder is 4. Wait, let me double-check the day count to make sure. Let's list the total days again month by month starting from October 1, 2022 to June 13, 2023. - Oct: 31 days (including the 1st) - Nov: 30 - Dec: 31 - Jan: 31 - Feb: 28 - Mar: 31 - Apr: 30 - May: 31 - June: 13 Adding all these: 31 + 30 + 31 + 31 + 28 + 31 + 30 + 31 + 13 Let me compute step by step: 1. Oct = 31 Add Nov: 31 + 30 = 61 Add Dec: 61 + 31 = 92 Add Jan: 92 + 31 = 123 Add Feb: 123 + 28 = 151 Add Mar: 151 + 31 = 182 Add Apr: 182 + 30 = 212 Add May: 212 + 31 = 243 Finally, add the days from Jun 1 to 13: 243 + 13 = 256. So the total number of days is indeed 256 days. Now divide 256 by 7: 256 \u00f7 7 = 36 with remainder 4 Wait, but sometimes gestational age is calculated as the LMP is considered week 0 until the end of week 1, but I think the standard is that the total days are divided by 7, and the remainder is days.", "Ground Truth Answer": "('36 weeks', '3 days')", "Ground Truth Explanation": "To compute the estimated gestational age, we compute the number of weeks and days apart today's date is from the patient's last menstrual period date. The current date is 06/13/2023 and the patient's last menstrual period date was 10/01/2022. The gap between these two dates is 36 weeks and 3 days. Hence, the estimated gestational age is 36 weeks and 3 days. ", "Result": "Incorrect", "Thought Type": "ensembled_thought_without_answer", "Transferred Thoughts": "Okay, so I need to figure out the estimated gestational age based on the last menstrual period (LMP) being on 10/01/2022, and today's date is 06/13/2023.\n\nStep 1. Calculate the total number of days between the LMP and today's date.\n\nFirst, I'll note the dates: LMP is October 1, 2022; today is June 13, 2023.\n\nWait, let me make sure the dates are correct. The user wrote \"10/01/2022\" which is October 1st, 2022, and \"06/13/2023\" which is June 13th, 2023.\n\nNow, I'll calculate the number of days from October 1, 2022 to June 13, 2023.\n\nWe will break this into calculating the number of days in each month between October 1, 2022, and June 13, 2023.\n\nLet me list the months from October 2022 through June 2023 and calculate the number of days in each month from the starting date (October 1, 2022) to the end of each month until we reach June 13, 2023.\n\n1. Days remaining in October 2022: Since the LMP is October 1, so the days in October from the 1st to the end. October has 31 days, so from Oct 1 to Oct 31 is 30 days (since Oct 1 is day 1, so Oct 31 is (31-1) = 30 days after Oct 1? Wait no, the total days including the starting day from Oct 1 to the end of the month is 31 days. But since we are counting from Oct 1 to today, for Oct 1 to Oct 1 is considered the first day.\n\nFor gestational age calculation, the LMP is counted as week 0, so perhaps each day is counted from the first day.\n\nWait, but actually, the standard method is to count 40 weeks from the LMP. The gestational age is calculated as the number of weeks and days from the first day of the LMP. So the first day is considered week 0 until the end of the first week (6 days later), and the second week starts the 8th day, and so on. But maybe the standard approach is to compute the total days first, then convert to weeks and days.\n\nSo perhaps the best approach is to calculate the total days between the two dates, then divide by 7 to get weeks, and the remainder will be the number of days within the current week.\n\nLet\u2019s compute the total number of days between October 1, 2022 and June 13, 2023:\n\n1. Days in the remaining part of October, 2022: Since the LMP is Oct 1st, the days in October from that day to the end of the month: October has 31 days, so from Oct 1 to Oct 31 is (31 - 1) + 1 = 31 days. But since we are considering the entire month from October 1: the total days in October is 31 days. Wait, but if we count from Oct 1 (which is considered the first day), it\u2019s 31 days.\n\nWait, perhaps I should use a date calculator or the difference directly in terms of year-month-day:\n\n- From October 1, 2022 to October 1, 2023 is exactly one year. But since the end date is June 13 in 2023, we need to calculate the period from October 1, 2022 to October 1, 2023 and then subtract the days from October 1, 2023 to June 13, 2023? No, that\u2019s more complicated. Let's simply count the number of days month by month and add them up.\n\nStep 2: Calculate total days month by month. Let's go step by step:\n\nStarting from October 1, 2022:\n\n- October 2022: 31 days (since we start on the 1st, so the entire month counts)\nWait, no. Wait, the period from October 1 to October 1 would be 1 day. So, October 1 to Oct 31 is 31 - 1 + 1 = 31 days. So, if LMP is October 1, then the first day is counted as day 0, so each day adds one. But for total days between the two dates, including both start and end dates?\n\nHmm, perhaps it's easier to use a formula. The total number of days between two dates is typically calculated by a date difference function, but since I have to compute manually here.\n\nLet me list each month's number of days from October 1, 2022 to the end of that year, and then continue into the next year until we reach June 13, 2023.\n\n- Days from October 1, 2022 to December 31, 2022:\n\nOctober: 31 days (since starting on the 1st, so full month)\nNovember: 30 days\nDecember: 31 days\n\nAdding these up gives the total days from October to the end of the year (2022):\n\n31 (Oct) + 30 (Nov) + 31 (Dec) = 92 days\n\nNow, from January 1, 2023 to June 13, 2023 (because we already counted till the end of December 2022):\n\n- Number of days in each of the months from Jan to June 13:\n\nJanuary: 31 days\nFebruary: Since 2023 is not a leap year, February has 28 days (because 2023 divided by 4 is 505.75), so February has 28 days.\nMarch: 31 days\nApril: 30 days\nMay: 31 days\nJune: From the 1st to the 13th is 13 days.\n\nNow, add up these days for January through June 13, 2023.\n\n- January: 31 days\n- February: 28 days\n- March: 31\n- April: 30\n- May: 31\n- June: 13\n\nTotal from January 1 to June 13:\n31 + 28 = 59\n\nAdd March: 59 + 31 = 90\n\nAdd April: 90 + 30 = 120\n\nAdd May: 120 + 31 = 151\n\nAdd June up to the 13th: 151 + 13 = 164\n\nSo the total number of days from Jan 1 to June 13, 2023 is 164 days.\n\nTherefore, the total days from October 1, 2022 to June 13, 2023 is:\n(days from October 1 to Dec 31, 2022) + (days from Jan 1 to June 13, 2023)\n\nThat is 92 + 164 = 256 days.\n\nNow, let's convert this into weeks and days:\n\nTo convert 256 days into weeks and days:\nWe divide by 7 to get the number of weeks: 256 \u00f7 7 = 36 weeks with remainder 4 days\n\nBecause 36 \u00d7 7 = 252, and 256 - 252 = 4. So the remainder is 4.\n\nWait, let me double-check the day count to make sure.\n\nLet's list the total days again month by month starting from October 1, 2022 to June 13, 2023.\n\n- Oct: 31 days (including the 1st)\n- Nov: 30\n- Dec: 31\n- Jan: 31\n- Feb: 28\n- Mar: 31\n- Apr: 30\n- May: 31\n- June: 13\n\nAdding all these:\n31 + 30 + 31 + 31 + 28 + 31 + 30 + 31 + 13\n\nLet me compute step by step:\n\n1. Oct = 31\nAdd Nov: 31 + 30 = 61\nAdd Dec: 61 + 31 = 92\nAdd Jan: 92 + 31 = 123\nAdd Feb: 123 + 28 = 151\nAdd Mar: 151 + 31 = 182\nAdd Apr: 182 + 30 = 212\nAdd May: 212 + 31 = 243\nFinally, add the days from Jun 1 to 13:\n243 + 13 = 256.\n\nSo the total number of days is indeed 256 days.\n\nNow divide 256 by 7: 256 \u00f7 7 = 36 with remainder 4\n\nWait, but sometimes gestational age is calculated as the LMP is considered week 0 until the end of week 1, but I think the standard is that the total days are divided by 7, and the remainder is days."}
